Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Z-score	Combined Score	Genes
positive regulation of transcription from RNA polymerase II promoter	74/1175	0.00000013309055801643619306733772912620938910777113051153719425201416015625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000000004213790943066692837152177518410975172157288855256940252047570538707077503204345703125	0.000000000019876451878445589802035624697265918554844876808829212677665054798126220703125	-7.7627581192958415	122.90181896766792	BARHL1;BARHL2;ONECUT2;LDB1;THRA;MYT1L;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MECOM;ZIC1;MYB;EOMES;DDX17;LMO1;MEF2C;ZBTB38;TET1;PAX3;MITF;EBF3;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;CASZ1;TNKS;GATA3;RAI1;CUX1;ERBB4;NKX2-1;OTX2;TBL1X;NKX6-1;ATF7IP;STAT5B;TCF7L2;FZD2;JUND;POU2F1;FZD5;NFYA;USP21;ATAD2;STAT3;NFATC3;GDF2;DEK;NR2F2;ELP4;TBX19;ACVR2A;PHOX2B;POU4F3;MLLT10;NFIB;ID2;FEV;CTNNB1;SP8;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation	56/770	0.00000005067728099913026061622362754104098581109383303555659949779510498046875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000000077927649135290253700670850724831365005196119610797467203155974857509136199951171875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.747581077092922	113.3444373453051	ONECUT2;LDB1;MYT1L;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;DDX17;LMO1;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;WNT8B;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;FZD2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;FZD8;ACVR2A;PHOX2B;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter	54/731	0.00000005323353722764103770628832325469137476403602704522199928760528564453125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000013040172489604044235283677365641163614835319750628883639365085400640964508056640625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.6695923908765735	111.70618331925311	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ANK3;ZEB2;TFDP2;TAL1;CNKSR3;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter	53/739	0.000000183051618162069015253960312279712940863873882335610687732696533203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000000681400010919061163484713880629868828814506287461227884705294854938983917236328125	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.619438621496543	102.69064554801456	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;EYA1;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.493153710406819	100.38456759963843	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.483969825820547	100.24258416228344	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of snRNA transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.478395531341425	100.1564052165944	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.473649907089437	100.08303756509977	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.470318297950341	100.03153067680554	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.46383954299561	99.93136871488059	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.463339107805036	99.92363195513981	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.463050152398944	99.91916468626094	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of termination of RNA polymerase II transcription	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.459916329156847	99.87071558046088	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in heart development	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.457705420856872	99.83653479811781	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.457254893600813	99.8295696182055	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter by histone modification	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.451493652762725	99.7405004699668	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.467798346200484	99.71293807966472	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.445227676989048	99.64362808765708	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
transcriptional activation by promoter-terminator looping	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.4425665637308915	99.60248710814729	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of posterior gap gene transcription	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.460270619157981	99.59688440261854	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.434300154230221	99.47468789372297	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of telomeric RNA transcription from RNA pol II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.432632852747249	99.44891130719951	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.43110689498884	99.42531990360966	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.431041543505011	99.4243095655307	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.430801959711713	99.42060558491254	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.448520295564003	99.41573167858058	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of terminal gap gene transcription	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.447640426200399	99.40216688347179	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.426375156081778	99.352166920427	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.4238207219156855	99.31267520643694	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription involved in G2/M transition of mitotic cell cycle	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.441318257442403	99.3046990917826	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.42298717376984	99.29978849931031	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.436245074884283	99.22648670617508	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
transcriptional activation by promoter-enhancer looping	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.433478133308012	99.18382924233704	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter in response to stress	52/722	0.000000210516464770585755018929828043250385150031434022821485996246337890625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.0000000000010014686438414325357463285450305542283004622827746743496390990912914276123046875	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.446424333049396	99.10540646488185	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription via serum response element binding	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.428029589703018	99.09982997983248	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.409537610079327	99.09185739284165	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.4065221964225385	99.0452389067298	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.4021244885219994	98.97725006406347	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	52/721	0.000000201630599003428222206751462171336886086692175013013184070587158203125	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000095260955044410537449522631016835105669839089959083366920822300016880035400390625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.420032093283851	98.97653394885693	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of pri-miRNA transcription from RNA polymerase II promoter	52/725	0.00000023943864815882232827834127410204789754288867698051035404205322265625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000001162946459358216153258606313813418309255354188280762173235416412353515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.492051279966626	98.97111803773817	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.400008868325655	98.9445424418375	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.395924917125433	98.88140429762952	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	52/720	0.000000193098901961551390483374959598783515701825308497063815593719482421875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000090604863028257731537672893436684412311714342802559940537321381270885467529296875	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-6.394520492504061	98.8596918040354	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of SREBP signaling pathway	52/725	0.00000023943864815882232827834127410204789754288867698051035404205322265625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000001162946459358216153258606313813418309255354188280762173235416412353515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.483048868721478	98.83387656080818	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process	52/725	0.00000023943864815882232827834127410204789754288867698051035404205322265625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000001162946459358216153258606313813418309255354188280762173235416412353515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.481367707333387	98.80824730820282	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of central gap gene transcription	52/725	0.00000023943864815882232827834127410204789754288867698051035404205322265625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000001162946459358216153258606313813418309255354188280762173235416412353515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.463968180509759	98.54299206778659	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	52/723	0.000000219770210000585203154088091530293791464600872131995856761932373046875	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000105273458467991482811085532514129345219890121487793521737330593168735504150390625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.412980795308919	98.31537781569104	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation	52/725	0.00000023943864815882232827834127410204789754288867698051035404205322265625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000001162946459358216153258606313813418309255354188280762173235416412353515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.448647008726979	98.30942128474777	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	52/724	0.00000022940603550544510434074248726721290125851737684570252895355224609375	0.0000225886420673032973518122579204003841368830762803554534912109375	0.00000000000110652095574598564661787221351298159989495761834632503450848162174224853515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.416041728401685	98.08698515632751	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter	52/728	0.00000027207221592493738812734813299620828530578364734537899494171142578125	0.00002421442721731942854918560870114419003584771417081356048583984375	0.0000000000013493262584449273164161547112573473765524678658067614378524012863636016845703125	0.000000000117866147427494858210851368939832937987599592588594532571732997894287109375	-6.48577301925612	98.04671690087054	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
SREBP signaling pathway	52/725	0.00000023943864815882232827834127410204789754288867698051035404205322265625	0.0000225886420673032973518122579204003841368830762803554534912109375	0.000000000001162946459358216153258606313813418309255354188280762173235416412353515625	0.0000000001075611460547589337405929436184315491076279869275822420604526996612548828125	-6.422889067179921	97.91674227416605	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
negative regulation of transcription from RNA polymerase II promoter	63/991	0.000000890450275386380353352666627841927038389258086681365966796875	0.000071190744898263664543723583388867837129510007798671722412109375	0.000000000000515608131753937263693138793257088599666405903665378218647674657404422760009765625	0.00000000010698712498678202689638119302667127429040672126347999437712132930755615234375	-7.020713651295607	97.80934305535425	BARHL1;BARHL2;LDB1;THRA;MYT1L;CITED2;BRCA1;PRDM1;VLDLR;MECOM;MYB;SIX3;EOMES;DDX17;TSC22D4;MEF2C;RBFOX2;TLE1;MSX2;FST;ZBTB38;KCTD1;MITF;FOXP2;FOXP1;ZEB2;TFDP2;TAL1;DLX1;GATA3;PRICKLE1;SCRT2;CUX1;NKX2-1;TBL1X;NKX6-1;JAZF1;ATF7IP;STAT5B;TCF7L2;JUND;POU2F1;CBX5;USP9X;PTCH1;ATAD2;STAT3;NFATC3;DEK;NR2F2;TBX6;ELP4;TBX19;EFNA1;DLG1;FEV;CTNNB1;SP8;TRIM37;SP7;NEUROG1;LHX9;FGFR2
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH	52/727	0.0000002607556913546140490054131393093950208594833384267985820770263671875	0.0000236535499253791246777010870427915278924047015607357025146484375	0.0000000000012842165985534420654398112145554229266385115604265365618630312383174896240234375	0.00000000011429527727125634584362711546122286232485265600189450196921825408935546875	-6.448411973814328	97.75587438919081	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter	52/729	0.00000028384975086323301850696715180333296046910618315450847148895263671875	0.00002479480138559018843435848011846900362797896377742290496826171875	0.0000000000014176055848937848503375516857791285006175352467749917195760644972324371337890625	0.0000000001215790098898905948833759946593204535891796780333606875501573085784912109375	-6.446967331494667	97.18687712926244	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription initiation from RNA polymerase II promoter	52/726	0.0000002498832772052460760278170572024070139605100848712027072906494140625	0.0000231117533054342287612836770449575851671397686004638671875	0.000000000001222135137148718346443773011150723574458343279047767282463610172271728515625	0.0000000001108617584986635438195493058525912567768845207183403545059263706207275390625	-6.3821578900539135	97.02329967644687	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription elongation from RNA polymerase II promoter	52/733	0.0000003359291477765694349376271281293337978013369138352572917938232421875	0.00002829603196539425108402797393036820494671701453626155853271484375	0.0000000000017254754838941386175446186766754973923067295604738546899170614778995513916015625	0.0000000001427906641671693510891804055042901382133191390266802045516669750213623046875	-6.483971191146725	96.65244491365617	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus	52/730	0.00000029610578904660056999954506097572082268243320868350565433502197265625	0.0000253951092169602674259755448193942584111937321722507476806640625	0.000000000001489202356419931597466051704753721147793388279723103551077656447887420654296875	0.00000000012543870562915745526230671029271034055962985576115897856652736663818359375	-6.297409558896473	94.66611808863202	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription of Notch receptor target	52/744	0.0000005293128331224112157179302780296570318796511855907738208770751953125	0.0000438029584883932197121765572678242506299284286797046661376953125	0.000000000002940171897696856007082093810374827922739238150739993216120637953281402587890625	0.00000000023911708347303569279367030817550453247744002283070585690438747406005859375	-6.463559229462931	93.40932980279261	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium	52/756	0.0000008571483014729513282608445827459586752183895441703498363494873046875	0.000069709802380136406366357981756465278522227890789508819580078125	0.0000000000051946231201252817916016210912218630489645132541909333667717874050140380859375	0.000000000415305716231033115922030608338781816624152298800254357047379016876220703125	-6.364719382162375	88.9129332156371	ONECUT2;LDB1;CITED2;ONECUT1;SIX1;ARRB1;BRCA1;AATF;HOXC10;MYB;EOMES;LMO1;DDX17;MEF2C;ZBTB38;TET1;PAX3;MITF;ZEB2;TFDP2;TAL1;HOXB3;PHIP;HOXB7;DLX1;ZNF593;TNKS;GATA3;NKX2-1;OTX2;TBL1X;NKX6-1;STAT5B;TCF7L2;JUND;POU2F1;FZD5;ATAD2;STAT3;NFATC3;GDF2;PHOX2B;ACVR2A;POU4F3;MLLT10;NFIB;CTNNB1;SP7;OGT;NEUROG1;SSBP3;FGFR2
synapse assembly	27/285	0.000001370750931554298629973308136509313470696724834851920604705810546875	0.00010776386906902711559919083583736210130155086517333984375	0.0000000022296498527579500319329637342442851366541844981838949024677276611328125	0.0000001752876392576541761714778271119552499612836982123553752899169921875	-3.9039175754771094	52.703480051762405	NLGN2;MYT1L;SHOX2;WNT8B;NRXN2;NR2E1;VLDLR;PTN;EFNA5;ROBO1;GBX2;ERBB4;SLITRK1;KIRREL3;MEF2C;RBFOX2;FZD5;DSCAM;BDNF;PCDHGC4;STAT3;DNM3;ZEB2;DLG1;APBA1;CNTN4;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in heart development	29/378	0.0000343066232021209982267113958176452115367283113300800323486328125	0.002610070026522657259115955952211152180097997188568115234375	0.00000004487800178722930790433631969942041006760291566024534404277801513671875	0.00000347032023656328937502406339898897158491308800876140594482421875	-4.7028577459526995	48.34618711324478	BARHL1;BARHL2;THRA;CITED2;MYT1L;SHOX2;BRCA1;CACNA1C;CUX1;ERBB4;DDX17;STAT5B;TCF7L2;MEF2C;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
BMP signaling pathway	29/381	0.000039601800537639666338098065612172149485559202730655670166015625	0.0029651062402547031897348528417523993994109332561492919921875	0.0000000526478432908630761306262931149835271327219743398018181324005126953125	0.000004005481883919372577637120491633737628944800235331058502197265625	-4.456977335716416	45.17875679035398	BARHL1;BARHL2;DLX1;THRA;MYT1L;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;JUND;POU2F1;USP9X;ATAD2;STAT3;GDF2;NFATC3;DEK;NR2F2;ELP4;TBX19;PHOX2B;ACVR2A;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
negative regulation of pri-miRNA transcription from RNA polymerase II promoter	33/488	0.0001211116013343633526951059753429262855206616222858428955078125	0.005011258100826245127923375122236393508501350879669189453125	0.000000085356462771376489007710101908354971556036616675555706024169921875	0.0000063908957919457603128279322979299337248448864556849002838134765625	-4.950941939452175	44.65154581798757	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;NFATC3;KCTD1;MITF;NR2F2;TBX6;NFATC4;EFNA1;ZEB2;DLG1;NFIB;TRIM37;FGFR2
regulation of transcription elongation from RNA polymerase II promoter	25/311	0.0000555156628475345708078995954348755503815482370555400848388671875	0.004028728948489546969613517291008975007571280002593994140625	0.000000175576541196648294419906956818910881423789760447107255458831787109375	0.000012741454535762924095616301090050370703465887345373630523681640625	-4.219847717642589	41.34963524294088	BARHL1;BARHL2;THRA;LDB1;MYT1L;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of phosphorylation of RNA polymerase II C-terminal domain	25/322	0.000097002984525585694429612726441547465583425946533679962158203125	0.00430932547015556825786841699255091953091323375701904296875	0.0000003234349529168441275697406557532165294333026395179331302642822265625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.222154903743758	39.01595735238268	BARHL1;BARHL2;THRA;MYT1L;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;PHIP;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in kidney development	26/340	0.00009084544773296329592086884030521787281031720340251922607421875	0.004285179769563878839078174820542699308134615421295166015625	0.000000245133247031975915375574814891734831689973361790180206298828125	0.0000169984035858088719343761407998272261465899646282196044921875	-4.166186140374347	38.77199001990718	BARHL1;BARHL2;THRA;MYT1L;SIX1;GATA3;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
torso signaling pathway	27/371	0.00015257762472744725002447852002518402514397166669368743896484375	0.005916753972729033896060801822613939293660223484039306640625	0.0000003584272194886739381429713140192472309308868716470897197723388671875	0.0000169984035858088719343761407998272261465899646282196044921875	-4.376340415721173	38.45856656603669	BARHL1;BARHL2;THRA;MYT1L;BRCA1;PTPRG;CUX1;ERBB4;GRAP2;DDX17;STAT5B;TCF7L2;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry	25/324	0.000106994712398282644017812048620186260450282134115695953369140625	0.00463022071910733183652819633380204322747886180877685546875	0.0000003603647145602898277554136489964076162095807376317679882049560546875	0.0000169984035858088719343761407998272261465899646282196044921875	-4.176924401136732	38.18849679822259	BARHL1;BARHL2;THRA;CITED2;MYT1L;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of telomeric RNA transcription from RNA pol II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.083802956462845	38.12490015946394	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
neurogenesis	23/272	0.0000504066229613675344570743186434214067048742435872554779052734375	0.00371512563294954141490666899017014657147228717803955078125	0.00000024230715984589185642872105792833270498931597103364765644073486328125	0.0000169984035858088719343761407998272261465899646282196044921875	-3.8514149149473793	38.11124486906088	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;SALL3;ERBB4;SALL4;APBA1;CNTN4;NEUROG1
regulation of ribosomal protein gene transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.081353531918594	38.1020332221525	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of oligopeptide transport by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.080732502344436	38.096235515758906	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of termination of RNA polymerase II transcription	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.074538525603086	38.038410800078076	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of fungal-type cell wall biogenesis by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.0741788087284325	38.03505261407399	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter in response to methionine	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.072061294304336	38.01528426901289	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of mating type switching by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.070031274266567	37.99633273974305	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription involved in anterior neural plate formation	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.068949514302438	37.98623382187933	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter	33/534	0.000611119643332750273230502546795150919933803379535675048828125	0.01916351675598752801743529516897979192435741424560546875	0.0000005968474229036671778082117668928763265512316138483583927154541015625	0.0000238587228291237121919655950197380889221676625311374664306640625	-5.128708871105969	37.95356269108092	DLX1;MYT1L;CITED2;SIX1;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;BDNF;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TYRO3;TRIM37;FGFR2
carbon catabolite regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.062835106586771	37.92915193370323	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of nodal signaling pathway involved in determination of left/right asymmetry	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.061877617998679	37.92021316824025	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of pyrimidine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.059555945651604	37.898538879010616	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription involved in posterior neural plate formation	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.0569811199022014	37.87450124162445	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of transcription involved in exit from mitosis	31/481	0.00044155232181848831120307696807003594585694372653961181640625	0.01566016768434443096058572564288624562323093414306640625	0.0000005774972579725653265556094100030559701508536818437278270721435546875	0.000023282517656893938194119508811041896478855051100254058837890625	-4.900507297633433	37.857467757859276	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;CLASP2;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
regulation of thiamine biosynthetic process by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.053916640721374	37.84589237776512	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
negative regulation of leucine import by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.053052948091026	37.83782925727387	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of pri-miRNA transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.047110750810272	37.782355063128904	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.046101810373279	37.77293596190456	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of thyroid hormone receptor activity	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.040944339926376	37.72478769227456	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in spinal cord anterior-posterior patterning	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.040206887328432	37.71790310284439	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of ergosterol biosynthetic process by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.03882601725964	37.70501180175393	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
nitrogen catabolite regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.037888293773632	37.69625755610046	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter by pheromones	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.035594173510544	37.674840483113236	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in mammary gland formation	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.0343344354372	37.66308002630733	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
autonomic nervous system development	22/245	0.00002951964560672268075955555766132221151565317995846271514892578125	0.0022826912840477196937893911155015302938409149646759033203125	0.00000017148902381651563256131204880661211831238688318990170955657958984375	0.00001263927695847662872863891025954075075787841342389583587646484375	-3.607751614446093	37.63048929086071	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;PHOX2B;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in lung bud formation	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.026003754957662	37.585307821103314	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.0259627729523055	37.58492522799605	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of iron ion transport by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.023174596486729	37.55889582586517	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter involved in somitogenesis	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.0225752262196615	37.553300322890586	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of mating-type specific transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.018496778719737	37.515225419326946	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter	24/303	0.000097752347955617100382606776687310912166140042245388031005859375	0.00430932547015556825786841699255091953091323375701904296875	0.00000040093740896567426790857136507939539882272583781741559505462646484375	0.00001784171469897250685422533666990574374722200445830821990966796875	-4.062235493574765	37.506918234012225	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.015561510833267	37.48782282515039	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter	24/303	0.000097752347955617100382606776687310912166140042245388031005859375	0.00430932547015556825786841699255091953091323375701904296875	0.00000040093740896567426790857136507939539882272583781741559505462646484375	0.00001784171469897250685422533666990574374722200445830821990966796875	-4.059109963044152	37.4780599813986	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of conjugation with cellular fusion by regulation of transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.01217730392796	37.45622909945909	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter	24/302	0.000092878949247514848495781147885708151079597882926464080810546875	0.00430932547015556825786841699255091953091323375701904296875	0.00000037916229595338045051585991289389010461263751494698226451873779296875	0.0000177080054456643125521987658377298657796927727758884429931640625	-4.031860055285908	37.432649691067795	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription initiation from RNA polymerase II promoter	24/303	0.000097752347955617100382606776687310912166140042245388031005859375	0.00430932547015556825786841699255091953091323375701904296875	0.00000040093740896567426790857136507939539882272583781741559505462646484375	0.00001784171469897250685422533666990574374722200445830821990966796875	-4.054015348218081	37.431021029073584	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of snRNA transcription from RNA polymerase II promoter	24/301	0.000088223556161850404783685009046934055731981061398983001708984375	0.0042035405496509935241444821940604015253484249114990234375	0.0000003584825716243811522532789794193153198875734233297407627105712890625	0.0000169984035858088719343761407998272261465899646282196044921875	-4.009332553738264	37.42967154560132	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction	24/303	0.000097752347955617100382606776687310912166140042245388031005859375	0.00430932547015556825786841699255091953091323375701904296875	0.00000040093740896567426790857136507939539882272583781741559505462646484375	0.00001784171469897250685422533666990574374722200445830821990966796875	-4.0533792599157294	37.42514797912766	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter by histone modification	24/306	0.000113770174930803705443983775413840930923470295965671539306640625	0.0047491496915805404832600089548577670939266681671142578125	0.00000047337309946062676203825075708919722927703332970850169658660888671875	0.00001993661526924800538040916109139288892038166522979736328125	-4.113851796635252	37.359246369175374	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of transcription involved in G1/S transition of mitotic cell cycle	31/487	0.000543511605631937498063488423127864734851755201816558837890625	0.018851060615925362140554710776996216736733913421630859375	0.0000007416415551257862903209556147687830929271513014100492000579833984375	0.0000282122839961962431731649914024018244163016788661479949951171875	-4.9680316106724245	37.34697641862158	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TFDP2;TAL1;ID2;CTNNB1;PHIP
negative regulation of transcription initiation from RNA polymerase II promoter	31/484	0.0004901944847332073522394590980866269092075526714324951171875	0.0172555774961682013846075989249584381468594074249267578125	0.0000006548107842728755916111827405090561882161637186072766780853271484375	0.00002511172739361914064688645342737771670726942829787731170654296875	-4.891424932882011	37.276122770655384	DLX1;THRA;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
regulation of glucose import by regulation of transcription from RNA polymerase II promoter	24/304	0.000102852564763571436711082907056180602012318558990955352783203125	0.004492180999905244671854820381895478931255638599395751953125	0.00000042386057355845914436812756249939315722485844162292778491973876953125	0.000018512503013659738736185200735917533165775239467620849609375	-4.057884445009851	37.26036338262761	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription involved in cell fate commitment	24/306	0.000113770174930803705443983775413840930923470295965671539306640625	0.0047491496915805404832600089548577670939266681671142578125	0.00000047337309946062676203825075708919722927703332970850169658660888671875	0.00001993661526924800538040916109139288892038166522979736328125	-4.089826662248385	37.14106619181808	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter	24/303	0.000097752347955617100382606776687310912166140042245388031005859375	0.00430932547015556825786841699255091953091323375701904296875	0.00000040093740896567426790857136507939539882272583781741559505462646484375	0.00001784171469897250685422533666990574374722200445830821990966796875	-4.014988812144353	37.07068615932287	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter in response to iron	24/306	0.000113770174930803705443983775413840930923470295965671539306640625	0.0047491496915805404832600089548577670939266681671142578125	0.00000047337309946062676203825075708919722927703332970850169658660888671875	0.00001993661526924800538040916109139288892038166522979736328125	-4.080882333765993	37.05983979186516	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of DNA-templated transcription, elongation	31/488	0.00056238736347067881486683216252231432008557021617889404296875	0.0190847567877064187846780640711585874669253826141357421875	0.0000007728812433242337090574976266044160411183838732540607452392578125	0.00002916544659808328212691024006186779615745763294398784637451171875	-4.940471817537087	36.97113001354316	CASZ1;LDB1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
regulation of cAMP-mediated signaling by regulation of transcription from RNA polymerase II promoter	24/305	0.00010818870516914511049032243672485265051363967359066009521484375	0.004639328384389612876248509820698018302209675312042236328125	0.0000004479867137687216454734339017573763186419455450959503650665283203125	0.000019386727787587703145631701229234522543265484273433685302734375	-4.048428571528471	36.96876631208891	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of transcription by transcription factor localization	31/490	0.000601880778718109367940447551603710962808690965175628662109375	0.01916351675598752801743529516897979192435741424560546875	0.00000083905497504789672885065592022879599198859068565070629119873046875	0.0000309204868539135092485488354174805181173724122345447540283203125	-4.956114586778524	36.75182573231798	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;GRID2;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
regulation of transcription from RNA polymerase II promoter in response to copper ion	24/309	0.0001320852755006329880098359108586691945674829185009002685546875	0.0052356827271973598036947095124560291878879070281982421875	0.000000557703466719278406378015010280702057343660271726548671722412109375	0.0000226783383837485884412972503287875269961659796535968780517578125	-4.104577374865836	36.66234295135799	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of transcription from RNA polymerase II promoter in response to stress	24/308	0.00012570827065263288392638063584172414266504347324371337890625	0.005111775109210942198700866612171012093313038349151611328125	0.0000005281679420067478314797519874101983106129409861750900745391845703125	0.00002204750603934362498275735531283459067708463408052921295166015625	-4.070857646492001	36.562597848412835	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of androgen receptor activity	24/309	0.0001320852755006329880098359108586691945674829185009002685546875	0.0052356827271973598036947095124560291878879070281982421875	0.000000557703466719278406378015010280702057343660271726548671722412109375	0.0000226783383837485884412972503287875269961659796535968780517578125	-4.082853539550747	36.46830428968783	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of BMP signaling pathway	24/309	0.0001320852755006329880098359108586691945674829185009002685546875	0.0052356827271973598036947095124560291878879070281982421875	0.000000557703466719278406378015010280702057343660271726548671722412109375	0.0000226783383837485884412972503287875269961659796535968780517578125	-4.034818327681679	36.03925075982411	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
positive regulation of transcription from mitochondrial promoter	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.836362113426012	35.771646599656556	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of transcription from a mobile element promoter	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.833499164682682	35.75047109867515	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
nitrogen catabolite activation of transcription	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.831665827222202	35.73691100987366	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of transcription from RNA polymerase V promoter	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.829397501598616	35.72013357661352	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of antisense RNA transcription	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.826163096520067	35.69621063769445	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of transcription by pheromones	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.821993864424094	35.66537334850242	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of transcription during mitotic cell cycle	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.819333566788257	35.645696735244925	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of chromatin-mediated maintenance of transcription	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.818744538184998	35.641340046779774	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of mating-type specific transcription, DNA-templated	30/469	0.000613460044552494531376607422856750417849980294704437255859375	0.01916351675598752801743529516897979192435741424560546875	0.000001028907943428399958659476449984726542652424541302025318145751953125	0.000035169266443128710942882253487340449282783083617687225341796875	-4.8146947902109005	35.61138650939991	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
regulation of transcription involved in anterior/posterior axis specification	24/311	0.00014570860995692335696123642652111129791592247784137725830078125	0.005727562609723396182259680387005573720671236515045166015625	0.000000621388587781149127000517896901587988622850389219820499420166015625	0.00002428760535308669172714808592861146507857483811676502227783203125	-4.030088005795677	35.601401498239596	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
carbon catabolite activation of transcription	30/470	0.000634989199106968950879481550231275832629762589931488037109375	0.0197055529749182410659269493180545396171510219573974609375	0.00000107253774533678444892442933877862998315322329290211200714111328125	0.0000363968384514648347969993646966457845337572507560253143310546875	-4.811840936298811	35.42430414813533	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
neural tube development	22/259	0.000068234820518690980097574472207355711361742578446865081787109375	0.0042035405496509935241444821940604015253484249114990234375	0.00000041525355955548072168075101652517933104036274016834795475006103515625	0.00001830608448993647105972580602095689528141519986093044281005859375	-3.690162752432837	35.39809122305664	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;BRCA1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
positive regulation of DNA-templated transcription, termination	30/472	0.00068004907898756091107206334100965250399895012378692626953125	0.0209659575528387265297425301469047553837299346923828125	0.000001164979272381870245477923468679914975609790417365729808807373046875	0.0000392514801987520192878312885742531079813488759100437164306640625	-4.842133110830953	35.31535015756421	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
regulation of SREBP signaling pathway	24/318	0.0002037496035070963788272957462055501309805549681186676025390625	0.00775070064308849664136413792903113062493503093719482421875	0.0000009007608251076080206178942934303055523059811093844473361968994140625	0.0000329371225738960267761558375898545136806205846369266510009765625	-4.079382658929516	34.669117961038474	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
chromatin-mediated maintenance of transcription	33/554	0.0011363679798352933035532341676798750995658338069915771484375	0.0274884500558106592560392300583771429955959320068359375	0.000001290119343661265823732897488340665148598418454639613628387451171875	0.0000428555841130295127306380764675708405775367282330989837646484375	-4.9949923398004055	33.8656389001706	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;PBRM1;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;DEK;NR2F2;BAZ1A;TAL1;ID2;CTNNB1;PHIP
ganglion development	21/244	0.000082197183050820960231556966402166608531842939555644989013671875	0.0042035405496509935241444821940604015253484249114990234375	0.0000006281721121637856037280456429627850667429811437614262104034423828125	0.00002428760535308669172714808592861146507857483811676502227783203125	-3.571084454110747	33.59101140540908	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
stomatogastric nervous system development	21/244	0.000082197183050820960231556966402166608531842939555644989013671875	0.0042035405496509935241444821940604015253484249114990234375	0.0000006281721121637856037280456429627850667429811437614262104034423828125	0.00002428760535308669172714808592861146507857483811676502227783203125	-3.569190399571219	33.5731951906269	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
regulation of transcription from RNA polymerase II promoter	40/736	0.0020135953890626011146547380548099681618623435497283935546875	0.04147654781750344243906880592476227320730686187744140625	0.0000008346037919214905411534181391142173112029922776855528354644775390625	0.0000309204868539135092485488354174805181173724122345447540283203125	-5.4074211476956595	33.56836963039466	BARHL1;BARHL2;THRA;LDB1;MYT1L;ONECUT1;SIX1;BRCA1;CUX1;SALL3;SALL4;MYB;APBB2;SOX6;DDX17;STAT5B;TCF7L2;MEF2C;SKOR1;JUND;POU2F1;NFYA;ATAD2;STAT3;NFATC3;MITF;DEK;NR2F2;BAZ1A;ELP4;MYT1;TBX19;SCRT1;TFDP2;TAL1;FEV;SP8;SP7;HOXB7;NEUROG1
nervous system development	21/244	0.000082197183050820960231556966402166608531842939555644989013671875	0.0042035405496509935241444821940604015253484249114990234375	0.0000006281721121637856037280456429627850667429811437614262104034423828125	0.00002428760535308669172714808592861146507857483811676502227783203125	-3.5660792447813803	33.543930456798165	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
positive regulation of transcription from RNA polymerase I promoter	30/482	0.0009500738549980312051823627683688755496405065059661865234375	0.0244890621531459705406685856132753542624413967132568359375	0.000001748132160182310525299337507221242304922270704992115497589111328125	0.00004822186783380092681312867330944982313667424023151397705078125	-4.786731066512042	33.31072188343882	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
transfer RNA gene-mediated silencing	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.752368629475322	33.22755292920633	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.7489940479351995	33.20395857121758	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
positive regulation of transcription from RNA polymerase III promoter	30/485	0.00104751812693506282485322866904198235715739428997039794921875	0.0257351198164202654705690065384260378777980804443359375	0.00000196974056902903677307632192283737282423317083157598972320556640625	0.0000516181459117220353140752242548927597454166971147060394287109375	-4.836340949498893	33.18373899178576	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
negative regulation of transcription from RNA polymerase II promoter in response to copper ion	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.740141170334758	33.14206112975649	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
regulation of transport by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.739384540419627	33.13677093395878	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.736892247276773	33.119345349208125	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.736246520592511	33.114830565265216	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter in response to iron	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.733788543790125	33.09764491308464	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.732543270541831	33.08893822679933	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.726388364755212	33.04590443170803	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.724832891673765	33.03502889401864	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.723474523628795	33.025531472915475	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
carbon catabolite repression of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.7216772715169215	33.01296546755469	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.716604749141984	32.97749946757892	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.71164233720276	32.942803336402484	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter involved in heart development	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.705296092942816	32.89843174331075	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.704922306515156	32.895818307931975	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.704796595015555	32.89493935980474	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of DNA-templated transcription, termination	27/414	0.000846234864933911347384398737858646200038492679595947265625	0.0243641363140104406925789959359462955035269260406494140625	0.00000260568708049911631192507681376024919472911278717219829559326171875	0.000066437978155212603910244328897505283748614601790904998779296875	-4.648384047389661	32.885985925301995	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;SLN;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
determination of left/right asymmetry in nervous system	22/270	0.00012547247193613956226833361373707020902656950056552886962890625	0.005111775109210942198700866612171012093313038349151611328125	0.0000007978875374355069848646116424661922650329870521090924739837646484375	0.00002987012312764513103486262168839715513968258164823055267333984375	-3.659153120666371	32.871724588028954	MEF2C;RBFOX2;DSCAM;CITED2;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.699593738444482	32.858562090788574	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of telomeric RNA transcription from RNA pol II promoter	30/482	0.0009500738549980312051823627683688755496405065059661865234375	0.0244890621531459705406685856132753542624413967132568359375	0.000001748132160182310525299337507221242304922270704992115497589111328125	0.00004822186783380092681312867330944982313667424023151397705078125	-4.7202355522596395	32.84798153914536	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter by pheromones	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.6971594101406	32.84154178389095	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter by histone modification	30/482	0.0009500738549980312051823627683688755496405065059661865234375	0.0244890621531459705406685856132753542624413967132568359375	0.000001748132160182310525299337507221242304922270704992115497589111328125	0.00004822186783380092681312867330944982313667424023151397705078125	-4.715658073175064	32.81612699570123	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.6932512523092305	32.814216773707166	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of snRNA transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.692608608077509	32.80972354161828	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.6919451976570015	32.805085116744316	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	30/482	0.0009500738549980312051823627683688755496405065059661865234375	0.0244890621531459705406685856132753542624413967132568359375	0.000001748132160182310525299337507221242304922270704992115497589111328125	0.00004822186783380092681312867330944982313667424023151397705078125	-4.713342381893292	32.80001216761017	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter	30/482	0.0009500738549980312051823627683688755496405065059661865234375	0.0244890621531459705406685856132753542624413967132568359375	0.000001748132160182310525299337507221242304922270704992115497589111328125	0.00004822186783380092681312867330944982313667424023151397705078125	-4.712534456630621	32.794389839270956	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.68926610635328	32.78635347889441	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter	30/481	0.000919401370340016603315003163032770316931419074535369873046875	0.0243641363140104406925789959359462955035269260406494140625	0.000001679540271383529577106132057995324657895253039896488189697265625	0.0000477252497597355996509886633116792609143885783851146697998046875	-4.686462597546324	32.76675194026526	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter	30/484	0.0010141105689402333915605236569490443798713386058807373046875	0.025176629229953055577606590986761148087680339813232421875	0.000001893142717493877574258119740602257508044203859753906726837158203125	0.000050451718635133451797657178072853412231779657304286956787109375	-4.726659423878672	32.58437691157196	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of chromatin silencing	31/509	0.00111690242651897825125473229235240069101564586162567138671875	0.02716464179447301841019424273326876573264598846435546875	0.000001788144167488961519218407421327743378469676827080547809600830078125	0.0000490388141746827445756166941048803664671140722930431365966796875	-4.791210116440938	32.56679479379777	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;DEK;NR2F2;TAL1;ID2;CTNNB1;PHIP
positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter	30/484	0.0010141105689402333915605236569490443798713386058807373046875	0.025176629229953055577606590986761148087680339813232421875	0.000001893142717493877574258119740602257508044203859753906726837158203125	0.000050451718635133451797657178072853412231779657304286956787109375	-4.718369037813711	32.52722511787208	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter	30/483	0.000981636431481234562890225703313262783922255039215087890625	0.0248945110069730309032554060877373558469116687774658203125	0.0000018193035614135581113834892741376592084634467028081417083740234375	0.0000496049416138020412008098614098372536318493075668811798095703125	-4.692194645896306	32.499498746521425	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	30/484	0.0010141105689402333915605236569490443798713386058807373046875	0.025176629229953055577606590986761148087680339813232421875	0.000001893142717493877574258119740602257508044203859753906726837158203125	0.000050451718635133451797657178072853412231779657304286956787109375	-4.7011611805841	32.40859856674433	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	30/484	0.0010141105689402333915605236569490443798713386058807373046875	0.025176629229953055577606590986761148087680339813232421875	0.000001893142717493877574258119740602257508044203859753906726837158203125	0.000050451718635133451797657178072853412231779657304286956787109375	-4.696024772297641	32.37318948634134	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription from RNA polymerase II promoter in response to stress	30/485	0.00104751812693506282485322866904198235715739428997039794921875	0.0257351198164202654705690065384260378777980804443359375	0.00000196974056902903677307632192283737282423317083157598972320556640625	0.0000516181459117220353140752242548927597454166971147060394287109375	-4.707706799394568	32.30113743265987	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
positive regulation of DNA-templated transcription, initiation	30/493	0.00135113676861175167898121429743696353398263454437255859375	0.031395626293308533105719249078902066685259342193603515625	0.00000269369813064009383114772409884007942082462250255048274993896484375	0.00006831276388295334420740212433287297244532965123653411865234375	-4.883496839864076	32.26433082441749	CASZ1;CITED2;SIX1;GATA3;BRCA1;RAI1;MECOM;ERBB4;MYB;ZIC1;NKX2-1;OTX2;TBL1X;EOMES;ATF7IP;MEF2C;FZD2;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;TAL1;ID2;CTNNB1;PHIP
negative regulation of transcription elongation from RNA polymerase II promoter	30/487	0.00111722291883141109335164653515448662801645696163177490234375	0.02716464179447301841019424273326876573264598846435546875	0.00000213159004602160373348916123925622656543055200017988681793212890625	0.000055550885343004998578354813876245543724508024752140045166015625	-4.7406830452465	32.221992249912084	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
central nervous system development	24/333	0.0004011001666547187711163446888207317897467873990535736083984375	0.0146665851636458011153507641211035661399364471435546875	0.0000019257337683208100589612489506041725917384610511362552642822265625	0.000051031944860501464444890729055259726010262966156005859375	-4.115743880761061	32.190465020419104	ROBO2;MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;HAPLN1;ROBO1;RCAN1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling	24/338	0.000496819145059265178908380899969188249087892472743988037109375	0.0173592289425522523782507988698853296227753162384033203125	0.000002455432023194990416559667367746300215003429912030696868896484375	0.000063638861831927305383327375665203362586908042430877685546875	-4.184725144109951	31.834394689282117	BARHL1;DDX17;STAT5B;BARHL2;TCF7L2;JUND;POU2F1;THRA;MYT1L;ATAD2;STAT3;NFATC3;DEK;NR2F2;BRCA1;ELP4;TBX19;CUX1;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter	30/491	0.00126883961391862742744407466233269587974064052104949951171875	0.030075962104794802531859687633186695165932178497314453125	0.00000249271139371846182507426459284971542729181237518787384033203125	0.000064252019913497182578877853220689075897098518908023834228515625	-4.739592286362862	31.611433475406645	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter	30/492	0.00130942678703863612209301603428457383415661752223968505859375	0.03057706017060023151454828393980278633534908294677734375	0.0000025914086028372191702786979383699161871845717541873455047607421875	0.00006643301293251719133979571463299862443818710744380950927734375	-4.707780414262182	31.25102696187673	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
peripheral nervous system development	21/255	0.00015303031262941320551906887459381323424167931079864501953125	0.005916753972729033896060801822613939293660223484039306640625	0.0000012191232031883389395616849870673803479803609661757946014404296875	0.0000407844265917687602758003040381851178608485497534275054931640625	-3.537833617758822	31.079424455715724	MEF2C;RBFOX2;DSCAM;MYT1L;BDNF;PCDHGC4;STAT3;SHOX2;WNT8B;NR2E1;VLDLR;PTN;EFNA5;ROBO1;ZEB2;DLG1;GBX2;ERBB4;APBA1;CNTN4;NEUROG1
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter	30/496	0.0014832611179271966948822747411895761615596711635589599609375	0.0341294765525004262229913365445099771022796630859375	0.000003023324695963160139316507069029427157147438265383243560791015625	0.000076262152892289983806273223621019496931694447994232177734375	-4.736428182841017	30.850782550642947	DLX1;MYT1L;CITED2;VLDLR;PRDM1;SCRT2;CUX1;MYB;NKX2-1;TBL1X;NKX6-1;JAZF1;EOMES;TCF7L2;MEF2C;JUND;MSX2;USP9X;PTCH1;FST;STAT3;KCTD1;MITF;NR2F2;TBX6;EFNA1;ZEB2;DLG1;TRIM37;FGFR2
negative regulation of transcription by transcription factor localization	27/432	0.001575729436544450433321795657093389309011399745941162109375	0.035906839382512913128042697508135461248457431793212890625	0.0000054924479837370883023874544581754975069998181425034999847412109375	0.00013780785712387151587497713389751652357517741620540618896484375	-4.51247274213353	29.11915347444363	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;GRID2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
chromatin organization involved in negative regulation of transcription	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.444745154201889	28.429090442157086	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of ncRNA transcription associated with protein coding gene TSS/TES	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.44248800079712	28.41465343484625	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription from RNA polymerase V promoter	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.4392601977686414	28.394008043256292	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.4364682245178795	28.376150267994877	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription by pheromones	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.434369094594644	28.36272399666387	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of antisense RNA transcription	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.4299447310120685	28.334425269048605	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of mating-type specific transcription, DNA-templated	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.426953297727506	28.315291724953706	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
nitrogen catabolite repression of transcription	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.42503858976244	28.3030450372313	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription during mitotic cell cycle	26/412	0.0016680289977481954806493025245117678423412144184112548828125	0.0359273643030969813683128677439526654779911041259765625	0.0000070155453870052621919155451390981426129656028933823108673095703125	0.00016798135832743056974382389601174736526445485651493072509765625	-4.421586794316244	28.280966964918214	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription by transcription factor catabolism	26/413	0.00172525411640256256910752608035863886470906436443328857421875	0.0364933796729636217293091249302960932254791259765625	0.0000073066421985099269946657696284120220298063941299915313720703125	0.00017146980721577774887769141098914360554772429168224334716796875	-4.4411941396183146	28.25656888031387	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription involved in G2/M transition of mitotic cell cycle	26/413	0.00172525411640256256910752608035863886470906436443328857421875	0.0364933796729636217293091249302960932254791259765625	0.0000073066421985099269946657696284120220298063941299915313720703125	0.00017146980721577774887769141098914360554772429168224334716796875	-4.428276946968655	28.174384780188774	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
carbon catabolite repression of transcription	26/413	0.00172525411640256256910752608035863886470906436443328857421875	0.0364933796729636217293091249302960932254791259765625	0.0000073066421985099269946657696284120220298063941299915313720703125	0.00017146980721577774887769141098914360554772429168224334716796875	-4.421774091054083	28.133011133756675	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription by competitive promoter binding	26/416	0.00190715823634364056542167542573906757752411067485809326171875	0.03963024405653282900008349542986252345144748687744140625	0.00000824735469572910785012766210488877050011069513857364654541015625	0.0001925879806918524644009094171082097091129980981349945068359375	-4.432557653145929	27.75730092253496	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription from RNA polymerase I promoter	26/419	0.0021052594855640927896944791797295692958869040012359619140625	0.042914069296558964017318515971055603586137294769287109375	0.00000929734623638664716099681839533985794332693330943584442138671875	0.000216037350724314369289358328529715436161495745182037353515625	-4.441252922974708	27.37284763576977	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of transcription from RNA polymerase III promoter	26/423	0.0023965732005008255102451730778057026327587664127349853515625	0.047698885176212631187286916656375979073345661163330078125	0.00001088692464368898129320299694722251615530694834887981414794921875	0.000250505480703809373620172262775440685800276696681976318359375	-4.4921416411802175	27.104304177259856	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of DNA-templated transcription, elongation	26/422	0.00232070074022759469112298091886259499005973339080810546875	0.046780963212194721922987383777581271715462207794189453125	0.000010467874203333605505100885324498705131190945394337177276611328125	0.0002420439343976696984668539602836290214327163994312286376953125	-4.453568114315877	27.01483690091822	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
negative regulation of DNA-templated transcription, initiation	26/424	0.00247455062318842865243251338824848062358796596527099609375	0.04904392978815048931284792388396454043686389923095703125	0.000011321201225480069282977764466568970647131209261715412139892578125	0.0002592335251484926606814485072760589901008643209934234619140625	-4.475410281020653	26.860054066764036	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
dephosphorylation of RNA polymerase II C-terminal domain	25/387	0.001477970482877808376664940936962011619471013545989990234375	0.0341294765525004262229913365445099771022796630859375	0.0000072497432386112585262112617545682269337703473865985870361328125	0.00017146980721577774887769141098914360554772429168224334716796875	-4.024272954446986	26.22653062829176	BARHL1;BARHL2;THRA;MYT1L;PTPN21;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
negative regulation of transcription involved in G1/S transition of mitotic cell cycle	26/430	0.0029892651854455942750377062111510895192623138427734375	0.056856305966721247535655692217915202490985393524169921875	0.000014275238337501640624557959491358616332945530302822589874267578125	0.000323732207874977075297284745403203487512655556201934814453125	-4.423468763597765	25.71241932005948	THRA;LDB1;CITED2;GATA3;BRCA1;PRICKLE1;MECOM;MYB;SIX3;NKX2-1;ATF7IP;TSC22D4;TCF7L2;RBFOX2;TLE1;POU2F1;CBX5;MSX2;ZBTB38;KCTD1;NR2F2;FOXP2;FOXP1;TFDP2;CTNNB1;LHX9
ventricular system development	11/87	0.00015635497450588594042612811119141724702785722911357879638671875	0.0059961497133679993176702538448807899840176105499267578125	0.00001269106833590845251238769797463845634410972706973552703857421875	0.0002891969533356530150207397422690291932667605578899383544921875	-2.702737650629154	23.685121554156655	EOMES;ROBO2;DLX2;PTCH1;ZIC1;SIX3;NKX2-1;HESX1;RAPGEF2;TBR1;CNTN4
negative regulation of transcription, DNA-templated	42/895	0.018546857099815357294847473212939803488552570343017578125	0.19515053352674682773937320234836079180240631103515625	0.000014847343404044733111116390056327674074054812081158161163330078125	0.000335095305439612502207413768928745412267744541168212890625	-5.201312004962404	20.73999721155582	LDB1;THRA;CITED2;ONECUT1;SIX1;GATA3;BRCA1;PRICKLE1;MECOM;SALL3;SALL4;MYB;SIX3;NKX2-1;APBB2;SOX6;ATF7IP;TSC22D4;TCF7L2;MEF2C;SKOR1;RBFOX2;TLE1;POU2F1;CBX5;MSX2;NFYA;ZBTB38;STAT3;KCTD1;MITF;NR2F2;BAZ1A;MYT1;FOXP2;SCRT1;FOXP1;TFDP2;ID2;CTNNB1;HOXB7;LHX9
brain segmentation	10/85	0.0005546758581978874537432577795925681130029261112213134765625	0.01895946393564808263310084157637902535498142242431640625	0.0000550955091084881891654208285746818773986888118088245391845703125	0.0012258750776638622885517104776909036445431411266326904296875	-2.6795116879362024	20.088638495648027	EOMES;ROBO2;DLX2;PTCH1;ZIC1;SIX3;NKX2-1;HESX1;TBR1;CNTN4
trigeminal sensory nucleus development	10/85	0.0005546758581978874537432577795925681130029261112213134765625	0.01895946393564808263310084157637902535498142242431640625	0.0000550955091084881891654208285746818773986888118088245391845703125	0.0012258750776638622885517104776909036445431411266326904296875	-2.677249867887301	20.071681344272587	EOMES;ROBO2;DLX2;PTCH1;ZIC1;SIX3;NKX2-1;HESX1;TBR1;CNTN4
negative regulation of photoreceptor cell differentiation	5/19	0.000331455835673284617166889365336146511253900825977325439453125	0.0122146654443037773474234342074851156212389469146728515625	0.00016958851071534919202794811088352844308246858417987823486328125	0.0035553289113080094839547395935142048983834683895111083984375	-2.4288944450178884	19.460341114346104	DLX1;DLX2;ID2;SIX3;CNTN4
negative regulation of neuron apoptotic process by transcription from RNA polymerase II promoter	20/317	0.00545179662149144865501693146825346047990024089813232421875	0.09184330236991129770007802335385349579155445098876953125	0.000082496143769993256406915238532207013122388161718845367431640625	0.001801547732236380601478220597755353082902729511260986328125	-3.652950368705324	19.038483514314766	MEF2C;NFYA;THRA;LMO4;MAX;BDNF;NFATC3;PAX3;SIX1;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;TYRO3;IRF9
axon guidance	14/182	0.00344661199674203659604199145860548014752566814422607421875	0.0647715887993314254345023073256015777587890625	0.00014674840336661003630143451648137897791457362473011016845703125	0.0031321819849787313309874559053014309029094874858856201171875	-3.126837372151779	17.730304694271364	ROBO2;ROBO3;BDNF;SEMA3A;ANK3;VLDLR;GP5;ROBO1;ENAH;SLITRK1;PARD3;OTX2;CNTN4;FGFR2
cochlea morphogenesis	5/18	0.000251138985917927735902477337504024035297334194183349609375	0.00940176663948305742224409442542309989221394062042236328125	0.00013676717718224740334177769174317518263706006109714508056640625	0.002932412612584822837746845181072785635478794574737548828125	-2.10582319375291	17.456229879146534	ZIC1;SIX1;NEUROG1;FGFR2;POU3F4
postsynapse assembly	8/54	0.0004137184878277334887375360494843334890902042388916015625	0.01478416747790468888101855782224447466433048248291015625	0.000072221480712695871402757863410926120195654220879077911376953125	0.00158450569545016939874970685053767738281749188899993896484375	-2.2220472924930603	17.31047012175635	KIRREL3;DNM3;NLGN2;DSCAM;FZD5;BDNF;SLITRK1;NRXN2
excitatory synapse assembly	8/54	0.0004137184878277334887375360494843334890902042388916015625	0.01478416747790468888101855782224447466433048248291015625	0.000072221480712695871402757863410926120195654220879077911376953125	0.00158450569545016939874970685053767738281749188899993896484375	-2.2210917148519607	17.303025861563885	KIRREL3;DNM3;NLGN2;DSCAM;FZD5;BDNF;SLITRK1;NRXN2
brain morphogenesis	10/94	0.00122434182429893173051083099522884367615915834903717041015625	0.0291677797233235412688312493401099345646798610687255859375	0.000119040028439123681089535644606058895078604109585285186767578125	0.00257574226673094701378641246947154286317527294158935546875	-2.55372360409606	17.12361533311068	EOMES;ROBO2;DLX2;PTCH1;ZIC1;SIX3;NKX2-1;HESX1;TBR1;CNTN4
inhibitory synapse assembly	8/54	0.0004137184878277334887375360494843334890902042388916015625	0.01478416747790468888101855782224447466433048248291015625	0.000072221480712695871402757863410926120195654220879077911376953125	0.00158450569545016939874970685053767738281749188899993896484375	-2.1630155625926135	16.850593772531226	KIRREL3;DNM3;NLGN2;DSCAM;FZD5;BDNF;SLITRK1;NRXN2
vestibular receptor cell morphogenesis	5/18	0.000251138985917927735902477337504024035297334194183349609375	0.00940176663948305742224409442542309989221394062042236328125	0.00013676717718224740334177769174317518263706006109714508056640625	0.002932412612584822837746845181072785635478794574737548828125	-1.999114292069726	16.571666007184792	MEF2C;ZIC1;SIX1;NEUROG1;FGFR2
positive regulation of DNA repair by transcription from RNA polymerase II promoter	18/282	0.007234691403709087552387213548854560940526425838470458984375	0.1137534645043192238489382361876778304576873779296875	0.0001629478147917257720329875514408968228963203728199005126953125	0.0034467481720743069727175278416098080924712121486663818359375	-3.358601933071161	16.5541041587382	NFYA;EYA1;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;BRCA1;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
presynapse assembly	8/57	0.000601541239586772112819812452499945720774121582508087158203125	0.01916351675598752801743529516897979192435741424560546875	0.0001016811385680341131391990483479048634762875735759735107421875	0.002210276177997312803402696346211087075062096118927001953125	-2.213507784476133	16.415407958602888	KIRREL3;DNM3;NLGN2;DSCAM;FZD5;BDNF;SLITRK1;NRXN2
dopaminergic neuron differentiation	9/78	0.00119344385146154187589406792113777555641718208789825439453125	0.0286007979815543871005001363982955808751285076141357421875	0.0001484676423974052900285613976194554197718389332294464111328125	0.00315460301436288649556960450581755139864981174468994140625	-2.357336290444055	15.867023499186667	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8;OTX2;PHOX2B
positive regulation of transcription, DNA-templated	44/1004	0.043658960346442350630713491455026087351143360137939453125	0.32950290552666972043738269348978064954280853271484375	0.00004483299553311931372016896357735049605253152549266815185546875	0.00100703447585582758251609991617669948027469217777252197265625	-4.991330349265647	15.62958602062778	CASZ1;LDB1;CITED2;ONECUT1;PRKAG1;SIX1;GATA3;BRCA1;RAI1;MECOM;SALL3;ERBB4;SALL4;ZIC1;MYB;NKX2-1;APBB2;OTX2;TBL1X;SOX6;EOMES;ATF7IP;MEF2C;SKOR1;FZD2;TLE1;NFYA;USP21;ATAD2;STAT3;GDF2;PAX3;MITF;EBF3;NR2F2;BAZ1A;ANK3;MYT1;SCRT1;TAL1;ID2;CTNNB1;PHIP;HOXB7
transcription elongation from RNA polymerase II promoter	17/270	0.010099596807665367492745644995011389255523681640625	0.148874369192992295207744746221578679978847503662109375	0.0002869973333610856334845162773916626974823884665966033935546875	0.00593757202396596843463338899482550914399325847625732421875	-3.325083953899061	15.27962454505862	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;ELP4;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
neuron development	9/86	0.0023753420867167634490668692848203136236406862735748291015625	0.047476646707809211367390389568754471838474273681640625	0.0002906121107810310925413654903337601353996433317661285400390625	0.005986101862681762579565525328462172183208167552947998046875	-2.4887214803299984	15.038382799613974	ALK;SKOR1;MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
cardiac neuron differentiation	8/66	0.0016056733815588606316404618468141052289865911006927490234375	0.0359273643030969813683128677439526654779911041259765625	0.0002547646142225877649752086018253294241731055080890655517578125	0.00531736586410595790663791149199823848903179168701171875	-2.2543086339665455	14.504699795153796	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8;PHOX2B
auditory receptor cell morphogenesis	5/19	0.000331455835673284617166889365336146511253900825977325439453125	0.0122146654443037773474234342074851156212389469146728515625	0.00016958851071534919202794811088352844308246858417987823486328125	0.0035553289113080094839547395935142048983834683895111083984375	-1.7959715231506928	14.389352548380018	MEF2C;ZIC1;SIX1;NEUROG1;FGFR2
noradrenergic neuron differentiation	8/67	0.00177079706603833057255992233791630496853031218051910400390625	0.03728950785938751899539767009628121741116046905517578125	0.0002796858425088341311252893017780252193915657699108123779296875	0.005811797881560223748287352663055571611039340496063232421875	-2.252553645783212	14.272913137349382	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8;PHOX2B
neuron fate commitment	8/68	0.00194904291836582306378378159905651045846752822399139404296875	0.0403229624821560828085154071231954731047153472900390625	0.0003065647586462986692347476580522425138042308390140533447265625	0.006287243332759089899097748599388069123961031436920166015625	-2.2468527783381327	14.021297910421676	MEF2C;FZD2;FZD5;LDB1;MYT1L;ID2;WNT8B;FZD8
hair cell differentiation	8/72	0.0028077557279988355799782429045308163040317595005035400390625	0.05427944167610863901440865220138221047818660736083984375	0.0004360101614881758806153977392483511721366085112094879150390625	0.008789145007434724654604707438920740969479084014892578125	-2.3631162410052906	13.884181768066838	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8;CTNNB1
canonical Wnt signaling pathway involved in metanephric kidney development	7/52	0.00168443174483303283010815487585887240129522979259490966796875	0.0361157479108064338735317733153351582586765289306640625	0.0003483345094614174997614541862134274197160266339778900146484375	0.007112960524370157307239015409550120239146053791046142578125	-2.1291744433587874	13.597604268291168	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X;GATA3
canonical Wnt signaling pathway involved in neural crest cell differentiation	7/53	0.0018855254803114003363251338640793619561009109020233154296875	0.03935408712667644304250558207058929838240146636962890625	0.0003868350499944436218964505247441820756648667156696319580078125	0.00783133446705489531802779623603782965801656246185302734375	-2.165666948467341	13.586417128822246	TCF7L2;MEF2C;FZD2;FZD5;FZD8;CTNNB1;TBL1X
neuron differentiation	8/70	0.0023477697032097334835232249616865374264307320117950439453125	0.0471252327235757995094189709561760537326335906982421875	0.0003666578983794762758123553236799807564239017665386199951171875	0.007454850459724093707236658445935972849838435649871826171875	-2.21312146211034	13.398877950462925	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8;SIX1
negative regulation of cellular amino acid biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0944443096343757	13.192921362065677	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of fungal-type cell wall biogenesis by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0930626717296827	13.187030856888153	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
snoRNA transcription from an RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.090887932883558	13.177759027858745	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of arginine biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0891787201573693	13.17047193304258	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of cellular hyperosmotic salinity response by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.083825554832611	13.147649131240076	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of pyrimidine-containing compound salvage by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0836302818438837	13.146816600120871	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of phosphatidylcholine biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.081574321550817	13.138051174165229	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of mating type switching by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0797594313353334	13.130313531636292	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of phosphatidylserine biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0789278266007223	13.126768049872767	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0748081265336373	13.109204030752718	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of transport by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.074496240936208	13.107874330894157	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of conjugation with cellular fusion by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.073134144535159	13.102067139389485	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of flocculation via cell wall protein-carbohydrate interaction by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.065950229355521	13.071439078725529	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of ethanol catabolic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.063302887634762	13.060152344292549	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of peroxisome organization by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0624748083268445	13.056621892910083	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of pyrimidine nucleotide biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0620732936496675	13.054910066478042	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
telomeric repeat-containing RNA transcription from RNA pol II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.060633013234553	13.048769543542546	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of pseudohyphal growth by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0556383173598545	13.027475048211938	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of purine nucleotide biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0511143042042854	13.008187271852044	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of pseudohyphal growth by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0503387953407413	13.004880950448726	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of mating type switching by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0475388612402323	12.992943650335755	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of sulfate assimilation by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.045314577413111	12.983460590153749	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of carbohydrate metabolic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0437335549715727	12.976720024593098	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of phospholipid biosynthetic process by transcription from RNA polymerase II promoter	16/259	0.01455185966643672036691103954808568232692778110504150390625	0.170331297404752779467429490978247486054897308349609375	0.000524433088491100120147325736041921118157915771007537841796875	0.0092649845633427686808492040881901630200445652008056640625	-3.065554367340492	12.967406809582773	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of cellular response to alkaline pH by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.040792062610243	12.964179201903441	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of invasive growth in response to glucose limitation by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.039775487660652	12.959845114091022	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of phenotypic switching by transcription from RNA polymerase II promoter	16/259	0.01455185966643672036691103954808568232692778110504150390625	0.170331297404752779467429490978247486054897308349609375	0.000524433088491100120147325736041921118157915771007537841796875	0.0092649845633427686808492040881901630200445652008056640625	-3.0626163939479243	12.954979074950813	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of arginine catabolic process by transcription from RNA polymerase II promoter	16/259	0.01455185966643672036691103954808568232692778110504150390625	0.170331297404752779467429490978247486054897308349609375	0.000524433088491100120147325736041921118157915771007537841796875	0.0092649845633427686808492040881901630200445652008056640625	-3.059689562757513	12.942598472240459	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of meiotic nuclear division by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0356766857415067	12.942370192590703	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of thiamine biosynthetic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0337964255248564	12.934353850173018	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
positive regulation of cellular alcohol catabolic process by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0298980749983677	12.917733537512161	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by transcription from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0298372984312305	12.917474421370242	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
promoter clearance from RNA polymerase II promoter	16/258	0.0140740611462714416968200481505846255458891391754150390625	0.170331297404752779467429490978247486054897308349609375	0.00050400454814493434417543848979903486906550824642181396484375	0.0090052630818168756532404728432084084488451480865478515625	-3.0260996371041884	12.901539194547068	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of cellular response to oxidative stress by transcription from RNA polymerase II promoter	16/260	0.0150421775724973692811570202820803388021886348724365234375	0.170331297404752779467429490978247486054897308349609375	0.00054556828537708347386103735487949961679987609386444091796875	0.0094961092329287934143966509736856096424162387847900390625	-3.062263916187569	12.85200681121431	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
pri-miRNA transcription from RNA polymerase II promoter	16/260	0.0150421775724973692811570202820803388021886348724365234375	0.170331297404752779467429490978247486054897308349609375	0.00054556828537708347386103735487949961679987609386444091796875	0.0094961092329287934143966509736856096424162387847900390625	-3.061917255939352	12.850551913794229	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
snRNA transcription from RNA polymerase II promoter	17/286	0.0169889604452284313784726776930256164632737636566162109375	0.1850737330719226803044108464746386744081974029541015625	0.000535722496276135507105309319086927644093520939350128173828125	0.0093940632525447258227568880784019711427390575408935546875	-3.085821327937334	12.575312943155977	POU2F1;NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of ceramide biosynthetic process by transcription from RNA polymerase II promoter	16/261	0.01554522308305243162573905379986172192730009555816650390625	0.1705274820529263102297790055672521702945232391357421875	0.00056742997670864467156526256275128616834990680217742919921875	0.00976849343114845510005483930626724031753838062286376953125	-3.005855727823595	12.516388916043176	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of cAMP-mediated signaling by transcription from RNA polymerase II promoter	16/262	0.0160612046409094148813334612668768386356532573699951171875	0.1757788916268438750289959671135875396430492401123046875	0.00059003840599656360264846366447955006151460111141204833984375	0.01012076785849378400550246936973053379915654659271240234375	-2.98913100339798	12.34914207999847	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration	9/94	0.00434011977847512629702375619444865151308476924896240234375	0.07843810342937614088487663366322522051632404327392578125	0.000530529881239965293328320061760905446135438978672027587890625	0.00933772182764520952691356114883092232048511505126953125	-2.265816906249684	12.325711648350822	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X;GATA3;AAMP;FOXP1
canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion	7/59	0.0035105356349506475731325760847312267287634313106536865234375	0.065193687362449626032656624374794773757457733154296875	0.0006951941628111726369232403754949700669385492801666259765625	0.01158738821901166525518700467500821105204522609710693359375	-2.174075510095805	12.287845760451146	TCF7L2;FZD2;FZD5;CITED2;FZD8;CTNNB1;TBL1X
pyramidal neuron migration	6/40	0.0020389620150895342888530681335623739869333803653717041015625	0.041816451413814494098009078015820705331861972808837890625	0.000552348530634358208211975860280062988749705255031585693359375	0.00957877948162598469306061588213196955621242523193359375	-1.9820666407805703	12.279526034586016	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B;FGFR2
cellular response to BMP stimulus	6/43	0.0029747011543150877858898706307400061632506549358367919921875	0.05680836172026020036707194549308042041957378387451171875	0.00077922420180283444475499710080157456104643642902374267578125	0.012718341037730000742111968747849459759891033172607421875	-2.0977479667382126	12.203883109412068	STAT5B;DLX1;GDF2;CTNNB1;PHOX2B;ACVR2A
positive regulation of fatty acid beta-oxidation by transcription from RNA polymerase II promoter	16/265	0.0176888517432925405914456717937355278991162776947021484375	0.1913722790667681528109511646107421256601810455322265625	0.000662552726021446258646008242720881753484718501567840576171875	0.01116164717372557756147610774632994434796273708343505859375	-3.0228389998907113	12.196613317683957	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of cell migration	10/126	0.01008702610717038435084180747480786521919071674346923828125	0.148874369192992295207744746221578679978847503662109375	0.001029743126659428235913917859534194576554000377655029296875	0.0160306875526485918814767472895255195908248424530029296875	-2.6050404836455177	11.974082193665728	LDB1;LMO4;CITED2;ERBB4;MAGI2;NKX2-1;PLXNA2;GATA3;LDB2;ROBO1
beta-catenin destruction complex disassembly	7/58	0.00318433957042657360403392630132657359354197978973388671875	0.060323412665470470261919189169930177740752696990966796875	0.0006334961811977784552907255744003123254515230655670166015625	0.01071039959394236816547785196007680497132241725921630859375	-2.078892701275036	11.952615139281919	TCF7L2;FZD2;FZD5;WNT8B;FZD8;CTNNB1;TBL1X
transcription from RNA polymerase II promoter	18/314	0.0199256074567331527280789060796450939960777759552001953125	0.2065694293921105095801493689577910117805004119873046875	0.000555234562889753732566056054764658256317488849163055419921875	0.00959355836319036002490800996156394830904901027679443359375	-3.031802539578703	11.871779483425298	NFYA;THRA;LDB1;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;BAZ1A;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
neuron migration	6/43	0.0029747011543150877858898706307400061632506549358367919921875	0.05680836172026020036707194549308042041957378387451171875	0.00077922420180283444475499710080157456104643642902374267578125	0.012718341037730000742111968747849459759891033172607421875	-2.028566297210286	11.801411019523417	MEF2C;USP9X;SEMA3A;RAPGEF2;SIX1;PHOX2B
regulation of fatty acid biosynthetic process by transcription from RNA polymerase II promoter	16/266	0.018258663597258861788219519439735449850559234619140625	0.193107883830201887409572236720123328268527984619140625	0.00068835879581061773339889509060185446287505328655242919921875	0.0115551190029846394258239428154411143623292446136474609375	-2.945880511224068	11.79270021236028	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
negative regulation of cell-cell adhesion by transcription from RNA polymerase II promoter	16/268	0.0194404316600774902668025134744311799295246601104736328125	0.2019835157281619497648961214508744888007640838623046875	0.000742556235996908657430448652547738674911670386791229248046875	0.0123332315675965427381743921841916744597256183624267578125	-2.9926467664239627	11.792226142771069	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
mRNA transcription from RNA polymerase II promoter	16/271	0.0213215593088464418214389439754086197353899478912353515625	0.21173430581016561280449650439550168812274932861328125	0.00083066356558018678186983141387145224143750965595245361328125	0.01351117254773014086932647614958113990724086761474609375	-2.9565505319664527	11.37691449132362	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
neuron differentiation involved in amphid sensory organ development	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.1296714043885254	11.251831794066995	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
neuron differentiation involved in salivary gland development	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.1295682010498327	11.2512865331384	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
brain development	12/174	0.01474245952139446695638991258192618261091411113739013671875	0.170331297404752779467429490978247486054897308349609375	0.0010671298360745607065880324881845808704383671283721923828125	0.016558063936722704212467505158201674930751323699951171875	-2.667953923215145	11.250824513312413	EOMES;ROBO2;RCAN1;DLX2;PTCH1;ZIC1;SIX3;NKX2-1;HESX1;TBR1;CNTN4;HAPLN1
regulation of endothelial cell chemotaxis to vascular endothelial growth factor	6/47	0.00467955761411768811353084629445220343768596649169921875	0.08329612553129484009417637935257516801357269287109375	0.001186397146658794109208567846280857338570058345794677734375	0.01805237206706300501224404797540046274662017822265625	-2.093598769187559	11.231218837239116	PDGFRA;LDB1;LMO4;ERBB4;PLXNA2;LDB2
medial motor column neuron differentiation	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.125737322821586	11.23104660440622	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
retinal bipolar neuron differentiation	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.123439639794933	11.2189071058532	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
regulation of fibroblast chemotaxis	6/47	0.00467955761411768811353084629445220343768596649169921875	0.08329612553129484009417637935257516801357269287109375	0.001186397146658794109208567846280857338570058345794677734375	0.01805237206706300501224404797540046274662017822265625	-2.0903308241971765	11.213687777384086	PDGFRA;LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of muscle cell chemotaxis toward tendon cell	6/47	0.00467955761411768811353084629445220343768596649169921875	0.08329612553129484009417637935257516801357269287109375	0.001186397146658794109208567846280857338570058345794677734375	0.01805237206706300501224404797540046274662017822265625	-2.0897096942914617	11.210355693892202	PDGFRA;LDB1;LMO4;ERBB4;PLXNA2;LDB2
mechanoreceptor differentiation	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.119018004656457	11.195545992617447	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
collateral sprouting	7/59	0.0035105356349506475731325760847312267287634313106536865234375	0.065193687362449626032656624374794773757457733154296875	0.0006951941628111726369232403754949700669385492801666259765625	0.01158738821901166525518700467500821105204522609710693359375	-1.9797978883818024	11.189791236013889	BDNF;SLITRK1;PARD3;CNTN4;ANK3;GP5;FGFR2
glutamatergic neuron differentiation	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.1166518272683783	11.183044613338595	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
photoreceptor cell differentiation	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.1154248145798253	11.176561857194931	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
Rohon-Beard neuron differentiation	7/63	0.00507532252637606963452387986990288482047617435455322265625	0.08702118223553055587071725085479556582868099212646484375	0.0009911332524628062475013923204869570326991379261016845703125	0.015532144690588230162564542524705757386982440948486328125	-2.11027638290518	11.149360812429533	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
GABAergic neuron differentiation	7/64	0.0055374813587726057217963671064353547990322113037109375	0.09295480273783053581926338893026695586740970611572265625	0.001078684641871700648774190511858250829391181468963623046875	0.016682476903963315562062774688456556759774684906005859375	-2.1119470180139226	10.97413185125606	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
commissural neuron axon guidance	10/130	0.01239632193627046401196434288749514962546527385711669921875	0.170331297404752779467429490978247486054897308349609375	0.00128437339153305717272257613359442984801717102527618408203125	0.01935587631904610306232683569760411046445369720458984375	-2.478989084674748	10.88364328403961	ENAH;ROBO2;ROBO3;BDNF;NFIB;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
positive regulation of chondrocyte differentiation	6/43	0.0029747011543150877858898706307400061632506549358367919921875	0.05680836172026020036707194549308042041957378387451171875	0.00077922420180283444475499710080157456104643642902374267578125	0.012718341037730000742111968747849459759891033172607421875	-1.8492966466409686	10.75848980338949	DLX1;DLX2;JUND;PKDCC;SOX6;GDF5
beta-catenin-TCF complex assembly	10/132	0.01369036314474118658235379797361019882373511791229248046875	0.170331297404752779467429490978247486054897308349609375	0.0014297060739469446936922292223925978760235011577606201171875	0.0213415302240751204865265577836908050812780857086181640625	-2.500529340498295	10.729929217876686	TLE4;TLE3;TCF7L2;TLE1;PARD3;CNKSR3;GEMIN5;CTNNB1;MITF;OTX2
noradrenergic neuron development	5/33	0.004589975178165937343133240489123636507429182529449462890625	0.08263707219621650723606620658756582997739315032958984375	0.00154692707921252740367601408166819965117610991001129150390625	0.0228741537073526395029698932148676249198615550994873046875	-1.9886658967969655	10.706739866398364	ALK;SKOR1;MEF2C;MYT1L;PHOX2B
regulation of chemokine activity	6/48	0.0051993945856569738495078780715630273334681987762451171875	0.088221382232172462778407862060703337192535400390625	0.00130981097408551711881730117426059223362244665622711181640625	0.0196138995706710596300670346181505010463297367095947265625	-2.0273933418534518	10.662493593961095	PDGFRA;LDB1;LMO4;ERBB4;PLXNA2;LDB2
positive regulation of smoothened signaling pathway	5/26	0.001543516991738613959583847901058106799609959125518798828125	0.035343541990441949829371282021384104155004024505615234375	0.000595670354327159918932099724742101898300461471080780029296875	0.01018035167159859859242754254182727891020476818084716796875	-1.6108076311181068	10.427872000734483	PTCH1;ZIC1;OTX2;GATA3;FGFR2
regulation of cell chemotaxis to fibroblast growth factor	6/50	0.006364109109041911523096946012856278684921562671661376953125	0.10645213711826488622858022381478804163634777069091796875	0.00158582715158414881868875756509851271403022110462188720703125	0.0233760833563200938478576773604800109751522541046142578125	-2.0543817053370215	10.38917473796198	PDGFRA;LDB1;LMO4;ERBB4;PLXNA2;LDB2
negative regulation of G1/S transition of mitotic cell cycle by transcription from RNA polymerase II promoter	16/276	0.0247597800916650769009752508509336621500551700592041015625	0.235943197358351841597112752424436621367931365966796875	0.0009972992626616611865075778808886752813123166561126708984375	0.01557702192706972126046149895728376577608287334442138671875	-2.8018224301654673	10.362637517073981	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
termination of RNA polymerase II transcription	18/329	0.029911916764683472991226409476439584977924823760986328125	0.2558094995941602167732753514428623020648956298828125	0.000926448084907102796352329487916676953318528831005096435546875	0.01493232267035306259916893623085343278944492340087890625	-2.9222096731056677	10.255489950094917	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;GATA3;MLLT3;PMF1;CDC40;NFATC4;SALL3;U2AF2;SALL4;FEV;IRF9
cellular response to transforming growth factor beta stimulus	6/48	0.0051993945856569738495078780715630273334681987762451171875	0.088221382232172462778407862060703337192535400390625	0.00130981097408551711881730117426059223362244665622711181640625	0.0196138995706710596300670346181505010463297367095947265625	-1.9467742698773596	10.238500715642614	STAT5B;DLX1;MEF2C;CTNNB1;SOX6;ZFP36L1
semicircular canal morphogenesis	4/14	0.000966035105357619834631766053689716500230133533477783203125	0.024631284280929151286887446303808246739208698272705078125	0.000607045061563907142714036080377582038636319339275360107421875	0.010300113508622123215108246085947030223906040191650390625	-1.4541970192679585	10.095487066463665	ZIC1;SIX1;NEUROG1;FGFR2
otolith morphogenesis	4/14	0.000966035105357619834631766053689716500230133533477783203125	0.024631284280929151286887446303808246739208698272705078125	0.000607045061563907142714036080377582038636319339275360107421875	0.010300113508622123215108246085947030223906040191650390625	-1.4468706900120423	10.044625414797654	ZIC1;SIX1;NEUROG1;FGFR2
positive regulation of axonogenesis	7/71	0.00970308694528797775757933408158351085148751735687255859375	0.1448400668383651446191606737556867301464080810546875	0.0018744042323496231360058228432308169431053102016448974609375	0.026871848832467348788810568294138647615909576416015625	-2.143232547591148	9.934549837023313	ROBO2;SIPA1L1;SLITRK1;MAGI2;STMN2;RAPGEF2;ROBO1
motor neuron axon guidance	10/133	0.01437410428913053934973920178208572906441986560821533203125	0.170331297404752779467429490978247486054897308349609375	0.00150723259023397026558355182856985265971161425113677978515625	0.0223572834218038925258031923704038490541279315948486328125	-2.3094345463103734	9.797376541079608	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;LHX9;ROBO1
amacrine cell differentiation	7/68	0.0077062719013516467470026327646337449550628662109375	0.11842561115663442772305558037260198034346103668212890625	0.00149130467786258544445054941007811066810972988605499267578125	0.022190801783841689054366241862226161174476146697998046875	-2.0044101064017945	9.752899844286874	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
cellular response to parathyroid hormone stimulus	5/36	0.0067136683360454370295133941226595197804272174835205078125	0.10787286952003131978994332484944607131183147430419921875	0.0021857960065869764566814925643711831071414053440093994140625	0.02988521670455294987345240542708779685199260711669921875	-1.9442979677206613	9.72850832750451	ROBO2;STAT5B;MEF2C;JUND;STAT3
canonical Wnt signaling pathway involved in mesonephros development	6/51	0.007012602811766364789558547698788970592431724071502685546875	0.11063025907391954572034364900900982320308685302734375	0.001739390699634733340739334295221851789392530918121337890625	0.0250535899750076347658467312840002705343067646026611328125	-1.9015869843023077	9.4319595750415	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
canonical Wnt signaling pathway involved in heart development	6/51	0.007012602811766364789558547698788970592431724071502685546875	0.11063025907391954572034364900900982320308685302734375	0.001739390699634733340739334295221851789392530918121337890625	0.0250535899750076347658467312840002705343067646026611328125	-1.898312724288379	9.415719093620199	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
regulation of heart induction by canonical Wnt signaling pathway	6/51	0.007012602811766364789558547698788970592431724071502685546875	0.11063025907391954572034364900900982320308685302734375	0.001739390699634733340739334295221851789392530918121337890625	0.0250535899750076347658467312840002705343067646026611328125	-1.8964559548063047	9.406509430933365	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation	6/52	0.007707581646191810804957800229431086336262524127960205078125	0.11842561115663442772305558037260198034346103668212890625	0.00190397821413735494726349184446689832839183509349822998046875	0.026889416874508693944267889719412778504192829132080078125	-1.9310627431604281	9.395683884830524	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
positive regulation of spinal cord association neuron differentiation by canonical Wnt signaling pathway	6/51	0.007012602811766364789558547698788970592431724071502685546875	0.11063025907391954572034364900900982320308685302734375	0.001739390699634733340739334295221851789392530918121337890625	0.0250535899750076347658467312840002705343067646026611328125	-1.8916088995906664	9.382467812417204	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	6/52	0.007707581646191810804957800229431086336262524127960205078125	0.11842561115663442772305558037260198034346103668212890625	0.00190397821413735494726349184446689832839183509349822998046875	0.026889416874508693944267889719412778504192829132080078125	-1.9260824657439028	9.371452092036547	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation	6/51	0.007012602811766364789558547698788970592431724071502685546875	0.11063025907391954572034364900900982320308685302734375	0.001739390699634733340739334295221851789392530918121337890625	0.0250535899750076347658467312840002705343067646026611328125	-1.8889420496546838	9.369240113134166	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
canonical Wnt signaling pathway involved in osteoblast differentiation	6/52	0.007707581646191810804957800229431086336262524127960205078125	0.11842561115663442772305558037260198034346103668212890625	0.00190397821413735494726349184446689832839183509349822998046875	0.026889416874508693944267889719412778504192829132080078125	-1.9244063302233878	9.36329676950512	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
response to estradiol	4/15	0.00128251402563799607285666137812540910090319812297821044921875	0.0300976052683304858004209592081679147668182849884033203125	0.000755350058513902500832715158907149088918231427669525146484375	0.01245799379723803480823907108288040035404264926910400390625	-1.3863588164150107	9.231670534588446	STAT5B;STAT3;CTNNB1;WNT8B
axon extension involved in axon guidance	10/139	0.019023924175631624911009254219607100822031497955322265625	0.1989708433180806534945617158882669173181056976318359375	0.0020472326813198190968712264492523900116793811321258544921875	0.028826258381449511303262767114574671722948551177978515625	-2.2598850366858136	8.953795418655004	ENAH;ROBO2;ROBO3;USP9X;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
positive regulation of skeletal muscle cell differentiation	5/34	0.005235283282746645838745536138958414085209369659423828125	0.08851193994521837360434091124261613003909587860107421875	0.00174211946402427482298580496689055507886223495006561279296875	0.0250535899750076347658467312840002705343067646026611328125	-1.6420302657869825	8.624491924227133	DDX17;DLX1;MEF2C;DLX2;JUND
axon extension	7/75	0.0129209258846360759698246312154878978617489337921142578125	0.170331297404752779467429490978247486054897308349609375	0.0024990567755623174263368557745934595004655420780181884765625	0.03348878071115753141118176472446066327393054962158203125	-1.971035381093406	8.57184980319603	USP9X;SLITRK1;PARD3;CNTN4;ANK3;GP5;FGFR2
regulation of hair cycle by canonical Wnt signaling pathway	6/55	0.01008910104075102197318525298896929598413407802581787109375	0.148874369192992295207744746221578679978847503662109375	0.0024689076926511922642493157553644778090529143810272216796875	0.03317902446220989676195500805988558568060398101806640625	-1.8559606722336999	8.530551188989987	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
regulation of neuron migration	6/55	0.01008910104075102197318525298896929598413407802581787109375	0.148874369192992295207744746221578679978847503662109375	0.0024689076926511922642493157553644778090529143810272216796875	0.03317902446220989676195500805988558568060398101806640625	-1.842119164677312	8.466931474138784	LDB1;LMO4;ERBB4;PLXNA2;CTNNB1;LDB2
interneuron migration	5/36	0.0067136683360454370295133941226595197804272174835205078125	0.10787286952003131978994332484944607131183147430419921875	0.0021857960065869764566814925643711831071414053440093994140625	0.02988521670455294987345240542708779685199260711669921875	-1.6850791530932419	8.431478531343654	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
gonadotrophin-releasing hormone neuronal migration to the hypothalamus	5/36	0.0067136683360454370295133941226595197804272174835205078125	0.10787286952003131978994332484944607131183147430419921875	0.0021857960065869764566814925643711831071414053440093994140625	0.02988521670455294987345240542708779685199260711669921875	-1.6797328967067628	8.404727950599176	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
sensory neuron migration	5/36	0.0067136683360454370295133941226595197804272174835205078125	0.10787286952003131978994332484944607131183147430419921875	0.0021857960065869764566814925643711831071414053440093994140625	0.02988521670455294987345240542708779685199260711669921875	-1.6791375308956056	8.40174897240349	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
otic vesicle morphogenesis	4/19	0.0032729281997916164458073406962057561031542718410491943359375	0.061753609273668221002484557402567588724195957183837890625	0.00160720639159267117933305168975266497000120580196380615234375	0.0236174222714723679172887926824841997586190700531005859375	-1.4677883540140546	8.398788030982237	ZIC1;SIX1;NEUROG1;FGFR2
neuron migration involved in retrograde extension	5/36	0.0067136683360454370295133941226595197804272174835205078125	0.10787286952003131978994332484944607131183147430419921875	0.0021857960065869764566814925643711831071414053440093994140625	0.02988521670455294987345240542708779685199260711669921875	-1.672890136142643	8.370489446914886	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
negative regulation of neuron differentiation	5/37	0.00755257301580410100871887379980762489140033721923828125	0.11757586440774898950412108433738467283546924591064453125	0.0024360894198176448466330867859142017550766468048095703125	0.032925598261546791534204459139800746925175189971923828125	-1.6983080395806927	8.297707167333735	CASZ1;ID2;SIX3;SIX1;CNTN4
positive regulation of synapse assembly	4/20	0.00398371164101716558614274532601484679616987705230712890625	0.0722737223487614210970519934562616981565952301025390625	0.00189472996770426974251499974144508087192662060260772705078125	0.026889416874508693944267889719412778504192829132080078125	-1.5015077844525233	8.29664330700887	MEF2C;NLGN2;BDNF;LRRC4B
peripheral nervous system neuron differentiation	7/77	0.014788985362270738732615171784345875494182109832763671875	0.170331297404752779467429490978247486054897308349609375	0.002865955711091127712519810444291579187847673892974853515625	0.03755198080338013888468395862219040282070636749267578125	-1.968042833133803	8.293081785065802	MEF2C;FZD2;FZD5;LDB1;MYT1L;WNT8B;FZD8
axonogenesis	8/95	0.0146297072927518735652174797223779023624956607818603515625	0.170331297404752779467429490978247486054897308349609375	0.002290008746688950748426893966325224027968943119049072265625	0.0312195701102074597843571979183252551592886447906494140625	-1.9465614100868327	8.223640074897315	MEF2C;SLITRK1;PARD3;CNTN4;ANK3;SRGAP2;GP5;FGFR2
canonical Wnt signaling pathway	8/97	0.01642013306991720045235894076540716923773288726806640625	0.179291128913887598539389500729157589375972747802734375	0.0025836985172599555120320768963892987812869250774383544921875	0.034524945909108241404172900956837111152708530426025390625	-1.99066451985415	8.180132347264536	TCF7L2;FZD2;FZD5;TNKS;FZD8;WNT8B;CTNNB1;TBL1X
cellular response to nerve growth factor stimulus	5/31	0.003472196200963134464501091969168555806390941143035888671875	0.06499345031723453847138927130799856968224048614501953125	0.00120536097897925675685726343289161377470009028911590576171875	0.0182819541409812054422179272705761832185089588165283203125	-1.4237724985666969	8.062778062053281	STAT5B;MAGI2;STMN2;RAPGEF2;CTNNB1
positive regulation of histone H3-K4 methylation	4/17	0.0021197748878732749523712275419029538170434534549713134765625	0.042914069296558964017318515971055603586137294769287109375	0.00112557949794052369885122288906131871044635772705078125	0.0172943273348060248817414930044833454303443431854248046875	-1.2996946791549049	8.0014993040657	MYB;CTNNB1;TET1;BRCA1
outward migration of deep nuclear neurons	5/37	0.00755257301580410100871887379980762489140033721923828125	0.11757586440774898950412108433738467283546924591064453125	0.0024360894198176448466330867859142017550766468048095703125	0.032925598261546791534204459139800746925175189971923828125	-1.6373555979484162	7.999901645596052	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
inner ear morphogenesis	4/15	0.00128251402563799607285666137812540910090319812297821044921875	0.0300976052683304858004209592081679147668182849884033203125	0.000755350058513902500832715158907149088918231427669525146484375	0.01245799379723803480823907108288040035404264926910400390625	-1.2006453344078591	7.995016892384451	ZIC1;SIX1;NEUROG1;FGFR2
inward migration of deep nuclear neurons	5/37	0.00755257301580410100871887379980762489140033721923828125	0.11757586440774898950412108433738467283546924591064453125	0.0024360894198176448466330867859142017550766468048095703125	0.032925598261546791534204459139800746925175189971923828125	-1.6359813023847105	7.993187020284726	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
motor neuron migration	5/38	0.0084617362927271629058356694486064952798187732696533203125	0.127520799018511266087472222352516837418079376220703125	0.0027065664804617321249902150981370141380466520786285400390625	0.036064616068751387256696716576698236167430877685546875	-1.6278481701446812	7.768418487773675	MEF2C;USP9X;SEMA3A;RAPGEF2;PHOX2B
regulation of trophoblast cell migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7607095665593815	7.66620606492477	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of glial cell migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7579674785077435	7.6542668942339995	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of mesenchymal stem cell migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7545882503252195	7.639553587690063	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of hematopoietic stem cell migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7534195256422676	7.634464909566855	LDB1;LMO4;ERBB4;PLXNA2;LDB2
neurotransmitter-mediated guidance of interneurons involved in substrate-independent cerebral cortex tangential migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7494894803253238	7.617353321252459	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of distal tip cell migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7446877747900875	7.596446486419873	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of formation of radial glial scaffolds	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7416333609364327	7.583147435597177	LDB1;LMO4;ERBB4;PLXNA2;LDB2
modulation of cell migration in other organism	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7405420978298378	7.578396028547942	LDB1;LMO4;ERBB4;PLXNA2;LDB2
negative regulation of neuron projection development	6/57	0.011941202457863696329010139152160263620316982269287109375	0.170331297404752779467429490978247486054897308349609375	0.00290996030057748440722509286615604651160538196563720703125	0.0380229438720886270264287531972513534128665924072265625	-1.7107931283168363	7.574982182016245	ID2;SEMA3A;SIX3;LPAR1;STMN2;CNTN4
axon arborization	6/58	0.0129516097143909138245110312936958507634699344635009765625	0.170331297404752779467429490978247486054897308349609375	0.0031513813187075399337155889867290170514024794101715087890625	0.0409505941607258006076364154068869538605213165283203125	-1.7401144707136533	7.563468792533759	SLITRK1;PARD3;CNTN4;ANK3;GP5;FGFR2
regulation of metanephric mesenchymal cell migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.734462687615836	7.551926011948431	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of neuroblast migration	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.7338031822084208	7.549054496708096	LDB1;LMO4;ERBB4;PLXNA2;LDB2
phosphorylation of RNA polymerase II C-terminal domain	26/596	0.10614816024754725187762005589320324361324310302734375	0.62587608985960041518836760587873868644237518310546875	0.00187994702453131760054583221375423818244598805904388427734375	0.026871848832467348788810568294138647615909576416015625	-3.36209602816068	7.540910482249564	BARHL1;BARHL2;THRA;MYT1L;PRKAG1;BRCA1;CUX1;DDX17;STAT5B;TCF7L2;PRKCH;JUND;POU2F1;ATAD2;STAT3;NFATC3;DEK;NR2F2;ELP4;TBX19;TFDP2;TAL1;FEV;SP8;SP7;NEUROG1
regulation of angioblast cell migration involved in selective angioblast sprouting	5/42	0.012854729099028593120035424135494395159184932708740234375	0.170331297404752779467429490978247486054897308349609375	0.004008579741593107197139556063802956487052142620086669921875	0.047508720203755495925523888445241027511656284332275390625	-1.728251315773826	7.524881428678646	LDB1;LMO4;ERBB4;PLXNA2;LDB2
sympathetic ganglion development	4/16	0.0016648897639215108103238893733077929937280714511871337890625	0.0359273643030969813683128677439526654779911041259765625	0.000927532444861871308017242654386791400611400604248046875	0.01493232267035306259916893623085343278944492340087890625	-1.1758617373667997	7.5231591221167875	SEMA3A;CTNNB1;GATA3;PHOX2B
regulation of BMP signaling pathway involved in spinal cord association neuron specification	4/16	0.0016648897639215108103238893733077929937280714511871337890625	0.0359273643030969813683128677439526654779911041259765625	0.000927532444861871308017242654386791400611400604248046875	0.01493232267035306259916893623085343278944492340087890625	-1.1170455419079641	7.146853317332944	PTCH1;ZIC1;OTX2;FGFR2
transforming growth factor beta receptor signaling pathway	8/104	0.0239321080201472975723664404767987434752285480499267578125	0.2313273637931041182280722523501026444137096405029296875	0.0038497052404702501900157773917499071103520691394805908203125	0.047506933692523033163634949005427188239991664886474609375	-1.8848844512649068	7.035395846725835	DLX1;MEF2C;USP9X;PARD3;SOX6;GDF5;ACVR2A;ZFP36L1
RNA 3'-end processing	6/59	0.01402041055389947887821477934267022646963596343994140625	0.170331297404752779467429490978247486054897308349609375	0.0034074374342821906434808365560229503898881375789642333984375	0.044156270267882123670144522975533618591725826263427734375	-1.6424359162838431	7.008670069666974	DDX17;DHX30;RBM39;LIN28A;CELF2;ELAVL4
regulation of leukocyte migration	5/43	0.01415473277605108250176702000544537440873682498931884765625	0.170331297404752779467429490978247486054897308349609375	0.004393667046389119514027132851197166019119322299957275390625	0.050311665809761867140803559550477075390517711639404296875	-1.6362174799577438	6.966533372793936	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis	5/43	0.01415473277605108250176702000544537440873682498931884765625	0.170331297404752779467429490978247486054897308349609375	0.004393667046389119514027132851197166019119322299957275390625	0.050311665809761867140803559550477075390517711639404296875	-1.6317045834967032	6.947318785375756	LDB1;LMO4;ERBB4;PLXNA2;LDB2
olfactory bulb axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9582995804481096	6.9447872859106665	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
sympathetic neuron axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9570244373773935	6.940265200794762	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
interneuron axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9558303659946987	6.936030623082648	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
serotonergic neuron axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9545065751419157	6.931336016611095	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance through the internal capsule	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.950220739383759	6.916137005193272	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
sensory neuron axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9487721731276841	6.910999903281783	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance	9/129	0.030108480301174612991932377781267859973013401031494140625	0.256356862058918111291205832458217628300189971923828125	0.0040892474367072891017205193975314614363014698028564453125	0.048222450397370712760203304014794412069022655487060546875	-1.9694551022833062	6.89889961778491	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
semaphorin-plexin signaling pathway involved in axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9451590326481316	6.898186494998836	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance through the medullary pyramid	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9436420358095539	6.892806715284585	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance through spinal cord	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9420126066272845	6.887028212760611	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance through the basilar pons	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9390452126975406	6.876504838379425	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
dorsal/ventral axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9373328588121508	6.870432257038468	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
axon choice point recognition	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9349192750813413	6.861872879415882	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
VEGF-activated neuropilin signaling pathway involved in axon guidance	9/129	0.030108480301174612991932377781267859973013401031494140625	0.256356862058918111291205832458217628300189971923828125	0.0040892474367072891017205193975314614363014698028564453125	0.048222450397370712760203304014794412069022655487060546875	-1.9570823490315714	6.855558501462745	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
photoreceptor cell axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.93273895954095	6.854140749053725	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance through the cerebral cortex	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9285770299995657	6.839381150648843	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
dopaminergic neuron axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9284952080799227	6.839090982672033	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
corticospinal neuron axon guidance through the cerebral peduncle	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9280037814965139	6.837348219142648	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
anterior/posterior axon guidance	9/128	0.0288300947253729532293586856894762604497373104095458984375	0.24861344939594920422365476042614318430423736572265625	0.003897643277296250312324854547796348924748599529266357421875	0.047506933692523033163634949005427188239991664886474609375	-1.9228806208282243	6.819179772686323	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
directional guidance of interneurons involved in migration from the subpallium to the cortex	5/43	0.01415473277605108250176702000544537440873682498931884765625	0.170331297404752779467429490978247486054897308349609375	0.004393667046389119514027132851197166019119322299957275390625	0.050311665809761867140803559550477075390517711639404296875	-1.6015027046913615	6.818728057556417	LDB1;LMO4;ERBB4;PLXNA2;LDB2
retinal ganglion cell axon guidance	9/130	0.03142591356708389349616794561370625160634517669677734375	0.266611572474702740453977867218782193958759307861328125	0.004288139574573771213572559446447485242970287799835205078125	0.0495763587580011766409171514169429428875446319580078125	-1.959624061876194	6.780539217075909	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
Roundabout signaling pathway involved in axon guidance	9/130	0.03142591356708389349616794561370625160634517669677734375	0.266611572474702740453977867218782193958759307861328125	0.004288139574573771213572559446447485242970287799835205078125	0.0495763587580011766409171514169429428875446319580078125	-1.9524776442765388	6.755811737076674	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	4/17	0.0021197748878732749523712275419029538170434534549713134765625	0.042914069296558964017318515971055603586137294769287109375	0.00112557949794052369885122288906131871044635772705078125	0.0172943273348060248817414930044833454303443431854248046875	-1.0950709633442954	6.741744574040536	PTCH1;ZIC1;OTX2;FGFR2
central nervous system neuron differentiation	10/159	0.042452247712699862913776627237893990240991115570068359375	0.320909058430777605064321278405259363353252410888671875	0.005057101508781351728583075555434334091842174530029296875	0.0566611587100276370421170213376171886920928955078125	-2.101445831303459	6.639256301626634	ROBO2;RCAN1;MEF2C;FZD2;FZD5;LDB1;MYT1L;FZD8;WNT8B;HAPLN1
planar cell polarity pathway involved in axon guidance	12/213	0.056542699460895386176506605124814086593687534332275390625	0.395715004980776774434758635834441520273685455322265625	0.005145812704524005583295309662617000867612659931182861328125	0.056844961422107105619705436083677341230213642120361328125	-2.2818622413828225	6.555240709616845	ENAH;ROBO2;ROBO3;FZD2;FZD5;BDNF;SEMA3A;OTX2;VLDLR;PRICKLE1;CNTN4;ROBO1
neuromast hair cell development	4/27	0.01198862366754693820070087895146571099758148193359375	0.170331297404752779467429490978247486054897308349609375	0.004957179999081829345486394089448367594741284847259521484375	0.05567385251349758756855834462839993648231029510498046875	-1.4611499095101768	6.463830741943046	ALK;SKOR1;MEF2C;MYT1L
regulation of substrate-dependent cell migration, cell attachment to substrate	5/44	0.01554016536690208151461067842546981410123407840728759765625	0.1705274820529263102297790055672521702945232391357421875	0.0048043991877884488495009662756274337880313396453857421875	0.05460807462360990627292522958668996579945087432861328125	-1.5492148935217627	6.451437863394099	LDB1;LMO4;ERBB4;PLXNA2;LDB2
neuron development involved in amphid sensory organ development	4/27	0.01198862366754693820070087895146571099758148193359375	0.170331297404752779467429490978247486054897308349609375	0.004957179999081829345486394089448367594741284847259521484375	0.05567385251349758756855834462839993648231029510498046875	-1.4579631542682954	6.4497331833246925	ALK;SKOR1;MEF2C;MYT1L
cardiac neuron development	4/27	0.01198862366754693820070087895146571099758148193359375	0.170331297404752779467429490978247486054897308349609375	0.004957179999081829345486394089448367594741284847259521484375	0.05567385251349758756855834462839993648231029510498046875	-1.4409905531433431	6.374649839577314	ALK;SKOR1;MEF2C;MYT1L
chemorepulsion of axon	9/134	0.03709590358795859799112548671473632566630840301513671875	0.29657860546508596488735065577202476561069488525390625	0.00516032146399030000605279155934113077819347381591796875	0.05687204753654730160494779056534753181040287017822265625	-1.9221276225492718	6.331966481179797	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
peripheral nervous system neuron axonogenesis	6/63	0.0189102484133814204014800708364418824203312397003173828125	0.198221426146489243524939638518844731152057647705078125	0.004588711564510601116639865182378343888558447360992431640625	0.052409085834858364083554960188848781399428844451904296875	-1.5551746466487664	6.171012715817983	SLITRK1;PARD3;CNTN4;ANK3;GP5;FGFR2
receptor internalization involved in canonical Wnt signaling pathway	7/87	0.02706864868897962406180113248410634696483612060546875	0.24790144602192742961932481193798594176769256591796875	0.005354747346127507710844550814499598345719277858734130859375	0.058604044621075303267421219288735301233828067779541015625	-1.6921820665969558	6.107726577358214	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X;LDLRAP1
canonical Wnt signaling pathway involved in positive regulation of wound healing	6/65	0.021744132951327772851346509241921012289822101593017578125	0.21457547098621987391453558302600868046283721923828125	0.005281119905450565137072782562199790845625102519989013671875	0.057932657195372827541035576359718106687068939208984375	-1.5872809546437627	6.076764354462325	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
neuron maturation	4/28	0.0136230768629259889335170186086543253622949123382568359375	0.170331297404752779467429490978247486054897308349609375	0.005566337113120219115547371302454848773777484893798828125	0.060498645535917223992061764192840200848877429962158203125	-1.3939527952141946	5.988407402629631	ALK;SKOR1;MEF2C;MYT1L
regulation of smoothened signaling pathway	4/27	0.01198862366754693820070087895146571099758148193359375	0.170331297404752779467429490978247486054897308349609375	0.004957179999081829345486394089448367594741284847259521484375	0.05567385251349758756855834462839993648231029510498046875	-1.3481315898267763	5.963860626339228	PTCH1;ZIC1;OTX2;FGFR2
regulation of fibroblast migration	5/46	0.0185759146816852523109719896865499322302639484405517578125	0.19515053352674682773937320234836079180240631103515625	0.00570637348342351198582367288736350019462406635284423828125	0.061736155324102530428387325400763074867427349090576171875	-1.4920081819763322	5.946979667331885	LDB1;LMO4;ERBB4;PLXNA2;LDB2
regulation of smooth muscle cell migration	5/46	0.0185759146816852523109719896865499322302639484405517578125	0.19515053352674682773937320234836079180240631103515625	0.00570637348342351198582367288736350019462406635284423828125	0.061736155324102530428387325400763074867427349090576171875	-1.4890566980655013	5.935215378758803	LDB1;LMO4;ERBB4;PLXNA2;LDB2
transcription initiation from RNA polymerase II promoter	17/355	0.09182255080113434220212553782403119839727878570556640625	0.561045300685169223697812412865459918975830078125	0.004738811851178056748501443706800273503176867961883544921875	0.053992694449292021052766443744985735975205898284912109375	-2.475902197840097	5.912200322074749	NFYA;THRA;LMO4;MAX;NFATC3;PAX3;ARRB1;DEK;NR2E1;GATA3;MLLT3;PMF1;NFATC4;SALL3;SALL4;FEV;IRF9
regulation of epithelial cell migration	5/47	0.0202302429037953222790147123077986179850995540618896484375	0.2088097500595241517995503954807645641267299652099609375	0.00619938280252256730673554585564488661475479602813720703125	0.06626689767381026274772892747932928614318370819091796875	-1.4532352196413443	5.668455322207561	LDB1;LMO4;ERBB4;PLXNA2;LDB2
positive regulation of osteoblast differentiation	6/68	0.026510682337590137092053765854871016927063465118408203125	0.2476255219532924323200262506361468695104122161865234375	0.006459103452020675990852272008169165928848087787628173828125	0.068620700412571011828077871541609056293964385986328125	-1.5588942093064606	5.659109481722209	DLX1;DLX2;MEF2C;JUND;ACVR2A;FGFR2
positive regulation of erythrocyte differentiation	4/25	0.0091098139695819611849625374588867998681962490081787109375	0.136415849188946392001042795527609996497631072998046875	0.0038763370149817798042402028357855670037679374217987060546875	0.047506933692523033163634949005427188239991664886474609375	-1.2035923994662416	5.65496212644579	STAT5B;TAL1;STAT3;ACVR2A
regulation of wound healing, spreading of epidermal cells	5/47	0.0202302429037953222790147123077986179850995540618896484375	0.2088097500595241517995503954807645641267299652099609375	0.00619938280252256730673554585564488661475479602813720703125	0.06626689767381026274772892747932928614318370819091796875	-1.4476157963311334	5.6465363310215615	LDB1;LMO4;ERBB4;PLXNA2;LDB2
cellular response to peptide hormone stimulus	5/48	0.021978015964161136397425622135415324009954929351806640625	0.216430691655423945718439426855184137821197509765625	0.00672156880844419594989158639464221778325736522674560546875	0.07124862936950847325245916863423190079629421234130859375	-1.457241684185462	5.563329938359108	ROBO2;STAT5B;JUND;STAT3;ZFP36L1
central nervous system neuron axonogenesis	6/65	0.021744132951327772851346509241921012289822101593017578125	0.21457547098621987391453558302600868046283721923828125	0.005281119905450565137072782562199790845625102519989013671875	0.057932657195372827541035576359718106687068939208984375	-1.436365587139658	5.498998255079278	SLITRK1;PARD3;CNTN4;ANK3;GP5;FGFR2
chemoattraction of axon	9/142	0.05044724532467916022770992867663153447210788726806640625	0.358122330414368528206381370182498358190059661865234375	0.007312283166307388150573220997330281534232199192047119140625	0.0756404379286665651260790355081553570926189422607421875	-1.789962702103939	5.3463091706439405	ENAH;ROBO2;ROBO3;BDNF;SEMA3A;OTX2;CNTN4;VLDLR;ROBO1
neuroligin clustering involved in postsynaptic membrane assembly	4/23	0.006723473317551242021961055428391773602925240993499755859375	0.10787286952003131978994332484944607131183147430419921875	0.002967384356799850075869784404858364723622798919677734375	0.038666165776311857416036588119823136366903781890869140625	-1.0586546860005606	5.2955499560043755	DLG1;NLGN2;MAGI2;NRXN2
positive regulation of axon extension involved in axon guidance	4/25	0.0091098139695819611849625374588867998681962490081787109375	0.136415849188946392001042795527609996497631072998046875	0.0038763370149817798042402028357855670037679374217987060546875	0.047506933692523033163634949005427188239991664886474609375	-1.1145061968332146	5.2363992457711905	SEMA7A;DSCAM;SEMA3A;PLXNA2
positive regulation of cell fate commitment	4/28	0.0136230768629259889335170186086543253622949123382568359375	0.170331297404752779467429490978247486054897308349609375	0.005566337113120219115547371302454848773777484893798828125	0.060498645535917223992061764192840200848877429962158203125	-1.2069412313966217	5.185007576618727	DLX1;DLX2;JUND;FGFR2
inner ear receptor cell development	4/29	0.01539243709895564589384964193641280871815979480743408203125	0.170331297404752779467429490978247486054897308349609375	0.0062234970679452931985320418561968836002051830291748046875	0.06626689767381026274772892747932928614318370819091796875	-1.2054853594057395	5.031550011556372	ALK;SKOR1;MEF2C;MYT1L
tyrosine phosphorylation of STAT protein	6/74	0.03800855772016420441872242008685134351253509521484375	0.302337886620597851017322454936220310628414154052734375	0.0093698934331492740590352497065396164543926715850830078125	0.09188729173423103302464909347690991126000881195068359375	-1.520381794532584	4.971563237719601	PDGFRA;STAT5B;PKDCC;ERBB4;STAT3;FGFR2
positive regulation of AMPA receptor activity	4/26	0.0104855043289659964622639876097309752367436885833740234375	0.1531273186369430383546585971998865716159343719482421875	0.00439440456086959661818891476059434353373944759368896484375	0.050311665809761867140803559550477075390517711639404296875	-1.089627686026298	4.96626313385612	MEF2C;NLGN2;ANK3;CACNG2
calcium ion transport from cytosol to endoplasmic reticulum	5/49	0.0238209373465364214472739234906839556060731410980224609375	0.231285049253998398199883013148792088031768798828125	0.0072737889955981523126826715497372788377106189727783203125	0.07540761031260766189543431892161606810986995697021484375	-1.3226151994216615	4.942864779337908	TRPM1;ATP2A2;CACNA1D;CACNA1C;CACNG2
calcium ion transmembrane transport via low voltage-gated calcium channel	5/49	0.0238209373465364214472739234906839556060731410980224609375	0.231285049253998398199883013148792088031768798828125	0.0072737889955981523126826715497372788377106189727783203125	0.07540761031260766189543431892161606810986995697021484375	-1.3203164955624107	4.934274085424072	TRPM1;ATP2A2;CACNA1D;CACNA1C;CACNG2
positive regulation of muscle cell differentiation	5/51	0.0277984090725269909760708486601288313977420330047607421875	0.248342984081647399907666340368450619280338287353515625	0.00847169827176048884087578016988118179142475128173828125	0.08466313717774200109378313072738819755613803863525390625	-1.3533467869989693	4.848739047934247	DLX1;DLX2;MEF2C;JUND;CTNNB1
positive regulation of stem cell differentiation	4/28	0.0136230768629259889335170186086543253622949123382568359375	0.170331297404752779467429490978247486054897308349609375	0.005566337113120219115547371302454848773777484893798828125	0.060498645535917223992061764192840200848877429962158203125	-1.1054926817604749	4.749185612121148	DLX1;DLX2;JUND;SP7
photoreceptor cell development	4/30	0.0172999430935302962730748532749203150160610675811767578125	0.1875950151084652961497312162464368157088756561279296875	0.00693022593661596179870354461627357522957026958465576171875	0.07313171307162751044739223971191677264869213104248046875	-1.1084984756560028	4.4972360317881135	ALK;SKOR1;MEF2C;MYT1L
cell morphogenesis involved in neuron differentiation	4/30	0.0172999430935302962730748532749203150160610675811767578125	0.1875950151084652961497312162464368157088756561279296875	0.00693022593661596179870354461627357522957026958465576171875	0.07313171307162751044739223971191677264869213104248046875	-1.1034855955837417	4.476898516329949	ALK;SKOR1;MEF2C;MYT1L
embryonic digestive tract morphogenesis	4/27	0.01198862366754693820070087895146571099758148193359375	0.170331297404752779467429490978247486054897308349609375	0.004957179999081829345486394089448367594741284847259521484375	0.05567385251349758756855834462839993648231029510498046875	-1.0080592805749473	4.459449728649456	PDGFRA;PKDCC;ID2;FGFR2
peripheral nervous system neuron development	4/31	0.01934849818766339046849367377944872714579105377197265625	0.2014721102675678110482948568460415117442607879638671875	0.00768803252586484388297893843855490558780729770660400390625	0.07918002057752067390783423661559936590492725372314453125	-1.1060059874276236	4.363348987211367	ALK;SKOR1;MEF2C;MYT1L
positive regulation of RNA splicing	12/248	0.1323564636944772054949481798757915385067462921142578125	0.7166611958547128846674922897364012897014617919921875	0.01522114204666650226493995745613574399612843990325927734375	0.1295995072818157123339943836981547065079212188720703125	-2.1547318447858372	4.35742050820871	MEF2C;MBNL2;TLE1;CITED2;U2AF2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
homophilic cell adhesion via plasma membrane adhesion molecules	5/52	0.0299357311375824559906977384571291622705757617950439453125	0.2558094995941602167732753514428623020648956298828125	0.009119035538556412301414155763268354348838329315185546875	0.09074787053875653375367704711607075296342372894287109375	-1.2345731342312247	4.331749831067045	KIRREL3;ROBO2;CADM1;DSCAM;ROBO1
Golgi calcium ion transmembrane transport	5/51	0.0277984090725269909760708486601288313977420330047607421875	0.248342984081647399907666340368450619280338287353515625	0.00847169827176048884087578016988118179142475128173828125	0.08466313717774200109378313072738819755613803863525390625	-1.2085932352590756	4.3301194262740905	TRPM1;ATP2A2;CACNA1D;CACNA1C;CACNG2
heterochromatin assembly	6/78	0.0472030674714834785898887048460892401635646820068359375	0.35174860863031209845530611346475780010223388671875	0.0117668739077416949212473440411486080847680568695068359375	0.10819560277352353871993528855455224402248859405517578125	-1.4081490123109823	4.2994963095297996	PBRM1;MYB;TNRC18;DEK;BAZ1A;BAHCC1
central nervous system neuron development	4/33	0.0238786981103873696685724326016497798264026641845703125	0.231285049253998398199883013148792088031768798828125	0.009362616583454573537803611316121532581746578216552734375	0.09188729173423103302464909347690991126000881195068359375	-1.1509857615672117	4.298665377684056	ALK;SKOR1;MEF2C;MYT1L
regulation of smooth muscle cell proliferation	8/127	0.06469805148537444150491637628874741494655609130859375	0.43784893666644364440543313321541063487529754638671875	0.011531340282998979451800636297775781713426113128662109375	0.1062369767869261460990770729040377773344516754150390625	-1.5692258362461882	4.296578305608795	TCF7L2;RBFOX2;JUND;GRAP2;SIX3;CTNNB1;PDS5B;BRCA1
progression of neural tube closure	4/29	0.01539243709895564589384964193641280871815979480743408203125	0.170331297404752779467429490978247486054897308349609375	0.0062234970679452931985320418561968836002051830291748046875	0.06626689767381026274772892747932928614318370819091796875	-1.0242064866938225	4.274913933837261	VANGL2;LMO4;PRICKLE1;FGFR2
neuropore closure	4/29	0.01539243709895564589384964193641280871815979480743408203125	0.170331297404752779467429490978247486054897308349609375	0.0062234970679452931985320418561968836002051830291748046875	0.06626689767381026274772892747932928614318370819091796875	-1.0176180226619156	4.247414482253525	VANGL2;LMO4;PRICKLE1;FGFR2
calcium ion transmembrane transport via high voltage-gated calcium channel	5/51	0.0277984090725269909760708486601288313977420330047607421875	0.248342984081647399907666340368450619280338287353515625	0.00847169827176048884087578016988118179142475128173828125	0.08466313717774200109378313072738819755613803863525390625	-1.1807392190264427	4.230324711832534	TRPM1;ATP2A2;CACNA1D;CACNA1C;CACNG2
cellular response to cytokinin stimulus	4/33	0.0238786981103873696685724326016497798264026641845703125	0.231285049253998398199883013148792088031768798828125	0.009362616583454573537803611316121532581746578216552734375	0.09188729173423103302464909347690991126000881195068359375	-1.0454167980746076	3.904389737205467	ROBO2;STAT5B;JUND;STAT3
cellular response to auxin stimulus	4/33	0.0238786981103873696685724326016497798264026641845703125	0.231285049253998398199883013148792088031768798828125	0.009362616583454573537803611316121532581746578216552734375	0.09188729173423103302464909347690991126000881195068359375	-1.039968019111092	3.884039809114936	ROBO2;STAT5B;JUND;STAT3
positive regulation of production of miRNAs involved in gene silencing by miRNA	11/227	0.1440318957706507863036904382170177996158599853515625	0.73858861214153648244717942361603491008281707763671875	0.019493267071005619672785513785129296593368053436279296875	0.1578978711498744968988461323533556424081325531005859375	-1.9939560828468958	3.8637295888507097	MEF2C;TLE1;LIN28A;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
cellular response to abscisic acid stimulus	4/33	0.0238786981103873696685724326016497798264026641845703125	0.231285049253998398199883013148792088031768798828125	0.009362616583454573537803611316121532581746578216552734375	0.09188729173423103302464909347690991126000881195068359375	-1.030123789085718	3.8472738888116185	ROBO2;STAT5B;JUND;STAT3
cellular response to gibberellin stimulus	4/33	0.0238786981103873696685724326016497798264026641845703125	0.231285049253998398199883013148792088031768798828125	0.009362616583454573537803611316121532581746578216552734375	0.09188729173423103302464909347690991126000881195068359375	-1.0297397519994291	3.8458395991951	ROBO2;STAT5B;JUND;STAT3
cellular response to ethylene stimulus	4/33	0.0238786981103873696685724326016497798264026641845703125	0.231285049253998398199883013148792088031768798828125	0.009362616583454573537803611316121532581746578216552734375	0.09188729173423103302464909347690991126000881195068359375	-1.025584442714073	3.830320480927114	ROBO2;STAT5B;JUND;STAT3
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	6/83	0.060478277293766195821245190700210514478385448455810546875	0.4131469140877346291063076932914555072784423828125	0.015333088555561848187469564663842902518808841705322265625	0.1303174391289823874640063650076626800000667572021484375	-1.3258333899243908	3.719587167916822	TCF7L2;FZD2;FZD5;FZD8;CTNNB1;TBL1X
negative regulation of mammary gland epithelial cell proliferation	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.9513221855004287	3.45875762363894	GPX1;GATA3;GDF5;ROBO1
RNA 5'-end processing	5/56	0.039501861588877640318884232328855432569980621337890625	0.312111023642773599551247798444819636642932891845703125	0.01204942810199045345742607793226852663792669773101806640625	0.1099364649073287514280394816523767076432704925537109375	-1.0658463180464273	3.4441837639763415	DDX17;DHX30;RBM39;CELF2;ELAVL4
dsRNA fragmentation	5/56	0.039501861588877640318884232328855432569980621337890625	0.312111023642773599551247798444819636642932891845703125	0.01204942810199045345742607793226852663792669773101806640625	0.1099364649073287514280394816523767076432704925537109375	-1.0522405040036111	3.400217834715696	DDX17;DHX30;RBM39;CELF2;ELAVL4
RNA capping	5/55	0.036955943683311891223564060737771796993911266326904296875	0.295961267154808471691040949735906906425952911376953125	0.01126413954392967153861349061116925440728664398193359375	0.1039783683536521785573114584622089751064777374267578125	-1.0304429034753395	3.398430359082986	DDX17;DHX30;RBM39;CELF2;ELAVL4
ncRNA processing	5/55	0.036955943683311891223564060737771796993911266326904296875	0.295961267154808471691040949735906906425952911376953125	0.01126413954392967153861349061116925440728664398193359375	0.1039783683536521785573114584622089751064777374267578125	-1.027047577125012	3.387232475038144	DDX17;DHX30;RBM39;CELF2;ELAVL4
chloroplast RNA processing	5/55	0.036955943683311891223564060737771796993911266326904296875	0.295961267154808471691040949735906906425952911376953125	0.01126413954392967153861349061116925440728664398193359375	0.1039783683536521785573114584622089751064777374267578125	-1.0248453788926022	3.3799695618728443	DDX17;DHX30;RBM39;CELF2;ELAVL4
negative regulation of protein monoubiquitination	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.9249629117421	3.3629222269092334	U2AF2;PRMT3;ARRB1;OGT
mitochondrial RNA processing	5/56	0.039501861588877640318884232328855432569980621337890625	0.312111023642773599551247798444819636642932891845703125	0.01204942810199045345742607793226852663792669773101806640625	0.1099364649073287514280394816523767076432704925537109375	-1.0347251041500374	3.3436184406249954	DDX17;DHX30;RBM39;CELF2;ELAVL4
negative regulation of protein polyubiquitination	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.9189036943767077	3.3408925038824213	U2AF2;PRMT3;ARRB1;OGT
conversion of ds siRNA to ss siRNA	5/56	0.039501861588877640318884232328855432569980621337890625	0.312111023642773599551247798444819636642932891845703125	0.01204942810199045345742607793226852663792669773101806640625	0.1099364649073287514280394816523767076432704925537109375	-1.0294555221220532	3.3265902738467017	DDX17;DHX30;RBM39;CELF2;ELAVL4
phosphatidylinositol 3-kinase signaling	7/114	0.0896280961586509439253944719894207082688808441162109375	0.55048923122442250388530737836845219135284423828125	0.019835593982757089570601038985842023976147174835205078125	0.1578978711498744968988461323533556424081325531005859375	-1.3628275882333312	3.2872579387611784	PDGFRA;ERBB4;TYRO3;GATA3;OGT;FGFR2;ZFP36L1
negative regulation of NF-kappaB transcription factor activity	7/115	0.0928362770332386288973935961621464230120182037353515625	0.56650545765302273704122626440948806703090667724609375	0.0206514938146891112447089966508428915403783321380615234375	0.160482860500640089895796336350031197071075439453125	-1.3752415603854755	3.268836143178016	CYLD;TCF7L2;PTCH1;ID2;TRIM37;ARRB1;TRIB1
positive regulation of gene expression, epigenetic	12/261	0.1703269139805464738035567506813094951212406158447265625	0.73858861214153648244717942361603491008281707763671875	0.02143468846481132172865358143099001608788967132568359375	0.1662951077113733744372581213610828854143619537353515625	-1.8374532594472461	3.252357802284973	MEF2C;TLE1;GPX1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;DEK;ANK3;BRCA1
positive regulation of endodermal cell differentiation	4/32	0.0215406710893917725802015894487340119667351245880126953125	0.2134608099341617215571886845282278954982757568359375	0.00849836646919738085415030326430496643297374248504638671875	0.084750094366181916161195886161294765770435333251953125	-0.838365764622088	3.2174905710007464	DLX1;DLX2;JUND;OTX2
extraocular skeletal muscle development	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.8761772902142784	3.185550519452884	SVIL;MEF2C;SIX1;CACNA1C
calcium ion transmembrane import into cytosol	5/58	0.044906671685898617851773195752684841863811016082763671875	0.33730058971717158389225232895114459097385406494140625	0.013729792641554862397956782160690636374056339263916015625	0.11818144505513557274145597375536453910171985626220703125	-1.020283004522031	3.1661104943264973	TRPM1;ATP2A2;CACNA1D;CACNA1C;CACNG2
negative regulation of Wnt signaling pathway by Wnt receptor internalization	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.8698035119823282	3.1623771357274273	DKK4;RNF43;TLE1;CXXC4
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	5/59	0.04776651068245622855368281989285605959594249725341796875	0.354855622704188633509403416610439307987689971923828125	0.01462626817725051243945788570499644265510141849517822265625	0.1247596871466377377313250462975702248513698577880859375	-1.0384652600359918	3.158419913367752	TCF7L2;SCRT2;GPX1;PHIP;BRCA1
skeletal muscle acetylcholine-gated channel clustering	4/31	0.01934849818766339046849367377944872714579105377197265625	0.2014721102675678110482948568460415117442607879638671875	0.00768803252586484388297893843855490558780729770660400390625	0.07918002057752067390783423661559936590492725372314453125	-0.780144514713773	3.0777797017826756	CACNB1;DLG1;MAGI2;ANK3
negative regulation of Wnt-mediated midbrain dopaminergic neuron differentiation	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.8437957799115651	3.067819852249389	DKK4;RNF43;TLE1;CXXC4
positive regulation of amacrine cell differentiation	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.8421801019789676	3.0619456716070266	DLX1;MEF2C;DLX2;NEUROG1
negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.840769058116701	3.0568154867019657	DKK4;RNF43;TLE1;CXXC4
negative regulation of smoothened signaling pathway	4/34	0.0263644867561196698246828162837118725292384624481201171875	0.2467485794218580996695067142354673705995082855224609375	0.01028210946639260790769210274220313294790685176849365234375	0.097195812330609088203203782541095279157161712646484375	-0.8259560557743415	3.002959300478719	PTCH1;ZIC1;OTX2;FGFR2
negative regulation of protein autoubiquitination	4/36	0.0317853644912801935884516524311038665473461151123046875	0.2682138896339332223561768842046149075031280517578125	0.01229181201240100128335708262738990015350282192230224609375	0.11150091781249139855081153882565558888018131256103515625	-0.827051936239121	2.852294812022305	U2AF2;PRMT3;ARRB1;OGT
calcium ion transmembrane transport	6/91	0.08588201425829970758751841231060097925364971160888671875	0.5351459197574632842275832445011474192142486572265625	0.02249185347365491305371421049130731262266635894775390625	0.1725106875369597225766682413450325839221477508544921875	-1.1578963889516083	2.8423818840958672	TRPM1;SLN;ATP2A2;CACNA1D;CACNA1C;CACNG2
neuron projection development	6/99	0.11629278580104641938053333660718635655939579010009765625	0.66491281287701331503825485924608074128627777099609375	0.0316177773440761422651945622419589199125766754150390625	0.2100578249746579972967452931698062457144260406494140625	-1.3059290510693138	2.8098947366800737	ALK;SKOR1;MEF2C;MYT1L;RAPGEF2;CNTN4
embryonic heart tube development	6/95	0.10047839009192245651735930778158945031464099884033203125	0.5976753670411074637058845837600529193878173828125	0.0267976167409720751610979760926056769676506519317626953125	0.1895117813600678824403900080142193473875522613525390625	-1.213801310745129	2.7890879439847995	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C;FGFR2
negative regulation of histone ubiquitination	4/35	0.0289996204740954645340256234931075596250593662261962890625	0.2487112905023787512437394298103754408657550811767578125	0.0112581083239067479551120953829013160429894924163818359375	0.1039783683536521785573114584622089751064777374267578125	-0.7874482358461679	2.7879388526778954	U2AF2;PRMT3;ARRB1;OGT
positive regulation of fat cell differentiation	5/61	0.0538024644206533120271984671489917673170566558837890625	0.37878540995853982042973484567482955753803253173828125	0.0165351468846830391978830476773509872145950794219970703125	0.137076077073901403391431585987447760999202728271484375	-0.9534760871257131	2.7864728476742022	DLX1;DLX2;JUND;LMO3;ZFP36L1
positive regulation of snoRNA processing	10/214	0.1849273837752351823393581753407488577067852020263671875	0.73858861214153648244717942361603491008281707763671875	0.0310630799369265610254675635815146961249411106109619140625	0.2075418527797203704921003009076230227947235107421875	-1.6297381478746833	2.7506590913473343	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
positive regulation of tRNA processing	10/214	0.1849273837752351823393581753407488577067852020263671875	0.73858861214153648244717942361603491008281707763671875	0.0310630799369265610254675635815146961249411106109619140625	0.2075418527797203704921003009076230227947235107421875	-1.6266985393065347	2.7455288641675764	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
regulation of cell migration	5/66	0.07073594593387440288001499766323831863701343536376953125	0.462134981953027101919673214069916866719722747802734375	0.022012168424168900016102412564578116871416568756103515625	0.1702154073062372152680410408720490522682666778564453125	-1.0351744360154786	2.7419715018166433	LDB1;LMO4;ERBB4;PLXNA2;LDB2
positive regulation of histone gene expression	10/214	0.1849273837752351823393581753407488577067852020263671875	0.73858861214153648244717942361603491008281707763671875	0.0310630799369265610254675635815146961249411106109619140625	0.2075418527797203704921003009076230227947235107421875	-1.624369236359155	2.7415974851683993	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
mitochondrial calcium ion transmembrane transport	5/68	0.07823992792697620490827148387324996292591094970703125	0.495462131706552899590434435594943352043628692626953125	0.0244965353483905974585344011984489043243229389190673828125	0.1758692630799752187886753063139622099697589874267578125	-1.0378075835172171	2.6443079586419658	TRPM1;ATP2A2;CACNA1D;CACNA1C;CACNG2
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification	4/35	0.0289996204740954645340256234931075596250593662261962890625	0.2487112905023787512437394298103754408657550811767578125	0.0112581083239067479551120953829013160429894924163818359375	0.1039783683536521785573114584622089751064777374267578125	-0.742786525889838	2.6298152951586076	DKK4;RNF43;TLE1;CXXC4
regulation of fibroblast proliferation	7/122	0.117047358743931406710458986708545126020908355712890625	0.66841693849288674744713034669985063374042510986328125	0.0270253729288663611940446429571238695643842220306396484375	0.18998313577565217880049885934568010270595550537109375	-1.2184758202554538	2.6138458788044527	RBFOX2;JUND;GRAP2;SIX3;CTNNB1;PDS5B;BRCA1
cellular response to gonadotropin stimulus	4/38	0.037812194463103430963624163041458814404904842376708984375	0.301283988652802203755953769359621219336986541748046875	0.014536803216324938048398252021797816269099712371826171875	0.1242211970496462647428614900491083972156047821044921875	-0.798033181971027	2.6136573266407837	ROBO2;STAT5B;JUND;STAT3
negative regulation of Wnt signaling pathway involved in heart development	4/35	0.0289996204740954645340256234931075596250593662261962890625	0.2487112905023787512437394298103754408657550811767578125	0.0112581083239067479551120953829013160429894924163818359375	0.1039783683536521785573114584622089751064777374267578125	-0.7335079046802956	2.596964591592592	DKK4;RNF43;TLE1;CXXC4
cellular response to estradiol stimulus	4/39	0.04105428437634124627653164907314931042492389678955078125	0.320909058430777605064321278405259363353252410888671875	0.0157501608302689118101813647854214650578796863555908203125	0.1336214184107526181666258935365476645529270172119140625	-0.8103867428992476	2.5874514798128634	STAT5B;STAT3;CTNNB1;WNT8B
regulation of osteoblast proliferation	7/124	0.12451480560482097725838457336067222058773040771484375	0.697549095056936518943757619126699864864349365234375	0.029067557367287145952960969452760764397680759429931640625	0.1972829756856021299338266317136003635823726654052734375	-1.2404683579116296	2.5843057499300324	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1;FGFR2
RNA processing	6/92	0.0894146062587920231745641785892075859010219573974609375	0.5498939996384901718329274444840848445892333984375	0.0235212138460801183093007438174026901833713054656982421875	0.1758692630799752187886753063139622099697589874267578125	-1.0648406422402705	2.5710270943475537	DDX17;DHX30;RBM39;RBFOX2;CELF2;ELAVL4
regulation of stem cell proliferation	7/125	0.1283374107129510999225630030196043662726879119873046875	0.71303600274792733326734150978154502809047698974609375	0.0301267576898956342124069607280034688301384449005126953125	0.2021449730060280447485610011426615528762340545654296875	-1.2351445282122042	2.535865920449297	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1;ZFP36L1
positive regulation of vasculogenesis	4/36	0.0317853644912801935884516524311038665473461151123046875	0.2682138896339332223561768842046149075031280517578125	0.01229181201240100128335708262738990015350282192230224609375	0.11150091781249139855081153882565558888018131256103515625	-0.7127518009783876	2.458102296978875	DLX1;DLX2;JUND;RAPGEF2
cellular response to jasmonic acid stimulus	4/37	0.03472267254877119124767403945952537469565868377685546875	0.281420698303356864311552953950013034045696258544921875	0.0133843542833098801125846222248583217151463031768798828125	0.115418645620425419640042719038319773972034454345703125	-0.7269166357368787	2.4427033436193697	ROBO2;STAT5B;JUND;STAT3
mesodermal to mesenchymal transition involved in gastrulation	4/41	0.047996160119837261159858599057770334184169769287109375	0.354855622704188633509403416610439307987689971923828125	0.0183632786859179823746313076071601244620978832244873046875	0.149602047601856857905744391246116720139980316162109375	-0.7960335344598415	2.417262709836915	EOMES;DDX17;CTNNB1;WNT8B
ureteric bud morphogenesis	3/15	0.01270520330622519622476573886160622350871562957763671875	0.170331297404752779467429490978247486054897308349609375	0.0072318243799945614025403983760043047368526458740234375	0.0753035664468749421640580976600176654756069183349609375	-0.5536038705384854	2.416892588106473	ROBO2;SIX1;FGFR2
synaptic transmission, glutamatergic	9/182	0.1604604655131540713597360081621445715427398681640625	0.73858861214153648244717942361603491008281707763671875	0.0295254329106996414588959254388100816868245601654052734375	0.1983924031905558715838111538687371648848056793212890625	-1.3062594721552812	2.39007299813012	CACNB1;GRIA1;SLC6A5;DLG1;GRID2;NRXN2;APBA1;PDE7B;SLC1A6
positive regulation of thyroid hormone receptor activity	6/99	0.11629278580104641938053333660718635655939579010009765625	0.66491281287701331503825485924608074128627777099609375	0.0316177773440761422651945622419589199125766754150390625	0.2100578249746579972967452931698062457144260406494140625	-1.076052418552591	2.3152820015811932	FZD2;CTNNB1;TRIM37;GATA3;NKX6-1;NEUROG1
negative regulation of non-canonical Wnt signaling pathway	4/37	0.03472267254877119124767403945952537469565868377685546875	0.281420698303356864311552953950013034045696258544921875	0.0133843542833098801125846222248583217151463031768798828125	0.115418645620425419640042719038319773972034454345703125	-0.6835108280090223	2.2968440986155	DKK4;RNF43;TLE1;CXXC4
astrocyte differentiation	6/103	0.1332734425911639430939459316505235619843006134033203125	0.72010404204183320331367212929762899875640869140625	0.03697105339665980594521244029238005168735980987548828125	0.2379160421173864836674738398869521915912628173828125	-1.1294159056597535	2.276170945409777	ROBO2;RCAN1;NFIB;STAT3;PHOX2B;HAPLN1
cellular response to leptin stimulus	4/40	0.044449009627008713441131959598351386375725269317626953125	0.33439549985741645610204386684927158057689666748046875	0.01702536285895929479838883935371995903551578521728515625	0.1406455982586882480500634073905530385673046112060546875	-0.724886533175277	2.2568708644197755	ROBO2;STAT5B;JUND;STAT3
cellular response to hormone stimulus	4/40	0.044449009627008713441131959598351386375725269317626953125	0.33439549985741645610204386684927158057689666748046875	0.01702536285895929479838883935371995903551578521728515625	0.1406455982586882480500634073905530385673046112060546875	-0.7178852590948456	2.235073009496566	ROBO2;STAT5B;JUND;STAT3
negative regulation of androgen receptor activity	5/66	0.07073594593387440288001499766323831863701343536376953125	0.462134981953027101919673214069916866719722747802734375	0.022012168424168900016102412564578116871416568756103515625	0.1702154073062372152680410408720490522682666778564453125	-0.8255461032615373	2.1867076792312403	TCF7L2;PTCH1;ID2;TRIB1;FOXP1
enzyme active site formation via O4'-phospho-L-tyrosine	4/46	0.06799277897267268222503133756617899052798748016357421875	0.450950064692920926656682922839536331593990325927734375	0.026019368932810323091775472903464105911552906036376953125	0.1842843292133127530707525920661282725632190704345703125	-0.8063817859032342	2.1678395150173	PDGFRA;PKDCC;ERBB4;FGFR2
positive regulation of epithelial to mesenchymal transition	5/69	0.082146036487409090920408516467432491481304168701171875	0.515269752807325343013644669554196298122406005859375	0.025803595630894869683569226026520482264459133148193359375	0.1835830476484631990086171526854741387069225311279296875	-0.8478749762392862	2.119057200650921	DLX1;DLX2;JUND;CTNNB1;CLASP2
positive regulation of rhodopsin gene expression	10/215	0.18856730390554166110206324447062797844409942626953125	0.73858861214153648244717942361603491008281707763671875	0.031886165640090537165551864973167539574205875396728515625	0.210949569879813558781478377568419091403484344482421875	-1.2445475850322423	2.0762790919558665	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
positive regulation of production of siRNA involved in RNA interference	10/215	0.18856730390554166110206324447062797844409942626953125	0.73858861214153648244717942361603491008281707763671875	0.031886165640090537165551864973167539574205875396728515625	0.210949569879813558781478377568419091403484344482421875	-1.2378298093084183	2.065071824795035	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
negative regulation of ubiquitin-protein transferase activity	4/41	0.047996160119837261159858599057770334184169769287109375	0.354855622704188633509403416610439307987689971923828125	0.0183632786859179823746313076071601244620978832244873046875	0.149602047601856857905744391246116720139980316162109375	-0.6784588498728559	2.060231393479356	U2AF2;PRMT3;ARRB1;OGT
ureter part of ureteric bud development	3/15	0.01270520330622519622476573886160622350871562957763671875	0.170331297404752779467429490978247486054897308349609375	0.0072318243799945614025403983760043047368526458740234375	0.0753035664468749421640580976600176654756069183349609375	-0.47127512887448036	2.0574664061285173	ROBO2;SIX1;FGFR2
tRNA-type intron splice site recognition and cleavage	5/69	0.082146036487409090920408516467432491481304168701171875	0.515269752807325343013644669554196298122406005859375	0.025803595630894869683569226026520482264459133148193359375	0.1835830476484631990086171526854741387069225311279296875	-0.8216311556235767	2.053467156591624	DDX17;DHX30;RBM39;CELF2;ELAVL4
positive regulation of mitotic cell cycle	5/71	0.09026211378619107550402844708514749072492122650146484375	0.55366240667030341970900053638615645468235015869140625	0.0285496206518250743300324501205977867357432842254638671875	0.1963095248506767642737713686074130237102508544921875	-0.8537912785604447	2.053400013080841	CYLD;TAL1;CITED2;GBF1;FGFR2
negative regulation of mRNA catabolic process	10/215	0.18856730390554166110206324447062797844409942626953125	0.73858861214153648244717942361603491008281707763671875	0.031886165640090537165551864973167539574205875396728515625	0.210949569879813558781478377568419091403484344482421875	-1.2236955043217792	2.0414915597444816	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
positive regulation of kinase activity	4/36	0.0317853644912801935884516524311038665473461151123046875	0.2682138896339332223561768842046149075031280517578125	0.01229181201240100128335708262738990015350282192230224609375	0.11150091781249139855081153882565558888018131256103515625	-0.5901736166406883	2.0353608657171183	LDB1;DSCAM;LMO4;LDB2
brain-derived neurotrophic factor receptor signaling pathway	5/75	0.10767908421698539622735069087866577319800853729248046875	0.63128733535686343270043607844854705035686492919921875	0.034579716868377630145658940818975679576396942138671875	0.22374831888633373022656769535387866199016571044921875	-0.8959565258788843	1.9967286399200237	BDNF;ERBB4;GRAP2;RAPGEF2;PTPRG
cellular response to brassinosteroid stimulus	4/45	0.06369566033658631554192908197364886291325092315673828125	0.4316845255857437724245073695783503353595733642578125	0.0243571531759347210954746998368136701174080371856689453125	0.1758692630799752187886753063139622099697589874267578125	-0.7239704428647283	1.9935531343278345	ROBO2;STAT5B;JUND;STAT3
cellular response to prostaglandin stimulus	4/42	0.051695258118954666437527833977583213709294795989990234375	0.36449406957714369781342611531727015972137451171875	0.019764711413223133573691114861503592692315578460693359375	0.1578978711498744968988461323533556424081325531005859375	-0.6659869562063127	1.9729125802878658	ROBO2;STAT5B;JUND;STAT3
negative regulation of focal adhesion assembly	4/37	0.03472267254877119124767403945952537469565868377685546875	0.281420698303356864311552953950013034045696258544921875	0.0133843542833098801125846222248583217151463031768798828125	0.115418645620425419640042719038319773972034454345703125	-0.5783886687816928	1.9435955454677456	LDB1;SEMA3E;EFNA5;CLASP2
negative regulation of gene silencing	10/216	0.1922391381042326263806074848616844974458217620849609375	0.73858861214153648244717942361603491008281707763671875	0.032724505107192526642823082738686935044825077056884765625	0.2155886740092557707360043650623993016779422760009765625	-1.1730208835741622	1.9343292329137756	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
sensory perception of sound	5/69	0.082146036487409090920408516467432491481304168701171875	0.515269752807325343013644669554196298122406005859375	0.025803595630894869683569226026520482264459133148193359375	0.1835830476484631990086171526854741387069225311279296875	-0.7616346307126041	1.9035204407555986	EYA1;COL11A2;PAX3;CACNA1D;TBL1X
cellular response to thyroid hormone stimulus	4/44	0.059546108717402679300079171298420988023281097412109375	0.4088486096360821608897140322369523346424102783203125	0.0227610099934298128199205990540576749481260776519775390625	0.1737276442378777041586346285839681513607501983642578125	-0.6588585334249609	1.858642775722936	ROBO2;STAT5B;JUND;STAT3
Wnt signaling pathway, calcium modulating pathway	4/38	0.037812194463103430963624163041458814404904842376708984375	0.301283988652802203755953769359621219336986541748046875	0.014536803216324938048398252021797816269099712371826171875	0.1242211970496462647428614900491083972156047821044921875	-0.5569722099583329	1.8241528424888938	TCF7L2;FZD2;FZD5;CTNNB1
positive regulation of fibroblast growth factor receptor signaling pathway	3/15	0.01270520330622519622476573886160622350871562957763671875	0.170331297404752779467429490978247486054897308349609375	0.0072318243799945614025403983760043047368526458740234375	0.0753035664468749421640580976600176654756069183349609375	-0.4159894637609568	1.816103364155127	OTX2;GATA3;FGFR2
negative regulation of protein ubiquitination	4/44	0.059546108717402679300079171298420988023281097412109375	0.4088486096360821608897140322369523346424102783203125	0.0227610099934298128199205990540576749481260776519775390625	0.1737276442378777041586346285839681513607501983642578125	-0.6419835861973665	1.8110384765234837	U2AF2;PRMT3;ARRB1;OGT
cell surface receptor signaling pathway involved in heart development	5/79	0.126604542747636605870553694330737926065921783447265625	0.7059026337359359803969027780112810432910919189453125	0.041343271165426458135794263171192142181098461151123046875	0.25626308815678922048419963175547309219837188720703125	-0.8703184939333583	1.7986758191285106	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
coronary vasculature development	5/80	0.131559945846273951275406943750567734241485595703125	0.7166611958547128846674922897364012897014617919921875	0.043150485876785583949644120593802654184401035308837890625	0.259197548393503007790883430061512626707553863525390625	-0.8863512008632722	1.79777964312644	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
larval heart development	5/79	0.126604542747636605870553694330737926065921783447265625	0.7059026337359359803969027780112810432910919189453125	0.041343271165426458135794263171192142181098461151123046875	0.25626308815678922048419963175547309219837188720703125	-0.8682296194230066	1.7943587695688914	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
heart development	5/79	0.126604542747636605870553694330737926065921783447265625	0.7059026337359359803969027780112810432910919189453125	0.041343271165426458135794263171192142181098461151123046875	0.25626308815678922048419963175547309219837188720703125	-0.8658756344467056	1.7894938196856265	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
cell migration involved in heart development	5/79	0.126604542747636605870553694330737926065921783447265625	0.7059026337359359803969027780112810432910919189453125	0.041343271165426458135794263171192142181098461151123046875	0.25626308815678922048419963175547309219837188720703125	-0.8636840826072875	1.7849645682364095	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
cardiocyte differentiation	5/80	0.131559945846273951275406943750567734241485595703125	0.7166611958547128846674922897364012897014617919921875	0.043150485876785583949644120593802654184401035308837890625	0.259197548393503007790883430061512626707553863525390625	-0.8752994868194192	1.7753635325482149	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
detection of mechanical stimulus involved in sensory perception of sound	5/73	0.09877635447230102838656051744692376814782619476318359375	0.5907768147202963060493630109704099595546722412109375	0.03147408735321903516801711475636693648993968963623046875	0.2096938842445398021308022862285724841058254241943359375	-0.7646750290556763	1.7701439537335537	EYA1;COL11A2;PAX3;CACNA1D;TBL1X
cardiac skeleton development	5/80	0.131559945846273951275406943750567734241485595703125	0.7166611958547128846674922897364012897014617919921875	0.043150485876785583949644120593802654184401035308837890625	0.259197548393503007790883430061512626707553863525390625	-0.8689261762977455	1.762436593538002	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
positive regulation of Rho protein signal transduction	4/44	0.059546108717402679300079171298420988023281097412109375	0.4088486096360821608897140322369523346424102783203125	0.0227610099934298128199205990540576749481260776519775390625	0.1737276442378777041586346285839681513607501983642578125	-0.6221975063017542	1.755221859462023	GPR17;LPAR1;ARRB1;ROBO1
positive regulation of rRNA processing	10/220	0.2072359557184862699497074345345026813447475433349609375	0.73858861214153648244717942361603491008281707763671875	0.036232846153034736769171786363585852086544036865234375	0.2334840646227661908884698505062260664999485015869140625	-1.1078252454360324	1.7436031097004505	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
positive regulation of macrophage derived foam cell differentiation	4/41	0.047996160119837261159858599057770334184169769287109375	0.354855622704188633509403416610439307987689971923828125	0.0183632786859179823746313076071601244620978832244873046875	0.149602047601856857905744391246116720139980316162109375	-0.5629087756765941	1.7093480784151929	DLX1;DLX2;PRKCH;JUND
mRNA processing	6/107	0.151356030603991609240210891584865748882293701171875	0.73858861214153648244717942361603491008281707763671875	0.04287283309540412812310705703566782176494598388671875	0.259197548393503007790883430061512626707553863525390625	-0.8917806203957162	1.6837891807042584	DDX17;DHX30;RBM39;U2AF2;CELF2;ELAVL4
positive regulation of peroxisome proliferator activated receptor signaling pathway	3/12	0.006621004312468350451459375705098864273168146610260009765625	0.10787286952003131978994332484944607131183147430419921875	0.004239218550275117465553353923723989282734692096710205078125	0.04925220172819637365346778778985026292502880096435546875	-0.3324171735441941	1.667905897970679	CITED2;LMO3;GATA3
activation of prostate induction by androgen receptor signaling pathway	4/46	0.06799277897267268222503133756617899052798748016357421875	0.450950064692920926656682922839536331593990325927734375	0.026019368932810323091775472903464105911552906036376953125	0.1842843292133127530707525920661282725632190704345703125	-0.6193912249755879	1.6651427354017376	DDX17;CTNNB1;OTX2;BRCA1
Wnt receptor catabolic process	4/45	0.06369566033658631554192908197364886291325092315673828125	0.4316845255857437724245073695783503353595733642578125	0.0243571531759347210954746998368136701174080371856689453125	0.1758692630799752187886753063139622099697589874267578125	-0.5881187776900799	1.6194667119030186	DKK4;RNF43;TLE1;CXXC4
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	4/47	0.0724358055866634320540953240197268314659595489501953125	0.4719332803208444726550396808306686580181121826171875	0.02774813450279405013798594836771371774375438690185546875	0.1947737357882135811326662633291562087833881378173828125	-0.6149836182891693	1.6143655450820442	U2AF2;PRMT3;ARRB1;OGT
anterior/posterior pattern specification involved in ureteric bud development	3/14	0.01042066545042021064038095801151939667761325836181640625	0.1526530401541370540741127115325070917606353759765625	0.006127694493670917015581967035586785641498863697052001953125	0.06599163225261579779346021723540616221725940704345703125	-0.34992020124003187	1.5970233349639218	ROBO2;SIX1;FGFR2
chondrocyte differentiation	4/41	0.047996160119837261159858599057770334184169769287109375	0.354855622704188633509403416610439307987689971923828125	0.0183632786859179823746313076071601244620978832244873046875	0.149602047601856857905744391246116720139980316162109375	-0.5217335097635232	1.584313854917531	MEF2C;NFIB;COL11A2;GDF2
forebrain dorsal/ventral pattern formation	3/15	0.01270520330622519622476573886160622350871562957763671875	0.170331297404752779467429490978247486054897308349609375	0.0072318243799945614025403983760043047368526458740234375	0.0753035664468749421640580976600176654756069183349609375	-0.36201327766741986	1.5804571719115053	PTCH1;SIX3;HOXD11
endocardial cushion development	5/84	0.152224372746097846853530199950910173356533050537109375	0.73858861214153648244717942361603491008281707763671875	0.05084902704546971630161777966350200586020946502685546875	0.285881836202003192237697248856420628726482391357421875	-0.8340794776799846	1.5700709669575281	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
transforming growth factor beta receptor signaling pathway involved in regulation of multicellular organism growth	5/82	0.1417273642227675767291117381319054402410984039306640625	0.73858861214153648244717942361603491008281707763671875	0.046905617554145073722082770473207347095012664794921875	0.273336492533569119789405021947459317743778228759765625	-0.8011684033321913	1.5653629146128618	STAT5B;USP9X;PARD3;GDF5;FGFR2
pericardium development	5/83	0.1469356390177740667724037848529405891895294189453125	0.73858861214153648244717942361603491008281707763671875	0.048853749601758533760431646442157216370105743408203125	0.28033967619558552986092081482638604938983917236328125	-0.797426435223947	1.529273013136832	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
negative regulation of epithelial to mesenchymal transition	4/46	0.06799277897267268222503133756617899052798748016357421875	0.450950064692920926656682922839536331593990325927734375	0.026019368932810323091775472903464105911552906036376953125	0.1842843292133127530707525920661282725632190704345703125	-0.5677091177196528	1.5262029474658245	EFNA1;SKOR1;NKX2-1;CLASP2
histone-tyrosine phosphorylation	4/54	0.10744301396497367429017089079934521578252315521240234375	0.63114408078802097801229820106527768075466156005859375	0.04173990573466757059151177600142545998096466064453125	0.257705674542443585739448508320492692291736602783203125	-0.6665697673376728	1.4869802872395141	PDGFRA;PKDCC;ERBB4;FGFR2
positive regulation of collateral sprouting	5/82	0.1417273642227675767291117381319054402410984039306640625	0.73858861214153648244717942361603491008281707763671875	0.046905617554145073722082770473207347095012664794921875	0.273336492533569119789405021947459317743778228759765625	-0.7315438673495853	1.4293270123967952	ROBO2;BDNF;SLITRK1;AKAP6;ROBO1
negative regulation of wound healing, spreading of epidermal cells	5/86	0.163035164528865073041430377998040057718753814697265625	0.73858861214153648244717942361603491008281707763671875	0.054981171958122500298404844443211914040148258209228515625	0.30539277788666774338111054021283052861690521240234375	-0.7772806385126854	1.4098233581926878	CITED2;MAGI2;NKX2-1;CLASP2;ROBO1
negative regulation of smooth muscle cell migration	5/86	0.163035164528865073041430377998040057718753814697265625	0.73858861214153648244717942361603491008281707763671875	0.054981171958122500298404844443211914040148258209228515625	0.30539277788666774338111054021283052861690521240234375	-0.7594944636122982	1.3775629832585488	CITED2;MAGI2;NKX2-1;TRIB1;ROBO1
adult heart development	5/86	0.163035164528865073041430377998040057718753814697265625	0.73858861214153648244717942361603491008281707763671875	0.054981171958122500298404844443211914040148258209228515625	0.30539277788666774338111054021283052861690521240234375	-0.755037485477268	1.3694789637032139	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
SMAD protein import into nucleus	4/50	0.0866207520817197929030584191423258744180202484130859375	0.53832686109284877407077374300570227205753326416015625	0.033337557845746150497756588038100744597613811492919921875	0.2179210237719404197331840578044648282229900360107421875	-0.5426611710161067	1.3274663635213686	STAT3;PRICKLE1;GDF5;ACVR2A
cardiac muscle tissue development	5/87	0.168553084599269153986966784941614605486392974853515625	0.73858861214153648244717942361603491008281707763671875	0.05711805471007082302126178774415166117250919342041015625	0.3136505984486659404097963488311506807804107666015625	-0.7329662235328646	1.3050496862282768	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
neuromuscular synaptic transmission	9/193	0.2026276539445455993071476541445008479058742523193359375	0.73858861214153648244717942361603491008281707763671875	0.040022272386847947134302927452154108323156833648681640625	0.25071056952026793407384275269578211009502410888671875	-0.8021561246584508	1.280550166455211	FCHSD1;SLC6A5;CACNB1;GRIA1;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
smooth muscle cell chemotaxis	4/49	0.08175193870468235035620097050923504866659641265869140625	0.51485166204270582657187560471356846392154693603515625	0.031406908301387780058089305157409398816525936126708984375	0.2095422722173212737306613462351378984749317169189453125	-0.503591893029391	1.261027213550517	PDGFRA;LPAR1;ELMO2;AAMP
embryonic heart tube anterior/posterior pattern specification	5/89	0.179803329336317430087177626774064265191555023193359375	0.73858861214153648244717942361603491008281707763671875	0.061533296899946930691438495841794065199792385101318359375	0.32908453682205174306574235743028111755847930908203125	-0.7279062860904377	1.2490083111726182	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
negative regulation of osteoblast differentiation	4/56	0.1186229154942196883926186501412303186953067779541015625	0.67577813090124905226474538721959106624126434326171875	0.046349896216077719757198138950116117484867572784423828125	0.271593118572967195945011553703807294368743896484375	-0.5834816612849263	1.243869469778256	SKOR1;MEF2C;PTCH1;FGFR2
cellular response to cAMP	4/50	0.0866207520817197929030584191423258744180202484130859375	0.53832686109284877407077374300570227205753326416015625	0.033337557845746150497756588038100744597613811492919921875	0.2179210237719404197331840578044648282229900360107421875	-0.5018694594216779	1.2276810316342976	JUND;RAPGEF2;AKAP6;ZFP36L1
regulation of lipid kinase activity	5/87	0.168553084599269153986966784941614605486392974853515625	0.73858861214153648244717942361603491008281707763671875	0.05711805471007082302126178774415166117250919342041015625	0.3136505984486659404097963488311506807804107666015625	-0.6850711548853208	1.2197722992170645	LDB1;TXNRD1;ID2;TBL1X;LDB2
positive regulation of cell cycle	5/86	0.163035164528865073041430377998040057718753814697265625	0.73858861214153648244717942361603491008281707763671875	0.054981171958122500298404844443211914040148258209228515625	0.30539277788666774338111054021283052861690521240234375	-0.6611249918513556	1.1991414812293437	JUND;MECOM;CITED2;STAT3;FGFR2
positive regulation of protein maturation	10/222	0.2149130267778122382882344254539930261671543121337890625	0.73858861214153648244717942361603491008281707763671875	0.038081658878843460680485577540821395814418792724609375	0.2430733219641469655680765526994946412742137908935546875	-0.7788470058756685	1.197494296593748	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
positive regulation of neuron differentiation	4/56	0.1186229154942196883926186501412303186953067779541015625	0.67577813090124905226474538721959106624126434326171875	0.046349896216077719757198138950116117484867572784423828125	0.271593118572967195945011553703807294368743896484375	-0.5066970741175683	1.080179657288392	MEF2C;CASZ1;SIX1;NEUROG1
cellular response to steroid hormone stimulus	4/61	0.148611236404865343363468355164513923227787017822265625	0.73858861214153648244717942361603491008281707763671875	0.05906113846294937241854228204829269088804721832275390625	0.322817369791114916477425822449731640517711639404296875	-0.5588846121232234	1.0654696598246671	ROBO2;STAT5B;JUND;STAT3
positive regulation of mRNA processing	10/224	0.2227036405723157030944747702960739843547344207763671875	0.73858861214153648244717942361603491008281707763671875	0.039994772010120506477992563532097847200930118560791015625	0.25071056952026793407384275269578211009502410888671875	-0.7047763490436132	1.0585130126251103	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1
positive regulation of sequence-specific DNA binding transcription factor activity	5/89	0.179803329336317430087177626774064265191555023193359375	0.73858861214153648244717942361603491008281707763671875	0.061533296899946930691438495841794065199792385101318359375	0.32908453682205174306574235743028111755847930908203125	-0.6009970033162998	1.0312457337930345	FZD2;CTNNB1;TRIM37;NKX6-1;NEUROG1
protein localization to T-tubule	4/53	0.1020408280031167291834748311885050497949123382568359375	0.60544224615182595794493636276456527411937713623046875	0.039537133017074461982520716674116556532680988311767578125	0.2483311004547806011277799598246929235756397247314453125	-0.4516584691200707	1.0308572825777533	DLG1;FCHO2;RAPGEF2;ANK3
maintenance of protein location in plasma membrane	4/53	0.1020408280031167291834748311885050497949123382568359375	0.60544224615182595794493636276456527411937713623046875	0.039537133017074461982520716674116556532680988311767578125	0.2483311004547806011277799598246929235756397247314453125	-0.44827758363319187	1.0231408094813883	DLG1;FCHO2;RAPGEF2;ANK3
negative regulation of outer hair cell apoptotic process	4/60	0.14239426775523700285930317477323114871978759765625	0.73858861214153648244717942361603491008281707763671875	0.056384217373568960851581977067326079122722148895263671875	0.310343469487893541813861020273179747164249420166015625	-0.5162431200092353	1.0062381349483942	MEF2C;BDNF;TYRO3;SIX1
negative regulation of sequence-specific DNA binding transcription factor activity	4/54	0.10744301396497367429017089079934521578252315521240234375	0.63114408078802097801229820106527768075466156005859375	0.04173990573466757059151177600142545998096466064453125	0.257705674542443585739448508320492692291736602783203125	-0.4389256016646914	0.9791528947479343	TCF7L2;PTCH1;ID2;TRIB1
negative regulation of axonogenesis	4/54	0.10744301396497367429017089079934521578252315521240234375	0.63114408078802097801229820106527768075466156005859375	0.04173990573466757059151177600142545998096466064453125	0.257705674542443585739448508320492692291736602783203125	-0.3898909119239346	0.8697665700026144	SIPA1L1;SEMA3A;LPAR1;STMN2
positive regulation of dendrite development	4/62	0.1549307171902507551664029961102642118930816650390625	0.73858861214153648244717942361603491008281707763671875	0.061804750824220190674740393887987011112272739410400390625	0.329788472441003011059734717491664923727512359619140625	-0.4638877170345222	0.8650472602877888	MAGI2;STMN2;RAPGEF2;VLDLR
negative regulation of CREB transcription factor activity	4/57	0.12439431099754495735343340356848784722387790679931640625	0.697549095056936518943757619126699864864349365234375	0.048756946610034414268941560521852807141840457916259765625	0.28033967619558552986092081482638604938983917236328125	-0.41025763983631935	0.8550995192237686	TCF7L2;PTCH1;ID2;TRIB1
negative regulation of Wnt signaling pathway	4/60	0.14239426775523700285930317477323114871978759765625	0.73858861214153648244717942361603491008281707763671875	0.056384217373568960851581977067326079122722148895263671875	0.310343469487893541813861020273179747164249420166015625	-0.429579742933319	0.8373177338094125	DKK4;RNF43;TLE1;CXXC4
negative regulation of motor neuron apoptotic process	4/62	0.1549307171902507551664029961102642118930816650390625	0.73858861214153648244717942361603491008281707763671875	0.061804750824220190674740393887987011112272739410400390625	0.329788472441003011059734717491664923727512359619140625	-0.44115120407609526	0.8226487282272356	MEF2C;BDNF;TYRO3;SIX1
positive regulation of gene expression	12/282	0.2413783517331719863374672740974347107112407684326171875	0.73858861214153648244717942361603491008281707763671875	0.035184532629676378012728577004963881336152553558349609375	0.2270389061753535775434187371502048335969448089599609375	-0.5428046579157931	0.7715369239981377	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;MITF;ANK3;BRCA1;PHOX2B;ZFP36L1
lens fiber cell differentiation	4/58	0.1302822842775619160970990151326986961066722869873046875	0.7166611958547128846674922897364012897014617919921875	0.05123183425327131057525065216395887546241283416748046875	0.28769114544366758412508033870835788547992706298828125	-0.3250368444600812	0.6624419145830599	SIX3;SIX1;FGFR2;CNN3
cell chemotaxis to fibroblast growth factor	4/63	0.161349034711513017459338925618794746696949005126953125	0.73858861214153648244717942361603491008281707763671875	0.06461465114175284074615746021663653664290904998779296875	0.3395020417727934169960235522012226283550262451171875	-0.3625931508763375	0.6614371113287687	PDGFRA;LPAR1;ELMO2;ZFP36L1
calcium ion import into sarcoplasmic reticulum	3/15	0.01270520330622519622476573886160622350871562957763671875	0.170331297404752779467429490978247486054897308349609375	0.0072318243799945614025403983760043047368526458740234375	0.0753035664468749421640580976600176654756069183349609375	-0.1477420503530834	0.6450039196848378	SLN;ATP2A2;CACNA1D
regulation of protein localization to cell surface	3/14	0.01042066545042021064038095801151939667761325836181640625	0.1526530401541370540741127115325070917606353759765625	0.006127694493670917015581967035586785641498863697052001953125	0.06599163225261579779346021723540616221725940704345703125	-0.13846718246620596	0.6319592888366788	BDNF;GBF1;CTNNB1
protein transport from ciliary membrane to plasma membrane	4/60	0.14239426775523700285930317477323114871978759765625	0.73858861214153648244717942361603491008281707763671875	0.056384217373568960851581977067326079122722148895263671875	0.310343469487893541813861020273179747164249420166015625	-0.307617319098903	0.5995940002887936	DLG1;FCHO2;RAPGEF2;ANK3
positive regulation of neuron projection development	5/91	0.1913248539496486821942511369343264959752559661865234375	0.73858861214153648244717942361603491008281707763671875	0.0661367050235388276302472831957857124507427215576171875	0.342267737608351330091949193956679664552211761474609375	-0.34839741202170066	0.5761735394405352	MEF2C;MAGI2;STMN2;RAPGEF2;NEUROG1
mesenchymal to epithelial transition	4/59	0.13628343145924048940287320874631404876708984375	0.73217419839776465284586492998641915619373321533203125	0.053774345550185655151498309578528278507292270660400390625	0.3011243487584887024155477774911560118198394775390625	-0.27276558527326705	0.5436268595300887	SIX1;GATA3;FGFR2;CNN3
negative regulation of ERK1 and ERK2 cascade	4/63	0.161349034711513017459338925618794746696949005126953125	0.73858861214153648244717942361603491008281707763671875	0.06461465114175284074615746021663653664290904998779296875	0.3395020417727934169960235522012226283550262451171875	-0.28923884434081	0.5276252604950726	DLG1;LMO3;CNKSR3;FGFR2
chromatin remodeling	4/66	0.181159592621030707260132430747034959495067596435546875	0.73858861214153648244717942361603491008281707763671875	0.07343739706956975421547895166440866887569427490234375	0.359520870078279097814544229549937881529331207275390625	-0.2728217530369819	0.4660823831671099	PBRM1;MYB;DEK;BAZ1A
chromatin remodeling at centromere	4/66	0.181159592621030707260132430747034959495067596435546875	0.73858861214153648244717942361603491008281707763671875	0.07343739706956975421547895166440866887569427490234375	0.359520870078279097814544229549937881529331207275390625	-0.2705927035330317	0.4622743264654959	PBRM1;MYB;DEK;BAZ1A
chromatin remodeling in response to cation stress	4/66	0.181159592621030707260132430747034959495067596435546875	0.73858861214153648244717942361603491008281707763671875	0.07343739706956975421547895166440866887569427490234375	0.359520870078279097814544229549937881529331207275390625	-0.2679950815709778	0.4578366090871561	PBRM1;MYB;DEK;BAZ1A
cellular response to brain-derived neurotrophic factor stimulus	3/15	0.01270520330622519622476573886160622350871562957763671875	0.170331297404752779467429490978247486054897308349609375	0.0072318243799945614025403983760043047368526458740234375	0.0753035664468749421640580976600176654756069183349609375	-0.10376204749796056	0.4529985010412583	MAGI2;STMN2;RAPGEF2
negative regulation of neuron migration	5/92	0.1971817647451322985663324516281136311590671539306640625	0.73858861214153648244717942361603491008281707763671875	0.06850870782198055508604994656707276590168476104736328125	0.343352282045512657848718163222656585276126861572265625	-0.25467428844670265	0.4134966397235439	CITED2;MAGI2;NKX2-1;SRGAP2;ROBO1
protein localization to plasma membrane	4/64	0.1678624664328511872923854753025807440280914306640625	0.73858861214153648244717942361603491008281707763671875	0.06749039221888446238306613622626173309981822967529296875	0.342267737608351330091949193956679664552211761474609375	-0.21614032647689538	0.38572625007549677	DLG1;FCHO2;RAPGEF2;ANK3
calcium ion transport into cytosol	5/92	0.1971817647451322985663324516281136311590671539306640625	0.73858861214153648244717942361603491008281707763671875	0.06850870782198055508604994656707276590168476104736328125	0.343352282045512657848718163222656585276126861572265625	-0.23182401448337753	0.3763962651304696	TRPM1;PDGFRA;LPAR1;CACNA1C;TAC1
regulation of mitotic cell cycle	5/92	0.1971817647451322985663324516281136311590671539306640625	0.73858861214153648244717942361603491008281707763671875	0.06850870782198055508604994656707276590168476104736328125	0.343352282045512657848718163222656585276126861572265625	-0.22856374312711547	0.3711027929915128	CYLD;JUND;MECOM;GBF1;STAT3
vesicle scission involved in endocytosis	4/64	0.1678624664328511872923854753025807440280914306640625	0.73858861214153648244717942361603491008281707763671875	0.06749039221888446238306613622626173309981822967529296875	0.342267737608351330091949193956679664552211761474609375	-0.2027654853346911	0.36185737098555326	DNM3;CYTH2;HOOK2;LDLR
ureteric bud development	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	-0.08527824393907275	0.356717288937039	ROBO2;SIX1;FGFR2
embryonic viscerocranium morphogenesis	3/13	0.0083946732338738179468595745902348426170647144317626953125	0.1269156206544320431017780492766178213059902191162109375	0.005131154950495567419743725423586511169560253620147705078125	0.056816098360299514824500732856904505752027034759521484375	-0.06324979599238563	0.30234401281549933	PDGFRA;SIX1;FGFR2
positive regulation of protein localization to cell surface	3/18	0.0211499341840897144007005437060797703452408313751220703125	0.2105670264248979683952001096258754841983318328857421875	0.0112142140327315779912975557408572058193385601043701171875	0.1039783683536521785573114584622089751064777374267578125	-0.07044547878642633	0.2716461129582378	BDNF;GBF1;CTNNB1
regulation of unidimensional cell growth	4/64	0.1678624664328511872923854753025807440280914306640625	0.73858861214153648244717942361603491008281707763671875	0.06749039221888446238306613622626173309981822967529296875	0.342267737608351330091949193956679664552211761474609375	-0.15104872072949999	0.2695631008585486	ARC;PHIP;EFNA5;PAPPA2
positive regulation of hh target transcription factor activity	5/92	0.1971817647451322985663324516281136311590671539306640625	0.73858861214153648244717942361603491008281707763671875	0.06850870782198055508604994656707276590168476104736328125	0.343352282045512657848718163222656585276126861572265625	-0.1525971041662667	0.24776113124391785	FZD2;CTNNB1;TRIM37;NKX6-1;NEUROG1
embryonic neurocranium morphogenesis	3/13	0.0083946732338738179468595745902348426170647144317626953125	0.1269156206544320431017780492766178213059902191162109375	0.005131154950495567419743725423586511169560253620147705078125	0.056816098360299514824500732856904505752027034759521484375	-0.05042139502183195	0.24102223040357862	PDGFRA;SIX1;FGFR2
negative regulation of glutamatergic neuron differentiation	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	-0.05679326285514741	0.23756514932520204	ID2;SIX3;CNTN4
mammary gland epithelial cell differentiation	4/65	0.17446725040189203781437754514627158641815185546875	0.73858861214153648244717942361603491008281707763671875	0.07043148441283218763597773204310215078294277191162109375	0.348976168041312428957922975314431823790073394775390625	-0.1114725214301594	0.1946330547543208	ERBB4;SIX1;FGFR2;CNN3
negative regulation of mechanoreceptor differentiation	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	-0.04568151571848822	0.19108492024385645	ID2;SIX3;CNTN4
metanephric part of ureteric bud development	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	-0.036877016715439054	0.1480116531867133	ROBO2;SIX1;FGFR2
negative regulation of cerebellar neuron development	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	-0.023796728686821176	0.09954126809644309	ID2;SIX3;CNTN4
epithelial to mesenchymal transition	3/34	0.1050088512120722350484669505021884106099605560302734375	0.6199333556537480749426549664349295198917388916015625	0.050378675345193628387630013776288251392543315887451171875	0.2835754315074920928196888780803419649600982666015625	-0.029180765433643105	0.06576500139873179	DDX17;CTNNB1;FGFR2
regulation of hair follicle cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	-0.0072275165256122055	0.010872772557220734	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
regulation of hemocyte proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	-0.00451120857403741	0.006786472865178002	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
regulation of sebum secreting cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	-0.0015040634787632627	0.002262649979182157	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
neutrophil degranulation	2/487	0.99999911886740644462179261608980596065521240234375	0.99999911886740633359949015357415191829204559326171875	0.9998539940996924446636739958194084465503692626953125	0.99985399409969233364137153330375440418720245361328125	8.145378084258786	-0.000007177161278887912	PGRMC1;CAB39
post-translational protein acetylation	2/368	0.9999569903424945227499165412154980003833770751953125	0.99999911886740633359949015357415191829204559326171875	0.99813895374857342090990641736425459384918212890625	0.99835060322986024505809155016322620213031768798828125	7.6371875617905305	-0.0003284798852920206	ICMT;ASB3
post-translational protein modification	3/429	0.99995180429249785891698820705641992390155792236328125	0.99999911886740633359949015357415191829204559326171875	0.99716443995939207933787429283256642520427703857421875	0.997979897757742318020746097317896783351898193359375	7.9648678347645605	-0.00038388169125668745	MSRA;ICMT;ASB3
regulation of fat cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.0003148935630468352	-0.0004737126616879063	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
N-terminal protein amino acid propionylation	2/355	0.999934631447533472936584075796417891979217529296875	0.99999911886740633359949015357415191829204559326171875	0.99755675597366011420064069170621223747730255126953125	0.997979897757742318020746097317896783351898193359375	7.527304567472362	-0.0004920650865167822	ICMT;ASB3
C-terminal protein amino acid modification	2/355	0.999934631447533472936584075796417891979217529296875	0.99999911886740633359949015357415191829204559326171875	0.99755675597366011420064069170621223747730255126953125	0.997979897757742318020746097317896783351898193359375	7.52932360674767	-0.0004921970725054956	ICMT;ASB3
CAAX-box protein modification	2/355	0.999934631447533472936584075796417891979217529296875	0.99999911886740633359949015357415191829204559326171875	0.99755675597366011420064069170621223747730255126953125	0.997979897757742318020746097317896783351898193359375	7.530842116227502	-0.0004922963385165721	ICMT;ASB3
I-kappaB phosphorylation	2/346	0.99991272977061218529826192025211639702320098876953125	0.99999911886740633359949015357415191829204559326171875	0.99705245281035115301193627601605840027332305908203125	0.997979897757742318020746097317896783351898193359375	7.765926464077215	-0.0006777637586584418	PRKCH;PRKAG1
protein phosphorylation involved in mitotic spindle assembly	2/323	0.9998179770040962477395396490464918315410614013671875	0.99999911886740633359949015357415191829204559326171875	0.99525356325114666677933428218238987028598785400390625	0.99673270867423757746195178697234950959682464599609375	7.581301213401934	-0.001380096768197201	PRKCH;PRKAG1
protein phosphorylation involved in cellular protein catabolic process	2/310	0.99972483778823073574670843299827538430690765380859375	0.99999911886740633359949015357415191829204559326171875	0.99379991651132926211431595220346935093402862548828125	0.9956997039473109989415888776420615613460540771484375	7.335723450140673	-0.0020187916497954547	PRKCH;PRKAG1
histone phosphorylation	2/303	0.99965651619880124822969946762896142899990081787109375	0.99999911886740633359949015357415191829204559326171875	0.99284543964776883484546488034538924694061279296875	0.99495473524931499209600360700278542935848236083984375	7.3800131716758	-0.0025353504279364784	PRKCH;PRKAG1
actin phosphorylation	2/299	0.99961020042523085482599753959220834076404571533203125	0.99999911886740633359949015357415191829204559326171875	0.9922371316665252738431490797665901482105255126953125	0.99455642797938803578716715492191724479198455810546875	7.361400587076284	-0.002870030223175293	PRKCH;PRKAG1
inhibitory G-protein coupled receptor phosphorylation	2/299	0.99961020042523085482599753959220834076404571533203125	0.99999911886740633359949015357415191829204559326171875	0.9922371316665252738431490797665901482105255126953125	0.99455642797938803578716715492191724479198455810546875	7.394014706759548	-0.0028827456715585197	PRKCH;PRKAG1
regulation of cell proliferation in bone marrow	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.0019265266351756551	-0.0028981858229536707	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
DNA damage induced protein phosphorylation	5/470	0.9996402585073393964876231621019542217254638671875	0.99999911886740633359949015357415191829204559326171875	0.9841054035468719263235470862127840518951416015625	0.9894498185256546118893083985312841832637786865234375	8.079708860504915	-0.002907129464645191	PRKCH;ZBTB38;PRKAG1;BRCA1;AATF
regulation of translational initiation by eIF2 alpha phosphorylation	2/298	0.99959768779029667395974456667318008840084075927734375	0.99999911886740633359949015357415191829204559326171875	0.992077340199539747800372424535453319549560546875	0.99455642797938803578716715492191724479198455810546875	7.380699041571524	-0.0029699428027621256	PRKCH;PRKAG1
peptidyl-cysteine phosphorylation	2/298	0.99959768779029667395974456667318008840084075927734375	0.99999911886740633359949015357415191829204559326171875	0.992077340199539747800372424535453319549560546875	0.99455642797938803578716715492191724479198455810546875	7.382462478700225	-0.0029706523977989924	PRKCH;PRKAG1
peptidyl-arginine phosphorylation	2/298	0.99959768779029667395974456667318008840084075927734375	0.99999911886740633359949015357415191829204559326171875	0.992077340199539747800372424535453319549560546875	0.99455642797938803578716715492191724479198455810546875	7.384647349498198	-0.0029715315748613355	PRKCH;PRKAG1
peptidyl-histidine phosphorylation	2/298	0.99959768779029667395974456667318008840084075927734375	0.99999911886740633359949015357415191829204559326171875	0.992077340199539747800372424535453319549560546875	0.99455642797938803578716715492191724479198455810546875	7.388714846249188	-0.002973168307728076	PRKCH;PRKAG1
protein phosphorylation involved in protein localization to spindle microtubule	2/298	0.99959768779029667395974456667318008840084075927734375	0.99999911886740633359949015357415191829204559326171875	0.992077340199539747800372424535453319549560546875	0.99455642797938803578716715492191724479198455810546875	7.392424495645159	-0.0029746610452672006	PRKCH;PRKAG1
peptidyl-aspartic acid phosphorylation	2/298	0.99959768779029667395974456667318008840084075927734375	0.99999911886740633359949015357415191829204559326171875	0.992077340199539747800372424535453319549560546875	0.99455642797938803578716715492191724479198455810546875	7.392743022251534	-0.002974789218194557	PRKCH;PRKAG1
ciliary basal body-plasma membrane docking	1/224	0.99954694564972068615560374382766894996166229248046875	0.99999911886740633359949015357415191829204559326171875	0.9943816625826966681955809690407477319240570068359375	0.9960709922281971717694659673725254833698272705078125	7.209306636469476	-0.003266947842509443	CEP164
translation	3/348	0.9994538626808899817177689328673295676708221435546875	0.99999911886740633359949015357415191829204559326171875	0.98700049344484686031364617520011961460113525390625	0.9916254158848440969364901320659555494785308837890625	7.3726092496298525	-0.004027556950150508	RPS25;USP9X;PAPPA2
protein phosphorylation involved in double-strand break repair via nonhomologous end joining	3/342	0.99934867304070473803534468970610760152339935302734375	0.99999911886740633359949015357415191829204559326171875	0.98549723229963503978723338150302879512310028076171875	0.9903260427689344336243948418996296823024749755859375	7.3817357456919614	-0.004809489942874423	PRKCH;PRKAG1;BRCA1
regulation of mesenchymal cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.004676763296458738	-0.00703552644205771	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
JUN phosphorylation	3/328	0.9990198320613643545584636740386486053466796875	0.99999911886740633359949015357415191829204559326171875	0.9813171186400795331650215302943252027034759521484375	0.987387553034397402740296456613577902317047119140625	7.579729796341963	-0.0074330515446884736	PRKCH;PRKAG1;TRIB1
extracellular matrix disassembly	1/198	0.998887636379580445833425983437336981296539306640625	0.99999911886740633359949015357415191829204559326171875	0.98972908724461106100278584563056938350200653076171875	0.99373182301677964733954695475404150784015655517578125	6.934835268604081	-0.007718352069726973	HAPLN1
negative regulation of canonical Wnt signaling pathway	8/179	0.255005555075341450166348522543557919561862945556640625	0.73858861214153648244717942361603491008281707763671875	0.06193576588848193065217628827667795121669769287109375	0.330114132989795805439570131056825630366802215576171875	0.0066343374792519815	-0.009065622799919704	DKK4;RNF43;CYLD;TCF7L2;TLE1;PRICKLE1;MLLT3;CXXC4
peptidyl-threonine phosphorylation	3/320	0.9987638317102771612354672470246441662311553955078125	0.99999911886740633359949015357415191829204559326171875	0.978436974486005084372663986869156360626220703125	0.985751219276054246876128672738559544086456298828125	7.5195127696750825	-0.009301133308229154	PRKCH;TNKS;PRKAG1
regulation of synoviocyte proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.006691845349175044	-0.01006693131891699	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
regulation of plasma cell differentiation	1/191	0.99858360689822356359712784978910349309444427490234375	0.99999911886740633359949015357415191829204559326171875	0.98792020231513066885753460155683569610118865966796875	0.99212680313401568898967752829776145517826080322265625	7.136676175441185	-0.010115504362123565	ZFP36L1
regulation of natural killer cell differentiation involved in immune response	1/190	0.998533872583351467255852185189723968505859375	0.99999911886740633359949015357415191829204559326171875	0.98763708202662947588379438457195647060871124267578125	0.99205368737640775567143691660021431744098663330078125	7.098913712446399	-0.010415549150404204	PRDM1
protein phosphorylation involved in DNA double-strand break processing	3/312	0.99844275754169320435948975500650703907012939453125	0.99999911886740633359949015357415191829204559326171875	0.97513842977436926418022267171181738376617431640625	0.98358898399937022549721632458386011421680450439453125	7.443913053414893	-0.011601012603617124	PRKCH;PRKAG1;BRCA1
regulation of skeletal muscle cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.009172992685975042	-0.013799465250646084	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
common-partner SMAD protein phosphorylation	3/303	0.99798373358398795307522277653333730995655059814453125	0.99999911886740633359949015357415191829204559326171875	0.97085801372022884070389636690379120409488677978515625	0.98109407383317048800819293319364078342914581298828125	7.318203680574795	-0.014770343789658205	PRKCH;PRKAG1;ACVR2A
mitochondrial transmembrane transport	1/180	0.9979298176795066144251222794991917908191680908203125	0.99999911886740633359949015357415191829204559326171875	0.9844155179861981963540529250167310237884521484375	0.9894498185256546118893083985312841832637786865234375	7.2734611966747496	-0.01507299809395449	ADD3
axoneme assembly	1/180	0.9979298176795066144251222794991917908191680908203125	0.99999911886740633359949015357415191829204559326171875	0.9844155179861981963540529250167310237884521484375	0.9894498185256546118893083985312841832637786865234375	7.328609138978622	-0.015187282724992573	CEP164
protein K48-linked ubiquitination	2/243	0.99775603533653356436161629972048103809356689453125	0.99999911886740633359949015357415191829204559326171875	0.97612066785011941671967861111625097692012786865234375	0.9838753391646803958536793288658373057842254638671875	6.762574059395029	-0.015192028793208856	TNKS;RNF217
regulation of mammary stem cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.010944669652990643	-0.01646470173111136	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
positive regulation of cerebellar granule cell migration by calcium	1/178	0.99778197344443919636347573032253421843051910400390625	0.99999911886740633359949015357415191829204559326171875	0.983677092512845963057088738423772156238555908203125	0.989340052320489160564420672017149627208709716796875	7.475317775155524	-0.016598868514727735	PDGFRA
peptidyl-serine phosphorylation	4/352	0.99781152389326466245478286509751342236995697021484375	0.99999911886740633359949015357415191829204559326171875	0.96207824126750740578728482432779856026172637939453125	0.9793365764714596632956045141327194869518280029296875	7.613040923878315	-0.016679215858484638	PRKCH;CAB39;TNKS;PRKAG1
endosome to lysosome transport	1/175	0.99754020899657225296408569192863069474697113037109375	0.99999911886740633359949015357415191829204559326171875	0.9825035662717678253130770826828666031360626220703125	0.98837051015225607653036377087119035422801971435546875	6.963564596991202	-0.017150014931620532	HOOK2
protein K63-linked ubiquitination	2/238	0.9973819895503857058116636835620738565921783447265625	0.99999911886740633359949015357415191829204559326171875	0.9736511058120793649095503496937453746795654296875	0.9826085293358104433281141609768383204936981201171875	6.926293552834269	-0.018156886742201967	TNKS;RNF217
protein K11-linked ubiquitination	2/236	0.99721576604141526356528402175172232091426849365234375	0.99999911886740633359949015357415191829204559326171875	0.97259589981292016158676005943561904132366180419921875	0.9822213688490044614098906095023266971111297607421875	6.817203012334072	-0.01900716061621244	TNKS;RNF217
pharyngeal system development	3/12	0.006621004312468350451459375705098864273168146610260009765625	0.10787286952003131978994332484944607131183147430419921875	0.004239218550275117465553353923723989282734692096710205078125	0.04925220172819637365346778778985026292502880096435546875	0.003912726840442424	-0.01963213905208924	PTCH1;BRCA1;GATA3
regulation of glial cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.013333592153678454	-0.020058496489623573	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
protein transmembrane transport	1/169	0.996974895561641094587912448332644999027252197265625	0.99999911886740633359949015357415191829204559326171875	0.9798982875633768241385723740677349269390106201171875	0.98659129614438600963666203824686817824840545654296875	7.146766813390884	-0.021652483055711384	ADD3
intraciliary transport involved in cilium assembly	1/170	0.997077405218215861992803183966316282749176025390625	0.99999911886740633359949015357415191829204559326171875	0.98035790976359649118165862091700546443462371826171875	0.986632869715144966704656326328404247760772705078125	7.5049953697176335	-0.02196617507752063	CEP164
positive regulation of NF-kappaB import into nucleus	1/170	0.997077405218215861992803183966316282749176025390625	0.99999911886740633359949015357415191829204559326171875	0.98035790976359649118165862091700546443462371826171875	0.986632869715144966704656326328404247760772705078125	7.614804860400849	-0.02228757360992394	LPAR1
regulation of cell proliferation involved in kidney development	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.015044279808541151	-0.022631983208312455	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
protein export from nucleus	1/168	0.996868795871737045644067620742134749889373779296875	0.99999911886740633359949015357415191829204559326171875	0.97942794622218176670003231265582144260406494140625	0.98632827120624078087729458275134675204753875732421875	7.264633026963447	-0.022782736266799324	TBC1D9
mitochondrial translation	1/167	0.9967589807101859822324740889598615467548370361328125	0.99999911886740633359949015357415191829204559326171875	0.97894663661749958816216121704201214015483856201171875	0.98605408603987731996909360532299615442752838134765625	7.199830958222383	-0.023372687176511992	RPS25
regulation of inflammatory response to antigenic stimulus	2/230	0.99665234987905926278273227580939419567584991455078125	0.99999911886740633359949015357415191829204559326171875	0.96918062731717657953822708805091679096221923828125	0.98109407383317048800819293319364078342914581298828125	7.187363380024114	-0.024101141528792485	SEMA7A;FOXP1
negative regulation of apoptotic signaling pathway	4/338	0.996820203512031266512849470018409192562103271484375	0.99999911886740633359949015357415191829204559326171875	0.9527181475542467747885666540241800248622894287109375	0.9793365764714596632956045141327194869518280029296875	7.917459422857868	-0.025216021855977835	CITED2;STAT3;PHIP;AATF
regulation of cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.017392922979526226	-0.026165183433548518	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
translational elongation	1/162	0.99614946298762274690119511433294974267482757568359375	0.99999911886740633359949015357415191829204559326171875	0.9763664326118017822153660745243541896343231201171875	0.9838753391646803958536793288658373057842254638671875	7.256247494379588	-0.02799438090327634	RPS25
regulation of leukocyte proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.018909206270295898	-0.028446216385106714	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
motile cilium assembly	1/162	0.99614946298762274690119511433294974267482757568359375	0.99999911886740633359949015357415191829204559326171875	0.9763664326118017822153660745243541896343231201171875	0.9838753391646803958536793288658373057842254638671875	7.478680260424667	-0.028852519711642287	CEP164
positive regulation of I-kappaB kinase/NF-kappaB signaling	1/162	0.99614946298762274690119511433294974267482757568359375	0.99999911886740633359949015357415191829204559326171875	0.9763664326118017822153660745243541896343231201171875	0.9838753391646803958536793288658373057842254638671875	7.5808537128705344	-0.029246701766235637	LPAR1
negative regulation of dopaminergic neuron differentiation	3/19	0.024501872806991224773565107852846267633140087127685546875	0.233958166053800820094465962029062211513519287109375	0.01277148816961725698304608300759355188347399234771728515625	0.11275211834681753142461957395425997674465179443359375	0.008231405349085804	-0.030530329550160166	ID2;SIX3;CNTN4
translational termination	1/159	0.99573011774929842676584712535259313881397247314453125	0.99999911886740633359949015357415191829204559326171875	0.97466943623991542100526430658646859228610992431640625	0.98342582475800666141907413475564680993556976318359375	7.145455933897252	-0.030575579080201414	RPS25
cilium assembly	1/160	0.9958747354536268137081833629054017364978790283203125	0.99999911886740633359949015357415191829204559326171875	0.9752481827782604195675730807124637067317962646484375	0.98358898399937022549721632458386011421680450439453125	7.461731997520481	-0.030845284777490066	CEP164
negative regulation of leukocyte apoptotic process	4/331	0.99617357785591698071669952696538530290126800537109375	0.99999911886740633359949015357415191829204559326171875	0.94728257956881034562712784463656134903430938720703125	0.97711172705577931107967515345080755650997161865234375	8.066359138656528	-0.030924498126629056	CITED2;STAT3;PHIP;AATF
regulation of cell proliferation involved in tissue homeostasis	6/122	0.22759672083919746388147586912964470684528350830078125	0.73858861214153648244717942361603491008281707763671875	0.07005214034133598610676330054047866724431514739990234375	0.347461562555291092468934266435098834335803985595703125	0.021093393258810156	-0.031222018504650454	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
negative regulation of execution phase of apoptosis	4/330	0.996071414279790179335805078153498470783233642578125	0.99999911886740633359949015357415191829204559326171875	0.946461104859458668414617932285182178020477294921875	0.97669154049924877813992907249485142529010772705078125	7.991624546371333	-0.03145761458071516	CITED2;STAT3;PHIP;AATF
cytoplasmic translation	1/157	0.9954255193502632437230204232037067413330078125	0.99999911886740633359949015357415191829204559326171875	0.97347116895735741337603030842728912830352783203125	0.9826085293358104433281141609768383204936981201171875	7.1815313401027625	-0.032927145997706846	RPS25
protein K29-linked ubiquitination	2/217	0.99501991767063113769609117298386991024017333984375	0.99999911886740633359949015357415191829204559326171875	0.960324008973171050485007071984000504016876220703125	0.9793365764714596632956045141327194869518280029296875	6.715534570122509	-0.03352746929021484	TNKS;RNF217
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	1/156	0.99526517871327635500477981622680090367794036865234375	0.99999911886740633359949015357415191829204559326171875	0.972851014471602493216551010846160352230072021484375	0.9822213688490044614098906095023266971111297607421875	7.064799358370832	-0.03353000446776309	TBC1D9
protein K27-linked ubiquitination	2/217	0.99501991767063113769609117298386991024017333984375	0.99999911886740633359949015357415191829204559326171875	0.960324008973171050485007071984000504016876220703125	0.9793365764714596632956045141327194869518280029296875	6.718267904016717	-0.03354111552600456	TNKS;RNF217
negative regulation of myeloid cell apoptotic process	4/327	0.995748883691903063919426131178624927997589111328125	0.99999911886740633359949015357415191829204559326171875	0.943926185494552871801943183527328073978424072265625	0.974715371492514304208043540711514651775360107421875	8.064056284549892	-0.03435431512313612	CITED2;STAT3;PHIP;AATF
regulation of germ cell proliferation	6/121	0.2221598669588033814203953397736768238246440887451171875	0.73858861214153648244717942361603491008281707763671875	0.0679891605128312981332072695295209996402263641357421875	0.342267737608351330091949193956679664552211761474609375	0.022981104416914273	-0.03457180907900929	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
positive regulation of wound healing, spreading of epidermal cells	1/156	0.99526517871327635500477981622680090367794036865234375	0.99999911886740633359949015357415191829204559326171875	0.972851014471602493216551010846160352230072021484375	0.9822213688490044614098906095023266971111297607421875	7.320182101448171	-0.03474206783743639	PDGFRA
negative regulation of fibroblast apoptotic process	4/326	0.99563580680063046290939610116765834391117095947265625	0.99999911886740633359949015357415191829204559326171875	0.94305724053325501454736468076589517295360565185546875	0.97403131237034468181690272103878669440746307373046875	7.959245741232796	-0.03481170401035494	CITED2;STAT3;PHIP;AATF
negative regulation of muscle cell apoptotic process	4/326	0.99563580680063046290939610116765834391117095947265625	0.99999911886740633359949015357415191829204559326171875	0.94305724053325501454736468076589517295360565185546875	0.97403131237034468181690272103878669440746307373046875	7.989041202323107	-0.034942021732165505	CITED2;STAT3;PHIP;AATF
positive regulation of substrate-dependent cell migration, cell attachment to substrate	1/155	0.99509922662083816202738262290949933230876922607421875	0.99999911886740633359949015357415191829204559326171875	0.97221641133007719037806282358360476791858673095703125	0.982211354089521204713264523888938128948211669921875	7.25106951490967	-0.035623210563989	PDGFRA
negative regulation of myofibroblast cell apoptotic process	4/325	0.9955198327597940544109178517828695476055145263671875	0.99999911886740633359949015357415191829204559326171875	0.94217607003804559884230229727108962833881378173828125	0.97376085065062689682946484026615507900714874267578125	8.000522268219362	-0.035924211231673914	CITED2;STAT3;PHIP;AATF
negative regulation of apoptotic process involved in development	4/325	0.9955198327597940544109178517828695476055145263671875	0.99999911886740633359949015357415191829204559326171875	0.94217607003804559884230229727108962833881378173828125	0.97376085065062689682946484026615507900714874267578125	8.000641437715537	-0.03592474633050989	CITED2;STAT3;PHIP;AATF
negative regulation of fat cell apoptotic process	4/325	0.9955198327597940544109178517828695476055145263671875	0.99999911886740633359949015357415191829204559326171875	0.94217607003804559884230229727108962833881378173828125	0.97376085065062689682946484026615507900714874267578125	8.006216899211513	-0.035949781453190714	CITED2;STAT3;PHIP;AATF
negative regulation of compound eye retinal cell apoptotic process	4/325	0.9955198327597940544109178517828695476055145263671875	0.99999911886740633359949015357415191829204559326171875	0.94217607003804559884230229727108962833881378173828125	0.97376085065062689682946484026615507900714874267578125	8.008189098217859	-0.035958637086775574	CITED2;STAT3;PHIP;AATF
negative regulation of epithelial cell apoptotic process	4/325	0.9955198327597940544109178517828695476055145263671875	0.99999911886740633359949015357415191829204559326171875	0.94217607003804559884230229727108962833881378173828125	0.97376085065062689682946484026615507900714874267578125	8.010344403219714	-0.03596831490899262	CITED2;STAT3;PHIP;AATF
negative regulation of apoptotic process in bone marrow	4/325	0.9955198327597940544109178517828695476055145263671875	0.99999911886740633359949015357415191829204559326171875	0.94217607003804559884230229727108962833881378173828125	0.97376085065062689682946484026615507900714874267578125	8.01051924587615	-0.03596909999330481	CITED2;STAT3;PHIP;AATF
protein linear polyubiquitination	2/214	0.99454421962053440875450860403361730277538299560546875	0.99999911886740633359949015357415191829204559326171875	0.95795850598293597055743475721101276576519012451171875	0.9793365764714596632956045141327194869518280029296875	6.709211422204556	-0.03670420035961142	TNKS;RNF217
protein K33-linked ubiquitination	2/214	0.99454421962053440875450860403361730277538299560546875	0.99999911886740633359949015357415191829204559326171875	0.95795850598293597055743475721101276576519012451171875	0.9793365764714596632956045141327194869518280029296875	6.754341943190638	-0.03695109669069507	TNKS;RNF217
N-terminal peptidyl-proline dimethylation involved in translation	1/153	0.994749696804628769086775719188153743743896484375	0.99999911886740633359949015357415191829204559326171875	0.97090250936044952823067433200776576995849609375	0.98109407383317048800819293319364078342914581298828125	7.128282363123563	-0.03752423690455413	RPS25
cellular protein catabolic process	2/216	0.99486605338221989480729234855971299111843109130859375	0.99999911886740633359949015357415191829204559326171875	0.9595500146812299124832179586519487202167510986328125	0.9793365764714596632956045141327194869518280029296875	7.33388785076293	-0.03774877194347096	USP9X;PAPPA2
plastid translation	1/152	0.99456570624691253978966187787591479718685150146484375	0.99999911886740633359949015357415191829204559326171875	0.97022251609787180104405024394509382545948028564453125	0.98109407383317048800819293319364078342914581298828125	7.1421812821044774	-0.038918554592046364	RPS25
maintenance of translational fidelity	1/152	0.99456570624691253978966187787591479718685150146484375	0.99999911886740633359949015357415191829204559326171875	0.97022251609787180104405024394509382545948028564453125	0.98109407383317048800819293319364078342914581298828125	7.148707074346806	-0.03895411437296032	RPS25
vesicle targeting, trans-Golgi to periciliary membrane compartment	1/153	0.994749696804628769086775719188153743743896484375	0.99999911886740633359949015357415191829204559326171875	0.97090250936044952823067433200776576995849609375	0.98109407383317048800819293319364078342914581298828125	7.438970482357814	-0.03915974094265004	CEP164
cytosolic ciliogenesis	1/153	0.994749696804628769086775719188153743743896484375	0.99999911886740633359949015357415191829204559326171875	0.97090250936044952823067433200776576995849609375	0.98109407383317048800819293319364078342914581298828125	7.440384906725493	-0.03916718666272012	CEP164
ciliary transition zone assembly	1/153	0.994749696804628769086775719188153743743896484375	0.99999911886740633359949015357415191829204559326171875	0.97090250936044952823067433200776576995849609375	0.98109407383317048800819293319364078342914581298828125	7.443950997451051	-0.03918595904383415	CEP164
protein targeting to mitochondrion	1/152	0.99456570624691253978966187787591479718685150146484375	0.99999911886740633359949015357415191829204559326171875	0.97022251609787180104405024394509382545948028564453125	0.98109407383317048800819293319364078342914581298828125	7.228129784295728	-0.039386897713358064	AKAP6
positive regulation of fibroblast migration	1/152	0.99456570624691253978966187787591479718685150146484375	0.99999911886740633359949015357415191829204559326171875	0.97022251609787180104405024394509382545948028564453125	0.98109407383317048800819293319364078342914581298828125	7.4006145674121795	-0.04032678682886325	PDGFRA
regulation of cell proliferation involved in imaginal disc-derived wing morphogenesis	6/122	0.22759672083919746388147586912964470684528350830078125	0.73858861214153648244717942361603491008281707763671875	0.07005214034133598610676330054047866724431514739990234375	0.347461562555291092468934266435098834335803985595703125	0.02789479764735072	-0.041289321146340395	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
extracellular matrix assembly	1/149	0.99397420018436177802101383349508978426456451416015625	0.99999911886740633359949015357415191829204559326171875	0.96808602940781385282065230057924054563045501708984375	0.98076928709550215135237749564112164080142974853515625	6.867952652616201	-0.04151009958660035	HAPLN1
positive regulation of leukocyte migration	1/151	0.9943752779045536005497751830262131989002227783203125	0.99999911886740633359949015357415191829204559326171875	0.96952668486613813314534127130173146724700927734375	0.98109407383317048800819293319364078342914581298828125	7.394841118105911	-0.041711343868667865	PDGFRA
drug transmembrane transport	1/150	0.994178186768361005221095183514989912509918212890625	0.99999911886740633359949015357415191829204559326171875	0.96881464804025629877770597886410541832447052001953125	0.98109407383317048800819293319364078342914581298828125	7.200476713493214	-0.042042330997955187	ADD3
positive regulation of fibroblast chemotaxis	1/149	0.99397420018436177802101383349508978426456451416015625	0.99999911886740633359949015357415191829204559326171875	0.96808602940781385282065230057924054563045501708984375	0.98076928709550215135237749564112164080142974853515625	7.329210539717943	-0.04429795526894909	PDGFRA
positive regulation of endothelial cell chemotaxis to vascular endothelial growth factor	1/149	0.99397420018436177802101383349508978426456451416015625	0.99999911886740633359949015357415191829204559326171875	0.96808602940781385282065230057924054563045501708984375	0.98076928709550215135237749564112164080142974853515625	7.330820461307713	-0.04430768568045571	PDGFRA
positive regulation of cell chemotaxis to fibroblast growth factor	1/149	0.99397420018436177802101383349508978426456451416015625	0.99999911886740633359949015357415191829204559326171875	0.96808602940781385282065230057924054563045501708984375	0.98076928709550215135237749564112164080142974853515625	7.333902415101664	-0.04432631309613242	PDGFRA
regulation of cell proliferation involved in compound eye morphogenesis	6/122	0.22759672083919746388147586912964470684528350830078125	0.73858861214153648244717942361603491008281707763671875	0.07005214034133598610676330054047866724431514739990234375	0.347461562555291092468934266435098834335803985595703125	0.030279846788340274	-0.044819623146630176	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
gene expression involved in extracellular matrix organization	1/146	0.9933184166985358221069191131391562521457672119140625	0.99999911886740633359949015357415191829204559326171875	0.965796789808132327692646867944858968257904052734375	0.9799233077059497087901718259672634303569793701171875	6.756516687612838	-0.04529572172383428	HAPLN1
positive regulation of smooth muscle cell migration	1/148	0.99376307730127677597664614950190298259258270263671875	0.99999911886740633359949015357415191829204559326171875	0.96734044421506759636741890062694437801837921142578125	0.98076928709550215135237749564112164080142974853515625	7.327045202816672	-0.045841317982825744	PDGFRA
positive regulation of trophoblast cell migration	1/148	0.99376307730127677597664614950190298259258270263671875	0.99999911886740633359949015357415191829204559326171875	0.96734044421506759636741890062694437801837921142578125	0.98076928709550215135237749564112164080142974853515625	7.383116686873266	-0.04619212661840222	PDGFRA
positive regulation by symbiont of host I-kappaB kinase/NF-kappaB cascade	1/148	0.99376307730127677597664614950190298259258270263671875	0.99999911886740633359949015357415191829204559326171875	0.96734044421506759636741890062694437801837921142578125	0.98076928709550215135237749564112164080142974853515625	7.4796986112850385	-0.04679638694242087	LPAR1
regulation of chorionic trophoblast cell proliferation	6/122	0.22759672083919746388147586912964470684528350830078125	0.73858861214153648244717942361603491008281707763671875	0.07005214034133598610676330054047866724431514739990234375	0.347461562555291092468934266435098834335803985595703125	0.032471012751788035	-0.048062943148211815	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
positive regulation of hematopoietic stem cell migration	1/146	0.9933184166985358221069191131391562521457672119140625	0.99999911886740633359949015357415191829204559326171875	0.965796789808132327692646867944858968257904052734375	0.9799233077059497087901718259672634303569793701171875	7.262973587474707	-0.04869101131785201	PDGFRA
basement membrane organization	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	6.853124860077758	-0.04923035514317727	HAPLN1
fibronectin fibril organization	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	6.855284144798125	-0.04924586665884484	HAPLN1
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis	1/145	0.99308435402246819645455389036214910447597503662109375	0.99999911886740633359949015357415191829204559326171875	0.96499790561307918768108038420905359089374542236328125	0.9795341340169774202450980737921781837940216064453125	7.242991157212242	-0.050263967587761534	PDGFRA
positive regulation of cell migration by vascular endothelial growth factor signaling pathway	1/145	0.99308435402246819645455389036214910447597503662109375	0.99999911886740633359949015357415191829204559326171875	0.96499790561307918768108038420905359089374542236328125	0.9795341340169774202450980737921781837940216064453125	7.252506328360347	-0.05032999973439809	PDGFRA
positive regulation of glial cell migration	1/145	0.99308435402246819645455389036214910447597503662109375	0.99999911886740633359949015357415191829204559326171875	0.96499790561307918768108038420905359089374542236328125	0.9795341340169774202450980737921781837940216064453125	7.2596167011566495	-0.05037934337434087	PDGFRA
cellulose microfibril organization	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	6.793614398259531	-0.05051866035915606	HAPLN1
extracellular matrix organization in marginal zone involved in cerebral cortex radial glia guided migration	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	6.794281069597972	-0.05052361785908813	HAPLN1
extracellular matrix organization involved in endocardium development	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	6.805274728366396	-0.05060536888010115	HAPLN1
extracellular matrix organization	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	6.805589478165135	-0.05060770942185823	HAPLN1
biofilm matrix organization	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	6.8082924407090175	-0.05062780918594741	HAPLN1
pathway-restricted SMAD protein phosphorylation	4/308	0.99302998226759886524206422109273262321949005126953125	0.99999911886740633359949015357415191829204559326171875	0.92518027912960387748597668178263120353221893310546875	0.960826811240497846711150486953556537628173828125	7.261829337493388	-0.05079229720690408	PRKCH;GDF2;PRKAG1;ACVR2A
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	3/258	0.99284792858629178358143008154002018272876739501953125	0.99999911886740633359949015357415191829204559326171875	0.936951208495150122956829363829456269741058349609375	0.97006120510790683209023654853808693587779998779296875	7.107523653650221	-0.05101617064003086	ABR;PNMA1;CTNNB1
regulation of epithelial cell proliferation	6/122	0.22759672083919746388147586912964470684528350830078125	0.73858861214153648244717942361603491008281707763671875	0.07005214034133598610676330054047866724431514739990234375	0.347461562555291092468934266435098834335803985595703125	0.03478999994545677	-0.051495461576347205	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
positive regulation of formation of radial glial scaffolds	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	7.251469971912132	-0.05209192146883917	PDGFRA
positive regulation of cell migration in other organism	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	7.252578425174187	-0.052099884193707716	PDGFRA
positive regulation of mesenchymal stem cell migration	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	7.25602023377504	-0.052124608894222345	PDGFRA
positive regulation of metanephric mesenchymal cell migration	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	7.259264619282892	-0.05214791537907911	PDGFRA
positive regulation of distal tip cell migration	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	7.262611305467417	-0.0521719567547699	PDGFRA
positive regulation of neuroblast migration	1/144	0.99284210453972365773012143108644522726535797119140625	0.99999911886740633359949015357415191829204559326171875	0.9641804242385962897543549843248911201953887939453125	0.9793365764714596632956045141327194869518280029296875	7.266963672964179	-0.05220322257904043	PDGFRA
protein phosphorylation	6/401	0.99326947685679833899285995357786305248737335205078125	0.99999911886740633359949015357415191829204559326171875	0.90147052218235745879582054840284399688243865966796875	0.94789042646771737299360438555595465004444122314453125	7.7701121500846115	-0.05247370615572149	ALK;MSRA;PRKCH;ICMT;STAT3;PRKAG1
nucleoside transmembrane transport	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	7.076259655997646	-0.05262046639946592	ADD3
heme transmembrane transport	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	7.102077526156898	-0.05281245318842854	ADD3
vitamin transmembrane transport	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	7.187494623809922	-0.05344763162103188	ADD3
carbon dioxide transmembrane transport	1/143	0.9925913823249532530468286495306529104709625244140625	0.99999911886740633359949015357415191829204559326171875	0.96334391425230136984936279986868612468242645263671875	0.9793365764714596632956045141327194869518280029296875	7.235874491577047	-0.05380739388669336	ADD3
siderophore transmembrane transport	1/142	0.99233189157919554634901260214974172413349151611328125	0.99999911886740633359949015357415191829204559326171875	0.96248793422869505231886932961060665547847747802734375	0.9793365764714596632956045141327194869518280029296875	7.055108502716563	-0.05430782319060671	ADD3
regulation of mRNA stability involved in cellular response to UV	1/142	0.99233189157919554634901260214974172413349151611328125	0.99999911886740633359949015357415191829204559326171875	0.96248793422869505231886932961060665547847747802734375	0.9793365764714596632956045141327194869518280029296875	7.241524644404078	-0.05574279117993564	ZFP36L1
protein stabilization	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.027398720973969	-0.055996682125057394	MSX1
negative regulation of spinal cord association neuron differentiation	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.013411218862778455	-0.05609887602152737	ID2;SIX3;CNTN4
activation of NF-kappaB-inducing kinase activity	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	6.841976452857793	-0.05643643540296882	CAB39
autoinducer AI-2 transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.11868397578471	-0.056724073809989915	ADD3
Notch receptor processing	2/202	0.99215507262455637782494477505679242312908172607421875	0.99999911886740633359949015357415191829204559326171875	0.9470804253470734845876677354681305587291717529296875	0.97711172705577931107967515345080755650997161865234375	7.213720564636919	-0.05681425832628945	USP9X;PAPPA2
oligopeptide transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.13145774680062	-0.0568258595238105	ADD3
S-adenosyl-L-methionine transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.13784259981651	-0.05687673618513882	ADD3
sterol transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.149010715791361	-0.05696572749828474	ADD3
carbohydrate transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.154737318544017	-0.05701135899960256	ADD3
reduced folate transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.155346318213032	-0.05701621171427468	ADD3
ATP hydrolysis coupled transmembrane transport	1/141	0.99206332591621471106435592446359805762767791748046875	0.99999911886740633359949015357415191829204559326171875	0.9616120325080277364548919649678282439708709716796875	0.9793365764714596632956045141327194869518280029296875	7.196322272284442	-0.057342721930360684	ADD3
protein exit from endoplasmic reticulum	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.021432670080343	-0.0579166903089487	TBC1D9
(+)-abscisic acid D-glucopyranosyl ester transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.144052371895933	-0.05892812595599136	ADD3
peptide pheromone export by transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.147248998235673	-0.058954493511795325	ADD3
purine nucleotide-sugar transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.150084745369923	-0.0589778843347635	ADD3
nucleotide transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.151170447908017	-0.05898683981445277	ADD3
vacuolar transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.157493729956408	-0.05903899776929485	ADD3
polyamine transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.162965121645396	-0.059084128857621085	ADD3
sulfathiazole transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.163274657454507	-0.059086682081505464	ADD3
urea transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.1669508481103135	-0.059117005351090636	ADD3
hydrogen peroxide transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.171040906600478	-0.05915074243325761	ADD3
organic acid transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.173459743808509	-0.059170694350774704	ADD3
transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.174281899447492	-0.05917747594874283	ADD3
phytochelatin transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.17496522166568	-0.059183112371272474	ADD3
triose phosphate transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.176653444992545	-0.05919703777826399	ADD3
pyrimidine-containing compound transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.1797538287898215	-0.0592226114719335	ADD3
purine-containing compound transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.181059089201377	-0.05923337798734149	ADD3
import across plasma membrane	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.182038313529246	-0.059241455175403385	ADD3
5-amino-1-ribofuranosylimidazole-4-carboxamide transmembrane transport	1/140	0.99178536861949406766569836690905503928661346435546875	0.99999911886740633359949015357415191829204559326171875	0.960715746997380382055098380078561604022979736328125	0.9793365764714596632956045141327194869518280029296875	7.1875652894266935	-0.05928704475326283	ADD3
intracellular protein transmembrane transport	1/139	0.99149769169503387811204220270155929028987884521484375	0.99999911886740633359949015357415191829204559326171875	0.95979860489014523494688546634279191493988037109375	0.9793365764714596632956045141327194869518280029296875	6.994577941352578	-0.059724316720804284	TBC1D9
proteolysis involved in cellular protein catabolic process	2/198	0.99115115619073257402504850688274018466472625732421875	0.99999911886740633359949015357415191829204559326171875	0.942893909416252284927395521663129329681396484375	0.97403131237034468181690272103878669440746307373046875	6.890450863815648	-0.06124389369903417	TBL1X;PAPPA2
regulation of myoblast proliferation	6/123	0.233075975948903113543764220594312064349651336669921875	0.73858861214153648244717942361603491008281707763671875	0.072151007047188298049178456494701094925403594970703125	0.356000314060237632585170786114758811891078948974609375	0.042252520069678244	-0.061536181571113485	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
autophagosome-endosome fusion	1/138	0.99119995586534559439684244352974928915500640869140625	0.99999911886740633359949015357415191829204559326171875	0.9588601224958053226288257064879871904850006103515625	0.9793365764714596632956045141327194869518280029296875	7.080936360603942	-0.06258834829635045	PRKAG1
autophagosome-lysosome fusion	1/138	0.99119995586534559439684244352974928915500640869140625	0.99999911886740633359949015357415191829204559326171875	0.9588601224958053226288257064879871904850006103515625	0.9793365764714596632956045141327194869518280029296875	7.081980895279651	-0.06259758093123961	PRKAG1
amphisome-lysosome fusion	1/138	0.99119995586534559439684244352974928915500640869140625	0.99999911886740633359949015357415191829204559326171875	0.9588601224958053226288257064879871904850006103515625	0.9793365764714596632956045141327194869518280029296875	7.086200474367717	-0.06263487776207928	PRKAG1
regulation of cardiac muscle cell proliferation	6/123	0.233075975948903113543764220594312064349651336669921875	0.73858861214153648244717942361603491008281707763671875	0.072151007047188298049178456494701094925403594970703125	0.356000314060237632585170786114758811891078948974609375	0.04357048465821342	-0.06345565307460377	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
regulation of cell proliferation involved in heart morphogenesis	6/122	0.22759672083919746388147586912964470684528350830078125	0.73858861214153648244717942361603491008281707763671875	0.07005214034133598610676330054047866724431514739990234375	0.347461562555291092468934266435098834335803985595703125	0.043206180300786205	-0.06395292328335914	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
protein transport within lipid bilayer	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.004357719182081	-0.06408933552734064	TBC1D9
microtubule polymerization based protein transport	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.004676418076128	-0.06409225159776019	TBC1D9
misfolded protein transport	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.008204891778415	-0.06412453686131632	TBC1D9
intracellular protein transport in other organism involved in symbiotic interaction	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.0085135285510045	-0.06412736086409682	TBC1D9
establishment of protein localization to T cell secretory granule	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.011695623088302	-0.06415647678487883	TBC1D9
endocytosed protein transport to vacuole	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.012520146633083	-0.0641640211120292	TBC1D9
protein transport along microtubule	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.013134330757229	-0.06416964084962486	TBC1D9
protein-DNA complex transport	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.020793185478719	-0.06423971878248892	TBC1D9
polyubiquitinated protein transport	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.023504241118594	-0.06426452473351302	TBC1D9
establishment of protein localization to mast cell secretory granule	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.026081758304066	-0.06428810881792875	TBC1D9
activation of MAPK activity	1/137	0.9908918099183063876722599161439575254917144775390625	0.99999911886740633359949015357415191829204559326171875	0.95789980497729187991495791720808483660221099853515625	0.9793365764714596632956045141327194869518280029296875	7.109138300556753	-0.06504806980472923	ALK
spliceosomal snRNP assembly	3/246	0.990056858321700428149370054597966372966766357421875	0.99999911886740633359949015357415191829204559326171875	0.92309499423960283959189609959139488637447357177734375	0.959506189472941084517287890776060521602630615234375	6.537657141313847	-0.06533018578456093	U2AF2;GEMIN5;CDC40
platelet degranulation	1/136	0.99057289037292595157424557328340597450733184814453125	0.99999911886740633359949015357415191829204559326171875	0.9569171459795062784081665085977874696254730224609375	0.9793365764714596632956045141327194869518280029296875	7.022124294035428	-0.06651234001250249	GTPBP2
CAAX-box protein maturation	2/196	0.99060319197424251402850359227159060537815093994140625	0.99999911886740633359949015357415191829204559326171875	0.94068463922078804362314485842944122850894927978515625	0.9734992196587224366766122329863719642162322998046875	7.085417281858364	-0.06689510075286438	USP9X;PAPPA2
retrograde transport, endosome to Golgi	2/194	0.99002215562627082778845988286775536835193634033203125	0.99999911886740633359949015357415191829204559326171875	0.93839455764549395411222576512955129146575927734375	0.9713423586600384851408307440578937530517578125	6.71715896503279	-0.06735937913713856	GBF1;VTI1A
regulation of cell proliferation involved in kidney morphogenesis	6/124	0.23859603545223084797299861747887916862964630126953125	0.73858861214153648244717942361603491008281707763671875	0.07428570857653016279442681479849852621555328369140625	0.360870944753339639721190224008751101791858673095703125	0.04723385844233904	-0.06768533437296438	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
regulation of neural precursor cell proliferation	6/123	0.233075975948903113543764220594312064349651336669921875	0.73858861214153648244717942361603491008281707763671875	0.072151007047188298049178456494701094925403594970703125	0.356000314060237632585170786114758811891078948974609375	0.04673444200158481	-0.06806361144593606	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
spliceosomal complex assembly	3/241	0.98860679806853191120552537540788762271404266357421875	0.99999911886740633359949015357415191829204559326171875	0.91654113742711340595548108467482961714267730712890625	0.956699390405774341417100004036910831928253173828125	6.565898827998948	-0.07523601929356963	U2AF2;GEMIN5;CDC40
protein polyubiquitination	6/381	0.9893557842229785403986852543312124907970428466796875	0.99999911886740633359949015357415191829204559326171875	0.87395283666566137004139136479352600872516632080078125	0.92493505284988219994346536623197607696056365966796875	7.0524085219999355	-0.07546973248839249	RNF43;USP9X;TNKS;RNF217;ARRB1;BRCA1
positive regulation of execution phase of apoptosis	3/241	0.98860679806853191120552537540788762271404266357421875	0.99999911886740633359949015357415191829204559326171875	0.91654113742711340595548108467482961714267730712890625	0.956699390405774341417100004036910831928253173828125	6.96946391514188	-0.07986031087616627	ABR;PNMA1;CTNNB1
rRNA processing	2/188	0.98806081015566549208273272597580216825008392333984375	0.99999911886740633359949015357415191829204559326171875	0.93101213857414466534834218691685236990451812744140625	0.964547388019819873505866780760698020458221435546875	6.655934869860004	-0.07994466260460024	RPS25;RPP25
positive regulation of anoikis	3/240	0.9882933248332153031157076839008368551731109619140625	0.99999911886740633359949015357415191829204559326171875	0.91517097001637048858668777029379270970821380615234375	0.95569215531707329969179909312515519559383392333984375	6.922679677391209	-0.0815196608486742	ABR;PNMA1;CTNNB1
G2/M transition of mitotic cell cycle	1/130	0.98841112405572217891602804229478351771831512451171875	0.99999911886740633359949015357415191829204559326171875	0.950522157835919312418582194368354976177215576171875	0.9793365764714596632956045141327194869518280029296875	7.120177313871921	-0.08299670515947132	CEP164
intracellular protein transport	2/188	0.98806081015566549208273272597580216825008392333984375	0.99999911886740633359949015357415191829204559326171875	0.93101213857414466534834218691685236990451812744140625	0.964547388019819873505866780760698020458221435546875	6.971651725111081	-0.08373674860981738	GRID2;TBC1D9
negative regulation of anoikis	5/336	0.98909287248370436618216672286507673561573028564453125	0.99999911886740633359949015357415191829204559326171875	0.88765866337382381967557876123464666306972503662109375	0.9350348180291037092359829330234788358211517333984375	7.658971988681595	-0.08399630059930759	TLE1;CITED2;STAT3;PHIP;AATF
rRNA modification	2/187	0.9876992948768277269522286587744019925594329833984375	0.99999911886740633359949015357415191829204559326171875	0.9297033242595762470017461964744143187999725341796875	0.96446241049756353813648956929682753980159759521484375	6.790156518231843	-0.08404166518710637	RPS25;RPP25
maturation of 5.8S rRNA	2/187	0.9876992948768277269522286587744019925594329833984375	0.99999911886740633359949015357415191829204559326171875	0.9297033242595762470017461964744143187999725341796875	0.96446241049756353813648956929682753980159759521484375	6.80944106607875	-0.08428034974600909	RPS25;RPP25
mRNA cis splicing, via spliceosome	3/236	0.9869545313704122246889482994447462260723114013671875	0.99999911886740633359949015357415191829204559326171875	0.90948398454278545077755779857398010790348052978515625	0.95122748449851857177606007098802365362644195556640625	6.481925548094001	-0.08511616156332603	U2AF2;GEMIN5;CDC40
positive regulation of fibroblast apoptotic process	3/238	0.987641328469201607020977462525479495525360107421875	0.99999911886740633359949015357415191829204559326171875	0.91236924765475391208013888899586163461208343505859375	0.95339958821166914670897085670731030404567718505859375	6.852371132944529	-0.08521386045732228	ABR;PNMA1;CTNNB1
maturation of SSU-rRNA	2/186	0.98732712763586294446582769523956812918186187744140625	0.99999911886740633359949015357415191829204559326171875	0.928371130578784953257809320348314940929412841796875	0.96359431008592222323017040253034792840480804443359375	6.715268854817832	-0.0856455864381065	RPS25;RPP25
prosthetic group metabolic process	2/188	0.98806081015566549208273272597580216825008392333984375	0.99999911886740633359949015357415191829204559326171875	0.93101213857414466534834218691685236990451812744140625	0.964547388019819873505866780760698020458221435546875	7.135937171143127	-0.08570998675151728	USP9X;PAPPA2
ferredoxin metabolic process	2/188	0.98806081015566549208273272597580216825008392333984375	0.99999911886740633359949015357415191829204559326171875	0.93101213857414466534834218691685236990451812744140625	0.964547388019819873505866780760698020458221435546875	7.141693583643856	-0.08577912722001368	USP9X;PAPPA2
rhodopsin metabolic process	2/188	0.98806081015566549208273272597580216825008392333984375	0.99999911886740633359949015357415191829204559326171875	0.93101213857414466534834218691685236990451812744140625	0.964547388019819873505866780760698020458221435546875	7.1424565439544745	-0.08578829116254102	USP9X;PAPPA2
cellular protein metabolic process	2/188	0.98806081015566549208273272597580216825008392333984375	0.99999911886740633359949015357415191829204559326171875	0.93101213857414466534834218691685236990451812744140625	0.964547388019819873505866780760698020458221435546875	7.148011434546609	-0.08585501114446341	USP9X;PAPPA2
spliceosomal complex disassembly	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.460319465811397	-0.08956899671880711	U2AF2;GEMIN5;CDC40
spliceosomal conformational changes to generate catalytic conformation	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.468584501742037	-0.08968358717831457	U2AF2;GEMIN5;CDC40
negative regulation of protein kinase activity by protein phosphorylation	6/374	0.98753777266558595560042022043489851057529449462890625	0.99999911886740633359949015357415191829204559326171875	0.86291811368136561721797761492780409753322601318359375	0.9169598428103180598469634787761606276035308837890625	7.211910815705445	-0.0904411993593734	PRKCH;LRRC4;PRKAG1;SFN;TRIB1;LRRC4B
cleavage involved in rRNA processing	2/184	0.9865496204697874471634122528485022485256195068359375	0.99999911886740633359949015357415191829204559326171875	0.92563509262698773216726522150565870106220245361328125	0.96108754829881160031135323151829652488231658935546875	6.736591104593093	-0.09122459444162914	RPS25;RPP25
mRNA trans splicing, via spliceosome	3/233	0.98585523795806595526158844222663901746273040771484375	0.99999911886740633359949015357415191829204559326171875	0.90499494999538565576102655541035346686840057373046875	0.94980506847621348764931781261111609637737274169921875	6.467126119491474	-0.092129079022245	U2AF2;GEMIN5;CDC40
regulation of transcription from RNA polymerase II promoter in response to hypoxia	1/128	0.9875856845913080217513879688340239226818084716796875	0.99999911886740633359949015357415191829204559326171875	0.94818683289628591381870137411169707775115966796875	0.97783062762828609759679920898634009063243865966796875	7.375224151387377	-0.09213142374256686	ZFP36L1
positive regulation of myeloid cell apoptotic process	3/235	0.98659753928337823314365095939137972891330718994140625	0.99999911886740633359949015357415191829204559326171875	0.90800938441497625053244746595737524330615997314453125	0.94989582308393061271800661415909416973590850830078125	6.8566428440055684	-0.0925172600715343	ABR;PNMA1;CTNNB1
ion transmembrane transport	6/372	0.98696701454088520133467454797937534749507904052734375	0.99999911886740633359949015357415191829204559326171875	0.85962301307341981715381962203537113964557647705078125	0.91428224411889991163349122871295548975467681884765625	7.112216209981895	-0.09330274648420446	GABRA2;SLC9A2;SLC24A2;ATP2A2;SLC1A6;ADD3
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway	2/183	0.98614365187808006307790265054791234433650970458984375	0.99999911886740633359949015357415191829204559326171875	0.92423047993161622226665485868579708039760589599609375	0.960263254149214429133962767082266509532928466796875	6.7590652322470826	-0.09431088255538662	GRAP2;NFATC3
positive regulation of muscle cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.832714258199072	-0.09473205840855642	ABR;PNMA1;CTNNB1
positive regulation of apoptotic process involved in development	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.839249474833958	-0.09482266581588736	ABR;PNMA1;CTNNB1
positive regulation of myofibroblast cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.84289482491662	-0.09487320671426255	ABR;PNMA1;CTNNB1
positive regulation of mesenchymal cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.843395332322267	-0.09488014599124589	ABR;PNMA1;CTNNB1
positive regulation of leukocyte apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.844160629181306	-0.094890756437404	ABR;PNMA1;CTNNB1
positive regulation of glial cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.84640791007684	-0.09492191382771938	ABR;PNMA1;CTNNB1
positive regulation of epithelial cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.851695656230456	-0.09499522570035812	ABR;PNMA1;CTNNB1
positive regulation of compound eye retinal cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.85503405838943	-0.09504151092411611	ABR;PNMA1;CTNNB1
positive regulation of apoptotic process in other organism	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.8571607624601265	-0.09507099657895689	ABR;PNMA1;CTNNB1
positive regulation of fat cell apoptotic process	3/234	0.986231185182928182797468252829276025295257568359375	0.99999911886740633359949015357415191829204559326171875	0.9065131266228350082059250780730508267879486083984375	0.94980506847621348764931781261111609637737274169921875	6.857895473180999	-0.09508118296408775	ABR;PNMA1;CTNNB1
maturation of 5S rRNA	2/182	0.98572577349148360337238727879594080150127410888671875	0.99999911886740633359949015357415191829204559326171875	0.92280095103355763708208314710645936429500579833984375	0.95941196518080029687070009458693675696849822998046875	6.670864297208609	-0.0959075713723517	RPS25;RPP25
Fc-epsilon receptor signaling pathway	2/182	0.98572577349148360337238727879594080150127410888671875	0.99999911886740633359949015357415191829204559326171875	0.92280095103355763708208314710645936429500579833984375	0.95941196518080029687070009458693675696849822998046875	6.722361501879917	-0.0966479509712227	GRAP2;NFATC3
negative regulation of glial cell apoptotic process	5/330	0.987425940409561775368274538777768611907958984375	0.99999911886740633359949015357415191829204559326171875	0.87848407115604632000582796536036767065525054931640625	0.92791398863695018217612187072518281638622283935546875	7.653026478725398	-0.0968397292598333	PRKCH;CITED2;STAT3;PHIP;AATF
DNA replication	1/125	0.98623617205360414317283357377164065837860107421875	0.99999911886740633359949015357415191829204559326171875	0.94447627901709030329158167660352773964405059814453125	0.97485658821085674485829031254979781806468963623046875	6.991292981549415	-0.09689531927030562	BRCA1
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	1/125	0.98623617205360414317283357377164065837860107421875	0.99999911886740633359949015357415191829204559326171875	0.94447627901709030329158167660352773964405059814453125	0.97485658821085674485829031254979781806468963623046875	7.054657327335	-0.09777351283642442	RPS25
chloroplast rRNA processing	2/181	0.98529564972370875519658284247270785272121429443359375	0.99999911886740633359949015357415191829204559326171875	0.9213461094098047698963682705652900040149688720703125	0.9585384401974612611496695535606704652309417724609375	6.713581354711723	-0.09945184446423279	RPS25;RPP25
maturation of 2S rRNA	2/181	0.98529564972370875519658284247270785272121429443359375	0.99999911886740633359949015357415191829204559326171875	0.9213461094098047698963682705652900040149688720703125	0.9585384401974612611496695535606704652309417724609375	6.71598590333969	-0.0994874643194964	RPS25;RPP25
rRNA 5'-end processing	2/181	0.98529564972370875519658284247270785272121429443359375	0.99999911886740633359949015357415191829204559326171875	0.9213461094098047698963682705652900040149688720703125	0.9585384401974612611496695535606704652309417724609375	6.719569735421669	-0.0995405535265785	RPS25;RPP25
rRNA 3'-end processing	2/181	0.98529564972370875519658284247270785272121429443359375	0.99999911886740633359949015357415191829204559326171875	0.9213461094098047698963682705652900040149688720703125	0.9585384401974612611496695535606704652309417724609375	6.722789785016585	-0.09958825383056841	RPS25;RPP25
maturation of 4.5S rRNA	2/181	0.98529564972370875519658284247270785272121429443359375	0.99999911886740633359949015357415191829204559326171875	0.9213461094098047698963682705652900040149688720703125	0.9585384401974612611496695535606704652309417724609375	6.725336938912823	-0.0996259861733719	RPS25;RPP25
snoRNA release from pre-rRNA	2/181	0.98529564972370875519658284247270785272121429443359375	0.99999911886740633359949015357415191829204559326171875	0.9213461094098047698963682705652900040149688720703125	0.9585384401974612611496695535606704652309417724609375	6.726826738390264	-0.09964805536388069	RPS25;RPP25
cellular response to fibroblast growth factor stimulus	3/37	0.126914191141404508744727763769333250820636749267578125	0.70596018822406259030088904182775877416133880615234375	0.06101631269409306390638647599189425818622112274169921875	0.328570507844122949858700621916796080768108367919921875	0.04860123716901469	-0.10032481616458873	STAT5B;CTNNB1;ZFP36L1
negative regulation of mesenchymal cell apoptotic process	5/327	0.98650484883780098499528321553952991962432861328125	0.99999911886740633359949015357415191829204559326171875	0.87366335648881776609897542584803886711597442626953125	0.92483618773737730212047836175770498812198638916015625	7.680542470003437	-0.10435582500149969	CITED2;STAT3;PHIP;AATF;POU3F4
tRNA aminoacylation for protein translation	2/179	0.98439727849578939622432471878710202872753143310546875	0.99999911886740633359949015357415191829204559326171875	0.918358877358883329833361131022684276103973388671875	0.95690276662289652787052318672067485749721527099609375	6.661229344180033	-0.10475266150485418	RPS25;LARS
membrane protein proteolysis	2/179	0.98439727849578939622432471878710202872753143310546875	0.99999911886740633359949015357415191829204559326171875	0.918358877358883329833361131022684276103973388671875	0.95690276662289652787052318672067485749721527099609375	6.739883009026565	-0.10598954741645902	TBL1X;PAPPA2
determination of pancreatic left/right asymmetry	3/36	0.1194392031525093045285501602847944013774394989013671875	0.6779719870883109678061373415403068065643310546875	0.0573619751424954971152914140475331805646419525146484375	0.313893778128945755145906559846480377018451690673828125	0.055171812126676587	-0.1172372206517973	TCF7L2;CITED2;NKX6-1
protein modification by small protein removal	2/175	0.9824378085935994153743422430125065147876739501953125	0.99999911886740633359949015357415191829204559326171875	0.91206266485934772703103590174578130245208740234375	0.95329040331077841141649287237669341266155242919921875	6.655825416216178	-0.11792948805229533	TBL1X;PAPPA2
self proteolysis	2/175	0.9824378085935994153743422430125065147876739501953125	0.99999911886740633359949015357415191829204559326171875	0.91206266485934772703103590174578130245208740234375	0.95329040331077841141649287237669341266155242919921875	6.6579034979651155	-0.11796630799594739	TBL1X;PAPPA2
proteolysis	2/174	0.9819117943099617829005865132785402238368988037109375	0.99999911886740633359949015357415191829204559326171875	0.9104191157074696949536019019433297216892242431640625	0.95199445107340607830082035434315912425518035888671875	6.65033724803784	-0.12139390715066137	TBL1X;PAPPA2
viral transcription	1/119	0.98308190294455688462704756602761335670948028564453125	0.99999911886740633359949015357415191829204559326171875	0.936241946700740346187785689835436642169952392578125	0.96953968443191917980783500752295367419719696044921875	7.350958265245129	-0.12542824627900123	RPS25
viral RNA editing	1/119	0.98308190294455688462704756602761335670948028564453125	0.99999911886740633359949015357415191829204559326171875	0.936241946700740346187785689835436642169952392578125	0.96953968443191917980783500752295367419719696044921875	7.35362235917932	-0.1254737032953562	RPS25
synaptic transmission, serotonergic	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.09535992089678998	-0.12855349074402844	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
protein K6-linked ubiquitination	3/220	0.979979962660923131778645256417803466320037841796875	0.99999911886740633359949015357415191829204559326171875	0.88314227490295194034075620947987772524356842041015625	0.93173386506759647840425486720050685107707977294921875	6.388629974450653	-0.12919824648654138	TNKS;RNF217;BRCA1
cellular protein modification process	4/271	0.9822672707630457633598553002229891717433929443359375	0.99999911886740633359949015357415191829204559326171875	0.8720188736923744077245146399945951998233795166015625	0.92392475903120629965314947185106575489044189453125	7.230320812581454	-0.1293637275052229	MSRA;ICMT;USP9X;PAPPA2
excitatory chemical synaptic transmission	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.09815436223159793	-0.1323206413969508	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
positive regulation of epithelial cell migration	2/172	0.98081353491296996427450949340709485113620758056640625	0.99999911886740633359949015357415191829204559326171875	0.90704558497995335653030224420945160090923309326171875	0.94989582308393061271800661415909416973590850830078125	6.915659742802448	-0.13397648162294118	PDGFRA;CLASP2
spontaneous synaptic transmission	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.10000703584212509	-0.13481820701574343	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
apoptotic mitochondrial changes	4/268	0.98090834966892070934108005531015805900096893310546875	0.99999911886740633359949015357415191829204559326171875	0.8665366804855925142447858888772316277027130126953125	0.91956209715422720929467459427542053163051605224609375	7.0166314612945095	-0.1352543365584005	ELMO1;PAX3;BRCA1;OGT
chemical synaptic transmission	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.10235526433184616	-0.1379838238344166	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
synaptic transmission, noradrenergic	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.1046674589608207	-0.14110086386589882	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
phenylethylamine metabolic process involved in synaptic transmission	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.10687167859251255	-0.14407234418337087	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
inhibitory chemical synaptic transmission	8/180	0.259736604553206629208972344713401980698108673095703125	0.73858861214153648244717942361603491008281707763671875	0.06348687386352980244197397041716612875461578369140625	0.335222031462011293978520143355126492679119110107421875	0.10892303532556555	-0.14683775198064292	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
mRNA stabilization	1/114	0.9799087298367064047255325931473635137081146240234375	0.99999911886740633359949015357415191829204559326171875	0.928457947708398734221191261895000934600830078125	0.96359431008592222323017040253034792840480804443359375	7.399444297116826	-0.1501779706508039	ZFP36L1
negative regulation of epithelial cell migration	5/95	0.215109739476681272041247439119615592062473297119140625	0.73858861214153648244717942361603491008281707763671875	0.07590410239353474752821426818627514876425266265869140625	0.367974975324052822056586364851682446897029876708984375	0.09826592257559935	-0.15099610104217573	CITED2;MAGI2;NKX2-1;PTPRG;ROBO1
heart morphogenesis	5/96	0.2211971102500705221860499705144320614635944366455078125	0.73858861214153648244717942361603491008281707763671875	0.0784617318525204499035652361271786503493785858154296875	0.37804288983487122077775666184606961905956268310546875	0.10444436097831045	-0.1575753195173249	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
nuclear-transcribed mRNA catabolic process, 5'-3' exonucleolytic nonsense-mediated decay	1/111	0.977726331251731917149072614847682416439056396484375	0.99999911886740633359949015357415191829204559326171875	0.9233401147719089152587912394665181636810302734375	0.959549531037473979466767559642903506755828857421875	7.058467094104264	-0.158995309960862	RPS25
late viral transcription	1/112	0.97847890328145992189234902980388142168521881103515625	0.99999911886740633359949015357415191829204559326171875	0.92508536624159554140334194016759283840656280517578125	0.960826811240497846711150486953556537628173828125	7.364836652704386	-0.16022977392077542	RPS25
acute inflammatory response	3/212	0.97527584530334099355286525678820908069610595703125	0.99999911886740633359949015357415191829204559326171875	0.867571006310613679346488424926064908504486083984375	0.92024565701982563581395879737101495265960693359375	6.696186810454058	-0.16763856631409393	STAT3;NFATC3;NFATC4
early viral transcription	1/110	0.9769474830075444149457553066895343363285064697265625	0.99999911886740633359949015357415191829204559326171875	0.921554340957279283230718647246249020099639892578125	0.9585384401974612611496695535606704652309417724609375	7.3453786841925	-0.17131172542510803	RPS25
inflammatory response	3/211	0.974618837924837944086675634025596082210540771484375	0.99999911886740633359949015357415191829204559326171875	0.86550151432615829438788068728172220289707183837890625	0.91867026171838173098649349412880837917327880859375	6.674020064442619	-0.17158117972016082	STAT3;NFATC3;NFATC4
inflammatory response to wounding	3/211	0.974618837924837944086675634025596082210540771484375	0.99999911886740633359949015357415191829204559326171875	0.86550151432615829438788068728172220289707183837890625	0.91867026171838173098649349412880837917327880859375	6.675737223166546	-0.17162532584450166	STAT3;NFATC3;NFATC4
chronic inflammatory response	3/211	0.974618837924837944086675634025596082210540771484375	0.99999911886740633359949015357415191829204559326171875	0.86550151432615829438788068728172220289707183837890625	0.91867026171838173098649349412880837917327880859375	6.677861358251668	-0.17167993485080837	STAT3;NFATC3;NFATC4
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	6/346	0.97694053993389806667124730665818788111209869384765625	0.99999911886740633359949015357415191829204559326171875	0.81063893055205971105436901780194602906703948974609375	0.87560884712939446306023683064267970621585845947265625	7.480071975196793	-0.17450625412587276	GPX1;CITED2;STAT3;SFN;PHIP;AATF
receptor internalization	2/164	0.97573822749612393323559444979764521121978759765625	0.99999911886740633359949015357415191829204559326171875	0.892332644412490605390075870673172175884246826171875	0.93890990044472866227209806311293505132198333740234375	7.148671645786288	-0.17557808162005734	VLDLR;LDLRAP1
B cell receptor apoptotic signaling pathway	1/110	0.9769474830075444149457553066895343363285064697265625	0.99999911886740633359949015357415191829204559326171875	0.921554340957279283230718647246249020099639892578125	0.9585384401974612611496695535606704652309417724609375	7.534828407239998	-0.17573014417953112	MEF2C
non-motile cilium assembly	2/163	0.9750190654012345081724788542487658560276031494140625	0.99999911886740633359949015357415191829204559326171875	0.89034869493107782201235522734350524842739105224609375	0.93724052532691237704653985929326154291629791259765625	7.0114038531575105	-0.17737627499738817	VANGL2;CEP164
DNA synthesis involved in DNA replication	1/108	0.97530726205059992128809653877397067844867706298828125	0.99999911886740633359949015357415191829204559326171875	0.91785745375285088254457832590560428798198699951171875	0.956803007591645826579451750149019062519073486328125	7.126820327063417	-0.17818987221728289	BRCA1
positive regulation of neuron migration	2/163	0.9750190654012345081724788542487658560276031494140625	0.99999911886740633359949015357415191829204559326171875	0.89034869493107782201235522734350524842739105224609375	0.93724052532691237704653985929326154291629791259765625	7.0626213625579775	-0.17867198855523828	PDGFRA;RAPGEF2
SRP-dependent cotranslational protein targeting to membrane, signal sequence processing	1/108	0.97530726205059992128809653877397067844867706298828125	0.99999911886740633359949015357415191829204559326171875	0.91785745375285088254457832590560428798198699951171875	0.956803007591645826579451750149019062519073486328125	7.159786930726841	-0.1790141268813041	RPS25
mRNA splicing, via spliceosome	4/252	0.97184372572328781014761034384719096124172210693359375	0.99999911886740633359949015357415191829204559326171875	0.83380989836095176226393732576980255544185638427734375	0.89347598604466360594500429215258918702602386474609375	6.292316377897713	-0.17971021347856744	U2AF2;ELAVL4;GEMIN5;CDC40
DNA-templated viral transcription	1/108	0.97530726205059992128809653877397067844867706298828125	0.99999911886740633359949015357415191829204559326171875	0.91785745375285088254457832590560428798198699951171875	0.956803007591645826579451750149019062519073486328125	7.301353844384221	-0.18255368436937647	RPS25
middle viral transcription	1/108	0.97530726205059992128809653877397067844867706298828125	0.99999911886740633359949015357415191829204559326171875	0.91785745375285088254457832590560428798198699951171875	0.956803007591645826579451750149019062519073486328125	7.305210959139056	-0.18265012271828243	RPS25
RNA-templated viral transcription	1/108	0.97530726205059992128809653877397067844867706298828125	0.99999911886740633359949015357415191829204559326171875	0.91785745375285088254457832590560428798198699951171875	0.956803007591645826579451750149019062519073486328125	7.310358024530901	-0.1827788133379946	RPS25
muscle filament sliding	1/108	0.97530726205059992128809653877397067844867706298828125	0.99999911886740633359949015357415191829204559326171875	0.91785745375285088254457832590560428798198699951171875	0.956803007591645826579451750149019062519073486328125	7.3309798125726084	-0.18329441406979496	SSPN
negative regulation of apoptotic process	9/467	0.9769940466478035379083166844793595373630523681640625	0.99999911886740633359949015357415191829204559326171875	0.7524191664041979255017622563173063099384307861328125	0.8296735102695347308099371730349957942962646484375	7.9407201071835285	-0.1848180407511953	ALK;MECOM;CITED2;STAT3;GDF2;PHIP;BRCA1;AATF;GDF5
negative regulation of calcium ion import	3/18	0.0211499341840897144007005437060797703452408313751220703125	0.2105670264248979683952001096258754841983318328857421875	0.0112142140327315779912975557408572058193385601043701171875	0.1039783683536521785573114584622089751064777374267578125	0.048142116194732215	-0.18564170418276266	SLN;CTNNB1;PACSIN3
positive regulation of inhibitory synapse assembly	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.04446017715544037	-0.18597608402771726	NLGN2;BDNF;LRRC4B
viral DNA repair	2/160	0.972735896355917617484010406769812107086181640625	0.99999911886740633359949015357415191829204559326171875	0.88419210241924905968602388384169898927211761474609375	0.93221594705221233478908970937482081353664398193359375	6.7819293998398615	-0.18747060894496512	PDS5B;PDS5A
telomere maintenance in response to DNA damage	3/207	0.97182150192499594520967320931958965957164764404296875	0.99999911886740633359949015357415191829204559326171875	0.85693753754128920707699990089167840778827667236328125	0.91225762613415717350306977095897309482097625732421875	6.584538289040528	-0.18820672299522642	ZBTB38;BRCA1;AATF
replication of extrachromosomal circular DNA	1/106	0.97355052289576760049527592855156399309635162353515625	0.99999911886740633359949015357415191829204559326171875	0.91398694036186467481996942296973429620265960693359375	0.95466704997495910323124235219438560307025909423828125	7.047959190117083	-0.1889244740493618	BRCA1
GPI anchor biosynthetic process	1/106	0.97355052289576760049527592855156399309635162353515625	0.99999911886740633359949015357415191829204559326171875	0.91398694036186467481996942296973429620265960693359375	0.95466704997495910323124235219438560307025909423828125	7.150035834025524	-0.19166069537853295	PIGB
UV-damage excision repair	2/158	0.97110329119444305234765124623663723468780517578125	0.99999911886740633359949015357415191829204559326171875	0.87991207047499309101823428136412985622882843017578125	0.92915720537957058322575676356791518628597259521484375	6.668300825634609	-0.19553085250845975	PDS5B;PDS5A
lateral sprouting involved in ureteric bud morphogenesis	3/19	0.024501872806991224773565107852846267633140087127685546875	0.233958166053800820094465962029062211513519287109375	0.01277148816961725698304608300759355188347399234771728515625	0.11275211834681753142461957395425997674465179443359375	0.05363320585209667	-0.19892586746173874	SIX1;HOXD11;FGFR2
protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process	5/292	0.9698832214201951185117422937764786183834075927734375	0.99999911886740633359949015357415191829204559326171875	0.80467488034428147347654203258571214973926544189453125	0.8701630927519430347416573567898012697696685791015625	6.515653773316873	-0.19924611883940066	RNF43;TNKS;BTBD3;RNF217;BTBD11
determination of dorsal identity	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.0482491426214848	-0.20182525524058934	PTCH1;WNT8B;HOXD11
negative regulation of neuron maturation	3/18	0.0211499341840897144007005437060797703452408313751220703125	0.2105670264248979683952001096258754841983318328857421875	0.0112142140327315779912975557408572058193385601043701171875	0.1039783683536521785573114584622089751064777374267578125	0.052558692592611964	-0.20267254607262286	ID2;SIX3;CNTN4
maturation of LSU-rRNA	3/203	0.9687340041567844561853917184635065495967864990234375	0.99999911886740633359949015357415191829204559326171875	0.84790202304141926159530839868239127099514007568359375	0.90590121012148916435080536757595837116241455078125	6.491392208002295	-0.20620043855595957	RPS25;RPP25;AAMP
protein targeting	2/156	0.96937665042716958385682346488465555012226104736328125	0.99999911886740633359949015357415191829204559326171875	0.87548675904524408952767089431290514767169952392578125	0.925759245104845973628471256233751773834228515625	6.657773410120944	-0.2070703514534806	TBC1D9;AKAP6
signal peptide processing	4/250	0.970461887319908900195741807692684233188629150390625	0.99999911886740633359949015357415191829204559326171875	0.82928325364000432529110184987075626850128173828125	0.88963591253579732409662028658203780651092529296875	6.907770460327712	-0.20711670630086423	USP9X;PTCH1;RHBDL3;PAPPA2
positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation	8/419	0.9728775301678054265863693217397667467594146728515625	0.99999911886740633359949015357415191829204559326171875	0.75289327570619846152766285740653984248638153076171875	0.8299597058906609259310016568633727729320526123046875	7.533037143451645	-0.20713647219883496	PDGFRA;TNKS;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of apoptotic signaling pathway	4/248	0.96901692250054327626429540032404474914073944091796875	0.99999911886740633359949015357415191829204559326171875	0.8246550979775106871016987497569061815738677978515625	0.88726012349015215274761203545494936406612396240234375	6.737971695569151	-0.2120655534288734	ABR;PNMA1;CTNNB1;GATA3
negative regulation of forebrain neuron differentiation	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.052938014994971326	-0.2124749725904024	ID2;SIX3;CNTN4
protein arginylation	2/155	0.96847648101095884509703637377242557704448699951171875	0.99999911886740633359949015357415191829204559326171875	0.873218322881133435231504336115904152393341064453125	0.92457257666224601511117953123175539076328277587890625	6.762865138716351	-0.21662187674150488	MSRA;ICMT
collagen fibril organization	2/154	0.9675508689041374399408823592239059507846832275390625	0.99999911886740633359949015357415191829204559326171875	0.870911997104469204344923127791844308376312255859375	0.92295931034414324667380924438475631177425384521484375	6.571165961523553	-0.21676487692218513	COL11A2;HAPLN1
regulation of mitochondrial mRNA stability	1/103	0.970678705891454551846209142240695655345916748046875	0.99999911886740633359949015357415191829204559326171875	0.90783774138772865835989023253205232322216033935546875	0.94989582308393061271800661415909416973590850830078125	7.446672447561036	-0.2216111503083474	ZFP36L1
regulation of 3'-UTR-mediated mRNA stabilization	1/103	0.970678705891454551846209142240695655345916748046875	0.99999911886740633359949015357415191829204559326171875	0.90783774138772865835989023253205232322216033935546875	0.94989582308393061271800661415909416973590850830078125	7.447944491858436	-0.22164900603544904	ZFP36L1
regulation of mRNA stability	1/103	0.970678705891454551846209142240695655345916748046875	0.99999911886740633359949015357415191829204559326171875	0.90783774138772865835989023253205232322216033935546875	0.94989582308393061271800661415909416973590850830078125	7.448383536685565	-0.22166207190209783	ZFP36L1
regulation of mRNA stability involved in response to stress	1/103	0.970678705891454551846209142240695655345916748046875	0.99999911886740633359949015357415191829204559326171875	0.90783774138772865835989023253205232322216033935546875	0.94989582308393061271800661415909416973590850830078125	7.453991353638737	-0.22182895916274512	ZFP36L1
regulation of mRNA stability, ncRNA-mediated	1/103	0.970678705891454551846209142240695655345916748046875	0.99999911886740633359949015357415191829204559326171875	0.90783774138772865835989023253205232322216033935546875	0.94989582308393061271800661415909416973590850830078125	7.454003735653921	-0.2218293276484879	ZFP36L1
positive regulation of apoptotic process	7/374	0.96993615301101454573284854632220230996608734130859375	0.99999911886740633359949015357415191829204559326171875	0.7614469436385269407452369705424644052982330322265625	0.8370415365049945766173777883523143827915191650390625	7.2727630259495974	-0.2220013189258808	ALK;ABR;PNMA1;GDF2;CTNNB1;BRCA1;GDF5
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition	1/102	0.96965384840414514666662171293864957988262176513671875	0.99999911886740633359949015357415191829204559326171875	0.90569215014908677208183007678599096834659576416015625	0.94980506847621348764931781261111609637737274169921875	7.257561308160567	-0.22364994178723394	RPS25
striated muscle contraction	1/102	0.96965384840414514666662171293864957988262176513671875	0.99999911886740633359949015357415191829204559326171875	0.90569215014908677208183007678599096834659576416015625	0.94980506847621348764931781261111609637737274169921875	7.273789460569258	-0.22415003061699512	SSPN
positive regulation of bone mineralization involved in bone maturation	3/32	0.091325011268925060381462799341534264385700225830078125	0.55872902484503172981789020923315547406673431396484375	0.043840158751714784768349630894590518437325954437255859375	0.259197548393503007790883430061512626707553863525390625	0.0942289008468847	-0.22552091019057452	MEF2C;PKDCC;ACVR2A
cation transmembrane transport	3/200	0.966211571380393596797375721507705748081207275390625	0.99999911886740633359949015357415191829204559326171875	0.8408047628606392098760125008993782103061676025390625	0.899949186842213588732874995912425220012664794921875	6.59857790963532	-0.22680929427461835	GABRA2;SLC24A2;ATP2A2
RNA splicing, via transesterification reactions	1/102	0.96965384840414514666662171293864957988262176513671875	0.99999911886740633359949015357415191829204559326171875	0.90569215014908677208183007678599096834659576416015625	0.94980506847621348764931781261111609637737274169921875	7.411964660501493	-0.22840805533206515	CDC40
SRP-dependent cotranslational protein targeting to membrane	1/100	0.96749558821712622336264075784129090607166290283203125	0.99999911886740633359949015357415191829204559326171875	0.90125046568439837191277774763875640928745269775390625	0.94787033369750428590805313433520495891571044921875	6.949118084429618	-0.22962953540943984	RPS25
embryonic skeletal system morphogenesis	3/30	0.07845038442461722827392378576405462808907032012939453125	0.495462131706552899590434435594943352043628692626953125	0.037758065740495998230397134420854854397475719451904296875	0.241334412056801672630257371565676294267177581787109375	0.0913589967548672	-0.2325350403155621	PDGFRA;SIX1;FGFR2
canonical Wnt signaling pathway involved in ureteric bud branching	3/19	0.024501872806991224773565107852846267633140087127685546875	0.233958166053800820094465962029062211513519287109375	0.01277148816961725698304608300759355188347399234771728515625	0.11275211834681753142461957395425997674465179443359375	0.06286617838893932	-0.2331710154435097	SIX1;GATA3;HOXD11
mRNA destabilization	2/153	0.96659913684769283026554376192507334053516387939453125	0.99999911886740633359949015357415191829204559326171875	0.86856724927127559876538498428999446332454681396484375	0.92109525962513638663864412592374719679355621337890625	6.971293070030188	-0.23682467288418713	LIN28A;ZFP36L1
DNA damage checkpoint	3/197	0.96349821898661025532106805258081294596195220947265625	0.99999911886740633359949015357415191829204559326171875	0.8334239941752004110497864530771039426326751708984375	0.893265389803322040762623146292753517627716064453125	6.427851089229123	-0.23901732623544308	ZBTB38;BRCA1;AATF
nucleosome mobilization	4/67	0.187935674251217876840058806919842027127742767333984375	0.73858861214153648244717942361603491008281707763671875	0.0765075599742958412097237896887236274778842926025390625	0.370139651691029192281945370268658734858036041259765625	0.14556522437981587	-0.2433349127381538	PBRM1;MYB;DEK;BAZ1A
peptidyl-tyrosine phosphorylation	6/327	0.96551642480035704263485740739270113408565521240234375	0.99999911886740633359949015357415191829204559326171875	0.76709301710627098014327884811791591346263885498046875	0.840505867988450727779081717017106711864471435546875	7.055978423063695	-0.24760956296841513	PDGFRA;PRKCH;PKDCC;ERBB4;PRKAG1;FGFR2
termination of T cell signal transduction	2/150	0.96358020238165753568182481103576719760894775390625	0.99999911886740633359949015357415191829204559326171875	0.8612970852681953726204255872289650142192840576171875	0.915443522129355091720981363323517143726348876953125	6.723607403540941	-0.24944283544534152	GRAP2;GATA3
regulation of translation by machinery localization	3/194	0.96058089001809887630400908165029250085353851318359375	0.99999911886740633359949015357415191829204559326171875	0.82575194872201984619408676735474728047847747802734375	0.88726012349015215274761203545494936406612396240234375	6.331126472193081	-0.25461944354390337	RPS25;GRID2;GEMIN5
alternative mRNA splicing, via spliceosome	4/237	0.95982175852771411950214996977592818439006805419921875	0.99999911886740633359949015357415191829204559326171875	0.79732699343361213006886600851430557668209075927734375	0.86360308335851854177889208585838787257671356201171875	6.285756141914204	-0.2577642761681061	DDX17;U2AF2;GEMIN5;CDC40
protein monoubiquitination	4/237	0.95982175852771411950214996977592818439006805419921875	0.99999911886740633359949015357415191829204559326171875	0.79732699343361213006886600851430557668209075927734375	0.86360308335851854177889208585838787257671356201171875	6.286950895311775	-0.2578132702330636	RNF43;USP9X;ARRB1;BRCA1
positive regulation of glycolytic process	3/38	0.134551505153658712554687326701241545379161834716796875	0.7236937854159728455982758532627485692501068115234375	0.0647767304633271312486186843671021051704883575439453125	0.3395020417727934169960235522012226283550262451171875	0.1288039839294761	-0.2583560891287063	DSCAM;PRKAG1;OGT
anion transmembrane transport	3/194	0.96058089001809887630400908165029250085353851318359375	0.99999911886740633359949015357415191829204559326171875	0.82575194872201984619408676735474728047847747802734375	0.88726012349015215274761203545494936406612396240234375	6.476150732956702	-0.2604518963843547	GABRA2;SLC24A2;ATP2A2
RNA polymerase II transcriptional preinitiation complex assembly	2/149	0.96251688783782884950568359272438101470470428466796875	0.99999911886740633359949015357415191829204559326171875	0.85879324037882709408364689807058311998844146728515625	0.91360570926182393947101445519365370273590087890625	6.890981467279064	-0.26326076244083163	THRA;NR2E1
generation of neurons	3/36	0.1194392031525093045285501602847944013774394989013671875	0.6779719870883109678061373415403068065643310546875	0.0573619751424954971152914140475331805646419525146484375	0.313893778128945755145906559846480377018451690673828125	0.12444042807992002	-0.26442941354387056	SALL3;SALL4;SIX1
DNA repair	5/279	0.95987631001566986466144726364291273057460784912109375	0.99999911886740633359949015357415191829204559326171875	0.77245769471617287127429563042824156582355499267578125	0.84500995964197300747144936394761316478252410888671875	6.541098217307589	-0.26786350939814213	ZBTB38;BRCA1;PDS5B;AATF;PDS5A
transcriptional open complex formation at RNA polymerase II promoter	2/148	0.96142381694697609528788007082766853272914886474609375	0.99999911886740633359949015357415191829204559326171875	0.85624824868943216760186487590544857084751129150390625	0.91225762613415717350306977095897309482097625732421875	6.8706183913237515	-0.2702897883598761	THRA;NR2E1
transcriptional start site selection at RNA polymerase II promoter	2/148	0.96142381694697609528788007082766853272914886474609375	0.99999911886740633359949015357415191829204559326171875	0.85624824868943216760186487590544857084751129150390625	0.91225762613415717350306977095897309482097625732421875	6.872762813821396	-0.2703741498350781	THRA;NR2E1
histone ubiquitination	4/235	0.95789979949906245426660689190612174570560455322265625	0.99999911886740633359949015357415191829204559326171875	0.79200750781671802602801335524418391287326812744140625	0.859815745540036591165744539466686546802520751953125	6.286188153910335	-0.2703821529059696	RNF43;USP9X;ARRB1;BRCA1
neurotransmitter receptor transport postsynaptic membrane to endosome	2/146	0.9591452700877616255326074679032899439334869384765625	0.99999911886740633359949015357415191829204559326171875	0.851032594539538944644618823076598346233367919921875	0.90821736390113250170230685398564673960208892822265625	6.54279421121421	-0.2729178395881895	DLG1;NLGN2
peptidyl-tyrosine dephosphorylation	1/97	0.9639674810246792180379316050675697624683380126953125	0.99999911886740633359949015357415191829204559326171875	0.894194013639881379873486366705037653446197509765625	0.94065859998646750295137053399230353534221649169921875	7.443711131847667	-0.27316721435311214	PTPN21
interstrand cross-link repair	2/147	0.9603002101802029510935199141385965049266815185546875	0.99999911886740633359949015357415191829204559326171875	0.85366155356204431736699689281522296369075775146484375	0.91037146299636628743456867596250958740711212158203125	6.784445015105152	-0.27483328445843597	PDS5B;PDS5A
protein repair	3/194	0.96058089001809887630400908165029250085353851318359375	0.99999911886740633359949015357415191829204559326171875	0.82575194872201984619408676735474728047847747802734375	0.88726012349015215274761203545494936406612396240234375	6.852807751764671	-0.27559994325358267	MSRA;USP9X;PAPPA2
snoRNA splicing	1/96	0.96270844121135279447543098285677842795848846435546875	0.99999911886740633359949015357415191829204559326171875	0.89173191231467907602592504190397448837757110595703125	0.93848715537446258938558685258612968027591705322265625	7.565488117522622	-0.2875239093221684	CDC40
sterol regulatory element binding protein cleavage	4/236	0.9588711522707933365694543681456707417964935302734375	0.99999911886740633359949015357415191829204559326171875	0.79468103736737294440217738156206905841827392578125	0.8619246845853985039553890601382590830326080322265625	6.85101750207177	-0.28773293446279014	USP9X;PTCH1;RHBDL3;PAPPA2
initiation of neural tube closure	3/33	0.0980696425820066497447413667032378725707530975341796875	0.5907768147202963060493630109704099595546722412109375	0.04705304895850288826597562774622929282486438751220703125	0.273336492533569119789405021947459317743778228759765625	0.12420208155615388	-0.288406848366211	VANGL2;LMO4;PRICKLE1
smooth muscle contraction	1/95	0.96140547618445670874365305280662141740322113037109375	0.99999911886740633359949015357415191829204559326171875	0.88921270963820731036975075767259113490581512451171875	0.93646268170650237561147832821006886661052703857421875	7.376169838098033	-0.2903188714022963	SSPN
activation of JUN kinase activity	2/143	0.95548419527619932178907902198261581361293792724609375	0.99999911886740633359949015357415191829204559326171875	0.84288647787525838861455440564895980060100555419921875	0.9017680916619628117558704616385512053966522216796875	6.410941959544159	-0.2919354244831086	ALK;TRIB1
negative regulation of amacrine cell differentiation	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.07334787354067236	-0.29439312036159776	ID2;SIX3;CNTN4
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay	2/143	0.95548419527619932178907902198261581361293792724609375	0.99999911886740633359949015357415191829204559326171875	0.84288647787525838861455440564895980060100555419921875	0.9017680916619628117558704616385512053966522216796875	6.510064555734528	-0.29644917571924684	EDC4;RPS25
signal transduction in response to DNA damage	3/188	0.9540783788418261135433340314193628728389739990234375	0.99999911886740633359949015357415191829204559326171875	0.80950337679146155966947162596625275909900665283203125	0.87458255344143942533463587096775881946086883544921875	6.33514959649604	-0.29781191589637995	ZBTB38;BRCA1;AATF
regulation of amacrine cell differentiation	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.07181661386943762	-0.30040754378627854	CASZ1;SIX3;SIX1
protein autophosphorylation	7/358	0.95875495383978559527093921133200637996196746826171875	0.99999911886740633359949015357415191829204559326171875	0.72160180179406852030155050670146010816097259521484375	0.80478399109725062832154662828543223440647125244140625	7.207822913518911	-0.3035917664568622	ALK;PDGFRA;PRKCH;ERBB4;PRKAG1;TYRO3;FGFR2
skin epidermis development	1/94	0.96005705571534605269334861077368259429931640625	0.99999911886740633359949015357415191829204559326171875	0.8866350856431826077397317931172437965869903564453125	0.93416522201896190491510196807212196290493011474609375	7.470795687003884	-0.30452878171565695	ATP2A2
vacuolar protein processing	4/233	0.95589326176488753628035510701010935008525848388671875	0.99999911886740633359949015357415191829204559326171875	0.78657717286521366961693502162233926355838775634765625	0.85529841503116943446372033577063120901584625244140625	6.803660533672915	-0.30690647975419033	USP9X;PTCH1;RHBDL3;PAPPA2
regulation of cytosolic calcium ion concentration	1/93	0.9586615964936162637144434484071098268032073974609375	0.99999911886740633359949015357415191829204559326171875	0.88399769006818995631391544520738534629344940185546875	0.93221594705221233478908970937482081353664398193359375	7.281469088034157	-0.3074027824129697	SLC24A2
mitochondrial protein processing	4/233	0.95589326176488753628035510701010935008525848388671875	0.99999911886740633359949015357415191829204559326171875	0.78657717286521366961693502162233926355838775634765625	0.85529841503116943446372033577063120901584625244140625	6.837172446324494	-0.30841816939402805	USP9X;PTCH1;RHBDL3;PAPPA2
RNA splicing, via endonucleolytic cleavage and ligation	1/94	0.96005705571534605269334861077368259429931640625	0.99999911886740633359949015357415191829204559326171875	0.8866350856431826077397317931172437965869903564453125	0.93416522201896190491510196807212196290493011474609375	7.571675148364729	-0.30864088713995486	CDC40
positive regulation of androgen receptor activity	5/95	0.215109739476681272041247439119615592062473297119140625	0.73858861214153648244717942361603491008281707763671875	0.07590410239353474752821426818627514876425266265869140625	0.367974975324052822056586364851682446897029876708984375	0.20234831145651785	-0.310929824720222	FZD2;CTNNB1;TRIM37;NKX6-1;NEUROG1
Rho protein signal transduction	1/94	0.96005705571534605269334861077368259429931640625	0.99999911886740633359949015357415191829204559326171875	0.8866350856431826077397317931172437965869903564453125	0.93416522201896190491510196807212196290493011474609375	7.733880755070908	-0.3152528034427405	GRAP2
antigen processing and presentation of exogenous peptide antigen via MHC class II	1/92	0.9572174601673830718340241219266317784786224365234375	0.99999911886740633359949015357415191829204559326171875	0.8812991415716358023502152718720026314258575439453125	0.929997326799419710141592076979577541351318359375	7.243085385619476	-0.316701606904325	AP1G1
SRP-dependent cotranslational protein targeting to membrane, translocation	1/92	0.9572174601673830718340241219266317784786224365234375	0.99999911886740633359949015357415191829204559326171875	0.8812991415716358023502152718720026314258575439453125	0.929997326799419710141592076979577541351318359375	7.289927207639976	-0.31874975068759065	RPS25
autophagosome organization	1/93	0.9586615964936162637144434484071098268032073974609375	0.99999911886740633359949015357415191829204559326171875	0.88399769006818995631391544520738534629344940185546875	0.93221594705221233478908970937482081353664398193359375	7.599649616190102	-0.32083545355147647	PRKAG1
positive regulation of canonical Wnt signaling pathway	2/141	0.95287134586089472509939923838828690350055694580078125	0.99999911886740633359949015357415191829204559326171875	0.837233987168770621423163902363739907741546630859375	0.8965341015834484839075457784929312765598297119140625	6.652897730421014	-0.3211711895737065	TNKS;FGFR2
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	1/92	0.9572174601673830718340241219266317784786224365234375	0.99999911886740633359949015357415191829204559326171875	0.8812991415716358023502152718720026314258575439453125	0.929997326799419710141592076979577541351318359375	7.352111232336661	-0.3214687274076937	ATP2A2
T cell receptor signaling pathway	2/141	0.95287134586089472509939923838828690350055694580078125	0.99999911886740633359949015357415191829204559326171875	0.837233987168770621423163902363739907741546630859375	0.8965341015834484839075457784929312765598297119140625	6.669434004281162	-0.3219694845365909	GRAP2;GATA3
protein ubiquitination	4/226	0.94815667927674240900159929879009723663330078125	0.99999911886740633359949015357415191829204559326171875	0.76668288888933677771575503356871195137500762939453125	0.84025166981668253374238020114717073738574981689453125	6.071163748510542	-0.3232015402430156	RNF43;USP9X;ARRB1;BRCA1
isopeptide cross-linking via N6-glycyl-L-lysine	4/226	0.94815667927674240900159929879009723663330078125	0.99999911886740633359949015357415191829204559326171875	0.76668288888933677771575503356871195137500762939453125	0.84025166981668253374238020114717073738574981689453125	6.098704957278938	-0.3246677107274279	RNF43;USP9X;ARRB1;BRCA1
actin ubiquitination	4/226	0.94815667927674240900159929879009723663330078125	0.99999911886740633359949015357415191829204559326171875	0.76668288888933677771575503356871195137500762939453125	0.84025166981668253374238020114717073738574981689453125	6.102396362490094	-0.3248642245918743	RNF43;USP9X;ARRB1;BRCA1
mismatch repair	2/140	0.9515106022520896100758136526565067470073699951171875	0.99999911886740633359949015357415191829204559326171875	0.83433948817882719328764551391941495239734649658203125	0.89384041920043788564953501918353140354156494140625	6.6472434588863685	-0.3303975777227518	PDS5B;PDS5A
G1/S transition of mitotic cell cycle	1/91	0.95572295128843787193062553342315368354320526123046875	0.99999911886740633359949015357415191829204559326171875	0.8785380269774474282229448363068513572216033935546875	0.92791398863695018217612187072518281638622283935546875	7.357716299947039	-0.3332104272912092	MAX
activation of MAPK activity by adrenergic receptor signaling pathway	1/90	0.954176315587430767806154108257032930850982666015625	0.99999911886740633359949015357415191829204559326171875	0.87571290049985639480922827715403400361537933349609375	0.925759245104845973628471256233751773834228515625	7.163393332726692	-0.336011911623906	ALK
positive regulation of neuron apoptotic process	5/270	0.95125413030787286938760871635167859494686126708984375	0.99999911886740633359949015357415191829204559326171875	0.7478875591154585666942011812352575361728668212890625	0.8263728311894162903428195932065136730670928955078125	6.728714706646784	-0.336260976052493	ABR;MEF2C;GRID2;PNMA1;CTNNB1
regulation of transcription from RNA polymerase II promoter in response to DNA damage	3/183	0.9479077797991111165032407370745204389095306396484375	0.99999911886740633359949015357415191829204559326171875	0.79500611390246300747008945108973421156406402587890625	0.86207904351216502192301049944944679737091064453125	6.348475287752033	-0.33963111281710373	ZBTB38;BRCA1;AATF
protein dephosphorylation	3/186	0.95169683593862941517471654151449911296367645263671875	0.99999911886740633359949015357415191829204559326171875	0.80381102075045163246613810770213603973388671875	0.86942824693416198567064157032291404902935028076171875	6.868789620245424	-0.3400651506827676	MSRA;ICMT;PTPN21
peptidyl-threonine dephosphorylation	1/89	0.952575737866279137477931726607494056224822998046875	0.99999911886740633359949015357415191829204559326171875	0.8728222831645544577128248420194722712039947509765625	0.924360734101302927712140444782562553882598876953125	7.078755044488368	-0.34392598809540315	PTPN21
macroautophagy	1/91	0.95572295128843787193062553342315368354320526123046875	0.99999911886740633359949015357415191829204559326171875	0.8785380269774474282229448363068513572216033935546875	0.92791398863695018217612187072518281638622283935546875	7.595134988497557	-0.34396245678430154	PRKAG1
base-excision repair	2/139	0.95011240853412826101731525341165252029895782470703125	0.99999911886740633359949015357415191829204559326171875	0.831398711588758221324724217993207275867462158203125	0.8914998232698732039125388837419450283050537109375	6.723664926205716	-0.34408339536303556	PDS5B;PDS5A
selective autophagy	1/91	0.95572295128843787193062553342315368354320526123046875	0.99999911886740633359949015357415191829204559326171875	0.8785380269774474282229448363068513572216033935546875	0.92791398863695018217612187072518281638622283935546875	7.600512918900627	-0.34420600823620545	PRKAG1
phagocytosis, engulfment	1/90	0.954176315587430767806154108257032930850982666015625	0.99999911886740633359949015357415191829204559326171875	0.87571290049985639480922827715403400361537933349609375	0.925759245104845973628471256233751773834228515625	7.360827424846942	-0.34527291456366827	ELMO1
nucleotide-excision repair	2/138	0.9486758109712856157358373820898123085498809814453125	0.99999911886740633359949015357415191829204559326171875	0.8284110729250462323847159495926462113857269287109375	0.88904728261910792586064644638099707663059234619140625	6.556380091499945	-0.3454435372886301	PDS5B;PDS5A
histone H3-K56 acetylation in response to DNA damage	3/182	0.9465845055220734050038799978210590779781341552734375	0.99999911886740633359949015357415191829204559326171875	0.7919990557645795181684889030293561518192291259765625	0.859815745540036591165744539466686546802520751953125	6.3175876450071575	-0.3468041645823359	ZBTB38;BRCA1;AATF
cellular response to DNA damage stimulus	3/182	0.9465845055220734050038799978210590779781341552734375	0.99999911886740633359949015357415191829204559326171875	0.7919990557645795181684889030293561518192291259765625	0.859815745540036591165744539466686546802520751953125	6.32002922513547	-0.3469381951972225	ZBTB38;BRCA1;AATF
SOS response	3/182	0.9465845055220734050038799978210590779781341552734375	0.99999911886740633359949015357415191829204559326171875	0.7919990557645795181684889030293561518192291259765625	0.859815745540036591165744539466686546802520751953125	6.3216141362722	-0.3470251989419423	ZBTB38;BRCA1;AATF
positive regulation of receptor binding	3/42	0.1665599708215675101019570547578041441738605499267578125	0.73858861214153648244717942361603491008281707763671875	0.080840352251703884167710612018709070980548858642578125	0.380104253920552193068971291722846217453479766845703125	0.19521534600169468	-0.3499039567541346	TCF7L2;BDNF;RAPGEF2
cellular response to interleukin-1	1/90	0.954176315587430767806154108257032930850982666015625	0.99999911886740633359949015357415191829204559326171875	0.87571290049985639480922827715403400361537933349609375	0.925759245104845973628471256233751773834228515625	7.46182505903651	-0.35001039114177085	AKAP6
spermatogenesis	2/138	0.9486758109712856157358373820898123085498809814453125	0.99999911886740633359949015357415191829204559326171875	0.8284110729250462323847159495926462113857269287109375	0.88904728261910792586064644638099707663059234619140625	6.664073370459277	-0.3511176969173791	TYRO3;PRKAG1
receptor-mediated endocytosis of virus by host cell	2/139	0.95011240853412826101731525341165252029895782470703125	0.99999911886740633359949015357415191829204559326171875	0.831398711588758221324724217993207275867462158203125	0.8914998232698732039125388837419450283050537109375	6.8788138407090536	-0.3520231374345256	VLDLR;LDLRAP1
positive regulation of B cell proliferation	1/90	0.954176315587430767806154108257032930850982666015625	0.99999911886740633359949015357415191829204559326171875	0.87571290049985639480922827715403400361537933349609375	0.925759245104845973628471256233751773834228515625	7.598764023932759	-0.3564337607982117	MEF2C
digestive tract mesoderm development	3/30	0.07845038442461722827392378576405462808907032012939453125	0.495462131706552899590434435594943352043628692626953125	0.037758065740495998230397134420854854397475719451904296875	0.241334412056801672630257371565676294267177581787109375	0.14117998366978712	-0.35934384527548296	TBX6;MEST;FGFR2
positive regulation of epithelial cell proliferation	7/348	0.949985201186538841255924126016907393932342529296875	0.99999911886740633359949015357415191829204559326171875	0.69452954068520467156844233613810501992702484130859375	0.7800505662209769042192419874481856822967529296875	7.016386560640177	-0.36000288139665354	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
embryonic cranial skeleton morphogenesis	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.0900958238974111	-0.3616136289758991	PDGFRA;SIX1;FGFR2
cell-cell adhesion involved in neural tube closure	3/35	0.11213471659613709341396514673760975711047649383544921875	0.64269679001698498677086490715737454593181610107421875	0.05381552385062667032133987277120468206703662872314453125	0.3011243487584887024155477774911560118198394775390625	0.16551203127245118	-0.36214931234848163	VANGL2;LMO4;PRICKLE1
testicular fusome organization	2/137	0.9471998347971941623058000914170406758785247802734375	0.99999911886740633359949015357415191829204559326171875	0.82537598554992774868566129953251220285892486572265625	0.88726012349015215274761203545494936406612396240234375	6.676623912577432	-0.3621747277833596	TYRO3;PRKAG1
male germ-line stem cell asymmetric division	2/137	0.9471998347971941623058000914170406758785247802734375	0.99999911886740633359949015357415191829204559326171875	0.82537598554992774868566129953251220285892486572265625	0.88726012349015215274761203545494936406612396240234375	6.678291744636419	-0.3622651996490602	TYRO3;PRKAG1
male germline ring canal formation	2/137	0.9471998347971941623058000914170406758785247802734375	0.99999911886740633359949015357415191829204559326171875	0.82537598554992774868566129953251220285892486572265625	0.88726012349015215274761203545494936406612396240234375	6.679036247954733	-0.36230558537246993	TYRO3;PRKAG1
protein ubiquitination involved in ubiquitin-dependent protein catabolic process	7/344	0.94603442371421297973910213841008953750133514404296875	0.99999911886740633359949015357415191829204559326171875	0.6832401472593050417714266586699523031711578369140625	0.76972624184909055333747573968139477074146270751953125	6.531415436466145	-0.36233890513810224	RNF43;USP9X;BTBD3;RNF217;BTBD11;ARRB1;BRCA1
male germ-line cyst encapsulation	2/137	0.9471998347971941623058000914170406758785247802734375	0.99999911886740633359949015357415191829204559326171875	0.82537598554992774868566129953251220285892486572265625	0.88726012349015215274761203545494936406612396240234375	6.683098015583984	-0.36252591672626566	TYRO3;PRKAG1
peptidyl-serine dephosphorylation	1/88	0.9509193395596737818920018980861641466617584228515625	0.99999911886740633359949015357415191829204559326171875	0.86986466184108646171324608076247386634349822998046875	0.922056541551551589463997515849769115447998046875	7.217998006787877	-0.36325323100256673	PTPN21
activation of cysteine-type endopeptidase activity involved in apoptotic process	1/89	0.952575737866279137477931726607494056224822998046875	0.99999911886740633359949015357415191829204559326171875	0.8728222831645544577128248420194722712039947509765625	0.924360734101302927712140444782562553882598876953125	7.512493035003106	-0.36499943477137553	ROBO1
SRP-dependent cotranslational protein targeting to membrane, docking	1/88	0.9509193395596737818920018980861641466617584228515625	0.99999911886740633359949015357415191829204559326171875	0.86986466184108646171324608076247386634349822998046875	0.922056541551551589463997515849769115447998046875	7.304206617146656	-0.3675917686723775	RPS25
RNA polymerase III complex localization to nucleus	3/30	0.07845038442461722827392378576405462808907032012939453125	0.495462131706552899590434435594943352043628692626953125	0.037758065740495998230397134420854854397475719451904296875	0.241334412056801672630257371565676294267177581787109375	0.14675347467699776	-0.3735299900679618	DLG1;SIX1;MSX1
cellular calcium ion homeostasis	1/87	0.94920517684334015928726557831396348774433135986328125	0.99999911886740633359949015357415191829204559326171875	0.86683848860422418880489203729666769504547119140625	0.91967547250250236690050087418057955801486968994140625	7.261545584058936	-0.378546553637336	SLC24A2
activation of MAPK activity involved in innate immune response	1/86	0.9474312385138208281176730451988987624645233154296875	0.99999911886740633359949015357415191829204559326171875	0.86374217991661794702196175421704538166522979736328125	0.91742217128274872184334753910661675035953521728515625	7.150963358218931	-0.3861585726872092	ALK
positive regulation of TORC1 signaling	3/34	0.1050088512120722350484669505021884106099605560302734375	0.6199333556537480749426549664349295198917388916015625	0.050378675345193628387630013776288251392543315887451171875	0.2835754315074920928196888780803419649600982666015625	0.17178133395961323	-0.38714541925981155	LIN28A;RHEB;LARS
DNA synthesis involved in double-strand break repair via homologous recombination	1/86	0.9474312385138208281176730451988987624645233154296875	0.99999911886740633359949015357415191829204559326171875	0.86374217991661794702196175421704538166522979736328125	0.91742217128274872184334753910661675035953521728515625	7.312091855599434	-0.39485965916336574	BRCA1
regulation of DNA damage response, signal transduction by p53 class mediator	2/134	0.94252556709452750549615984709816984832286834716796875	0.99999911886740633359949015357415191829204559326171875	0.815980136115812104691258355160243809223175048828125	0.879727665442860295996752029168419539928436279296875	6.675106713438852	-0.39511447279724976	PRKAG1;BRCA1
pinocytosis	4/67	0.187935674251217876840058806919842027127742767333984375	0.73858861214153648244717942361603491008281707763671875	0.0765075599742958412097237896887236274778842926025390625	0.370139651691029192281945370268658734858036041259765625	0.23669963978654143	-0.39568026249404775	DNM3;CYTH2;HOOK2;LDLR
positive regulation of signal transduction by p53 class mediator	2/134	0.94252556709452750549615984709816984832286834716796875	0.99999911886740633359949015357415191829204559326171875	0.815980136115812104691258355160243809223175048828125	0.879727665442860295996752029168419539928436279296875	6.70720879397815	-0.39701466663271956	PRKAG1;BRCA1
positive regulation of excitatory synapse assembly	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.09636550723920799	-0.403095102591141	NLGN2;BDNF;LRRC4B
muscle contraction	1/85	0.94559544332548639555824365743319503962993621826171875	0.99999911886740633359949015357415191829204559326171875	0.8605741157097555049659831638564355671405792236328125	0.91488124944848248087936326555791310966014862060546875	7.292925619753089	-0.40796954944632335	SSPN
Fc-gamma receptor signaling pathway involved in phagocytosis	2/133	0.94088190039090624505746518480009399354457855224609375	0.99999911886740633359949015357415191829204559326171875	0.8127493507701568642431766420486383140087127685546875	0.87708503490799138990752226163749583065509796142578125	6.706441296061567	-0.408674783442305	ELMO1;ELMO2
protein autosumoylation	4/68	0.194791658397976685801467056080582551658153533935546875	0.73858861214153648244717942361603491008281707763671875	0.07964136478883689085339625535198138095438480377197265625	0.380104253920552193068971291722846217453479766845703125	0.25265967406303164	-0.4133069380670492	IFIH1;TOP2B;EYA1;MITF
protein processing	4/218	0.93780584578598091827217331228894181549549102783203125	0.99999911886740633359949015357415191829204559326171875	0.742215740895125986043012744630686938762664794921875	0.82164554090643260320092622350784949958324432373046875	6.442268155937834	-0.41367310569988347	PTCH1;TBL1X;RHBDL3;PAPPA2
regulation of translational initiation by eIF2 alpha dephosphorylation	1/84	0.9436956375270730834614596460596658289432525634765625	0.99999911886740633359949015357415191829204559326171875	0.8573326386798216791618187926360405981540679931640625	0.91225762613415717350306977095897309482097625732421875	7.276996078384217	-0.42171344003181255	PTPN21
positive regulation of axon guidance	3/36	0.1194392031525093045285501602847944013774394989013671875	0.6779719870883109678061373415403068065643310546875	0.0573619751424954971152914140475331805646419525146484375	0.313893778128945755145906559846480377018451690673828125	0.1988629158807144	-0.4225733150659792	ROBO2;SLITRK1;ROBO1
ubiquitin-dependent SMAD protein catabolic process	1/85	0.94559544332548639555824365743319503962993621826171875	0.99999911886740633359949015357415191829204559326171875	0.8605741157097555049659831638564355671405792236328125	0.91488124944848248087936326555791310966014862060546875	7.5599944711485705	-0.42290950148420664	ACVR2A
activation of MAPK activity involved in conjugation with cellular fusion	1/84	0.9436956375270730834614596460596658289432525634765625	0.99999911886740633359949015357415191829204559326171875	0.8573326386798216791618187926360405981540679931640625	0.91225762613415717350306977095897309482097625732421875	7.355945643923042	-0.426288692308132	ALK
activation of MAPK activity involved in osmosensory signaling pathway	1/84	0.9436956375270730834614596460596658289432525634765625	0.99999911886740633359949015357415191829204559326171875	0.8573326386798216791618187926360405981540679931640625	0.91225762613415717350306977095897309482097625732421875	7.356576937759076	-0.4263252767850778	ALK
activation of MAPK activity involved in cell wall organization or biogenesis	1/84	0.9436956375270730834614596460596658289432525634765625	0.99999911886740633359949015357415191829204559326171875	0.8573326386798216791618187926360405981540679931640625	0.91225762613415717350306977095897309482097625732421875	7.357675183621944	-0.4263889218710229	ALK
recombinational repair	2/132	0.93919365727681725086739561447757296264171600341796875	0.99999911886740633359949015357415191829204559326171875	0.80946815808655803170523768130806274712085723876953125	0.87458255344143942533463587096775881946086883544921875	6.8421910516105955	-0.4292351619929133	PDS5B;PDS5A
negative regulation of thyroid hormone receptor activity	4/69	0.201723696653925477217939032925642095506191253662109375	0.73858861214153648244717942361603491008281707763671875	0.0828381664941268969215570905362255871295928955078125	0.38841712858130872376705156057141721248626708984375	0.26884777379927216	-0.4303866675563166	TCF7L2;PTCH1;ID2;TRIB1
DNA ligation involved in DNA repair	2/132	0.93919365727681725086739561447757296264171600341796875	0.99999911886740633359949015357415191829204559326171875	0.80946815808655803170523768130806274712085723876953125	0.87458255344143942533463587096775881946086883544921875	6.868894589298124	-0.43091037059767623	PDS5B;PDS5A
protein autoubiquitination	5/253	0.93025889743824807798233678113319911062717437744140625	0.99999911886740633359949015357415191829204559326171875	0.696283515970031796626926734461449086666107177734375	0.7805060230110836272388041834346950054168701171875	5.97046257226473	-0.43161875342393774	RNF43;USP9X;TRIM37;ARRB1;BRCA1
Golgi vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane	1/84	0.9436956375270730834614596460596658289432525634765625	0.99999911886740633359949015357415191829204559326171875	0.8573326386798216791618187926360405981540679931640625	0.91225762613415717350306977095897309482097625732421875	7.527903071073257	-0.43625389736821746	GBF1
peptidyl-histidine dephosphorylation	1/83	0.941729592788861591401428086101077497005462646484375	0.99999911886740633359949015357415191829204559326171875	0.8540160533726777192242707315017469227313995361328125	0.91037146299636628743456867596250958740711212158203125	7.269109606434388	-0.4364162756305448	PTPN21
peptidyl-N-phospho-arginine dephosphorylation	1/83	0.941729592788861591401428086101077497005462646484375	0.99999911886740633359949015357415191829204559326171875	0.8540160533726777192242707315017469227313995361328125	0.91037146299636628743456867596250958740711212158203125	7.2713836411466275	-0.4365528020847465	PTPN21
negative regulation of mammary gland development in males by androgen receptor signaling pathway	3/40	0.1502802859352786735147589070038520731031894683837890625	0.73858861214153648244717942361603491008281707763671875	0.0726081787084265350973311115012620575726032257080078125	0.3575081200079832655092104687355458736419677734375	0.23094733051329044	-0.43770365693147745	DDX17;CTNNB1;BRCA1
membrane repolarization	3/173	0.93319208235798611905664756704936735332012176513671875	0.99999911886740633359949015357415191829204559326171875	0.7632643865400565719170344891608692705631256103515625	0.838386807731307026614331334712915122509002685546875	6.484529409881682	-0.44836774932282436	GABRA2;SLC24A2;ATP2A2
noradrenergic neuron fate commitment	3/13	0.0083946732338738179468595745902348426170647144317626953125	0.1269156206544320431017780492766178213059902191162109375	0.005131154950495567419743725423586511169560253620147705078125	0.056816098360299514824500732856904505752027034759521484375	0.0940409762494297	-0.4495307167751582	MYT1L;ID2;PHOX2B
intrinsic apoptotic signaling pathway in response to DNA damage	4/213	0.9304169952225420647806686247349716722965240478515625	0.99999911886740633359949015357415191829204559326171875	0.72596599546746298781130235511227510869503021240234375	0.8082090159594106371088173546013422310352325439453125	6.235668071422018	-0.4497314178030561	ZBTB38;SFN;BRCA1;AATF
protein localization to cell surface	3/42	0.1665599708215675101019570547578041441738605499267578125	0.73858861214153648244717942361603491008281707763671875	0.080840352251703884167710612018709070980548858642578125	0.380104253920552193068971291722846217453479766845703125	0.25299888630202766	-0.4534751656803682	GRID2;PIGK;CTNNB1
positive regulation of osteoblast proliferation	7/335	0.93611661512181643107766149114468134939670562744140625	0.99999911886740633359949015357415191829204559326171875	0.65689880325163851892966704326681792736053466796875	0.75190285244794441421589681340265087783336639404296875	6.910844734388934	-0.45622094561446813	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
activation of JNKK activity	1/82	0.9396950031157960125938188866712152957916259765625	0.99999911886740633359949015357415191829204559326171875	0.85062262525248100164532161215902306139469146728515625	0.90798527343651347365494075347669422626495361328125	7.419600617199327	-0.46149857326970534	TRIB1
regulation of mitotic cell cycle phase transition	3/37	0.126914191141404508744727763769333250820636749267578125	0.70596018822406259030088904182775877416133880615234375	0.06101631269409306390638647599189425818622112274169921875	0.328570507844122949858700621916796080768108367919921875	0.22460393361764197	-0.46363734058192596	CYLD;GBF1;SIX3
B cell receptor signaling pathway	1/83	0.941729592788861591401428086101077497005462646484375	0.99999911886740633359949015357415191829204559326171875	0.8540160533726777192242707315017469227313995361328125	0.91037146299636628743456867596250958740711212158203125	7.729154123682581	-0.4640360152839395	MEF2C
establishment or maintenance of transmembrane electrochemical gradient	3/171	0.9298231032116481831195642371312715113162994384765625	0.99999911886740633359949015357415191829204559326171875	0.75645995650874364724103315893444232642650604248046875	0.833525840581595733880249099456705152988433837890625	6.419436782148948	-0.4670841423776289	GABRA2;SLC24A2;ATP2A2
viral genome replication	1/83	0.941729592788861591401428086101077497005462646484375	0.99999911886740633359949015357415191829204559326171875	0.8540160533726777192242707315017469227313995361328125	0.91037146299636628743456867596250958740711212158203125	7.791356991125058	-0.4677704951876071	DEK
positive regulation of double-strand break repair	3/34	0.1050088512120722350484669505021884106099605560302734375	0.6199333556537480749426549664349295198917388916015625	0.050378675345193628387630013776288251392543315887451171875	0.2835754315074920928196888780803419649600982666015625	0.20778376329074144	-0.46828447713351695	EYA1;DEK;BRCA1
cellular response to interferon-gamma	1/82	0.9396950031157960125938188866712152957916259765625	0.99999911886740633359949015357415191829204559326171875	0.85062262525248100164532161215902306139469146728515625	0.90798527343651347365494075347669422626495361328125	7.559259154332683	-0.47018532326573226	AKAP6
synaptic transmission, GABAergic	8/182	0.269277332239134470359687156815198250114917755126953125	0.73858861214153648244717942361603491008281707763671875	0.06666132798600137021605149811875890009105205535888671875	0.342267737608351330091949193956679664552211761474609375	0.35868089584312807	-0.4705941616140009	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
negative regulation of translational initiation	1/82	0.9396950031157960125938188866712152957916259765625	0.99999911886740633359949015357415191829204559326171875	0.85062262525248100164532161215902306139469146728515625	0.90798527343651347365494075347669422626495361328125	7.570310511747076	-0.470872716825382	LIN28A
negative regulation of signal transduction by p53 class mediator	2/128	0.9319724493482881566563946762471459805965423583984375	0.99999911886740633359949015357415191829204559326171875	0.7958274049431526275810711013036780059337615966796875	0.86237488378517135334533350032870657742023468017578125	6.724792677892915	-0.47377526535002473	PRKAG1;BRCA1
DNA dealkylation involved in DNA repair	2/128	0.9319724493482881566563946762471459805965423583984375	0.99999911886740633359949015357415191829204559326171875	0.7958274049431526275810711013036780059337615966796875	0.86237488378517135334533350032870657742023468017578125	6.759354662822658	-0.47621022719426753	PDS5B;PDS5A
early endosome to late endosome transport	1/81	0.93758948235782713087616002667346037924289703369140625	0.99999911886740633359949015357415191829204559326171875	0.84715057993035058903075196212739683687686920166015625	0.9053034176555196932412172827753238379955291748046875	7.391258715949666	-0.4763154607976664	HOOK2
caveolin-mediated endocytosis	4/69	0.201723696653925477217939032925642095506191253662109375	0.73858861214153648244717942361603491008281707763671875	0.0828381664941268969215570905362255871295928955078125	0.38841712858130872376705156057141721248626708984375	0.2976225974438641	-0.47645102688838614	DNM3;CYTH2;HOOK2;LDLR
regulation of protein kinase activity	3/44	0.1833255589815639130524260735910502262413501739501953125	0.73858861214153648244717942361603491008281707763671875	0.089456287477205520541900796160916797816753387451171875	0.410871770233669331151560299986158497631549835205078125	0.2808512394931722	-0.4764617955772036	LDB1;PHIP;LDB2
vesicle targeting, cis-Golgi to rough ER	1/82	0.9396950031157960125938188866712152957916259765625	0.99999911886740633359949015357415191829204559326171875	0.85062262525248100164532161215902306139469146728515625	0.90798527343651347365494075347669422626495361328125	7.669784378267856	-0.4770599834783262	GBF1
cellular response to epidermal growth factor stimulus	3/42	0.1665599708215675101019570547578041441738605499267578125	0.73858861214153648244717942361603491008281707763671875	0.080840352251703884167710612018709070980548858642578125	0.380104253920552193068971291722846217453479766845703125	0.2680702434794673	-0.48048906401393043	STAT5B;CTNNB1;ZFP36L1
proteasome-mediated ubiquitin-dependent protein catabolic process	5/249	0.92427182144107444816683027966064400970935821533203125	0.99999911886740633359949015357415191829204559326171875	0.6831504319292431848253954740357585251331329345703125	0.76972624184909055333747573968139477074146270751953125	6.142384748291941	-0.48370709605447637	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
regulation of MAP kinase activity	3/43	0.1748860510062382467300068356053088791668415069580078125	0.73858861214153648244717942361603491008281707763671875	0.0851014434701020949791683278817799873650074005126953125	0.398237607984594788046450730689684860408306121826171875	0.2779537917523785	-0.484645972225902	GDF2;TRIB1;GDF5
regulation of growth plate cartilage chondrocyte proliferation	6/126	0.2497521384066196947770777114783413708209991455078125	0.73858861214153648244717942361603491008281707763671875	0.07866234279333926548982702797729871235787868499755859375	0.37862272546549113894087668086285702884197235107421875	0.3498836340899706	-0.48538877192282215	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
ERAD pathway	1/80	0.93541056158550295318576672798371873795986175537109375	0.99999911886740633359949015357415191829204559326171875	0.84359810213492381070210512916673906147480010986328125	0.90191574065513047120390410782420076429843902587890625	7.293084130271266	-0.4869573513861223	ATP2A2
inorganic ion transmembrane transport	3/169	0.92629866733427679292844914016313850879669189453125	0.99999911886740633359949015357415191829204559326171875	0.74949934659183325980080780936987139284610748291015625	0.82795981683224295633038991581997834146022796630859375	6.426846849288328	-0.49203014925419797	GABRA2;SLC24A2;ATP2A2
positive regulation of I-kappaB phosphorylation	5/252	0.92880299255481790776656225716578774154186248779296875	0.99999911886740633359949015357415191829204559326171875	0.69303546891410550134793311372050084173679351806640625	0.7792725403737390532654671915224753320217132568359375	6.680564215343357	-0.4934172981616703	ERBB4;LPAR1;ARRB1;EFNA5;ACVR2A
peptide cross-linking	2/128	0.9319724493482881566563946762471459805965423583984375	0.99999911886740633359949015357415191829204559326171875	0.7958274049431526275810711013036780059337615966796875	0.86237488378517135334533350032870657742023468017578125	7.023223646597755	-0.49480033157275055	MSRA;ICMT
negative regulation of endothelial cell migration	3/34	0.1050088512120722350484669505021884106099605560302734375	0.6199333556537480749426549664349295198917388916015625	0.050378675345193628387630013776288251392543315887451171875	0.2835754315074920928196888780803419649600982666015625	0.22098388829747379	-0.4980337392460978	GDF2;NR2F2;PTPRG
neuron-neuron synaptic transmission	8/184	0.278916683025037581700189548428170382976531982421875	0.73858861214153648244717942361603491008281707763671875	0.06993235986963079742206872424503671936690807342529296875	0.347461562555291092468934266435098834335803985595703125	0.3902889270918765	-0.4983373601692132	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
histone H4 acetylation involved in response to DNA damage stimulus	4/209	0.923945060709755683348021193523891270160675048828125	0.99999911886740633359949015357415191829204559326171875	0.712429029614344955234628287144005298614501953125	0.79633358594570269328727363244979642331600189208984375	6.301765849505458	-0.4984864868570125	ZBTB38;BRCA1;ELP4;AATF
positive regulation of chondrocyte proliferation	7/330	0.92994040134268118880100928436149843037128448486328125	0.99999911886740633359949015357415191829204559326171875	0.641716580296889826939832346397452056407928466796875	0.73750895564786811409163647113018669188022613525390625	6.863555625810224	-0.49853284923404845	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of myoblast proliferation	7/330	0.92994040134268118880100928436149843037128448486328125	0.99999911886740633359949015357415191829204559326171875	0.641716580296889826939832346397452056407928466796875	0.73750895564786811409163647113018669188022613525390625	6.894976632509424	-0.5008151071262478	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of cell proliferation involved in kidney development	7/330	0.92994040134268118880100928436149843037128448486328125	0.99999911886740633359949015357415191829204559326171875	0.641716580296889826939832346397452056407928466796875	0.73750895564786811409163647113018669188022613525390625	6.901802054852313	-0.5013108701728866	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
regulation of AMPA receptor activity	3/18	0.0211499341840897144007005437060797703452408313751220703125	0.2105670264248979683952001096258754841983318328857421875	0.0112142140327315779912975557408572058193385601043701171875	0.1039783683536521785573114584622089751064777374267578125	0.13105700166555148	-0.5053713267581355	MEF2C;NLGN2;CACNG2
positive regulation of mesenchymal cell proliferation	7/329	0.92864429376932944304456896134070120751857757568359375	0.99999911886740633359949015357415191829204559326171875	0.638634390096008974779806521837599575519561767578125	0.73527908666899544076756001231842674314975738525390625	6.8608009252854965	-0.5079016965343192	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of cell proliferation involved in heart morphogenesis	7/329	0.92864429376932944304456896134070120751857757568359375	0.99999911886740633359949015357415191829204559326171875	0.638634390096008974779806521837599575519561767578125	0.73527908666899544076756001231842674314975738525390625	6.861504818067923	-0.5079538053685888	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
ubiquitin-dependent ERAD pathway	5/247	0.92111078985407390806727789822616614401340484619140625	0.99999911886740633359949015357415191829204559326171875	0.67644344659024835397787001056713052093982696533203125	0.7655431232164591204281123282271437346935272216796875	6.191312581273158	-0.5087708448938056	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	1/80	0.93541056158550295318576672798371873795986175537109375	0.99999911886740633359949015357415191829204559326171875	0.84359810213492381070210512916673906147480010986328125	0.90191574065513047120390410782420076429843902587890625	7.68282848602438	-0.5129804817662414	CITED2
endoplasmic reticulum-Golgi intermediate compartment (ERGIC) derived vesicle fusion with endoplasmic reticulum membrane	1/80	0.93541056158550295318576672798371873795986175537109375	0.99999911886740633359949015357415191829204559326171875	0.84359810213492381070210512916673906147480010986328125	0.90191574065513047120390410782420076429843902587890625	7.738234369222187	-0.516679918335364	GBF1
positive regulation of secondary heart field cardioblast proliferation	7/328	0.9273273010532829818686195721966214478015899658203125	0.99999911886740633359949015357415191829204559326171875	0.6355371725670051485934664015076123178005218505859375	0.73207053553078471619386391466832719743251800537109375	6.851414212904466	-0.5169302966413188	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of hair follicle cell proliferation	7/328	0.9273273010532829818686195721966214478015899658203125	0.99999911886740633359949015357415191829204559326171875	0.6355371725670051485934664015076123178005218505859375	0.73207053553078471619386391466832719743251800537109375	6.853735525466411	-0.5171054366567894	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of myoblast differentiation	3/33	0.0980696425820066497447413667032378725707530975341796875	0.5907768147202963060493630109704099595546722412109375	0.04705304895850288826597562774622929282486438751220703125	0.273336492533569119789405021947459317743778228759765625	0.22274185913522787	-0.5172238402733811	MEF2C;CTNNB1;ZFP36L1
positive regulation of chorionic trophoblast cell proliferation	7/328	0.9273273010532829818686195721966214478015899658203125	0.99999911886740633359949015357415191829204559326171875	0.6355371725670051485934664015076123178005218505859375	0.73207053553078471619386391466832719743251800537109375	6.859568099557247	-0.517545496790547	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of hemocyte proliferation	7/328	0.9273273010532829818686195721966214478015899658203125	0.99999911886740633359949015357415191829204559326171875	0.6355371725670051485934664015076123178005218505859375	0.73207053553078471619386391466832719743251800537109375	6.869527545681241	-0.5182969240549448	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
synaptic transmission, glycinergic	8/184	0.278916683025037581700189548428170382976531982421875	0.73858861214153648244717942361603491008281707763671875	0.06993235986963079742206872424503671936690807342529296875	0.347461562555291092468934266435098834335803985595703125	0.40606782692909876	-0.5184845248603721	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
positive regulation of fat cell proliferation	7/328	0.9273273010532829818686195721966214478015899658203125	0.99999911886740633359949015357415191829204559326171875	0.6355371725670051485934664015076123178005218505859375	0.73207053553078471619386391466832719743251800537109375	6.875011784756402	-0.5187107027645483	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
regulation of signal transduction by p53 class mediator	2/125	0.9260319686206692768593029541079886257648468017578125	0.99999911886740633359949015357415191829204559326171875	0.78503838607437537167044183661346323788166046142578125	0.85401892691716529970591409437474794685840606689453125	6.790462118106667	-0.5218233937204786	PRKAG1;BRCA1
regulation of trophectodermal cell proliferation	6/127	0.25538495074691613950790269882418215274810791015625	0.73858861214153648244717942361603491008281707763671875	0.08090410662205520242462597479971009306609630584716796875	0.380104253920552193068971291722846217453479766845703125	0.38457395836970404	-0.5249370159328209	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
adenylate cyclase-modulating G-protein coupled receptor signaling pathway	1/81	0.93758948235782713087616002667346037924289703369140625	0.99999911886740633359949015357415191829204559326171875	0.84715057993035058903075196212739683687686920166015625	0.9053034176555196932412172827753238379955291748046875	8.17427795391897	-0.5267756305035332	CACNA1D
positive regulation of leukocyte proliferation	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.853297832707688	-0.5269688859329227	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of cell proliferation in bone marrow	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.854110913871895	-0.5270314059759347	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of synoviocyte proliferation	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.859704156970951	-0.527461485793945	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
regulation of cell proliferation involved in embryonic placenta development	6/127	0.25538495074691613950790269882418215274810791015625	0.73858861214153648244717942361603491008281707763671875	0.08090410662205520242462597479971009306609630584716796875	0.380104253920552193068971291722846217453479766845703125	0.3864994749296865	-0.5275653138066846	RBFOX2;JUND;GRAP2;SIX3;PDS5B;BRCA1
positive regulation of cell proliferation involved in compound eye morphogenesis	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.86427809481805	-0.5278131884326526	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of mammary stem cell proliferation	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.86509761425952	-0.5278762035324795	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of skeletal muscle cell proliferation	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.866693858889346	-0.5279989431645208	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of sebum secreting cell proliferation	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.8699621534838435	-0.5282502513089214	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of germ cell proliferation	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.873434767050142	-0.5285172701000171	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	7/327	0.92598916480618509439182162168435752391815185546875	0.99999911886740633359949015357415191829204559326171875	0.6324250288385979690275462417048402130603790283203125	0.73174682028696624858099539778777398169040679931640625	6.874067095752241	-0.5285658915899658	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
small GTPase mediated signal transduction	3/38	0.134551505153658712554687326701241545379161834716796875	0.7236937854159728455982758532627485692501068115234375	0.0647767304633271312486186843671021051704883575439453125	0.3395020417727934169960235522012226283550262451171875	0.2637334087424457	-0.528998637903839	ABR;RAPGEF2;RASGRP3
mRNA export from nucleus in response to heat stress	2/125	0.9260319686206692768593029541079886257648468017578125	0.99999911886740633359949015357415191829204559326171875	0.78503838607437537167044183661346323788166046142578125	0.85401892691716529970591409437474794685840606689453125	6.89481676745377	-0.5298426855338609	U2AF2;CDC40
positive regulation of epithelial cell differentiation	3/30	0.07845038442461722827392378576405462808907032012939453125	0.495462131706552899590434435594943352043628692626953125	0.037758065740495998230397134420854854397475719451904296875	0.241334412056801672630257371565676294267177581787109375	0.20937296266361807	-0.5329146777367529	DLX1;DLX2;JUND
single strand break repair	2/124	0.92394533260458244772195257610292173922061920166015625	0.99999911886740633359949015357415191829204559326171875	0.78133250607123405639953261925256811082363128662109375	0.85116522659076465640026754044811241328716278076171875	6.788855271578054	-0.537014561518255	PDS5B;PDS5A
regulation of transcription from RNA polymerase III promoter	18/469	0.31488590030654617368810477273655124008655548095703125	0.743029910828403306055633947835303843021392822265625	0.02800019139557662073425348125965683721005916595458984375	0.1962509700043609528474775061113177798688411712646484375	0.4658228908585525	-0.5382792784230341	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;BRCA1;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of vesicle-mediated transport involved in floral organ abscission by small GTPase mediated signal transduction	3/38	0.134551505153658712554687326701241545379161834716796875	0.7236937854159728455982758532627485692501068115234375	0.0647767304633271312486186843671021051704883575439453125	0.3395020417727934169960235522012226283550262451171875	0.26836380649071134	-0.5382863277474023	ABR;RAPGEF2;RASGRP3
positive regulation of insulin secretion involved in cellular response to glucose stimulus	3/39	0.142342940211046597998034712873050011694431304931640625	0.73858861214153648244717942361603491008281707763671875	0.06864134025204969569156077113802894018590450286865234375	0.343352282045512657848718163222656585276126861572265625	0.2775253819246855	-0.5410401894171454	TCF7L2;NLGN2;EFNA5
negative regulation of neuron projection regeneration	3/33	0.0980696425820066497447413667032378725707530975341796875	0.5907768147202963060493630109704099595546722412109375	0.04705304895850288826597562774622929282486438751220703125	0.273336492533569119789405021947459317743778228759765625	0.23370843867578311	-0.5426890869344763	SEMA3A;LPAR1;STMN2
positive regulation of floral organ abscission by small GTPase mediated signal transduction	3/38	0.134551505153658712554687326701241545379161834716796875	0.7236937854159728455982758532627485692501068115234375	0.0647767304633271312486186843671021051704883575439453125	0.3395020417727934169960235522012226283550262451171875	0.27064471533745776	-0.5428613934505495	ABR;RAPGEF2;RASGRP3
neuron apoptotic process	4/206	0.91874159574651148574275794089771807193756103515625	0.99999911886740633359949015357415191829204559326171875	0.70196131496423841422682698976132087409496307373046875	0.7866613831286048963420398649759590625762939453125	6.41092278325717	-0.5433281162836376	ELMO1;PAX3;BRCA1;OGT
positive regulation of macroautophagy	2/123	0.92180331922394953547694740336737595498561859130859375	0.99999911886740633359949015357415191829204559326171875	0.7775708708064119623060150843230076134204864501953125	0.848831705066846797791413337108679115772247314453125	6.741195100825102	-0.54889101098332	RHEB;PRKAG1
mitochondrial DNA repair	2/123	0.92180331922394953547694740336737595498561859130859375	0.99999911886740633359949015357415191829204559326171875	0.7775708708064119623060150843230076134204864501953125	0.848831705066846797791413337108679115772247314453125	6.744179620611467	-0.5491340207254112	PDS5B;PDS5A
mitochondrial fission	1/79	0.93315568590155895112303596761194057762622833251953125	0.99999911886740633359949015357415191829204559326171875	0.83996333486953711489064744455390609800815582275390625	0.89925262155687846199469959174166433513164520263671875	7.947000940924851	-0.5497991632092791	DNM3
interferon-gamma-mediated signaling pathway	4/204	0.91509793923184934438808113554841838777065277099609375	0.99999911886740633359949015357415191829204559326171875	0.69483256966688899947115487520932219922542572021484375	0.7800505662209769042192419874481856822967529296875	6.2751909249858855	-0.5567611818566065	STAT3;LRRC4;IRF9;LRRC4B
protein glycosylation	2/122	0.91960460795157761282325736829079687595367431640625	0.99999911886740633359949015357415191829204559326171875	0.773752892448207330033937978441826999187469482421875	0.84550474714046275348522385684191249310970306396484375	6.672774711164056	-0.5592550927806097	MSRA;ICMT
protein heterooligomerization	1/77	0.92840740336580263036836413448327220976352691650390625	0.99999911886740633359949015357415191829204559326171875	0.8324392890652811960450208061956800520420074462890625	0.8924127560274843773413522285409271717071533203125	7.557361051591672	-0.5613957716552017	MAGI2
cell migration involved in kidney development	3/43	0.1748860510062382467300068356053088791668415069580078125	0.73858861214153648244717942361603491008281707763671875	0.0851014434701020949791683278817799873650074005126953125	0.398237607984594788046450730689684860408306121826171875	0.32218603878286944	-0.5617702317320511	VANGL2;SIX1;GATA3
chemical synaptic transmission, postsynaptic	8/185	0.28377099663786287120359475011355243623256683349609375	0.73858861214153648244717942361603491008281707763671875	0.07160416827749972734640238059000694192945957183837890625	0.35441433553511669796165506340912543237209320068359375	0.4478302897569982	-0.5640815318138569	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
positive regulation of potassium ion transmembrane transport	3/26	0.05536339021525253645261699375623720698058605194091796875	0.388037312994570948720962633160525001585483551025390625	0.026999589455807992965929997808416374027729034423828125	0.18998313577565217880049885934568010270595550537109375	0.19812156731527825	-0.5733314685239954	DLG1;CACNA1D;AKAP6
positive regulation of actin cytoskeleton reorganization	3/31	0.08478272937660967512041310101267299614846706390380859375	0.5289948868643754575913362714345566928386688232421875	0.040741405075243868061374286071441019885241985321044921875	0.25386685302500044958406988371280021965503692626953125	0.23333989218686585	-0.5758043163618256	PDGFRA;BAIAP2L2;SEMA3E
DNA replication proofreading	2/121	0.91734785357539727623787939592148177325725555419921875	0.99999911886740633359949015357415191829204559326171875	0.76987798572419896547813777942792512476444244384765625	0.842383312145916551827440343913622200489044189453125	6.7115337637133825	-0.5789942187551534	PDS5B;PDS5A
negative regulation of neuron apoptotic process	9/399	0.92304817114283144174891049260622821748256683349609375	0.99999911886740633359949015357415191829204559326171875	0.57605805913292063014097266204771585762500762939453125	0.6974292378601434361229394198744557797908782958984375	7.243532843288741	-0.5800176064567172	MEF2C;GRID2;BDNF;CITED2;STAT3;TYRO3;SIX1;PHIP;AATF
skeletal muscle fiber development	3/31	0.08478272937660967512041310101267299614846706390380859375	0.5289948868643754575913362714345566928386688232421875	0.040741405075243868061374286071441019885241985321044921875	0.25386685302500044958406988371280021965503692626953125	0.236547586846598	-0.5837198271359773	SVIL;MEF2C;SIX1
anoikis	4/203	0.9132220228919314397586504128412343561649322509765625	0.99999911886740633359949015357415191829204559326171875	0.691223109630897170063690282404422760009765625	0.77741998286336244650129856381681747734546661376953125	6.476912022122671	-0.587949774852507	ELMO1;PAX3;BRCA1;OGT
negative regulation of dendrite development	3/40	0.1502802859352786735147589070038520731031894683837890625	0.73858861214153648244717942361603491008281707763671875	0.0726081787084265350973311115012620575726032257080078125	0.3575081200079832655092104687355458736419677734375	0.3111134053459725	-0.589638663229756	SEMA3A;LPAR1;STMN2
negative regulation of TRAIL-activated apoptotic signaling pathway	3/31	0.08478272937660967512041310101267299614846706390380859375	0.5289948868643754575913362714345566928386688232421875	0.040741405075243868061374286071441019885241985321044921875	0.25386685302500044958406988371280021965503692626953125	0.24002265260150654	-0.5922951197812447	SCRT2;GPX1;BRCA1
phagolysosome assembly	1/76	0.9259084306303548839167660844395868480205535888671875	0.99999911886740633359949015357415191829204559326171875	0.8285460789471270626194154829136095941066741943359375	0.88904728261910792586064644638099707663059234619140625	7.704164423512113	-0.5930660860571065	HOOK2
non-recombinational repair	2/120	0.9150316862451204347195243826718069612979888916015625	0.99999911886740633359949015357415191829204559326171875	0.76594556857462159360494524662499316036701202392578125	0.8400291204293164337713051281752996146678924560546875	6.6825875730434205	-0.5933909523097108	PDS5B;PDS5A
DNA 3' dephosphorylation involved in DNA repair	2/120	0.9150316862451204347195243826718069612979888916015625	0.99999911886740633359949015357415191829204559326171875	0.76594556857462159360494524662499316036701202392578125	0.8400291204293164337713051281752996146678924560546875	6.687027624938216	-0.5937852137531052	PDS5B;PDS5A
non-photoreactive DNA repair	2/120	0.9150316862451204347195243826718069612979888916015625	0.99999911886740633359949015357415191829204559326171875	0.76594556857462159360494524662499316036701202392578125	0.8400291204293164337713051281752996146678924560546875	6.689591169219976	-0.5940128477296172	PDS5B;PDS5A
pyrimidine dimer repair	2/120	0.9150316862451204347195243826718069612979888916015625	0.99999911886740633359949015357415191829204559326171875	0.76594556857462159360494524662499316036701202392578125	0.8400291204293164337713051281752996146678924560546875	6.691525386106403	-0.5941845995828724	PDS5B;PDS5A
nucleotide phosphorylation involved in DNA repair	2/120	0.9150316862451204347195243826718069612979888916015625	0.99999911886740633359949015357415191829204559326171875	0.76594556857462159360494524662499316036701202392578125	0.8400291204293164337713051281752996146678924560546875	6.693224999299162	-0.5943355194294118	PDS5B;PDS5A
negative regulation of DNA replication	3/31	0.08478272937660967512041310101267299614846706390380859375	0.5289948868643754575913362714345566928386688232421875	0.040741405075243868061374286071441019885241985321044921875	0.25386685302500044958406988371280021965503692626953125	0.24113154992641508	-0.5950315051463887	ZBTB38;GDF2;PDS5A
intrinsic apoptotic signaling pathway in response to hypoxia	1/75	0.9233223642829802013665130289155058562755584716796875	0.99999911886740633359949015357415191829204559326171875	0.8245627139839191155346043160534463822841644287109375	0.88726012349015215274761203545494936406612396240234375	7.542802189791472	-0.6017409866353829	ZFP36L1
catenin import into nucleus	3/41	0.158355348493015579691700622788630425930023193359375	0.73858861214153648244717942361603491008281707763671875	0.0766752140123890535416961711234762333333492279052734375	0.37024585595837156137832835156586952507495880126953125	0.32874338976427214	-0.605845706698357	STAT3;CTNNB1;PRICKLE1
regulation of microtubule cytoskeleton organization	3/39	0.142342940211046597998034712873050011694431304931640625	0.73858861214153648244717942361603491008281707763671875	0.06864134025204969569156077113802894018590450286865234375	0.343352282045512657848718163222656585276126861572265625	0.31246718511147	-0.6091597959325771	CYLD;EFNA5;CLASP2
positive regulation of type I interferon production	1/76	0.9259084306303548839167660844395868480205535888671875	0.99999911886740633359949015357415191829204559326171875	0.8285460789471270626194154829136095941066741943359375	0.88904728261910792586064644638099707663059234619140625	7.9286543614146145	-0.6103473071619835	CTNNB1
negative regulation of phosphoprotein phosphatase activity	1/75	0.9233223642829802013665130289155058562755584716796875	0.99999911886740633359949015357415191829204559326171875	0.8245627139839191155346043160534463822841644287109375	0.88726012349015215274761203545494936406612396240234375	7.706463680331454	-0.6147973845514031	SLC7A14
Golgi vesicle transport	1/76	0.9259084306303548839167660844395868480205535888671875	0.99999911886740633359949015357415191829204559326171875	0.8285460789471270626194154829136095941066741943359375	0.88904728261910792586064644638099707663059234619140625	8.058367152471792	-0.6203325895462806	CUX1
substrate adhesion-dependent cell spreading	3/30	0.07845038442461722827392378576405462808907032012939453125	0.495462131706552899590434435594943352043628692626953125	0.037758065740495998230397134420854854397475719451904296875	0.241334412056801672630257371565676294267177581787109375	0.24621531770787342	-0.6266891150647301	EFNA1;TYRO3;SRGAP2
protein import into nucleus, translocation	4/198	0.9032786330812399011591651287744753062725067138671875	0.99480861831524836080831164508708752691745758056640625	0.67272559933944275911699151038192212581634521484375	0.76353384313863126298116412726812995970249176025390625	6.1610567916356676	-0.6267286311641218	STAT3;SIX3;TBC1D9;PRICKLE1
translesion synthesis	1/75	0.9233223642829802013665130289155058562755584716796875	0.99999911886740633359949015357415191829204559326171875	0.8245627139839191155346043160534463822841644287109375	0.88726012349015215274761203545494936406612396240234375	7.8999179236488555	-0.6302305543884916	BRCA1
negative regulation of autophagy	1/73	0.9178767233302573824715864247991703450679779052734375	0.99999911886740633359949015357415191829204559326171875	0.8163171489598048946589869956369511783123016357421875	0.879727665442860295996752029168419539928436279296875	7.3948014869371805	-0.6336767021622346	LARS
DNA-dependent DNA replication	2/118	0.91021550782897275855276575384777970612049102783203125	0.99999911886740633359949015357415191829204559326171875	0.75790589267774333137595021980814635753631591796875	0.833525840581595733880249099456705152988433837890625	6.759641580958237	-0.6359057495885667	BAZ1A;BRCA1
interleukin-1-mediated signaling pathway	3/157	0.901534068676959510213464454864151775836944580078125	0.99381542462005556526349892010330222547054290771484375	0.7043731273603957010465137500432319939136505126953125	0.78844829255236703602349734865128993988037109375	6.164224401636883	-0.6389677577516792	STAT3;LRRC4;LRRC4B
negative regulation of protein phosphorylation	1/76	0.9259084306303548839167660844395868480205535888671875	0.99999911886740633359949015357415191829204559326171875	0.8285460789471270626194154829136095941066741943359375	0.88904728261910792586064644638099707663059234619140625	8.341771392781492	-0.6421490298937258	PHIP
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.1600127795542552	-0.6422362257658144	SEMA3A;PLXNA2;SEMA3E
double-strand break repair via break-induced replication	1/73	0.9178767233302573824715864247991703450679779052734375	0.99999911886740633359949015357415191829204559326171875	0.8163171489598048946589869956369511783123016357421875	0.879727665442860295996752029168419539928436279296875	7.576861210108621	-0.6492777977669837	BRCA1
regulation of gene silencing by miRNA	1/75	0.9233223642829802013665130289155058562755584716796875	0.99999911886740633359949015357415191829204559326171875	0.8245627139839191155346043160534463822841644287109375	0.88726012349015215274761203545494936406612396240234375	8.204670241648804	-0.6545427338542212	GEMIN5
muscle cell apoptotic process	4/197	0.90117311913193798300625303454580716788768768310546875	0.9936497435589881632722608628682792186737060546875	0.6689362850750750766337660024873912334442138671875	0.75941575371820191353577911286265589296817779541015625	6.322603197231345	-0.6579168032049839	ELMO1;PAX3;BRCA1;OGT
mesenchymal cell apoptotic process	4/197	0.90117311913193798300625303454580716788768768310546875	0.9936497435589881632722608628682792186737060546875	0.6689362850750750766337660024873912334442138671875	0.75941575371820191353577911286265589296817779541015625	6.349006711079992	-0.6606642973751523	ELMO1;PAX3;BRCA1;OGT
fibroblast apoptotic process	4/197	0.90117311913193798300625303454580716788768768310546875	0.9936497435589881632722608628682792186737060546875	0.6689362850750750766337660024873912334442138671875	0.75941575371820191353577911286265589296817779541015625	6.356263048517194	-0.6614193766013404	ELMO1;PAX3;BRCA1;OGT
melanocyte apoptotic process	4/197	0.90117311913193798300625303454580716788768768310546875	0.9936497435589881632722608628682792186737060546875	0.6689362850750750766337660024873912334442138671875	0.75941575371820191353577911286265589296817779541015625	6.3575028605316595	-0.6615483888343855	ELMO1;PAX3;BRCA1;OGT
ERBB2-EGFR signaling pathway	1/73	0.9178767233302573824715864247991703450679779052734375	0.99999911886740633359949015357415191829204559326171875	0.8163171489598048946589869956369511783123016357421875	0.879727665442860295996752029168419539928436279296875	7.743580297661015	-0.6635643207756567	ERBB4
protein targeting to vacuolar membrane	3/32	0.091325011268925060381462799341534264385700225830078125	0.55872902484503172981789020923315547406673431396484375	0.043840158751714784768349630894590518437325954437255859375	0.259197548393503007790883430061512626707553863525390625	0.2800206612717276	-0.6701820124675091	ICMT;PARD3;VTI1A
mitochondrial calcium ion homeostasis	1/74	0.9206461738202762479232887926627881824970245361328125	0.99999911886740633359949015357415191829204559326171875	0.8204871135160238804218124641920439898967742919921875	0.884019578450224940979751409031450748443603515625	8.11816628974463	-0.67120586994053	SLC24A2
fat cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.332378128474301	-0.6740303246837583	ELMO1;PAX3;BRCA1;OGT
apoptotic process in bone marrow	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.3345511187550025	-0.6742616218859658	ELMO1;PAX3;BRCA1;OGT
hepatoblast apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.336792155562526	-0.6745001620894024	ELMO1;PAX3;BRCA1;OGT
inflammatory cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.33746827493561	-0.6745721295163815	ELMO1;PAX3;BRCA1;OGT
myofibroblast cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.343165868101363	-0.6751785921270332	ELMO1;PAX3;BRCA1;OGT
epithelial cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.344005726744906	-0.6752679882721639	ELMO1;PAX3;BRCA1;OGT
apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.3472014548669025	-0.6756081476277754	ELMO1;PAX3;BRCA1;OGT
myeloid cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.352069528519708	-0.6761263146099445	ELMO1;PAX3;BRCA1;OGT
leukocyte apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.3526515777038055	-0.6761882690277919	ELMO1;PAX3;BRCA1;OGT
retinal cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.353290004563202	-0.6762562243922056	ELMO1;PAX3;BRCA1;OGT
glial cell apoptotic process	4/196	0.89902728507370388566499741500592790544033050537109375	0.99230463680021696593058777580154128372669219970703125	0.66511714517485476250158171751536428928375244140625	0.75737214214156989289250532237929292023181915283203125	6.354040989923864	-0.6763361606967361	ELMO1;PAX3;BRCA1;OGT
anterior neural tube closure	3/28	0.06644469513715216268945340516438591293990612030029296875	0.448382871190195597677075056708417832851409912109375	0.03214207273988102520068110834472463466227054595947265625	0.2120477721874388932210564462366164661943912506103515625	0.25158522415232476	-0.6821444858623534	VANGL2;LMO4;PRICKLE1
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	1/72	0.915010767649453438110640490776859223842620849609375	0.99999911886740633359949015357415191829204559326171875	0.8120506427721132514108148825471289455890655517578125	0.87653155193502474418210113071836531162261962890625	7.681774924457032	-0.6822909919574163	ATP2A2
tumor necrosis factor-mediated signaling pathway	6/272	0.89808697022164840628732918048626743257045745849609375	0.99230463680021696593058777580154128372669219970703125	0.6019151179797950224070746116922236979007720947265625	0.71016348461998324292920869993395172059535980224609375	6.405867331084684	-0.688556215884446	STAT3;LRRC4;GATA3;BRCA1;ZFP36L1;LRRC4B
semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.1785137559915404	-0.7164927777309998	SEMA3A;PLXNA2;SEMA3E
positive regulation of protein targeting to mitochondrion	2/113	0.89703462541807377217395469415350817143917083740234375	0.99230463680021696593058777580154128372669219970703125	0.736760329466330521341888015740551054477691650390625	0.81714048297500141426752406914602033793926239013671875	6.611836154590674	-0.7184475138685207	FZD5;U2AF2
retinoic acid metabolic process	1/72	0.915010767649453438110640490776859223842620849609375	0.99999911886740633359949015357415191829204559326171875	0.8120506427721132514108148825471289455890655517578125	0.87653155193502474418210113071836531162261962890625	8.094684727508325	-0.7189654118516858	SDC3
neural crest cell migration involved in autonomic nervous system development	3/13	0.0083946732338738179468595745902348426170647144317626953125	0.1269156206544320431017780492766178213059902191162109375	0.005131154950495567419743725423586511169560253620147705078125	0.056816098360299514824500732856904505752027034759521484375	0.1511127107949198	-0.7223426202776094	ERBB4;SEMA3A;PHOX2B
semaphorin-plexin signaling pathway involved in outflow tract morphogenesis	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.18066676089678604	-0.7251341984240978	SEMA3A;PLXNA2;SEMA3E
charged-tRNA amino acid modification	2/112	0.8941908354809926517958729164092801511287689208984375	0.99174657205827465578096280296449549496173858642578125	0.73234740438133594242486879011266864836215972900390625	0.81396859247567421302704815389006398618221282958984375	6.519051696360793	-0.7290650832667654	MSRA;ICMT
negative regulation of I-kappaB phosphorylation	1/73	0.9178767233302573824715864247991703450679779052734375	0.99999911886740633359949015357415191829204559326171875	0.8163171489598048946589869956369511783123016357421875	0.879727665442860295996752029168419539928436279296875	8.549883007221409	-0.7326581622859751	TLE1
positive regulation of myeloid cell differentiation	3/29	0.0723353402926988076071523892096593044698238372802734375	0.47193056730381777175153956704889424145221710205078125	0.034891286768459726930213804507729946635663509368896484375	0.2254550680641431992246026538850856013596057891845703125	0.27976888891719043	-0.7347968912207178	DLX1;DLX2;JUND
positive regulation of fibroblast proliferation	8/345	0.89712647488916441584905214767786674201488494873046875	0.99230463680021696593058777580154128372669219970703125	0.5461786421499204013940698132500983774662017822265625	0.6831940214853287063334619233501143753528594970703125	6.7950487188484185	-0.7376598153629628	PDGFRA;ERBB4;TET1;CTNNB1;PHIP;PTN;HOXC10;FGFR2
regulation of neuroblast proliferation	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.17667849850743222	-0.7390428330825592	SIX3;CTNNB1;ZFP36L1
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	3/44	0.1833255589815639130524260735910502262413501739501953125	0.73858861214153648244717942361603491008281707763671875	0.089456287477205520541900796160916797816753387451171875	0.410871770233669331151560299986158497631549835205078125	0.43846280060518367	-0.7438485001780953	TRPM1;GABBR1;LPAR1
positive regulation of presynapse assembly	3/18	0.0211499341840897144007005437060797703452408313751220703125	0.2105670264248979683952001096258754841983318328857421875	0.0112142140327315779912975557408572058193385601043701171875	0.1039783683536521785573114584622089751064777374267578125	0.19325148175305967	-0.7452006111108097	NLGN2;BDNF;LRRC4B
cellular response to UV	1/72	0.915010767649453438110640490776859223842620849609375	0.99999911886740633359949015357415191829204559326171875	0.8120506427721132514108148825471289455890655517578125	0.87653155193502474418210113071836531162261962890625	8.45944721386187	-0.7513634137575546	TRPM1
negative regulation of neuron death	1/71	0.91204494933066249107156409081653691828250885009765625	0.99999911886740633359949015357415191829204559326171875	0.807685367399839204693989813677035272121429443359375	0.87321839973069936835514681661152280867099761962890625	8.165200215619723	-0.7517373522464786	CTNNB1
regulation of SNARE complex assembly	1/70	0.90897579397159000702544062733068130910396575927734375	0.999915769627796269247710370109416544437408447265625	0.80321904394272392035958318956545554101467132568359375	0.868987208779318454077156275161541998386383056640625	7.886260089368242	-0.7526395408803267	TBC1D9
septation initiation signaling	1/70	0.90897579397159000702544062733068130910396575927734375	0.999915769627796269247710370109416544437408447265625	0.80321904394272392035958318956545554101467132568359375	0.868987208779318454077156275161541998386383056640625	8.004270738042145	-0.7639021012613438	GRAP2
positive regulation of B cell differentiation	1/70	0.90897579397159000702544062733068130910396575927734375	0.999915769627796269247710370109416544437408447265625	0.80321904394272392035958318956545554101467132568359375	0.868987208779318454077156275161541998386383056640625	8.058365886203068	-0.7690647698792074	ZFP36L1
double-strand break repair via homologous recombination	2/110	0.8882830347564178996577766156406141817569732666015625	0.9872834766602316403094619090552441775798797607421875	0.72333344703854052237801397495786659419536590576171875	0.80546833561869579654057815787382423877716064453125	6.496451632889694	-0.7696011938229819	EYA1;BRCA1
clathrin-dependent endocytosis	3/150	0.88383161319849923298619387423968873918056488037109375	0.98492296481746988145999921471229754388332366943359375	0.675321627843163962978678682702593505382537841796875	0.764456951892537706072516812128014862537384033203125	6.254017021674531	-0.7723005399525322	FCHO2;VLDLR;LDLRAP1
regulation of macroautophagy	2/110	0.8882830347564178996577766156406141817569732666015625	0.9872834766602316403094619090552441775798797607421875	0.72333344703854052237801397495786659419536590576171875	0.80546833561869579654057815787382423877716064453125	6.543834744009202	-0.7752144271610095	RHEB;PRKAG1
cellular response to amino acid starvation	1/70	0.90897579397159000702544062733068130910396575927734375	0.999915769627796269247710370109416544437408447265625	0.80321904394272392035958318956545554101467132568359375	0.868987208779318454077156275161541998386383056640625	8.135404970028645	-0.7764171346279292	LARS
double-strand break repair via synthesis-dependent strand annealing	1/68	0.9025129674069993779284004631335847079753875732421875	0.9941974935214423769735958558158017694950103759765625	0.79397387443691702646475505389389581978321075439453125	0.86135574188568020392864355017081834375858306884765625	7.645247481186112	-0.784190010878449	BRCA1
replication-born double-strand break repair via sister chromatid exchange	1/68	0.9025129674069993779284004631335847079753875732421875	0.9941974935214423769735958558158017694950103759765625	0.79397387443691702646475505389389581978321075439453125	0.86135574188568020392864355017081834375858306884765625	7.647697146453804	-0.7844412784845857	BRCA1
Wnt signaling pathway involved in dorsal/ventral axis specification	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.5241303282225739	-0.7866479875321506	FZD5;TNKS;WNT8B;CTNNB1
semaphorin-plexin signaling pathway	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.1960173900189733	-0.7867463405169208	SEMA3A;PLXNA2;SEMA3E
neuron cell-cell adhesion	3/13	0.0083946732338738179468595745902348426170647144317626953125	0.1269156206544320431017780492766178213059902191162109375	0.005131154950495567419743725423586511169560253620147705078125	0.056816098360299514824500732856904505752027034759521484375	0.1655660610009801	-0.7914319166360366	NLGN2;NRXN2;CNTN4
epidermis development	1/68	0.9025129674069993779284004631335847079753875732421875	0.9941974935214423769735958558158017694950103759765625	0.79397387443691702646475505389389581978321075439453125	0.86135574188568020392864355017081834375858306884765625	7.8066357315963915	-0.8007439620953762	ATP2A2
positive regulation of posterior neural plate formation by Wnt signaling pathway	4/74	0.237389965738306341069829841217142529785633087158203125	0.73858861214153648244717942361603491008281707763671875	0.0997421652712217887692958129264297895133495330810546875	0.4226564265451748791946329220081679522991180419921875	0.5568672113833859	-0.800803486404342	TNKS;WNT8B;CTNNB1;OTX2
positive regulation of synaptic growth at neuromuscular junction	3/22	0.0361650430262040745166274291477748192846775054931640625	0.29111008183379627478615248037385754287242889404296875	0.018151441429829738571921637912964797578752040863037109375	0.1489049551730554366013592471063020639121532440185546875	0.24397989439630743	-0.8099308546923887	NLGN2;BDNF;LRRC4B
lipopolysaccharide-mediated signaling pathway	1/69	0.90579970657729591554385706331231631338596343994140625	0.9973522912990440136837833051686175167560577392578125	0.79864934123401865040392522132606245577335357666015625	0.8648367636824760840141834705718792974948883056640625	8.196004697054708	-0.8108887051668269	MEF2C
positive regulation of growth plate cartilage chondrocyte proliferation	8/337	0.88274678998494471304780972786829806864261627197265625	0.98461021715748031635229153835098259150981903076171875	0.5200000301851865902591498524998314678668975830078125	0.6690780530233293443842512715491466224193572998046875	6.540294907359421	-0.8156851787944969	PDGFRA;ERBB4;TET1;PHIP;PTN;SOX6;HOXC10;FGFR2
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	1/67	0.89911172730212574055741470147040672600269317626953125	0.99230463680021696593058777580154128372669219970703125	0.7891902038607681024728890406549908220767974853515625	0.8575466923776187133654502758872695267200469970703125	7.694758422012623	-0.8183219585772843	ROBO1
mitochondrial fusion	2/109	0.88521576156717862726708290210808627307415008544921875	0.98573247103691719050999608953134156763553619384765625	0.71873137864119396311934906407259404659271240234375	0.8020477674593120553936387295834720134735107421875	6.8106977633015235	-0.8303865967408958	DNM3;RABIF
negative regulation of dendritic spine morphogenesis	3/18	0.0211499341840897144007005437060797703452408313751220703125	0.2105670264248979683952001096258754841983318328857421875	0.0112142140327315779912975557408572058193385601043701171875	0.1039783683536521785573114584622089751064777374267578125	0.21771507608812068	-0.8395351294445392	EFNA1;SIPA1L1;RAPGEF2
positive regulation of trophectodermal cell proliferation	8/335	0.87890281412601167776443844559253193438053131103515625	0.98148309049062432141141698593855835497379302978515625	0.513375019173242463921269518323242664337158203125	0.66781052522122108516811067602247931063175201416015625	6.519522343091327	-0.8415461476576496	PDGFRA;ERBB4;TET1;PHIP;OTX2;PTN;HOXC10;FGFR2
positive regulation of synapse maturation by synaptic transmission	8/188	0.29846116313263693076152094363351352512836456298828125	0.73996546891932102330002862800029106438159942626953125	0.07676498773103400397044282499336986802518367767333984375	0.37024585595837156137832835156586952507495880126953125	0.7026409752768783	-0.8495740670010796	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
positive regulation of axon extension	5/100	0.24604119168297911013354450915358029305934906005859375	0.73858861214153648244717942361603491008281707763671875	0.08914842560323725517701376475088181905448436737060546875	0.41025670592240992551325007298146374523639678955078125	0.6062916004157275	-0.8501762231114116	ROBO2;SEMA7A;SLITRK1;AKAP6;ROBO1
positive regulation of keratinocyte differentiation	3/22	0.0361650430262040745166274291477748192846775054931640625	0.29111008183379627478615248037385754287242889404296875	0.018151441429829738571921637912964797578752040863037109375	0.1489049551730554366013592471063020639121532440185546875	0.2563612362184276	-0.8510327282260308	PRKCH;SFN;ZFP36L1
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	1/66	0.89559200354367030083579948041005991399288177490234375	0.99230463680021696593058777580154128372669219970703125	0.78429583380796785707644858121057040989398956298828125	0.85360485650027329018740829269518144428730010986328125	7.727796195539253	-0.8521465817861149	ATP2A2
positive regulation of sprouting of injured axon	1/67	0.89911172730212574055741470147040672600269317626953125	0.99230463680021696593058777580154128372669219970703125	0.7891902038607681024728890406549908220767974853515625	0.8575466923776187133654502758872695267200469970703125	8.020234528170532	-0.8529356826286214	AKAP6
positive regulation of neural precursor cell proliferation	8/335	0.87890281412601167776443844559253193438053131103515625	0.98148309049062432141141698593855835497379302978515625	0.513375019173242463921269518323242664337158203125	0.66781052522122108516811067602247931063175201416015625	6.615555690676554	-0.8539422235438924	PDGFRA;ERBB4;SIX3;TET1;PHIP;PTN;HOXC10;FGFR2
synaptic transmission, dopaminergic	8/188	0.29846116313263693076152094363351352512836456298828125	0.73996546891932102330002862800029106438159942626953125	0.07676498773103400397044282499336986802518367767333984375	0.37024585595837156137832835156586952507495880126953125	0.7064811658124267	-0.8542173007522273	CACNB1;GRIA1;SLC6A5;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
neural tube closure	3/27	0.060785236034956079131941208970602019689977169036865234375	0.4131469140877346291063076932914555072784423828125	0.029511276666270742918829483869558316655457019805908203125	0.1983924031905558715838111538687371648848056793212890625	0.3052863971033854	-0.8549265749394859	VANGL2;LMO4;PRICKLE1
positive regulation of stem cell proliferation	8/334	0.87694227719161521594770647425320930778980255126953125	0.9797576318126122174589909263886511325836181640625	0.51005147430610264791539520956575870513916015625	0.6653519923401234326121311823953874409198760986328125	6.520580760943012	-0.8562442414250305	PDGFRA;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2;ZFP36L1
negative regulation of AMPA receptor activity	3/17	0.01806722362986588892308503773165284655988216400146484375	0.1915125704765784087069135921410634182393550872802734375	0.00977298052770285939627736837564953020773828029632568359375	0.09407989622280486796679355165906599722802639007568359375	0.2140526393768461	-0.8591336242739546	MEF2C;NLGN2;CACNG2
positive regulation of cardiac muscle cell proliferation	8/334	0.87694227719161521594770647425320930778980255126953125	0.9797576318126122174589909263886511325836181640625	0.51005147430610264791539520956575870513916015625	0.6653519923401234326121311823953874409198760986328125	6.558331056895114	-0.8612013878366951	PDGFRA;MEF2C;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
midbrain dopaminergic neuron differentiation	3/21	0.0320111839260765196346625316436984576284885406494140625	0.26963706174875523569056667838594876229763031005859375	0.016239187646203599724170629770014784298837184906005859375	0.136788299883131347911557895713485777378082275390625	0.25271889911885015	-0.8697750382541752	CTNNB1;OTX2;PHOX2B
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	4/74	0.237389965738306341069829841217142529785633087158203125	0.73858861214153648244717942361603491008281707763671875	0.0997421652712217887692958129264297895133495330810546875	0.4226564265451748791946329220081679522991180419921875	0.6050731824575678	-0.8701261344478706	MEF2C;BDNF;TYRO3;SIX1
protein deubiquitination involved in ubiquitin-dependent protein catabolic process	8/329	0.86674563532333681603603281473624520003795623779296875	0.97426051812587799449971726062358357012271881103515625	0.493331137820905707425112041164538823068141937255859375	0.6596842167393817124576571586658246815204620361328125	6.112244638835299	-0.8741104561714104	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
transferrin transport	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	7.672069303229157	-0.8772671072666468	REP15
histone-threonine phosphorylation	1/67	0.89911172730212574055741470147040672600269317626953125	0.99230463680021696593058777580154128372669219970703125	0.7891902038607681024728890406549908220767974853515625	0.8575466923776187133654502758872695267200469970703125	8.285606390140957	-0.8811574421601104	TNKS
gluconeogenesis	1/64	0.88818047769884922448824227103614248335361480712890625	0.9872834766602316403094619090552441775798797607421875	0.7741647239558318016605653610895387828350067138671875	0.84550474714046275348522385684191249310970306396484375	7.483875057486056	-0.887440269136595	SLC37A4
establishment of planar polarity involved in neural tube closure	3/27	0.060785236034956079131941208970602019689977169036865234375	0.4131469140877346291063076932914555072784423828125	0.029511276666270742918829483869558316655457019805908203125	0.1983924031905558715838111538687371648848056793212890625	0.31694387999745743	-0.8875722873511973	VANGL2;LMO4;PRICKLE1
ER overload response	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	7.787173598265169	-0.8904287730375371	ATP2A2
Golgi calcium ion homeostasis	1/66	0.89559200354367030083579948041005991399288177490234375	0.99230463680021696593058777580154128372669219970703125	0.78429583380796785707644858121057040989398956298828125	0.85360485650027329018740829269518144428730010986328125	8.107444713823616	-0.8940105464857699	SLC24A2
vacuolar calcium ion homeostasis	1/66	0.89559200354367030083579948041005991399288177490234375	0.99230463680021696593058777580154128372669219970703125	0.78429583380796785707644858121057040989398956298828125	0.85360485650027329018740829269518144428730010986328125	8.113301016069892	-0.8946563228254657	SLC24A2
fibroblast growth factor receptor apoptotic signaling pathway	2/106	0.8755403716744083464362802260438911616802215576171875	0.979243363185759552180797982146032154560089111328125	0.70453880710371574735972899361513555049896240234375	0.78844829255236703602349734865128993988037109375	6.739767489210461	-0.8958095612891779	RBFOX2;FGFR2
negative regulation of protein localization to cell surface	3/19	0.024501872806991224773565107852846267633140087127685546875	0.233958166053800820094465962029062211513519287109375	0.01277148816961725698304608300759355188347399234771728515625	0.11275211834681753142461957395425997674465179443359375	0.24419888359488037	-0.905735056864976	BDNF;GBF1;CTNNB1
gap filling involved in double-strand break repair via nonhomologous end joining	1/66	0.89559200354367030083579948041005991399288177490234375	0.99230463680021696593058777580154128372669219970703125	0.78429583380796785707644858121057040989398956298828125	0.85360485650027329018740829269518144428730010986328125	8.267394788206945	-0.9116482928358698	BRCA1
positive regulation of glial cell proliferation	8/330	0.8688381882301625669384748107404448091983795166015625	0.9750915379209319500120045631774701178073883056640625	0.496688223712808685217368065423215739428997039794921875	0.65996573274741365811024706999887712299823760986328125	6.493925225695304	-0.9130353381516096	PDGFRA;PRKCH;ERBB4;TET1;PHIP;PTN;HOXC10;FGFR2
DNA synthesis involved in DNA repair	3/142	0.86017547484195155949038280596141703426837921142578125	0.97021705280475500909886932277004234492778778076171875	0.6396191501745442931081697679474018514156341552734375	0.736233170174066753332908774609677493572235107421875	6.122234153449417	-0.9221239902768545	PDS5B;BRCA1;PDS5A
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.6159571402005513	-0.924467481948612	MEF2C;BDNF;TYRO3;SIX1
negative regulation of voltage-gated calcium channel activity	3/24	0.0452561295785736950048061544293886981904506683349609375	0.3377739924400824378381003043614327907562255859375	0.0223354279530613465676314177699168794788420200347900390625	0.171589924518876835168867955871974118053913116455078125	0.2989119168986838	-0.925257076212216	CACNB1;SLN;CRHR1
receptor-mediated endocytosis involved in cholesterol transport	3/143	0.863347670642791609196819990756921470165252685546875	0.971935790554188105971888944623060524463653564453125	0.64422783661007965161360289130243472754955291748046875	0.73901330381559959814552485113381408154964447021484375	6.303302840348772	-0.9261934910011331	VLDLR;LDLRAP1;LDLR
mitochondrial ATP synthesis coupled proton transport	1/64	0.88818047769884922448824227103614248335361480712890625	0.9872834766602316403094619090552441775798797607421875	0.7741647239558318016605653610895387828350067138671875	0.84550474714046275348522385684191249310970306396484375	7.81751293677171	-0.9270031542880852	ATP5G2
positive regulation of unidimensional cell growth	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	8.109207646975504	-0.9272519386252845	AKAP6
positive regulation of chondrocyte hypertrophy	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	8.114014906832875	-0.9278016274748339	AKAP6
positive regulation of root hair elongation	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	8.116928046262128	-0.9281347320518598	AKAP6
positive regulation of cytokine secretion	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	8.118970110812107	-0.9283682330787415	CADM1
activation of JNKKK activity	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	8.128921524008039	-0.929506133053646	TRIB1
negative regulation of fibroblast proliferation	7/294	0.8682330332947338913385237901820801198482513427734375	0.9750915379209319500120045631774701178073883056640625	0.52220714265400214326717787116649560630321502685546875	0.67045484265076982222097967678564600646495819091796875	6.597251298582626	-0.9321594720654771	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
positive regulation of translation	11/277	0.328896489231641442341214087718981318175792694091796875	0.75121918332311110599874837134848348796367645263671875	0.06268095745202771629234206329783773981034755706787109375	0.333708889730490676495122670530690811574459075927734375	0.8399540021389641	-0.9340390979156301	MEF2C;TLE1;CITED2;ID2;STAT3;NKX2-1;PRKAG1;GEMIN5;MITF;ANK3;BRCA1
poly(A)+ mRNA export from nucleus	2/104	0.86867826984394647116261012342874892055988311767578125	0.9750915379209319500120045631774701178073883056640625	0.69475034098000321147736713101039640605449676513671875	0.7800505662209769042192419874481856822967529296875	6.651172339136909	-0.9363683545562655	U2AF2;CDC40
positive regulation of cell growth	2/104	0.86867826984394647116261012342874892055988311767578125	0.9750915379209319500120045631774701178073883056640625	0.69475034098000321147736713101039640605449676513671875	0.7800505662209769042192419874481856822967529296875	6.688844571645585	-0.9416719438436824	AKAP6;PAPPA2
gene silencing by miRNA	1/64	0.88818047769884922448824227103614248335361480712890625	0.9872834766602316403094619090552441775798797607421875	0.7741647239558318016605653610895387828350067138671875	0.84550474714046275348522385684191249310970306396484375	7.949569169149379	-0.9426624240517055	LIN28A
tRNA aminoacylation for mitochondrial protein translation	1/65	0.89194967509213107792476193935726769268512725830078125	0.9894935600681049603366545852622948586940765380859375	0.77928821109742951733778681955300271511077880859375	0.84913432472778349602293701536837033927440643310546875	8.254009100421463	-0.9438093427846912	LARS
nucleotide-excision repair, preincision complex stabilization	1/64	0.88818047769884922448824227103614248335361480712890625	0.9872834766602316403094619090552441775798797607421875	0.7741647239558318016605653610895387828350067138671875	0.84550474714046275348522385684191249310970306396484375	7.96596612070248	-0.9446067797481236	TAL1
positive regulation of histone H3-K4 trimethylation	3/12	0.006621004312468350451459375705098864273168146610260009765625	0.10787286952003131978994332484944607131183147430419921875	0.004239218550275117465553353923723989282734692096710205078125	0.04925220172819637365346778778985026292502880096435546875	0.1883369190509426	-0.944982037905845	MYB;CTNNB1;BRCA1
positive regulation of endothelial cell migration	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.631682959018402	-0.9480697866794007	GATA3;AAMP;FOXP1;CLASP2
cellular response to calcium ion	1/64	0.88818047769884922448824227103614248335361480712890625	0.9872834766602316403094619090552441775798797607421875	0.7741647239558318016605653610895387828350067138671875	0.84550474714046275348522385684191249310970306396484375	8.00064211443782	-0.9487186700424821	MEF2C
protein sumoylation	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.636997164033312	-0.9560456820916902	IFIH1;TOP2B;EYA1;MITF
chemokine-mediated signaling pathway	3/139	0.85026887640962256487142667538137175142765045166015625	0.96411497356350717158335328349494375288486480712890625	0.62554434936686742485534296065452508628368377685546875	0.7273122029137428778966523168492130935192108154296875	5.896244026165959	-0.9563864316229852	STAT3;LRRC4;LRRC4B
regulation of atrial cardiac muscle cell action potential	1/64	0.88818047769884922448824227103614248335361480712890625	0.9872834766602316403094619090552441775798797607421875	0.7741647239558318016605653610895387828350067138671875	0.84550474714046275348522385684191249310970306396484375	8.069571657076377	-0.9568923569895184	ATP2A2
autophagosome maturation	2/103	0.8651183878173751562457027830532751977443695068359375	0.9736968349641037523412023801938630640506744384765625	0.68975671534274896057326031950651668012142181396484375	0.775955742015680183243375722668133676052093505859375	6.669917046455463	-0.9663970565843718	LIX1;PRKAG1
semaphorin-plexin signaling pathway involved in neuron projection guidance	3/19	0.024501872806991224773565107852846267633140087127685546875	0.233958166053800820094465962029062211513519287109375	0.01277148816961725698304608300759355188347399234771728515625	0.11275211834681753142461957395425997674465179443359375	0.2610364857730028	-0.9681858197094597	SEMA3A;PLXNA2;SEMA3E
response to manganese-induced endoplasmic reticulum stress	1/63	0.8842799991524241676188466954044997692108154296875	0.98492296481746988145999921471229754388332366943359375	0.76892270056138156686387219451717101037502288818359375	0.84153326648446336033515535746118985116481781005859375	7.894313931057069	-0.9708547690204173	ATP2A2
hepatocyte differentiation	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.6477169245537243	-0.9721345775173866	CITED2;SIX1;FGFR2;CNN3
skeletal muscle satellite stem cell asymmetric division	3/19	0.024501872806991224773565107852846267633140087127685546875	0.233958166053800820094465962029062211513519287109375	0.01277148816961725698304608300759355188347399234771728515625	0.11275211834681753142461957395425997674465179443359375	0.26214012016662036	-0.9722792059917641	SVIL;MEF2C;SIX1
positive regulation of hematopoietic progenitor cell differentiation	3/28	0.06644469513715216268945340516438591293990612030029296875	0.448382871190195597677075056708417832851409912109375	0.03214207273988102520068110834472463466227054595947265625	0.2120477721874388932210564462366164661943912506103515625	0.35878064942251237	-0.9727925893195563	DLX1;DLX2;JUND
positive regulation of sodium ion transmembrane transport	3/20	0.0281227247744543253082927236619070754386484622955322265625	0.24861344939594920422365476042614318430423736572265625	0.01444613043666434330780656836168418521992862224578857421875	0.123895267763173999586712170639657415449619293212890625	0.2724629988352118	-0.9730136816084479	DLG1;CNKSR3;ANK3
positive regulation of pigment cell differentiation	3/27	0.060785236034956079131941208970602019689977169036865234375	0.4131469140877346291063076932914555072784423828125	0.029511276666270742918829483869558316655457019805908203125	0.1983924031905558715838111538687371648848056793212890625	0.34774520696087524	-0.9738285805050269	DLX1;DLX2;JUND
histone-serine phosphorylation	3/140	0.85363704351550373505830293652252294123172760009765625	0.96521793019262902557642291867523454129695892333984375	0.63027730903900802683637039081077091395854949951171875	0.73143569506205474706206359769566915929317474365234375	6.186321270837381	-0.9789802876772584	PRKCH;CAB39;TNKS
positive regulation of smooth muscle cell differentiation	3/27	0.060785236034956079131941208970602019689977169036865234375	0.4131469140877346291063076932914555072784423828125	0.029511276666270742918829483869558316655457019805908203125	0.1983924031905558715838111538687371648848056793212890625	0.35176195567923724	-0.985077117147224	MEF2C;CTNNB1;FGFR2
strand displacement	1/63	0.8842799991524241676188466954044997692108154296875	0.98492296481746988145999921471229754388332366943359375	0.76892270056138156686387219451717101037502288818359375	0.84153326648446336033515535746118985116481781005859375	8.024821532046962	-0.9869047928630194	BRCA1
mitotic sister chromatid cohesion	3/27	0.060785236034956079131941208970602019689977169036865234375	0.4131469140877346291063076932914555072784423828125	0.029511276666270742918829483869558316655457019805908203125	0.1983924031905558715838111538687371648848056793212890625	0.35274894666827383	-0.9878410949521945	CHTF8;PDS5B;PDS5A
branchiomeric skeletal muscle development	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.6586940860746814	-0.988609796664807	SVIL;MEF2C;SIX1;SOX6
endoplasmic reticulum stress-induced pre-emptive quality control	1/62	0.88024367399318681481901194274541921913623809814453125	0.9820504754555019477635369185009039938449859619140625	0.763559407677272705683435560786165297031402587890625	0.838386807731307026614331334712915122509002685546875	7.757123846016018	-0.9894716266265442	ATP2A2
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway	1/63	0.8842799991524241676188466954044997692108154296875	0.98492296481746988145999921471229754388332366943359375	0.76892270056138156686387219451717101037502288818359375	0.84153326648446336033515535746118985116481781005859375	8.047624510795451	-0.9897091379725731	TRPM1
determination of heart left/right asymmetry	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7486235306932931	-0.9938301756027167	MEF2C;CITED2;ERBB4;SHOX2;CACNA1C
regulation of dendrite extension	4/72	0.2229376092690321387035368161377846263349056243896484375	0.73858861214153648244717942361603491008281707763671875	0.0927995826587506844607133871249970979988574981689453125	0.415100284076937831034825876486138440668582916259765625	0.6682894545752497	-1.0030111333441758	ARC;PHIP;EFNA5;PAPPA2
protein heterotetramerization	1/62	0.88024367399318681481901194274541921913623809814453125	0.9820504754555019477635369185009039938449859619140625	0.763559407677272705683435560786165297031402587890625	0.838386807731307026614331334712915122509002685546875	7.865986117475929	-1.0033577177806798	MAGI2
regulation of translation in response to endoplasmic reticulum stress	1/62	0.88024367399318681481901194274541921913623809814453125	0.9820504754555019477635369185009039938449859619140625	0.763559407677272705683435560786165297031402587890625	0.838386807731307026614331334712915122509002685546875	7.915628812925774	-1.009689966638884	ATP2A2
regulation of neuron differentiation	3/23	0.040581278480883477277618709422313258983194828033447265625	0.317976562449048760772285504572209902107715606689453125	0.0201834231087742767274395561116762110032141208648681640625	0.1578978711498744968988461323533556424081325531005859375	0.3170446729138335	-1.0159533074922706	CASZ1;CTNNB1;SIX1
negative regulation of multicellular organism growth	3/12	0.006621004312468350451459375705098864273168146610260009765625	0.10787286952003131978994332484944607131183147430419921875	0.004239218550275117465553353923723989282734692096710205078125	0.04925220172819637365346778778985026292502880096435546875	0.20252010238715076	-1.0161462767634262	STAT5B;PTCH1;FGFR2
serine phosphorylation of STAT protein	3/138	0.8468334530153913686234545821207575500011444091796875	0.96150978311794299546733100214623846113681793212890625	0.62077018656782823047279862294089980423450469970703125	0.7230056716149249051994729597936384379863739013671875	6.116780911771621	-1.016922382565212	PRKCH;CAB39;TNKS
retinol metabolic process	1/63	0.8842799991524241676188466954044997692108154296875	0.98492296481746988145999921471229754388332366943359375	0.76892270056138156686387219451717101037502288818359375	0.84153326648446336033515535746118985116481781005859375	8.279322737776306	-1.0182037393530654	SDC3
positive regulation of CREB transcription factor activity	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.768971432507979	-1.0208428969566772	FZD2;CTNNB1;TRIM37;NKX6-1;NEUROG1
retinal metabolic process	1/63	0.8842799991524241676188466954044997692108154296875	0.98492296481746988145999921471229754388332366943359375	0.76892270056138156686387219451717101037502288818359375	0.84153326648446336033515535746118985116481781005859375	8.3296700037503	-1.0243955229209436	SDC3
negative regulation of cardiac muscle cell proliferation	7/287	0.8520793915235513882322493373067118227481842041015625	0.96500677308988869196326731980661861598491668701171875	0.4972708161145533711788857544888742268085479736328125	0.66018194191172197005101907052448950707912445068359375	6.401875364490141	-1.024783873356989	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of growth plate cartilage chondrocyte proliferation	7/287	0.8520793915235513882322493373067118227481842041015625	0.96500677308988869196326731980661861598491668701171875	0.4972708161145533711788857544888742268085479736328125	0.66018194191172197005101907052448950707912445068359375	6.4050224114894085	-1.025287638711659	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of fat cell proliferation	7/287	0.8520793915235513882322493373067118227481842041015625	0.96500677308988869196326731980661861598491668701171875	0.4972708161145533711788857544888742268085479736328125	0.66018194191172197005101907052448950707912445068359375	6.446394491885214	-1.031910298226716	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
RIP homotypic interaction motif-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7794623184191022	-1.034770002584287	PARD3;CNKSR3;GEMIN5;MITF;OTX2
C3HC4-type RING finger domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7819156394137551	-1.0380268925095446	PARD3;CNKSR3;GEMIN5;MITF;OTX2
TORC1 complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7836790811587593	-1.0403679378377346	PARD3;CNKSR3;GEMIN5;MITF;OTX2
origin recognition complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7850946570818411	-1.0422471762139482	PARD3;CNKSR3;GEMIN5;MITF;OTX2
TIR domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7917681182444991	-1.0511064850751328	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of chondrocyte proliferation	7/285	0.84718076381872198243883076429483480751514434814453125	0.96150978311794299546733100214623846113681793212890625	0.49007181608095773395206151690217666327953338623046875	0.65878277470899904155743342926143668591976165771484375	6.3460465081544974	-1.0524359081924635	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
positive regulation of canonical Wnt signaling pathway involved in heart development	2/100	0.85390172200420633163986394720268435776233673095703125	0.96521793019262902557642291867523454129695892333984375	0.674373190260020738406865348224528133869171142578125	0.76356657188106524802861940770526416599750518798828125	6.679089915285996	-1.0548899271674952	TNKS;FGFR2
positive regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation	2/100	0.85390172200420633163986394720268435776233673095703125	0.96521793019262902557642291867523454129695892333984375	0.674373190260020738406865348224528133869171142578125	0.76356657188106524802861940770526416599750518798828125	6.679974543902334	-1.0550296446781884	TNKS;FGFR2
protein complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.7961076619318146	-1.0568674173568182	PARD3;CNKSR3;GEMIN5;MITF;OTX2
positive regulation of small GTPase mediated signal transduction	3/136	0.83975697375436320069042039904161356389522552490234375	0.9574893993713635698128427975461818277835845947265625	0.611098818344763206056313720182515680789947509765625	0.71669645105227453019125505306874401867389678955078125	6.054372576866802	-1.0573522519137304	ARHGAP10;ABR;SRGAP2
negative regulation of chorionic trophoblast cell proliferation	7/285	0.84718076381872198243883076429483480751514434814453125	0.96150978311794299546733100214623846113681793212890625	0.49007181608095773395206151690217666327953338623046875	0.65878277470899904155743342926143668591976165771484375	6.391131924144924	-1.0599129272567185	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
zf-TRAF domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.798997947348269	-1.0607043964861234	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of myoblast proliferation	7/285	0.84718076381872198243883076429483480751514434814453125	0.96150978311794299546733100214623846113681793212890625	0.49007181608095773395206151690217666327953338623046875	0.65878277470899904155743342926143668591976165771484375	6.398374551615649	-1.0611140532191672	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
ciliary transition fiber assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8011606204496116	-1.063575438738947	PARD3;CNKSR3;GEMIN5;MITF;OTX2
FACT complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8015335351314234	-1.0640704991378191	PARD3;CNKSR3;GEMIN5;MITF;OTX2
branching involved in blood vessel morphogenesis	3/23	0.040581278480883477277618709422313258983194828033447265625	0.317976562449048760772285504572209902107715606689453125	0.0201834231087742767274395561116762110032141208648681640625	0.1578978711498744968988461323533556424081325531005859375	0.3321189105279638	-1.0642579246973114	GDF2;CTNNB1;SEMA3E
ATG1/ULK1 kinase complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8018457009903907	-1.0644849128420575	PARD3;CNKSR3;GEMIN5;MITF;OTX2
positive regulation of hemocyte differentiation	3/26	0.05536339021525253645261699375623720698058605194091796875	0.388037312994570948720962633160525001585483551025390625	0.026999589455807992965929997808416374027729034423828125	0.18998313577565217880049885934568010270595550537109375	0.36844159263791804	-1.0662098136759866	DLX1;DLX2;JUND
positive regulation of metanephric DCT cell differentiation	3/27	0.060785236034956079131941208970602019689977169036865234375	0.4131469140877346291063076932914555072784423828125	0.029511276666270742918829483869558316655457019805908203125	0.1983924031905558715838111538687371648848056793212890625	0.381283562658802	-1.0677496717753352	DLX1;DLX2;JUND
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	5/207	0.8289715702722866286222824783180840313434600830078125	0.95001430927462970910113426725729368627071380615234375	0.5240404747054927536709101332235150039196014404296875	0.6724669267087850510478119758772663772106170654296875	5.706231419511517	-1.070314508824493	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
negative regulation of mesenchymal cell proliferation	7/284	0.8446830451160411978861475290614180266857147216796875	0.960320540807993783261053977184928953647613525390625	0.486461135882853279444049121593707241117954254150390625	0.6544886417454132132576205549412406980991363525390625	6.342123490863913	-1.0705112289131842	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
protein complex assembly involved in synapse maturation	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8067567150923396	-1.0710044968615542	PARD3;CNKSR3;GEMIN5;MITF;OTX2
protein deglycosylation	2/100	0.85390172200420633163986394720268435776233673095703125	0.96521793019262902557642291867523454129695892333984375	0.674373190260020738406865348224528133869171142578125	0.76356657188106524802861940770526416599750518798828125	6.793899806293587	-1.0730229062259034	MSRA;ICMT
NLRP1 inflammasome complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8083428014895846	-1.0731100952806092	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of glial cell proliferation	7/284	0.8446830451160411978861475290614180266857147216796875	0.960320540807993783261053977184928953647613525390625	0.486461135882853279444049121593707241117954254150390625	0.6544886417454132132576205549412406980991363525390625	6.364031385835002	-1.0742091461174432	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
Rel homology domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8104161382720315	-1.0758625396990669	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of trophectodermal cell proliferation	7/284	0.8446830451160411978861475290614180266857147216796875	0.960320540807993783261053977184928953647613525390625	0.486461135882853279444049121593707241117954254150390625	0.6544886417454132132576205549412406980991363525390625	6.380879165661794	-1.0770529471744266	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
DNA recombinase mediator complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8113715011605079	-1.07713082533035	PARD3;CNKSR3;GEMIN5;MITF;OTX2
positive regulation of direction of cell growth	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.14915951628336	-1.078239418412369	AKAP6
positive regulation of pseudohyphal growth	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.163889721914611	-1.0801884155231996	AKAP6
intracellular signal transduction involved in positive regulation of cell growth	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.164718275769681	-1.0802980439364156	AKAP6
oligodendrocyte differentiation	5/104	0.271563866068516623908379870044882409274578094482421875	0.73858861214153648244717942361603491008281707763671875	0.1005507523928037827420922667442937381565570831298828125	0.4226564265451748791946329220081679522991180419921875	0.8312342190386386	-1.0835619605195774	ROBO2;RCAN1;NFIB;PHOX2B;HAPLN1
eukaryotic translation initiation factor 2B complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8164515712862408	-1.083874838546787	PARD3;CNKSR3;GEMIN5;MITF;OTX2
RING-like zinc finger domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.818085780043179	-1.0860443214835245	PARD3;CNKSR3;GEMIN5;MITF;OTX2
exon-exon junction complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.821234813884726	-1.0902248003589685	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of leukocyte proliferation	7/283	0.8421527508972725950542326245340518653392791748046875	0.958485975313668081554396849242039024829864501953125	0.482843337213618550851634836362791247665882110595703125	0.65448207929557333795145268595661036670207977294921875	6.351136738060242	-1.09108633897267	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
response to endoplasmic reticulum stress	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	7.952663343346001	-1.091574538614649	ATP2A2
negative regulation of cell proliferation involved in kidney development	7/283	0.8421527508972725950542326245340518653392791748046875	0.958485975313668081554396849242039024829864501953125	0.482843337213618550851634836362791247665882110595703125	0.65448207929557333795145268595661036670207977294921875	6.359854321894547	-1.0925839664089458	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
starch utilization system complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8231550729184065	-1.0927740274329265	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of hemocyte proliferation	7/283	0.8421527508972725950542326245340518653392791748046875	0.958485975313668081554396849242039024829864501953125	0.482843337213618550851634836362791247665882110595703125	0.65448207929557333795145268595661036670207977294921875	6.365664582688547	-1.0935821335780154	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
VCP-NPL4-UFD1 AAA ATPase complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8269918418609739	-1.0978675044552257	PARD3;CNKSR3;GEMIN5;MITF;OTX2
lateral cortical node assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8271231426324924	-1.0980418119188105	PARD3;CNKSR3;GEMIN5;MITF;OTX2
ripoptosome assembly	5/104	0.271563866068516623908379870044882409274578094482421875	0.73858861214153648244717942361603491008281707763671875	0.1005507523928037827420922667442937381565570831298828125	0.4226564265451748791946329220081679522991180419921875	0.8432735714545316	-1.0992559538711009	PARD3;CNKSR3;GEMIN5;MITF;OTX2
apoptosome assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.829412995790833	-1.1010816912081385	PARD3;CNKSR3;GEMIN5;MITF;OTX2
Wnt-Frizzled-LRP5/6 complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8294575724805469	-1.1011408686952862	PARD3;CNKSR3;GEMIN5;MITF;OTX2
SH2 domain-mediated complex assembly	5/104	0.271563866068516623908379870044882409274578094482421875	0.73858861214153648244717942361603491008281707763671875	0.1005507523928037827420922667442937381565570831298828125	0.4226564265451748791946329220081679522991180419921875	0.8472872710745782	-1.1044880438520261	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of sebum secreting cell proliferation	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.326997142290014	-1.1062249026791948	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
peptidyl-threonine trans-autophosphorylation	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.363688482318135	-1.106624380948412	TNKS
negative regulation of cell proliferation involved in heart morphogenesis	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.330312338902321	-1.1068045383210854	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
cholesterol biosynthetic process	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	7.773468672810098	-1.1069663577706221	LDLRAP1
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.36688040861365	-1.107046714165183	TNKS
negative regulation of germ cell proliferation	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.333268109942226	-1.1073213312731647	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of cell proliferation involved in compound eye morphogenesis	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.334652893627861	-1.107563449637283	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of skeletal muscle cell proliferation	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.337265079747857	-1.108020169511085	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of cell proliferation in bone marrow	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.342289534104757	-1.1088986552140145	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of synoviocyte proliferation	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.342957597732757	-1.109015460802076	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
negative regulation of hair follicle cell proliferation	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.344966558923732	-1.1093667116163237	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
enzyme active site formation via O-phospho-L-threonine	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.385707768569059	-1.1095378178928736	TNKS
negative regulation of mammary stem cell proliferation	7/282	0.83958965639019134119536147409235127270221710205078125	0.9574893993713635698128427975461818277835845947265625	0.479218675465416465986123739639879204332828521728515625	0.65448207929557333795145268595661036670207977294921875	6.346923032172244	-1.1097087853331686	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B
mitotic checkpoint complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8390393762753355	-1.1138611284220232	PARD3;CNKSR3;GEMIN5;MITF;OTX2
Y-shaped link assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8392217042291903	-1.1141031766812182	PARD3;CNKSR3;GEMIN5;MITF;OTX2
protein complex oligomerization	5/104	0.271563866068516623908379870044882409274578094482421875	0.73858861214153648244717942361603491008281707763671875	0.1005507523928037827420922667442937381565570831298828125	0.4226564265451748791946329220081679522991180419921875	0.8549768331875539	-1.114511833546716	PARD3;CNKSR3;GEMIN5;MITF;OTX2
FHA domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8405774504961574	-1.1159029885964606	PARD3;CNKSR3;GEMIN5;MITF;OTX2
regulation of translation involved in cellular response to UV	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	8.143269178372895	-1.1177369030256643	GEMIN5
eukaryotic translation initiation factor 2 complex assembly	5/104	0.271563866068516623908379870044882409274578094482421875	0.73858861214153648244717942361603491008281707763671875	0.1005507523928037827420922667442937381565570831298828125	0.4226564265451748791946329220081679522991180419921875	0.8575338604814579	-1.1178450667609225	PARD3;CNKSR3;GEMIN5;MITF;OTX2
pyroptosome complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8435063365291112	-1.119791211716772	PARD3;CNKSR3;GEMIN5;MITF;OTX2
regulation of Ras protein signal transduction	3/134	0.83239989549739779040038456514594145119190216064453125	0.95232362528770930776289560526493005454540252685546875	0.60126450832151245862178257084451615810394287109375	0.7095733514517323925474556745029985904693603515625	6.104892542573275	-1.1198955903504693	ARHGAP10;ABR;SRGAP2
ciliary necklace assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8438739492732203	-1.1202792335636054	PARD3;CNKSR3;GEMIN5;MITF;OTX2
negative regulation of peptidyl-serine phosphorylation	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.487947779469028	-1.1230654963818003	CNKSR3
lung development	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.3759300482038296	-1.1247961107073756	NKX2-1;PHOX2B;FGFR2
enzyme active site formation via O-phospho-L-serine	3/134	0.83239989549739779040038456514594145119190216064453125	0.95232362528770930776289560526493005454540252685546875	0.60126450832151245862178257084451615810394287109375	0.7095733514517323925474556745029985904693603515625	6.145505486485632	-1.1273457225979122	PRKCH;CAB39;TNKS
ankyrin repeat-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8495209365268471	-1.1277758538324083	PARD3;CNKSR3;GEMIN5;MITF;OTX2
histone H2A SQE motif phosphorylation	3/134	0.83239989549739779040038456514594145119190216064453125	0.95232362528770930776289560526493005454540252685546875	0.60126450832151245862178257084451615810394287109375	0.7095733514517323925474556745029985904693603515625	6.14825772308654	-1.127850599237667	PRKCH;CAB39;TNKS
glucose import in response to insulin stimulus	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.52710015295033	-1.1282458628143863	ZFP36L1
Wnt signalosome assembly	5/104	0.271563866068516623908379870044882409274578094482421875	0.73858861214153648244717942361603491008281707763671875	0.1005507523928037827420922667442937381565570831298828125	0.4226564265451748791946329220081679522991180419921875	0.8656978811842277	-1.1284873407142817	PARD3;CNKSR3;GEMIN5;MITF;OTX2
phospholipid biosynthetic process	1/62	0.88024367399318681481901194274541921913623809814453125	0.9820504754555019477635369185009039938449859619140625	0.763559407677272705683435560786165297031402587890625	0.838386807731307026614331334712915122509002685546875	8.84877374303795	-1.1287186749855502	AGPAT3
positive regulation of gene silencing by miRNA	1/61	0.876066778173395288575875383685342967510223388671875	0.979243363185759552180797982146032154560089111328125	0.75807204920395288016976564904325641691684722900390625	0.833525840581595733880249099456705152988433837890625	8.558013730111366	-1.1323361297176855	STAT3
gamma-tubulin complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8530444033711315	-1.1324534087435432	PARD3;CNKSR3;GEMIN5;MITF;OTX2
regulation of mating-type specific transcription, DNA-templated	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1672475119696686	-1.1336528725488597	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of transcription during mitotic cell cycle	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1688044114872873	-1.135164962823047	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
positive regulation of tendon cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.3796399261621018	-1.1358961978608269	DLX1;DLX2;JUND
regulation of bundle of His cell action potential	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	7.984942343248568	-1.1370808727423578	ATP2A2
ESCRT complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.856547354356503	-1.1371037279629983	PARD3;CNKSR3;GEMIN5;MITF;OTX2
regulation of transcription from mitochondrial promoter	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1717733129003534	-1.138048416058734	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
LRR domain-mediated complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8583146511827051	-1.1394498910785231	PARD3;CNKSR3;GEMIN5;MITF;OTX2
regulation of cell communication by electrical coupling involved in cardiac conduction	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	8.30690046007275	-1.140196767490302	ATP2A2
RNA catabolic process	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	8.307759926132675	-1.1403147369336586	RBFOX2
regulation of transcription by pheromones	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1747556110559048	-1.1409448804642421	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
telomere maintenance via recombination	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	8.314120457982469	-1.1411877771114616	TOP2B
TCR signalosome assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8607335773707862	-1.1426611204076953	PARD3;CNKSR3;GEMIN5;MITF;OTX2
chromatin organization involved in regulation of transcription	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1770911309024272	-1.1432131815364261	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
heterotrimeric G-protein complex assembly	5/103	0.265127793131970712625644637228106148540973663330078125	0.73858861214153648244717942361603491008281707763671875	0.0976342524384704313344940374008729122579097747802734375	0.416402141728991870284204424024210311472415924072265625	0.8632707547799485	-1.1460293333567966	PARD3;CNKSR3;GEMIN5;MITF;OTX2
regulation of transcription by galactose	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1804614869890817	-1.1464865351482072	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of transcription by carbon monoxide	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1826513749619858	-1.148613395788804	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
vitamin A metabolic process	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	8.372862602269523	-1.1492506645089304	SDC3
regulation of transcription from RNA polymerase V promoter	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1845909743397522	-1.1504971714093566	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of antisense RNA transcription	17/460	0.378621246214117024297962643686332739889621734619140625	0.76643914967559323425660977591178379952907562255859375	0.042972229838841975724239574674356845207512378692626953125	0.259197548393503007790883430061512626707553863525390625	1.1881288899810059	-1.1539332620314515	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of AV node cell action potential	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	8.10680634080056	-1.1544346888045933	ATP2A2
positive regulation of mesodermal cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.38696756468687976	-1.1578207536464578	DLX1;DLX2;JUND
negative regulation of small GTPase mediated signal transduction	3/132	0.82475455340194259168384860458900220692157745361328125	0.94615364397168788546110818060697056353092193603515625	0.5912688422952594446968532793107442557811737060546875	0.70252270254577797725659138450282625854015350341796875	6.027208335558434	-1.1612589026349667	ARHGAP10;ABR;SRGAP2
anaphase-promoting complex-dependent catabolic process	5/201	0.8094573489738585703179296615417115390300750732421875	0.93696698390411448098546998153324238955974578857421875	0.498602660507613315576946888540987856686115264892578125	0.66176385751671695789610794236068613827228546142578125	5.512290624026043	-1.1652497042059125	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
positive regulation of synergid differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.39154107877597205	-1.1715048709024616	DLX1;DLX2;JUND
endosome to plasma membrane protein transport	5/203	0.8161507816766242484618487651459872722625732421875	0.94034763975784974032734453430748544633388519287109375	0.5071406480668898542063516288180835545063018798828125	0.662886382214889380293243448249995708465576171875	5.768369574894365	-1.1718798101134542	DLG1;FCHO2;RAPGEF2;TBC1D9;ANK3
positive regulation of MAPK cascade	8/194	0.32832869960865396219418244072585366666316986083984375	0.75121918332311110599874837134848348796367645263671875	0.0877410155615118980687583416511188261210918426513671875	0.40417418984731601216964236300555057823657989501953125	1.0523839425132069	-1.1720821336457217	ERBB4;GDF2;LPAR1;ARRB1;EFNA5;GDF5;FGFR2;ACVR2A
neurexin clustering involved in presynaptic membrane assembly	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.3922594925420038	-1.173654390510623	DLG1;NLGN2;MAGI2
chondroitin sulfate biosynthetic process	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	8.249741812311974	-1.1747891489503777	SDC3
regulation of synaptic vesicle fusion to presynaptic active zone membrane	1/60	0.8717444237722269395618468479369767010211944580078125	0.976726471955723152262862640782259404659271240234375	0.75245776487875126736781794534181244671344757080078125	0.8296735102695347308099371730349957942962646484375	8.59450062768909	-1.1796724760318906	TBC1D9
positive regulation of cell differentiation involved in phenotypic switching	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.39570056660711256	-1.1839502068295988	DLX1;DLX2;JUND
ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome	5/200	0.8060386596784689938743895254447124898433685302734375	0.93447903733788384439407082027173601090908050537109375	0.494312912980729934897539123994647525250911712646484375	0.6596842167393817124576571586658246815204620361328125	5.497252884390874	-1.1853373073204545	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
retinoid metabolic process	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	8.376246202134759	-1.1928037714488178	SDC3
regulation of Purkinje myocyte action potential	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.119405306190364	-1.1996780619199565	ATP2A2
positive regulation of embryo sac central cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.40263477588555635	-1.204697608279657	DLX1;DLX2;JUND
negative regulation of chaperone-mediated autophagy	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.158032596534165	-1.2053854149919283	LARS
regulation of apoptotic signaling pathway	4/167	0.81653719876883157358093967559398151934146881103515625	0.9405631176050253117182364803738892078399658203125	0.54195579914685365618964851819328032433986663818359375	0.67870599887879190514894389707478694617748260498046875	5.9536885706915275	-1.2067103222211724	ALK;GDF2;BRCA1;GDF5
post-Golgi vesicle-mediated transport	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4048649422344474	-1.2113703455281117	RABIF;CUX1;GBF1
regulation of SA node cell action potential	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.201131340815271	-1.2117534451690795	ATP2A2
positive regulation of bone mineralization	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.7358060186808066	-1.2147674268352489	MEF2C;PKDCC;ACVR2A
positive regulation of myofibroblast differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.40649381976549903	-1.2162440051903267	DLX1;DLX2;JUND
negative regulation of peptidyl-tyrosine phosphorylation	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	8.545501952240016	-1.2169063219461391	EFNA1
ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome	5/198	0.79905569492348160753891761487466283142566680908203125	0.93068914004334868383949697090429253876209259033203125	0.48569380631980241247447338537313044071197509765625	0.6544886417454132132576205549412406980991363525390625	5.430208160983926	-1.2181294357679366	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
double-strand break repair	4/164	0.8054515862153086569463766863918863236904144287109375	0.93447903733788384439407082027173601090908050537109375	0.52795746471774318564484929083846509456634521484375	0.6724669267087850510478119758772663772106170654296875	5.659898240069637	-1.2245313351964602	EYA1;PDS5B;BRCA1;PDS5A
regulation of small GTPase mediated signal transduction	3/130	0.81681335620141559683560217308695428073406219482421875	0.94065151396535096051110258486005477607250213623046875	0.58111370238804427312828693175106309354305267333984375	0.6974292378601434361229394198744557797908782958984375	6.056365293784002	-1.2254731786455297	ARHGAP10;ABR;SRGAP2
negative regulation of distal tip cell migration	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9115852686931181	-1.2298781470790574	CITED2;MAGI2;NKX2-1;ROBO1
positive regulation of plant epidermal cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4114466892258293	-1.2310631672457106	DLX1;DLX2;JUND
negative regulation of cell migration in other organism	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9145062072566433	-1.2338189726184943	CITED2;MAGI2;NKX2-1;ROBO1
regulation of lamellipodium morphogenesis	3/24	0.0452561295785736950048061544293886981904506683349609375	0.3377739924400824378381003043614327907562255859375	0.0223354279530613465676314177699168794788420200347900390625	0.171589924518876835168867955871974118053913116455078125	0.39885553586393285	-1.2346242691608933	ARC;PHIP;EFNA5
negative regulation of hematopoietic stem cell migration	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9171210022711607	-1.2373467602626018	CITED2;MAGI2;NKX2-1;ROBO1
negative regulation of dendrite extension	6/137	0.31333395084124482377063714011455886065959930419921875	0.73996546891932102330002862800029106438159942626953125	0.10525094919461321085751848158906796015799045562744140625	0.43626425953514103017738534617819823324680328369140625	1.0666884518788018	-1.2378767178203811	SEMA3A;GDF2;LPAR1;STMN2;APBB2;MSX1
cellular response to hypoxia	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.391615251175631	-1.239898285805847	ZFP36L1
mRNA catabolic process	3/132	0.82475455340194259168384860458900220692157745361328125	0.94615364397168788546110818060697056353092193603515625	0.5912688422952594446968532793107442557811737060546875	0.70252270254577797725659138450282625854015350341796875	6.43893691110776	-1.2405864199874208	MEF2C;CITED2;ID2
neuromast deposition	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9215440195236884	-1.2433141364915268	CITED2;MAGI2;NKX2-1;ROBO1
bicellular tight junction assembly	3/47	0.2092457357834389408690611844576778821647167205810546875	0.73858861214153648244717942361603491008281707763671875	0.1030606939961578316644619235376012511551380157470703125	0.42793775843298986760743218837887980043888092041015625	0.7952057603036361	-1.2438973886945066	DLG1;PARD3;TLN2
negative regulation of mesenchymal stem cell migration	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9251388665203032	-1.248164175116622	CITED2;MAGI2;NKX2-1;ROBO1
modulation by symbiont of host small GTPase mediated signal transduction	3/129	0.8127294675269365331615745162707753479480743408203125	0.93696698390411448098546998153324238955974578857421875	0.575977002393993853246456637862138450145721435546875	0.6974292378601434361229394198744557797908782958984375	6.022349043098293	-1.2487761286321597	ARHGAP10;ABR;SRGAP2
hematopoietic progenitor cell differentiation	3/47	0.2092457357834389408690611844576778821647167205810546875	0.73858861214153648244717942361603491008281707763671875	0.1030606939961578316644619235376012511551380157470703125	0.42793775843298986760743218837887980043888092041015625	0.7991705599280826	-1.250099310443241	KIRREL3;TAL1;FST
negative regulation of metanephric mesenchymal cell migration	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9267242665202554	-1.2503031399302107	CITED2;MAGI2;NKX2-1;ROBO1
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.17121437245779	-1.2528297984562733	GDF2
positive regulation of leukocyte differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.41884381274980714	-1.2531956246269336	DLX1;DLX2;JUND
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	3/129	0.8127294675269365331615745162707753479480743408203125	0.93696698390411448098546998153324238955974578857421875	0.575977002393993853246456637862138450145721435546875	0.6974292378601434361229394198744557797908782958984375	6.043750577354628	-1.2532138862088387	RBFOX2;LPAR1;FGFR2
negative regulation of neuroblast migration	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9290427566400014	-1.2534311636383846	CITED2;MAGI2;NKX2-1;ROBO1
negative regulation of formation of radial glial scaffolds	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9313573788262252	-1.2565539688693885	CITED2;MAGI2;NKX2-1;ROBO1
Ran protein signal transduction	1/59	0.86727155302322689323091253754682838916778564453125	0.97426051812587799449971726062358357012271881103515625	0.746713628700379050684432513662613928318023681640625	0.82526902216018938052144449102343060076236724853515625	8.832114186236808	-1.2577208044010144	GRAP2
regulation of vesicle fusion	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.525017799257048	-1.2596091025839526	TBC1D9
negative regulation of glial cell migration	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9348724813235944	-1.2612964190764386	CITED2;MAGI2;NKX2-1;ROBO1
positive regulation of embryo sac egg cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4238963702873858	-1.2683130569645378	DLX1;DLX2;JUND
histone dephosphorylation	2/92	0.81972264655709248248882659027003683149814605712890625	0.9419322104286980135157136828638613224029541015625	0.63033413195404974782576346115092746913433074951171875	0.73143569506205474706206359769566915929317474365234375	6.383347246048339	-1.2689406956385825	EYA1;PTPN21
cardiac muscle contraction	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.30060394032997	-1.2726681112027896	GPX1
positive regulation of cardiocyte differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4286263386676966	-1.282465291039367	DLX1;DLX2;JUND
positive regulation of transdifferentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4286430357242338	-1.2825152492279797	DLX1;DLX2;JUND
positive regulation of cell development	3/26	0.05536339021525253645261699375623720698058605194091796875	0.388037312994570948720962633160525001585483551025390625	0.026999589455807992965929997808416374027729034423828125	0.18998313577565217880049885934568010270595550537109375	0.4432246027794112	-1.2826196352116592	DLX1;DLX2;JUND
positive regulation of vascular wound healing	2/92	0.81972264655709248248882659027003683149814605712890625	0.9419322104286980135157136828638613224029541015625	0.63033413195404974782576346115092746913433074951171875	0.73143569506205474706206359769566915929317474365234375	6.47120506044916	-1.2864058830748573	GDF2;BRCA1
skeletal muscle tissue development	3/20	0.0281227247744543253082927236619070754386484622955322265625	0.24861344939594920422365476042614318430423736572265625	0.01444613043666434330780656836168418521992862224578857421875	0.123895267763173999586712170639657415449619293212890625	0.36025503423827837	-1.2865346071969588	SVIL;MEF2C;SIX1
synaptic transmission, cholinergic	8/200	0.35867563451832518151007889173342846333980560302734375	0.76035323823870781811962160645634867250919342041015625	0.0995856398982648827189478879517992027103900909423828125	0.4226564265451748791946329220081679522991180419921875	1.2582951113174696	-1.2901763130139772	SLC6A5;CACNB1;GRIA1;DLG1;NRXN2;APBA1;PDE7B;SLC1A6
ATP-dependent chromatin remodeling	4/75	0.2446976210302328202939037282703793607652187347412109375	0.73858861214153648244717942361603491008281707763671875	0.103301528598319813934125477317138575017452239990234375	0.428560519259696182103880346403457224369049072265625	0.9167647259635816	-1.2905590692319253	PBRM1;MYB;DEK;BAZ1A
astrocyte chemotaxis	3/47	0.2092457357834389408690611844576778821647167205810546875	0.73858861214153648244717942361603491008281707763671875	0.1030606939961578316644619235376012511551380157470703125	0.42793775843298986760743218837887980043888092041015625	0.825216131213833	-1.2908409898005824	PDGFRA;LPAR1;ELMO2
DNA replication initiation	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.425005036858815	-1.2917415797948386	BAZ1A
androgen receptor signaling pathway	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.7843647607629942	-1.2949347218450011	DDX17;CTNNB1;BRCA1
ubiquitin-dependent protein catabolic process via the N-end rule pathway	5/195	0.7882126414963861460449834339669905602931976318359375	0.925796571199814177788312008487991988658905029296875	0.472672042811925263716688050408265553414821624755859375	0.6505106321718450157476354434038512408733367919921875	5.442971895930655	-1.2953585986775495	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
regulation of cell morphogenesis involved in differentiation	3/23	0.040581278480883477277618709422313258983194828033447265625	0.317976562449048760772285504572209902107715606689453125	0.0201834231087742767274395561116762110032141208648681640625	0.1578978711498744968988461323533556424081325531005859375	0.4046217859529184	-1.2965896507399124	ARC;PHIP;EFNA5
positive regulation of transcription factor import into nucleus in response to oxidative stress	2/92	0.81972264655709248248882659027003683149814605712890625	0.9419322104286980135157136828638613224029541015625	0.63033413195404974782576346115092746913433074951171875	0.73143569506205474706206359769566915929317474365234375	6.527117357504113	-1.2975206456570723	GPX1;TXNRD1
postreplication repair	3/128	0.80856881775633837605710141360759735107421875	0.936645165362634646299966334481723606586456298828125	0.57080128120855289086676975784939713776111602783203125	0.69640654405878665844653596650459803640842437744140625	6.118744801587985	-1.300168936439283	PDS5B;BRCA1;PDS5A
negative regulation of mitotic cell cycle	4/77	0.2594570420712998259915593735058791935443878173828125	0.73858861214153648244717942361603491008281707763671875	0.11059209003849439223454709235738846473395824432373046875	0.448163993738469101923982407242874614894390106201171875	0.9683475972187403	-1.3064598447309603	CYLD;DLG1;GBF1;GATA3
negative regulation of cell cycle arrest	3/46	0.20051318704746334820043784930021502077579498291015625	0.73858861214153648244717942361603491008281707763671875	0.0984382144907550438173160500809899531304836273193359375	0.41907315681668910745116818361566402018070220947265625	0.8131413209693042	-1.3066166744668672	CITED2;PHOX2B;FGFR2
negative regulation of phosphatase activity	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.865465288781325	-1.309911725622934	SLC7A14
positive regulation of vesicle fusion	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.556695091663423	-1.3119326086063772	TBC1D9
muscle cell chemotaxis toward tendon cell	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.7948628331105186	-1.3122663500303702	PDGFRA;LPAR1;ELMO2
cell chemotaxis	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.7964265735319614	-1.3148479827973867	PDGFRA;LPAR1;ELMO2
transcription factor catabolic process	5/194	0.78449882857115227352551301009953022003173828125	0.92313651971084154101987451213062740862369537353515625	0.468308263123583368159330575508647598326206207275390625	0.6505106321718450157476354434038512408733367919921875	5.420144458880508	-1.3155243457917845	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
colon epithelial cell chemotaxis	3/46	0.20051318704746334820043784930021502077579498291015625	0.73858861214153648244717942361603491008281707763671875	0.0984382144907550438173160500809899531304836273193359375	0.41907315681668910745116818361566402018070220947265625	0.8202563570330138	-1.3180496499171788	PDGFRA;LPAR1;ELMO2
Schwann cell chemotaxis	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.7984458578643902	-1.3181816886522952	PDGFRA;LPAR1;ELMO2
regulation of cell morphogenesis involved in conjugation with cellular fusion	3/23	0.040581278480883477277618709422313258983194828033447265625	0.317976562449048760772285504572209902107715606689453125	0.0201834231087742767274395561116762110032141208648681640625	0.1578978711498744968988461323533556424081325531005859375	0.41325486647684245	-1.3242539121561936	ARC;PHIP;EFNA5
Rab protein signal transduction	1/58	0.86264293251712864663005575494025833904743194580078125	0.97137424509030700914280487268115393817424774169921875	0.74083664735870424777886000811122357845306396484375	0.8203113768992975618488117106608115136623382568359375	8.963128889272967	-1.324341954751736	GRAP2
negative regulation of axon extension	3/127	0.8043304929055665741799430179526098072528839111328125	0.93447903733788384439407082027173601090908050537109375	0.56558686381295142364677985824528150260448455810546875	0.693855198076902990322878395090810954570770263671875	6.097703035706748	-1.3277445514031814	GDF2;APBB2;MSX1
regulation of intrinsic apoptotic signaling pathway by p53 class mediator	3/127	0.8043304929055665741799430179526098072528839111328125	0.93447903733788384439407082027173601090908050537109375	0.56558686381295142364677985824528150260448455810546875	0.693855198076902990322878395090810954570770263671875	6.098181937628603	-1.327848829918169	CYLD;PRKAG1;BRCA1
mitochondria-associated ubiquitin-dependent protein catabolic process	5/193	0.78073483011304534162633217420079745352268218994140625	0.921372577844191908980064908973872661590576171875	0.4639335922447986870764680134016089141368865966796875	0.6470652733940613909879857601481489837169647216796875	5.373360614515519	-1.3300126766030744	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
positive regulation of sporulation resulting in formation of a cellular spore	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.44457505251885954	-1.330184411647801	DLX1;DLX2;JUND
negative regulation of cardiac conduction	1/56	0.85289659466011158439613382142852060496807098388671875	0.96500677308988869196326731980661861598491668701171875	0.72867183094483289895748612252646125853061676025390625	0.810074246185900737060592291527427732944488525390625	8.37113381935953	-1.3319894012969111	ATP2A2
fibroblast chemotaxis	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.8072696035350091	-1.3327491134235192	PDGFRA;LPAR1;ELMO2
ribosome-associated ubiquitin-dependent protein catabolic process	5/192	0.7769203910120781042536464156000874936580657958984375	0.9190216065753202823174206059775315225124359130859375	0.459548464896196662277105815519462339580059051513671875	0.643478477306171470218032482080161571502685546875	5.281731916209484	-1.3332009888432652	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
protein denaturation involved in proteasomal ubiquitin-dependent protein catabolic process	5/192	0.7769203910120781042536464156000874936580657958984375	0.9190216065753202823174206059775315225124359130859375	0.459548464896196662277105815519462339580059051513671875	0.643478477306171470218032482080161571502685546875	5.284777806160218	-1.3339698244370908	BTBD3;CTNNB1;BTBD11;ARRB1;TBL1X
positive regulation of antipodal cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4464266320696463	-1.3357244036951008	DLX1;DLX2;JUND
cell chemotaxis to angiotensin	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.810124203612468	-1.3374618707300652	PDGFRA;LPAR1;ELMO2
cell chemotaxis involved in Malpighian tubule morphogenesis	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.8114582311831787	-1.339664262662527	PDGFRA;LPAR1;ELMO2
BMP signaling pathway involved in nephric duct formation	4/76	0.252054559470577921320710856889490969479084014892578125	0.73858861214153648244717942361603491008281707763671875	0.1069184660612136628099477775322156958281993865966796875	0.44239860036030254075711809491622261703014373779296875	0.9727918999191674	-1.3406139621823743	USP9X;GDF2;GATA3;ACVR2A
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter	2/92	0.81972264655709248248882659027003683149814605712890625	0.9419322104286980135157136828638613224029541015625	0.63033413195404974782576346115092746913433074951171875	0.73143569506205474706206359769566915929317474365234375	6.780597631883771	-1.3479097946887348	ELP4;MLLT3
regulation of chromatin-mediated maintenance of transcription	17/462	0.385419824468075822299084620681242085993289947509765625	0.77355606841369339843339503204333595931529998779296875	0.044392591567682847253362155015565804205834865570068359375	0.261423039231910070423481329271453432738780975341796875	1.414881349351534	-1.3489791270357099	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
positive regulation of NF-kappaB transcription factor activity by ER overload response	3/127	0.8043304929055665741799430179526098072528839111328125	0.93447903733788384439407082027173601090908050537109375	0.56558686381295142364677985824528150260448455810546875	0.693855198076902990322878395090810954570770263671875	6.201737338814607	-1.3503975042120708	ALK;PRKCH;TRIM37
negative regulation of vessel branching	3/47	0.2092457357834389408690611844576778821647167205810546875	0.73858861214153648244717942361603491008281707763671875	0.1030606939961578316644619235376012511551380157470703125	0.42793775843298986760743218837887980043888092041015625	0.8639611066594552	-1.3514476606620207	GDF2;CTNNB1;SEMA3E
skeletal muscle cell differentiation	3/22	0.0361650430262040745166274291477748192846775054931640625	0.29111008183379627478615248037385754287242889404296875	0.018151441429829738571921637912964797578752040863037109375	0.1489049551730554366013592471063020639121532440185546875	0.40764413526994503	-1.3532408631722206	SVIL;MEF2C;SIX1
sphingomyelin biosynthetic process	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.82692528880816	-1.3533649377552461	AGPAT3
positive regulation of receptor internalization	3/45	0.191870551725404847598355217996868304908275604248046875	0.73858861214153648244717942361603491008281707763671875	0.0939026393089793243174057124633691273629665374755859375	0.415100284076937831034825876486138440668582916259765625	0.8204517983375227	-1.3545120515535987	MAGI2;ARRB1;LDLRAP1
positive regulation of sorocarp spore cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4552557913230566	-1.362141563048288	DLX1;DLX2;JUND
positive regulation of phosphatidylinositol 3-kinase signaling	3/126	0.80001359015589501577636610818444751203060150146484375	0.93068914004334868383949697090429253876209259033203125	0.5603340964981009530987421385361813008785247802734375	0.68963337723497775133552067927666939795017242431640625	6.1160721117732635	-1.3646581540305378	PDGFRA;ERBB4;FGFR2
ciliary receptor clustering involved in smoothened signaling pathway	3/47	0.2092457357834389408690611844576778821647167205810546875	0.73858861214153648244717942361603491008281707763671875	0.1030606939961578316644619235376012511551380157470703125	0.42793775843298986760743218837887980043888092041015625	0.8729974073292485	-1.3655826573732144	DLG1;PTCH1;MAGI2
cellular process regulating host cell cycle in response to virus	4/76	0.252054559470577921320710856889490969479084014892578125	0.73858861214153648244717942361603491008281707763671875	0.1069184660612136628099477775322156958281993865966796875	0.44239860036030254075711809491622261703014373779296875	0.9938076164755565	-1.369575925211778	JUND;MECOM;GBF1;STAT3
regulation of DNA-templated transcription, termination	17/461	0.382018451094280397928315551325795240700244903564453125	0.7687632396807682066963707256945781409740447998046875	0.043678258089639744599086412790711619891226291656494140625	0.259197548393503007790883430061512626707553863525390625	1.4254052491673237	-1.3716480433538183	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of transcription by glucose	17/461	0.382018451094280397928315551325795240700244903564453125	0.7687632396807682066963707256945781409740447998046875	0.043678258089639744599086412790711619891226291656494140625	0.259197548393503007790883430061512626707553863525390625	1.4254601476695523	-1.3717008714342598	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
Ral protein signal transduction	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.974699644621568	-1.3760220494123265	GRAP2
Golgi to vacuole transport	3/24	0.0452561295785736950048061544293886981904506683349609375	0.3377739924400824378381003043614327907562255859375	0.0223354279530613465676314177699168794788420200347900390625	0.171589924518876835168867955871974118053913116455078125	0.44460813279002354	-1.376247642695711	RABIF;GBF1;VTI1A
ARF protein signal transduction	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	8.992928653724817	-1.3788169639452093	GRAP2
positive regulation of cardiac conduction	1/55	0.84776747678344810399408970624790526926517486572265625	0.96150978311794299546733100214623846113681793212890625	0.7223776591701842608728156847064383327960968017578125	0.80478399109725062832154662828543223440647125244140625	8.352743209734706	-1.3794462085406476	ATP2A2
negative regulation of epithelial cell proliferation	8/302	0.799419403076537360419706601533107459545135498046875	0.93068914004334868383949697090429253876209259033203125	0.4011099236802611045504818321205675601959228515625	0.60493277589116190018359020541538484394550323486328125	6.170160806900179	-1.3813111908301992	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B;GDF5
negative regulation of cytoplasmic translation	1/55	0.84776747678344810399408970624790526926517486572265625	0.96150978311794299546733100214623846113681793212890625	0.7223776591701842608728156847064383327960968017578125	0.80478399109725062832154662828543223440647125244140625	8.365756528575195	-1.381595343607331	LIN28A
regulation of cysteine-type endopeptidase activity involved in apoptotic process	4/161	0.7938281409497343066306029868428595364093780517578125	0.92846202352092654930260096080019138753414154052734375	0.5137560415909379063492679051705636084079742431640625	0.66781052522122108516811067602247931063175201416015625	5.98639083969485	-1.3821875342494487	ALK;GDF2;BRCA1;GDF5
regulation of cell morphogenesis	3/24	0.0452561295785736950048061544293886981904506683349609375	0.3377739924400824378381003043614327907562255859375	0.0223354279530613465676314177699168794788420200347900390625	0.171589924518876835168867955871974118053913116455078125	0.4466253637474008	-1.3824918140122406	ARC;PHIP;EFNA5
regulation of chromatin silencing	17/465	0.39564629761695158105538894233177416026592254638671875	0.77355606841369339843339503204333595931529998779296875	0.04658586278846026107469668886551517061889171600341796875	0.2722992748118551187275215852423571050167083740234375	1.491176438942297	-1.3826704704498565	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
positive regulation of sclerenchyma cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.4627321780231729	-1.3845111786792141	DLX1;DLX2;JUND
negative regulation of JUN kinase activity	1/57	0.8578531473805188767300933250226080417633056640625	0.9678290591231542006056542959413491189479827880859375	0.73482375889924111955764374215505085885524749755859375	0.815184306379990619717545996536500751972198486328125	9.050958664343504	-1.3877142616042788	MECOM
regulation of DNA-templated transcription in response to stress	17/465	0.39564629761695158105538894233177416026592254638671875	0.77355606841369339843339503204333595931529998779296875	0.04658586278846026107469668886551517061889171600341796875	0.2722992748118551187275215852423571050167083740234375	1.499186232509928	-1.3900974286227057	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
negative regulation of mitochondrial translation	1/55	0.84776747678344810399408970624790526926517486572265625	0.96150978311794299546733100214623846113681793212890625	0.7223776591701842608728156847064383327960968017578125	0.80478399109725062832154662828543223440647125244140625	8.41773756304086	-1.3901799533707575	LIN28A
regulation of actin cytoskeleton organization	1/56	0.85289659466011158439613382142852060496807098388671875	0.96500677308988869196326731980661861598491668701171875	0.72867183094483289895748612252646125853061676025390625	0.810074246185900737060592291527427732944488525390625	8.743756470205078	-1.3912799863382816	EFNA5
cytoskeletal rearrangement involved in phagocytosis, engulfment	4/155	0.76891599421175527151461892572115175426006317138671875	0.9190216065753202823174206059775315225124359130859375	0.484791262467401617985984785264008678495883941650390625	0.65448207929557333795145268595661036670207977294921875	5.297493845653656	-1.392041294335594	ARC;ELMO1;MICAL3;PHIP
regulation of transcription from RNA polymerase I promoter	17/466	0.399061688373425094145119373933994211256504058837890625	0.77355606841369339843339503204333595931529998779296875	0.047333854058688562549406242396798916161060333251953125	0.274629507496720715042926030946546234190464019775390625	1.5176626808038276	-1.3941845320255228	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
Golgi vesicle fusion to target membrane	1/55	0.84776747678344810399408970624790526926517486572265625	0.96150978311794299546733100214623846113681793212890625	0.7223776591701842608728156847064383327960968017578125	0.80478399109725062832154662828543223440647125244140625	8.472733139606833	-1.3992624113938918	CUX1
DNA-templated transcription, initiation	2/90	0.81012431627836445358070704969577491283416748046875	0.93696698390411448098546998153324238955974578857421875	0.618626392332021879383319173939526081085205078125	0.72068676034333101210194172381306998431682586669921875	6.667553239489074	-1.4039704581825136	LDB1;BAZ1A
positive regulation of sorocarp stalk cell differentiation	3/25	0.050185172613900839999612202291245921514928340911865234375	0.358122330414368528206381370182498358190059661865234375	0.024607528860034692808067546820893767289817333221435546875	0.1758692630799752187886753063139622099697589874267578125	0.470671475578873	-1.408265840098453	DLX1;DLX2;JUND
nitrogen catabolite regulation of transcription	17/464	0.392234013289692595716218193047097884118556976318359375	0.77355606841369339843339503204333595931529998779296875	0.04584635047897260562432819597233901731669902801513671875	0.2693116254163310241409590162220411002635955810546875	1.5048240754226143	-1.4083598029482611	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
transcription from RNA polymerase III promoter	2/89	0.8051562859776935088262916906387545168399810791015625	0.93447903733788384439407082027173601090908050537109375	0.612666721804810077145475588622502982616424560546875	0.717999733354854452471727199736051261425018310546875	6.514521749428222	-1.4118198333987788	LDB1;BAZ1A
carbon catabolite regulation of transcription	17/464	0.392234013289692595716218193047097884118556976318359375	0.77355606841369339843339503204333595931529998779296875	0.04584635047897260562432819597233901731669902801513671875	0.2693116254163310241409590162220411002635955810546875	1.5089278916619544	-1.4122005507968425	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
neuropeptide signaling pathway	1/56	0.85289659466011158439613382142852060496807098388671875	0.96500677308988869196326731980661861598491668701171875	0.72867183094483289895748612252646125853061676025390625	0.810074246185900737060592291527427732944488525390625	8.879662996456567	-1.4129050202274083	RAPGEF2
protein import into nucleus	6/224	0.7676470894312557025074283956200815737247467041015625	0.9190216065753202823174206059775315225124359130859375	0.418488996690370596009955761473975144326686859130859375	0.614878345832392536607358124456368386745452880859375	5.343947220680537	-1.4130741545192504	STAT3;GEMIN5;TBC1D9;SIX1;PRICKLE1;MSX1
regulation of apoptosis by sphingosine-1-phosphate signaling pathway	4/159	0.78577381656408051835427386322407983243465423583984375	0.92316191599819863444764678206411190330982208251953125	0.50418126450432565466286405353457666933536529541015625	0.662886382214889380293243448249995708465576171875	5.863238552920887	-1.413546448583288	ALK;GDF2;BRCA1;GDF5
galanin-activated signaling pathway	1/56	0.85289659466011158439613382142852060496807098388671875	0.96500677308988869196326731980661861598491668701171875	0.72867183094483289895748612252646125853061676025390625	0.810074246185900737060592291527427732944488525390625	8.885807138220695	-1.4138826574133003	RAPGEF2
positive regulation of cell adhesion mediated by integrin	1/56	0.85289659466011158439613382142852060496807098388671875	0.96500677308988869196326731980661861598491668701171875	0.72867183094483289895748612252646125853061676025390625	0.810074246185900737060592291527427732944488525390625	8.91034780807302	-1.4177874943027102	EFNA1
positive regulation of peptidyl-serine phosphorylation	4/160	0.789831828628501764200109391822479665279388427734375	0.92631445441090065617828486210783012211322784423828125	0.5089790704814587396498382076970301568508148193359375	0.66432049680715021811039378007990308105945587158203125	6.0096667961127705	-1.4178921257931247	ERBB4;ARRB1;EFNA5;ACVR2A
negative regulation of protein binding	1/54	0.84245979513471869193352858928847126662731170654296875	0.958485975313668081554396849242039024829864501953125	0.71593796569589474021455544061609543859958648681640625	0.79911958925403114850638530697324313223361968994140625	8.344058222526671	-1.430416384018519	LDLRAP1
canonical Wnt signaling pathway involved in negative regulation of apoptotic process	10/371	0.8029840072781173621052630551275797188282012939453125	0.93384505974627207702809528200305067002773284912109375	0.358931919609571270513015406322665512561798095703125	0.57817199210730663150314967424492351710796356201171875	6.525562122526932	-1.4318419826583557	TCF7L2;FZD2;FZD5;CITED2;STAT3;FZD8;CTNNB1;PHIP;TBL1X;AATF
calcium ion import into cytosol	3/22	0.0361650430262040745166274291477748192846775054931640625	0.29111008183379627478615248037385754287242889404296875	0.018151441429829738571921637912964797578752040863037109375	0.1489049551730554366013592471063020639121532440185546875	0.43247099231292524	-1.435657644251256	TRPM1;CACNA1D;CACNA1C
positive regulation of calcium ion transport into cytosol	5/107	0.29106111088631958505601460274192504584789276123046875	0.73858861214153648244717942361603491008281707763671875	0.10955854452590320369242959941402659751474857330322265625	0.447822924201633776331021863370551727712154388427734375	1.1672094803923536	-1.4405956552733667	PDGFRA;LPAR1;CACNA1D;CACNA1C;TAC1
chondroblast differentiation	3/23	0.040581278480883477277618709422313258983194828033447265625	0.317976562449048760772285504572209902107715606689453125	0.0201834231087742767274395561116762110032141208648681640625	0.1578978711498744968988461323533556424081325531005859375	0.452143763193328	-1.4488713765681462	COL11A2;GDF2;GDF5
positive regulation of protein import into mitochondrial outer membrane	2/89	0.8051562859776935088262916906387545168399810791015625	0.93447903733788384439407082027173601090908050537109375	0.612666721804810077145475588622502982616424560546875	0.717999733354854452471727199736051261425018310546875	6.7084277572497415	-1.4538429255285468	FZD5;U2AF2
integrin activation	5/110	0.310793678944817741705008984354208223521709442138671875	0.73996546891932102330002862800029106438159942626953125	0.1189448302742308616331001758226193487644195556640625	0.46911602374878513810330105116008780896663665771484375	1.2521251012071974	-1.4632659469091875	PARD3;CNKSR3;GEMIN5;MITF;OTX2
pore complex assembly	5/107	0.29106111088631958505601460274192504584789276123046875	0.73858861214153648244717942361603491008281707763671875	0.10955854452590320369242959941402659751474857330322265625	0.447822924201633776331021863370551727712154388427734375	1.186337159776572	-1.4642034585676857	PARD3;CNKSR3;GEMIN5;MITF;OTX2
cellular response to retinoic acid	1/56	0.85289659466011158439613382142852060496807098388671875	0.96500677308988869196326731980661861598491668701171875	0.72867183094483289895748612252646125853061676025390625	0.810074246185900737060592291527427732944488525390625	9.206975674723994	-1.4649860199784879	WNT8B
neutrophil chemotaxis	1/55	0.84776747678344810399408970624790526926517486572265625	0.96150978311794299546733100214623846113681793212890625	0.7223776591701842608728156847064383327960968017578125	0.80478399109725062832154662828543223440647125244140625	8.872220641312412	-1.465237325951889	GBF1
protein deglycation	2/89	0.8051562859776935088262916906387545168399810791015625	0.93447903733788384439407082027173601090908050537109375	0.612666721804810077145475588622502982616424560546875	0.717999733354854452471727199736051261425018310546875	6.789387572247822	-1.4713884456632549	MSRA;ICMT
negative regulation of cell growth	4/155	0.76891599421175527151461892572115175426006317138671875	0.9190216065753202823174206059775315225124359130859375	0.484791262467401617985984785264008678495883941650390625	0.65448207929557333795145268595661036670207977294921875	5.609427734911698	-1.4740092715718793	GDF2;APBB2;MSX1;PAPPA2
cellular response to tumor necrosis factor	5/109	0.30419379518172939835807255803956650197505950927734375	0.73996546891932102330002862800029106438159942626953125	0.115774762868319058828348033785005100071430206298828125	0.4599593104434607226949083269573748111724853515625	1.239327108561699	-1.4749111661285828	AKAP6;GATA3;BRCA1;AFF3;ZFP36L1
protein lipidation	2/88	0.80007302583756179092944194053416140377521514892578125	0.93068914004334868383949697090429253876209259033203125	0.606636364142378869956928610918112099170684814453125	0.713798483429763930274702943279407918453216552734375	6.6159471643212155	-1.4757020542620105	MSRA;ICMT
JNK cascade	1/55	0.84776747678344810399408970624790526926517486572265625	0.96150978311794299546733100214623846113681793212890625	0.7223776591701842608728156847064383327960968017578125	0.80478399109725062832154662828543223440647125244140625	8.950088571139874	-1.4780971275608041	TRIB1
beta-catenin destruction complex assembly	5/107	0.29106111088631958505601460274192504584789276123046875	0.73858861214153648244717942361603491008281707763671875	0.10955854452590320369242959941402659751474857330322265625	0.447822924201633776331021863370551727712154388427734375	1.197755313602682	-1.478295995571076	PARD3;CNKSR3;GEMIN5;MITF;OTX2
microglia differentiation	5/110	0.310793678944817741705008984354208223521709442138671875	0.73996546891932102330002862800029106438159942626953125	0.1189448302742308616331001758226193487644195556640625	0.46911602374878513810330105116008780896663665771484375	1.2689812631525033	-1.4829644959969523	ROBO2;RCAN1;NFIB;PHOX2B;HAPLN1
regulation of cytoskeleton polarization involved in growth plate cartilage chondrocyte division	3/122	0.781942593737994684488512575626373291015625	0.9225670872091347174404063480324111878871917724609375	0.5389472229181111462281705826171673834323883056640625	0.67849080402499295505691634389222599565982818603515625	6.035505118195615	-1.4845770382335775	FZD2;FZD5;PRICKLE1
lagging strand elongation	1/54	0.84245979513471869193352858928847126662731170654296875	0.958485975313668081554396849242039024829864501953125	0.71593796569589474021455544061609543859958648681640625	0.79911958925403114850638530697324313223361968994140625	8.664985647184562	-1.4854327602312567	RBFOX2
positive regulation of vascular endothelial cell proliferation	1/54	0.84245979513471869193352858928847126662731170654296875	0.958485975313668081554396849242039024829864501953125	0.71593796569589474021455544061609543859958648681640625	0.79911958925403114850638530697324313223361968994140625	8.701435455015309	-1.4916813266871651	GDF2
ISG15-protein conjugation	2/88	0.80007302583756179092944194053416140377521514892578125	0.93068914004334868383949697090429253876209259033203125	0.606636364142378869956928610918112099170684814453125	0.713798483429763930274702943279407918453216552734375	6.699676058876323	-1.4943779745236465	MSRA;ICMT
N-terminal protein amino acid modification	2/88	0.80007302583756179092944194053416140377521514892578125	0.93068914004334868383949697090429253876209259033203125	0.606636364142378869956928610918112099170684814453125	0.713798483429763930274702943279407918453216552734375	6.737586714153616	-1.5028340323611127	MSRA;ICMT
regulation of anoikis	4/154	0.764543039152386416645867939223535358905792236328125	0.9190216065753202823174206059775315225124359130859375	0.47989658031657211889609015997848473489284515380859375	0.65448207929557333795145268595661036670207977294921875	5.603521260268645	-1.5044163424499386	ALK;GDF2;BRCA1;GDF5
regulation of apoptosis involved in tissue homeostasis	4/154	0.764543039152386416645867939223535358905792236328125	0.9190216065753202823174206059775315225124359130859375	0.47989658031657211889609015997848473489284515380859375	0.65448207929557333795145268595661036670207977294921875	5.61505893704131	-1.5075139428130842	ALK;GDF2;BRCA1;GDF5
regulation of fibroblast apoptotic process	4/154	0.764543039152386416645867939223535358905792236328125	0.9190216065753202823174206059775315225124359130859375	0.47989658031657211889609015997848473489284515380859375	0.65448207929557333795145268595661036670207977294921875	5.616253375286942	-1.5078346219598768	ALK;GDF2;BRCA1;GDF5
regulation of DNA-templated transcription, elongation	17/469	0.409323855223475641107455658129765652120113372802734375	0.7769671408471967577469285970437340438365936279296875	0.0496291202024294608730059508161502890288829803466796875	0.28069611510175029867042439946089871227741241455078125	1.6907255457224737	-1.5102382507137861	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
regulation of execution phase of apoptosis	4/154	0.764543039152386416645867939223535358905792236328125	0.9190216065753202823174206059775315225124359130859375	0.47989658031657211889609015997848473489284515380859375	0.65448207929557333795145268595661036670207977294921875	5.630154683878559	-1.5115668030037772	ALK;GDF2;BRCA1;GDF5
protein delipidation	2/88	0.80007302583756179092944194053416140377521514892578125	0.93068914004334868383949697090429253876209259033203125	0.606636364142378869956928610918112099170684814453125	0.713798483429763930274702943279407918453216552734375	6.780511931180331	-1.512408599595805	MSRA;ICMT
regulation of microtubule polymerization or depolymerization	3/16	0.01525296797031493352403419550000762683339416980743408203125	0.170331297404752779467429490978247486054897308349609375	0.00844616331510976252328060098761852714233100414276123046875	0.08466313717774200109378313072738819755613803863525390625	0.3631560776284694	-1.5190750358929712	CYLD;EFNA5;CLASP2
histone modification	2/88	0.80007302583756179092944194053416140377521514892578125	0.93068914004334868383949697090429253876209259033203125	0.606636364142378869956928610918112099170684814453125	0.713798483429763930274702943279407918453216552734375	6.821905247129363	-1.5216414728128285	MSRA;ICMT
maintenance of mitotic sister chromatid cohesion	3/12	0.006621004312468350451459375705098864273168146610260009765625	0.10787286952003131978994332484944607131183147430419921875	0.004239218550275117465553353923723989282734692096710205078125	0.04925220172819637365346778778985026292502880096435546875	0.3034865696258729	-1.5227463552408376	CHTF8;PDS5B;PDS5A
negative regulation of MAPK cascade	2/87	0.79487254385333294681714733087574131786823272705078125	0.92853238963748674361653456799103878438472747802734375	0.6005352446958884815586543481913395226001739501953125	0.70924505488996147928304480956285260617733001708984375	6.635752469552907	-1.5233929154404564	GDF2;GDF5
retrograde vesicle-mediated transport, Golgi to ER	2/86	0.7895528491843879503875314185279421508312225341796875	0.92621755523570203916250420661526732146739959716796875	0.5943633230061760031048834207467734813690185546875	0.70531114330066213558012577777844853699207305908203125	6.507378965423073	-1.537618863202996	CUX1;GBF1
regulation of compound eye retinal cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.611883439884937	-1.5393255114001376	ALK;GDF2;BRCA1;GDF5
regulation of fat cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.612951309723554	-1.539618425410745	ALK;GDF2;BRCA1;GDF5
regulation of apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.613924692792587	-1.539885421938128	ALK;GDF2;BRCA1;GDF5
regulation of myofibroblast cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.614657174713055	-1.5400863398864235	ALK;GDF2;BRCA1;GDF5
regulation of mesenchymal cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.621030829006383	-1.5418346172267607	ALK;GDF2;BRCA1;GDF5
regulation of glial cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.621438806374465	-1.5419465243925974	ALK;GDF2;BRCA1;GDF5
regulation of apoptotic process in bone marrow	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.6219573311760245	-1.542088754441365	ALK;GDF2;BRCA1;GDF5
integrin-mediated signaling pathway	1/54	0.84245979513471869193352858928847126662731170654296875	0.958485975313668081554396849242039024829864501953125	0.71593796569589474021455544061609543859958648681640625	0.79911958925403114850638530697324313223361968994140625	8.999529127106102	-1.5427833277949423	SEMA7A
regulation of leukocyte apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.627265635838549	-1.543544809057759	ALK;GDF2;BRCA1;GDF5
regulation of myeloid cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.628286995474308	-1.5438249654367144	ALK;GDF2;BRCA1;GDF5
co-translational protein modification	2/87	0.79487254385333294681714733087574131786823272705078125	0.92853238963748674361653456799103878438472747802734375	0.6005352446958884815586543481913395226001739501953125	0.70924505488996147928304480956285260617733001708984375	6.725259680564632	-1.5439413990919695	MSRA;ICMT
modulation of apoptotic process in other organism	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.629733159880659	-1.5442216446956871	ALK;GDF2;BRCA1;GDF5
regulation of muscle cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.631732343130403	-1.544770015632336	ALK;GDF2;BRCA1;GDF5
positive regulation of endothelial cell proliferation	2/86	0.7895528491843879503875314185279421508312225341796875	0.92621755523570203916250420661526732146739959716796875	0.5943633230061760031048834207467734813690185546875	0.70531114330066213558012577777844853699207305908203125	6.5400534570366275	-1.5453394700583096	GDF2;FGFR2
regulation of epithelial cell apoptotic process	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.635195185021325	-1.5457198644525658	ALK;GDF2;BRCA1;GDF5
regulation of apoptotic process involved in development	4/153	0.76010592182174374631387081535649485886096954345703125	0.9190216065753202823174206059775315225124359130859375	0.4749840792626827123967814259231090545654296875	0.65111883228191647088323179559665732085704803466796875	5.637651132079092	-1.5463935245528095	ALK;GDF2;BRCA1;GDF5
regulation of transcription, DNA-templated	19/529	0.415939028141309286024096536493743769824504852294921875	0.7769671408471967577469285970437340438365936279296875	0.04248012208176428494699194970962707884609699249267578125	0.259197548393503007790883430061512626707553863525390625	1.7679891258612992	-1.5509094035148345	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;PHOX2B;SCRT1;ZFP36L1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
nerve growth factor signaling pathway	3/12	0.006621004312468350451459375705098864273168146610260009765625	0.10787286952003131978994332484944607131183147430419921875	0.004239218550275117465553353923723989282734692096710205078125	0.04925220172819637365346778778985026292502880096435546875	0.3092329166822544	-1.5515786987835543	MAGI2;STMN2;RAPGEF2
negative regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis	4/78	0.26690136477796799763240187530755065381526947021484375	0.73858861214153648244717942361603491008281707763671875	0.11432148876536564474637458488359698094427585601806640625	0.4599593104434607226949083269573748111724853515625	1.1770640641492438	-1.5547558012638696	CITED2;MAGI2;NKX2-1;ROBO1
oxidative stress-induced premature senescence	2/86	0.7895528491843879503875314185279421508312225341796875	0.92621755523570203916250420661526732146739959716796875	0.5943633230061760031048834207467734813690185546875	0.70531114330066213558012577777844853699207305908203125	6.590418152570898	-1.557240068794676	GPX1;TXNRD1
negative regulation of collateral sprouting	3/120	0.772413168483211176607028392027132213115692138671875	0.9190216065753202823174206059775315225124359130859375	0.52803433002398791895615204339264892041683197021484375	0.6724669267087850510478119758772663772106170654296875	6.034215142670695	-1.558249649342151	GDF2;APBB2;MSX1
negative regulation of osteoblast proliferation	8/290	0.762315145967690011019612938980571925640106201171875	0.9190216065753202823174206059775315225124359130859375	0.359899246203237710428624041014700196683406829833984375	0.57817199210730663150314967424492351710796356201171875	5.745025301456158	-1.5591724711428427	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B;FGFR2
negative regulation of leukocyte migration	4/81	0.289448931456206481893644877345650456845760345458984375	0.73858861214153648244717942361603491008281707763671875	0.125834880796927894852643703416106291115283966064453125	0.482693649175157613040454407382640056312084197998046875	1.26369563067792	-1.5667000198228147	CITED2;MAGI2;NKX2-1;ROBO1
negative regulation of phosphatidate phosphatase activity	1/54	0.84245979513471869193352858928847126662731170654296875	0.958485975313668081554396849242039024829864501953125	0.71593796569589474021455544061609543859958648681640625	0.79911958925403114850638530697324313223361968994140625	9.145984660461318	-1.5678901030420156	SLC7A14
regulation of signal transduction by receptor internalization	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	8.19922072982195	-1.573303197494789	LDLRAP1
protein hydroxylation	2/87	0.79487254385333294681714733087574131786823272705078125	0.92853238963748674361653456799103878438472747802734375	0.6005352446958884815586543481913395226001739501953125	0.70924505488996147928304480956285260617733001708984375	6.857386346029396	-1.5742741800438418	MSRA;ICMT
protein sialylation	2/87	0.79487254385333294681714733087574131786823272705078125	0.92853238963748674361653456799103878438472747802734375	0.6005352446958884815586543481913395226001739501953125	0.70924505488996147928304480956285260617733001708984375	6.858850822394536	-1.574610385007743	MSRA;ICMT
regulation of autophagosome assembly	2/87	0.79487254385333294681714733087574131786823272705078125	0.92853238963748674361653456799103878438472747802734375	0.6005352446958884815586543481913395226001739501953125	0.70924505488996147928304480956285260617733001708984375	6.86180778226119	-1.5752892246318506	RHEB;PRKAG1
RNA phosphodiester bond hydrolysis	1/53	0.83696734288683327651625631915521807968616485595703125	0.95662102166154416860166520564234815537929534912109375	0.709349397325049313423050989513285458087921142578125	0.793079191083730261624396007391624152660369873046875	8.86094046223164	-1.5769835776588899	RBFOX2
stress-activated MAPK cascade	7/250	0.73915739778989231201222764866543002426624298095703125	0.911769206426496392481340080848895013332366943359375	0.36129993432625140403757768581272102892398834228515625	0.57817199210730663150314967424492351710796356201171875	5.219740479897607	-1.5776372938802135	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
RNA secondary structure unwinding	2/86	0.7895528491843879503875314185279421508312225341796875	0.92621755523570203916250420661526732146739959716796875	0.5943633230061760031048834207467734813690185546875	0.70531114330066213558012577777844853699207305908203125	6.699115982344613	-1.582924116755824	DDX17;RBFOX2
negative regulation of stem cell proliferation	8/288	0.7556813220284832599560331800603307783603668212890625	0.917988358487858757683852672926150262355804443359375	0.3530673596347801979078440126613713800907135009765625	0.57115553050993261852141813506023027002811431884765625	5.694414726760669	-1.5952078498263007	PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B;ZFP36L1
negative regulation of peptidyl-threonine phosphorylation	1/53	0.83696734288683327651625631915521807968616485595703125	0.95662102166154416860166520564234815537929534912109375	0.709349397325049313423050989513285458087921142578125	0.793079191083730261624396007391624152660369873046875	8.974159117416553	-1.5971331273226357	PARD3
negative regulation of fibroblast chemotaxis	4/79	0.274383861966334074988793645388795994222164154052734375	0.73858861214153648244717942361603491008281707763671875	0.1181057276250532250827518510050140321254730224609375	0.466977969159577621649503953449311666190624237060546875	1.235168643969801	-1.5973536831842403	CITED2;MAGI2;NKX2-1;ROBO1
mRNA export from nucleus	3/117	0.7574835419141419112776247857254929840564727783203125	0.9190216065753202823174206059775315225124359130859375	0.51140170040229915304763608219218440353870391845703125	0.6669288970963906937328147250809706747531890869140625	5.752076696162841	-1.5976592544764283	U2AF2;CDC40;ZFP36L1
negative regulation of muscle cell chemotaxis toward tendon cell	4/79	0.274383861966334074988793645388795994222164154052734375	0.73858861214153648244717942361603491008281707763671875	0.1181057276250532250827518510050140321254730224609375	0.466977969159577621649503953449311666190624237060546875	1.2367163420013993	-1.5993552083713474	CITED2;MAGI2;NKX2-1;ROBO1
protein de-ADP-ribosylation	2/86	0.7895528491843879503875314185279421508312225341796875	0.92621755523570203916250420661526732146739959716796875	0.5943633230061760031048834207467734813690185546875	0.70531114330066213558012577777844853699207305908203125	6.771902516237959	-1.6001227382125192	MSRA;ICMT
negative regulation of endothelial cell chemotaxis to vascular endothelial growth factor	4/80	0.28190091017205742840445736874244175851345062255859375	0.73858861214153648244717942361603491008281707763671875	0.12194385044818989438653034085291437804698944091796875	0.47566540249663702422111555279116146266460418701171875	1.270566688691374	-1.6087910992694694	CITED2;MAGI2;NKX2-1;ROBO1
positive regulation of interleukin-6 secretion	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	8.398419829605	-1.6115264129629205	CADM1
tRNA export from nucleus	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.656741618560248	-1.6189426598573315	U2AF2;CDC40
viral replication complex formation and maintenance	1/54	0.84245979513471869193352858928847126662731170654296875	0.958485975313668081554396849242039024829864501953125	0.71593796569589474021455544061609543859958648681640625	0.79911958925403114850638530697324313223361968994140625	9.449150079279862	-1.6198615503379055	DEK
negative regulation of alkaline phosphatase activity	1/53	0.83696734288683327651625631915521807968616485595703125	0.95662102166154416860166520564234815537929534912109375	0.709349397325049313423050989513285458087921142578125	0.793079191083730261624396007391624152660369873046875	9.106433699066482	-1.6206740645281998	SLC7A14
negative regulation of cell chemotaxis to fibroblast growth factor	4/80	0.28190091017205742840445736874244175851345062255859375	0.73858861214153648244717942361603491008281707763671875	0.12194385044818989438653034085291437804698944091796875	0.47566540249663702422111555279116146266460418701171875	1.2818247126282267	-1.623046005262342	CITED2;MAGI2;NKX2-1;ROBO1
negative regulation of chemokine activity	4/80	0.28190091017205742840445736874244175851345062255859375	0.73858861214153648244717942361603491008281707763671875	0.12194385044818989438653034085291437804698944091796875	0.47566540249663702422111555279116146266460418701171875	1.284657734533474	-1.626633176613333	CITED2;MAGI2;NKX2-1;ROBO1
positive regulation of protein kinase activity	7/176	0.37947959911007611566446939832530915737152099609375	0.76643914967559323425660977591178379952907562255859375	0.12105005758234259338745886225296999327838420867919921875	0.47566540249663702422111555279116146266460418701171875	1.679067946062048	-1.626940342871261	LMO4;ERBB4;PRKAG1;RAPGEF2;ARRB1;EFNA5;ACVR2A
leading strand elongation	1/52	0.83128369764848131229229011296411044895648956298828125	0.95173912665239956965024248347617685794830322265625	0.70260852387551675501953241109731607139110565185546875	0.7866613831286048963420398649759590625762939453125	8.83047151538497	-1.6317311669699588	RBFOX2
DNA-templated transcription, termination	2/83	0.77285864735424925076046065441914834082126617431640625	0.9190216065753202823174206059775315225124359130859375	0.57542288646713724009629231659346260130405426025390625	0.6974292378601434361229394198744557797908782958984375	6.333917112805222	-1.6319914431205362	LDB1;BAZ1A
negative regulation of translation in response to stress	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	8.519649068004881	-1.6347884222061493	LIN28A
protein sulfhydration	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.741208830348318	-1.6394853788569146	MSRA;ICMT
type I interferon signaling pathway	4/148	0.7369464061911739083399197625112719833850860595703125	0.90927967512523333315499485252075828611850738525390625	0.450174087528850741524166778617654927074909210205078125	0.64056445576880516323825531799229793250560760498046875	5.377811663042497	-1.6415238144933866	STAT3;LRRC4;IRF9;LRRC4B
RNA splicing	6/142	0.34309110867473180395137433151830919086933135986328125	0.76035323823870781811962160645634867250919342041015625	0.11870348485313393649409619001744431443512439727783203125	0.468948356827665613355549112384323962032794952392578125	1.5365123226383097	-1.6436982608609556	DDX17;DHX30;RBM39;CELF2;ELAVL4;CDC40
mRNA transcription	2/83	0.77285864735424925076046065441914834082126617431640625	0.9190216065753202823174206059775315225124359130859375	0.57542288646713724009629231659346260130405426025390625	0.6974292378601434361229394198744557797908782958984375	6.381244028534809	-1.6441856540842106	LDB1;BAZ1A
negative regulation of protein histidine kinase activity	4/79	0.274383861966334074988793645388795994222164154052734375	0.73858861214153648244717942361603491008281707763671875	0.1181057276250532250827518510050140321254730224609375	0.466977969159577621649503953449311666190624237060546875	1.2750603715022497	-1.6489427501619613	LRRC4;SFN;TRIB1;LRRC4B
fatty acid biosynthetic process	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	8.600320500396425	-1.6502680179763265	STAT5B
transcription from mitochondrial promoter	2/83	0.77285864735424925076046065441914834082126617431640625	0.9190216065753202823174206059775315225124359130859375	0.57542288646713724009629231659346260130405426025390625	0.6974292378601434361229394198744557797908782958984375	6.4089262201087935	-1.651318222914995	LDB1;BAZ1A
negative regulation of tau-protein kinase activity	4/80	0.28190091017205742840445736874244175851345062255859375	0.73858861214153648244717942361603491008281707763671875	0.12194385044818989438653034085291437804698944091796875	0.47566540249663702422111555279116146266460418701171875	1.3090179680260652	-1.657478095788234	LRRC4;SFN;TRIB1;LRRC4B
transcription from RNA polymerase I promoter	2/81	0.761096897117558679468629634357057511806488037109375	0.9190216065753202823174206059775315225124359130859375	0.5624428634236113833111403437214903533458709716796875	0.69053695647297630433314452602644450962543487548828125	6.073718118640719	-1.6580922516909011	LDB1;BAZ1A
actin modification	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.836509191805667	-1.662662757446005	MSRA;ICMT
canonical Wnt signaling pathway involved in positive regulation of apoptotic process	8/279	0.72422785913333342922015845033456571400165557861328125	0.90658517487771927978457142671686597168445587158203125	0.3225587132378302523960655889823101460933685302734375	0.548489347636209600977963418699800968170166015625	5.156492246584993	-1.663738168044148	ABR;TCF7L2;FZD2;FZD5;PNMA1;FZD8;CTNNB1;TBL1X
protein deglutathionylation	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.845096972660504	-1.6647513355486365	MSRA;ICMT
actin filament reorganization	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.654779619424668	-1.665856307103862	DLG1;SIPA1L1
protein esterification	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.850904027019681	-1.6661636313186825	MSRA;ICMT
protein biotinylation	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.864820189544805	-1.6695480903324762	MSRA;ICMT
ceramide phosphoethanolamine biosynthetic process	1/52	0.83128369764848131229229011296411044895648956298828125	0.95173912665239956965024248347617685794830322265625	0.70260852387551675501953241109731607139110565185546875	0.7866613831286048963420398649759590625762939453125	9.036439599706744	-1.6697908042162135	AGPAT3
sphinganine-1-phosphate biosynthetic process	1/52	0.83128369764848131229229011296411044895648956298828125	0.95173912665239956965024248347617685794830322265625	0.70260852387551675501953241109731607139110565185546875	0.7866613831286048963420398649759590625762939453125	9.042750311532318	-1.670956923732438	AGPAT3
genome retention in viral capsid	1/53	0.83696734288683327651625631915521807968616485595703125	0.95662102166154416860166520564234815537929534912109375	0.709349397325049313423050989513285458087921142578125	0.793079191083730261624396007391624152660369873046875	9.412665850384883	-1.6751742697421559	DEK
ERK1 and ERK2 cascade	7/245	0.7200973491337325782524203532375395298004150390625	0.90602805971294120279679873419809155166149139404296875	0.34290138012987980697943157792906276881694793701171875	0.567332799043368307678747441968880593776702880859375	5.108485637210619	-1.6774676508991504	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
protein deamination	2/85	0.78411195435889802229922906917636282742023468017578125	0.92313651971084154101987451213062740862369537353515625	0.588120594394399898163783291238360106945037841796875	0.70151609358561817231247914605773985385894775390625	6.910496762695479	-1.6806567914158321	MSRA;ICMT
regulation of transcription from RNA polymerase II promoter in response to oxidative stress	2/83	0.77285864735424925076046065441914834082126617431640625	0.9190216065753202823174206059775315225124359130859375	0.57542288646713724009629231659346260130405426025390625	0.6974292378601434361229394198744557797908782958984375	6.538818759704426	-1.684786219001761	GPX1;TXNRD1
regulation of inhibitory G-protein coupled receptor phosphorylation	1/50	0.81931601703245460210922601618221960961818695068359375	0.9419322104286980135157136828638613224029541015625	0.688655745269330044067146445740945637226104736328125	0.7749019919931845468141773380921222269535064697265625	8.455693981275727	-1.6850964619357833	PHIP
regulation of mRNA export from nucleus	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.735145047006975	-1.6859737658428877	PHOX2B;ZFP36L1
transcription, DNA-templated	2/82	0.76704230225162162160046364078880287706851959228515625	0.9190216065753202823174206059775315225124359130859375	0.56896809189115915561529845945187844336032867431640625	0.69640654405878665844653596650459803640842437744140625	6.364315317991957	-1.6879012348859246	LDB1;BAZ1A
protein initiator methionine removal	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.772249963157799	-1.6952620461660992	MSRA;ICMT
protein flavinylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.772770595717801	-1.695392373402065	MSRA;ICMT
protein nitrosylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.776166336523969	-1.696242411504414	MSRA;ICMT
enzyme active site formation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.7768915653951645	-1.6964239542689028	MSRA;ICMT
regulation of mRNA processing	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.781457840025751	-1.6975670060043995	PHOX2B;ZFP36L1
protein nucleotidylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.787484443539251	-1.6990756142600467	MSRA;ICMT
metal incorporation into metallo-sulfur cluster	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.789415891170673	-1.6995591034817266	MSRA;ICMT
protein halogenation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.79152053372275	-1.7000859476854537	MSRA;ICMT
protein acylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.792507688079282	-1.7003330568919126	MSRA;ICMT
nucleic acid-protein covalent cross-linking	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.803021217925483	-1.7029648540370947	MSRA;ICMT
protein deacylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.804567728906454	-1.7033519840727966	MSRA;ICMT
protein-cofactor linkage	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.810731456472056	-1.7048949178779158	MSRA;ICMT
protein phosphopantetheinylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.811756640805462	-1.7051515469303284	MSRA;ICMT
negative regulation of tumor necrosis factor-mediated signaling pathway	1/52	0.83128369764848131229229011296411044895648956298828125	0.95173912665239956965024248347617685794830322265625	0.70260852387551675501953241109731607139110565185546875	0.7866613831286048963420398649759590625762939453125	9.228084872454767	-1.7052038129100957	CYLD
protein amidation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.815017240227085	-1.7059677557940445	MSRA;ICMT
protein glucuronidation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.8169919298276715	-1.7064620695525508	MSRA;ICMT
peptidyl-tyrosine autophosphorylation	7/178	0.390504783567024726931293798770639114081859588623046875	0.77355606841369339843339503204333595931529998779296875	0.1261090878018709116048512441921047866344451904296875	0.482693649175157613040454407382640056312084197998046875	1.8150381872330361	-1.7067077417958099	ALK;PDGFRA;PKDCC;ERBB4;GRAP2;TYRO3;FGFR2
protein-chromophore linkage	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.818760897727416	-1.7069048860696074	MSRA;ICMT
protein dealkylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.819616128527383	-1.707118971539545	MSRA;ICMT
protein modification by small protein conjugation or removal	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.8222444674327685	-1.7077769099226525	MSRA;ICMT
trans-translation-dependent protein tagging	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.824161174978077	-1.7082567093353793	MSRA;ICMT
regulation of DNA-templated transcription, initiation	17/474	0.426465003448662061114049492971389554440975189208984375	0.7822618681448572086623016730300150811672210693359375	0.0536279666964014911645364236392197199165821075439453125	0.300788488593253078295930436070193536579608917236328125	2.004834262923016	-1.708569820851891	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
protein alkylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.826339522823428	-1.7088020038011271	MSRA;ICMT
protein dehydration	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.829672299860022	-1.709636280511114	MSRA;ICMT
protein-tetrapyrrole linkage	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.835923351413409	-1.7112010736750898	MSRA;ICMT
peptidyl-amino acid modification	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.83895899886173	-1.7119609714834514	MSRA;ICMT
formation of oxidatively modified proteins involved in replicative cell aging	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.839588146288839	-1.7121184626806787	MSRA;ICMT
protein polyamination	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.8448868019346705	-1.7134448475396176	MSRA;ICMT
positive regulation of sprouting angiogenesis	2/82	0.76704230225162162160046364078880287706851959228515625	0.9190216065753202823174206059775315225124359130859375	0.56896809189115915561529845945187844336032867431640625	0.69640654405878665844653596650459803640842437744140625	6.462043146414574	-1.7138199573305726	GDF2;BRCA1
negative regulation of translational elongation	1/50	0.81931601703245460210922601618221960961818695068359375	0.9419322104286980135157136828638613224029541015625	0.688655745269330044067146445740945637226104736328125	0.7749019919931845468141773380921222269535064697265625	8.600901696791958	-1.7140342414017877	LIN28A
metal incorporation into metallo-oxygen cluster	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.84758436443586	-1.7141201143047702	MSRA;ICMT
metal incorporation into metallo-molybdopterin complex	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.8523401709433465	-1.715310610567447	MSRA;ICMT
sulfur incorporation into metallo-sulfur cluster	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.853677730280073	-1.715645434826797	MSRA;ICMT
protein tyrosinylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.854055700257833	-1.7157400500819002	MSRA;ICMT
7-methylguanosine mRNA capping	2/82	0.76704230225162162160046364078880287706851959228515625	0.9190216065753202823174206059775315225124359130859375	0.56896809189115915561529845945187844336032867431640625	0.69640654405878665844653596650459803640842437744140625	6.469637310852136	-1.715834030941264	U2AF2;ELAVL4
protein denucleotidylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.856458651273476	-1.7163415682889624	MSRA;ICMT
protein carboxylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.859099868306813	-1.7170027303867381	MSRA;ICMT
protein glutathionylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.8597079345772585	-1.7171549444478624	MSRA;ICMT
protein prenylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.86153204484097	-1.7176115644655692	MSRA;ICMT
protein desulfurization	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.862678155029623	-1.7178984642572364	MSRA;ICMT
protein carbamoylation	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	6.863570589292417	-1.718121862676173	MSRA;ICMT
ribonucleoprotein complex export from nucleus	2/82	0.76704230225162162160046364078880287706851959228515625	0.9190216065753202823174206059775315225124359130859375	0.56896809189115915561529845945187844336032867431640625	0.69640654405878665844653596650459803640842437744140625	6.4840030651107785	-1.7196440204125087	U2AF2;CDC40
double-strand break repair via nonhomologous end joining	2/83	0.77285864735424925076046065441914834082126617431640625	0.9190216065753202823174206059775315225124359130859375	0.57542288646713724009629231659346260130405426025390625	0.6974292378601434361229394198744557797908782958984375	6.676126208153302	-1.7201647339008983	EYA1;BRCA1
positive regulation of cell differentiation	3/48	0.2180605930153150795458572019924758933484554290771484375	0.73858861214153648244717942361603491008281707763671875	0.10776772896274099122759793090153834782540798187255859375	0.444957872634645645870676844424451701343059539794921875	1.1328199465854107	-1.7252647336298494	DLX1;DLX2;JUND
ascorbate glutathione cycle	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	9.0278041234292	-1.73229549023938	GPX1
glutathione catabolic process	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	9.044274863660025	-1.7354559696464058	GPX1
cellular response to hydroperoxide	2/82	0.76704230225162162160046364078880287706851959228515625	0.9190216065753202823174206059775315225124359130859375	0.56896809189115915561529845945187844336032867431640625	0.69640654405878665844653596650459803640842437744140625	6.545901211393272	-1.736060233677746	GPX1;TXNRD1
dermatan sulfate biosynthetic process	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	9.066393322836653	-1.7397001586605736	SDC3
growth hormone receptor signaling pathway	4/80	0.28190091017205742840445736874244175851345062255859375	0.73858861214153648244717942361603491008281707763671875	0.12194385044818989438653034085291437804698944091796875	0.47566540249663702422111555279116146266460418701171875	1.374320958817828	-1.7401647200138934	ERBB4;GRAP2;STAT3;PTPRG
podosome assembly	5/112	0.324049366632242985541978441688115708529949188232421875	0.75121918332311110599874837134848348796367645263671875	0.1254064843912180704510461737299920059740543365478515625	0.482693649175157613040454407382640056312084197998046875	1.547472005350147	-1.743783388847354	PARD3;CNKSR3;GEMIN5;MITF;OTX2
sensory processing	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.467960096101713	-1.7528850155294469	SOBP
NMS complex assembly	5/111	0.317412939715617514746526239832746796309947967529296875	0.74304557649556712828342597276787273585796356201171875	0.1221555686736001955505770411036792211234569549560546875	0.47566540249663702422111555279116146266460418701171875	1.5278808739093366	-1.753322300166156	PARD3;CNKSR3;GEMIN5;MITF;OTX2
positive regulation of cell growth involved in cardiac muscle cell development	2/81	0.761096897117558679468629634357057511806488037109375	0.9190216065753202823174206059775315225124359130859375	0.5624428634236113833111403437214903533458709716796875	0.69053695647297630433314452602644450962543487548828125	6.457212381368656	-1.7627841147600112	MEF2C;AKAP6
planar cell polarity pathway involved in neural tube closure	5/111	0.317412939715617514746526239832746796309947967529296875	0.74304557649556712828342597276787273585796356201171875	0.1221555686736001955505770411036792211234569549560546875	0.47566540249663702422111555279116146266460418701171875	1.5389288719152903	-1.7660004491022485	FZD2;VANGL2;FZD5;LMO4;PRICKLE1
RNA polymerase II complex import to nucleus	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.1947940374655905	-1.7719085692095582	DLG1;STAT3;PRICKLE1
negative regulation of cyclin-dependent protein serine/threonine kinase activity	2/81	0.761096897117558679468629634357057511806488037109375	0.9190216065753202823174206059775315225124359130859375	0.5624428634236113833111403437214903533458709716796875	0.69053695647297630433314452602644450962543487548828125	6.4983494663170145	-1.7740143168335458	NR2F2;GATA3
DNA-templated transcription, elongation	2/80	0.75502050517415586483593870070762932300567626953125	0.91742187607070924126873023851658217608928680419921875	0.55584740135610422040457478942698799073696136474609375	0.6894378627916759594285167622729204595088958740234375	6.313602879040835	-1.7741878869493386	LDB1;BAZ1A
negative regulation of sprouting of injured axon	3/111	0.72526571249061400070701211006962694227695465087890625	0.90658517487771927978457142671686597168445587158203125	0.477246569467807579822959951343364082276821136474609375	0.65403023479943300788619353625108487904071807861328125	5.529207091797723	-1.7760763720610508	GDF2;APBB2;MSX1
posttranscriptional regulation of gene expression	2/84	0.7785478778619843165387237604591064155101776123046875	0.9190216065753202823174206059775315225124359130859375	0.5818070915793225328371818250161595642566680908203125	0.6974292378601434361229394198744557797908782958984375	7.101870765216842	-1.777774304041614	PHOX2B;ZFP36L1
DNA double-strand break processing	2/81	0.761096897117558679468629634357057511806488037109375	0.9190216065753202823174206059775315225124359130859375	0.5624428634236113833111403437214903533458709716796875	0.69053695647297630433314452602644450962543487548828125	6.523882374711252	-1.7809846629616755	EYA1;BRCA1
chondroitin sulfate proteoglycan biosynthetic process	1/50	0.81931601703245460210922601618221960961818695068359375	0.9419322104286980135157136828638613224029541015625	0.688655745269330044067146445740945637226104736328125	0.7749019919931845468141773380921222269535064697265625	8.941772126606232	-1.781964745572174	SDC3
positive regulation of interferon-gamma production	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.61018186200286	-1.7823252112201446	FZD5
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation	12/413	0.73628871680376539732293394990847446024417877197265625	0.909131982703142771384818843216635286808013916015625	0.254035457770600381355308172715012915432453155517578125	0.521558539066333093359162376145832240581512451171875	5.845776937739025	-1.7895849910678234	DKK4;CYLD;TCF7L2;PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PRICKLE1;PDS5B;MLLT3
positive regulation of tumor necrosis factor secretion	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.649506378244094	-1.7904654663087272	CADM1
chloride transmembrane transport	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.65032954756099	-1.790635864036687	GABRA2
embryonic hemopoiesis	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.2096785247522184	-1.793982625276503	KIRREL3;TAL1;FGFR2
positive regulation of cell proliferation	13/442	0.72675878945054350754872984907706268131732940673828125	0.90658517487771927978457142671686597168445587158203125	0.22999437105871367581499953303136862814426422119140625	0.51657998938210114570068753891973756253719329833984375	5.62420260610834	-1.7950241337895159	PDGFRA;RBFOX2;JUND;TET1;BRCA1;PTN;PDS5B;HOXC10;ERBB4;GRAP2;SIX3;PHIP;FGFR2
MAPK cascade involved in axon regeneration	7/237	0.68768869950219357889409366180188953876495361328125	0.8896948972989158210822324690525420010089874267578125	0.313742138089141364698519964804290793836116790771484375	0.54756353354058318050334719373495317995548248291015625	4.812345733793419	-1.8018337499616959	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
negative regulation of oskar mRNA translation	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.70593136373428	-1.8021455534188147	LIN28A
negative regulation of translation, ncRNA-mediated	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.706871735864704	-1.8023402123682823	LIN28A
negative regulation by symbiont of host translation	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.721304214167079	-1.8053277648208303	LIN28A
negative regulation of macroautophagy	3/107	0.70198791348284161895065835778950713574886322021484375	0.89615074097390101659499350716941989958286285400390625	0.45387692185516537168865625062608160078525543212890625	0.643478477306171470218032482080161571502685546875	5.102318167040207	-1.8053996291852739	RHEB;LARS;PRKAG1
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	1/51	0.82540221431916382943683174744364805519580841064453125	0.94615364397168788546110818060697056353092193603515625	0.6957118363560843565807090271846391260623931884765625	0.7800505662209769042192419874481856822967529296875	9.409157501862978	-1.8054712845539613	SLC7A14
negative regulation of translational fidelity	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.723298253296651	-1.8057405349887266	LIN28A
regulation of actin cytoskeleton reorganization	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.2191753721683194	-1.8080666805943213	PDGFRA;SEMA3E;EFNA5
negative regulation of protein kinase activity	4/141	0.70175068498506021352767447751830331981182098388671875	0.8960904117689574288618814534856937825679779052734375	0.414859204364542877296884171300916932523250579833984375	0.61210224178528271909982549914275296032428741455078125	5.107571314304321	-1.8089847329669735	LRRC4;SFN;TRIB1;LRRC4B
white fat cell differentiation	1/50	0.81931601703245460210922601618221960961818695068359375	0.9419322104286980135157136828638613224029541015625	0.688655745269330044067146445740945637226104736328125	0.7749019919931845468141773380921222269535064697265625	9.108942668594256	-1.815279395968428	TCF7L2
actin polymerization or depolymerization	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.788089081718661	-1.8191523686530071	DLG1
negative regulation of trophoblast cell migration	4/82	0.2970243964490471011430372527684085071086883544921875	0.73996546891932102330002862800029106438159942626953125	0.1297778232125592345891362811016733758151531219482421875	0.482693649175157613040454407382640056312084197998046875	1.4993586061464235	-1.8201328866439408	CITED2;MAGI2;NKX2-1;ROBO1
brown fat cell differentiation	1/50	0.81931601703245460210922601618221960961818695068359375	0.9419322104286980135157136828638613224029541015625	0.688655745269330044067146445740945637226104736328125	0.7749019919931845468141773380921222269535064697265625	9.13439834297243	-1.820352340534047	TCF7L2
activation of transmembrane receptor protein tyrosine kinase activity	3/112	0.7308580334746601625539597080205567181110382080078125	0.90842090748352355422667869788710959255695343017578125	0.483017136756796083840725941627169959247112274169921875	0.65448207929557333795145268595661036670207977294921875	5.825051070209993	-1.8263634846489258	ERBB4;GRAP2;PTPRG
regulation of translation in response to oxidative stress	2/80	0.75502050517415586483593870070762932300567626953125	0.91742187607070924126873023851658217608928680419921875	0.55584740135610422040457478942698799073696136474609375	0.6894378627916759594285167622729204595088958740234375	6.515384816377719	-1.8308907040075215	GPX1;TXNRD1
positive regulation of neuron projection regeneration	3/50	0.2359074922813300390078694590556551702320575714111328125	0.73858861214153648244717942361603491008281707763671875	0.117425947410695730166452221965300850570201873779296875	0.465460667173320852274542858140193857252597808837890625	1.2690575087674818	-1.832919471752019	MAGI2;STMN2;RAPGEF2
negative regulation of epidermal growth factor receptor signaling pathway	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.875353506716134	-1.8372162826571936	ERBB4
cellular response to reactive oxygen species	3/108	0.70794453174157734309801526251249015331268310546875	0.89931624229308193552157035810523666441440582275390625	0.45976082049397126727541262880549766123294830322265625	0.643478477306171470218032482080161571502685546875	5.338701777064445	-1.843931715503501	PDGFRA;GPX1;TXNRD1
endosome organization	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.932525523875986	-1.8490510068469346	HOOK2
neural crest cell migration involved in sympathetic nervous system development	3/11	0.005091763047913171712222091258581713191233575344085693359375	0.08702118223553055587071725085479556582868099212646484375	0.003448509799230563450944675452092269551940262317657470703125	0.0443232172288026415873929408917319960892200469970703125	0.3510109373686443	-1.8533837786195655	SEMA3A;GATA3;PHOX2B
endocytosis involved in viral entry into host cell	4/80	0.28190091017205742840445736874244175851345062255859375	0.73858861214153648244717942361603491008281707763671875	0.12194385044818989438653034085291437804698944091796875	0.47566540249663702422111555279116146266460418701171875	1.469238163048078	-1.8603488509944126	DNM3;CYTH2;HOOK2;LDLR
sequestering of iron ion	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	8.989582789247795	-1.8608619771824435	GDF2
planar cell polarity pathway involved in heart morphogenesis	3/106	0.69593921675442638186126487198635004460811614990234375	0.8932038389477359174861703650094568729400634765625	0.447966791131849062512770842658937908709049224853515625	0.63832322422468390499261658987961709499359130859375	5.135174263709465	-1.861464491806838	FZD2;FZD5;PRICKLE1
iron assimilation	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	9.020264494903413	-1.8672131528474514	GDF2
MAPK cascade	7/232	0.6662589038320414491778365118079818785190582275390625	0.8818022585229348120350323370075784623622894287109375	0.295761650940268350229445104559999890625476837158203125	0.536579887494325280528073562891222536563873291015625	4.6036048924014885	-1.8694177853310698	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
MAPK cascade involved in innate immune response	7/232	0.6662589038320414491778365118079818785190582275390625	0.8818022585229348120350323370075784623622894287109375	0.295761650940268350229445104559999890625476837158203125	0.536579887494325280528073562891222536563873291015625	4.604423363078132	-1.869750147398504	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
MAPK cascade involved in osmosensory signaling pathway	7/232	0.6662589038320414491778365118079818785190582275390625	0.8818022585229348120350323370075784623622894287109375	0.295761650940268350229445104559999890625476837158203125	0.536579887494325280528073562891222536563873291015625	4.608108456538673	-1.8712465788726982	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling	6/151	0.397183377248136848525206232807249762117862701416015625	0.77355606841369339843339503204333595931529998779296875	0.1449414973711506682274574586699600331485271453857421875	0.482693649175157613040454407382640056312084197998046875	2.0265849693728155	-1.8712618178467233	PDGFRA;SEMA7A;ERBB4;RAPGEF2;ARRB1;FGFR2
cellular response to thyroxine stimulus	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	8.70217307258117	-1.8714059661181313	LARS
ERK5 cascade	7/232	0.6662589038320414491778365118079818785190582275390625	0.8818022585229348120350323370075784623622894287109375	0.295761650940268350229445104559999890625476837158203125	0.536579887494325280528073562891222536563873291015625	4.611508766575118	-1.8726273663656172	PDGFRA;MEF2C;ERBB4;RAPGEF2;FGFR2;ZFP36L1;RASGRP3
O-glycan processing	2/81	0.761096897117558679468629634357057511806488037109375	0.9190216065753202823174206059775315225124359130859375	0.5624428634236113833111403437214903533458709716796875	0.69053695647297630433314452602644450962543487548828125	6.86333786821498	-1.8736541798174242	TET1;OGT
negative regulation of sprouting angiogenesis	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.2645773198969534	-1.8753988715130328	GDF2;CTNNB1;SEMA3E
positive regulation of stress-activated MAPK cascade	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.118999105697574	-1.875739451452106	LPAR1;FGFR2
positive regulation of inflammatory response	2/79	0.74881122175129544160654404549859464168548583984375	0.91601206768694520832241323660127818584442138671875	0.5491819526003458573626403449452482163906097412109375	0.68372636404988573755048264501965604722499847412109375	6.494979657904032	-1.87879216335328	SEMA7A;FOXP1
positive regulation of cell motility	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	8.40894647857225	-1.8789593658369101	ERBB4
negative regulation of smooth muscle cell proliferation	9/303	0.6930174408025120413867625757120549678802490234375	0.8932038389477359174861703650094568729400634765625	0.273741484818763980424449755446403287351131439208984375	0.52663609428336044526730574943940155208110809326171875	5.127972026726457	-1.8804279216908044	TCF7L2;PBRM1;ERBB4;MAGI2;RAPGEF2;CTNNB1;GATA3;PDS5B;TRIB1
regulation of eIF2 alpha phosphorylation by amino acid starvation	2/80	0.75502050517415586483593870070762932300567626953125	0.91742187607070924126873023851658217608928680419921875	0.55584740135610422040457478942698799073696136474609375	0.6894378627916759594285167622729204595088958740234375	6.693939188656423	-1.881066334392885	LARS;PHIP
ribosomal large subunit assembly	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	8.772111798858042	-1.886446318513515	AAMP
activation of Janus kinase activity	4/83	0.304623827194299201526206388734863139688968658447265625	0.73996546891932102330002862800029106438159942626953125	0.1337716644490487272189938039446133188903331756591796875	0.482693649175157613040454407382640056312084197998046875	1.5920544839199837	-1.8924395301476347	PDGFRA;PKDCC;ERBB4;FGFR2
positive regulation blood vessel branching	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.366022703263506	-1.8956527691711391	GDF2;BRCA1
glycosaminoglycan biosynthetic process	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	8.818876213886528	-1.8965030255631685	SDC3
cholesterol metabolic process	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	8.849558142236194	-1.9031011871127808	LDLRAP1
promoter clearance during DNA-templated transcription	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.214966215415772	-1.9051575459199814	LDB1;BAZ1A
positive regulation of peptidyl-tyrosine phosphorylation	5/169	0.6748969244472267092760375817306339740753173828125	0.8861389195434308252430355423712171614170074462890625	0.356920563790909917134541728955809958279132843017578125	0.57578464411823604418572131180553697049617767333984375	4.846569083262042	-1.905648205469087	EFNA1;ERBB4;ARRB1;EFNA5;ACVR2A
regulation of endosomal vesicle fusion	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	9.216387247744512	-1.9078109627990842	TBC1D9
regulation of Golgi vesicle fusion to target membrane	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	9.226984208651588	-1.9100045553258977	TBC1D9
positive regulation of calcium-mediated signaling involved in cellular response to calcium ion	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	9.244108611462076	-1.9135493416434683	MEF2C
negative regulation of mRNA processing	3/108	0.70794453174157734309801526251249015331268310546875	0.89931624229308193552157035810523666441440582275390625	0.45976082049397126727541262880549766123294830322265625	0.643478477306171470218032482080161571502685546875	5.543720608617082	-1.914743074062519	MEF2C;CITED2;ID2
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation	2/79	0.74881122175129544160654404549859464168548583984375	0.91601206768694520832241323660127818584442138671875	0.5491819526003458573626403449452482163906097412109375	0.68372636404988573755048264501965604722499847412109375	6.626027224540267	-1.91670007903444	RBFOX2;FGFR2
apolipoprotein E recycling	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	8.91630712102221	-1.917455582973514	LDLR
receptor-mediated endocytosis	6/195	0.643373936432163784360227509750984609127044677734375	0.875715838054236694887322300928644835948944091796875	0.302055544657279961828777459231787361204624176025390625	0.5415890136073973071262344092247076332569122314453125	4.350402102335698	-1.9186542462733296	DNM3;CYTH2;HOOK2;VLDLR;LDLRAP1;LDLR
cellular protein complex assembly	5/115	0.344039899307249374960093746267375536262989044189453125	0.76035323823870781811962160645634867250919342041015625	0.13539515709763094708506514507462270557880401611328125	0.482693649175157613040454407382640056312084197998046875	1.798216736955119	-1.918693018093524	PARD3;CNKSR3;GEMIN5;MITF;OTX2
positive regulation of actin filament polymerization	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.2947811861394645	-1.9201919385523432	FCHSD1;BAIAP2L2;GPX1
age-dependent response to oxidative stress involved in chronological cell aging	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.475522931861522	-1.928259377919218	GPX1;TXNRD1
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.3009778689009006	-1.9293817695536366	TCF7L2;EYA1;PHIP
age-dependent response to oxidative stress involved in replicative cell aging	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.482490866996508	-1.9303342661421692	GPX1;TXNRD1
cellular response to oxidative stress	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.484812234504817	-1.9310255151292541	GPX1;TXNRD1
positive regulation of pathway-restricted SMAD protein phosphorylation	6/155	0.42121510628227987194094339429284445941448211669921875	0.7769671408471967577469285970437340438365936279296875	0.1573885586443294626324274076978326775133609771728515625	0.4884190844811817644455231857136823236942291259765625	2.2349059383737058	-1.932325676325983	ERBB4;GDF2;ARRB1;EFNA5;GDF5;ACVR2A
negative regulation of insulin secretion	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.493107090284543	-1.93349552930634	CACNA1D;CACNA1C
protein deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.478722252686632	-1.9342679551627249	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
ER to Golgi vesicle-mediated transport	6/152	0.40319880750381165146478679162100888788700103759765625	0.7740695054926656215599223287426866590976715087890625	0.1480096743853744067909161685747676528990268707275390625	0.483043119420448807677104241520282812416553497314453125	2.1329670976071298	-1.9374284476698829	GRIA1;CUX1;GBF1;VTI1A;TRAPPC8;ANK3
protein K33-linked deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.4875678009498325	-1.9391863301603667	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
positive regulation of protein phosphorylation	6/151	0.397183377248136848525206232807249762117862701416015625	0.77355606841369339843339503204333595931529998779296875	0.1449414973711506682274574586699600331485271453857421875	0.482693649175157613040454407382640056312084197998046875	2.1027788187431695	-1.9416159570692366	DSCAM;ERBB4;PHIP;ARRB1;EFNA5;ACVR2A
ephrin receptor signaling pathway	6/151	0.397183377248136848525206232807249762117862701416015625	0.77355606841369339843339503204333595931529998779296875	0.1449414973711506682274574586699600331485271453857421875	0.482693649175157613040454407382640056312084197998046875	2.103081408304721	-1.9418953553187883	EFNA1;SIPA1L1;ERBB4;GRAP2;EFNA5;PTPRG
protein K27-linked deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.492878763153068	-1.9421393753460998	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
positive regulation of presynaptic cytosolic calcium concentration	4/83	0.304623827194299201526206388734863139688968658447265625	0.73996546891932102330002862800029106438159942626953125	0.1337716644490487272189938039446133188903331756591796875	0.482693649175157613040454407382640056312084197998046875	1.6346588387053265	-1.9430823730695037	PDGFRA;LPAR1;CACNA1C;TAC1
positive regulation of postsynaptic cytosolic calcium concentration	4/83	0.304623827194299201526206388734863139688968658447265625	0.73996546891932102330002862800029106438159942626953125	0.1337716644490487272189938039446133188903331756591796875	0.482693649175157613040454407382640056312084197998046875	1.635142429353351	-1.9436572064486215	PDGFRA;LPAR1;CACNA1C;TAC1
response to interleukin-1	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	9.041808522762171	-1.9444447120121402	JUND
protein K48-linked deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.4971779703476815	-1.9445298561333266	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
protein K11-linked deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.4981091783357923	-1.9450476341104568	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
protein linear deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.4991031202969882	-1.9456002939508188	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
protein K29-linked deubiquitination	8/243	0.57348225684218478992448808639892376959323883056640625	0.85592922282387073895648654797696508467197418212890625	0.207969881660629407615914487905683927237987518310546875	0.50931227109647247974777428680681623518466949462890625	3.499975509636436	-1.9460853670958267	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
negative regulation of cyclin-dependent protein kinase activity	4/82	0.2970243964490471011430372527684085071086883544921875	0.73996546891932102330002862800029106438159942626953125	0.1297778232125592345891362811016733758151531219482421875	0.482693649175157613040454407382640056312084197998046875	1.6031964896681155	-1.9461859508692427	LRRC4;SFN;TRIB1;LRRC4B
endoplasmic reticulum calcium ion homeostasis	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.53588824799883	-1.9462347581576387	SLC24A2;ATP2A2
protein ADP-ribosylation	1/49	0.8130179913333772656613973595085553824901580810546875	0.93696698390411448098546998153324238955974578857421875	0.6814365786436160643546600113040767610073089599609375	0.76806125244012835029394636876531876623630523681640625	9.4058861238474	-1.9470376167524184	TNKS
negative regulation of mitotic nuclear division	1/48	0.80650077612943082971952435400453396141529083251953125	0.93447903733788384439407082027173601090908050537109375	0.6740505802341782981557116727344691753387451171875	0.76356657188106524802861940770526416599750518798828125	9.057643269371905	-1.9478499809065033	DLG1
histone deubiquitination	8/250	0.60565740404158585619143195799551904201507568359375	0.8665107597404186901002276499639265239238739013671875	0.2289573634447703287531084015427040867507457733154296875	0.51657998938210114570068753891973756253719329833984375	3.8940532848921774	-1.9526371657705242	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
regulation of cardiac conduction	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.558821758180782	-1.9530638214691698	CELF2;ATP2A2
fibroblast growth factor receptor signaling pathway involved in forebrain neuroblast division	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.565625445652534	-1.95508980057694	RBFOX2;FGFR2
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.56681335962969	-1.9554435335944453	RBFOX2;FGFR2
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.573203930098817	-1.9573464961145401	RBFOX2;FGFR2
protein K63-linked deubiquitination	8/244	0.578151850732689265299768521799705922603607177734375	0.85592922282387073895648654797696508467197418212890625	0.2109204411963003511498726538775372318923473358154296875	0.50931227109647247974777428680681623518466949462890625	3.584677847263294	-1.9641121237933683	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
regulation of autophagy of mitochondrion	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.408185647347715	-1.9643877084026726	FZD5;U2AF2
monoubiquitinated protein deubiquitination	8/242	0.568789460899719490072357075405307114124298095703125	0.85592922282387073895648654797696508467197418212890625	0.2050358792197883583963147202666732482612133026123046875	0.5066287282764492250208832047064788639545440673828125	3.484878962391219	-1.9663252838304304	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
protein K6-linked deubiquitination	8/242	0.568789460899719490072357075405307114124298095703125	0.85592922282387073895648654797696508467197418212890625	0.2050358792197883583963147202666732482612133026123046875	0.5066287282764492250208832047064788639545440673828125	3.4873039786081517	-1.9676935869343584	IFIH1;CYLD;USP9X;USP21;TNKS;GATA3;BRCA1;OGT
negative regulation of root hair elongation	3/105	0.6897981325076096847936923950328491628170013427734375	0.89193470149078801778586012005689553916454315185546875	0.44203133014944118173161768936552107334136962890625	0.63549581966318624548506477367482148110866546630859375	5.307263339025965	-1.9708856012290568	GDF2;APBB2;MSX1
engulfment of apoptotic cell	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.432306228840478	-1.9717817160690267	ELMO1;TYRO3
negative regulation of gene expression	5/169	0.6748969244472267092760375817306339740753173828125	0.8861389195434308252430355423712171614170074462890625	0.356920563790909917134541728955809958279132843017578125	0.57578464411823604418572131180553697049617767333984375	5.023125477039816	-1.9750693504453707	MEF2C;CITED2;ID2;PHOX2B;ZFP36L1
regulation of transcription involved in G2/M transition of mitotic cell cycle	18/583	0.67746078751132199347040341308456845581531524658203125	0.88618484045782197622287412741570733487606048583984375	0.1359604621800773738282686053935321979224681854248046875	0.482693649175157613040454407382640056312084197998046875	5.072736473016171	-1.975341875465411	MEF2C;SKOR1;NFYA;LDB1;STAT3;ONECUT1;CEP164;SIX1;MITF;BAZ1A;MYT1;SCRT1;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
antisense RNA transcription	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.264600761512226	-1.9769683444474817	LDB1;BAZ1A
skeletal system development	3/103	0.6772378216989756172239367515430785715579986572265625	0.8861389195434308252430355423712171614170074462890625	0.430088182533494844950183733089943416416645050048828125	0.62480010995087631453515086832339875400066375732421875	5.075786359854853	-1.9782003295553787	SHOX2;COL11A2;HAPLN1
transcription from RNA polymerase V promoter	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.2693905510659995	-1.9784798952525307	LDB1;BAZ1A
transcription from plastid promoter	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.270933293521193	-1.9789667503792439	LDB1;BAZ1A
dendrite morphogenesis	3/49	0.226950287855583354712507571093738079071044921875	0.73858861214153648244717942361603491008281707763671875	0.1125569451960547195934481123913428746163845062255859375	0.4533997527666866478313068000716157257556915283203125	1.3344882570431762	-1.9790784888583197	MEF2C;BTBD3;SRGAP2
ncRNA transcription	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.27253650209462	-1.9794726872649084	LDB1;BAZ1A
transcription from RNA polymerase IV promoter	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.277090586531558	-1.9809098547896262	LDB1;BAZ1A
transcription from bacterial-type RNA polymerase promoter	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.277745376311732	-1.9811164918471105	LDB1;BAZ1A
telomeric repeat-containing RNA transcription	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.280309089983386	-1.981925542729367	LDB1;BAZ1A
response to interferon-gamma	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	8.881294570672281	-1.9845044390334328	JUND
fibroblast growth factor receptor signaling pathway involved in heart development	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.480344941294536	-1.9865076715056174	RBFOX2;FGFR2
fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.482080263317847	-1.9870396232061933	RBFOX2;FGFR2
negative regulation of cell proliferation	12/399	0.692954073287023408767026921850629150867462158203125	0.8932038389477359174861703650094568729400634765625	0.2200984960007555668592971187536022625863552093505859375	0.50931227109647247974777428680681623518466949462890625	5.418166995631777	-1.9873378937925328	PBRM1;RBFOX2;JUND;ERBB4;GRAP2;MAGI2;SIX3;RAPGEF2;CTNNB1;GATA3;BRCA1;PDS5B
fibroblast growth factor receptor signaling pathway involved in spinal cord anterior/posterior pattern formation	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.48500772672667	-1.9879370181091438	RBFOX2;FGFR2
interleukin-6-mediated signaling pathway	3/105	0.6897981325076096847936923950328491628170013427734375	0.89193470149078801778586012005689553916454315185546875	0.44203133014944118173161768936552107334136962890625	0.63549581966318624548506477367482148110866546630859375	5.35636742068893	-1.9891207106119793	STAT3;LRRC4;LRRC4B
fibroblast growth factor receptor signaling pathway involved in lung induction	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.490039453773527	-1.989479461369503	RBFOX2;FGFR2
epidermis morphogenesis	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.125072090462398	-1.9899641262480228	ATP2A2;FGFR2
fibroblast growth factor receptor signaling pathway involved in heart induction	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.4921124713264495	-1.9901149314423698	RBFOX2;FGFR2
fibroblast growth factor receptor signaling pathway involved in somitogenesis	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.496392546523315	-1.9914269607078205	RBFOX2;FGFR2
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.500040570514654	-1.9925452387794789	RBFOX2;FGFR2
positive regulation of cell migration	6/193	0.63349747834151004521885397480218671262264251708984375	0.87543673796358711935994278974249027669429779052734375	0.29419636206980204207184215192683041095733642578125	0.536422203279186771140985001693479716777801513671875	4.366645448638364	-1.9933704148827553	PDGFRA;LDB1;LMO4;ERBB4;PLXNA2;LDB2
fibroblast growth factor receptor signaling pathway involved in mammary gland specification	2/77	0.73598649616511779836258710929541848599910736083984375	0.909131982703142771384818843216635286808013916015625	0.53564232816128665159993715860764496028423309326171875	0.67774272047660655271528185039642266929149627685546875	6.504404947697555	-1.9938831102714625	RBFOX2;FGFR2
regulation of transcription involved in G1/S transition of mitotic cell cycle	19/557	0.50641969572653888764790508503210730850696563720703125	0.82665656283998334430407339823432266712188720703125	0.06353370704410389591121344210478127934038639068603515625	0.335222031462011293978520143355126492679119110107421875	2.942341763990968	-2.0019384866302232	MEF2C;SKOR1;NFYA;LDB1;MAX;STAT3;ONECUT1;SIX1;MITF;BAZ1A;MYT1;SCRT1;TFDP2;SALL3;SALL4;MYB;APBB2;SOX6;HOXB7
negative regulation of unidimensional cell growth	3/104	0.68356440253125916317600285765365697443485260009765625	0.88963772515681238672868857975117862224578857421875	0.436071472203911181253488393849693238735198974609375	0.628267909097693699749243023688904941082000732421875	5.266437556991273	-2.0035340259921206	GDF2;APBB2;MSX1
negative regulation of chondrocyte hypertrophy	3/104	0.68356440253125916317600285765365697443485260009765625	0.88963772515681238672868857975117862224578857421875	0.436071472203911181253488393849693238735198974609375	0.628267909097693699749243023688904941082000732421875	5.267932558911051	-2.0041027761544044	GDF2;APBB2;MSX1
activation of GTPase activity	6/182	0.5764404854974711778226037495187483727931976318359375	0.85592922282387073895648654797696508467197418212890625	0.25183903537442375863975030370056629180908203125	0.521558539066333093359162376145832240581512451171875	3.640715581078552	-2.0056089723316926	ABR;SIPA1L1;LARS;RAPGEF2;TBC1D9;SRGAP2
negative regulation of neural precursor cell proliferation	9/288	0.63452583148789287736946107543190009891986846923828125	0.87543673796358711935994278974249027669429779052734375	0.2297351609813686190708637013813131488859653472900390625	0.51657998938210114570068753891973756253719329833984375	4.418084425225931	-2.0096862309796726	PBRM1;ERBB4;ID2;MAGI2;SIX3;RAPGEF2;CTNNB1;GATA3;PDS5B
positive regulation of calcium ion transport into cytosol involved in cellular response to calcium ion	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.029897939366897	-2.0177095131904834	MEF2C
MAPK import into nucleus	9/273	0.5705088170183623130782279986306093633174896240234375	0.85592922282387073895648654797696508467197418212890625	0.1886932513922108534121235834390972740948200225830078125	0.4969659781223108030445700933341868221759796142578125	3.5953413136410006	-2.0178013786896263	PDGFRA;MEF2C;ERBB4;STAT3;RAPGEF2;PRICKLE1;FGFR2;ZFP36L1;RASGRP3
negative regulation of MAP kinase activity	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	8.695567002848955	-2.019214901894165	TRIB1
neuron projection morphogenesis	3/104	0.68356440253125916317600285765365697443485260009765625	0.88963772515681238672868857975117862224578857421875	0.436071472203911181253488393849693238735198974609375	0.628267909097693699749243023688904941082000732421875	5.310894781736818	-2.0204470837308635	RAPGEF2;CNTN4;SRGAP2
positive regulation of smooth muscle cell proliferation	11/347	0.6208012681587764536317308738944120705127716064453125	0.8740844799579179369430903534521348774433135986328125	0.187544044370288653933442901688977144658565521240234375	0.494215227538911505700269799490342848002910614013671875	4.241233640978386	-2.021983824759198	PDGFRA;TCF7L2;ERBB4;ID2;TET1;CTNNB1;PHIP;PTN;HOXC10;FGFR2;FOXP1
hepatoblast differentiation	4/87	0.335193593782497745170445568874129094183444976806640625	0.75121918332311110599874837134848348796367645263671875	0.1502351971354645154832496700691990554332733154296875	0.488057455157015207536375100971781648695468902587890625	1.8515961405603705	-2.0238816477273294	CITED2;SIX1;FGFR2;CNN3
negative regulation of translation	5/166	0.65955716394124486168237808669800870120525360107421875	0.88153179538752846067239943295135162770748138427734375	0.343472844707061797375757805639295838773250579833984375	0.56807903523254232869277302597765810787677764892578125	4.882429910103784	-2.0320020645779855	MEF2C;LIN28A;CITED2;ID2;GEMIN5
COPII-coated vesicle budding	5/150	0.57026677182142970767841916313045658171176910400390625	0.85592922282387073895648654797696508467197418212890625	0.272807382296281264455473092311876825988292694091796875	0.52663609428336044526730574943940155208110809326171875	3.6186678345244494	-2.0324284329035844	GRIA1;GBF1;VTI1A;TRAPPC8;ANK3
positive regulation of stress fiber assembly	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.09852849528982	-2.033044849925302	LPAR1
dendritic spine morphogenesis	4/131	0.64580317224369909734349448626744560897350311279296875	0.87712455038109082838815311333746649324893951416015625	0.3636694035172443051351365284062922000885009765625	0.57817199210730663150314967424492351710796356201171875	4.655022310353635	-2.0354574227614357	BTBD3;RAPGEF2;CNTN4;SRGAP2
regulation of rhodopsin gene expression	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.846828133440635	-2.0388253885022873	PHOX2B;ZFP36L1
negative regulation of protein serine/threonine kinase activity	4/87	0.335193593782497745170445568874129094183444976806640625	0.75121918332311110599874837134848348796367645263671875	0.1502351971354645154832496700691990554332733154296875	0.488057455157015207536375100971781648695468902587890625	1.8672736634076363	-2.0410179173907586	LRRC4;SFN;TRIB1;LRRC4B
double-strand break repair via alternative nonhomologous end joining	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.137517403935014	-2.041756830106092	BRCA1
pre-B cell allelic exclusion	2/78	0.74246716820651836865607720028492622077465057373046875	0.91243518168016268798936607709038071334362030029296875	0.5424468127566346442591793675092048943042755126953125	0.67870599887879190514894389707478694617748260498046875	6.861388627727869	-2.04316116338131	PHOX2B;ZFP36L1
negative regulation of substrate-dependent cell migration, cell attachment to substrate	4/87	0.335193593782497745170445568874129094183444976806640625	0.75121918332311110599874837134848348796367645263671875	0.1502351971354645154832496700691990554332733154296875	0.488057455157015207536375100971781648695468902587890625	1.870853967431848	-2.0449313580429376	CITED2;MAGI2;NKX2-1;ROBO1
positive regulation of canonical Wnt signaling pathway involved in osteoblast differentiation	4/133	0.65752339530781112042490121893933974206447601318359375	0.88085458024697771417521607872913591563701629638671875	0.3739461609723877533184577259817160665988922119140625	0.5880911994772668460740305818035267293453216552734375	4.878158328339395	-2.0452895079659603	MEF2C;TNKS;FGFR2;ACVR2A
inactivation of MAPKK activity	4/90	0.3582106801867810386141854905872605741024017333984375	0.76035323823870781811962160645634867250919342041015625	0.1630654196162578395412623422089382074773311614990234375	0.4884190844811817644455231857136823236942291259765625	1.99852252443008	-2.051751120451224	LRRC4;SFN;TRIB1;LRRC4B
positive regulation of protein autophosphorylation	4/128	0.62773362571084045935521089631947688758373260498046875	0.8740844799579179369430903534521348774433135986328125	0.34824526987091342089541967652621679008007049560546875	0.57115553050993261852141813506023027002811431884765625	4.409339397882702	-2.053161998963166	ERBB4;ARRB1;EFNA5;ACVR2A
negative regulation of direction of cell growth	3/103	0.6772378216989756172239367515430785715579986572265625	0.8861389195434308252430355423712171614170074462890625	0.430088182533494844950183733089943416416645050048828125	0.62480010995087631453515086832339875400066375732421875	5.270418753377807	-2.054054953393461	GDF2;APBB2;MSX1
positive regulation of dendrite extension	4/131	0.64580317224369909734349448626744560897350311279296875	0.87712455038109082838815311333746649324893951416015625	0.3636694035172443051351365284062922000885009765625	0.57817199210730663150314967424492351710796356201171875	4.698644943039773	-2.0545318773142967	MAGI2;STMN2;RAPGEF2;AKAP6
negative regulation of pseudohyphal growth	3/103	0.6772378216989756172239367515430785715579986572265625	0.8861389195434308252430355423712171614170074462890625	0.430088182533494844950183733089943416416645050048828125	0.62480010995087631453515086832339875400066375732421875	5.272612242218736	-2.0549098278976996	GDF2;APBB2;MSX1
muscle thin filament assembly	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	8.860844930135302	-2.0575944179879895	DLG1
double-strand break repair via classical nonhomologous end joining	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.221511432265546	-2.060525098712413	BRCA1
endocytosis	4/131	0.64580317224369909734349448626744560897350311279296875	0.87712455038109082838815311333746649324893951416015625	0.3636694035172443051351365284062922000885009765625	0.57817199210730663150314967424492351710796356201171875	4.721585228143807	-2.06456275804529	DNM3;CYTH2;HOOK2;LDLR
planar cell polarity pathway involved in axis elongation	4/87	0.335193593782497745170445568874129094183444976806640625	0.75121918332311110599874837134848348796367645263671875	0.1502351971354645154832496700691990554332733154296875	0.488057455157015207536375100971781648695468902587890625	1.892516016159578	-2.0686089958991922	FZD2;FZD5;MAGI2;PRICKLE1
regulation of eIF2 alpha phosphorylation by dsRNA	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.298631459835816	-2.077757387973144	PHIP
peptidyl-serine autophosphorylation	8/240	0.55933615996595287267467710989876650273799896240234375	0.84892917371396936498939567172783426940441131591796875	0.199218530699933726868522398945060558617115020751953125	0.5051662884607235337597330726566724479198455810546875	3.5835503085590976	-2.0820593105803415	ALK;PDGFRA;PRKCH;CAB39;TNKS;ERBB4;TYRO3;FGFR2
endoplasmic reticulum-derived vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane	5/151	0.57619428535587069450940589376841671764850616455078125	0.85592922282387073895648654797696508467197418212890625	0.277141964949380203986351034473045729100704193115234375	0.5293904906524435904913161721196956932544708251953125	3.777404226159477	-2.082522137407393	GRIA1;GBF1;VTI1A;TRAPPC8;ANK3
negative regulation of inflammatory response	4/87	0.335193593782497745170445568874129094183444976806640625	0.75121918332311110599874837134848348796367645263671875	0.1502351971354645154832496700691990554332733154296875	0.488057455157015207536375100971781648695468902587890625	1.9059014689362543	-2.083239925197326	SEMA7A;TYRO3;GATA3;FOXP1
negative regulation of fibroblast migration	4/85	0.31988094738357808477502430832828395068645477294921875	0.74696951921204834956569129644776694476604461669921875	0.1419079086861576299849474480652133934199810028076171875	0.482693649175157613040454407382640056312084197998046875	1.829276978846555	-2.0850215929323617	CITED2;MAGI2;NKX2-1;ROBO1
regulation of cardiac muscle contraction	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	8.987748774025393	-2.087063011882622	CELF2
pre-miRNA export from nucleus	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.249925516389976	-2.0905041518123686	U2AF2;CDC40
positive regulation of GTPase activity	6/160	0.4510643311501230101612236467190086841583251953125	0.7941283521609532325413738362840376794338226318359375	0.1735782876952543241078075197947327978909015655517578125	0.4930103205458740145417095845914445817470550537109375	2.629637743719369	-2.0935737527709883	ABR;SIPA1L1;LARS;RAPGEF2;EFNA5;SRGAP2
positive regulation of ERK1 and ERK2 cascade	7/207	0.54677646298440496508419528254307806491851806640625	0.8379287121174263663903047927306033670902252197265625	0.210398374691703804462150628751260228455066680908203125	0.50931227109647247974777428680681623518466949462890625	3.470609809917799	-2.095259965193675	PDGFRA;SEMA7A;ERBB4;LPAR1;RAPGEF2;ARRB1;FGFR2
COPII vesicle coating	6/168	0.49802703362051981006430878551327623426914215087890625	0.81913871240060753819989258772693574428558349609375	0.20081997523494587998271754258894361555576324462890625	0.5051662884607235337597330726566724479198455810546875	3.011976009461218	-2.099651244358815	GRIA1;PARD3;CNKSR3;GEMIN5;MITF;OTX2
positive regulation of NF-kappaB transcription factor activity	7/189	0.450982168210397826868529591592960059642791748046875	0.7941283521609532325413738362840376794338226318359375	0.1557797421689170180858496905784704722464084625244140625	0.4884190844811817644455231857136823236942291259765625	2.639284696998392	-2.1017349280610786	ALK;FZD2;PRKCH;CTNNB1;TRIM37;NKX6-1;NEUROG1
kidney development	3/52	0.25399587698904546595457532021100632846355438232421875	0.73858861214153648244717942361603491008281707763671875	0.1273936471997833830283042289011063985526561737060546875	0.482693649175157613040454407382640056312084197998046875	1.5342146911589205	-2.102544953703487	PTCH1;SIX1;GATA3
negative regulation of RNA splicing	4/129	0.63382152540146952102162458686507306993007659912109375	0.87543673796358711935994278974249027669429779052734375	0.353386668787709634642624223488382995128631591796875	0.57115553050993261852141813506023027002811431884765625	4.613400466371745	-2.1036546514304026	MEF2C;MBNL2;CITED2;ID2
positive regulation of vascular endothelial growth factor production	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	9.062096280941004	-2.1043273942780996	BRCA1
skeletal muscle thin filament assembly	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	9.06656885627467	-2.1053659798885174	DLG1
regulation of neuron apoptotic process	6/182	0.5764404854974711778226037495187483727931976318359375	0.85592922282387073895648654797696508467197418212890625	0.25183903537442375863975030370056629180908203125	0.521558539066333093359162376145832240581512451171875	3.8218198167107715	-2.1053762493469566	ALK;MEF2C;GRID2;GDF2;BRCA1;GDF5
protein oligomerization	5/154	0.5937140225566677198543175109080038964748382568359375	0.861327890478403190854805870912969112396240234375	0.29022764656078425815621812944300472736358642578125	0.5293904906524435904913161721196956932544708251953125	4.038324680305519	-2.105410936474461	PARD3;CNKSR3;GEMIN5;MITF;OTX2
actin filament network formation	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	9.071833762622774	-2.106588554259077	DLG1
positive regulation of spinal cord association neuron differentiation by negative regulation of canonical Wnt signaling pathway	5/151	0.57619428535587069450940589376841671764850616455078125	0.85592922282387073895648654797696508467197418212890625	0.277141964949380203986351034473045729100704193115234375	0.5293904906524435904913161721196956932544708251953125	3.824784289566732	-2.1086432578938	DKK4;CYLD;TCF7L2;PRICKLE1;MLLT3
COPII vesicle uncoating	5/147	0.5522322786260704940985988287138752639293670654296875	0.8449171775151393948277700474136509001255035400390625	0.259895297751918941120408135247998870909214019775390625	0.52663609428336044526730574943940155208110809326171875	3.5600032900662044	-2.1138819882994615	GRIA1;GBF1;VTI1A;TRAPPC8;ANK3
peptidyl-threonine autophosphorylation	6/181	0.57103774878244617507760949592920951545238494873046875	0.85592922282387073895648654797696508467197418212890625	0.2480748807062959915281652456542360596358776092529296875	0.521558539066333093359162376145832240581512451171875	3.7746861099547298	-2.1149564823069977	ALK;PDGFRA;TNKS;ERBB4;TYRO3;FGFR2
RNA polyadenylation	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.486294685576937	-2.119690295564835	RBFOX2
neuron projection regeneration	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.71972900883223	-2.1205966731900645	RAPGEF2;CNTN4
positive regulation of protein homodimerization activity	3/51	0.24492502873533827933982820468372665345668792724609375	0.73858861214153648244717942361603491008281707763671875	0.1223723232682889239253398727669264189898967742919921875	0.47566540249663702422111555279116146266460418701171875	1.5106685299935543	-2.125213201927958	TCF7L2;MEF2C;RAPGEF2
phosphatidic acid biosynthetic process	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	9.159797733061513	-2.1270148427209437	AGPAT3
axon development	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.5508006606101725	-2.1282783484483008	RAPGEF2;CNTN4
rRNA export from nucleus	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.363054194051855	-2.1283439580182195	U2AF2;CDC40
positive regulation of membrane protein ectodomain proteolysis	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.553310690796558	-2.1290938278341653	PACSIN3;OGT
inner ear receptor stereocilium organization	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.556378518619307	-2.1300905291337764	RAPGEF2;CNTN4
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	9.17562552856656	-2.1306902465833315	MEF2C
positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway	5/143	0.52763107478650106418882614889298565685749053955078125	0.829434943229018006860542300273664295673370361328125	0.2429192052797398415631136003867140971124172210693359375	0.521558539066333093359162376145832240581512451171875	3.3332505133316976	-2.1311402533429833	DKK4;CYLD;TCF7L2;PRICKLE1;MLLT3
cartilage development	4/121	0.5833551534700049945314503929694183170795440673828125	0.85592922282387073895648654797696508467197418212890625	0.312341116464066093083573605326819233596324920654296875	0.54756353354058318050334719373495317995548248291015625	3.95699516979142	-2.1326585375441223	SHOX2;COL11A2;GDF2;HAPLN1
Wnt signaling pathway, regulating spindle positioning	3/52	0.25399587698904546595457532021100632846355438232421875	0.73858861214153648244717942361603491008281707763671875	0.1273936471997833830283042289011063985526561737060546875	0.482693649175157613040454407382640056312084197998046875	1.5564172114811121	-2.1329721144730533	CYLD;GBF1;EFNA5
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation	6/164	0.47469530098923018446299693096079863607883453369140625	0.80316997434788539589334277479792945086956024169921875	0.187003483131042591569581645671860314905643463134765625	0.49306619895423586807936544573749415576457977294921875	2.864284908663747	-2.1341275647768856	DKK4;CYLD;TCF7L2;PTCH1;PRICKLE1;MLLT3
negative regulation of protein kinase activity by regulation of protein phosphorylation	4/85	0.31988094738357808477502430832828395068645477294921875	0.74696951921204834956569129644776694476604461669921875	0.1419079086861576299849474480652133934199810028076171875	0.482693649175157613040454407382640056312084197998046875	1.874776036016004	-2.136881709116726	LRRC4;SFN;TRIB1;LRRC4B
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation	5/143	0.52763107478650106418882614889298565685749053955078125	0.829434943229018006860542300273664295673370361328125	0.2429192052797398415631136003867140971124172210693359375	0.521558539066333093359162376145832240581512451171875	3.3429624025616436	-2.137349627043269	DKK4;CYLD;TCF7L2;PRICKLE1;MLLT3
platelet-derived growth factor receptor signaling pathway	4/85	0.31988094738357808477502430832828395068645477294921875	0.74696951921204834956569129644776694476604461669921875	0.1419079086861576299849474480652133934199810028076171875	0.482693649175157613040454407382640056312084197998046875	1.8765994272075608	-2.1389600220516845	PDGFRA;ERBB4;GRAP2;PTPRG
cytoskeletal anchoring at nuclear membrane	3/97	0.63732433587352421699989690750953741371631622314453125	0.87543673796358711935994278974249027669429779052734375	0.3937545538067934725035001974902115762233734130859375	0.59858894715301236288951258757151663303375244140625	4.759147264636764	-2.1438844381811304	ARC;MICAL3;PHIP
Golgi to endosome transport	3/100	0.657699773506435381165147191495634615421295166015625	0.88085458024697771417521607872913591563701629638671875	0.412007862839841809687868590117432177066802978515625	0.60808544712626211303785339623573236167430877685546875	5.117826779141469	-2.1444038278504713	RABIF;GBF1;VPS13A
histone H3 acetylation	1/47	0.7997567545928205845484626479446887969970703125	0.93068914004334868383949697090429253876209259033203125	0.66649390757465687418203970082686282694339752197265625	0.75737214214156989289250532237929292023181915283203125	9.600119456186288	-2.1451241735596196	ELP4
negative regulation of canonical Wnt signaling pathway involved in neural crest cell differentiation	5/142	0.52138802432906683481661502810311503708362579345703125	0.829434943229018006860542300273664295673370361328125	0.23872272823541751396447807564982213079929351806640625	0.51657998938210114570068753891973756253719329833984375	3.294481941093406	-2.14556676678891	DKK4;CYLD;TCF7L2;PRICKLE1;MLLT3
negative regulation of canonical Wnt signaling pathway involved in heart development	5/142	0.52138802432906683481661502810311503708362579345703125	0.829434943229018006860542300273664295673370361328125	0.23872272823541751396447807564982213079929351806640625	0.51657998938210114570068753891973756253719329833984375	3.2967799091659495	-2.1470633431902226	DKK4;CYLD;TCF7L2;PRICKLE1;MLLT3
endoplasmic reticulum-Golgi intermediate compartment (ERGIC) derived vesicle fusion with Golgi cis cisterna membrane	5/146	0.546139621562795607445650603040121495723724365234375	0.83722476272723655998930780697264708578586578369140625	0.255624154331089370462137821959913708269596099853515625	0.521558539066333093359162376145832240581512451171875	3.5532164195114255	-2.1492717464908817	GRIA1;GBF1;VTI1A;TRAPPC8;ANK3
vesicle targeting, rough ER to cis-Golgi	5/146	0.546139621562795607445650603040121495723724365234375	0.83722476272723655998930780697264708578586578369140625	0.255624154331089370462137821959913708269596099853515625	0.521558539066333093359162376145832240581512451171875	3.554971594646536	-2.1503334179126736	GRIA1;GBF1;VTI1A;TRAPPC8;ANK3
insulin receptor signaling pathway	6/177	0.5490992764887494548275981287588365375995635986328125	0.8403962645027356348492730830912478268146514892578125	0.23318840847715216479940636418177746236324310302734375	0.51657998938210114570068753891973756253719329833984375	3.587561152312952	-2.1506568894516986	BAIAP2L2;ERBB4;GRAP2;PHIP;ZFP36L1;PTPRG
spinal cord development	3/104	0.68356440253125916317600285765365697443485260009765625	0.88963772515681238672868857975117862224578857421875	0.436071472203911181253488393849693238735198974609375	0.628267909097693699749243023688904941082000732421875	5.6556899978502395	-2.151619045803306	ROBO2;RCAN1;HAPLN1
positive regulation of angiogenesis	3/100	0.657699773506435381165147191495634615421295166015625	0.88085458024697771417521607872913591563701629638671875	0.412007862839841809687868590117432177066802978515625	0.60808544712626211303785339623573236167430877685546875	5.140516953740498	-2.153911163554576	GDF2;CTNNB1;BRCA1
Kit signaling pathway	6/163	0.468812905242327104815558413974940776824951171875	0.80316997434788539589334277479792945086956024169921875	0.183609410215672730348757113461033441126346588134765625	0.4930103205458740145417095845914445817470550537109375	2.8437369183598693	-2.1542772046536025	ERBB4;GRAP2;STAT3;LRRC4;LRRC4B;PTPRG
negative regulation of rRNA processing	3/101	0.6643055677199922737230508573702536523342132568359375	0.88153179538752846067239943295135162770748138427734375	0.4180553310082635309896659236983396112918853759765625	0.614878345832392536607358124456368386745452880859375	5.2702417827546215	-2.1555976289752556	MEF2C;CITED2;ID2
positive regulation of tyrosine phosphorylation of STAT protein	3/100	0.657699773506435381165147191495634615421295166015625	0.88085458024697771417521607872913591563701629638671875	0.412007862839841809687868590117432177066802978515625	0.60808544712626211303785339623573236167430877685546875	5.153258545525936	-2.1592499761749955	EFNA1;ERBB4;EFNA5
positive regulation of protein export from nucleus in response to glucose starvation	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	9.30631349421579	-2.161037558915086	TCF7L2
epidermal cell differentiation	4/124	0.6027462193661017320067685432150028645992279052734375	0.86325738119619532806581219119834713637828826904296875	0.32770079393469841999575464797089807689189910888671875	0.5556884571923312865493471690570004284381866455078125	4.269731438514798	-2.161590114564858	SIX1;ATP2A2;FGFR2;CNN3
negative regulation of production of miRNAs involved in gene silencing by miRNA	3/103	0.6772378216989756172239367515430785715579986572265625	0.8861389195434308252430355423712171614170074462890625	0.430088182533494844950183733089943416416645050048828125	0.62480010995087631453515086832339875400066375732421875	5.555886342269343	-2.1653110304594714	MEF2C;CITED2;ID2
regulation of autophagosome maturation	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.496917050215844	-2.173119028673129	RHEB;PRKAG1
protein lipidation involved in autophagosome assembly	3/100	0.657699773506435381165147191495634615421295166015625	0.88085458024697771417521607872913591563701629638671875	0.412007862839841809687868590117432177066802978515625	0.60808544712626211303785339623573236167430877685546875	5.188480556682322	-2.1740082356487593	CNTN5;NTM;CNTN4
cation transport	3/100	0.657699773506435381165147191495634615421295166015625	0.88085458024697771417521607872913591563701629638671875	0.412007862839841809687868590117432177066802978515625	0.60808544712626211303785339623573236167430877685546875	5.206046613873819	-2.1813685317094254	SLC9A2;SLC24A2;SLC1A6
leptin-mediated signaling pathway	3/101	0.6643055677199922737230508573702536523342132568359375	0.88153179538752846067239943295135162770748138427734375	0.4180553310082635309896659236983396112918853759765625	0.614878345832392536607358124456368386745452880859375	5.340807863418049	-2.1844600763608586	STAT3;LRRC4;LRRC4B
metanephros development	3/53	0.263113179927899232257715311789070256054401397705078125	0.73858861214153648244717942361603491008281707763671875	0.132487484040738845436635529040358960628509521484375	0.482693649175157613040454407382640056312084197998046875	1.6381435088283773	-2.1872017026383537	ROBO2;SIX1;GATA3
positive regulation of interleukin-8 production	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	8.723755521733224	-2.188975377142175	GDF2
regulation of dosage compensation by inactivation of X chromosome	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.7428710109140795	-2.1906797538808713	PHOX2B;ZFP36L1
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	4/92	0.37355185664059675776371705069323070347309112548828125	0.76643914967559323425660977591178379952907562255859375	0.171832207344338738774780495077720843255519866943359375	0.4930103205458740145417095845914445817470550537109375	2.2248633140120173	-2.19081944411614	TFDP2;ID2;SFN;BRCA1
positive regulation of phosphorylation of RNA polymerase II C-terminal domain	4/122	0.58987939518771448366152299058740027248859405517578125	0.85693289408698769538119677235954441130161285400390625	0.317454435677735513632313768539461307227611541748046875	0.54756353354058318050334719373495317995548248291015625	4.151942760646994	-2.191549749640495	ERBB4;ARRB1;EFNA5;ACVR2A
regulation of gene silencing	2/76	0.7293673917862426581137924586073495447635650634765625	0.906807060373143514198090997524559497833251953125	0.52876889815203842459823135868646204471588134765625	0.6724669267087850510478119758772663772106170654296875	6.9462410999673905	-2.1920788395493327	PHOX2B;ZFP36L1
fibroblast growth factor receptor signaling pathway	6/166	0.486402828883562732276146789445192553102970123291015625	0.81526193339578589824867549396003596484661102294921875	0.1938645750320656391263440809780149720609188079833984375	0.5051662884607235337597330726566724479198455810546875	3.0423550153415286	-2.1926804247115803	RBFOX2;ERBB4;GRAP2;FGFR2;ZFP36L1;PTPRG
positive regulation of histone phosphorylation	4/120	0.5767714352089992058125744733843021094799041748046875	0.85592922282387073895648654797696508467197418212890625	0.307235694357377242535989125826745294034481048583984375	0.542872413580284263190378624130971729755401611328125	3.994434409468591	-2.198174072659825	ERBB4;ARRB1;EFNA5;ACVR2A
bone development	4/118	0.5634291338820747174764846931793726980686187744140625	0.8532482517465702631653812204604037106037139892578125	0.297052582359178585225123470081598497927188873291015625	0.53850769830447553498942170335794799029827117919921875	3.8339770627574	-2.1996052202417995	SHOX2;COL11A2;FGFR2;HAPLN1
Golgi disassembly	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.578752368278393	-2.200491686431371	GBF1;CLASP2
granulocyte colony-stimulating factor signaling pathway	3/97	0.63732433587352421699989690750953741371631622314453125	0.87543673796358711935994278974249027669429779052734375	0.3937545538067934725035001974902115762233734130859375	0.59858894715301236288951258757151663303375244140625	4.884929428269278	-2.2005463585247704	STAT3;LRRC4;LRRC4B
RNA export from nucleus	2/73	0.70866196154407157248300563878729008138179779052734375	0.89931624229308193552157035810523666441440582275390625	0.50773977081670451649841879770974628627300262451171875	0.662886382214889380293243448249995708465576171875	6.415959696506755	-2.2095066950895537	U2AF2;CDC40
regulation of protein maturation	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.803491309961599	-2.2103745784715616	PHOX2B;ZFP36L1
negative regulation of cell cycle	4/92	0.37355185664059675776371705069323070347309112548828125	0.76643914967559323425660977591178379952907562255859375	0.171832207344338738774780495077720843255519866943359375	0.4930103205458740145417095845914445817470550537109375	2.2492389240631807	-2.214822069412695	JUND;MECOM;STAT3;GATA3
positive regulation of autophagy of mitochondrion	2/73	0.70866196154407157248300563878729008138179779052734375	0.89931624229308193552157035810523666441440582275390625	0.50773977081670451649841879770974628627300262451171875	0.662886382214889380293243448249995708465576171875	6.439810404939226	-2.2177203221160555	FZD5;U2AF2
interleukin-15-mediated signaling pathway	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.047700677381695	-2.21963570000355	STAT3;LRRC4;LRRC4B
oncostatin-M-mediated signaling pathway	3/97	0.63732433587352421699989690750953741371631622314453125	0.87543673796358711935994278974249027669429779052734375	0.3937545538067934725035001974902115762233734130859375	0.59858894715301236288951258757151663303375244140625	4.932543408342901	-2.2219953419756946	STAT3;LRRC4;LRRC4B
interleukin-18-mediated signaling pathway	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.06900176149724	-2.22900246910765	STAT3;LRRC4;LRRC4B
regulation of rRNA processing	2/75	0.722608080098603000607226931606419384479522705078125	0.90658517487771927978457142671686597168445587158203125	0.52182697726697802043105411939905025064945220947265625	0.67014915648470874121045426363707520067691802978515625	6.865255089378051	-2.230440906430643	PHOX2B;ZFP36L1
negative regulation of rhodopsin gene expression	3/99	0.65100089151774376272641120522166602313518524169921875	0.87792562889559089267521585497888736426830291748046875	0.4059411510788446530995088323834352195262908935546875	0.60493277589116190018359020541538484394550323486328125	5.208112222421448	-2.2355523150107457	MEF2C;CITED2;ID2
ciliary neurotrophic factor-mediated signaling pathway	3/97	0.63732433587352421699989690750953741371631622314453125	0.87543673796358711935994278974249027669429779052734375	0.3937545538067934725035001974902115762233734130859375	0.59858894715301236288951258757151663303375244140625	4.971546106237356	-2.2395651443821736	STAT3;LRRC4;LRRC4B
adiponectin-activated signaling pathway	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.094082612713218	-2.240031322897439	STAT3;LRRC4;LRRC4B
positive regulation of peptidyl-tyrosine autophosphorylation	2/73	0.70866196154407157248300563878729008138179779052734375	0.89931624229308193552157035810523666441440582275390625	0.50773977081670451649841879770974628627300262451171875	0.662886382214889380293243448249995708465576171875	6.506407604520736	-2.2406548424855766	EFNA1;EFNA5
erythropoietin-mediated signaling pathway	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.102344033319064	-2.24366413420728	STAT3;LRRC4;LRRC4B
peptidyl-aspartic acid autophosphorylation	5/145	0.540007889523191675351654339465312659740447998046875	0.83722476272723655998930780697264708578586578369140625	0.251370622268126897580486911465413868427276611328125	0.521558539066333093359162376145832240581512451171875	3.648689055196629	-2.2482183150894817	ALK;PDGFRA;ERBB4;TYRO3;FGFR2
positive regulation of ubiquitin-protein transferase activity	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.342925253923624	-2.24903963813229	BRCA1;PRICKLE1
peptidyl-histidine autophosphorylation	5/145	0.540007889523191675351654339465312659740447998046875	0.83722476272723655998930780697264708578586578369140625	0.251370622268126897580486911465413868427276611328125	0.521558539066333093359162376145832240581512451171875	3.650834179437971	-2.249540079573813	ALK;PDGFRA;ERBB4;TYRO3;FGFR2
mitotic spindle assembly	2/71	0.694134918693584790361228442634455859661102294921875	0.8932038389477359174861703650094568729400634765625	0.49338553897935411018949025674373842775821685791015625	0.6596842167393817124576571586658246815204620361328125	6.1619354905869566	-2.2496544351755485	TNKS;CLASP2
actin nucleation	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.730717861932749	-2.2513218114598277	BAIAP2L2;DLG1
protein cis-autophosphorylation	5/145	0.540007889523191675351654339465312659740447998046875	0.83722476272723655998930780697264708578586578369140625	0.251370622268126897580486911465413868427276611328125	0.521558539066333093359162376145832240581512451171875	3.6538115500349706	-2.2513746505678665	ALK;PDGFRA;ERBB4;TYRO3;FGFR2
positive regulation of epithelial cell proliferation involved in wound healing	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.351918262475476	-2.252228329767379	PDGFRA;FGFR2
protein trans-autophosphorylation	5/145	0.540007889523191675351654339465312659740447998046875	0.83722476272723655998930780697264708578586578369140625	0.251370622268126897580486911465413868427276611328125	0.521558539066333093359162376145832240581512451171875	3.6560849127307478	-2.2527754319367825	ALK;PDGFRA;ERBB4;TYRO3;FGFR2
interleukin-12-mediated signaling pathway	3/96	0.63034707489756358622656762236147187650203704833984375	0.8747711539546358938679304628749378025531768798828125	0.387637032546652104958440077098202891647815704345703125	0.5955973558705400794366369154886342585086822509765625	4.884015300367927	-2.2538983296165456	STAT3;LRRC4;LRRC4B
embryonic skeletal system development	4/112	0.522078049984161740582067068316973745822906494140625	0.829434943229018006860542300273664295673370361328125	0.26679978903811640833509954973123967647552490234375	0.52663609428336044526730574943940155208110809326171875	3.473415991248272	-2.2575056720216873	SHOX2;COL11A2;BRCA1;HAPLN1
macrophage colony-stimulating factor signaling pathway	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.1473214164011	-2.2634421304797145	STAT3;LRRC4;LRRC4B
negative regulation of cell-substrate adhesion	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.388287014654386	-2.26598418613759	DSCAM
interleukin-8-mediated signaling pathway	3/96	0.63034707489756358622656762236147187650203704833984375	0.8747711539546358938679304628749378025531768798828125	0.387637032546652104958440077098202891647815704345703125	0.5955973558705400794366369154886342585086822509765625	4.913942879093662	-2.267709449269328	STAT3;LRRC4;LRRC4B
regulation of histone gene expression	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.787391882671973	-2.270278401477509	PHOX2B;ZFP36L1
regulation of snoRNA processing	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.7896338868770085	-2.2710283174703823	PHOX2B;ZFP36L1
interleukin-2-mediated signaling pathway	3/96	0.63034707489756358622656762236147187650203704833984375	0.8747711539546358938679304628749378025531768798828125	0.387637032546652104958440077098202891647815704345703125	0.5955973558705400794366369154886342585086822509765625	4.926978995729304	-2.273725417627893	STAT3;LRRC4;LRRC4B
regulation of mRNA catabolic process	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.800125432285328	-2.2745375783691726	PHOX2B;ZFP36L1
regulation of RNA splicing	3/100	0.657699773506435381165147191495634615421295166015625	0.88085458024697771417521607872913591563701629638671875	0.412007862839841809687868590117432177066802978515625	0.60808544712626211303785339623573236167430877685546875	5.428826114216068	-2.2747146401098886	MBNL2;PHOX2B;ZFP36L1
regulation of tRNA processing	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.80528077739863	-2.276261962177447	PHOX2B;ZFP36L1
regulation of gene expression	2/74	0.7157068305071543345974305339041166007518768310546875	0.9035864487591396265742105242679826915264129638671875	0.514817077502957687329399050213396549224853515625	0.66781052522122108516811067602247931063175201416015625	6.805682246054137	-2.2763962472803585	PHOX2B;ZFP36L1
protein sulfation	3/96	0.63034707489756358622656762236147187650203704833984375	0.8747711539546358938679304628749378025531768798828125	0.387637032546652104958440077098202891647815704345703125	0.5955973558705400794366369154886342585086822509765625	4.934050346198107	-2.2769887376687956	MSRA;ICMT;CHST5
interleukin-13-mediated signaling pathway	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.178427410288285	-2.2771204325283025	STAT3;LRRC4;LRRC4B
positive regulation of cyclin-dependent protein serine/threonine kinase activity	3/92	0.60151984965783100722802601012517698109149932861328125	0.86325738119619532806581219119834713637828826904296875	0.36303467338014849818961238270276226103305816650390625	0.57817199210730663150314967424492351710796356201171875	4.485003730708959	-2.279708307468513	CAB39;CITED2;FGFR2
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway	5/129	0.43748675904360012633986798391561023890972137451171875	0.78640967509848469507716117732343263924121856689453125	0.186282200580412948820452356812893413007259368896484375	0.4930103205458740145417095845914445817470550537109375	2.763457834718968	-2.2845750172973154	PDGFRA;GPR17;LPAR1;CACNA1C;TAC1
protein targeting to membrane	3/51	0.24492502873533827933982820468372665345668792724609375	0.73858861214153648244717942361603491008281707763671875	0.1223723232682889239253398727669264189898967742919921875	0.47566540249663702422111555279116146266460418701171875	1.6241292060197325	-2.2848300350075044	ICMT;PARD3;AKAP6
cortical cytoskeleton organization	3/92	0.60151984965783100722802601012517698109149932861328125	0.86325738119619532806581219119834713637828826904296875	0.36303467338014849818961238270276226103305816650390625	0.57817199210730663150314967424492351710796356201171875	4.497126341410438	-2.2858701788924196	ARC;MICAL3;PHIP
positive regulation of peptidyl-threonine phosphorylation	5/131	0.450668003343062284482556378861772827804088592529296875	0.7941283521609532325413738362840376794338226318359375	0.194063889413547296936002339862170629203319549560546875	0.5051662884607235337597330726566724479198455810546875	2.8687229169621866	-2.286442004032661	CAB39;ERBB4;ARRB1;EFNA5;ACVR2A
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.4879778027729	-2.290045843927508	PHIP
interleukin-35-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.850364261456145	-2.2930744155543303	STAT3;LRRC4;LRRC4B
interleukin-23-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.854101786566794	-2.2948413804144394	STAT3;LRRC4;LRRC4B
granulocyte-macrophage colony-stimulating factor signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.855973481443182	-2.295726249138398	STAT3;LRRC4;LRRC4B
interleukin-7-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.857772585133851	-2.2965767994108357	STAT3;LRRC4;LRRC4B
interleukin-17-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.865610309118489	-2.3002821879912707	STAT3;LRRC4;LRRC4B
interleukin-3-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.865939159087323	-2.3004376562013764	STAT3;LRRC4;LRRC4B
interleukin-21-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.866064391466452	-2.3004968614793926	STAT3;LRRC4;LRRC4B
positive regulation of MAP kinase activity	4/118	0.5634291338820747174764846931793726980686187744140625	0.8532482517465702631653812204604037106037139892578125	0.297052582359178585225123470081598497927188873291015625	0.53850769830447553498942170335794799029827117919921875	4.010039479789538	-2.3006146434212265	CAB39;LPAR1;TRIB1;FGFR2
interleukin-11-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.867220036778115	-2.3010432082184797	STAT3;LRRC4;LRRC4B
fatty acid beta-oxidation using acyl-CoA oxidase	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.177944489779799	-2.302941027044528	CRAT
negative regulation of histone gene expression	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.237990181971214	-2.303312091437675	MEF2C;CITED2;ID2
interleukin-33-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.872639534170421	-2.3036053479147114	STAT3;LRRC4;LRRC4B
interleukin-9-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.873508284085324	-2.304016061027376	STAT3;LRRC4;LRRC4B
interleukin-32-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.875281595756283	-2.3048544177783916	STAT3;LRRC4;LRRC4B
interleukin-17A-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.881351496032401	-2.3077240441152713	STAT3;LRRC4;LRRC4B
regulation of eIF2 alpha phosphorylation by heme	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.564800227035496	-2.308587927083687	PHIP
interleukin-5-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.88340623692745	-2.3086954502866535	STAT3;LRRC4;LRRC4B
type III interferon signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.883709268329859	-2.3088387124250245	STAT3;LRRC4;LRRC4B
macrophage migration inhibitory factor signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.884146020306346	-2.3090451927488185	STAT3;LRRC4;LRRC4B
negative regulation of snoRNA processing	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.2526756065060765	-2.3097697430796096	MEF2C;CITED2;ID2
suppression by virus of host gene expression	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.253342570815193	-2.310063028653728	MEF2C;CITED2;ID2
interleukin-34-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.888908088054079	-2.3112965238095056	STAT3;LRRC4;LRRC4B
regulation of insulin secretion	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.520118785951817	-2.3118679486039535	CACNA1D;CACNA1C
negative regulation of protein maturation	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.259252105292948	-2.3126616402861493	MEF2C;CITED2;ID2
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	2/73	0.70866196154407157248300563878729008138179779052734375	0.89931624229308193552157035810523666441440582275390625	0.50773977081670451649841879770974628627300262451171875	0.662886382214889380293243448249995708465576171875	6.715918325815713	-2.312805442441236	ELMO1;ELMO2
negative regulation of tRNA processing	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.261274859366972	-2.313551110055058	MEF2C;CITED2;ID2
phagocytosis	4/89	0.350536040699080120308650521110394038259983062744140625	0.76035323823870781811962160645634867250919342041015625	0.158744903757833011326283667585812509059906005859375	0.4884190844811817644455231857136823236942291259765625	2.2087841026920376	-2.315450155172642	DNM3;CYTH2;HOOK2;LDLR
negative regulation of production of siRNA involved in RNA interference	3/98	0.6442090222701295498808349293540231883525848388671875	0.875715838054236694887322300928644835948944091796875	0.39985632644169488703056458689388819038867950439453125	0.6033660562461531373656953292083926498889923095703125	5.2660464495983845	-2.315649331146275	MEF2C;CITED2;ID2
interleukin-27-mediated signaling pathway	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	4.898325014534209	-2.315748501438555	STAT3;LRRC4;LRRC4B
adherens junction organization	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.596549312463349	-2.3162509784360314	CADM1
cellular response to lipopolysaccharide	5/132	0.45722848919913994247821165117784403264522552490234375	0.7941283521609532325413738362840376794338226318359375	0.19799718394172993729540621643536724150180816650390625	0.5051662884607235337597330726566724479198455810546875	2.9601619802780066	-2.3165399897755226	MEF2C;JUND;FZD5;TRIB1;FOXP1
male gonad development	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.234787521547458	-2.317204149915353	GATA3
RNA modification	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.608582669546529	-2.319155384406372	RBFOX2
mRNA metabolic process	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.609796583140199	-2.3194483781124973	RBFOX2
sucrose catabolic process via 3'-ketosucrose	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	8.89062300812909	-2.319645744641879	SLC37A4
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia	4/112	0.522078049984161740582067068316973745822906494140625	0.829434943229018006860542300273664295673370361328125	0.26679978903811640833509954973123967647552490234375	0.52663609428336044526730574943940155208110809326171875	3.5710312992681867	-2.3209495877767665	RNF217;PRICKLE1;TRIB1;ZFP36L1
transforming growth factor beta receptor signaling pathway involved in determination of left/right asymmetry	4/98	0.419309266265943059170950846237246878445148468017578125	0.7769671408471967577469285970437340438365936279296875	0.1990571131761719458896919832113781012594699859619140625	0.5051662884607235337597330726566724479198455810546875	2.6745717855686486	-2.324594775107044	USP9X;CITED2;PARD3;GDF5
negative regulation of GTPase activity	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.193297277119976	-2.3282527186709716	SIPA1L1;EFNA5
negative regulation of gene expression, epigenetic	5/133	0.463766861699475396729752674218616448342800140380859375	0.79875776801935816084920816138037480413913726806640625	0.2019578720060852816686747246421873569488525390625	0.5051662884607235337597330726566724479198455810546875	3.035142674234959	-2.3321226115778813	MEF2C;GPX1;CITED2;ID2;PHF19
RNA repair	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	9.663923853867624	-2.3325126931803775	RBFOX2
vascular endothelial growth factor receptor signaling pathway	5/133	0.463766861699475396729752674218616448342800140380859375	0.79875776801935816084920816138037480413913726806640625	0.2019578720060852816686747246421873569488525390625	0.5051662884607235337597330726566724479198455810546875	3.039933916765539	-2.335804074442205	ERBB4;GRAP2;ELMO1;ELMO2;PTPRG
negative regulation of insulin receptor signaling pathway	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	8.275743107765342	-2.3360090993835625	OGT
positive regulation of telomere maintenance via telomerase	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.313628745992176	-2.3369870861270883	TNKS
positive regulation of protein import into nucleus	1/46	0.79277804593430889479321876933681778609752655029296875	0.92746380026590646838968723386642523109912872314453125	0.65876262997258716591630900438758544623851776123046875	0.75221092364577424316252063363208435475826263427734375	10.096418745143765	-2.344509470087284	ZIC1
attachment of GPI anchor to protein	4/108	0.49350627466956720201807229386758990585803985595703125	0.81526193339578589824867549396003596484661102294921875	0.2469639049895757387798056470273877494037151336669921875	0.521558539066333093359162376145832240581512451171875	3.3200386331487635	-2.344676705950528	MSRA;PIGB;ICMT;PIGK
negative regulation of type I interferon-mediated signaling pathway	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	8.996366143050606	-2.347235106233469	TYRO3
negative regulation of protein tyrosine kinase activity	4/97	0.4117262319990333541142035755910910665988922119140625	0.7769671408471967577469285970437340438365936279296875	0.1944299809564904446546051985933445394039154052734375	0.5051662884607235337597330726566724479198455810546875	2.6453595783372097	-2.3474831906684868	LRRC4;SFN;TRIB1;LRRC4B
cytoskeleton organization	3/90	0.58656295073045339183437363317352719604969024658203125	0.85592922282387073895648654797696508467197418212890625	0.350672770030429126197901723571703769266605377197265625	0.57115553050993261852141813506023027002811431884765625	4.4045242653111805	-2.3497048323290786	ARC;MICAL3;PHIP
microtubule cytoskeleton attachment to nuclear envelope	3/90	0.58656295073045339183437363317352719604969024658203125	0.85592922282387073895648654797696508467197418212890625	0.350672770030429126197901723571703769266605377197265625	0.57115553050993261852141813506023027002811431884765625	4.406990551705429	-2.3510205351631197	ARC;MICAL3;PHIP
skeletal system morphogenesis	4/110	0.5078851408799558431184095752541907131671905517578125	0.8276041771222535370355899431160651147365570068359375	0.256842762441591043742761257817619480192661285400390625	0.521558539066333093359162376145832240581512451171875	3.4742724665658393	-2.3538194487831734	SHOX2;COL11A2;FGFR2;HAPLN1
positive regulation of inhibitory G-protein coupled receptor phosphorylation	4/113	0.52910106936105893993271820363588631153106689453125	0.829434943229018006860542300273664295673370361328125	0.271804861760769067569043500043335370719432830810546875	0.52663609428336044526730574943940155208110809326171875	3.6986406672780543	-2.3544651711989966	ERBB4;ARRB1;EFNA5;ACVR2A
induction by virus of host protein phosphorylation	4/113	0.52910106936105893993271820363588631153106689453125	0.829434943229018006860542300273664295673370361328125	0.271804861760769067569043500043335370719432830810546875	0.52663609428336044526730574943940155208110809326171875	3.70269258600457	-2.3570445246361964	ERBB4;ARRB1;EFNA5;ACVR2A
ubiquitin-dependent endocytosis	4/92	0.37355185664059675776371705069323070347309112548828125	0.76643914967559323425660977591178379952907562255859375	0.171832207344338738774780495077720843255519866943359375	0.4930103205458740145417095845914445817470550537109375	2.39411478090621	-2.3574811002645024	DNM3;CYTH2;HOOK2;LDLR
septin cytoskeleton organization	3/91	0.59408611072968364741342384149902500212192535400390625	0.861327890478403190854805870912969112396240234375	0.35685762773565865568770050231250934302806854248046875	0.57578464411823604418572131180553697049617767333984375	4.532182769067973	-2.3600480771576504	ARC;MICAL3;PHIP
positive regulation of cytosolic calcium ion concentration	4/113	0.52910106936105893993271820363588631153106689453125	0.829434943229018006860542300273664295673370361328125	0.271804861760769067569043500043335370719432830810546875	0.52663609428336044526730574943940155208110809326171875	3.708479662397742	-2.36072843746702	PDGFRA;LPAR1;CACNA1C;TAC1
neuron projection fasciculation	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.672397186552461	-2.365861988462832	RAPGEF2;CNTN4
positive regulation of guanyl-nucleotide exchange factor activity	4/114	0.53607329020869276536842562563833780586719512939453125	0.83619633264365200719936410678201355040073394775390625	0.276826187788100142039837692209403030574321746826171875	0.5293904906524435904913161721196956932544708251953125	3.7952306950200225	-2.3662671016055055	ABR;LARS;RAPGEF2;SRGAP2
retrograde extension	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.676084520198701	-2.3671694229977547	RAPGEF2;CNTN4
Golgi to plasma membrane protein transport	4/114	0.53607329020869276536842562563833780586719512939453125	0.83619633264365200719936410678201355040073394775390625	0.276826187788100142039837692209403030574321746826171875	0.5293904906524435904913161721196956932544708251953125	3.7998306902123278	-2.3691351268102387	DLG1;FCHO2;RAPGEF2;ANK3
response to lipopolysaccharide	3/89	0.57895120841141889389547259270329959690570831298828125	0.85592922282387073895648654797696508467197418212890625	0.344481548540527260371391093940474092960357666015625	0.56934809546799824975238379920483566820621490478515625	4.3352500044573015	-2.369374851104845	JUND;TRIB1;FOXP1
death-inducing signaling complex assembly	5/132	0.45722848919913994247821165117784403264522552490234375	0.7941283521609532325413738362840376794338226318359375	0.19799718394172993729540621643536724150180816650390625	0.5051662884607235337597330726566724479198455810546875	3.0356082261343293	-2.3755821120543152	PARD3;CNKSR3;GEMIN5;MITF;OTX2
central nervous system maturation	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	5.031522573172836	-2.378719424335145	ROBO2;RCAN1;HAPLN1
Ras protein signal transduction	4/93	0.3812126255313825762272017527720890939235687255859375	0.7677967355386556835838973711361177265644073486328125	0.1762762288214681227760394222059403546154499053955078125	0.4930103205458740145417095845914445817470550537109375	2.4718609690586453	-2.383857743344243	ABR;GRAP2;RAPGEF2;RASGRP3
ventral cord development	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	5.051762698565582	-2.3882882136474315	ROBO2;RCAN1;HAPLN1
positive regulation of telomerase activity	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.16003903871762	-2.389938878016398	TNKS
Golgi reassembly	2/71	0.694134918693584790361228442634455859661102294921875	0.8932038389477359174861703650094568729400634765625	0.49338553897935411018949025674373842775821685791015625	0.6596842167393817124576571586658246815204620361328125	6.546248742475772	-2.38996294910419	GBF1;CLASP2
RNA biosynthetic process	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.530204928610287	-2.3913306460589814	RBFOX2
central nervous system segmentation	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	5.062865671389438	-2.3935372921798006	ROBO2;RCAN1;HAPLN1
Rac protein signal transduction	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.753381373878035	-2.3945769173112335	GRAP2;ELMO1
cellular glucose homeostasis	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.379063411315979	-2.3980879756635063	TCF7L2;STAT3
larval central nervous system remodeling	3/95	0.62327755768050951967751416304963640868663787841796875	0.8740844799579179369430903534521348774433135986328125	0.381504996904904969401428616038174368441104888916015625	0.5880911994772668460740305818035267293453216552734375	5.073243584196318	-2.398443588915783	ROBO2;RCAN1;HAPLN1
triglyceride catabolic process	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	8.84442201818627	-2.399941776551029	LMF1
DNA synthesis involved in UV-damage excision repair	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.574247516945297	-2.40238186604913	BRCA1
regulation of translational initiation	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.577254269373514	-2.40313632403619	GEMIN5
mRNA polyadenylation	2/72	0.70147184629428938063000487090903334319591522216796875	0.89597690196863333245147487104986794292926788330078125	0.50059569155475436286195645152474753558635711669921875	0.662886382214889380293243448249995708465576171875	6.79093923978975	-2.4078939793571488	U2AF2;CDC40
insulin receptor signaling pathway via phosphatidylinositol 3-kinase	2/67	0.66329023508770112993460088546271435916423797607421875	0.88153179538752846067239943295135162770748138427734375	0.46390060514184006112969882451579906046390533447265625	0.6470652733940613909879857601481489837169647216796875	5.865889907647022	-2.408197836376586	BAIAP2L2;PHIP
membrane reorganization involved in phagocytosis, engulfment	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.412310240517066	-2.4105864909149197	ELMO1;ANK3
negative regulation of I-kappaB kinase/NF-kappaB signaling	1/45	0.78555649567931273846710382713354192674160003662109375	0.92313651971084154101987451213062740862369537353515625	0.6508527265179140375295219200779683887958526611328125	0.7451631822779127833911161360447295010089874267578125	10.00088563937774	-2.413842767144538	TLE1
determination of liver left/right asymmetry	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.268560520308041	-2.4182531359422246	CITED2
Golgi distribution to daughter cells	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.44122531510048	-2.421456565125327	GBF1;CLASP2
regulation of xenophagy	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.444011898406713	-2.422504128300198	RHEB;PRKAG1
tRNA threonylcarbamoyladenosine metabolic process	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.654569413692398	-2.4225363343611703	RBFOX2
regulation of lipophagy	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.4523998151220665	-2.4256574065981176	RHEB;PRKAG1
regulation of aggrephagy	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.453988090407849	-2.42625448858638	RHEB;PRKAG1
positive regulation of protein tyrosine kinase activity	4/109	0.50071817865549006487668748377473093569278717041015625	0.8226707240396888831668320563039742410182952880859375	0.25189300807514924951391321883420459926128387451171875	0.521558539066333093359162376145832240581512451171875	3.5333613023664827	-2.4440678966877716	EFNA1;PRKAG1;RAPGEF2;EFNA5
positive regulation of insulin secretion	4/111	0.51500559700895631731754065185668878257274627685546875	0.8291071723704404039523296887637116014957427978515625	0.261812057295872147033577448382857255637645721435546875	0.52663609428336044526730574943940155208110809326171875	3.687466116395821	-2.446919585198243	TCF7L2;NLGN2;CACNA1D;CACNA1C
fat cell differentiation	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	9.771648939270593	-2.451914071738116	TCF7L2
hyaluronan biosynthetic process	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.4041774125635	-2.4536368370320463	SDC3
G2 DNA damage checkpoint	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	9.062450125629171	-2.459103897313543	BRCA1
negative regulation of cell growth involved in cardiac muscle cell development	4/113	0.52910106936105893993271820363588631153106689453125	0.829434943229018006860542300273664295673370361328125	0.271804861760769067569043500043335370719432830810546875	0.52663609428336044526730574943940155208110809326171875	3.8641524858507004	-2.4598259908370634	GDF2;APBB2;MSX1;SOX6
regulation of cell growth by extracellular stimulus	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	9.067012340098618	-2.460341858265236	PAPPA2
positive regulation of Wnt signaling pathway by BMP signaling pathway	4/104	0.4642429328591364257050599917420186102390289306640625	0.79891788190315449202927311489474959671497344970703125	0.2274764440949884336529152051298297010362148284912109375	0.51657998938210114570068753891973756253719329833984375	3.208445025529482	-2.4619916325768076	USP9X;GDF2;FGFR2;ACVR2A
positive regulation of activation of Janus kinase activity	4/114	0.53607329020869276536842562563833780586719512939453125	0.83619633264365200719936410678201355040073394775390625	0.276826187788100142039837692209403030574321746826171875	0.5293904906524435904913161721196956932544708251953125	3.951081198627789	-2.4634374580583067	EFNA1;PRKAG1;RAPGEF2;EFNA5
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	4/100	0.43440370746190382078566472046077251434326171875	0.78640967509848469507716117732343263924121856689453125	0.2084097678715885748612635097742895595729351043701171875	0.50931227109647247974777428680681623518466949462890625	2.955125116396619	-2.4639271029414065	LRRC4;SFN;TRIB1;LRRC4B
phosphatidylinositol-mediated signaling	4/99	0.426869206827403535609022355856723152101039886474609375	0.7822618681448572086623016730300150811672210693359375	0.20371742567951567348671915169688872992992401123046875	0.5051662884607235337597330726566724479198455810546875	2.8946986319278887	-2.4641921616311806	PDGFRA;ERBB4;OGT;FGFR2
negative regulation of endothelial cell proliferation	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	1.8942822302482218	-2.464385685430845	GDF2;NR2F2;GDF5
transforming growth factor beta receptor complex assembly	3/89	0.57895120841141889389547259270329959690570831298828125	0.85592922282387073895648654797696508467197418212890625	0.344481548540527260371391093940474092960357666015625	0.56934809546799824975238379920483566820621490478515625	4.510220739321451	-2.4650028445170373	USP9X;PARD3;GDF5
cytoskeletal anchoring at plasma membrane	4/99	0.426869206827403535609022355856723152101039886474609375	0.7822618681448572086623016730300150811672210693359375	0.20371742567951567348671915169688872992992401123046875	0.5051662884607235337597330726566724479198455810546875	2.9008559506638094	-2.469433749269482	ARC;MICAL3;PHIP;ANK3
fibroblast growth factor receptor signaling pathway involved in hemopoiesis	4/112	0.522078049984161740582067068316973745822906494140625	0.829434943229018006860542300273664295673370361328125	0.26679978903811640833509954973123967647552490234375	0.52663609428336044526730574943940155208110809326171875	3.8016909000646146	-2.4708640692026034	KIRREL3;RBFOX2;TAL1;FGFR2
antimicrobial humoral immune response mediated by antimicrobial peptide	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.4744125225547	-2.4719618266156305	HMGN2
vascular endothelial growth factor signaling pathway	3/90	0.58656295073045339183437363317352719604969024658203125	0.85592922282387073895648654797696508467197418212890625	0.350672770030429126197901723571703769266605377197265625	0.57115553050993261852141813506023027002811431884765625	4.641733953270479	-2.476250337927254	ERBB4;GRAP2;PTPRG
prolactin signaling pathway	4/97	0.4117262319990333541142035755910910665988922119140625	0.7769671408471967577469285970437340438365936279296875	0.1944299809564904446546051985933445394039154052734375	0.5051662884607235337597330726566724479198455810546875	2.795751413069891	-2.480940398883135	STAT5B;STAT3;LRRC4;LRRC4B
positive regulation of protein binding	3/55	0.28146056603243174709660934240673668682575225830078125	0.73858861214153648244717942361603491008281707763671875	0.1428829280697837267322114485068595968186855316162109375	0.482693649175157613040454407382640056312084197998046875	1.9605300089150566	-2.4854872613139856	TCF7L2;RAPGEF2;LDLRAP1
positive regulation of intrinsic apoptotic signaling pathway	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	8.807637689606873	-2.486147953008532	CYLD
B cell proliferation	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.548509727105372	-2.4912944723783257	MEF2C
mitochondrial RNA metabolic process	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.559149330273204	-2.4940704432175314	RBFOX2
RNA exon ligation	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.571999171639375	-2.4974230856383275	RBFOX2
RNA replication	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.574319886516907	-2.498028581606976	RBFOX2
ncRNA metabolic process	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.584671229505565	-2.5007293427002106	RBFOX2
RNA metabolic process	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.592085352768281	-2.5026637560097034	RBFOX2
planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation	3/87	0.56346582662509359096247862908057868480682373046875	0.8532482517465702631653812204604037106037139892578125	0.33208598905258668310125358402729034423828125	0.55814126245555895078354069482884369790554046630859375	4.364332736741406	-2.5035933303009807	FZD2;FZD5;PRICKLE1
establishment of endothelial blood-brain barrier	4/112	0.522078049984161740582067068316973745822906494140625	0.829434943229018006860542300273664295673370361328125	0.26679978903811640833509954973123967647552490234375	0.52663609428336044526730574943940155208110809326171875	3.8566646536341995	-2.5065936106132365	ROBO2;RCAN1;RAPGEF2;HAPLN1
Golgi organization	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.296971831953464	-2.510259202308573	GBF1;CLASP2
regulation of cell growth involved in cardiac muscle cell development	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	8.89490724600391	-2.510781689844969	PAPPA2
regulation of cell growth	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	8.89677020539939	-2.511307550790983	PAPPA2
Golgi inheritance	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.305366505326694	-2.5136057006966697	GBF1;CLASP2
Wnt signaling pathway, planar cell polarity pathway	3/87	0.56346582662509359096247862908057868480682373046875	0.8532482517465702631653812204604037106037139892578125	0.33208598905258668310125358402729034423828125	0.55814126245555895078354069482884369790554046630859375	4.386748092945736	-2.5164518678311376	FZD2;FZD5;PRICKLE1
vascular endothelial growth factor receptor-2 signaling pathway	2/70	0.68664967919578268062963388729258440434932708740234375	0.88963772515681238672868857975117862224578857421875	0.48611008000299282816314416777458973228931427001953125	0.6544886417454132132576205549412406980991363525390625	6.694747680519202	-2.5167634929407674	ELMO1;ELMO2
negative regulation of phosphatidylinositol 3-kinase signaling	3/91	0.59408611072968364741342384149902500212192535400390625	0.861327890478403190854805870912969112396240234375	0.35685762773565865568770050231250934302806854248046875	0.57578464411823604418572131180553697049617767333984375	4.836926462228515	-2.518737566023379	PDGFRA;ERBB4;FGFR2
glutathione biosynthetic process	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.66269620653187	-2.5210867806175936	GPX1
planar cell polarity pathway involved in cardiac muscle cell fate commitment	3/86	0.5555943703089776253278841977589763700962066650390625	0.84892917371396936498939567172783426940441131591796875	0.32588472964665882170010036134044639766216278076171875	0.55354637009120988277999231286230497062206268310546875	4.292583886456323	-2.5228236688558483	FZD2;FZD5;PRICKLE1
planar cell polarity pathway involved in gastrula mediolateral intercalation	3/86	0.5555943703089776253278841977589763700962066650390625	0.84892917371396936498939567172783426940441131591796875	0.32588472964665882170010036134044639766216278076171875	0.55354637009120988277999231286230497062206268310546875	4.292738335590098	-2.522914441206635	FZD2;FZD5;PRICKLE1
positive regulation of proteolysis	3/55	0.28146056603243174709660934240673668682575225830078125	0.73858861214153648244717942361603491008281707763671875	0.1428829280697837267322114485068595968186855316162109375	0.482693649175157613040454407382640056312084197998046875	1.996435694177946	-2.53100715793574	BTBD3;BTBD11;OGT
regulation of root hair elongation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	8.97867651348882	-2.534427393746752	PAPPA2
regulation of chondrocyte hypertrophy	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.007423573133376	-2.5425418786982235	PAPPA2
negative regulation of G2/M transition of mitotic cell cycle	2/67	0.66329023508770112993460088546271435916423797607421875	0.88153179538752846067239943295135162770748138427734375	0.46390060514184006112969882451579906046390533447265625	0.6470652733940613909879857601481489837169647216796875	6.1957189253431135	-2.543606706862626	KCNH5;ZFP36L1
leading edge cell differentiation	3/55	0.28146056603243174709660934240673668682575225830078125	0.73858861214153648244717942361603491008281707763671875	0.1428829280697837267322114485068595968186855316162109375	0.482693649175157613040454407382640056312084197998046875	2.0065981411337868	-2.5438907314274304	SIX1;FGFR2;CNN3
cytokine-mediated signaling pathway	4/109	0.50071817865549006487668748377473093569278717041015625	0.8226707240396888831668320563039742410182952880859375	0.25189300807514924951391321883420459926128387451171875	0.521558539066333093359162376145832240581512451171875	3.6834392314729714	-2.547878579247997	STAT3;LRRC4;AKAP6;LRRC4B
protein O-linked glycosylation	2/67	0.66329023508770112993460088546271435916423797607421875	0.88153179538752846067239943295135162770748138427734375	0.46390060514184006112969882451579906046390533447265625	0.6470652733940613909879857601481489837169647216796875	6.210354352390066	-2.5496151734898245	TET1;OGT
termination of RNA polymerase II transcription, poly(A)-coupled	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.403424626055507	-2.55269612487032	U2AF2;CDC40
termination of RNA polymerase II transcription, exosome-dependent	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.4064861884367845	-2.5539166027994167	U2AF2;CDC40
activation of protein kinase activity	2/66	0.6551983238403693565743424187530763447284698486328125	0.87925191850782991043189440460992045700550079345703125	0.45637303855276367681170768264564685523509979248046875	0.643478477306171470218032482080161571502685546875	6.045868872336452	-2.5562979810968303	PRKAG1;RAPGEF2
actin filament branching	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.065050899168414	-2.558808449112266	DLG1
preganglionic parasympathetic fiber development	4/96	0.404122522905271452930975328854401595890522003173828125	0.77552723374457510630008982843719422817230224609375	0.1898371790139179726697449268613127060234546661376953125	0.49969976194679188719049989231280051171779632568359375	2.8254049092810534	-2.559921875120098	ROBO2;RCAN1;PHOX2B;HAPLN1
positive regulation of mitotic nuclear division	2/64	0.63854985173042722035319229689775966107845306396484375	0.87543673796358711935994278974249027669429779052734375	0.441138060146478938605696384911425411701202392578125	0.634598423211631956775136131909675896167755126953125	5.708905447086626	-2.560761109891823	TAL1;PHIP
regulation of blood vessel size	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	9.820368258051245	-2.5622248766791924	RCAN1
neurotransmitter receptor transport, postsynaptic endosome to lysosome	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	9.456850129154326	-2.5661246888571374	HOOK2
phospholipid transport	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	9.502778204305256	-2.578587312875377	LDLR
interleukin-4-mediated signaling pathway	4/104	0.4642429328591364257050599917420186102390289306640625	0.79891788190315449202927311489474959671497344970703125	0.2274764440949884336529152051298297010362148284912109375	0.51657998938210114570068753891973756253719329833984375	3.3729793275220903	-2.588246585226594	STAT3;LRRC4;GATA3;LRRC4B
mRNA 3'-end processing	4/99	0.426869206827403535609022355856723152101039886474609375	0.7822618681448572086623016730300150811672210693359375	0.20371742567951567348671915169688872992992401123046875	0.5051662884607235337597330726566724479198455810546875	3.0407570421321015	-2.5885284174319536	LIN28A;U2AF2;ELAVL4;CDC40
peptidyl-glycine cholesteryl ester biosynthesis from peptidyl-glycine	4/102	0.449387368199955006264900703172315843403339385986328125	0.7941283521609532325413738362840376794338226318359375	0.2178859406601061088348814109849627129733562469482421875	0.50931227109647247974777428680681623518466949462890625	3.2396576799123364	-2.5913050783975584	CNTN5;NTM;CNTN4;LDLRAP1
positive regulation of G-protein coupled receptor protein signaling pathway	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.182049153081522	-2.5918337596123653	GATA3
insulin receptor signaling pathway involved in dauer larval development	2/64	0.63854985173042722035319229689775966107845306396484375	0.87543673796358711935994278974249027669429779052734375	0.441138060146478938605696384911425411701202392578125	0.634598423211631956775136131909675896167755126953125	5.799130820268819	-2.6012322000004087	BAIAP2L2;PHIP
regulation of mitophagy	4/95	0.39650063073747376929389929500757716596126556396484375	0.77355606841369339843339503204333595931529998779296875	0.185279855941891724580017353218863718211650848388671875	0.4930103205458740145417095845914445817470550537109375	2.816739546179597	-2.6057027920019	FZD5;RHEB;U2AF2;PRKAG1
regulation of lysosomal lumen pH	2/64	0.63854985173042722035319229689775966107845306396484375	0.87543673796358711935994278974249027669429779052734375	0.441138060146478938605696384911425411701202392578125	0.634598423211631956775136131909675896167755126953125	5.823196541989667	-2.6120270125674434	SLC9A2;HOOK2
regulation of ERK1 and ERK2 cascade	3/55	0.28146056603243174709660934240673668682575225830078125	0.73858861214153648244717942361603491008281707763671875	0.1428829280697837267322114485068595968186855316162109375	0.482693649175157613040454407382640056312084197998046875	2.0636677947117583	-2.6162415224536524	GDF2;GDF5;FGFR2
negative regulation of vascular wound healing	3/55	0.28146056603243174709660934240673668682575225830078125	0.73858861214153648244717942361603491008281707763671875	0.1428829280697837267322114485068595968186855316162109375	0.482693649175157613040454407382640056312084197998046875	2.0657598315874055	-2.618893729245171	GDF2;CTNNB1;SEMA3E
vascular endothelial growth factor receptor-3 signaling pathway	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.575473808861521	-2.621282749666208	ELMO1;ELMO2
vascular endothelial growth factor receptor signaling pathway involved in lymphatic endothelial cell fate commitment	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.575855005449167	-2.6214347119534094	ELMO1;ELMO2
cellular response to insulin stimulus	2/67	0.66329023508770112993460088546271435916423797607421875	0.88153179538752846067239943295135162770748138427734375	0.46390060514184006112969882451579906046390533447265625	0.6470652733940613909879857601481489837169647216796875	6.389377138259472	-2.623111657805151	OGT;ZFP36L1
vascular endothelial growth factor receptor-1 signaling pathway	2/68	0.67122863979724034511065156038966961205005645751953125	0.8861389195434308252430355423712171614170074462890625	0.471366664696513948396017212871811352670192718505859375	0.6505106321718450157476354434038512408733367919921875	6.584229898711929	-2.624773325090365	ELMO1;ELMO2
adenylate cyclase-activating adrenergic receptor signaling pathway	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	10.06273996709433	-2.625461896513383	RAPGEF2
epithelial cell differentiation involved in embryonic placenta development	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.0183027570907965	-2.6257314480474236	SIX1;FGFR2;CNN3
columnar/cuboidal epithelial cell differentiation	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.0218415407717845	-2.6303352645790925	SIX1;FGFR2;CNN3
regulation of defense response to virus by virus	2/67	0.66329023508770112993460088546271435916423797607421875	0.88153179538752846067239943295135162770748138427734375	0.46390060514184006112969882451579906046390533447265625	0.6470652733940613909879857601481489837169647216796875	6.4102188128814905	-2.6316680535986996	AP1G1;ELMO1
Malpighian tubule stellate cell differentiation	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.0237918181437853	-2.6328724977122717	SIX1;FGFR2;CNN3
postsynaptic membrane assembly	3/11	0.005091763047913171712222091258581713191233575344085693359375	0.08702118223553055587071725085479556582868099212646484375	0.003448509799230563450944675452092269551940262317657470703125	0.0443232172288026415873929408917319960892200469970703125	0.49918436726122783	-2.635758918961473	NLGN2;NRXN2;ANK3
epithelial cell differentiation involved in kidney development	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.026940662565038	-2.6369690188079518	SIX1;FGFR2;CNN3
cellular response to ionizing radiation	2/65	0.6469518456245746396149343127035535871982574462890625	0.87792562889559089267521585497888736426830291748046875	0.448785112567647193060338395298458635807037353515625	0.63878074109281579584518340197973884642124176025390625	6.0566731896323285	-2.6375807206203024	EYA1;BRCA1
regulation of mRNA splicing, via spliceosome	1/43	0.77035082893807393933371940875076688826084136962890625	0.9190216065753202823174206059775315225124359130859375	0.63448049501244263570498560511623509228229522705078125	0.73174682028696624858099539778777398169040679931640625	10.114767443078378	-2.6390363460385187	MBNL2
epithelial cell differentiation involved in salivary gland development	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.029838590052438	-2.640739106972918	SIX1;FGFR2;CNN3
epithelial cell development	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.030781422544495	-2.6419656944687424	SIX1;FGFR2;CNN3
negative regulation of barbed-end actin filament capping	1/44	0.77808366669643136415146500439732335507869720458984375	0.9190216065753202823174206059775315225124359130859375	0.6427600840933613834948801013524644076824188232421875	0.73750895564786811409163647113018669188022613525390625	10.539492536722038	-2.644582323860746	BAIAP2L2
ERBB2 signaling pathway	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.378112954411424	-2.6471770463725144	ERBB4
glutathione metabolic process	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	9.75743365808326	-2.6476882966244224	GPX1
positive regulation of blood vessel endothelial cell migration	3/57	0.29991576266555319829620884775067679584026336669921875	0.73996546891932102330002862800029106438159942626953125	0.1535391073243632664713231861242093145847320556640625	0.4884190844811817644455231857136823236942291259765625	2.1994719199698256	-2.6487220544180827	GATA3;AAMP;FOXP1
granulosa cell differentiation	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.0392272992402436	-2.652953443441708	SIX1;FGFR2;CNN3
positive regulation of posterior neural plate formation by fibroblast growth factor receptor signaling pathway	3/84	0.5396001957700542472906590774073265492916107177734375	0.83722476272723655998930780697264708578586578369140625	0.313483222101136382864439156037406064569950103759765625	0.54756353354058318050334719373495317995548248291015625	4.30134791395519	-2.653616769155749	RBFOX2;OTX2;FGFR2
positive regulation of endothelial cell chemotaxis	3/58	0.309168497854623025578035822036326862871646881103515625	0.73996546891932102330002862800029106438159942626953125	0.1589588742566369339304088725839392282068729400634765625	0.4884190844811817644455231857136823236942291259765625	2.261026571699535	-2.654148662006791	GATA3;AAMP;FOXP1
epithelial cell fate commitment	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.0404905968249802	-2.654596943251056	SIX1;FGFR2;CNN3
Malpighian tubule principal cell differentiation	3/54	0.272270248504665079991582388174720108509063720703125	0.73858861214153648244717942361603491008281707763671875	0.1376513924334513971903248830130905844271183013916015625	0.482693649175157613040454407382640056312084197998046875	2.0426895548973647	-2.6574577000643305	SIX1;FGFR2;CNN3
regulation of gene expression, epigenetic	3/86	0.5555943703089776253278841977589763700962066650390625	0.84892917371396936498939567172783426940441131591796875	0.32588472964665882170010036134044639766216278076171875	0.55354637009120988277999231286230497062206268310546875	4.525850757235946	-2.6599185278799298	GPX1;PHOX2B;ZFP36L1
positive regulation of transcription from RNA polymerase II promoter in response to amino acid starvation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.444583519805718	-2.6659398140877837	LARS
insulin-like growth factor receptor signaling pathway	3/82	0.52328069209760130764408359027584083378314971923828125	0.829434943229018006860542300273664295673370361328125	0.301094116649662513207630354372668080031871795654296875	0.5415890136073973071262344092247076332569122314453125	4.1204899025426736	-2.668582801530718	ERBB4;GRAP2;PTPRG
Rap protein signal transduction	2/66	0.6551983238403693565743424187530763447284698486328125	0.87925191850782991043189440460992045700550079345703125	0.45637303855276367681170768264564685523509979248046875	0.643478477306171470218032482080161571502685546875	6.332122708532587	-2.677331056573807	GRAP2;RAPGEF2
regulation of direction of cell growth	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.116454686552597	-2.6774996795298884	PAPPA2
regulation of pseudohyphal growth	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.118388665423092	-2.678067688474594	PAPPA2
regulation of rate of cell growth	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.12877563381431	-2.6811183376024617	PAPPA2
actin cytoskeleton reorganization	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.507729644757017	-2.683764185936474	SIPA1L1
store-operated calcium entry	2/64	0.63854985173042722035319229689775966107845306396484375	0.87543673796358711935994278974249027669429779052734375	0.441138060146478938605696384911425411701202392578125	0.634598423211631956775136131909675896167755126953125	5.984965381608908	-2.6845893201987043	SLN;CACNA1D
cellular response to hydrogen peroxide	2/66	0.6551983238403693565743424187530763447284698486328125	0.87925191850782991043189440460992045700550079345703125	0.45637303855276367681170768264564685523509979248046875	0.643478477306171470218032482080161571502685546875	6.355050882969998	-2.6870254854908433	PDGFRA;GPX1
actin filament organization	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.155761681138262	-2.6890441306378	DLG1
actin filament bundle organization	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.163905219254058	-2.691435885047269	DLG1
keratan sulfate biosynthetic process	2/65	0.6469518456245746396149343127035535871982574462890625	0.87792562889559089267521585497888736426830291748046875	0.448785112567647193060338395298458635807037353515625	0.63878074109281579584518340197973884642124176025390625	6.1842161298651295	-2.6931235557174826	SDC3;CHST5
detection of lipopolysaccharide	3/80	0.506649167515452969468014998710714280605316162109375	0.82665656283998334430407339823432266712188720703125	0.28873118777371920007368544247583486139774322509765625	0.5293904906524435904913161721196956932544708251953125	3.967097451677142	-2.6973743255280214	JUND;TRIB1;FOXP1
regulation of fatty acid metabolic process	3/85	0.54763870489980315259259668891900219023227691650390625	0.83843290198389208711660103290341794490814208984375	0.3196832637712798685925008612684905529022216796875	0.54756353354058318050334719373495317995548248291015625	4.481254512175794	-2.698340383126415	TXNRD1;ID2;TBL1X
calcium ion import	2/64	0.63854985173042722035319229689775966107845306396484375	0.87543673796358711935994278974249027669429779052734375	0.441138060146478938605696384911425411701202392578125	0.634598423211631956775136131909675896167755126953125	6.0256933160593995	-2.7028580604316095	SLN;CACNA1D
hyaluronan catabolic process	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.597544135012605	-2.709116285894323	SDC3
anion transport	3/85	0.54763870489980315259259668891900219023227691650390625	0.83843290198389208711660103290341794490814208984375	0.3196832637712798685925008612684905529022216796875	0.54756353354058318050334719373495317995548248291015625	4.500064848800865	-2.7096668299501165	SLC9A2;SLC24A2;SLC1A6
UV protection	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	9.991961500263237	-2.7113276350746602	GPX1
engulfment of target by autophagosome	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.240577022008145	-2.7139543677646634	FCHO2
histone methylation	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	10.002211099764311	-2.714108873010273	PRMT3
hepatocyte growth factor receptor signaling pathway	3/83	0.53148032450065663123695003378088586032390594482421875	0.83261132204237708887006874647340737283229827880859375	0.307286271837896751701890707408892922103404998779296875	0.542872413580284263190378624130971729755401611328125	4.302272450093424	-2.719419523940722	ERBB4;GRAP2;PTPRG
regulation of phosphatidylinositol 3-kinase signaling	3/82	0.52328069209760130764408359027584083378314971923828125	0.829434943229018006860542300273664295673370361328125	0.301094116649662513207630354372668080031871795654296875	0.5415890136073973071262344092247076332569122314453125	4.199092342030941	-2.7194886702836816	PDGFRA;ERBB4;FGFR2
glycosaminoglycan catabolic process	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.636136041960205	-2.720009693847932	SDC3
negative regulation of lipid metabolic process	3/84	0.5396001957700542472906590774073265492916107177734375	0.83722476272723655998930780697264708578586578369140625	0.313483222101136382864439156037406064569950103759765625	0.54756353354058318050334719373495317995548248291015625	4.422239266876883	-2.728197883675255	TXNRD1;ID2;TBL1X
regulation of steroid metabolic process	3/82	0.52328069209760130764408359027584083378314971923828125	0.829434943229018006860542300273664295673370361328125	0.301094116649662513207630354372668080031871795654296875	0.5415890136073973071262344092247076332569122314453125	4.2157783664663535	-2.730295161474641	TXNRD1;ID2;TBL1X
histone H3-K14 acetylation	1/42	0.76234894967441813040665010703378356993198394775390625	0.9190216065753202823174206059775315225124359130859375	0.62600965525329577143764936408842913806438446044921875	0.7273122029137428778966523168492130935192108154296875	10.074596945305528	-2.733750836542556	ELP4
positive regulation of ureteric bud formation	3/10	0.003797240025174056753110019002406261279247701168060302734375	0.069156684165042558998237609557691030204296112060546875	0.002755244303871814438855469830969013855792582035064697265625	0.03620191471131851967957260285402298904955387115478515625	0.4915694293031242	-2.7397527688642116	SIX1;OTX2;GATA3
regulation of heart contraction involved in acute-phase response	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.72920305428365	-2.7462798891414537	CELF2
multi-ciliated epithelial cell differentiation	3/58	0.309168497854623025578035822036326862871646881103515625	0.73996546891932102330002862800029106438159942626953125	0.1589588742566369339304088725839392282068729400634765625	0.4884190844811817644455231857136823236942291259765625	2.3409329496725286	-2.7479482700420976	SIX1;FGFR2;CNN3
mitochondrial depolarization	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.358976828150201	-2.7487283510620717	CACNG2
regulation of lipid biosynthetic process	3/82	0.52328069209760130764408359027584083378314971923828125	0.829434943229018006860542300273664295673370361328125	0.301094116649662513207630354372668080031871795654296875	0.5415890136073973071262344092247076332569122314453125	4.253053546423536	-2.7544359569893486	TXNRD1;ID2;TBL1X
epithelial cell differentiation	3/57	0.29991576266555319829620884775067679584026336669921875	0.73996546891932102330002862800029106438159942626953125	0.1535391073243632664713231861242093145847320556640625	0.4884190844811817644455231857136823236942291259765625	2.293872461416003	-2.762404249588335	SIX1;FGFR2;CNN3
miRNA export from nucleus	2/62	0.62127613569979434071655077786999754607677459716796875	0.8740844799579179369430903534521348774433135986328125	0.425671954709346656020585442092851735651493072509765625	0.61914727424113114029324833609280176460742950439453125	5.825498926425259	-2.7728188405716967	U2AF2;CDC40
seminiferous tubule development	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.449092611121912	-2.7751953262540017	GATA3
early endosome to Golgi transport	3/79	0.498221107881565206110252574944752268493175506591796875	0.81913871240060753819989258772693574428558349609375	0.28256400246224477879053438300616107881069183349609375	0.5293904906524435904913161721196956932544708251953125	3.990704875763244	-2.7803692168782863	CUX1;GBF1;VTI1A
cell-cell junction assembly	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.099231355216235	-2.7813088936925303	TLN2
intracellular pH reduction	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.476008054015464	-2.7831003827918455	SLC9A2
snRNA export from nucleus	2/62	0.62127613569979434071655077786999754607677459716796875	0.8740844799579179369430903534521348774433135986328125	0.425671954709346656020585442092851735651493072509765625	0.61914727424113114029324833609280176460742950439453125	5.853826087325941	-2.786301992218849	U2AF2;CDC40
positive regulation of tumor necrosis factor-mediated signaling pathway	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.883671953171586	-2.7898821069332786	CYLD
regulation of triglyceride metabolic process	3/81	0.51500302273564024790886151095037348568439483642578125	0.8291071723704404039523296887637116014957427978515625	0.294908496564629973857307732032495550811290740966796875	0.536579887494325280528073562891222536563873291015625	4.213647313790215	-2.7961026562986233	TXNRD1;ID2;TBL1X
polarized epithelial cell differentiation	3/57	0.29991576266555319829620884775067679584026336669921875	0.73996546891932102330002862800029106438159942626953125	0.1535391073243632664713231861242093145847320556640625	0.4884190844811817644455231857136823236942291259765625	2.3259319692235496	-2.801012028397715	SIX1;FGFR2;CNN3
positive regulation of lipid metabolic process	3/83	0.53148032450065663123695003378088586032390594482421875	0.83261132204237708887006874647340737283229827880859375	0.307286271837896751701890707408892922103404998779296875	0.542872413580284263190378624130971729755401611328125	4.433769859132726	-2.802537602964595	TXNRD1;ID2;TBL1X
histone H3-K18 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.944870078280978	-2.807156613314054	ELP4
histone H3-K56 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.948425769234456	-2.8081602846839555	ELP4
histone H3-K27 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.959775440869526	-2.811363977194621	ELP4
mRNA 3'-end processing by stem-loop binding and cleavage	2/65	0.6469518456245746396149343127035535871982574462890625	0.87792562889559089267521585497888736426830291748046875	0.448785112567647193060338395298458635807037353515625	0.63878074109281579584518340197973884642124176025390625	6.462767557999134	-2.8144280827316113	U2AF2;CDC40
regulation of isoprenoid metabolic process	3/81	0.51500302273564024790886151095037348568439483642578125	0.8291071723704404039523296887637116014957427978515625	0.294908496564629973857307732032495550811290740966796875	0.536579887494325280528073562891222536563873291015625	4.241630480753844	-2.814671796440604	TXNRD1;ID2;TBL1X
positive regulation of interferon-beta production	2/62	0.62127613569979434071655077786999754607677459716796875	0.8740844799579179369430903534521348774433135986328125	0.425671954709346656020585442092851735651493072509765625	0.61914727424113114029324833609280176460742950439453125	5.91383670948535	-2.814865826125544	IFIH1;CTNNB1
regulation of cyclin-dependent protein kinase activity	3/82	0.52328069209760130764408359027584083378314971923828125	0.829434943229018006860542300273664295673370361328125	0.301094116649662513207630354372668080031871795654296875	0.5415890136073973071262344092247076332569122314453125	4.353510797976419	-2.8194958164050075	JUND;MECOM;STAT3
histone H3-K36 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	9.991625936565855	-2.8203544747001184	ELP4
histone H3-K9 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	10.005938913239124	-2.824394624728053	ELP4
histone H3-K79 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	10.00721415402449	-2.824754589270177	ELP4
neurotrophin TRK receptor signaling pathway	3/80	0.506649167515452969468014998710714280605316162109375	0.82665656283998334430407339823432266712188720703125	0.28873118777371920007368544247583486139774322509765625	0.5293904906524435904913161721196956932544708251953125	4.155508136907202	-2.8254816259372544	ERBB4;GRAP2;PTPRG
positive regulation of anaphase-promoting complex-dependent catabolic process	3/57	0.29991576266555319829620884775067679584026336669921875	0.73996546891932102330002862800029106438159942626953125	0.1535391073243632664713231861242093145847320556640625	0.4884190844811817644455231857136823236942291259765625	2.3468179030106002	-2.826163990078424	RNF217;PRICKLE1;TRIB1
intralumenal vesicle formation	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.24961044831078	-2.8272743926145365	HOOK2
histone H3-K23 acetylation	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	10.020301114485763	-2.8284486694660838	ELP4
regulation of actin filament length	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.255198028682727	-2.82898231566606	EFNA5
positive regulation of transcription factor catabolic process	3/57	0.29991576266555319829620884775067679584026336669921875	0.73996546891932102330002862800029106438159942626953125	0.1535391073243632664713231861242093145847320556640625	0.4884190844811817644455231857136823236942291259765625	2.352531699029972	-2.8330448497036578	RNF217;PRICKLE1;TRIB1
regulation of actin filament bundle assembly	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.272492215405396	-2.8342685286947424	EFNA5
visual perception	3/81	0.51500302273564024790886151095037348568439483642578125	0.8291071723704404039523296887637116014957427978515625	0.294908496564629973857307732032495550811290740966796875	0.536579887494325280528073562891222536563873291015625	4.272025944287033	-2.834841694392535	TRPM1;SIX3;POU4F3
late endosome to Golgi transport	3/76	0.4725135489533511812254573669633828103542327880859375	0.80316997434788539589334277479792945086956024169921875	0.2641418432188959997120036859996616840362548828125	0.52663609428336044526730574943940155208110809326171875	3.7820872642509555	-2.835388679821396	CUX1;GBF1;VTI1A
ncRNA export from nucleus	2/61	0.612403158655653090391979276319034397602081298828125	0.87232958031308716062568464622017927467823028564453125	0.41785582478607918854862646185210905969142913818359375	0.614878345832392536607358124456368386745452880859375	5.783708613666796	-2.836125135990498	U2AF2;CDC40
ERBB2-ERBB3 signaling pathway	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.27993674328457	-2.8365440540431353	ERBB4
regulation of lipid catabolic process	3/81	0.51500302273564024790886151095037348568439483642578125	0.8291071723704404039523296887637116014957427978515625	0.294908496564629973857307732032495550811290740966796875	0.536579887494325280528073562891222536563873291015625	4.279139840742513	-2.839562351650845	TXNRD1;ID2;TBL1X
adenylate cyclase-activating G-protein coupled receptor signaling pathway	3/85	0.54763870489980315259259668891900219023227691650390625	0.83843290198389208711660103290341794490814208984375	0.3196832637712798685925008612684905529022216796875	0.54756353354058318050334719373495317995548248291015625	4.716948570932145	-2.8402610874910597	RAPGEF2;AKAP6;CACNA1D
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.681065389686308	-2.8433256534065077	EDC4
Wnt signaling pathway involved in wound healing, spreading of epidermal cells	3/73	0.446222755762159584147497071171528659760951995849609375	0.7941283521609532325413738362840376794338226318359375	0.245879423414060938046787896382738836109638214111328125	0.521558539066333093359162376145832240581512451171875	3.531960941984343	-2.8500699640473552	TNKS;WNT8B;CTNNB1
positive regulation of interferon-gamma biosynthetic process	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	8.964393734540865	-2.852446872692665	FZD5
ureter epithelial cell differentiation	3/56	0.290677791542660102219741702356259338557720184326171875	0.73858861214153648244717942361603491008281707763671875	0.148179646767307493515630767433322034776210784912109375	0.483043119420448807677104241520282812416553497314453125	2.3097062077200086	-2.853734109513321	SIX1;FGFR2;CNN3
negative regulation of cytokine production involved in inflammatory response	2/60	0.60337217682589472378396067142602987587451934814453125	0.8635032033033207543581966092460788786411285400390625	0.40998642174065924592696319450624287128448486328125	0.60624011014128209584583828473114408552646636962890625	5.6487072619019685	-2.853845892988816	TYRO3;GATA3
regulation of lipid metabolic process	3/80	0.506649167515452969468014998710714280605316162109375	0.82665656283998334430407339823432266712188720703125	0.28873118777371920007368544247583486139774322509765625	0.5293904906524435904913161721196956932544708251953125	4.207005660340832	-2.8604966713779523	TXNRD1;ID2;TBL1X
regulation of lipoprotein lipid oxidation	3/80	0.506649167515452969468014998710714280605316162109375	0.82665656283998334430407339823432266712188720703125	0.28873118777371920007368544247583486139774322509765625	0.5293904906524435904913161721196956932544708251953125	4.207272350155626	-2.8606780035151296	TXNRD1;ID2;TBL1X
negative regulation of autophagy of mitochondrion	3/59	0.31843019785720105829796011676080524921417236328125	0.74468777555399967571503339058835990726947784423828125	0.1644365203610824444080407147339428775012493133544921875	0.4884190844811817644455231857136823236942291259765625	2.5007882921428513	-2.8617820511621055	FZD5;LARS;U2AF2
positive regulation of protein serine/threonine kinase activity	3/68	0.4013228793426011353773219525464810431003570556640625	0.77355606841369339843339503204333595931529998779296875	0.2159463603298727718549088194777141325175762176513671875	0.50931227109647247974777428680681623518466949462890625	3.1365405150298944	-2.863626957759357	CAB39;PRKAG1;RAPGEF2
regulation of membrane lipid metabolic process	3/80	0.506649167515452969468014998710714280605316162109375	0.82665656283998334430407339823432266712188720703125	0.28873118777371920007368544247583486139774322509765625	0.5293904906524435904913161721196956932544708251953125	4.211824392747441	-2.8637731033873752	TXNRD1;ID2;TBL1X
regulation of phospholipid metabolic process	3/80	0.506649167515452969468014998710714280605316162109375	0.82665656283998334430407339823432266712188720703125	0.28873118777371920007368544247583486139774322509765625	0.5293904906524435904913161721196956932544708251953125	4.21232113594256	-2.864110857212991	TXNRD1;ID2;TBL1X
regulation of hair cycle by BMP signaling pathway	3/78	0.489720959283100387704479317108052782714366912841796875	0.81526193339578589824867549396003596484661102294921875	0.276408788547690742465334778898977674543857574462890625	0.5293904906524435904913161721196956932544708251953125	4.022340655926368	-2.8716275141299654	USP9X;GDF2;ACVR2A
DNA replication, synthesis of RNA primer	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.400583039756832	-2.8734213027106295	BAZ1A
cell chemotaxis to vascular endothelial growth factor	3/65	0.373887044460887718599906293093226850032806396484375	0.76643914967559323425660977591178379952907562255859375	0.198383554711667964287613585838698782026767730712890625	0.5051662884607235337597330726566724479198455810546875	2.9223960288223347	-2.875057735104254	PDGFRA;LPAR1;ELMO2
positive regulation of protein targeting to membrane	1/41	0.7540686829435134796995043870992958545684814453125	0.9169739565466752395650473772548139095306396484375	0.6173431618359839223586504886043258011341094970703125	0.71936948971846248479522500929306261241436004638671875	10.187918326570545	-2.8757622856023732	ANK3
sarcoplasmic reticulum calcium ion transport	3/59	0.31843019785720105829796011676080524921417236328125	0.74468777555399967571503339058835990726947784423828125	0.1644365203610824444080407147339428775012493133544921875	0.4884190844811817644455231857136823236942291259765625	2.5154768380043344	-2.878590917804729	SLN;ATP2A2;CACNA1D
sympathetic nervous system development	3/10	0.003797240025174056753110019002406261279247701168060302734375	0.069156684165042558998237609557691030204296112060546875	0.002755244303871814438855469830969013855792582035064697265625	0.03620191471131851967957260285402298904955387115478515625	0.5178545563194895	-2.88625241922922	SEMA3A;GATA3;PHOX2B
BMP signaling pathway involved in mesodermal cell fate specification	3/78	0.489720959283100387704479317108052782714366912841796875	0.81526193339578589824867549396003596484661102294921875	0.276408788547690742465334778898977674543857574462890625	0.5293904906524435904913161721196956932544708251953125	4.046626495699088	-2.8889656492260922	USP9X;GDF2;ACVR2A
fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	3/78	0.489720959283100387704479317108052782714366912841796875	0.81526193339578589824867549396003596484661102294921875	0.276408788547690742465334778898977674543857574462890625	0.5293904906524435904913161721196956932544708251953125	4.047285448041943	-2.8894360881670242	RBFOX2;GATA3;FGFR2
erythrocyte differentiation	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.100002435097135	-2.8955972100457865	TAL1
NLS-bearing protein import into nucleus	2/61	0.612403158655653090391979276319034397602081298828125	0.87232958031308716062568464622017927467823028564453125	0.41785582478607918854862646185210905969142913818359375	0.614878345832392536607358124456368386745452880859375	5.909401473254156	-2.897760446878719	STAT3;PRICKLE1
regulation of MAPK cascade	3/56	0.290677791542660102219741702356259338557720184326171875	0.73858861214153648244717942361603491008281707763671875	0.148179646767307493515630767433322034776210784912109375	0.483043119420448807677104241520282812416553497314453125	2.3463560871813325	-2.899016496848451	GDF2;PHIP;GDF5
cholesterol catabolic process	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.11623836672296	-2.9007634414455623	LDLRAP1
regulation of cellular pH reduction	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.117512616693244	-2.9011689044863878	SLC9A2
neuron projection extension	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.879563146285896	-2.9016243778510846	SRGAP2
cytoplasmic microtubule depolymerization	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	9.882705324378604	-2.9025472345015606	HOOK2
BMP signaling pathway involved in spinal cord dorsal/ventral patterning	3/76	0.4725135489533511812254573669633828103542327880859375	0.80316997434788539589334277479792945086956024169921875	0.2641418432188959997120036859996616840362548828125	0.52663609428336044526730574943940155208110809326171875	3.8768274843958017	-2.906414367214065	USP9X;GDF2;ACVR2A
positive regulation of MAPK cascade involved in axon regeneration	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.4182599795809585	-2.9064892822836006	LPAR1;FGFR2
transforming growth factor beta receptor signaling pathway involved in neural plate anterior/posterior pattern formation	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.6949989592538626	-2.909276939204598	USP9X;PARD3;GDF5
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	3/70	0.41942546353301468631258330788114108145236968994140625	0.7769671408471967577469285970437340438365936279296875	0.2278312858242342031633853594030370004475116729736328125	0.51657998938210114570068753891973756253719329833984375	3.357566635061862	-2.9172870693774655	TNKS;WNT8B;CTNNB1
positive regulation of interleukin-10 secretion	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.194040378348365	-2.9255198400735005	CADM1
endothelial cell differentiation	3/63	0.355457088918777974750895509714609943330287933349609375	0.76035323823870781811962160645634867250919342041015625	0.18687777255374660168030231943703256547451019287109375	0.4930103205458740145417095845914445817470550537109375	2.829561282216775	-2.9267588154758677	SIX1;FGFR2;CNN3
ERBB2-ERBB4 signaling pathway	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.204811913621857	-2.9289473147042253	ERBB4
Wnt signaling pathway	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.129405493017493	-2.9289820572603005	TNKS;WNT8B;CTNNB1
collagen-activated tyrosine kinase receptor signaling pathway	3/76	0.4725135489533511812254573669633828103542327880859375	0.80316997434788539589334277479792945086956024169921875	0.2641418432188959997120036859996616840362548828125	0.52663609428336044526730574943940155208110809326171875	3.9069918179642955	-2.9290282319820435	ERBB4;GRAP2;PTPRG
intracellular pH elevation	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.211001850111083	-2.9309169364660215	SLC9A2
Wnt signaling pathway involved in forebrain neuroblast division	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.134653111066292	-2.933893590502823	TNKS;WNT8B;CTNNB1
Wnt-activated signaling pathway involved in forebrain neuron fate commitment	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.137609412917415	-2.936660555377495	TNKS;WNT8B;CTNNB1
Wnt signaling pathway involved in mammary gland specification	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.139255496887514	-2.9382012155520623	TNKS;WNT8B;CTNNB1
Wnt signaling pathway involved in somitogenesis	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.140725314740666	-2.939576898610371	TNKS;WNT8B;CTNNB1
negative regulation of angiogenesis	3/70	0.41942546353301468631258330788114108145236968994140625	0.7769671408471967577469285970437340438365936279296875	0.2278312858242342031633853594030370004475116729736328125	0.51657998938210114570068753891973756253719329833984375	3.3832960275268245	-2.9396425524100724	GDF2;CTNNB1;SEMA3E
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	10.01094361532866	-2.940210777482662	ID2
respiratory basal cell differentiation	3/71	0.428408916846526433008790490930550731718540191650390625	0.78447393663240105876610641644219867885112762451171875	0.2338200464284278801141425674359197728335857391357421875	0.51657998938210114570068753891973756253719329833984375	3.4713141288756773	-2.9425535853339597	SIX1;FGFR2;CNN3
Wnt signaling pathway involved in kidney development	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.14557482841169	-2.9441158241540757	TNKS;WNT8B;CTNNB1
ion transport	3/77	0.481150974860152569334559302660636603832244873046875	0.808258243737656645322431359090842306613922119140625	0.27026742934478698021649734073434956371784210205078125	0.52663609428336044526730574943940155208110809326171875	4.0264968599203526	-2.9456811429067016	SLC9A2;SLC24A2;SLC1A6
negative regulation of cholesterol biosynthetic process	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	10.034976951873345	-2.9472693603538462	NFYA
positive regulation of ERK5 cascade	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.496147918338701	-2.9482703079397465	LPAR1;FGFR2
visual perception involved in equilibrioception	3/79	0.498221107881565206110252574944752268493175506591796875	0.81913871240060753819989258772693574428558349609375	0.28256400246224477879053438300616107881069183349609375	0.5293904906524435904913161721196956932544708251953125	4.2318286222110215	-2.948362857839658	TRPM1;SIX3;POU4F3
negative regulation of anterior neural cell fate commitment of the neural plate by Wnt signaling pathway	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.1513366439148633	-2.9495086229664045	TNKS;WNT8B;CTNNB1
angiogenesis involved in wound healing	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.276449558191327	-2.951742227697828	PDGFRA
ERBB signaling pathway	3/76	0.4725135489533511812254573669633828103542327880859375	0.80316997434788539589334277479792945086956024169921875	0.2641418432188959997120036859996616840362548828125	0.52663609428336044526730574943940155208110809326171875	3.939792317531827	-2.9536184010258255	ERBB4;GRAP2;PTPRG
Wnt signaling pathway involved in primitive streak formation	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.1557525044444263	-2.953641668775685	TNKS;WNT8B;CTNNB1
Wnt signaling pathway involved in regulation of cell proliferation in dorsal spinal cord	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.157063103886824	-2.954868330599984	TNKS;WNT8B;CTNNB1
Wnt signaling pathway involved in heart development	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.1615977644446165	-2.959112567864594	TNKS;WNT8B;CTNNB1
calcium-mediated signaling using extracellular calcium source	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.682165845051978	-2.9594910738929308	CACNA1C
Wnt signaling pathway involved in digestive tract morphogenesis	3/72	0.437342451945334553808919508810504339635372161865234375	0.78640967509848469507716117732343263924121856689453125	0.2398367981231294410182641740902909077703952789306640625	0.51657998938210114570068753891973756253719329833984375	3.580573650828928	-2.9612731488694584	TNKS;WNT8B;CTNNB1
cellular response to nitric oxide	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.697388931197386	-2.964144225706836	PDGFRA
heparin biosynthetic process	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	10.096224669848409	-2.9652577945520733	SDC3
recycling endosome to Golgi transport	3/75	0.46381122039538313917006462361314333975315093994140625	0.79875776801935816084920816138037480413913726806640625	0.258033983166688962729296008546953089535236358642578125	0.52327871822754590258597318097599782049655914306640625	3.8598014095285675	-2.9653992032334706	CUX1;GBF1;VTI1A
negative regulation of transforming growth factor beta receptor signaling pathway	3/62	0.34621384823404077746289431161130778491497039794921875	0.76035323823870781811962160645634867250919342041015625	0.181192635200256246807981597157777287065982818603515625	0.4930103205458740145417095845914445817470550537109375	2.7961113651044607	-2.9658315120882017	DLX1;SKOR1;NKX2-1
transmembrane receptor protein tyrosine kinase signaling pathway	3/77	0.481150974860152569334559302660636603832244873046875	0.808258243737656645322431359090842306613922119140625	0.27026742934478698021649734073434956371784210205078125	0.52663609428336044526730574943940155208110809326171875	4.054193770563651	-2.9659434876289446	ERBB4;GRAP2;PTPRG
activation of protein kinase A activity	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.709751732402827	-2.967923090931967	PRKAR2A
transforming growth factor beta receptor signaling pathway involved in heart development	3/73	0.446222755762159584147497071171528659760951995849609375	0.7941283521609532325413738362840376794338226318359375	0.245879423414060938046787896382738836109638214111328125	0.521558539066333093359162376145832240581512451171875	3.682162014277835	-2.971272766610307	USP9X;PARD3;GDF5
transforming growth factor receptor beta signaling pathway involved in oral/aboral axis specification	3/73	0.446222755762159584147497071171528659760951995849609375	0.7941283521609532325413738362840376794338226318359375	0.245879423414060938046787896382738836109638214111328125	0.521558539066333093359162376145832240581512451171875	3.6873375730888607	-2.9754491165067978	USP9X;PARD3;GDF5
positive regulation of chemokine secretion	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.352120632771843	-2.975820567676225	CADM1
transforming growth factor beta receptor signaling pathway involved in primitive streak formation	3/73	0.446222755762159584147497071171528659760951995849609375	0.7941283521609532325413738362840376794338226318359375	0.245879423414060938046787896382738836109638214111328125	0.521558539066333093359162376145832240581512451171875	3.6887630753930476	-2.976599407058584	USP9X;PARD3;GDF5
non-canonical Wnt signaling pathway	3/68	0.4013228793426011353773219525464810431003570556640625	0.77355606841369339843339503204333595931529998779296875	0.2159463603298727718549088194777141325175762176513671875	0.50931227109647247974777428680681623518466949462890625	3.261623510893948	-2.9778263558532765	TNKS;WNT8B;CTNNB1
detection of light stimulus involved in visual perception	3/78	0.489720959283100387704479317108052782714366912841796875	0.81526193339578589824867549396003596484661102294921875	0.276408788547690742465334778898977674543857574462890625	0.5293904906524435904913161721196956932544708251953125	4.171627637050407	-2.978206404176378	TRPM1;SIX3;POU4F3
positive regulation of cytokinesis	3/61	0.336958212842776105855335799788008444011211395263671875	0.75150443970656033432220510803745128214359283447265625	0.1755557968924423006829016458141268230974674224853515625	0.4930103205458740145417095845914445817470550537109375	2.7385012833804385	-2.978931710985187	SVIL;TAL1;FGFR2
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	2/62	0.62127613569979434071655077786999754607677459716796875	0.8740844799579179369430903534521348774433135986328125	0.425671954709346656020585442092851735651493072509765625	0.61914727424113114029324833609280176460742950439453125	6.260982734057856	-2.980100263470961	BRCA1;PRICKLE1
transforming growth factor beta receptor signaling pathway involved in primary germ layer cell fate commitment	3/73	0.446222755762159584147497071171528659760951995849609375	0.7941283521609532325413738362840376794338226318359375	0.245879423414060938046787896382738836109638214111328125	0.521558539066333093359162376145832240581512451171875	3.6931301604731033	-2.980123369588621	USP9X;PARD3;GDF5
regulation of cholesterol biosynthetic process	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	10.166247920758659	-2.985823599825958	NFYA
positive regulation of exit from mitosis	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.016325014617573	-2.987416216896735	PHIP
negative regulation of cell adhesion involved in substrate-bound cell migration	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	10.198350104806499	-2.9952520004987644	DSCAM
BMP signaling pathway involved in heart development	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8057471500354683	-2.996475111938216	USP9X;GDF2;ACVR2A
negative regulation of translational termination	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.588774395049461	-2.997957451567051	LIN28A;SLN
protein localization to pre-autophagosomal structure	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.590669317697463	-2.9989739351591878	GRID2;TRAPPC8
BMP signaling pathway involved in heart induction	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8092155802695022	-2.9992059987953943	USP9X;GDF2;ACVR2A
response to interferon-alpha	1/40	0.74550035831998029411948891720385290682315826416015625	0.91243518168016268798936607709038071334362030029296875	0.6084765108906255992593514747568406164646148681640625	0.713798483429763930274702943279407918453216552734375	10.211922325320863	-2.9992381571053808	JUND
BMP signaling pathway involved in Malpighian tubule cell chemotaxis	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.816892506981026	-3.005250467573894	USP9X;GDF2;ACVR2A
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.818990532900222	-3.006902359358406	USP9X;GDF2;ACVR2A
BMP signaling pathway involved in growth plate cartilage chondrocyte development	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8190888994379364	-3.006979808771225	USP9X;GDF2;ACVR2A
embryonic heart tube morphogenesis	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.45127790258541	-3.0073721541593836	FGFR2
BMP signaling pathway involved in forebrain neuron fate commitment	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.822042855448364	-3.0093056216321568	USP9X;GDF2;ACVR2A
calcium ion transport	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.612411222159999	-3.0106368329409365	SLN;CACNA1D
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8242899460561257	-3.0110748802862335	USP9X;GDF2;ACVR2A
protein insertion into membrane	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.091057421664274	-3.012177614070982	GRID2
BMP signaling pathway involved in renal system segmentation	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.826467671447403	-3.012789523870881	USP9X;GDF2;ACVR2A
cellular response to 3,3',5-triiodo-L-thyronine	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.47308618939156	-3.014311494547713	LARS
BMP signaling pathway involved in ureter morphogenesis	3/75	0.46381122039538313917006462361314333975315093994140625	0.79875776801935816084920816138037480413913726806640625	0.258033983166688962729296008546953089535236358642578125	0.52327871822754590258597318097599782049655914306640625	3.9252837215622405	-3.015707800834158	USP9X;GDF2;ACVR2A
C-terminal protein lipidation	3/78	0.489720959283100387704479317108052782714366912841796875	0.81526193339578589824867549396003596484661102294921875	0.276408788547690742465334778898977674543857574462890625	0.5293904906524435904913161721196956932544708251953125	4.2248922403993685	-3.016233044282242	CNTN5;NTM;CNTN4
lung epithelial cell differentiation	3/61	0.336958212842776105855335799788008444011211395263671875	0.75150443970656033432220510803745128214359283447265625	0.1755557968924423006829016458141268230974674224853515625	0.4930103205458740145417095845914445817470550537109375	2.7735529676378827	-3.017060805315589	SIX1;FGFR2;CNN3
BMP signaling pathway involved in determination of left/right symmetry	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8347513562917053	-3.0193117268687497	USP9X;GDF2;ACVR2A
cellular response to proline	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.491709488827837	-3.0202373802025946	LARS
regulation of actin phosphorylation	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.63409290495658	-3.0222674263247207	PHIP;EFNA5
mRNA cleavage involved in mRNA processing	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.641250083860545	-3.026106714925518	U2AF2;ELAVL4
negative regulation of tyrosine phosphorylation of STAT protein	2/59	0.5941829458589620305275502687436528503894805908203125	0.861327890478403190854805870912969112396240234375	0.402065457170801554553918322199024260044097900390625	0.60493277589116190018359020541538484394550323486328125	5.819874026991998	-3.0296402836152354	LRRC4;LRRC4B
cellular response to phenylalanine	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.521365251859162	-3.029673767204437	LARS
endothelial cell chemotaxis	3/72	0.437342451945334553808919508810504339635372161865234375	0.78640967509848469507716117732343263924121856689453125	0.2398367981231294410182641740902909077703952789306640625	0.51657998938210114570068753891973756253719329833984375	3.663375338240812	-3.0297533527488367	PDGFRA;LPAR1;ELMO2
positive regulation of protein complex assembly	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.526860741482778	-3.0314224177718923	TAL1
chondroitin sulfate catabolic process	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	9.925808471448706	-3.033963892225147	SDC3
cellular response to kainic acid	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.550250449552864	-3.038864962311256	LARS
modulation by symbiont of host cell cycle	3/63	0.355457088918777974750895509714609943330287933349609375	0.76035323823870781811962160645634867250919342041015625	0.18687777255374660168030231943703256547451019287109375	0.4930103205458740145417095845914445817470550537109375	2.9407217841938875	-3.0417377633215756	JUND;MECOM;STAT3
glial cell-derived neurotrophic factor receptor signaling pathway	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8640190894052076	-3.042355831061705	ERBB4;GRAP2;PTPRG
regulation of cell cycle	3/63	0.355457088918777974750895509714609943330287933349609375	0.76035323823870781811962160645634867250919342041015625	0.18687777255374660168030231943703256547451019287109375	0.4930103205458740145417095845914445817470550537109375	2.9423291900062294	-3.0434003847183573	JUND;MECOM;STAT3
Golgi calcium ion transport	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.677177852819353	-3.045379262903774	SLN;CACNA1D
cellular response to histidine	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.579586546231868	-3.0481996323075777	LARS
cytosolic calcium ion transport	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.68311509190558	-3.048564145474102	SLN;CACNA1D
sevenless signaling pathway	3/72	0.437342451945334553808919508810504339635372161865234375	0.78640967509848469507716117732343263924121856689453125	0.2398367981231294410182641740902909077703952789306640625	0.51657998938210114570068753891973756253719329833984375	3.6907441756455657	-3.052388441766963	ERBB4;GRAP2;PTPRG
regulation of insulin secretion involved in cellular response to glucose stimulus	3/69	0.410395569449722275034986296304850839078426361083984375	0.7769671408471967577469285970437340438365936279296875	0.221872664482902159921451357149635441601276397705078125	0.50931227109647247974777428680681623518466949462890625	3.4274247071743686	-3.0525802256036583	CACNA1D;CACNA1C;EFNA5
vesicle fusion with Golgi apparatus	2/59	0.5941829458589620305275502687436528503894805908203125	0.861327890478403190854805870912969112396240234375	0.402065457170801554553918322199024260044097900390625	0.60493277589116190018359020541538484394550323486328125	5.8683715305359465	-3.0548865328828434	CUX1;VTI1A
RNA-directed DNA methylation	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.7082797209080045	-3.062063077744577	ATF7IP;RBFOX2
Tie signaling pathway	3/74	0.455046676426210883192879919079132378101348876953125	0.7941283521609532325413738362840376794338226318359375	0.251945836325318028858788466095575131475925445556640625	0.521558539066333093359162376145832240581512451171875	3.8986678818006086	-3.0696367406908602	ERBB4;GRAP2;PTPRG
positive regulation of ER-associated ubiquitin-dependent protein catabolic process	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.2845555731628515	-3.0741955177537417	RNF217;PRICKLE1;TRIB1
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	2/59	0.5941829458589620305275502687436528503894805908203125	0.861327890478403190854805870912969112396240234375	0.402065457170801554553918322199024260044097900390625	0.60493277589116190018359020541538484394550323486328125	5.907975148403917	-3.0755029097173296	SFN;BRCA1
STAT protein import into nucleus	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.287444524875539	-3.076899445943819	STAT5B;STAT3;PRICKLE1
positive regulation of proteasomal ubiquitin-dependent protein catabolic process	3/71	0.428408916846526433008790490930550731718540191650390625	0.78447393663240105876610641644219867885112762451171875	0.2338200464284278801141425674359197728335857391357421875	0.51657998938210114570068753891973756253719329833984375	3.6373405737267634	-3.083290404999153	RNF217;PRICKLE1;TRIB1
cellular response to leucine starvation	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.69972268783388	-3.086426641468234	LARS
calcium ion export	2/57	0.57532963996458963418234588971245102584362030029296875	0.85592922282387073895648654797696508467197418212890625	0.38607622812643882515004634115030057728290557861328125	0.5939731141788688884020075420266948640346527099609375	5.587252895971621	-3.0887010935684702	SLN;CACNA1D
positive regulation of MAPK cascade involved in cell wall organization or biogenesis	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	5.42260392385863	-3.089536662559367	LPAR1;FGFR2
positive regulation of interleukin-8 secretion	2/57	0.57532963996458963418234588971245102584362030029296875	0.85592922282387073895648654797696508467197418212890625	0.38607622812643882515004634115030057728290557861328125	0.5939731141788688884020075420266948640346527099609375	5.593920997083608	-3.0923873006509295	CADM1;GDF2
Golgi ribbon formation	3/76	0.4725135489533511812254573669633828103542327880859375	0.80316997434788539589334277479792945086956024169921875	0.2641418432188959997120036859996616840362548828125	0.52663609428336044526730574943940155208110809326171875	4.1304787630979884	-3.0965739045289298	GBF1;VTI1A;CLASP2
glucose homeostasis	2/59	0.5941829458589620305275502687436528503894805908203125	0.861327890478403190854805870912969112396240234375	0.402065457170801554553918322199024260044097900390625	0.60493277589116190018359020541538484394550323486328125	5.969227509251147	-3.107388929763234	TCF7L2;STAT3
regulation of intracellular pH	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.38205095066179	-3.108593702236595	SLC9A2
regulation of actomyosin structure organization	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.404840375116558	-3.1161446163928104	EFNA5
positive regulation of mitotic spindle organization	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.802283920451476	-3.1190613601009436	TAL1
regulation of actin cytoskeleton organization by cell-cell adhesion	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.464572756588707	-3.135935993122737	EFNA5
regulation of myosin II filament organization	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.467880544132747	-3.137031976035409	EFNA5
positive regulation of cytokine biosynthetic process	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.47108489361136	-3.1380936863865214	GATA3
regulation of cell cycle checkpoint	3/64	0.364683053953996194618270010323612950742244720458984375	0.76643914967559323425660977591178379952907562255859375	0.1926088563681766785418147946984390728175640106201171875	0.5051662884607235337597330726566724479198455810546875	3.113198374157597	-3.1403661604027593	JUND;MECOM;STAT3
positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.880449104762672	-3.1439333193370507	CRHR1
epithelial cilium movement involved in determination of left/right asymmetry	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	9.883761373313705	-3.1449872746127445	CITED2
wound healing involved in inflammatory response	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.529315653573116	-3.1573875246576506	PDGFRA
regulation of meiotic cell cycle	3/64	0.364683053953996194618270010323612950742244720458984375	0.76643914967559323425660977591178379952907562255859375	0.1926088563681766785418147946984390728175640106201171875	0.5051662884607235337597330726566724479198455810546875	3.1312420718943277	-3.1585673191375596	JUND;MECOM;STAT3
long-term maintenance of gene activation	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.585410528430872	-3.1759736712931335	DEK
oxidative phosphorylation	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	5.944261576047881	-3.1886496083581375	ALK;STAT3
positive regulation of protein oligomerization	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.635212525996522	-3.192474772897198	TAL1
visceral muscle development	2/57	0.57532963996458963418234588971245102584362030029296875	0.85592922282387073895648654797696508467197418212890625	0.38607622812643882515004634115030057728290557861328125	0.5939731141788688884020075420266948640346527099609375	5.777264792442726	-3.1937419720374702	MEF2C;SOX6
negative regulation of cell cycle process	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.640775679724081	-3.1943180356052143	GATA3
negative regulation of JNK cascade	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.668253139096212	-3.2034222557386216	MECOM
regulation of synaptic vesicle exocytosis	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	10.093962366399044	-3.2118726862890394	MEF2C
skeletal muscle organ development	2/57	0.57532963996458963418234588971245102584362030029296875	0.85592922282387073895648654797696508467197418212890625	0.38607622812643882515004634115030057728290557861328125	0.5939731141788688884020075420266948640346527099609375	5.819260290894869	-3.216957592380628	MEF2C;SOX6
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex	2/58	0.58483539505434112282244996094959788024425506591796875	0.85592922282387073895648654797696508467197418212890625	0.394094749541649580493185567320324480533599853515625	0.59858894715301236288951258757151663303375244140625	6.002724388981187	-3.2200105138597492	U2AF2;CDC40
positive regulation of protein ubiquitination	2/60	0.60337217682589472378396067142602987587451934814453125	0.8635032033033207543581966092460788786411285400390625	0.40998642174065924592696319450624287128448486328125	0.60624011014128209584583828473114408552646636962890625	6.374394805771412	-3.220478526022029	BRCA1;PRICKLE1
renal water transport	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	10.121046779855584	-3.2204908765147926	PRKAR2A
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.773873820091302	-3.238417992331175	CYLD
blood circulation	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	10.597816842597396	-3.239372765386749	RCAN1
monocyte migration into blood stream	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	10.60288840050741	-3.2409229588667636	RCAN1
positive regulation of type B pancreatic cell proliferation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.395253762148657	-3.2424140960480092	FGFR2
gastric mucosal blood circulation	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	10.608347765552319	-3.2425916910882617	RCAN1
cellular iron ion homeostasis	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	5.692597815980691	-3.2433660847504378	GDF2;NEO1
positive regulation of endocytosis	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	10.19622323125809	-3.244411828678792	PACSIN3
positive regulation of protein kinase B signaling	3/67	0.3922112078353350295145673953811638057231903076171875	0.77355606841369339843339503204333595931529998779296875	0.2100545800279058905601914375438354909420013427734375	0.50931227109647247974777428680681623518466949462890625	3.472580727546894	-3.2501785614127563	TCF7L2;LIN28A;GATA3
regulation of cell cycle process	3/68	0.4013228793426011353773219525464810431003570556640625	0.77355606841369339843339503204333595931529998779296875	0.2159463603298727718549088194777141325175762176513671875	0.50931227109647247974777428680681623518466949462890625	3.5644515122469254	-3.254304987034136	JUND;MECOM;STAT3
negative regulation of respiratory burst involved in inflammatory response	2/52	0.5254465621137247577365769757307134568691253662109375	0.829434943229018006860542300273664295673370361328125	0.34534223049800394367281342056230641901493072509765625	0.56957318225842124004287825300707481801509857177734375	5.058251823036546	-3.25501936046507	TYRO3;GATA3
insulin receptor internalization	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.062685754307404	-3.2586844723358386	LDLRAP1
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	3/68	0.4013228793426011353773219525464810431003570556640625	0.77355606841369339843339503204333595931529998779296875	0.2159463603298727718549088194777141325175762176513671875	0.50931227109647247974777428680681623518466949462890625	3.581074134181437	-3.2694812578497725	GABBR1;LPAR1;CACNA1D
ATP biosynthetic process	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	5.768235789637798	-3.2864609329039505	PPAT;ATP5G2
pharyngeal muscle development	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	5.7803586673453315	-3.2933679605347828	MEF2C;SOX6
negative regulation of cell differentiation	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	9.940850009824903	-3.293742903116564	SKOR1
regulation of mitotic nuclear division	2/55	0.5558449878960181056442024782882072031497955322265625	0.84892917371396936498939567172783426940441131591796875	0.36990404036207269466984826067346148192882537841796875	0.58277800881359287377136979557690210640430450439453125	5.609644848428037	-3.2943526950109345	CYLD;GBF1
sequestering of TGFbeta in extracellular matrix	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.4427228071411475	-3.294911397657938	SKOR1;NKX2-1
muscle organ development	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	5.785348357434776	-3.2962108438953615	MEF2C;SOX6
mitochondrial mRNA 3'-end processing	2/57	0.57532963996458963418234588971245102584362030029296875	0.85592922282387073895648654797696508467197418212890625	0.38607622812643882515004634115030057728290557861328125	0.5939731141788688884020075420266948640346527099609375	5.964623291773664	-3.297316020420004	U2AF2;CDC40
muscle organ morphogenesis	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	5.793266261452137	-3.300722081502931	MEF2C;SOX6
negative regulation of inflammatory response to antigenic stimulus	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.289200000300576	-3.301080894085454	TYRO3;GATA3
negative regulation of glucose transport	1/39	0.73663397029709809515907181776128709316253662109375	0.909131982703142771384818843216635286808013916015625	0.59940509513359874205207233899272978305816650390625	0.70879765197923927377843256181222386658191680908203125	10.825792110572433	-3.309056633793658	YRDC
negative regulation of histamine secretion by mast cell	2/52	0.5254465621137247577365769757307134568691253662109375	0.829434943229018006860542300273664295673370361328125	0.34534223049800394367281342056230641901493072509765625	0.56957318225842124004287825300707481801509857177734375	5.143061615980167	-3.30959503752632	TYRO3;GATA3
pre-mRNA cleavage required for polyadenylation	2/57	0.57532963996458963418234588971245102584362030029296875	0.85592922282387073895648654797696508467197418212890625	0.38607622812643882515004634115030057728290557861328125	0.5939731141788688884020075420266948640346527099609375	6.005468241259061	-3.319895603354804	U2AF2;CDC40
response to interferon-beta	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	10.434875018398131	-3.3203502093488813	JUND
cardiac epithelial to mesenchymal transition	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.502730066089901	-3.3312385464873886	DDX17;CTNNB1
positive regulation of non-canonical Wnt signaling pathway	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.280064683376796	-3.3368477629955353	FGFR2
wound healing	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.691795470660262	-3.344754175420628	PDGFRA
regulation of extent of cell growth	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.533735997290508	-3.3500088935595995	LARS;PAPPA2
epiboly involved in wound healing	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.728326229041492	-3.3573613757063536	PDGFRA
positive regulation of lens epithelial cell proliferation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.338371624048502	-3.3578132833001524	FGFR2
Notch receptor processing, ligand-independent	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.552761187922509	-3.3615263490092406	PTCH1;RHBDL3
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.75013991677627	-3.3648895394354676	KCNH5
negative regulation of oxidative stress-induced cell death	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	10.194389068385204	-3.377749046853819	CTNNB1
zymogen activation	2/51	0.5150061511650181333976661335327662527561187744140625	0.8291071723704404039523296887637116014957427978515625	0.337084085792108301138370052285608835518360137939453125	0.55814126245555895078354069482884369790554046630859375	5.092252768932316	-3.379098935369717	PTCH1;RHBDL3
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.792291503833	-3.3794365547161154	CTNNB1
cognition	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.429603186126927	-3.390617562604508	SOBP
negative regulation of necrotic cell death	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	10.243699239753726	-3.3940871896520717	CTNNB1
regulation of epithelial to mesenchymal transition	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.469493195010335	-3.40496087716641	CLASP2
positive regulation of hepatocyte proliferation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.477839032334057	-3.4079618032972236	FGFR2
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.46062815963469	-3.4080721633613225	GPX1;SFN
protein initiator methionine removal involved in protein maturation	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.635119642775875	-3.4113844478331985	PTCH1;RHBDL3
phenylalanyl-tRNA aminoacylation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.915361672373557	-3.421909537285949	LARS
protein heterotrimerization	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	9.91631112426553	-3.422237204454499	MAGI2
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.484608921535914	-3.423038970238212	GPX1;SFN
peptidoglycan biosynthetic process	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	10.34268781823788	-3.4268854843199867	SDC3
regulation of respiratory burst involved in inflammatory response	2/56	0.56566599517610993697047661044052802026271820068359375	0.85465935273725524012888854485936462879180908203125	0.378011937226087724184253602288663387298583984375	0.5880911994772668460740305818035267293453216552734375	6.026925164807037	-3.4338495897231307	SEMA7A;FOXP1
galactosaminoglycan biosynthetic process	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	10.390364188230693	-3.4426822929585823	SDC3
DNA replication termination	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.578266323240694	-3.444072605585681	BAZ1A
positive regulation of actin nucleation	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	10.833767886069719	-3.447276886893741	BAIAP2L2
positive regulation of ryanodine-sensitive calcium-release channel activity	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.69610299108034	-3.448302500895186	AKAP6;ANK3
endosome to lysosome transport via multivesicular body sorting pathway	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.625217236822902	-3.460954820990712	HOOK2
DNA-dependent DNA replication maintenance of fidelity	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.630220400511202	-3.4627538165937395	BAZ1A
inhibition of cysteine-type endopeptidase activity involved in apoptotic process	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.720657855091469	-3.4631675058136904	GPX1;SFN
fatty acid catabolic process	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.039156616929542	-3.4646326487004524	STAT5B
glycyl-tRNA aminoacylation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.043346806892977	-3.46607873321786	LARS
ventricular cardiac muscle tissue morphogenesis	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.658561516080011	-3.472944477037732	FGFR2
positive regulation of Wnt signaling pathway	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.08009709979215	-3.476597283689015	GATA3;FGFR2
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.30135589300643	-3.4857537028533145	FGFR2
asparaginyl-tRNA aminoacylation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.123602426096378	-3.493775904319352	LARS
glutamyl-tRNA aminoacylation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.131242015332285	-3.4964124176540228	LARS
regulation of mRNA endonucleolytic cleavage involved in unfolded protein response	1/38	0.72745916618871475645136115417699329555034637451171875	0.90658517487771927978457142671686597168445587158203125	0.59012420168491264149679409456439316272735595703125	0.70151609358561817231247914605773985385894775390625	10.994686719332392	-3.49848084293249	MBNL2
endodermal cell differentiation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.757374024483042	-3.5084746493878507	EOMES
spliceosomal tri-snRNP complex assembly	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	10.59734902254893	-3.51126343324484	GEMIN5
negative regulation of vascular endothelial cell proliferation	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.0483576175650073	-3.5128778654223267	GDF2;NR2F2
regulation of mitotic cytokinesis	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.1382185621191265	-3.5163730820804013	CYLD;GBF1
threonyl-tRNA aminoacylation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.200266047284066	-3.5202334340770363	LARS
negative regulation of acute inflammatory response	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	4.9876312713270705	-3.520664161538378	TYRO3;GATA3
negative regulation of transforming growth factor beta receptor signaling pathway involved in primitive streak formation	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.149803650120391	-3.5243014119302662	SKOR1;NKX2-1
positive regulation of interferon-gamma secretion	2/51	0.5150061511650181333976661335327662527561187744140625	0.8291071723704404039523296887637116014957427978515625	0.337084085792108301138370052285608835518360137939453125	0.55814126245555895078354069482884369790554046630859375	5.312330126376105	-3.5251370835100366	CADM1;FZD5
cysteinyl-tRNA aminoacylation	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.220578657256445	-3.5272435579724983	LARS
B cell receptor internalization	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.423568127014349	-3.5315536649370554	LDLRAP1
regulation of cytokine production involved in inflammatory response	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.663884274206929	-3.534927808143583	SEMA7A;FOXP1
regulation of endocytosis	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	9.834485341755615	-3.5362016895887165	PACSIN3
neurotransmitter receptor internalization	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.459245702045921	-3.5449241069140833	LDLRAP1
Wnt receptor internalization	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.476818685120945	-3.5515097156714046	LDLRAP1
keratan sulfate catabolic process	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.310703717616201	-3.558346790893673	SDC3
double-strand break repair via single-strand annealing	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.7015814672889364	-3.5584552761607866	EYA1;BRCA1
low-density lipoprotein particle receptor catabolic process	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.109505712491412	-3.5592505534659056	VLDLR
mitochondrial double-strand break repair	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.707416741615143	-3.5620971714547616	EYA1;BRCA1
endosomal lumen acidification	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.51090081337098	-3.5642822518602424	HOOK2
mRNA splicing, via endonucleolytic cleavage and ligation	2/51	0.5150061511650181333976661335327662527561187744140625	0.8291071723704404039523296887637116014957427978515625	0.337084085792108301138370052285608835518360137939453125	0.55814126245555895078354069482884369790554046630859375	5.379938776603061	-3.5700005905608836	U2AF2;ELAVL4
cellular response to interferon-beta	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.355444565140477	-3.573787390834283	AKAP6
regulation of histamine secretion by mast cell	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.72902434339962	-3.575582848194853	SEMA7A;FOXP1
cellular response to cytokine stimulus	2/54	0.545867372523861416055979134398512542247772216796875	0.83722476272723655998930780697264708578586578369140625	0.361754824644498540475723302733968012034893035888671875	0.57817199210730663150314967424492351710796356201171875	5.924782843982276	-3.586740536496176	JUND;AKAP6
positive regulation of potassium ion transmembrane transporter activity	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.094798734558435	-3.592523123912705	CACNA1D;AKAP6
positive regulation of protein monoubiquitination	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.763502915815539	-3.5971015195725777	BRCA1;PRICKLE1
glutaminyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.021101135534556	-3.603303430283083	LARS
prolyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.02239829224365	-3.6037698510043468	LARS
protein autoprocessing	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.2684410775771795	-3.6054917021821984	PTCH1;RHBDL3
positive regulation of SNARE complex assembly	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.050879987981371	-3.614011060085462	TAL1
positive regulation of protein export from nucleus	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	10.910774049611994	-3.6151118423374013	TCF7L2
chloroplast mRNA processing	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.284489777132203	-3.616474733447884	U2AF2;ELAVL4
polycistronic mRNA processing	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.286525918670752	-3.617868180069685	U2AF2;ELAVL4
valyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.062185197485823	-3.6180760924243742	LARS
alanyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.071056938344435	-3.621266118533887	LARS
mitochondrial mRNA processing	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.294272996571743	-3.62316994290178	U2AF2;ELAVL4
leucyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.085655174605307	-3.6265152297925645	LARS
positive regulation of interferon-alpha production	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	5.812113346076263	-3.6274401270326533	IFIH1;CTNNB1
aspartyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.092995914368194	-3.6291547513791325	LARS
methionyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.094537778254663	-3.6297091618531914	LARS
seryl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.094566903275243	-3.6297196343836196	LARS
cell morphogenesis involved in differentiation	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.117105427580406	-3.630778498606898	SHROOM3;MSX1
arginyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.098432782600636	-3.6311096948216735	LARS
lysyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.100438386318814	-3.6318308529718366	LARS
adherens junction assembly	2/51	0.5150061511650181333976661335327662527561187744140625	0.8291071723704404039523296887637116014957427978515625	0.337084085792108301138370052285608835518360137939453125	0.55814126245555895078354069482884369790554046630859375	5.4749923929398365	-3.6330759303645643	CADM1;CTNNB1
apoptotic cell clearance	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.695636133344982	-3.633513214856867	TYRO3
histidyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.108368819284726	-3.634682411490528	LARS
positive regulation of epithelial cell proliferation involved in lung morphogenesis	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.699376048161666	-3.6349147763142042	FGFR2
tyrosyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.11227481193878	-3.636086895542596	LARS
regulation of translation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.118620173184489	-3.6383685072770557	GEMIN5
positive regulation of mitotic cytokinesis	2/52	0.5254465621137247577365769757307134568691253662109375	0.829434943229018006860542300273664295673370361328125	0.34534223049800394367281342056230641901493072509765625	0.56957318225842124004287825300707481801509857177734375	5.65921420336885	-3.641742728800362	SVIL;TAL1
tryptophanyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.130827091005047	-3.6427577683234325	LARS
isoleucyl-tRNA aminoacylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.131192792943397	-3.6428892643567616	LARS
positive regulation of mitotic centrosome separation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.336307472157783	-3.6478661506341075	PHIP
negative regulation of vesicle fusion	2/52	0.5254465621137247577365769757307134568691253662109375	0.829434943229018006860542300273664295673370361328125	0.34534223049800394367281342056230641901493072509765625	0.56957318225842124004287825300707481801509857177734375	5.681299188086812	-3.6559545662785102	YRDC;TBC1D9
activation of signaling protein activity involved in unfolded protein response	2/51	0.5150061511650181333976661335327662527561187744140625	0.8291071723704404039523296887637116014957427978515625	0.337084085792108301138370052285608835518360137939453125	0.55814126245555895078354069482884369790554046630859375	5.516609664851818	-3.660692171268539	PRKAG1;RAPGEF2
positive regulation of cytokinesis, actomyosin contractile ring assembly	1/37	0.717965234248305161912639960064552724361419677734375	0.9035864487591396265742105242679826915264129638671875	0.58062900944964968008576988722779788076877593994140625	0.6974292378601434361229394198744557797908782958984375	11.072336378375445	-3.6686429562008698	SVIL
cardiac muscle thin filament assembly	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.207612581180008	-3.6759443479988017	PDGFRA;DLG1
regulation of endocytosis by exocyst localization	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.817158944142491	-3.6790548103609226	PACSIN3
response to type I interferon	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.249092279751004	-3.6852825721875786	JUND
protein localization to membrane	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.44383450866536	-3.6898789311604254	GRID2
protein catabolic process, modulating synaptic transmission	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.44634491966775	-3.690859794670663	NLGN2
positive regulation of histone ubiquitination	2/52	0.5254465621137247577365769757307134568691253662109375	0.829434943229018006860542300273664295673370361328125	0.34534223049800394367281342056230641901493072509765625	0.56957318225842124004287825300707481801509857177734375	5.736934556544209	-3.691756303279955	BRCA1;PRICKLE1
negative regulation of cell-cell adhesion	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.39583290468261	-3.6926731224147056	DSCAM;EFNA5
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.154815881270646	-3.6954509058699196	GTPBP1;ZFP36L1
positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.461812493975607	-3.6969032589544084	FGFR2
positive regulation of transforming growth factor beta receptor signaling pathway	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	9.867597447800863	-3.6979570223519445	CITED2
positive regulation of telomerase RNA reverse transcriptase activity	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.289861999998502	-3.699942205977579	TNKS
positive regulation of cell-cell adhesion	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.4087156628079756	-3.70148952120104	CITED2;EFNA5
membrane depolarization during action potential	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.244918706522271	-3.7022779583547685	AKAP6;CACNG2
trifid subdivision of terminal units involved in ureteric bud branching	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.1609946311782418	-3.706047294703709	SIX1;HOXD11
positive regulation of protein autoubiquitination	2/52	0.5254465621137247577365769757307134568691253662109375	0.829434943229018006860542300273664295673370361328125	0.34534223049800394367281342056230641901493072509765625	0.56957318225842124004287825300707481801509857177734375	5.7803569098375895	-3.7196988821771164	BRCA1;PRICKLE1
positive regulation of interleukin-4 production	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.536880750260268	-3.726233800167256	GATA3
histone H4 acetylation	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.36783290914329	-3.7279783310085355	ELP4
CAAX-box protein processing	2/48	0.482787744624386727654297146727913059294223785400390625	0.80985412211708107665941724917502142488956451416015625	0.3121366583929316984580282223760150372982025146484375	0.54756353354058318050334719373495317995548248291015625	5.135512258949167	-3.7395679394835395	PTCH1;RHBDL3
positive regulation of endocardial cushion to mesenchymal transition	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.024883460564912	-3.756901149176674	CTNNB1
cytoplasmic sequestering of NF-kappaB	2/53	0.5357341457206761248244220041669905185699462890625	0.83619633264365200719936410678201355040073394775390625	0.3535667053400473047730656617204658687114715576171875	0.57115553050993261852141813506023027002811431884765625	6.0213298900840515	-3.758015778570022	CYLD;TLE1
positive regulation of interleukin-5 secretion	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.194754686354181	-3.7639448754513394	CADM1;GATA3
glutathione deglycation	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.053256310605278	-3.767534090032434	GPX1
positive regulation of extrinsic apoptotic signaling pathway	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.05465808125987	-3.7680594142223693	CYLD
endosome to lysosome transport of low-density lipoprotein particle	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.074899659228661	-3.775645099166363	HOOK2
regulation of GTPase activity	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.529436071966964	-3.784105313443503	SIPA1L1;EFNA5
activation of plasma proteins involved in acute inflammatory response	2/47	0.47175744660811080866125166721758432686328887939453125	0.80316997434788539589334277479792945086956024169921875	0.3037736198132952036843335008597932755947113037109375	0.5415890136073973071262344092247076332569122314453125	5.039105002802315	-3.785830758595621	PTCH1;RHBDL3
activation of adenylate cyclase activity	1/36	0.708141091521711896206170422374270856380462646484375	0.89931624229308193552157035810523666441440582275390625	0.57091458678722240005498633763636462390422821044921875	0.69640654405878665844653596650459803640842437744140625	10.9730031574013	-3.7869142243796623	CRHR1
heterotrimeric G-protein complex cycle	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.5381838359370805	-3.7900919022545914	SIPA1L1;EFNA5
positive regulation of Wnt signaling pathway by Wnt receptor internalization	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.322884331923584	-3.7991375264575513	FGFR2
positive regulation of urothelial cell proliferation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.741138626117973	-3.8060410894584193	FGFR2
histone deacetylation	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.158928523477229	-3.8071355536839926	TBL1X
positive regulation of granulosa cell proliferation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.747641388415236	-3.8085818376654106	FGFR2
negative regulation of chronic inflammatory response	2/46	0.460586735531551882960599186844774521887302398681640625	0.79436476471748818095619526502559892833232879638671875	0.295392582861357444468097810386097989976406097412109375	0.536579887494325280528073562891222536563873291015625	4.913513366259899	-3.8092213346826034	TYRO3;GATA3
positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.349086417289513	-3.8098150509490094	FGFR2
positive regulation of epithelial cell proliferation involved in prostate gland development	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.765120645931267	-3.8154113033852464	FGFR2
assembly of apicomedial cortex actomyosin	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.18344824618706	-3.8163245058337534	DLG1
positive regulation of exocytosis	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.773151458494032	-3.8185490887888616	CLASP2
positive regulation of acinar cell proliferation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.775170405210446	-3.8193379282105173	FGFR2
actomyosin contractile ring organization	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.194713003808893	-3.820546059233465	DLG1
positive regulation of cholangiocyte proliferation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.79128632268617	-3.8256347120323255	FGFR2
mesonephros development	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.419795409974446	-3.8257197504678873	SIX1;GATA3
positive regulation of protein polyubiquitination	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.600140445071455	-3.8324923081507625	BRCA1;PRICKLE1
positive regulation of thyroid gland epithelial cell proliferation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.808936997535659	-3.8325311536406708	FGFR2
establishment of bipolar cell polarity involved in cell morphogenesis	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.147504741971292	-3.8326446926105393	SHROOM3;MSX1
protein kinase B signaling	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	1.9794829819359232	-3.8350229534657996	TYRO3;ZFP36L1
cholesterol homeostasis	2/50	0.50441473461590236038176726651727221906185150146484375	0.82500842690125220091346136541687883436679840087890625	0.3287950994326471754192198204691521823406219482421875	0.5556884571923312865493471690570004284381866455078125	5.608583086181805	-3.838270084160714	LDLRAP1;LDLR
triglyceride biosynthetic process	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.245641503192658	-3.8396319008408373	LMF1
negative regulation of potassium ion transmembrane transport	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.2398693084110968	-3.8413152310335983	CAB39;CACNA1D
negative regulation of protein kinase B signaling	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	9.832538113347118	-3.841752541404791	MAGI2
mitotic recombination	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.284149863667398	-3.854063201143685	TOP2B
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.2550701964835276	-3.867384342592293	EFNA1;NKX2-1
negative regulation of leukotriene production involved in inflammatory response	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.8343451429523485	-3.868011666297339	TYRO3;GATA3
suppression by virus of host autophagy	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.49251178938078	-3.8682618463782137	LARS
negative regulation of fat cell differentiation	2/46	0.460586735531551882960599186844774521887302398681640625	0.79436476471748818095619526502559892833232879638671875	0.295392582861357444468097810386097989976406097412109375	0.536579887494325280528073562891222536563873291015625	4.992678472693066	-3.8705944072498566	SKOR1;GATA3
negative regulation of inflammatory response to wounding	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.837766707261275	-3.870749296787625	TYRO3;GATA3
glucose transmembrane transport	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.786330606466134	-3.878458220187753	SLC37A4
cell morphogenesis involved in conjugation	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.1744554679574373	-3.8807435651736717	SHROOM3;MSX1
positive regulation of interleukin-8 biosynthetic process	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.531495202329937	-3.884147847080528	GDF2
negative regulation of protein targeting to vacuole involved in autophagy	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.533213158724877	-3.8848479257661	LARS
negative regulation by organism of inflammatory response of other organism involved in symbiotic interaction	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.858168313352207	-3.8870728417637164	TYRO3;GATA3
regulation of tumor necrosis factor-mediated signaling pathway	1/35	0.69797527037552564710409797044121660292148590087890625	0.8932038389477359174861703650094568729400634765625	0.56097588900797312749801903919433243572711944580078125	0.68963337723497775133552067927666939795017242431640625	10.814831418540566	-3.8887063029607623	CYLD
photosynthetic phosphorylation	2/48	0.482787744624386727654297146727913059294223785400390625	0.80985412211708107665941724917502142488956451416015625	0.3121366583929316984580282223760150372982025146484375	0.54756353354058318050334719373495317995548248291015625	5.350382562161327	-3.8960318045320705	ALK;STAT3
mitotic spindle elongation	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.523419631249303	-3.8988659118946605	TNKS;CLASP2
heart contraction	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.5242398904482	-3.899444915635641	RCAN1;GPX1
positive regulation of interleukin-17 secretion	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.578316789666752	-3.9032279561075702	CADM1
actin crosslink formation	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.558894787439137	-3.923907079580918	BAIAP2L2;DLG1
positive regulation of podosome assembly	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.046485930549212	-3.9253458680707127	TAL1
cell morphogenesis	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.20288892855636	-3.931488669353036	SHROOM3;MSX1
establishment of skin barrier	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.069809977970555	-3.934459000145447	SFN
regulation of I-kappaB phosphorylation	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.658375162602386	-3.935852276875491	PHIP
positive regulation of tau-protein kinase activity	2/47	0.47175744660811080866125166721758432686328887939453125	0.80316997434788539589334277479792945086956024169921875	0.3037736198132952036843335008597932755947113037109375	0.5415890136073973071262344092247076332569122314453125	5.25374567256795	-3.9470882138763526	PRKAG1;RAPGEF2
cholesterol efflux	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.126671589450293	-3.9566758721160853	LDLR
positive regulation of keratinocyte migration	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.72050168007886	-3.9611692469814894	CLASP2
dibasic protein processing	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.95891112019265	-3.9676782475904915	PTCH1;RHBDL3
DNA synthesis involved in double-strand break repair via single-strand annealing	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.591547956153738	-3.9692629689474264	BRCA1
negative regulation of programmed cell death	2/47	0.47175744660811080866125166721758432686328887939453125	0.80316997434788539589334277479792945086956024169921875	0.3037736198132952036843335008597932755947113037109375	0.5415890136073973071262344092247076332569122314453125	5.291662032420943	-3.9755744076162354	MECOM;CTNNB1
bone morphogenesis	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.62050208390081	-3.980113748034713	FGFR2
negative regulation of meiotic cell cycle	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.192932388681644	-3.9825651787130267	GATA3
protein targeting to Golgi	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.19630661724413	-3.9838835515487863	AKAP6
neuropeptide processing	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.980702758983184	-3.9851139727150002	PTCH1;RHBDL3
pronephros development	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.98086539879138	-3.985244102578902	SIX1;GATA3
negative regulation of bone mineralization	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.780111603054563	-3.9854606880487964	MEF2C
negative regulation of type I interferon production	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.646701223305972	-3.9858877985017322	IFIH1;CYLD
phosphorylation	2/46	0.460586735531551882960599186844774521887302398681640625	0.79436476471748818095619526502559892833232879638671875	0.295392582861357444468097810386097989976406097412109375	0.536579887494325280528073562891222536563873291015625	5.14562475116609	-3.989166635224322	ALK;STAT3
cellular response to glucose stimulus	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.654583529187884	-3.991451752675383	TCF7L2;LIN28A
protein processing in phagocytic vesicle	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.991659628645871	-3.9938806822543795	PTCH1;RHBDL3
protein localization to organelle	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.80323000748205	-3.99488159199711	GRID2
peptide bond cleavage involved in epidermal growth factor receptor ligand maturation	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	4.99511524295921	-3.9966455565202783	PTCH1;RHBDL3
regulation of inflammatory response by sphingosine-1-phosphate signaling pathway	2/49	0.493674444898304809470346299349330365657806396484375	0.81526193339578589824867549396003596484661102294921875	0.32047824734778951327740514898323453962802886962890625	0.54756353354058318050334719373495317995548248291015625	5.664237721757763	-3.9982664444479603	SEMA7A;FOXP1
protein splicing	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.007357533548229	-4.006440745200499	PTCH1;RHBDL3
positive regulation of interleukin-12 secretion	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	4.8566151307392875	-4.011100092782421	CADM1;FOXP1
positive regulation of interferon-beta secretion	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.5594257220005865	-4.014550458175791	IFIH1;CADM1
regulation of potassium ion transmembrane transport	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.2524358854469875	-4.019914961342293	CACNA1D;ANK3
multivesicular body organization	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.885368095831552	-4.028353410662878	HOOK2
trachea cartilage development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.1700012400354183	-4.033358389516564	COL11A2;GDF2
glycoprotein transport	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	9.51449234081966	-4.045378728587288	VLDLR
definitive erythrocyte differentiation	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.940873720528458	-4.050972322815785	TAL1
lateral mesoderm development	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.2711872021139357	-4.053380374898059	TBX6;MEST
neuron projection arborization	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.386797297878228	-4.058311745775319	SRGAP2
very long-chain fatty acid metabolic process	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.830774691576092	-4.058915003383285	STAT5B
glucose import	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	10.855371722172723	-4.068132927250263	SLC37A4
rhabdomere morphogenesis	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.414840956725534	-4.0692689163863	SRGAP2
regulation of cell motility involved in somitogenic axis elongation	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	9.987587947607311	-4.070008681821872	ERBB4
positive regulation of cyclin-dependent protein kinase activity	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.101775943700907	-4.081985933056236	PRKAG1;RAPGEF2
negative regulation of fibroblast growth factor receptor signaling pathway	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.4770479351040207	-4.084998350858025	OTX2;FGFR2
phospholipid translocation	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.486898270259452	-4.097423027176876	LDLR
positive regulation of DNA replication	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	4.818135116156645	-4.108338430845307	PDGFRA;ZBTB38
negative regulation of neural crest formation	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.3965180910396326	-4.10996365278492	EFNA1;NKX2-1
ribosomal protein import into nucleus	2/46	0.460586735531551882960599186844774521887302398681640625	0.79436476471748818095619526502559892833232879638671875	0.295392582861357444468097810386097989976406097412109375	0.536579887494325280528073562891222536563873291015625	5.303888454536318	-4.111861218599932	STAT3;PRICKLE1
G-protein coupled glutamate receptor signaling pathway	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.308501923488286	-4.119975836149691	TRPM1;GRID2
positive regulation of dendritic spine development	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.314168457015453	-4.130088880011219	MEF2C;VLDLR
regulation of cell-cell adhesion mediated by integrin	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.222511466072025	-4.130958592139812	EFNA1;EFNA5
mixed acid fermentation	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.175317135747759	-4.140827033635356	STAT5B;SLC37A4
bronchus cartilage development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.2291284593692753	-4.143257527705584	COL11A2;GDF2
response to tumor necrosis factor	2/48	0.482787744624386727654297146727913059294223785400390625	0.80985412211708107665941724917502142488956451416015625	0.3121366583929316984580282223760150372982025146484375	0.54756353354058318050334719373495317995548248291015625	5.690580386134483	-4.143756434805351	JUND;AFF3
positive regulation of tumor necrosis factor production	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.171450123020435	-4.144933744220881	FOXP1
left ventricular cardiac muscle tissue morphogenesis	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	9.75792060073873	-4.148879732039543	FGFR2
kidney mesenchyme development	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.027372425333951	-4.152129303818064	SIX1;GATA3
adenylate cyclase-inhibiting dopamine receptor signaling pathway	2/47	0.47175744660811080866125166721758432686328887939453125	0.80316997434788539589334277479792945086956024169921875	0.3037736198132952036843335008597932755947113037109375	0.5415890136073973071262344092247076332569122314453125	5.5295904771205135	-4.154327742541293	GABBR1;LPAR1
negative regulation of cell adhesion mediated by integrin	2/48	0.482787744624386727654297146727913059294223785400390625	0.80985412211708107665941724917502142488956451416015625	0.3121366583929316984580282223760150372982025146484375	0.54756353354058318050334719373495317995548248291015625	5.707051007247923	-4.155749981613046	EFNA1;DSCAM
negative regulation of reactive oxygen species metabolic process	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.32905255792018	-4.156652486238425	BRCA1;AATF
kidney epithelium development	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.037099396534607	-4.160162852706569	SIX1;GATA3
tRNA threonylcarbamoyladenosine modification	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.2150388393965	-4.16269643677595	YRDC
renal glucose absorption	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	10.686504270669143	-4.175412743617704	SLC37A4
sterol regulatory element binding protein import into nucleus	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.218708876451905	-4.1755452331642555	STAT3;PRICKLE1
regulation of fibroblast growth factor receptor signaling pathway	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.5336839017244115	-4.17839897785632	OTX2;FGFR2
myeloid cell differentiation	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.2238356707995655	-4.179647236592034	KIRREL3;TAL1
cholesterol ester hydrolysis involved in cholesterol transport	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	9.833465264029636	-4.18099986656571	LDLRAP1
T cell differentiation in thymus	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	9.441268268764608	-4.190074807549159	ZFP36L1
positive regulation of NMDA glutamate receptor activity	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.254359158394207	-4.190153561545599	MEF2C;ANK3
histone H4-K12 acetylation	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	11.18319436663454	-4.190986950895475	ELP4
cAMP-mediated signaling	2/23	0.179968592367181212665627754176966845989227294921875	0.73858861214153648244717942361603491008281707763671875	0.108574626118820682929566601160331629216670989990234375	0.444957872634645645870676844424451701343059539794921875	2.445364517559096	-4.19373395200112	RAPGEF2;AKAP6
kidney morphogenesis	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.085673793020209	-4.200280663363842	SIX1;GATA3
positive regulation of apoptosome assembly	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.309856249123635	-4.201335163443659	TAL1
kidney smooth muscle tissue development	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.095915422260951	-4.2087392706225835	SIX1;GATA3
response to gamma radiation	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.276021906080813	-4.22140200604251	EYA1;BRCA1
positive regulation of chondrocyte development	3/11	0.005091763047913171712222091258581713191233575344085693359375	0.08702118223553055587071725085479556582868099212646484375	0.003448509799230563450944675452092269551940262317657470703125	0.0443232172288026415873929408917319960892200469970703125	0.8010012616207577	-4.2293916995030205	PKDCC;SOX6;GDF5
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	2/47	0.47175744660811080866125166721758432686328887939453125	0.80316997434788539589334277479792945086956024169921875	0.3037736198132952036843335008597932755947113037109375	0.5415890136073973071262344092247076332569122314453125	5.642201214014573	-4.238931097947573	GRID2;CADM1
negative regulation of STAT protein import into nucleus	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.304506250436439	-4.244192637041418	LRRC4;LRRC4B
regulation of mitotic spindle organization	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.304712579309409	-4.244357722997043	CYLD;GBF1
ribosomal large subunit biogenesis	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.428314928179923	-4.24960786499336	AAMP
negative regulation of brown fat cell differentiation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.001868751777693	-4.252601783173823	GATA3
collecting duct development	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.830194859745076	-4.252961265209411	SIX1;GATA3
plasma membrane repair	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.324072643894023	-4.259847919385425	PDGFRA;ANK3
Schwann cell differentiation	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.3887650454975673	-4.26322116761231	NFIB;PHOX2B
cell differentiation involved in kidney development	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.843864644221942	-4.264997438815654	SIX1;GATA3
cellular response to drug	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.039387993548198	-4.268554241500995	MEF2C
kidney vasculature development	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.848674185441531	-4.269232214658925	SIX1;GATA3
positive regulation of G2/M transition of mitotic cell cycle	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.2983342698820466	-4.2718896368883525	KCNH5;PHOX2B
positive regulation of DNA-dependent DNA replication	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.048049285818694	-4.272236856007165	PDGFRA
regulation of proteolysis	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.299438125171004	-4.2739413610571635	BTBD3;BTBD11
response to X-ray	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.180296008178759	-4.278429572796566	EYA1;BRCA1
cellular response to amino acid stimulus	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.074123611204131	-4.283323156515703	LARS
renal capsule development	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.026390236464259	-4.285913881419754	SIX1;GATA3
positive regulation of microtubule binding	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.8679310161174945	-4.286187753168998	TCF7L2;RAPGEF2
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway	2/46	0.460586735531551882960599186844774521887302398681640625	0.79436476471748818095619526502559892833232879638671875	0.295392582861357444468097810386097989976406097412109375	0.536579887494325280528073562891222536563873291015625	5.528842953372207	-4.286258113942208	GABBR1;LPAR1
cellular response to nitroglycerin	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.08402150306051	-4.287531549327358	MEF2C
negative regulation of ryanodine-sensitive calcium-release channel activity	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.084021590038187	-4.28753158630859	SLN
neural crest cell differentiation	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.704034456428757	-4.290941687555404	MEF2C;FGFR2
Wnt receptor recycling	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.569366699429058	-4.292667034563366	REP15;FGFR2
cellular response to vascular endothelial growth factor stimulus	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.576181582604086	-4.299069240005424	STAT5B;CTNNB1
negative regulation of tumor necrosis factor production	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.577051112946812	-4.310218851998218	FOXP1
positive regulation of exosomal secretion	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.581398573715052	-4.311990471248375	CLASP2
positive regulation of mitotic G1 cell cycle arrest in response to nitrogen starvation	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.4170164210581095	-4.313641305218929	ID2;BRCA1
negative regulation of cell adhesion	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	11.041598377677518	-4.314154508186659	DSCAM
cellular response to fluoxetine	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.155066192605304	-4.3177383817644985	MEF2C
histone H3 deacetylation	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.611850914532855	-4.3244000031754455	TBL1X
protein localization involved in establishment of planar polarity	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.7257977167094873	-4.325477076175798	GRID2;VANGL2
ribonucleoprotein complex import into nucleus	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.917162831338679	-4.329536108511063	STAT3;PRICKLE1
regulation of acute inflammatory response	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.246085518155247	-4.332765422450485	SEMA7A;FOXP1
adherens junction maintenance	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	11.092261988619072	-4.333949707945636	CADM1
negative regulation of JAK-STAT cascade	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.086498290926217	-4.3371669542780324	LRRC4;LRRC4B
negative regulation of cell death	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.088175715758782	-4.33859726470693	JUND;CTNNB1
negative regulation of cell adhesion in ventricular zone	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	11.106877696568697	-4.3396603324570915	DSCAM
regulation of neuron projection development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.335848133022601	-4.34161625815916	CASZ1;SIX1
regulation of chronic inflammatory response	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.257896697047887	-4.342520327765563	SEMA7A;FOXP1
regulation of inflammatory response to wounding	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.259387425008744	-4.343751526635793	SEMA7A;FOXP1
embryonic camera-type eye development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.3380500882999065	-4.345709009180314	CACNA1C;FGFR2
positive regulation cytokinesis, site selection	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	11.596788744436314	-4.345984582475816	SVIL
positive regulation of focal adhesion assembly	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.433773280243644	-4.347620581173789	LDB1;EFNA5
positive regulation of keratinocyte proliferation	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.940893220676308	-4.350430591982606	FGFR2;ZFP36L1
positive regulation of protein histidine kinase activity	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.102926143404823	-4.3511746929667625	PRKAG1;RAPGEF2
proteasome core complex import into nucleus	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.789175226345345	-4.355257363935938	STAT3;PRICKLE1
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.344074431264597	-4.3569063918313775	AKAP6;CACNA1C
endosome membrane tubulation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.25496520441253	-4.3602135157911475	HOOK2
fatty acid oxidation	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	9.826025524409411	-4.3608317056697965	STAT5B
positive regulation of cell septum assembly	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	11.64131584529429	-4.362671451409593	SVIL
negative regulation of mitotic cell cycle, embryonic	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.4447212238351526	-4.363085976165633	DLG1;CTNNB1
synaptic vesicle endocytosis	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.718324201300758	-4.367788577453911	FCHO2
regulation of phagocytosis	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.72110033553561	-4.368919870664747	PACSIN3
cellular response to glial cell derived neurotrophic factor	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.2561277897992973	-4.3709907782942725	STAT5B;CTNNB1
ventricular trabecula myocardium morphogenesis	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.289565884962336	-4.374925058149568	FGFR2
positive regulation of FtsZ-dependent cytokinesis	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	11.682079527286051	-4.377947950565114	SVIL
cellular response to platelet-derived growth factor stimulus	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.7592344775454065	-4.3785367517382	STAT5B;CTNNB1
negative regulation of endocardial cushion to mesenchymal transition	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.3614785676912113	-4.389255276418849	EFNA1;NKX2-1
positive regulation of TOR signaling	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.314660259307507	-4.389401606952198	LIN28A;RHEB
positive regulation of actomyosin contractile ring localization	1/34	0.68745590591405159042182049233815632760524749755859375	0.88963772515681238672868857975117862224578857421875	0.55080775564756534468102699975133873522281646728515625	0.68372636404988573755048264501965604722499847412109375	11.713574113728688	-4.389750785826455	SVIL
negative regulation of proteolysis	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	4.986757586255907	-4.390813925559698	BTBD3;BTBD11
histone H4-K5 acetylation	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.149602308168608	-4.3909746315074	ELP4;OGT
positive regulation of heparan sulfate proteoglycan binding	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.828784586562975	-4.3912779623929845	TCF7L2;RAPGEF2
histone H4-K8 acetylation	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.156510360948103	-4.396865005694114	ELP4;OGT
transcription factor import into nucleus	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.837880879471349	-4.399550095860932	STAT3;PRICKLE1
posttranslational protein targeting to endoplasmic reticulum membrane	2/39	0.378816608828733192293469755895785056054592132568359375	0.76643914967559323425660977591178379952907562255859375	0.2365484655270917169200828311659279279410839080810546875	0.51657998938210114570068753891973756253719329833984375	4.5366386218543715	-4.403729050084346	ICMT;PARD3
response to interleukin-6	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.814294775967564	-4.406897226523371	JUND
neurotrophin signaling pathway	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.2765096861932967	-4.410478382491659	STAT5B;CTNNB1
positive regulation of interleukin-2 secretion	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.392800985815267	-4.418818632927309	CADM1
heart looping	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.185102836699727	-4.421245303077121	MEF2C;VANGL2
splicing factor protein import into nucleus	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.863692646950316	-4.423023217030224	STAT3;PRICKLE1
positive regulation of exocyst assembly	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.866071672252474	-4.425186693406952	TAL1;CLASP2
lipoxygenase pathway	2/45	0.449279189916022669848416626336984336376190185546875	0.7941283521609532325413738362840376794338226318359375	0.286997168543287106690087284732726402580738067626953125	0.5293904906524435904913161721196956932544708251953125	5.537303367977439	-4.430456120492058	STAT5B;GPX1
cellular response to hepatocyte growth factor stimulus	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.792384927282379	-4.431142089809762	STAT5B;CTNNB1
cytoplasmic microtubule organization	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.87550833013713	-4.431842157994537	HOOK2
cartilage morphogenesis	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.2876203001599107	-4.432003932333664	COL11A2;GDF2
N-glycan processing to lysosome	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	9.986753696749501	-4.43216354866103	LARS
embryonic digestive tract development	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.012860086663287	-4.434534179767608	PKDCC;FGFR2
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.884647517500662	-4.435566437781558	MSX1
regulation of osteoblast differentiation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.43255474779596	-4.4357211661721	FGFR2
mRNA-binding (hnRNP) protein import into nucleus	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.722280567685083	-4.4363211478286075	STAT3;PRICKLE1
embryonic forelimb morphogenesis	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.3903756433874817	-4.442965965860734	PTCH1;CACNA1C
positive regulation of C-C chemokine binding	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.729752229614753	-4.443340360548589	TCF7L2;RAPGEF2
negative regulation of cell cycle checkpoint	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.6955042741316597	-4.445263395395773	CITED2;FGFR2
G-protein coupled receptor internalization	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.287448629349424	-4.446624694034088	ARRB1;LDLRAP1
cellular response to interleukin-4	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.803961792718405	-4.449513029718667	AKAP6;GATA3
positive regulation of collagen binding	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.738128141883933	-4.451209066399401	TCF7L2;RAPGEF2
positive regulation of sodium:potassium-exchanging ATPase activity	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.474265171683303	-4.453455634340234	ANK3
paraxial mesoderm development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.400833340864007	-4.462403577726468	TBX6;MEST
steroid hormone receptor import into nucleus	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.752423178421963	-4.464638461792935	STAT3;PRICKLE1
negative regulation by symbiont of host I-kappaB kinase/NF-kappaB cascade	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	11.427336396660596	-4.464869409838867	TLE1
in utero embryonic development	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.815504544823521	-4.467829836325627	BRCA1;FGFR2
protein import into nucleus, substrate release	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.756667689189184	-4.468625944664594	STAT3;PRICKLE1
regulation of leukotriene production involved in inflammatory response	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.243583642152412	-4.471110849541851	SEMA7A;FOXP1
olfactory bulb interneuron fate commitment	3/10	0.003797240025174056753110019002406261279247701168060302734375	0.069156684165042558998237609557691030204296112060546875	0.002755244303871814438855469830969013855792582035064697265625	0.03620191471131851967957260285402298904955387115478515625	0.8026287352393591	-4.473435833590066	MYT1L;ERBB4;ID2
positive regulation of Ras GTPase binding	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.762014072922621	-4.473648576183644	TCF7L2;RAPGEF2
negative regulation of type B pancreatic cell proliferation	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	10.978821918585618	-4.473943134140259	GDF5
histone H4-K16 acetylation	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.9262724599205026	-4.479933056071574	ELP4;OGT
modulation by organism of inflammatory response of other organism involved in symbiotic interaction	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.254277280739603	-4.480229125662005	SEMA7A;FOXP1
positive regulation of phosphorylation	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.099575230787417	-4.482234222861158	DSCAM
regulation of inflammatory response	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.257022225433834	-4.482569691359309	SEMA7A;FOXP1
positive regulation of apolipoprotein binding	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.771793984222347	-4.482836261392304	TCF7L2;RAPGEF2
membrane depolarization during cardiac muscle cell action potential	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.773726707337822	-4.484651947755531	CACNA1D;CACNA1C
negative regulation of cell motility	2/39	0.378816608828733192293469755895785056054592132568359375	0.76643914967559323425660977591178379952907562255859375	0.2365484655270917169200828311659279279410839080810546875	0.51657998938210114570068753891973756253719329833984375	4.620341545866472	-4.4849797356190955	ERBB4;GATA3
nucleotide phosphorylation	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.045120991204862	-4.487157281570576	ALK;STAT3
positive regulation of actin binding	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.7787054900816335	-4.48932923849678	TCF7L2;RAPGEF2
positive regulation of release of sequestered calcium ion into cytosol	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.57717461214927	-4.497210744599324	AKAP6
positive regulation of neural crest formation	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.789947651416908	-4.499890626657464	CTNNB1;OTX2
positive regulation of mitotic spindle elongation	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.148279743183101	-4.503849491551095	PHIP
regulation of mitotic G1 cell cycle arrest in response to nitrogen starvation	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.492482071685109	-4.507033873830626	CYLD;GBF1
positive regulation of mitotic cell cycle spindle assembly checkpoint	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	11.063072883076629	-4.50827596392149	TAL1
negative regulation of BMP signaling pathway involved in spinal cord association neuron specification	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.347170589183886	-4.508563894788156	DLX1;SKOR1
determination of digestive tract left/right asymmetry	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	5.121699937922395	-4.509629959143927	CITED2;FGFR2
regulation of sodium:potassium-exchanging ATPase activity	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	11.087381815008971	-4.518182015765985	CACNA1D
cartilage development involved in endochondral bone morphogenesis	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.7401464046010284	-4.51888450977219	COL11A2;GDF2
regulation of peptidase activity	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.4316055609408425	-4.5195995782268765	BTBD3;BTBD11
positive regulation of dopaminergic neuron differentiation	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.07840097401476	-4.524073981348076	MEF2C;NEUROG1
negative regulation of skeletal muscle cell differentiation	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.4373497039106127	-4.530276156106311	DDX17;SKOR1
mesectoderm development	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.8577114071102376	-4.534806492061801	TBX6;MEST
right ventricular cardiac muscle tissue morphogenesis	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.31923335218098	-4.540794553247318	GATA3;FGFR2
negative regulation of endothelial cell chemotaxis	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.4436698621147994	-4.5420233674192	GDF2;NR2F2
positive regulation of mesodermal to mesenchymal transition involved in gastrulation	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	4.9965464879623465	-4.54383998443766	CTNNB1;OTX2
positive regulation of heart contraction	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.243452459901745	-4.546087545945558	CELF2
regulation of mitotic DNA damage checkpoint	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	5.001389758748249	-4.54824443609351	CYLD;GBF1
positive regulation of cholesterol biosynthetic process	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.387412060140191	-4.55029937291229	NFYA;LDLRAP1
regulation of protein deubiquitination	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.448493748378369	-4.550989473876782	BTBD3;BTBD11
protein targeting to lysosome	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.390596904379753	-4.553602457862474	LARS;VTI1A
cell projection morphogenesis	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.76892867552974	-4.56635049846441	SHROOM3;MSX1
DNA unwinding involved in DNA replication	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.740924148588043	-4.566833890826838	BAZ1A
positive regulation of meiotic cell cycle	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.7697261682356893	-4.567665675430692	CITED2;FGFR2
odontogenesis of dentin-containing tooth	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.553532868576953	-4.5682824231237085	MSX1;FGFR2
regulation of alternative mRNA splicing, via spliceosome	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.8669068916691645	-4.572189572084012	DDX17;RBFOX2
negative regulation of hepatocyte proliferation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.754275590731991	-4.572510666645277	GDF5
maintenance of DNA repeat elements	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.771691010796168	-4.579915367532447	TCF7L2
lung connective tissue development	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.5667065932060766	-4.580792866100807	NKX2-1;FGFR2
positive regulation of multicellular organism growth	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.2665708295489497	-4.581399081783472	STAT5B;FGFR2
gonadal mesoderm development	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.3516373003775515	-4.5851239678629	TBX6;MEST
positive regulation of vascular smooth muscle cell proliferation	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.6005772568410017	-4.586344050953346	ID2;FOXP1
negative regulation of calcium ion transport	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.4692519242397157	-4.589572476142742	SLN;PACSIN3
insulin secretion involved in cellular response to glucose stimulus	1/33	0.67657072157213449248303049898822791874408721923828125	0.8861389195434308252430355423712171614170074462890625	0.540404907933410783016370260156691074371337890625	0.67849080402499295505691634389222599565982818603515625	11.74847163513551	-4.590342823145135	LIN28A
cellular protein complex localization	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.357454978494269	-4.593082697576067	GRID2;DLG1
embryonic heart tube dorsal/ventral pattern formation	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.3714257057102603	-4.5943673660398625	PTCH1;HOXD11
atrial cardiac muscle cell action potential	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.577229504514544	-4.599573071512687	CACNA1D;CACNA1C
lipid phosphorylation	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.58725722849381	-4.602116021142168	ALK;STAT3
protein O-linked fucosylation	2/43	0.426270022069640319717365173346479423344135284423828125	0.7822618681448572086623016730300150811672210693359375	0.270178576652316759787453293029102496802806854248046875	0.52663609428336044526730574943940155208110809326171875	5.398838939177006	-4.6034942900185545	TET1;OGT
positive regulation of neuron maturation	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	3.87563993238696	-4.603775846660669	MEF2C;NEUROG1
long-chain fatty acid metabolic process	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	11.30205529873427	-4.60566289173947	STAT5B
nucleobase-containing small molecule interconversion	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.617566893223797	-4.6079851135368655	DCTD;TXNRD1
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.906104033140659	-4.609013116376228	AKAP6;ANK3
positive regulation of brown fat cell differentiation	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.909927748003302	-4.612605284792584	LMO3;ZFP36L1
regulation of mitotic cell cycle, embryonic	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.160166697284887	-4.614774769124798	CYLD;GBF1
positive regulation of interleukin-13 secretion	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.138481966338286	-4.619433080852123	CADM1;GATA3
neuroblast differentiation	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.9123843908006624	-4.6215652182098825	SIX3;SIX1
negative regulation of endocytosis	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.460394193068886	-4.6259910447104104	YRDC;PACSIN3
renal water homeostasis	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	10.887324999774263	-4.62908071052261	PRKAR2A
negative regulation of kinase activity	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.919050804685132	-4.632143927063004	LDB1;LDB2
histone H3-K4 acetylation	2/42	0.414577744324350627724840023802244104444980621337890625	0.7769671408471967577469285970437340438365936279296875	0.261763544446234786011729056554031558334827423095703125	0.52663609428336044526730574943940155208110809326171875	5.26839201516151	-4.6387915645297575	LDB1;ELP4
definitive hemopoiesis	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	4.939388051123714	-4.6402816085266885	KIRREL3;TAL1
positive regulation of forebrain neuron differentiation	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	3.90865653816392	-4.642995447775954	MEF2C;NEUROG1
protein targeting to ER	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.466290465240933	-4.644983995633924	AKAP6
negative regulation of NF-kappaB import into nucleus	2/44	0.43783880601676161692381583634414710104465484619140625	0.78640967509848469507716117732343263924121856689453125	0.278591173599117503112410076937521807849407196044921875	0.5293904906524435904913161721196956932544708251953125	5.635685339138869	-4.654537651879243	CYLD;TLE1
negative regulation of chondrocyte differentiation	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.414395701172821	-4.670979035664754	SKOR1;GDF5
negative regulation by symbiont of host cell cycle	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.52906006594553	-4.672841410030503	GATA3
chondroitin sulfate proteoglycan metabolic process	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.544026106188332	-4.679483402017702	SDC3
JAK-STAT cascade involved in growth hormone signaling pathway	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.370595930210086	-4.687215501215076	STAT5B;STAT3
glucose catabolic process	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.129690400891525	-4.694579614053295	SLC37A4
maintenance of protein location in nucleus	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.6897151139262863	-4.699886089186544	SIX1;MSX1
liver morphogenesis	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.3267551642832554	-4.703049132289225	CITED2;FGFR2
carbohydrate phosphorylation	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.2412244389366	-4.704690209595174	ALK;STAT3
positive regulation of mammary gland epithelial cell proliferation	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.689766274530661	-4.704957108872731	GPX1;FGFR2
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.081695546077685	-4.708405261482076	GDF2;NR2F2
positive regulation of phosphoprotein phosphatase activity	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.245426381089333	-4.709351324891446	MAGI2;AKAP6
ATP synthesis coupled proton transport	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.083954021178293	-4.712683579926178	ATP5G2
smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.094824276104564	-4.717305402770514	PTCH1
negative regulation of mitotic DNA damage checkpoint	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	5.023106344189718	-4.718930309861876	DLG1;TAL1
protein localization to nuclear envelope	2/39	0.378816608828733192293469755895785056054592132568359375	0.76643914967559323425660977591178379952907562255859375	0.2365484655270917169200828311659279279410839080810546875	0.51657998938210114570068753891973756253719329833984375	4.8622696642033425	-4.719820103467668	SIX1;MSX1
positive regulation of calcineurin-NFAT signaling cascade	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.540026766077527	-4.721120927280301	RCAN1;AKAP6
regulation of protein processing	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.541197274906838	-4.723296539680702	BTBD3;BTBD11
regulation of kainate selective glutamate receptor activity	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.64301557742274	-4.723415348216513	CACNA1D
protein localization to cleavage furrow	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.541494874996043	-4.723849685823834	PIGK;CTNNB1
negative regulation of keratinocyte proliferation	2/39	0.378816608828733192293469755895785056054592132568359375	0.76643914967559323425660977591178379952907562255859375	0.2365484655270917169200828311659279279410839080810546875	0.51657998938210114570068753891973756253719329833984375	4.867413446422785	-4.724813188673517	GDF5;ZFP36L1
cell migration involved in sprouting angiogenesis	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.711006155243742	-4.726265788645396	SEMA3E;ROBO1
cortical microtubule organization	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.563396251702545	-4.732817163703764	DLG1;HOOK2
purine nucleoside interconversion	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.124704062466867	-4.734003855128894	DCTD;TXNRD1
positive regulation of integrin activation	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.66867891112069	-4.734804844303734	TAL1
mesoderm morphogenesis	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.4489532465423007	-4.744568151462051	TBX6;MEST
protein import into peroxisome membrane	2/37	0.354471951449586375471056953756487928330898284912109375	0.76035323823870781811962160645634867250919342041015625	0.2198117043062237374595468963889288716018199920654296875	0.50931227109647247974777428680681623518466949462890625	4.579717005929971	-4.749743843192387	ICMT;PARD3
regulation of endodermal cell differentiation	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.70426313477932	-4.750597273334853	CLASP2
chondrocyte differentiation involved in endochondral bone morphogenesis	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	2.994134910206618	-4.751292378625438	MEF2C;NFIB
sequestering of BMP in extracellular matrix	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.4747082406322884	-4.753488103757274	DLX1;SKOR1
mitochondrial DNA inheritance	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.182879066592834	-4.754744602218203	DNM3
response to interleukin-12	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.183684275050023	-4.75508696133187	JUND
astral microtubule organization	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.7403074885825	-4.755662033260046	DLG1;HOOK2
positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	10.716446197649827	-4.756004168188311	CHD6
deactivation of mitotic spindle assembly checkpoint	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.199684816612196	-4.7618900831551745	DLG1
positive regulation of calcium ion import	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.481340021166409	-4.762560546015026	CTNNB1;CACNA1D
positive regulation of dendritic spine morphogenesis	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.296356655128017	-4.765847076316918	SIPA1L1;CUX1
regulation of centromere clustering at the mitotic nuclear envelope	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.29712524121035	-4.766699650725285	CYLD;GBF1
branch elongation involved in ureteric bud branching	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.3601970456800245	-4.770644904160497	SIX1;HOXD11
negative regulation of BMP signaling pathway by negative regulation of BMP secretion	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.244528246783181	-4.7755192719606265	DLX1;SKOR1
positive regulation of photoreceptor cell differentiation	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.8869122177469033	-4.780335839176592	MEF2C;NEUROG1
mitotic G2 DNA damage checkpoint	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.318380244480977	-4.782027448887023	BRCA1
mitochondrial calcium uptake	1/32	0.6653070153868139158248595776967704296112060546875	0.88153179538752846067239943295135162770748138427734375	0.52976194607798288149780319145065732300281524658203125	0.6724669267087850510478119758772663772106170654296875	11.741477809807492	-4.784730494892285	CACNA1D
response to ionizing radiation	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.316150091965989	-4.787803468827283	EYA1;BRCA1
positive regulation of DNA repair	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.774130741393094	-4.7895948445006935	EYA1;BRCA1
Golgi to lysosome transport	2/22	0.1678479563792367457164544930492411367595195770263671875	0.73858861214153648244717942361603491008281707763671875	0.10134077134250431273532200293630012311041355133056640625	0.4226564265451748791946329220081679522991180419921875	2.6860272764089212	-4.7937440993429075	AP1G1;VTI1A
positive regulation of cell cycle process	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.765606793291983	-4.796555408394847	CITED2;FGFR2
regulation of protein phosphorylation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.292276103522974	-4.8012581134298316	PHIP
positive regulation of T cell differentiation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.362449506016466	-4.8024512376330915	GATA3
zonula adherens assembly	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.2652377882207815	-4.806000995874352	CTNNB1;TLN2
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.377784893428877	-4.80619506146274	MEF2C;GRID2
negative regulation of death-inducing signaling complex assembly	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.7914689794506256	-4.806989243630376	TCF7L2;PHIP
pyrimidine nucleotide interconversion	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.9093625218320196	-4.807946442968593	DCTD;TXNRD1
positive regulation of spinal cord association neuron differentiation	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.9125912870112485	-4.8119173538196485	MEF2C;NEUROG1
positive regulation of receptor-mediated endocytosis	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.388806221368704	-4.814666191268311	LDLRAP1
regulation of peptidyl-tyrosine phosphorylation	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.521402493705627	-4.817367014194243	EFNA1;PHIP
negative regulation of extrinsic apoptotic signaling pathway	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.055483027730718	-4.81740696641806	TCF7L2;PHIP
positive regulation of mechanoreceptor differentiation	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.919476146331233	-4.820384727897391	MEF2C;NEUROG1
negative regulation of interleukin-6 secretion	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.401210241928768	-4.820414803491292	ARRB1
positive regulation of proteolysis involved in cellular protein catabolic process	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.343867241401068	-4.8231936707123	OGT
positive regulation of interferon-alpha secretion	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.656758579235591	-4.826144333893446	IFIH1;CADM1
positive regulation of glutamatergic neuron differentiation	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.9242099785948596	-4.8262066520260465	MEF2C;NEUROG1
pyrimidine nucleoside interconversion	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.205277464655877	-4.82647953115485	DCTD;TXNRD1
response to interleukin-4	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.358373835186905	-4.8293615947405435	JUND
phospholipid efflux	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.42416444663598	-4.831052872100556	LDLR
positive regulation of cerebellar neuron development	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.930305838480152	-4.833703671729042	MEF2C;NEUROG1
stress fiber assembly	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.43360349252572	-4.835427374247845	ARRB1
cellular response to indole-3-methanol	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.29100088288551	-4.83628466026779	CTNNB1;BRCA1
response to interleukin-2	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.379928541756021	-4.838526240454907	JUND
cellular response to growth factor stimulus	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.075700051969775	-4.841422264409326	STAT5B;CTNNB1
cellular response to glucagon stimulus	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	5.325893326012537	-4.843346720757621	PRKAR2A;ZFP36L1
regulation of ventricular cardiac muscle cell action potential	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.5002808196062296	-4.844009481669068	DLG1;CACNA1C
response to interleukin-15	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.401264360390979	-4.847597819239259	JUND
response to type III interferon	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.407507024086687	-4.850252079500313	JUND
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	5.3365656424870105	-4.853052083939994	CACNA1D;CRHR1
positive regulation of transcription from RNA polymerase II promoter in response to reactive oxygen species	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.677446534612115	-4.853448039198794	PDGFRA;CHD6
regulation of dendritic spine morphogenesis	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.0596056718009303	-4.8551857367788935	MEF2C;SIPA1L1
regulation of vascular wound healing	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.483056565885592	-4.858346277082932	CTNNB1
protein localization to nucleoplasm	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.614603753662858	-4.8597363865679	SIX1;MSX1
regulation of mitotic cell cycle DNA replication	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.822967200360838	-4.869619959702744	CYLD;GBF1
ventricular cardiac muscle cell action potential	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.0704711353977165	-4.872427776942701	CACNA1D;CACNA1C
response to interleukin-9	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.465944509199558	-4.875098571647195	JUND
positive regulation of mitotic cell cycle, embryonic	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.0771474387843702	-4.8830221791155175	TAL1;OTX2
erythrocyte development	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.538266991739931	-4.883933410493857	TAL1
positive regulation of transcription regulatory region DNA binding	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.539287626843644	-4.8844064212732246	GATA3
purine nucleotide interconversion	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	3.973457820221496	-4.88677432351989	DCTD;TXNRD1
cellular response to oxygen radical	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.5726379073225716	-4.887458346258114	PDGFRA;TXNRD1
positive regulation of excitatory postsynaptic potential	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.5727181350727193	-4.887568099834389	NLGN2;GATA3
platelet aggregation	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.558954237102745	-4.889219070052762	PDGFRA;TYRO3
negative regulation of innate immune response	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.55651107120073	-4.892388583369259	TYRO3
rescue of stalled ribosome	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.02397391022698	-4.89248626830571	GEMIN5
negative regulation of interferon-beta production	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	5.38544858249649	-4.897506039868767	IFIH1;CYLD
establishment of epithelial cell apical/basal polarity	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.52843572454298	-4.8985564051184864	DLG1;PARD3
modulation of excitatory postsynaptic potential	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.5953482037045	-4.910387555036196	NLGN2
membrane depolarization during ventricular cardiac muscle cell action potential	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.9807335757914744	-4.915646390566918	CACNA1D;CACNA1C
regulation of proteolysis involved in cellular protein catabolic process	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.5376805312806407	-4.916467165838748	BTBD3;BTBD11
negative regulation of plant-type hypersensitive response	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.537701334308007	-4.916507469336267	MECOM;TYRO3
ventricular septum morphogenesis	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.4660444904126866	-4.917130913667434	CITED2;GATA3
protein localization to Mei2 nuclear dot	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.6459652049938933	-4.918027584978175	SIX1;MSX1
protein localization to Mmi1 nuclear focus complex	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.646107179019874	-4.9182914706010115	SIX1;MSX1
neuronal action potential	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.86523059305379	-4.92345423288273	AKAP6;ANK3
protein O-linked mannosylation	2/40	0.390844836344191703947359428639174439013004302978515625	0.77355606841369339843339503204333595931529998779296875	0.2449438217865103906145662904236814938485622406005859375	0.521558539066333093359162376145832240581512451171875	5.242344154600147	-4.924892094806012	TET1;OGT
glucose 1-phosphate phosphorylation	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.731770961734252	-4.9251447401066	ALK;STAT3
deoxyribose 5-phosphate phosphorylation	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.735894425665	-4.930586836338601	ALK;STAT3
regulation of stress-activated MAPK cascade	2/41	0.402767374183597814951696136631653644144535064697265625	0.77355606841369339843339503204333595931529998779296875	0.25335043852397010066823668239521794021129608154296875	0.521558539066333093359162376145832240581512451171875	5.423613656850774	-4.932213210366995	GDF2;GDF5
dichotomous subdivision of terminal units involved in ureteric bud branching	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.440827668217039	-4.933622850950812	SIX1;HOXD11
negative regulation of G1/S transition of mitotic cell cycle	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.29905327969904	-4.934107875687931	ID2;ZFP36L1
positive regulation of neuroblast proliferation	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.877423050027898	-4.9389847432761576	SIX3;CTNNB1
N-terminal protein amino acid methylation	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	11.620742746791633	-4.940915798162912	PRMT3
positive regulation of attachment of mitotic spindle microtubules to kinetochore	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	10.662851501656958	-4.94167178919414	PHIP
protein targeting to vacuole	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	2.9969591118317456	-4.942404567922703	VTI1A;AKAP6
regulation of cell cycle switching, mitotic to meiotic cell cycle	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.608581733860274	-4.942441737122148	CYLD;GBF1
protein localization to condensed nuclear chromosome	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.659834895792504	-4.943807032800825	SIX1;MSX1
retrograde transport, vesicle recycling within Golgi	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.221771882373286	-4.949261813095769	VTI1A
left lung development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.6645300707256943	-4.952533904867829	NKX2-1;FGFR2
regulation of blood vessel branching	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.241896839218767	-4.953170716162293	CTNNB1;FGFR2
organic acid phosphorylation	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.7573997639089964	-4.958969313350912	ALK;STAT3
positive regulation of STAT protein import into nucleus	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.246799731807382	-4.960661659026554	ERBB4;ZIC1
regulation of mitotic nuclear envelope disassembly	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.630029513297789	-4.965443260450187	CYLD;GBF1
cellular response to interleukin-6	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.271717471200354	-4.9734448802155375	AKAP6
positive regulation of border follicle cell migration	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.272043228585256	-4.973602608112812	CLASP2
regulation of protein desumoylation	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.571912010897196	-4.982786761035366	BTBD3;BTBD11
regulation of protein deneddylation	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.573199454349585	-4.9852810361750155	BTBD3;BTBD11
activation of phospholipase C activity	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.05673321307708	-4.989190926388224	PDGFRA;LPAR1
mitotic spindle organization in nucleus	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.9189523387728884	-4.991883929375838	TNKS;CLASP2
suppression by virus of host type I interferon production	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.204201028187826	-4.9940653635892405	IFIH1;CYLD
intra-Golgi vesicle-mediated transport	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.9209367701575966	-4.994411658799915	CUX1;VTI1A
camera-type eye development	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.980120810918335	-4.996252145789543	SIX3;CACNA1C
microtubule anchoring at mitotic spindle pole body	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.9266911615562106	-5.001741488678652	TNKS;CLASP2
regulation of autophagy of mitochondrion in response to mitochondrial depolarization	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.9307709892771268	-5.006938292485927	FZD5;U2AF2
positive regulation of calcium ion transport	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.794840017143553	-5.008382492288544	SLN;CACNA1D
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	2/38	0.3666897540369988828246050616144202649593353271484375	0.76643914967559323425660977591178379952907562255859375	0.228169356493789388107273907735361717641353607177734375	0.51657998938210114570068753891973756253719329833984375	4.998992389399427	-5.0151848520551985	TFDP2;SFN
sequestering of BMP from receptor via BMP binding	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.5354101850944035	-5.015537094722219	DLX1;SKOR1
mitotic spindle organization	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.938876919611245	-5.01726346612154	TNKS;CLASP2
regulation of synaptic transmission, glutamatergic	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.163327441409701	-5.01977833805406	MEF2C;NLGN2
lung morphogenesis	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.049139708272071	-5.028457666607112	NKX2-1;FGFR2
Golgi to plasma membrane transport	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.2436857654930815	-5.040968296547134	RABIF;GBF1
membrane depolarization during atrial cardiac muscle cell action potential	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.4965584572757504	-5.046270989933284	CACNA1D;CACNA1C
adrenergic receptor signaling pathway involved in positive regulation of heart rate	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.1831127266791555	-5.051174944395757	RAPGEF2;ATP2A2
negative regulation of interferon-alpha production	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.721147945912208	-5.063162595894725	IFIH1;CYLD
smoothened signaling pathway	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.411403763203234	-5.064429276430898	PTCH1
positive regulation of mitotic chromosome condensation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.463179557877249	-5.066148572408047	PHIP
detection of glucose	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.0730597876483117	-5.067905221666329	TCF7L2;NKX6-1
adenylate cyclase-inhibiting adrenergic receptor signaling pathway	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.725743369271262	-5.0680909260234195	GABBR1;LPAR1
lung cell differentiation	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.7276167882117335	-5.069792520459783	NKX2-1;FGFR2
adenylate cyclase-inhibiting serotonin receptor signaling pathway	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.728359171435532	-5.07089622503716	GABBR1;LPAR1
hemopoiesis	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.572656011605915	-5.07233943390244	KIRREL3;TAL1
negative regulation of BMP signaling pathway	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.419505434357345	-5.072353179078247	DLX1;SKOR1
positive regulation of cell death	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.477231576201282	-5.072952394532858	JUND
hematopoietic stem cell differentiation	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.42138557402004	-5.074511052292078	FST;SP7
triglyceride acyl-chain remodeling	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.481811250084402	-5.07516981880401	LMF1
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.442000670299684	-5.078008313268343	PTCH1
positive regulation of sodium ion transport	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.4504595139800323	-5.078623039410599	CNKSR3;ANK3
smoothened signaling pathway involved in lung development	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.454914393135168	-5.083739478105979	PTCH1
response to leukemia inhibitory factor	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.467816048896808	-5.089465287525183	JUND
mitotic spindle disassembly	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	3.996979314002009	-5.091273146195458	TNKS;CLASP2
right lung development	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.7417419429336225	-5.096046796378916	NKX2-1;FGFR2
negative regulation of erythrocyte differentiation	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.6310597849503234	-5.097378840487503	LDB1;ZFP36L1
determination of left/right asymmetry in lateral mesoderm	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.491340692711473	-5.099905623992531	CITED2
chondrocyte development	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.4652627413526793	-5.100411445067224	MEF2C;NFIB
negative regulation of macrophage derived foam cell differentiation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.53846721257233	-5.10260196998606	SKOR1
response to interleukin-11	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.498335044028858	-5.10300974670315	JUND
regulation of mitotic cohesin unloading	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.867401148369643	-5.104147767665542	CYLD;GBF1
smoothened signaling pathway involved in dorsal/ventral neural tube patterning	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.503284762258646	-5.105206452597814	PTCH1
positive regulation of toll-like receptor signaling pathway	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.54747357489938	-5.106962744776685	GATA3
signal transduction downstream of smoothened	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.512646224905193	-5.109361109332533	PTCH1
response to interleukin-21	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.51490146197901	-5.110361993088724	JUND
negative regulation of blood vessel endothelial cell migration	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.8724470952445342	-5.110807345373971	GDF2;NR2F2
smoothened signaling pathway involved in ventral spinal cord patterning	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.516602381452001	-5.111116868348125	PTCH1
regulation of translation involved in anterior/posterior axis specification	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.560305472463313	-5.113175798769041	GEMIN5
response to stem cell factor	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.521691551529779	-5.113375463563004	JUND
organelle membrane fusion	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.610874532290453	-5.114734337232489	DNM3;RABIF
response to interleukin-8	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.526075598604061	-5.115321122205269	JUND
leukocyte differentiation	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.773691432397592	-5.119512496062764	KIRREL3;TAL1
response to interleukin-17	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.54140034788524	-5.122122310781545	JUND
axial mesoderm development	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.534615384936108	-5.123195113003093	TBX6;MEST
response to interleukin-3	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.543987710605723	-5.123270593305086	JUND
preassembly of GPI anchor in ER membrane	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.585815447712742	-5.125527428976397	PIGB
positive regulation of mismatch repair	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.4856470344502704	-5.130414446159711	EYA1;BRCA1
adenylate cyclase-inhibiting opioid receptor signaling pathway	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.470364787712906	-5.130725457721334	GABBR1;LPAR1
negative regulation of stress fiber assembly	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.073813132164828	-5.132130926283913	CLASP2
response to macrophage colony-stimulating factor	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.564306532740215	-5.132288172545628	JUND
mesoderm development	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.5396381734775364	-5.13334762997353	TBX6;MEST
mitotic cell cycle arrest	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	4.031819625422677	-5.13565204536057	DLG1;MAGI2
intracellular estrogen receptor signaling pathway	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.47563407884646	-5.136773126635822	DDX17;RBFOX2
smoothened signaling pathway involved in growth plate cartilage chondrocyte development	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.576181490238808	-5.137558328931311	PTCH1
mitotic cytokinetic process	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	12.08651069131757	-5.138951349377695	ANK3
response to granulocyte colony-stimulating factor	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.57961921343858	-5.1390840050337845	JUND
response to interleukin-18	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.582952032619858	-5.140563124288958	JUND
mitotic spindle elongation during mitotic anaphase	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.180808592096842	-5.141785569091885	TNKS;CLASP2
primitive erythrocyte differentiation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.622674558622927	-5.143374177288891	TAL1
response to cytokine	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.590730599534997	-5.144015285200198	JUND
plasma membrane fusion	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	4.801558280187229	-5.149398105031266	DNM3;RABIF
response to interleukin-13	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.60455184547957	-5.15014921263375	JUND
response to interleukin-32	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.608520654253983	-5.151910586761489	JUND
regulation of protein tyrosine kinase activity	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.128282408624825	-5.157374575866611	EFNA1
intermediate mesoderm development	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.5516973584267113	-5.157722751250548	TBX6;MEST
response to erythropoietin	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.62445680633589	-5.158983118487823	JUND
mitotic cytokinesis	1/31	0.65365164483385951310623340759775601327419281005859375	0.87792562889559089267521585497888736426830291748046875	0.51887334639299875771456527218106202781200408935546875	0.66781052522122108516811067602247931063175201416015625	12.140017361858064	-5.161701354221715	ANK3
response to chemokine	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.632336677491399	-5.162480238649599	JUND
protein localization to nuclear periphery	2/21	0.1558767824469201312975741302579990588128566741943359375	0.73858861214153648244717942361603491008281707763671875	0.0942489727043460678856945378356613218784332275390625	0.415100284076937831034825876486138440668582916259765625	2.7779536965407208	-5.163353200410239	SIX1;MSX1
response to interleukin-7	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.637585206254919	-5.164809557923523	JUND
receptor clustering	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.6421405206094493	-5.166950913453854	DLG1;MAGI2
response to granulocyte macrophage colony-stimulating factor	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.654023916698524	-5.172105127177309	JUND
clearance of cells from fusion plate by epithelial to mesenchymal transition	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.207810683481296	-5.17499420822412	DDX17;CTNNB1
regulation of activation of Janus kinase activity	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.183604929368125	-5.183013659372725	EFNA1
negative regulation of mitotic cell cycle phase transition	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.6534889579074847	-5.1830504620933295	DLG1;ZFP36L1
positive regulation of Notch signaling pathway	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	3.929832748061399	-5.186544213747377	STAT3;GATA3
negative regulation of BMP signaling pathway involved in determination of lateral mesoderm left/right asymmetry	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.6569650206516644	-5.187981805480447	DLX1;SKOR1
positive regulation of histone H4 acetylation	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.5686258808069957	-5.191940220159039	ARRB1;BRCA1
neuromuscular junction development, skeletal muscle fiber	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.68228703781154	-5.196625811721187	CACNB1;ANK3
JAK-STAT cascade	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.1526966021563188	-5.19923746248513	STAT5B;STAT3
positive regulation of G1/S transition of mitotic cell cycle	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.224856964202827	-5.202131811469078	ID2
mitotic spindle elongation during mitotic prophase	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.230860735547365	-5.203342414670157	TNKS;CLASP2
epicardial cell to mesenchymal cell transition	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.232398897273499	-5.205234129536348	DDX17;CTNNB1
positive regulation of G-protein coupled receptor internalization	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.5787183198248282	-5.212339975704492	MAGI2;ARRB1
cotranslational protein targeting to membrane	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.545272835753617	-5.21669889553273	ICMT;PARD3
positive regulation of kinetochore assembly	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.759658370630099	-5.218986144814765	TAL1
DNA topological change	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.28003155736438	-5.227702338308389	TOP2B
pharyngeal arch artery morphogenesis	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.42162580745189	-5.227771761923173	PTCH1;GATA3
cellular response to interferon-alpha	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.2528150356184256	-5.230343005775495	AKAP6;GATA3
negative regulation of adenylate cyclase activity	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.8237998320009225	-5.231054164495236	GABBR1;AKAP6
regulation of MAPK cascade involved in axon regeneration	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.724607240569614	-5.240895347302937	GDF2;GDF5
peptidoglycan metabolic process	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.824282887504875	-5.240990560712407	SDC3
glycosaminoglycan metabolic process	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.840955926516058	-5.24906345025014	SDC3
protein O-linked glycosylation via threonine	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.735953153859009	-5.25348110123793	TET1;OGT
positive regulation of error-prone translesion synthesis	2/31	0.279772023550787951595708591412403620779514312744140625	0.73858861214153648244717942361603491008281707763671875	0.1704381572534386102280024033461813814938068389892578125	0.4930103205458740145417095845914445817470550537109375	4.12600303121012	-5.255621003674422	EYA1;BRCA1
membrane fusion	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.428271897749301	-5.260233551352762	DNM3;RABIF
branching involved in ureteric bud morphogenesis	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.7099895507744862	-5.263205466622366	SIX1;HOXD11
nuclear import	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.864866421339233	-5.265677922897814	GEMIN5
tooth mineralization	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.368381679036238	-5.268647980641479	FGFR2
protein O-linked glycosylation via hydroxylysine	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	4.75060367208019	-5.269732575460305	TET1;OGT
multi-organism membrane fusion	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.439445042426277	-5.2735058507645975	DNM3;RABIF
regulation of skeletal muscle cell differentiation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.386037449031514	-5.276830502970388	DDX17
mucopolysaccharide metabolic process	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.902867812913886	-5.279040458018616	SDC3
protein import into chloroplast thylakoid membrane	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.4569064484661967	-5.281675709700121	ICMT;PARD3
establishment of mitotic spindle asymmetry	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	4.004841599784052	-5.285539960086422	TNKS;CLASP2
galactosaminoglycan metabolic process	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.918810660034747	-5.286759797224706	SDC3
enteric smooth muscle cell differentiation	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.5050832982582585	-5.288210938094564	MEF2C;FGFR2
positive regulation of striated muscle cell differentiation	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.4656328847108733	-5.295008499300547	MEF2C;CTNNB1
negative regulation of epithelial cell proliferation involved in lung morphogenesis	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	4.013745886400393	-5.297291726430757	NFIB;GDF5
B cell proliferation involved in immune response	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	11.938344340368811	-5.2982877342783	MEF2C
regulation of ubiquitin-dependent endocytosis	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.433346702067887	-5.29875585765261	PACSIN3
glucose transport	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.438138642252246	-5.300976670314296	SLC37A4
positive regulation of 1-phosphatidylinositol-3-kinase activity	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.96729075979868	-5.310233291763403	PDGFRA
positive regulation of maintenance of mitotic sister chromatid cohesion	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	10.967997768817614	-5.31057561722118	PHIP
positive regulation of endosome to plasma membrane protein transport	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.496436992852924	-5.312380747230914	PRKCH
positive regulation of phosphatidylinositol 3-kinase activity	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.474174419934473	-5.31767736111415	PDGFRA
positive regulation of base-excision repair	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.354050181820002	-5.322429865162265	EYA1;BRCA1
peptidyl-arginine methylation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.486359532741332	-5.323324521087863	PRMT3
lung epithelium development	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.6186409582484784	-5.326164027560858	NKX2-1;FGFR2
negative regulation of acinar cell proliferation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.49359729021441	-5.326678841638626	GDF5
positive regulation of synaptic transmission, glutamatergic	2/27	0.2294962459097859841516964252150501124560832977294921875	0.73858861214153648244717942361603491008281707763671875	0.138736621810813087751768080124747939407825469970703125	0.482693649175157613040454407382640056312084197998046875	3.620571713138122	-5.329005845071329	MEF2C;NLGN2
positive regulation of dendrite morphogenesis	2/29	0.25460929012328670228981764012132771313190460205078125	0.73858861214153648244717942361603491008281707763671875	0.1544278362852936903326650508461170829832553863525390625	0.4884190844811817644455231857136823236942291259765625	3.900173744445635	-5.335535594043197	CUX1;VLDLR
bronchiole development	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.240591132533453	-5.344187831249373	NKX2-1;FGFR2
negative regulation of cholangiocyte proliferation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.533143590247404	-5.3450064752186	GDF5
negative regulation of granulosa cell proliferation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.536646122498242	-5.346629715006946	GDF5
regulation of membrane protein ectodomain proteolysis	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.665335895639551	-5.354497627211591	BTBD3;BTBD11
regulation of centrosome cycle	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.649496945087498	-5.355404169666974	CYLD;EFNA5
gliogenesis	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.354916992740778	-5.355913540312798	SALL3;SALL4
negative regulation of glycolytic process	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.7756110727332883	-5.356299947988101	PRKAG1;OGT
negative regulation of urothelial cell proliferation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.55898073019323	-5.3569806329346585	GDF5
protein localization to nuclear pericentric heterochromatin	2/25	0.2045656153085983197659203369767055846750736236572265625	0.73858861214153648244717942361603491008281707763671875	0.12342897024716636966701344135799445211887359619140625	0.47566540249663702422111555279116146266460418701171875	3.3761537264651853	-5.357505239640304	SIX1;MSX1
vesicle targeting, trans-Golgi to endosome	2/20	0.1440800587638162710835132429565419442951679229736328125	0.73858861214153648244717942361603491008281707763671875	0.08730959511235929226824481474977801553905010223388671875	0.402580019692080959270441553599084727466106414794921875	2.76760947199131	-5.361928315713911	GBF1;VPS13A
regulation of translation at synapse, modulating synaptic transmission	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	4.063919430984415	-5.363510144370763	NLGN2;GEMIN5
negative regulation of epithelial cell proliferation involved in prostate gland development	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.574742865035507	-5.364285554800583	GDF5
regulation of membrane repolarization during ventricular cardiac muscle cell action potential	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.5121704900581205	-5.366111534171283	DLG1;CACNA1C
lung smooth muscle development	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.258720499627218	-5.37408569217915	NKX2-1;FGFR2
negative regulation of lens epithelial cell proliferation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.623000490334588	-5.3866504302297225	GDF5
positive regulation of mitotic sister chromatid separation	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.647254124047288	-5.388711222482189	PHIP
positive regulation of histone H3-K9 acetylation	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.6660201948020346	-5.388802464608112	ARRB1;BRCA1
myelin maintenance	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.644223780640006	-5.396486310900091	ANK3
histone H2A monoubiquitination	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.676930070501927	-5.403730597791051	TRIM37
negative regulation of thyroid gland epithelial cell proliferation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.664677357727747	-5.405965469909939	GDF5
positive regulation of cell cycle arrest	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	4.099240057986602	-5.410125867061377	ID2;BRCA1
AMP phosphorylation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.174622897526678	-5.410621076160568	ATP5G2
cellular response to leucine	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.189677032618391	-5.417910111446817	LARS
negative regulation of ERBB signaling pathway	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.729802773555972	-5.430490147717338	ERBB4
cristae formation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.22385522239965	-5.434458789256466	ATP5G2
non-phosphorylated glucose metabolic process	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.743521252836194	-5.437433245195002	SLC37A4
cellular bud site selection	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	12.269032568579163	-5.445048569235336	ANK3
glycolytic fermentation to butanediol	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.760280272906314	-5.445915199178394	SLC37A4
cellular bud neck septin ring organization	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	12.277314899875899	-5.448724302910762	ANK3
glycolytic fermentation to ethanol	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.769542589746877	-5.4506029759632275	SLC37A4
poly(hydroxyalkanoate) biosynthetic process from glucose	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.771434719224988	-5.4515606068447955	SLC37A4
positive regulation of calcium-transporting ATPase activity	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.784621538836978	-5.458234624577826	SLN
protein O-linked glycosylation via tyrosine	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.59530990629904	-5.458653828429937	TET1;OGT
negative regulation of telomere maintenance via telomerase	2/36	0.342171531993349875566678974792012013494968414306640625	0.759540290076532453866775540518574416637420654296875	0.211480948967409598804323422882589511573314666748046875	0.50931227109647247974777428680681623518466949462890625	5.101235870271874	-5.470785272374372	TNKS;GDF2
vacuole fusion, non-autophagic	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.7676001458778545	-5.471868315517519	DNM3;RABIF
translational readthrough	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.312845650215888	-5.477546908536594	GEMIN5
glucose metabolic process	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.823953077181617	-5.478140818194127	SLC37A4
protein localization to mitotic actomyosin contractile ring	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	12.350137201126389	-5.4810431483467	ANK3
blood vessel endothelial cell proliferation involved in sprouting angiogenesis	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.84487918133405	-5.4887317866236645	SEMA3E
protein O-linked glycosylation via hydroxyproline	2/33	0.3048684167389719146257220927509479224681854248046875	0.73996546891932102330002862800029106438159942626953125	0.1867080858090240103042134478528168983757495880126953125	0.4930103205458740145417095845914445817470550537109375	4.620900398101843	-5.489052134289417	TET1;OGT
lung-associated mesenchyme development	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.3300645321935636	-5.491741976196457	NKX2-1;FGFR2
negative regulation of heart contraction	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	10.85097871967487	-5.491818840837474	CELF2
plant-type primary cell wall biogenesis	1/30	0.64159101190165801487097496647038497030735015869140625	0.87543673796358711935994278974249027669429779052734375	0.50773345869648711659039008736726827919483184814453125	0.662886382214889380293243448249995708465576171875	12.3795232825033	-5.494084815606315	ANK3
regulation of neurotransmitter secretion	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.722842800684616	-5.503657483044402	MEF2C;NLGN2
protein localization to nucleus	2/32	0.292335157699437908629391813519760034978389739990234375	0.73858861214153648244717942361603491008281707763671875	0.1785442042576221854943696598638780415058135986328125	0.4930103205458740145417095845914445817470550537109375	4.476350216148206	-5.505258716483964	SIX1;MSX1
histone H4 deacetylation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.894191191415095	-5.512333080580153	TBL1X
negative regulation of ventricular cardiac muscle cell action potential	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.7272819600372338	-5.512630315623396	DLG1;CACNA1C
positive regulation of protein processing	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	11.895613691521806	-5.512992334687403	OGT
positive regulation of natural killer cell mediated cytotoxicity	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.729238262868123	-5.516584572810633	CADM1;AP1G1
regulation of focal adhesion assembly	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.731966517380604	-5.522099168937699	LDB1;EFNA5
mesenchymal cell differentiation involved in lung development	2/26	0.2169991340559826731304582381198997609317302703857421875	0.73858861214153648244717942361603491008281707763671875	0.1310306195847813770516410158961662091314792633056640625	0.482693649175157613040454407382640056312084197998046875	3.6327488544558886	-5.550338625025197	NKX2-1;FGFR2
hypophysis morphogenesis	3/10	0.003797240025174056753110019002406261279247701168060302734375	0.069156684165042558998237609557691030204296112060546875	0.002755244303871814438855469830969013855792582035064697265625	0.03620191471131851967957260285402298904955387115478515625	0.9984025561088781	-5.564577462472035	SIX3;HESX1;FGFR2
positive regulation of cAMP-dependent protein kinase activity	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.9256062150656703	-5.569091720656514	CAB39;RAPGEF2
positive regulation of NLRP3 inflammasome complex assembly	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.509914204456523	-5.572965186432922	TAL1
protein localization to nucleolus	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.383828201272271	-5.580405782984425	SIX1;MSX1
positive regulation of insulin-like growth factor receptor signaling pathway	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.6437391534643986	-5.580912346723082	PHIP;GATA3
eye morphogenesis	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.531595986310842	-5.583463250389573	SIX3
myelination in peripheral nervous system	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.551661272945873	-5.59317862635906	PARD3
positive regulation of single strand break repair	2/24	0.1922151798949970069596560051650158129632472991943359375	0.73858861214153648244717942361603491008281707763671875	0.11594055970262344412713417796112480573356151580810546875	0.4599593104434607226949083269573748111724853515625	3.391736291220932	-5.593447328907257	EYA1;BRCA1
regulation of MAPK cascade involved in cell wall organization or biogenesis	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.8765436140721645	-5.596904873440788	GDF2;GDF5
lung vasculature development	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	3.9490679406808398	-5.602375879769139	NKX2-1;FGFR2
positive regulation of insulin receptor signaling pathway	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.4277699680118303	-5.609808891649722	GATA3;OGT
mitotic DNA damage checkpoint	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.612937879612847	-5.6228480391480415	TOP2B
enucleate erythrocyte differentiation	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.1114489679833	-5.623646158362681	TAL1
reverse cholesterol transport	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.113135813338092	-5.6244998923290215	LDLR
intestinal D-glucose absorption	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.637022252630455	-5.634509409509276	SLC37A4
metanephric mesenchyme development	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.676902332841491	-5.650919554884929	ROBO2;SIX1
regulation of calcium ion import	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.678651630021455	-5.6546123073325205	SLN;CTNNB1
protein O-linked glycosylation via serine	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.928531280980675	-5.6565721397068796	TET1;OGT
regulation of ERK5 cascade	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.928787623545567	-5.656866349102767	GDF2;GDF5
peptidyl-lysine methylation	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	12.23835134875521	-5.671833242448485	PRMT3
histone H2A K63-linked deubiquitination	2/35	0.3297975137204380846611684319213964045047760009765625	0.75121918332311110599874837134848348796367645263671875	0.203182768695840898498516935433144681155681610107421875	0.5051662884607235337597330726566724479198455810546875	5.128803270894594	-5.689260467801951	CYLD;USP21
positive regulation of mitochondrial membrane potential	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.257629135646528	-5.697629807180836	ANK3
clathrin coat assembly	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	10.774087001392964	-5.702908756999157	FCHO2
mesodermal cell differentiation	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.5871436469249347	-5.710297000800695	EOMES;MSGN1
positive regulation of BMP signaling pathway	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	10.788217853689131	-5.710388459111573	GDF5
regulation of heart rate by cardiac conduction	2/34	0.317359639594943898632806167370290495455265045166015625	0.74304557649556712828342597276787273585796356201171875	0.1949230879758435952542328095660195685923099517822265625	0.5051662884607235337597330726566724479198455810546875	4.985594996589866	-5.722065286752277	CACNA1D;CACNA1C
evasion or tolerance by virus of host immune response	2/30	0.267192069098024453932538335720892064273357391357421875	0.73858861214153648244717942361603491008281707763671875	0.16239693957945100510897873391513712704181671142578125	0.4884190844811817644455231857136823236942291259765625	4.34513359909266	-5.734653093684598	AP1G1;ELMO1
regulation of translational termination	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	10.838659714259547	-5.737088199732673	GEMIN5
regulation of glycolysis involved in cellular glucose homeostasis	2/19	0.1324843253731841363762811170090571977198123931884765625	0.7166611958547128846674922897364012897014617919921875	0.080533403572673079029442533283145166933536529541015625	0.380104253920552193068971291722846217453479766845703125	2.838572423833981	-5.73758072176232	PRKAG1;OGT
regulation of cell motility	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.346738868174643	-5.7427293802831745	ERBB4
regulation of heart contraction	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	10.854461816384417	-5.745452522999717	CELF2
cellular response to methionine	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.899857349699102	-5.761771074515358	LARS
negative regulation of cell fate commitment	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.6140191083013984	-5.769616036554881	SKOR1;FGFR2
positive regulation of peptidase activity	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	10.901566117205586	-5.770385636089545	OGT
positive regulation of hepatic stellate cell proliferation	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.410705001922498	-5.775103457089264	PDGFRA
postsynaptic density protein 95 clustering	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.617220014535208	-5.776681019316272	NLGN2;NRXN2
inactivation of MAPK activity involved in innate immune response	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	11.956573995422346	-5.7892326078067615	TYRO3
positive regulation of DNA damage response, signal transduction by p53 class mediator	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.463303783045273	-5.80172437162957	MSX1
positive regulation of TORC2 signaling	2/28	0.242038672894972162197291254415176808834075927734375	0.73858861214153648244717942361603491008281707763671875	0.146538432180665145754261402544216252863407135009765625	0.482693649175157613040454407382640056312084197998046875	4.092530486314007	-5.805900133435681	LIN28A;RHEB
regulation of caveolin-mediated endocytosis	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.508218715580371	-5.824456392316694	PACSIN3
embryonic hindlimb morphogenesis	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.7603191643044362	-5.82701182330181	PTCH1;AFF3
cellular age-dependent response to reactive oxygen species	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.514731767565257	-5.827752731064193	PDGFRA
embryonic skeletal limb joint morphogenesis	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.761075819614633	-5.828609116649512	PTCH1;CTNNB1
positive regulation of pancreatic stellate cell proliferation	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.545411788441566	-5.843280281254693	PDGFRA
negative regulation of reactive oxygen species biosynthetic process	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.654585142994461	-5.85915265989526	BRCA1;AATF
modulation by virus of host protein phosphorylation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	12.146451833315195	-5.8811692253570715	PHIP
protein targeting to peroxisome	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.127948080019344	-5.890213485817352	AKAP6
dolichyl diphosphate biosynthetic process	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	12.234917564270367	-5.924003292583621	AGPAT3
positive regulation of core promoter binding	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.684022653025475	-5.924126603433702	CTNNB1;GATA3
cardiac muscle cell action potential involved in contraction	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.8095555440418365	-5.930949429712155	CACNA1D;CACNA1C
negative regulation of cell migration involved in sprouting angiogenesis	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.222659849622675	-5.940346047415554	GDF2
SMAD protein complex assembly	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.760428686385971	-5.952103077956749	ACVR2A
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	10.746847881920054	-5.952773184107004	BRCA1
nucleate erythrocyte differentiation	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.281984778831452	-5.971747748390249	TAL1
positive regulation of potassium ion transport	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.589417428442719	-5.983325070194599	DLG1;ANK3
negative regulation of cell-matrix adhesion	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.822704369970873	-5.983621596357073	SEMA3E
mesenchymal cell differentiation involved in renal system development	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.7140721298423434	-5.990451269072947	PTCH1;FGFR2
B-1 B cell proliferation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	12.377008406522249	-5.992802008465802	MEF2C
B cell homeostatic proliferation	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	12.385258829500236	-5.99679676630786	MEF2C
detection of nodal flow	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.86383561406431	-6.004438644025764	CITED2
regulation of sprouting angiogenesis	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.375132434652514	-6.021052397777914	CTNNB1
cellular response to L-arginine	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.900150340875072	-6.0228179908157085	LARS
protocatechuate catabolic process, meta-cleavage	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.39235784733014	-6.030170103694847	STAT5B
positive regulation of synaptic vesicle priming	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	11.944055526255765	-6.045038965578746	TAL1
negative regulation of toll-like receptor signaling pathway	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.455608039718868	-6.063649513691158	TYRO3
positive regulation of histone acetylation	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.7504831154021585	-6.0708169425776015	ARRB1;BRCA1
negative regulation of transcription regulatory region DNA binding	1/29	0.62911104716072319131825452132034115493297576904296875	0.8740844799579179369430903534521348774433135986328125	0.496336503118097460696134248792077414691448211669921875	0.6596842167393817124576571586658246815204620361328125	13.106182083331174	-6.074027220127274	MSX2
negative regulation of mitotic cytokinesis	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.018991913345193	-6.082965227634335	DLG1
neurotransmitter-gated ion channel clustering	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.7561381237179097	-6.083298575386556	DLG1;MAGI2
modulation by symbiont of host cell motility	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.506397411789646	-6.090533198100563	ERBB4
regulation of receptor-mediated endocytosis	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.074452482602009	-6.111034529679494	PACSIN3
positive regulation of sodium ion transmembrane transporter activity	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.099281918723758	-6.1236010242440395	ANK3
regulation of sodium ion transmembrane transporter activity	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.590052867802472	-6.134813463574996	DLG1
lysosomal membrane organization	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.600576134800736	-6.1403836090090245	HOOK2
cellular response to L-glutamate	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.134543053590052	-6.141447134701975	LARS
regulation of bacterial-type flagellum-dependent cell motility	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.610078146353077	-6.145413186446439	ERBB4
positive regulation of protein kinase C activity	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.1454239245762	-6.146954082400444	CAB39
equilibrioception	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.644739364045785	-6.163759962547509	NEUROG1
regulation of amoeboid sperm motility	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.650949582897665	-6.167047137736338	ERBB4
regulation of cilium-dependent cell motility	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.657653722528043	-6.170595753651662	ERBB4
positive regulation of interferon-beta biosynthetic process	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.672648270602238	-6.178532624730252	IFIH1
cellular response to ozone	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.714396036463743	-6.20063043213481	PDGFRA
positive regulation of clathrin-dependent endocytosis	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.729158638273796	-6.20844453008369	LDLRAP1
regulation of flagellated sperm motility	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.731871942886423	-6.209880728680727	ERBB4
lysosome organization	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.743626410399585	-6.2161025696317065	HOOK2
programmed cell death in response to reactive oxygen species	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.754225021152296	-6.221712595805232	PDGFRA
regulation of glycolytic process	2/18	0.12111775142182175379890196609267150051891803741455078125	0.6801338493532538276298282653442583978176116943359375	0.07393157599659332113173348943746532313525676727294921875	0.359520870078279097814544229549937881529331207275390625	2.9493307604585386	-6.226013800962111	PRKAG1;OGT
positive regulation of gastrulation	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.826170334514166	-6.237872413505142	OTX2;CLASP2
positive regulation of proteasomal protein catabolic process	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.348649198114051	-6.249808987472359	GPX1
negative regulation of neuroblast proliferation	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.8333263610474133	-6.253667066770346	ID2;SIX3
inter-Golgi cisterna vesicle-mediated transport	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.352709087108742	-6.2883650130008935	VTI1A
cisternal progression	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.366181158117383	-6.295827311147826	VTI1A
protein localization to juxtaparanode region of axon	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.368585085532303	-6.297158867601337	GRID2
eye development	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.45734689886111	-6.304822281327228	SIX3
cellular response to singlet oxygen	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.912404804866679	-6.305439864167586	PDGFRA
actin rod assembly	1/28	0.61619719347110579743542757569230161607265472412109375	0.87232958031308716062568464622017927467823028564453125	0.484676567415414927264549760366207920014858245849609375	0.65448207929557333795145268595661036670207977294921875	13.02664468266305	-6.3073482584608564	BAIAP2L2
positive regulation of oxidative phosphorylation	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.392924685107552	-6.310640785020788	DSCAM
deadenylation-independent decapping of nuclear-transcribed mRNA	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.8615013102697975	-6.315854308763469	EDC4;ZFP36L1
cellular response to L-dopa	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.940168050603612	-6.3201354255841045	LARS
cellular response to L-thialysine	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.955665406705261	-6.3283384415622566	LARS
cellular response to L-canavanine	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	11.974331058304843	-6.338218490604796	LARS
DNA strand elongation involved in DNA replication	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.45420604536504	-6.3445850672916935	BAZ1A
nucleotide-binding oligomerization domain containing 2 signaling pathway	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.545352179825358	-6.349362877394965	CYLD
positive regulation of telomere capping	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.031728516730151	-6.368599948285699	TNKS
cellular response to L-cysteine	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.0808548413955	-6.394603353223582	LARS
cellular response to homocysteine	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.085877147915538	-6.397261746072067	LARS
regulation of pinocytosis	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.108302541520905	-6.409131890944172	PACSIN3
cellular response to glycine	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.121109145099096	-6.415910645532291	LARS
cellular response to 1-aminocyclopropane-1-carboxylic acid	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.124473135251284	-6.4176912631284635	LARS
cellular response to L-glutamine	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.126400300351799	-6.418711344619033	LARS
regulation of cell fate commitment	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.151842728555447	-6.432178457570984	FGFR2
mRNA 5'-splice site recognition	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.694767203476633	-6.4778340000837495	PRPF39
histone deacetylation at centromere	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.242054794114232	-6.479929248760591	TBL1X
modulation of inhibitory postsynaptic potential	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.250001807918645	-6.484135739260559	NLGN2
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.707997872086258	-6.485162583327185	FGFR2
lactation	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	11.186610628069971	-6.488327077188085	ERBB4
peptidyl-cysteine methylation	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.829270053609324	-6.4930573374781035	PRMT3
positive regulation of NFAT protein import into nucleus	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	11.226736422686145	-6.5116003713392665	AKAP6
positive regulation of mitotic cell cycle phase transition	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.770283423140262	-6.519663095676984	TAL1
peptidyl-glutamine methylation	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	12.883613794853249	-6.5205613986098285	PRMT3
regulation of motor neuron apoptotic process	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.82657719713335	-6.531326321001656	MEF2C;GRID2
regulation of neurogenesis	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.9648853419060996	-6.544041686949892	CTNNB1;SIX1
RNA import into nucleus	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.46531285138931	-6.5981035617896255	GEMIN5
embryonic digit morphogenesis	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.472738520513598	-6.60203409562233	PTCH1
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.8628457432107433	-6.61513146520928	MEF2C;GRID2
regulation of axon guidance	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	2.9990829589582413	-6.619522053229314	PDGFRA;SIPA1L1
presynaptic membrane assembly	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.8663700919494004	-6.623275120972344	NLGN2;ANK3
negative regulation of mRNA splicing, via spliceosome	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.960801035046437	-6.625192469844748	U2AF2
positive regulation of cytokine secretion involved in immune response	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	11.98329282781401	-6.637650870886652	CADM1
determination of left/right symmetry	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.588624509761864	-6.66337453428892	CITED2
mitotic sister chromatid cohesion, centromeric	3/10	0.003797240025174056753110019002406261279247701168060302734375	0.069156684165042558998237609557691030204296112060546875	0.002755244303871814438855469830969013855792582035064697265625	0.03620191471131851967957260285402298904955387115478515625	1.1993319653839114	-6.6844536642690775	CHTF8;PDS5B;PDS5A
positive regulation of chaperone-mediated protein complex assembly	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.09895653551076	-6.701718011793145	TAL1
negative regulation of androgen receptor signaling pathway	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.106308328666628	-6.705790234423835	FOXP1
regulation of pathway-restricted SMAD protein phosphorylation	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.116471926608279	-6.711419940356762	PHIP
positive regulation of ventricular cardiac muscle cell action potential	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	3.054423965775459	-6.741669729731646	DLG1;CACNA1C
negative regulation of DNA-dependent DNA replication	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.9379997153882527	-6.7887885360682	GDF2;PDS5A
neural crest cell differentiation involved in thymus development	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.961173778030449	-6.842336468688976	MEF2C;SIX1
peptidyl-glutamic acid methylation	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.926923463446608	-6.842441963872786	PRMT3
negative regulation of hydrogen peroxide metabolic process	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.9655575247183075	-6.852465921426389	BRCA1;AATF
p38MAPK cascade	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.947256730835745	-6.8532047105108	ZFP36L1
regulation of angiogenesis	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	11.821908234369042	-6.856804965448527	CTNNB1
protein methylation	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.964138903381892	-6.8621407335481255	PRMT3
negative regulation of necroptotic process	1/27	0.6028343891584200253674907798995263874530792236328125	0.86325738119619532806581219119834713637828826904296875	0.472747603791622783564463361472007818520069122314453125	0.6505106321718450157476354434038512408733367919921875	13.562792552503028	-6.864302437452213	MECOM
peptidyl-histidine methylation	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.985000702383484	-6.873183241019761	PRMT3
C-terminal protein methylation	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	12.989162438590581	-6.875386119264266	PRMT3
regulation of neuron death	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	11.873376268053601	-6.886656852464887	JUND
radial glial cell differentiation	3/9	0.0027257627634410387489072302713566386955790221691131591796875	0.05291120557675464686209210185552365146577358245849609375	0.002155207327728885825790516861388823599554598331451416015625	0.02988521670455294987345240542708779685199260711669921875	1.1684645767192279	-6.899791477724385	NFIB;STAT3;PHOX2B
plasma membrane tubulation	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	2.99804184648064	-6.927526919569791	PACSIN3;ANK3
asymmetric Golgi ribbon formation	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	3.1386641540750757	-6.927603160666547	PARD3;VTI1A
protein localization to paranode region of axon	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	11.955196296403749	-6.934113148482598	GRID2
positive regulation of neurogenesis	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	11.957135837086435	-6.935238098187846	CTNNB1
positive regulation of histone H3-K14 acetylation	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	3.011880376057661	-6.959503386570949	ARRB1;BRCA1
positive regulation of mRNA splicing, via spliceosome	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.625729687399506	-6.993502275153408	U2AF2
regulation of mitochondrial translation	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.627454647329968	-6.994457745569528	GEMIN5
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.652801792488518	-7.00849775131366	CYLD
positive regulation of mitotic cohesin loading	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	11.532131423760205	-7.008674212771343	PHIP
regulation of spindle organization	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	3.1787493924783243	-7.016078579069588	CYLD;EFNA5
Golgi vesicle docking	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.28060250308151	-7.029650336335359	CUX1
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	3.046875986486286	-7.040367178914496	ZNF593;MSX2
cytoplasmic sequestering of protein involved in G2 DNA damage checkpoint	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	11.645194439458681	-7.077388469782965	BRCA1
Bolwig's organ development	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.793177630751128	-7.086253157818671	SIX3
peptidoglycan catabolic process	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.395940308903173	-7.090700612126559	SDC3
compound eye development	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.803497115270144	-7.0919692106923655	SIX3
nucleotide-binding oligomerization domain containing signaling pathway	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.8324482178963	-7.108005480048448	CYLD
regulation of spindle pole body separation	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	3.2293741923389856	-7.127816728265158	CYLD;EFNA5
actomyosin contractile ring actin filament bundle assembly	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.483980303336224	-7.1373016888724115	BAIAP2L2
DNA-dependent DNA replication DNA ligation	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.917821617791596	-7.1552945541208315	BAZ1A
positive regulation of interleukin-1 beta secretion	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	12.96561289143981	-7.181766559245797	FOXP1
adrenergic receptor signaling pathway involved in cardiac muscle relaxation	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	12.410388431688013	-7.198128367648003	RAPGEF2
negative regulation of myeloid cell differentiation	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.629271603106757	-7.214206861966896	SKOR1
positive regulation of transcription factor import into nucleus	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	13.041317016123651	-7.223699737075774	ZIC1
positive regulation of mediator complex assembly	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	12.48534124934005	-7.24160162442365	TAL1
negative regulation of interleukin-6 production	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	11.92493999492953	-7.2474043487839905	ARRB1
contractile actin filament bundle assembly	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.698066375075404	-7.250621112886257	BAIAP2L2
parallel actin filament bundle assembly	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.702579550688144	-7.253010014026599	BAIAP2L2
response to hydrogen peroxide	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	12.535554867625345	-7.270725940089607	GPX1
actin filament bundle assembly	1/26	0.58900705051649027144122783283819444477558135986328125	0.85592922282387073895648654797696508467197418212890625	0.460543425776051507103403537257690913975238800048828125	0.643478477306171470218032482080161571502685546875	13.776155160172042	-7.291954844115035	BAIAP2L2
negative regulation of interleukin-6 biosynthetic process	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.042893480177463	-7.319090797714013	ARRB1
membrane repolarization during action potential	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.113784127483463	-7.362174719795975	AKAP6
protein localization to myelin sheath abaxonal region	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.131898998502331	-7.3731840661789025	GRID2
protein localization to cell leading edge	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.138616250776805	-7.377266488678856	GRID2
spindle assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.181834396358646	-7.403532396630544	TNKS
fatty acid metabolic process	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	13.455852753451444	-7.453314713311768	STAT5B
positive regulation of eukaryotic translation initiation factor 4F complex assembly	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	12.852882180253163	-7.45477841704702	TAL1
histone H3-K4 trimethylation	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	13.459102942649189	-7.455115021580032	OGT
triglyceride mobilization	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.269487548535128	-7.456803762066225	LMF1
dermatan sulfate catabolic process	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	13.465795434909593	-7.458822051669255	SDC3
heparin catabolic process	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	13.475278112773092	-7.464074590006039	SDC3
regulation of outer hair cell apoptotic process	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.081709759465787	-7.46539848922661	MEF2C;GRID2
galactosaminoglycan catabolic process	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	13.494186304979515	-7.474548003304806	SDC3
anastral spindle assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.322918484559711	-7.489276512308056	TNKS
membrane depolarization during AV node cell action potential	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	3.2445123249961583	-7.497042277335671	CACNA1D;CACNA1C
cellular response to granulocyte macrophage colony-stimulating factor stimulus	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.338443469221088	-7.498711850464685	AKAP6
signal transduction involved in G2 DNA damage checkpoint	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.345220296829384	-7.502830479984012	BRCA1
endothelial tip cell fate specification	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.38845120707912	-7.529104145686233	SEMA3E
inactivation of MAPKKK activity	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.403686809410676	-7.538363611196417	TRIB1
nucleotide-binding oligomerization domain containing 1 signaling pathway	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.013001023564708	-7.547648676070739	CYLD
melanosome assembly	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.019669219382447	-7.551516285029225	AP1G1
clathrin coat assembly involved in endocytosis	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.535322680284503	-7.618365555309561	FCHO2
regulation of histone phosphorylation	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.177160993807355	-7.642862822278983	PHIP
positive regulation of myosin light chain kinase activity	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.208940587870247	-7.661295250788017	CAB39
positive regulation of cell-cell adhesion mediated by integrin	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.221608241124509	-7.668642594889529	CITED2
regulation of protein autophosphorylation	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.62967516832761	-7.6757084545151715	PHIP
regulation of peptidyl-serine phosphorylation	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.275162492080787	-7.699704505251032	PHIP
cellular response to type I interferon	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.672137063282136	-7.701514749748681	AKAP6
tRNA 5'-leader removal	2/17	0.11001021616776378297952732054909574799239635467529296875	0.63128733535686343270043607844854705035686492919921875	0.0675157164501791751121118068112991750240325927734375	0.342267737608351330091949193956679664552211761474609375	3.4930431717024617	-7.709782164878242	POP5;RPP25
embryonic ectodermal digestive tract morphogenesis	3/9	0.0027257627634410387489072302713566386955790221691131591796875	0.05291120557675464686209210185552365146577358245849609375	0.002155207327728885825790516861388823599554598331451416015625	0.02988521670455294987345240542708779685199260711669921875	1.3056544693339063	-7.709898750766808	PDGFRA;ID2;FGFR2
positive regulation of mitotic cell cycle DNA replication	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.702013522074939	-7.719672222865803	TAL1
regulation of double-strand break repair via homologous recombination	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.127769905930878	-7.728951135301745	DEK
miRNA catabolic process	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	3.3450659176510267	-7.729389841394449	DDX17;LIN28A
nodal signaling pathway	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	3.3483610130629233	-7.737003765194499	GDF2;ACVR2A
protein localization to Golgi membrane	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.143854884499564	-7.739201990515363	GBF1
regulation of insulin receptor signaling pathway	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.152845053734644	-7.744931368567138	OGT
negative regulation of synaptic transmission, glutamatergic	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.393199192247652	-7.768166771728142	MEF2C
activin receptor signaling pathway	2/16	0.09919339352522253683286379555283929221332073211669921875	0.5907768147202963060493630109704099595546722412109375	0.06129786875192456963024056904032477177679538726806640625	0.328570507844122949858700621916796080768108367919921875	3.364778245162442	-7.774938798505575	GDF2;ACVR2A
regulation of transforming growth factor beta receptor signaling pathway involved in primitive streak formation	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.826913217463764	-7.795580243862777	CLASP2
regulation of cell-cell adhesion involved in gastrulation	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.224890858274652	-7.812252684515526	EFNA5;CLASP2
regulation of sodium ion transmembrane transport	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.259426657207516	-7.812855151055878	DLG1
negative regulation of hydrogen peroxide-mediated programmed cell death	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.272276133485917	-7.821044041102465	MECOM
positive regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.914468189498448	-7.848791940135601	TAL1
positive regulation of signal transduction	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.320185732258985	-7.851576525697829	GATA3
autophagosome membrane docking	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.919930697633506	-7.852111789562945	LIX1
positive regulation of BMP signaling pathway involved in determination of lateral mesoderm left/right asymmetry	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.321087294481949	-7.852151085606268	GDF5
positive regulation of natural killer cell degranulation	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.245208983218837	-7.861473056030502	CADM1;AP1G1
ionotropic glutamate receptor signaling pathway	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.34099634361663	-7.864838996830328	GRID2
positive regulation of clathrin coat assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.941131205883435	-7.864996437682961	TAL1
cellular protein localization	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.345336828452933	-7.867605160392427	GRID2
positive regulation of FACT complex assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.94759161340403	-7.868922762308459	TAL1
protein localization to trailing edge	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.357145421863422	-7.875130702363806	GRID2
ventricular compact myocardium morphogenesis	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	12.98540232838852	-7.891902294308263	FGFR2
protein localization to cell tip	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.39719770922409	-7.900655772040159	GRID2
positive regulation of ATG1/ULK1 kinase complex assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.032381885705426	-7.920454207202354	TAL1
positive regulation of starch utilization system complex assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.035001441513208	-7.922046247091969	TAL1
protein localization to rhabdomere	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.446985802768937	-7.932385409484861	GRID2
methyl-branched fatty acid metabolic process	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.683036855951526	-7.936275023988213	STAT5B
cellular response to macrophage colony-stimulating factor stimulus	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	11.867059229493668	-7.936804013114998	AKAP6
negative regulation of interleukin-12 secretion	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.460557160384873	-7.9410343499468645	FOXP1
positive regulation of protein polymerization	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.070219890478407	-7.943450324621613	TAL1
oogenesis	1/25	0.574699053743154220086353234364651143550872802734375	0.85592922282387073895648654797696508467197418212890625	0.448057705195660016528336200281046330928802490234375	0.63832322422468390499261658987961709499359130859375	14.345500349375966	-7.9460983100010125	USP9X
positive regulation of beta-catenin-TCF complex assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.087203504845656	-7.95377214768115	TAL1
mesenchymal cell differentiation involved in bone development	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.481512266803984	-7.954388906869086	FGFR2
positive regulation of myosin II filament assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.102406390391783	-7.963011729504448	TAL1
protein localization to bud neck	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.509798700930737	-7.97241567261855	GRID2
positive regulation of Wnt-Frizzled-LRP5/6 complex assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.126537184529308	-7.977677264295086	TAL1
protein localization to cell periphery	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.53366987328505	-7.987628619936969	GRID2
endothelial stalk cell fate specification	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.56837162819369	-8.009743829087412	SEMA3E
protein localization to cell division site	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.568973792832955	-8.010127584807416	GRID2
astral spindle assembly	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.584942630180805	-8.020304423954796	TNKS
protein localization to barrier septum	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.589865982109803	-8.023442045032395	GRID2
negative regulation of lipopolysaccharide-mediated signaling pathway	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.202324574594114	-8.023737190850039	TRIB1
positive regulation of mitotic nuclear envelope disassembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.242844511408986	-8.048363257430617	TAL1
spindle assembly involved in meiosis	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.66247512908265	-8.069715395638646	TNKS
mitochondrial large ribosomal subunit assembly	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	13.923032342910261	-8.075474399760708	DHX30
positive regulation of cilium assembly	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.324813900822935	-8.098180305529679	CYLD
medium-chain fatty acid metabolic process	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	14.007147746120827	-8.124262032262214	STAT5B
regulation of proteasomal ubiquitin-dependent protein catabolic process	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	13.411198587207172	-8.150680758532852	GPX1
negative regulation of endothelial cell apoptotic process	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	12.198864194610652	-8.15871838362449	GATA3
valine catabolic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.807484684418935	-8.162129069054226	STAT5B
positive regulation of triglyceride biosynthetic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.838246380480241	-8.181733303595365	LDLR
Golgi to plasma membrane CFTR protein transport	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.85902282626124	-8.194974001221732	ANK3
viral RNA genome replication	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.874023827490145	-8.204534044525499	DEK
Golgi vesicle prefusion complex stabilization	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.92075556564804	-8.234315885992778	CUX1
regulation of potassium ion import	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.4050468238314826	-8.248677973744018	DLG1;CACNA1D
isoleucine catabolic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	12.962613697208585	-8.260991808768017	STAT5B
positive regulation of inhibitory postsynaptic potential	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.2560309156726537	-8.282657768924464	NLGN2;GATA3
positive regulation of histone H3-K27 acetylation	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.4196511645272585	-8.284056783390678	ARRB1;BRCA1
positive regulation of protein deubiquitination	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.056203787042623	-8.320636181697788	OGT
positive regulation of BMP signaling pathway involved in spinal cord association neuron specification	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.086317138910895	-8.339827230581077	GDF5
regulation of proteasome-activating ATPase activity	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.123593731649224	-8.363583367612025	GPX1
muscular septum morphogenesis	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.126217400860298	-8.365255415423361	CITED2
negative regulation of oxidoreductase activity	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.13086720569413	-8.368218706665537	SLN
short-chain fatty acid metabolic process	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	14.445919983178982	-8.378753574077322	STAT5B
positive regulation of type III interferon production	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.150543968453512	-8.380758583250252	IFIH1
mitochondrial membrane fission	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	14.453310199053707	-8.383039960665762	DNM3
membrane depolarization during bundle of His cell action potential	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.468114816660352	-8.401459298116634	CACNA1D;CACNA1C
positive regulation of catenin import into nucleus	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	12.564938460667527	-8.403552394119465	ZIC1
regulation of translation in response to stress	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.193514607728988	-8.408143500163163	GEMIN5
positive regulation of macrophage colony-stimulating factor production	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.208533923818527	-8.417715215411894	FOXP1
negative regulation of platelet activation	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.291324825994765	-8.47047733427884	PDGFRA
regulation of dopaminergic neuron differentiation	2/15	0.08870084032623883063539693694110610522329807281494140625	0.5462165324006116318145132026984356343746185302734375	0.055290530488703470979316989541985094547271728515625	0.30539277788666774338111054021283052861690521240234375	3.504102047706658	-8.488637858478889	CASZ1;SIX1
positive regulation of SMAD protein import into nucleus	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.335837196851811	-8.498844786987709	ZIC1
triglyceride metabolic process	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	12.728136773709986	-8.512701004642096	LMF1
positive regulation of basement membrane assembly involved in embryonic body morphogenesis	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.348068285150821	-8.516781477538647	OTX2;CLASP2
positive regulation of interleukin-1 secretion	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	12.741536074164019	-8.52166258640889	CADM1
neural crest cell development	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	12.759281110072934	-8.533530638088004	MEF2C
translational attenuation	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.43513671567769	-8.56212774294063	GEMIN5
negative regulation of interleukin-8 secretion	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	14.121555575692886	-8.582401532786601	ARRB1
spinal cord dorsal/ventral patterning	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.3935048272280093	-8.632362483363016	PTCH1;HOXD11
neural crest cell migration	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.563385804576113	-8.643860076991439	ERBB4
negative regulation of insulin secretion involved in cellular response to glucose stimulus	1/24	0.55989371622305672548947086397674866020679473876953125	0.84892917371396936498939567172783426940441131591796875	0.43528396883470055200859860633499920368194580078125	0.6279004529031444459263866519904695451259613037109375	14.923189154590734	-8.655573657562455	EFNA5
negative regulation of release of cytochrome c from mitochondria	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	12.430044556699807	-8.732124966069598	GPX1
dorsal/ventral axis specification	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.433265601437388	-8.7335055295849	PTCH1;HOXD11
stress-induced premature senescence	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.721160872324823	-8.74440913081232	ID2
positive regulation of low-density lipoprotein receptor activity	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.099163271260233	-8.760847115467097	LDLRAP1
mitochondrial DNA replication	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.749759152521662	-8.76263463409194	BAZ1A
positive regulation of glial cell-derived neurotrophic factor secretion	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.181777435073416	-8.816100267424323	CADM1
response to retinoic acid	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	13.876919085341909	-8.843672855855639	WNT8B
planar cell polarity pathway involved in ventricular septum morphogenesis	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.23179145775019	-8.849550129619878	CITED2
sprouting angiogenesis	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.268105878484922	-8.87383756550838	SEMA3E
positive regulation of protein kinase A signaling	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.269689409746961	-8.874896646535312	AKAP6
negative regulation of platelet aggregation	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	12.633702201169028	-8.875194767122087	PDGFRA
positive regulation of histone H3-K18 acetylation	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.4905479190587303	-8.879219696727688	ARRB1;BRCA1
ventricular septum intermedium morphogenesis	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.339942559370813	-8.921882632623825	CITED2
negative regulation of exit from mitosis	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.365538788953037	-8.939001638583104	ZFP36L1
histidine catabolic process to 2-oxoglutarate	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.04575098445208	-8.951268358443842	STAT5B
desmosome assembly	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.400339616511133	-8.96227676871276	TLN2
negative regulation of vascular smooth muscle cell proliferation	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	14.774448669545475	-8.979198518741267	TRIB1
positive regulation of osmolarity-sensing cation channel activity	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.530216202030357	-8.980127464695537	ANK3;GATA3
negative regulation of stem cell differentiation	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.099277485576255	-8.98538045941882	SKOR1
mitotic sister chromatid cohesion, arms	3/9	0.0027257627634410387489072302713566386955790221691131591796875	0.05291120557675464686209210185552365146577358245849609375	0.002155207327728885825790516861388823599554598331451416015625	0.02988521670455294987345240542708779685199260711669921875	1.5241101345861081	-8.999880978212582	CHTF8;PDS5B;PDS5A
response to glucose	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.481075020230987	-9.01627338774468	TCF7L2
positive regulation of mitotic DNA damage checkpoint	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.499104687818829	-9.028331803844152	TAL1
negative regulation of substrate adhesion-dependent cell spreading	1/23	0.54457377719496824486355990302399732172489166259765625	0.83722476272723655998930780697264708578586578369140625	0.422215595113656860792872294041444547474384307861328125	0.614878345832392536607358124456368386745452880859375	14.903028361841638	-9.057343064668437	EFNA5
mitotic sister chromatid segregation	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.222319491575005	-9.063794352437089	TOP2B
mitotic sister chromatid cohesion, telomeric	3/9	0.0027257627634410387489072302713566386955790221691131591796875	0.05291120557675464686209210185552365146577358245849609375	0.002155207327728885825790516861388823599554598331451416015625	0.02988521670455294987345240542708779685199260711669921875	1.53610523177201	-9.070712110783278	CHTF8;PDS5B;PDS5A
establishment of mitotic sister chromatid cohesion	3/9	0.0027257627634410387489072302713566386955790221691131591796875	0.05291120557675464686209210185552365146577358245849609375	0.002155207327728885825790516861388823599554598331451416015625	0.02988521670455294987345240542708779685199260711669921875	1.5366717508131547	-9.074057409673753	CHTF8;PDS5B;PDS5A
membrane depolarization during SA node cell action potential	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.587996400771536	-9.127108136681803	CACNA1D;CACNA1C
negative regulation of actin filament polymerization	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.672220109509519	-9.144113072567574	FCHSD1
vesicle cytoskeletal trafficking	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.056892391990722	-9.172486511637844	HOOK2
tooth replacement	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.421028334937464	-9.190430242828588	FGFR2
odontogenesis	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.439436667794178	-9.202161757050533	FGFR2
lamellipodium assembly involved in ameboidal cell migration	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.454131190725997	-9.211526483671959	SRGAP2
regulation of glutamate secretion, neurotransmission	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.45474834667822	-9.211919793260993	MEF2C
regulation of gene expression by genetic imprinting	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.115918686921413	-9.213952572460697	GPX1
regulation of neuron maturation	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.626573193435789	-9.225239382894113	CASZ1;SIX1
negative regulation of potassium ion transmembrane transporter activity	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.6414130983039734	-9.262988979421262	CAB39;CACNA1D
regulation of peptidyl-threonine phosphorylation	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.858766204052026	-9.268876905220921	PHIP
regulation of cytoplasmic translation	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	13.890863692769216	-9.290344016182022	GEMIN5
regulation of potassium ion transmembrane transporter activity	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.258810635190592	-9.314334380686724	CACNA1D
positive regulation of regulated secretory pathway	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.305850157043237	-9.347379715422878	CLASP2
negative regulation of intrinsic apoptotic signaling pathway	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.345759269686209	-9.375415926982196	CYLD
oncogene-induced cell senescence	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	14.064205136015138	-9.406276450308086	ID2
positive regulation of brain-derived neurotrophic factor-activated receptor activity	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	12.10167613557536	-9.407620033949208	BDNF
positive regulation of cardiac myofibril assembly	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.5161245244531463	-9.40941553232775	MEF2C;GPX1
negative regulation of removal of superoxide radicals	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.708828744777906	-9.43448020369885	BRCA1;AATF
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.718878535647612	-9.460044757776753	CADM1;AP1G1
regulation of translational elongation	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	14.144960750268023	-9.460286586340011	GEMIN5
bone marrow development	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.476698382163049	-9.467400850115695	FGFR2
methane biosynthetic process from 3-(methylthio)propionic acid	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.892000786888795	-9.490578010756222	STAT5B
oxylipin metabolic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.957444618430639	-9.532284951110233	STAT5B
poly(hydroxyalkanoate) biosynthetic process from fatty acid	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	14.965485836782708	-9.537409568759934	STAT5B
positive regulation of protein import into nucleus, translocation	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.606551867534133	-9.558623118577222	ZIC1
lipoate metabolic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	15.004313038031707	-9.562153898797666	STAT5B
unsaturated fatty acid metabolic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	15.040540385838606	-9.585241358663158	STAT5B
mycolic acid metabolic process	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	15.053231249067272	-9.5933291656153	STAT5B
cellular response to interleukin-3	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.676310113777246	-9.607628391312177	AKAP6
cellular response to cGMP	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	12.379907209793224	-9.623911744168137	RAPGEF2
negative regulation of sodium:potassium-exchanging ATPase activity	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.103625955320803	-9.67836349791304	CAB39
camera-type eye morphogenesis	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.787586870167754	-9.685800479769982	CACNA1C
platelet activating factor secretion	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.828872902826873	-9.714803979708229	LDLR
cellular response to chemokine	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.928507615358269	-9.784797514873285	AKAP6
GPI anchor biosynthetic process via N-aspartyl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.250521859104099	-9.786861096823204	PIGB
regulation of translation, ncRNA-mediated	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	13.9317625766902	-9.787084130096625	GEMIN5
GPI anchor biosynthetic process via N-asparaginyl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.280338639082807	-9.80888382823779	PIGB
GPI anchor biosynthetic process via N-threonyl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.280851195112604	-9.809262403113655	PIGB
positive regulation of microtubule polymerization	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.315107970202744	-9.834564523512933	GPX1
modulation by symbiont of host translation	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.004608991274724	-9.838258845728623	GEMIN5
positive regulation of phospholipase C activity	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.6793294655388995	-9.846164315519314	PDGFRA;FGFR2
cellular response to interleukin-9	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.343334978360636	-9.855413046383024	AKAP6
negative regulation of autophagosome maturation	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	12.687155819930757	-9.862761152113846	SLN
GPI anchor biosynthetic process via N-alanyl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.361370079486168	-9.8687338069885	PIGB
positive regulation of mesenchymal stem cell differentiation	3/8	0.0018635371275926679475454239565124225919134914875030517578125	0.039068020581576066996287721622138633392751216888427734375	0.001643731482061198956312608743246528320014476776123046875	0.0240791347853499225484252832529818988405168056488037109375	1.5707266279654404	-9.872454957021176	PDGFRA;SP7;SOX6
cellular response to interleukin-13	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.402907310973186	-9.899413286576749	AKAP6
regulation of axonogenesis	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.412051053576494	-9.906166872564926	SIPA1L1
GPI anchor biosynthetic process via N-cysteinyl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.43966165530316	-9.926560116451613	PIGB
excitatory postsynaptic potential	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.902320069024984	-9.926681433202061	MEF2C;GRID2
negative regulation of Rac protein signal transduction	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.13253225729609	-9.928125132198549	OGT
GPI anchor biosynthetic process via N-seryl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.460870238703167	-9.942224817208562	PIGB
GPI anchor biosynthetic process via N-glycyl-glycosylphosphatidylinositolethanolamine	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.465117593275343	-9.945361921518025	PIGB
positive regulation of calcium ion transmembrane transport	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.168485486400703	-9.953382329632005	CACNA1D
regulation of oskar mRNA translation	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.177023565876661	-9.959380343284668	GEMIN5
septate junction assembly	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	14.907607155995777	-9.970351880235576	TLN2
negative regulation of centriole replication	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.7346853293876587	-9.994300799731272	TRIM37;BRCA1
cellular response to interleukin-11	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.556246646920025	-10.012670016956747	AKAP6
apical junction assembly	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	15.00494605006276	-10.035453074231722	TLN2
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.28579317492051	-10.035791156966706	CHD6
negative regulation of mitotic nuclear envelope disassembly	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.286866915966943	-10.036545461664158	DLG1
synaptic transmission involved in micturition	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.321052066053253	-10.060560580932304	FCHSD1
cellular response to interleukin-2	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.629837672567666	-10.06702449096498	AKAP6
endothelial tip cell filopodium assembly	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.9757754425674325	-10.11353645273277	DNM3;SRGAP2
negative regulation by host of symbiont adenylate cyclase activity	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	15.132090040628526	-10.120488205096985	GABBR1
filopodium assembly	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.986710092644071	-10.141351902509921	DNM3;SRGAP2
protein localization to Golgi apparatus	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	15.18839134755862	-10.158143063823552	GBF1
negative regulation by symbiont of host adenylate cyclase activity	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	15.190888439757241	-10.159813143242545	GABBR1
negative regulation of fatty acid biosynthetic process	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.465988143548378	-10.162378393009028	BRCA1
negative regulation of axon extension involved in axon guidance	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	3.9995786762401075	-10.174086872372683	SEMA3A;PLXNA2
detection of DNA damage stimulus involved in G2 DNA damage checkpoint	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.788565832201394	-10.18426141695234	BRCA1
regulation of G1/S transition of mitotic cell cycle	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.51293650847594	-10.19535968986843	ID2
DNA methylation involved in embryo development	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	12.481642751453924	-10.224431141279428	ATF7IP
regulation of kinase activity	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	4.021813125809808	-10.23064663523605	LDB1;LDB2
limb morphogenesis	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.566789481114967	-10.233191484013112	PTCH1
negative regulation of mitotic cell cycle DNA replication	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.587649359814218	-10.247845580122586	DLG1
regulation of mechanoreceptor differentiation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.830258047906081	-10.250060632990845	CASZ1;SIX1
positive regulation of endothelin secretion	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.919275063494322	-10.280803508225334	CADM1
mitotic DNA replication checkpoint	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.667511448193306	-10.30394881713002	TOP2B
positive regulation of receptor-mediated endocytosis involved in cholesterol transport	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	13.974109251172319	-10.321304145397821	LDLRAP1
regulation of glutamatergic neuron differentiation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.859830802704726	-10.329199564618804	CASZ1;SIX1
negative regulation of butyryl-CoA catabolic process to butyrate	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.001436249902017	-10.34148791956192	BRCA1
establishment of endothelial intestinal barrier	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	15.499172092581022	-10.365996232548143	RAPGEF2
glutamate catabolic process to 2-oxoglutarate	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.050288545452638	-10.377570319628783	STAT5B
regulation of timing of neuron differentiation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.9043889777517387	-10.448440615799933	CASZ1;SIX1
positive regulation of cornification	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.884772207241387	-10.456574826600631	PRKCH
gap junction assembly	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.894323029098137	-10.463284293296537	TLN2
regulation of JUN kinase activity	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.175499011646586	-10.470051012354608	TRIB1
positive regulation by symbiont of host cytokine secretion	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.178328673150167	-10.472141005819095	CADM1
negative regulation of proteasomal protein catabolic process	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.907875340233108	-10.47280481221904	GPX1
glycerophospholipid biosynthetic process	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	14.908979876562658	-10.473580750649123	AGPAT3
liver regeneration	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	13.47542490328832	-10.47554701232517	CITED2
positive regulation of transforming growth factor-beta secretion	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.216221142084828	-10.500128456730277	CADM1
protein targeting to chloroplast	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.226822766860636	-10.507958837313376	AKAP6
regulation of sevenless signaling pathway	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.230477928136292	-10.510658546507605	FGFR2
regulation of forebrain neuron differentiation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.9327007086903314	-10.524204952070734	CASZ1;SIX1
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	1/21	0.5123180405335976406178133402136154472827911376953125	0.8276041771222535370355899431160651147365570068359375	0.395167687393360334002778699868940748274326324462890625	0.59858894715301236288951258757151663303375244140625	15.789588174573344	-10.560229317633045	CTNNB1
cellular response to interleukin-8	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	13.660102006832151	-10.619111589632217	AKAP6
cellular response to erythropoietin	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.383713944679787	-10.623838964976276	AKAP6
clathrin-dependent endocytosis of virus by host cell	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.410719508528324	-10.643785326714884	FCHO2
thymus epithelium morphogenesis	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.414931772967284	-10.646896513384025	SIX1
regulation of spinal cord association neuron differentiation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	3.9809846867422665	-10.653416534278595	CASZ1;SIX1
negative regulation of epithelial cell differentiation	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	15.30745202801896	-10.753508035394018	SKOR1
regulation of protein heterodimerization activity	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	13.145403233159135	-10.768155511111024	LDLRAP1
activin receptor signaling pathway involved in heart jogging	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	4.234746995216574	-10.772305610038737	GDF2;ACVR2A
negative regulation of histone H3-S10 phosphorylation	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	15.342554574463867	-10.778167626981643	CNKSR3
regulation of cerebellar neuron development	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.046775565443313	-10.829477908564364	CASZ1;SIX1
cell cycle switching, mitotic to meiotic cell cycle	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.687364910406549	-10.848116156100051	DLG1
dorsal/ventral neural tube patterning	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.069507112392682	-10.890309249846991	PTCH1;HOXD11
negative regulation of hydrolase activity	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.765087366444318	-10.905522112592472	SLN
regulation of photoreceptor cell differentiation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.080342461165331	-10.919305463812254	CASZ1;SIX1
positive regulation of centromere clustering at the mitotic nuclear envelope	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.812761863660645	-10.940734588529523	TAL1
membrane depolarization during Purkinje myocyte cell action potential	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.097720008238692	-10.965809095924453	CACNA1D;CACNA1C
bone maturation	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.142313324119582	-10.993973782132512	FGFR2
negative regulation of cell cycle switching, mitotic to meiotic cell cycle	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	14.893574877214496	-11.000423236786332	TAL1
establishment of synaptic specificity at neuromuscular junction	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.111441236098056	-11.00252814089701	CACNB1;ANK3
cellular response to leukemia inhibitory factor	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.190610114257934	-11.031518816836037	AKAP6
positive regulation of cell division	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.1256015566706425	-11.040422231226236	TAL1;FGFR2
cellular response to type III interferon	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.243930308164206	-11.072968953064034	AKAP6
actin filament-based transport	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.2603171279879	-11.085707764840107	HOOK2
negative regulation of actin cytoskeleton reorganization	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.143422093412938	-11.088111337243735	PDGFRA;SEMA3E
clathrin-dependent extracellular exosome endocytosis	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.288291315128872	-11.107454382451795	FCHO2
transport along microtubule	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.29148102872705	-11.109934007027153	HOOK2
2'-(5''-triphosphoribosyl)-3'-dephospho-CoA biosynthetic process	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.087389820968989	-11.143575329449805	PPAT
positive regulation of protein desumoylation	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.090861314661927	-11.146139381411874	OGT
positive regulation of heterotypic cell-cell adhesion	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.357316946478509	-11.161113636349022	CITED2
susceptibility to natural killer cell mediated cytotoxicity	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.178699480560234	-11.182516297095187	CADM1;AP1G1
cytoskeleton-dependent intracellular transport	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.38752820555331	-11.184599312460236	HOOK2
cardiac right ventricle formation	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.181308774741245	-11.189498965946779	MEF2C;GATA3
miRNA mediated inhibition of translation	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.172810999854097	-11.206667577541229	STAT3
proline catabolic process to 2-oxoglutarate	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.417378596683655	-11.207804456481032	STAT5B
cellular senescence	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.200033234824133	-11.22677397298963	ID2
cellular response to interleukin-15	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.44559667879638	-11.229740673549582	AKAP6
cellular response to interleukin-12	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.452874084534685	-11.235397994672034	AKAP6
establishment of protein localization to mitochondrial membrane involved in mitochondrial fission	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	15.993518384782899	-11.235470681219754	DNM3
negative regulation of phagocytosis	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.261578849320713	-11.272231683002975	PACSIN3
positive regulation of interleukin-4 biosynthetic process	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.052336219399782	-11.281193196549175	GATA3
establishment of mitochondrion localization involved in mitochondrial fission	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	16.060787900716047	-11.282727617174874	DNM3
liver development	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	13.790604005306532	-11.296676555855152	CITED2
mitochondrial nucleoid organization involved in mitochondrial fission	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	16.08857439340351	-11.302247670012088	DNM3
positive regulation of G2/M transition of mitotic cell cycle involved in cellular response to nitrogen starvation	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.345478625055847	-11.334200219782543	PHOX2B
regulation of axon extension	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.59248296137373	-11.34392736299707	SIPA1L1
positive regulation of lipoprotein lipase activity	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.364754931051378	-11.348437736707849	LMF1
negative regulation of intracellular estrogen receptor signaling pathway	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	16.157275823474425	-11.350510527799157	BRCA1
protein import into peroxisome matrix, receptor recycling	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	13.863706928194512	-11.356559362644132	REP15
positive regulation of vascular endothelial growth factor receptor signaling pathway	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.656328558774657	-11.393559753953454	GATA3
mannosyl-inositol phosphorylceramide biosynthetic process	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.67965676317822	-11.41169467019517	AGPAT3
glutamate catabolic process via 2-oxoglutarate	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.682333041913017	-11.413775159968639	STAT5B
cellular response to glucocorticoid stimulus	1/20	0.495344647257223325009789505202206782996654510498046875	0.81526193339578589824867549396003596484661102294921875	0.3811741377507240624566975384368561208248138427734375	0.5880911994772668460740305818035267293453216552734375	16.277032571043208	-11.434639822793278	ZFP36L1
negative regulation of vasculogenesis	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.72952748062535	-11.450463246986265	SKOR1
negative regulation of megakaryocyte differentiation	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.51065906837244	-11.456202814989046	MEF2C
positive regulation of protein targeting to vacuolar membrane	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.519788524694585	-11.462945849102299	ANK3
establishment of protein localization to Golgi	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.616315181402035	-11.534240624612403	GBF1
regulation of vascular smooth muscle cell membrane depolarization	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.360509620923981	-11.547548860561642	CACNG2
positive regulation of actin filament depolymerization	2/13	0.06883274254375727763122227997882873751223087310791015625	0.450950064692920926656682922839536331593990325927734375	0.0439597283686246342870873604624648578464984893798828125	0.259197548393503007790883430061512626707553863525390625	4.319993285024165	-11.560629219177025	GPX1;SLN
microtubule nucleation	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.660059795250016	-11.56655048108573	CLASP2
positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.145991831580002	-11.587795155428818	U2AF2
maintenance of animal organ identity	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.912480173328712	-11.592687299081119	SKOR1
regulation of peptidoglycan recognition protein signaling pathway	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.168436116862834	-11.606180559815016	FOXP1
positive regulation of mitotic cohesin unloading	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.93940475497078	-11.613617972718716	TAL1
lysophospholipid transport	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.73371872809666	-11.62095511148261	LDLR
positive regulation of calcium ion export from cell	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.949369856098725	-11.62136465871174	CACNA1D
multi-organism nuclear import	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.745807804363718	-11.629884126616705	GEMIN5
regulation of neural crest formation	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	14.974397642343995	-11.640820798559528	CLASP2
embryonic skeletal joint morphogenesis	2/14	0.0785680887251434256768334307707846164703369140625	0.495462131706552899590434435594943352043628692626953125	0.0495066674307658993736680486108525656163692474365234375	0.28033967619558552986092081482638604938983917236328125	4.577604289545546	-11.64446244947084	PDGFRA;SIX1
regulation of protein homodimerization activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.502144651858893	-11.669964658049384	LDLRAP1
renal system vasculature development	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.256868284698239	-11.678620432411261	PTCH1
regulation of delayed rectifier potassium channel activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.520697813783004	-11.686000239768592	CACNA1D
TORC2 signaling	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.284156416879213	-11.700973710262128	GATA3
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.137044218069596	-11.767259249490413	FGFR2
negative regulation of neurogenesis	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	15.949704625394228	-11.780482713353752	CTNNB1
induction by virus of catabolism of host mRNA	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.1792566228768	-11.800074395152592	GTPBP1
DNA double-strand break processing involved in repair via single-strand annealing	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	16.03600476620211	-11.844224164422922	BRCA1
negative regulation of cornification	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.474667019855756	-11.857031897522004	MECOM
positive regulation of lipid kinase activity	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.491209347398687	-11.870582669022774	LMO4
cellular response to granulocyte colony-stimulating factor	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.51025775199621	-11.886186312312109	AKAP6
regulation of calcium ion transport into cytosol	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.512819472209813	-11.88828476461112	SLN
cellular response to interleukin-17	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.521233215046488	-11.895176945070618	AKAP6
cellular response to stem cell factor stimulus	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.550994736511663	-11.919556318278119	AKAP6
protein targeting to lysosome involved in chaperone-mediated autophagy	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.338667784412957	-11.92399769471058	LARS
cellular response to interleukin-18	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.58900015658868	-11.950688742776297	AKAP6
membrane depolarization	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.837777223269784	-11.96005340672207	CACNG2
positive regulation of T cell differentiation in thymus	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.853426458452306	-11.973579111431535	GATA3
release of cytochrome c from mitochondria	1/22	0.5287213778598047753121136338450014591217041015625	0.829434943229018006860542300273664295673370361328125	0.4088458107994539236784703462035395205020904541015625	0.60493277589116190018359020541538484394550323486328125	18.8085334824233	-11.986559552160173	SFN
regulation of follicle cell microvillus length	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.46438075851197	-12.021724644301022	LARS
negative regulation of telomerase activity	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.677934928947225	-12.023540327631935	GDF2
positive regulation of constitutive secretory pathway	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.686938860591695	-12.030915965673564	CLASP2
cellular response to interleukin-7	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.687898246389114	-12.031701853734853	AKAP6
liver trabecula formation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	13.923712160742365	-12.034327361642159	CITED2
negative regulation of cell size	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	16.379010367709785	-12.097568765721128	LARS
regulation of protein catabolic process at synapse, modulating synaptic transmission	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	16.409191125589672	-12.119860331918149	NLGN2
melanosome organization	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.600721334084806	-12.127713295445684	AP1G1
actin filament depolymerization	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.812536227478594	-12.133799989422084	MICAL3
megakaryocyte differentiation	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.817633516853451	-12.137975472189712	TAL1
cellular response to interleukin-32	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.818935655024998	-12.139042128425316	AKAP6
monoubiquitinated histone deubiquitination	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.643590716989136	-12.161039163774637	USP21
positive regulation of potassium ion import	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.313006858303898	-12.167846287292582	DLG1;AKAP6
paranodal junction assembly	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.664767470890622	-12.17750158204015	TLN2
entrainment of circadian clock by photoperiod	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	16.547694902209187	-12.222159489458823	ID2
positive regulation of mini excitatory postsynaptic potential	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.72866434189545	-12.227173832151404	NLGN2
positive regulation of cAMP-mediated signaling	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.986012148630227	-12.275904089483614	RAPGEF2
positive regulation by symbiont of host receptor-mediated endocytosis	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	14.993844455429192	-12.28231998225815	LDLRAP1
negative regulation of peptidyl-serine phosphorylation of STAT protein	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.837521252196359	-12.311797188346677	CNKSR3
negative regulation of keratinocyte migration	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.250537025264851	-12.316803569436608	PTPRG
positive regulation of chemotaxis	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	15.894928989390444	-12.356424905406724	PDGFRA
negative regulation of muscle cell differentiation	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	16.850445661143258	-12.445771786102805	SKOR1
intrahepatic bile duct development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.410777981722827	-12.455300552460645	CITED2
long-term synaptic potentiation	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	16.029962456359826	-12.461397434408747	SLC24A2
DNA methylation on cytosine	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	13.664747507500854	-12.479606533840304	ATF7IP
negative regulation of border follicle cell migration	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	16.129861909417055	-12.539057428399081	PTPRG
DNA methylation on adenine	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	13.738319913628263	-12.546798019062697	ATF7IP
positive regulation of ribosomal subunit export from nucleus	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.51882300645924	-12.548684355749883	TCF7L2
positive regulation of Notch signaling pathway involved in heart induction	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	17.004919928026702	-12.559866778669694	STAT3
outflow tract septum morphogenesis	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	16.216868566054607	-12.606694800024336	FGFR2
DNA methylation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	13.87049835024687	-12.667512644807	ATF7IP
negative regulation of microtubule depolymerization	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.490843872413106	-12.66955971436626	STMN2;CLASP2
positive regulation of tRNA export from nucleus	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.719475964288039	-12.72210961423819	TCF7L2
thorax and anterior abdomen determination	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.579570448204391	-12.762121816042406	NEUROG1
cell migration involved in metanephros development	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.52616873654135	-12.769218150105681	ROBO2;VANGL2
ceramide 1-phosphate transport	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	16.479690910820896	-12.811008047899506	LDLR
negative regulation of lyase activity	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.642877237695402	-12.813980046790991	SLN
bone cell development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.842565611803165	-12.828496553003175	FGFR2
maintenance of epithelial cell apical/basal polarity	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	16.55323501226637	-12.868179877188783	DLG1
cell-cell adhesion involved in gastrulation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.980227620316807	-12.94747844925246	WNT8B
positive regulation of cytokine-mediated signaling pathway	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	14.989720017147741	-12.955682770743115	GATA3
regulation of ERAD pathway	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.003327448931739	-12.967443735545414	GPX1
regulation of actin filament polymerization	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.848146939718312	-12.982128260573166	FCHSD1
negative regulation of hematopoietic progenitor cell differentiation	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.86741609598683	-12.997912734247118	SKOR1
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.048738591523524	-13.00669279136521	ATF7IP
dorsal/ventral pattern formation	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.6146574006300805	-13.018862191530406	PTCH1;HOXD11
tooth placode formation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.09988781219063	-13.050901294004065	MSX1
glucose mediated signaling pathway	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.935583629015799	-13.053752679469424	LIN28A
regulation of calcium ion transmembrane transport	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	14.294635003983105	-13.054864006572185	SLN
AV node cell to bundle of His cell communication by electrical coupling	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.11798405771162	-13.066541960810598	CACNA1C
regulation of gluconeogenesis involved in cellular glucose homeostasis	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	17.698729403086535	-13.07231580009484	OGT
TORC1 signaling	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.12487360853126	-13.072496630727718	GATA3
hermaphrodite genitalia development	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.962993388492526	-13.076205589230536	NEUROG1
cellular response to cholesterol	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.144125055634733	-13.089135743483995	PTCH1
regulation of synaptic activity	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.642489966903426	-13.097383371607577	MEF2C;NLGN2
baculum development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.156688259860118	-13.099994177687032	FGFR2
mature miRNA 3'-end processing	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	15.996102738705057	-13.10332736143004	DDX17
neuromuscular junction development	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.647893053154507	-13.112626547688683	CACNB1;ANK3
positive regulation of myosin-light-chain-phosphatase activity	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	4.403959619465967	-13.130497012389178	MAGI2;AKAP6
isopentenyl diphosphate biosynthetic process	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.032307850410444	-13.132985049842164	AGPAT3
determination of ventral identity	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.656883659232231	-13.137990827500277	PTCH1;HOXD11
aminophospholipid transport	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	16.90203789597333	-13.139332811699605	LDLR
dorsal/ventral pattern formation, imaginal disc	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.6618538171822195	-13.152012627127743	PTCH1;HOXD11
determination of dorsal/ventral asymmetry	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	4.671801513550873	-13.180077048146085	PTCH1;HOXD11
cardiac left ventricle formation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.260148299512753	-13.189415157642273	MEF2C
renal system development	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.106894865392817	-13.194083561785396	PTCH1
pre-replicative complex assembly	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.168271634340503	-13.244360801751002	BAZ1A
negative regulation of telomeric DNA binding	1/19	0.477781417854603873696106575152953155338764190673828125	0.80316997434788539589334277479792945086956024169921875	0.366857912312310519009628251296817325055599212646484375	0.57817199210730663150314967424492351710796356201171875	17.940832105808166	-13.251133325011725	TNKS
cargo loading involved in clathrin-dependent endocytosis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.343709002853469	-13.261637051269643	FCHO2
regulation of cardiac muscle cell action potential involved in regulation of contraction	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.358238394415284	-13.274194870075561	ATP2A2
negative regulation of signal transduction involved in mitotic G2 DNA damage checkpoint	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.246297665123862	-13.308276409244165	PHOX2B
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.25036257185396	-13.311606208036295	ZFP36L1
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.412682425220225	-13.321251092010492	GATA3
dentin secretion	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.466975605572983	-13.368176933217693	MSX1
metanephric epithelium development	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.35562888360471	-13.397835895700336	ROBO2
nucleation of clathrin-coated pit	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.511019749503676	-13.406244485915291	FCHO2
vesicle scission involved in clathrin-mediated endocytosis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.537866275156016	-13.429448059394344	FCHO2
cell-cell junction maintenance	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.551295240612653	-13.441054774943163	NLGN2
metanephric collecting duct development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.597322007192307	-13.480835917358556	ROBO2
protein localization to postsynaptic membrane	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.616523424598522	-13.497431789221338	NLGN2
cardiac muscle myosin thick filament assembly	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	17.431541760569225	-13.550959359032342	PDGFRA
embryonic nail plate morphogenesis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.722981722825896	-13.589444177616132	MSX1
rolling circle DNA replication	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.744690747704293	-13.608207385952575	BAZ1A
phospholipid transfer to membrane	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.620742394946994	-13.615005614087464	LDLR
3'-UTR-mediated mRNA destabilization	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.63080787350589	-13.623250826234518	ZFP36L1
positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.763856975548716	-13.624772843318027	OTX2
digestive tract morphogenesis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.816975952761485	-13.670683815443436	FGFR2
regulation of store-operated calcium entry	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.819827109117437	-13.673148082770327	SLN
positive regulation of cardiac muscle cell myoblast differentiation	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.733464435448273	-13.707342717797276	MEF2C
plastid DNA replication	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.87573780047386	-13.721471946049835	BAZ1A
embryonic limb morphogenesis	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.770053922640372	-13.737315270268127	PTCH1
acetyl-CoA assimilation pathway	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	15.904219681140306	-13.746088964260082	STAT5B
response to insulin	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.80427344031059	-13.765346444455208	OGT
positive regulation of protection from non-homologous end joining at telomere	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.819344082421598	-13.77769167381221	TNKS
anterior/posterior axis specification, embryo	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	16.835948873205357	-13.791293612544525	FZD5
cortical actin cytoskeleton organization	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.061825135407418	-13.882308070826964	DLG1
response to cAMP	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.219403490104355	-13.899427496336882	JUND
epithelial cell morphogenesis involved in gastrulation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.233019058854511	-13.911862189377723	WNT8B
rhodopsin mediated signaling pathway	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.107480488315286	-13.921768198726886	TRPM1
positive regulation of motor neuron apoptotic process	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	17.9203582841675	-13.930956317206592	CTNNB1
intermembrane phospholipid transfer	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.011236887087854	-13.934882101938234	LDLR
positive regulation of integrin-mediated signaling pathway	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.270356257618007	-13.945961139935607	GATA3
SA node cell to atrial cardiac muscle cell communication by electrical coupling	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.333499803759013	-14.003628258230957	CACNA1C
negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.207765562898363	-14.008445042020313	NR2F2
negative regulation of lipoprotein lipase activity	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.116106173974973	-14.020786563711708	LMF1
lipid A biosynthetic process	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.12229053107621	-14.02585252614901	AGPAT3
intestinal epithelial cell differentiation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.38239215950547	-14.048280189186388	FGFR2
negative regulation of high voltage-gated calcium channel activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.257980017787162	-14.051845622371436	CRHR1
negative regulation of cell differentiation involved in embryonic placenta development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.261990002634242	-14.055311470401607	SKOR1
osteoclast development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.285324511286174	-14.075479591711396	FOXP1
negative regulation of endoplasmic reticulum calcium ion concentration	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.193837841116125	-14.084461041022715	ATP2A2
green leaf volatile biosynthetic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.49758166059099	-14.153479326571661	GPX1
myeloid progenitor cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	14.658198220763854	-14.168537984971492	FST
intracellular cholesterol transport	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.33827073117428	-14.202774324645866	LDLR
negative regulation of cilium assembly	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.44316369765972	-14.211900713994437	CYLD
negative regulation of MyD88-independent toll-like receptor signaling pathway	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.456538447468	-14.2234605707133	TYRO3
lymphoid progenitor cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	14.72814759658255	-14.236150686982054	FST
positive regulation of memory T cell differentiation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.492225854201497	-14.25430535767535	GATA3
regulation of transcription elongation from RNA polymerase I promoter	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.51897267709274	-14.277422757607289	LDB1
theta DNA replication	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.540141320973326	-14.29571891220457	BAZ1A
intestinal cholesterol absorption	1/18	0.45960788666512664146779343354864977300167083740234375	0.7941283521609532325413738362840376794338226318359375	0.35221159548987868159741765339276753365993499755859375	0.57115553050993261852141813506023027002811431884765625	18.463305190568033	-14.353033237527477	LDLR
Golgi vesicle budding	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.646184319487645	-14.38737235518004	CUX1
regulation of axon extension involved in axon guidance	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	4.831707855907828	-14.40583725752423	SEMA3A;PLXNA2
regulation of skeletal muscle contraction by action potential	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	14.947204013915067	-14.447889478004202	AKAP6
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.750999739060774	-14.47796479612746	ZFP36L1
negative regulation of ligase activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.793354660795867	-14.514572346445394	SLN
cardiac myofibril assembly	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.817155006571003	-14.53514309288655	PDGFRA
positive regulation of Rac protein signal transduction	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.924103463893598	-14.543008974331254	OGT
regulation of proteasomal protein catabolic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.965795913019194	-14.58108544520889	GPX1
positive regulation of protein localization to plasma membrane	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	15.979787995932316	-14.593863997410368	PRKCH
negative regulation of transferase activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.89440166429878	-14.601907728348479	SLN
postganglionic parasympathetic fiber development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.902339676244353	-14.608768587956234	PHOX2B
negative regulation of prostaglandin-E synthase activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.940477675975735	-14.64173143352408	SLN
cholesterol transport involved in cholesterol storage	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.94545979059255	-14.646037497708676	LDLR
miRNA 2'-O-methylation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	16.970287252402215	-14.667495985181477	DDX17
positive regulation of cholesterol efflux	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.927864722119107	-14.685744658100194	PTCH1
epithelial tube branching involved in lung morphogenesis	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.08825811961034	-14.692926527723182	NKX2-1
negative regulation of catalytic activity in other organism involved in symbiotic interaction	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.014923518322753	-14.70607531159154	SLN
purine nucleotide salvage	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	17.9546391088436	-14.707677097512681	PPAT
positive regulation of sodium ion transport by transcription from RNA polymerase II promoter	2/12	0.05953457803366672684841631735253031365573406219482421875	0.4088486096360821608897140322369523346424102783203125	0.03866366039321018910346339225725387223064899444580078125	0.2434933058408177142251105351533624343574047088623046875	5.213755865831792	-14.709037578451548	CNKSR3;ANK3
negative regulation of histone demethylase activity (H3-K4 specific)	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.089927563279687	-14.770901646698064	SLN
regulation of cytokine biosynthetic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	15.299503395134803	-14.788420223305698	GATA3
negative regulation of toll-like receptor 4 signaling pathway	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.196732849685127	-14.791993264920833	TYRO3
sodium ion import across plasma membrane	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	15.31288098724888	-14.801350934103922	SLC9A2
terminal web assembly	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.21483561587545	-14.808525981614308	DLG1
ventricular cardiac myofibril assembly	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.25012641998629	-14.840756020941734	PDGFRA
negative regulation of catalytic activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.17535544960638	-14.844737355020674	SLN
2-oxoglutarate metabolic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.268286627481974	-14.857341197066988	STAT5B
male genitalia development	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.22960859919232	-14.891628597455162	NEUROG1
cholesterol import	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.23186080091615	-14.893575185585977	LDLR
negative regulation of cyclase activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.24611163248145	-14.905892243727699	SLN
chromosome passenger complex localization to kinetochore	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.354572716945622	-14.936143710268128	DLG1
positive regulation of regulatory T cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	15.460397710409541	-14.943939829685895	GATA3
somite rostral/caudal axis specification	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.398654955412912	-14.976402704508653	FZD5
exocyst localization	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	15.563692965996855	-15.04378448524411	DLG1
entry of bacterium into host cell	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.477568492556117	-15.105941454173875	CTNNB1
trabecular meshwork development	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.56638377521914	-15.1295844354128	CACNA1C
mitochondrial fragmentation involved in apoptotic process	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	18.50212578698644	-15.156154910321995	ERBB4
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.62706375612125	-15.185001653017705	GATA3
positive regulation of sarcomere organization	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	15.741143055938506	-15.215306817109797	GPX1
iron ion homeostasis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.628303474212952	-15.23622238020623	NEO1
regulation of G2/M transition of mitotic cell cycle	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.672026058510973	-15.274012007459723	KCNH5
negative regulation of dendrite morphogenesis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.695177006193525	-15.294021476193903	RAPGEF2
positive regulation of cell size	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.715787240712803	-15.311834995055957	LARS
negative regulation of receptor-mediated endocytosis	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.767125287744445	-15.356206701175257	PACSIN3
negative regulation of superoxide anion generation	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.153580616889343	-15.365507575062185	BRCA1;AATF
negative regulation of cAMP-dependent protein kinase activity	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	17.79098974870718	-15.37683286266288	PRKAR2A
regulation of tumor necrosis factor biosynthetic process	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	4.868739265817252	-15.385829391805673	GATA3;FOXP1
GMP biosynthetic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.87122533894673	-15.407987147822427	PPAT
positive regulation of outer hair cell apoptotic process	1/17	0.440802879152086768410612194202258251607418060302734375	0.78640967509848469507716117732343263924121856689453125	0.33722760186524125547435914995730854570865631103515625	0.55814126245555895078354069482884369790554046630859375	18.852304093382134	-15.443006092671013	CTNNB1
DNA double-strand break processing involved in repair via synthesis-dependent strand annealing	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.927015676834003	-15.45893880022881	BRCA1
cellular response to corticotropin-releasing hormone stimulus	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.194885663447902	-15.488659428688747	CRHR1;ZFP36L1
mesenchymal cell differentiation involved in mammary gland development	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	16.986799364354574	-15.513537459808086	FGFR2
negative regulation of phosphatidylcholine catabolic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.117739661657318	-15.579323132947302	LDLR
cellular response to trichostatin A	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.118328465061126	-15.633659066421497	MEF2C
negative regulation of hydrogen:potassium-exchanging ATPase activity	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.184402289784696	-15.643758881773705	CAB39
negative regulation of astral microtubule depolymerization	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.254784161785047	-15.667248044711943	STMN2;CLASP2
negative regulation of axonemal microtubule depolymerization	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.2729085451701785	-15.72128626995769	STMN2;CLASP2
positive regulation of T-helper 1 cell cytokine production	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.265665553680755	-15.768217637138243	FZD5
purine nucleotide catabolic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.267686030445685	-15.770062878334485	GPX1
L-arabinose catabolic process to 2-oxoglutarate	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.346453584584797	-15.800396818531624	STAT5B
regulation of synaptic transmission, GABAergic	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.334525904604593	-15.831105742816007	NLGN2
astral microtubule depolymerization	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.367654747249247	-15.861361327187387	DLG1
actin cortical patch assembly	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.41740066589477	-15.868973897468877	DLG1
negative regulation of response to interferon-gamma	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.411416558210476	-15.901327684539005	TYRO3
negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.43822206717178	-15.925808356764582	NR2F2
negative regulation of endodermal cell differentiation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	18.44023326400131	-15.937976967788961	SKOR1
positive regulation of protein export from nucleus during meiotic anaphase II	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.522327379356675	-15.970395511703654	TCF7L2
negative regulation of keratinocyte differentiation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	15.5868188858712	-15.975537283548244	ZFP36L1
bundle of His cell to Purkinje myocyte communication by electrical coupling	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.530793598973677	-15.978578915449873	CACNA1C
insulin receptor recycling	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	15.599957859667915	-15.989003929134745	REP15
regulation of NMDA receptor activity	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.518261175255173	-15.998905688102171	MEF2C
positive regulation of axon extension involved in regeneration	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.56474000126823	-16.011391330940487	SEMA7A
protein poly-ADP-ribosylation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.567439030576406	-16.014000198599355	TNKS
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.542529220426	-16.021068970293165	AKAP6
atrial cardiac muscle cell to AV node cell communication by electrical coupling	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.60600616536245	-16.05127899002773	CACNA1C
female germ-line cyst encapsulation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	18.58782807607798	-16.065543831058275	USP9X
negative regulation of smooth muscle cell chemotaxis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	15.68860512427576	-16.079861960603303	TRIB1
ventral spinal cord interneuron fate commitment	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.4013408165561145	-16.104209752787416	MYT1L;ID2
myoblast fate commitment	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.101781452201337	-16.122272056947455	DDX17;TCF7L2
histone H2B conserved C-terminal lysine deubiquitination	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	18.679346670646975	-16.144643766047306	USP21
negative regulation of myoblast differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.732265089169726	-16.173320207574573	ZFP36L1
rostrocaudal neural tube patterning	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.722488380190786	-16.185420306078345	PTCH1
positive regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	4.81713838358931	-16.19106507244316	SIX1;GATA3
negative regulation of myoblast fusion	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	15.81087681066704	-16.205182970552087	BDNF
neuron fate specification	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.442729369100855	-16.227610581244996	MYT1L;ID2
multinuclear osteoclast differentiation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	17.778411846748245	-16.236493540930464	FOXP1
establishment of endothelial barrier	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	18.817028236593114	-16.263642565873905	RAPGEF2
GDP-alpha-D-mannosylchitobiosyldiphosphodolichol biosynthetic process	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	18.83253771188403	-16.27704747547728	AGPAT3
regulation of light-activated voltage-gated calcium channel activity	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.86344227595946	-16.300115392480674	CACNB1
glutamate receptor signaling pathway	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.890408699285185	-16.32618099668762	GRID2
negative regulation of methylation-dependent chromatin silencing	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.1672931634658665	-16.329297317009743	ATAD2;TET1
positive regulation of calcium-mediated signaling involved in cellular response to salt stress	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.93101688269038	-16.36543265507099	ZFP36L1
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.178861531500843	-16.36585481725984	SLN;ATP2A2
ear morphogenesis	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.183076250746183	-16.379173861000474	GATA3;FGFR2
positive regulation of histone H3-K27 methylation	3/7	0.0011944789489858414176237655368595369509421288967132568359375	0.0286007979815543871005001363982955808751285076141357421875	0.001215673518888912320312645221065395162440836429595947265625	0.018379269194227561279308957864486728794872760772705078125	2.4352364795639603	-16.38925161580349	TET1;OGT;PHF19
purine ribonucleotide catabolic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	16.95982241455953	-16.393275932008482	GPX1
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.007293555932034	-16.40649813691605	PTCH1
piecemeal microautophagy of nucleus	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.004593946067526	-16.436551860963913	TRAPPC8
cardiac right ventricle morphogenesis	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.021994481753904	-16.45337112804696	GATA3
4-amino-4-deoxy-alpha-L-arabinopyranosyl undecaprenyl phosphate biosynthetic process	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	19.04946271484024	-16.464536736125787	AGPAT3
female gamete generation	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	19.059186556743644	-16.47294109663881	USP9X
regulation of cell diameter	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.061537367325936	-16.49506363851615	LARS
metanephros morphogenesis	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.1137704939453	-16.542766595916873	ROBO2
beta-L-Ara4N-lipid A biosynthetic process	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	19.159522414851587	-16.55966183236234	AGPAT3
suppression by virus of host cell lysis in response to superinfection	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.146597143373704	-16.573811411197717	GBF1
negative regulation of hemocyte differentiation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.168377635485164	-16.592637670371865	SKOR1
late nucleophagy	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.182467045248725	-16.60848307135534	TRAPPC8
positive regulation of neurotransmitter secretion	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.200071109117893	-16.62158237501496	MEF2C
embryonic eye morphogenesis	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.23653960444318	-16.660749325184955	FGFR2
mitral valve morphogenesis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.281250613350394	-16.687287386917884	EFNA1
establishment of protein localization to telomere	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.279698587406653	-16.694303777132355	TNKS
nucleobase-containing small molecule catabolic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.307996918453366	-16.720147799265472	ENTPD4
myoblast differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.31863421255164	-16.740101545412024	DDX17
positive regulation of hemoglobin biosynthetic process	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.338313655125198	-16.745773519210882	LDB1
mitotic G2 cell cycle arrest in response to glucose starvation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.33705731295594	-16.757909218220647	MAGI2
regulation of DNA-dependent DNA replication	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.34316561906911	-16.76381347506619	ZBTB38
neuromuscular process controlling balance	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.345094887192985	-16.765678295577185	NEUROG1
cholesterol transport	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	19.402977072516077	-16.77008079350056	LDLR
positive regulation of interferon-alpha biosynthetic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.367067314221732	-16.77409503075166	IFIH1
mitotic G1 cell cycle arrest in response to nitrogen starvation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.388812765299345	-16.807935768647432	MAGI2
purine deoxyribonucleotide catabolic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.41950378118396	-16.821983692825665	GPX1
glomerular visceral epithelial cell development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.416646290887517	-16.826059686151197	MAGI2
regulation of potassium ion export	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.421810146706747	-16.839830865495905	CACNA1D
negative regulation of neurotransmitter secretion	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.42198420511895	-16.83999910944975	MEF2C
regulation of membrane repolarization	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.423645134875493	-16.841604555493767	AKAP6
Kdo2-lipid A biosynthetic process	1/16	0.421344487234922515650481500415480695664882659912109375	0.7769671408471967577469285970437340438365936279296875	0.32189817225101491349192883717478252947330474853515625	0.54756353354058318050334719373495317995548248291015625	19.498191596271006	-16.85237513679217	AGPAT3
platelet-derived growth factor receptor-beta signaling pathway	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.45521116591489	-16.854594182814584	PDGFRA
regulation of hydrogen:potassium-exchanging ATPase activity	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.491271831395142	-16.88752731358008	CACNA1D
peptidyl-serine ADP-ribosylation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.488508902446654	-16.90430153508424	TNKS
regulation of DNA replication	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.48945831103212	-16.905219228473555	ZBTB38
cellular response to luteinizing hormone stimulus	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.51382678280891	-16.925663754389333	ZFP36L1
cellular response to molecule of bacterial origin	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	15.596366671987345	-16.986347313001993	FZD5
cardiac muscle cell action potential	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.57677619059785	-16.990183052295663	AKAP6
glucocorticoid mediated signaling pathway	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.621700072985032	-17.006643538380356	ZFP36L1
Bub1-Bub3 complex localization to kinetochore	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.60268518218087	-17.014663731858565	DLG1
negative regulation of myotube differentiation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.605616898520502	-17.01974301626752	BDNF
dosage compensation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.619074917040194	-17.033536663207173	GPX1
sclerotome development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.636928840869473	-17.051835844578353	PTCH1
recognition of apoptotic cell	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.662246599757964	-17.07223548758666	TYRO3
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.4087293569571955	-17.092266101997872	DLG1;CACNA1D
negative regulation of myofibroblast differentiation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.73908193476912	-17.11384489343437	SKOR1
negative regulation of ERBB3 signaling pathway	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.736549764599534	-17.144056539369824	ERBB4
Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.730420967022393	-17.147659563196655	CACNA1C
regulation of multicellular organism growth	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.429800581763688	-17.15885382671446	STAT5B;FGFR2
endoderm formation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.804662114099813	-17.1737373161825	EOMES
TOR signaling	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.771590217766356	-17.18985553050799	GATA3
negative regulation of cytokine biosynthetic process	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.78225039583361	-17.200781561881655	GATA3
branchiomotor neuron axon guidance	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	5.76995562631514	-17.203242458916137	PLXNA2;LHX9
negative regulation of cardiocyte differentiation	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	18.844449151663884	-17.210073631483912	SKOR1
negative regulation of skeletal muscle fiber development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.832118803991822	-17.25189363418044	BDNF
regulation of gastrulation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	16.89865702525453	-17.320091246685383	CLASP2
thymus development	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.91880883657178	-17.320227208196396	SIX1
negative regulation of NMDA glutamate receptor activity	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	17.960737255315788	-17.360754999175697	MEF2C
mitotic cell size control checkpoint	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.01173263195643	-17.410046864390576	LARS
phagosome maturation involved in apoptotic cell clearance	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	19.084930598105345	-17.429698167438993	TYRO3
negative regulation of nitric oxide metabolic process	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.5166010368069545	-17.433154198846342	BRCA1;AATF
negative regulation of sorocarp spore cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.10672990553607	-17.5018707337987	SKOR1
exocrine pancreas development	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.546276149924165	-17.526931294450847	TCF7L2;NKX6-1
microglial cell activation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	16.106588310748783	-17.542040965561295	FOXP1
regulation of cilium assembly	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.155376678857902	-17.548892451289213	CYLD
negative regulation of cell differentiation involved in phenotypic switching	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.161960042711552	-17.555255896470165	SKOR1
zygotic specification of dorsal/ventral axis	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.555957145903412	-17.557524461253845	FZD5;CXXC4
osteoclast differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.173383122074085	-17.56629738543189	FOXP1
peptidyl-glutamic acid poly-ADP-ribosylation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.19191915838162	-17.584214221495827	TNKS
cell communication by electrical coupling involved in cardiac conduction	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.15813830030959	-17.586043703974944	CACNA1C
gephyrin clustering involved in postsynaptic density assembly	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.232576693862653	-17.587410408532428	NLGN2;NRXN2
renal tubule development	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	19.277104635995478	-17.605204987273883	PTCH1
positive regulation of protein tyrosine phosphatase activity	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.244868019609046	-17.628723245976424	MAGI2;AKAP6
negative regulation of smooth muscle cell-matrix adhesion	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.24116902835924	-17.631818889069798	SEMA3E
negative regulation of mesodermal cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.288706599944664	-17.67776845794432	SKOR1
axonal fasciculation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.248352490977997	-17.67850773894456	CNTN4
regulation of cell size	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.30543491280779	-17.693937957950805	LARS
tricellular tight junction assembly	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.327081351131795	-17.714861292388903	TLN2
necroptotic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.376224935851177	-17.76236322518634	CYLD
negative regulation of cell development	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.43714273500711	-17.821246052277537	SKOR1
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.403037142672293	-17.837050058479363	PTCH1
positive regulation of diacylglycerol kinase activity	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	16.402893839949183	-17.864753859892055	LMO4
negative regulation of sporulation resulting in formation of a cellular spore	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.482651421632223	-17.86523451152628	SKOR1
filtration diaphragm assembly	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.54259226984116	-17.923173022925088	TLN2
negative regulation of plant epidermal cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.543557617780813	-17.924106123211065	SKOR1
regulation of calcium ion transport	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.51157063074237	-17.948290254305896	SLN
negative regulation of embryo sac central cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.57459808643548	-17.9541096783944	SKOR1
regulation of defense response to bacterium, incompatible interaction	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.601527340872906	-17.98013935534768	FOXP1
gamma-aminobutyric acid signaling pathway	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.700951210266412	-18.01572396944606	GABRA2;GABBR1
maintenance of plant organ identity	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.65442885581737	-18.03127368391007	SKOR1
regulation of barbed-end actin filament capping	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.61286564067492	-18.052111452182373	FCHSD1
cellular response to laminar fluid shear stress	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	19.767152897281548	-18.052751455299415	MEF2C
regulation of prostatic bud formation	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.71695602841971	-18.066301210926703	CITED2;FGFR2
negative regulation of ubiquitin-dependent endocytosis	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.700121960373675	-18.075440400569708	PACSIN3
negative regulation of pigment cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.712264875666882	-18.087177679189423	SKOR1
ripoptosome assembly involved in necroptotic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.71226697297975	-18.08717970644111	CYLD
negative regulation of antipodal cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.730838575387057	-18.105130920511673	SKOR1
negative regulation of leukocyte differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.746319827428202	-18.12009501802873	SKOR1
positive regulation of synaptic transmission, GABAergic	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.685916391618992	-18.12698400981221	NLGN2
positive regulation of heart rate by epinephrine	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.708935494753167	-18.150577184471295	ATP2A2
positive regulation of lipopolysaccharide-mediated signaling pathway	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.722543395068648	-18.164524451096547	GATA3
negative regulation of synergid differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.8015656270118	-18.173495319902226	SKOR1
positive regulation of monocyte differentiation	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.7635907399951085	-18.213672774048334	FOXP1;ZFP36L1
glial cell development	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.434701204786592	-18.266778707407575	NFIB;PHOX2B
negative regulation of embryo sac egg cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.911008788596238	-18.279282509347375	SKOR1
negative regulation of tendon cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	18.913286163496693	-18.281483808053885	SKOR1
peptidyl-cysteine ADP-ribosylation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.84013076987959	-18.28504432780273	TNKS
positive regulation of protein serine/threonine phosphatase activity	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.4436551975287095	-18.29687430931922	MAGI2;AKAP6
regulation of calcium ion export from cell	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.858982428223918	-18.30436612610819	SLN
positive regulation of Golgi to plasma membrane protein transport	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	16.817963365020557	-18.316815244455974	PRKCH
positive regulation of hexokinase activity	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	16.838849693722686	-18.339563006219304	LMO4
regulation of intrinsic apoptotic signaling pathway in response to DNA damage	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	17.901348211224445	-18.34778846589589	CYLD
smooth muscle cell differentiation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	16.855396340242763	-18.357584324297207	MEF2C
maintenance of imaginal histoblast diploidy	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.002213022225764	-18.367440046113366	SKOR1
negative regulation of transdifferentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.051215178482707	-18.414805274896295	SKOR1
viral DNA genome replication	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.028905499204907	-18.478526894618334	DEK
positive regulation of actin filament bundle assembly	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.18141688695237	-18.54065756754352	GPX1
metanephric cortex development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.138884263799962	-18.591248410602557	ROBO2
negative regulation of activin receptor signaling pathway	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.531551969705056	-18.592307457516334	FST;MAGI2
negative regulation of Golgi to plasma membrane protein transport	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.153909104236835	-18.606647954302662	PKDCC
cellular response to virus	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.244241878627086	-18.699233530343836	GBF1
virus induced gene silencing	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.256678267936447	-18.71198006974608	GBF1
vascular smooth muscle cell differentiation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.192431801075436	-18.724657086492787	MEF2C
negative regulation of sorocarp stalk cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.37834045471765	-18.731002861555588	SKOR1
regulation of microtubule binding	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.201179861077605	-18.734184791799862	LDLRAP1
protein auto-ADP-ribosylation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.281721356787035	-18.737647706135338	TNKS
negative regulation of metanephric DCT cell differentiation	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.386853128976608	-18.739231168116547	SKOR1
peptidyl-arginine ADP-ribosylation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.303144505824818	-18.759605125329728	TNKS
paraxial mesoderm formation	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.938625234571372	-18.76680382588733	EOMES;MSGN1
VEGF-activated platelet-derived growth factor receptor signaling pathway	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.41789828255644	-18.769239251724123	PDGFRA
positive regulation of intracellular signal transduction	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.2383218629601	-18.774636966152073	GATA3
IMP biosynthetic process	1/15	0.401210043870122989861926043886342085897922515869140625	0.77355606841369339843339503204333595931529998779296875	0.306215369788197688816211439188919030129909515380859375	0.5415890136073973071262344092247076332569122314453125	20.561929962275453	-18.778597655370064	PPAT
peptidyl-asparagine ADP-ribosylation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.32714559498301	-18.784204775681733	TNKS
metanephric smooth muscle tissue development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.327788724143506	-18.78486394378761	ROBO2
regulation of bicellular tight junction assembly	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	5.96051227342575	-18.835969625762782	PRKCH;RAPGEF2
hydrogen peroxide catabolic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.570285085856813	-18.91653554138074	GPX1
ADP biosynthetic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.614755335647747	-18.95952025299908	PPAT
positive regulation of asymmetric cell division	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.641679420388771	-18.962460975703973	TAL1;FGFR2
regulation of phragmoplast microtubule organization	2/11	0.050715649081364881645139774946073885075747966766357421875	0.358122330414368528206381370182498358190059661865234375	0.033632924593167821958328289611017680726945400238037109375	0.2179210237719404197331840578044648282229900360107421875	6.361288385483412	-18.966313353859626	CYLD;EFNA5
exit from mitosis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.52474635803478	-18.986733487954936	CLASP2
regulation of endocardial cushion to mesenchymal transition	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.574363642077582	-19.037588173374598	CLASP2
ventricular cardiac muscle cell differentiation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.499932052951408	-19.059562400470973	MEF2C
alignment of 3' and 5' splice sites of mRNA	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.804265498974324	-19.142699788927803	PRPF39
female genitalia development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.715779887705096	-19.18253118715207	NEUROG1
mesoderm formation	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	6.074267185673133	-19.19544947809459	EOMES;MSGN1
positive regulation of intracellular estrogen receptor signaling pathway	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	19.865969401525707	-19.202342459462972	DDX17
regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.79934963024596	-19.268185068647302	CACNA1D
negative regulation of appetite by leptin-mediated signaling pathway	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.70124858554661	-19.27882068122513	STAT3
negative regulation of calcium ion transmembrane transport	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.815628468102187	-19.284869883105543	PACSIN3
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.861582244698067	-19.331969697166564	CLASP2
eye photoreceptor cell development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.75438485522799	-19.336692565793374	STAT3
negative regulation of mRNA cis splicing, via spliceosome	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.876382702757784	-19.347139262635817	U2AF2
protein kinase C-activating G-protein coupled receptor signaling pathway	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.802984876676078	-19.389623922249573	PARD3
negative regulation of p38MAPK cascade	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.925914055300368	-19.39790587351662	DLG1
mesonephros morphogenesis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.927945798001723	-19.39998828568255	GATA3
positive regulation of glutamate secretion, neurotransmission	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.821841102712398	-19.410160654374543	NLGN2
negative regulation of calcium-transporting ATPase activity	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.82310300691754	-19.41153502210743	SLN
resolution of mitotic recombination intermediates	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	18.941755521083167	-19.414142408315172	TOP2B
axial mesoderm formation	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	6.152750771467724	-19.443467495730214	EOMES;MSGN1
inner ear receptor cell fate commitment	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.792832059837453	-19.470505799477877	MYT1L;ID2
positive regulation of D-erythro-sphingosine kinase activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	16.78250801966381	-19.47069795820355	LMO4
regulation of dendritic spine development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.909041094216153	-19.505132090512554	MEF2C
positive regulation of alpha-beta T cell differentiation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	17.92957058439075	-19.527491211556487	GATA3
positive regulation of phosphatidate phosphatase activity	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.08482032772036	-19.56077509643012	LDLR
lateral mesoderm formation	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	6.211120157381413	-19.62792210796991	EOMES;MSGN1
fasciculation of sensory neuron axon	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	18.05424008732738	-19.66327151992949	CNTN4
ureter development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.20005050337853	-19.678878987987208	PTCH1
negative regulation of platelet-derived growth factor receptor-beta signaling pathway	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	20.38609778957845	-19.705095847853382	PDGFRA
positive regulation of branching involved in ureteric bud morphogenesis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.333368588257738	-19.815521881649726	SIX1
endochondral bone morphogenesis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.367131223593958	-19.8501265205792	FGFR2
AMP biosynthetic process	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	20.539659598778517	-19.853527892087172	PPAT
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.403920054581004	-19.887832825204605	MSX1
negative regulation of protein targeting to mitochondrion	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.41633046483895	-19.900552737666	SIAH3
microtubule nucleation by microtubule organizing center	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.42636768609182	-19.91084027635639	CLASP2
positive regulation of delayed rectifier potassium channel activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	17.162257647272444	-19.911275152639842	AKAP6
mitotic spindle-templated microtubule nucleation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.488625077564784	-19.974650299808598	CLASP2
autophagy of nucleus	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	18.40276045672926	-20.042852749636616	TRAPPC8
regulation of membrane repolarization during action potential	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.56995169306256	-20.058005113099412	AKAP6
negative regulation of microtubule polymerization	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	20.76671833539248	-20.073001683209565	STMN2
chromatin-templated microtubule nucleation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.606366693193916	-20.095328263932082	CLASP2
positive regulation of histone H3-K9 methylation	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	5.991595753139844	-20.13857792778992	MYB;TET1
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	20.85216396527631	-20.155592983615367	AKAP6
positive regulation of NAD+ kinase activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	17.387739090460464	-20.17287378082758	LMO4
positive regulation of T cell cytokine production	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	20.87344920380308	-20.176167184212442	FZD5
urinary bladder development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	18.5775389585709	-20.233207875132646	PTCH1
transmembrane receptor protein serine/threonine kinase signaling pathway	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	18.66214141613243	-20.325350279700167	ACVR2A
negative regulation of hh target transcription factor activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	17.583328951365296	-20.399792850426888	PTCH1
plasma membrane respiratory chain complex IV assembly	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.911900943985593	-20.408482208342633	ANK3
positive regulation of endoplasmic reticulum calcium ion concentration	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.926343111475962	-20.423284547863418	ATP2A2
glycine catabolic process to creatine	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	19.941743695273576	-20.439069205557118	STAT5B
glial cell differentiation	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.090749820313097	-20.47184839377212	NFIB;PHOX2B
positive regulation of retinoic acid receptor signaling pathway	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	17.70312444020506	-20.538776950849865	GATA3
negative regulation of nodal signaling pathway	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.113492526478648	-20.5482897591903	FST;MAGI2
positive regulation of amyloid fibril formation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	18.915291683324835	-20.60106182530218	GPX1
negative regulation of interleukin-8 biosynthetic process	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.149550931361066	-20.652058929259887	ARRB1
negative regulation of sodium ion transmembrane transport	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.21290628501501	-20.716994296881847	DLG1
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.047581016572757	-20.74514105911442	GTPBP1
positive regulation of voltage-gated calcium channel activity	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	6.571567503828525	-20.766981128053505	CACNB1;ANK3
regulation of collateral sprouting	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.069368622244983	-20.768870421526238	SIPA1L1
regulation of microtubule-based movement	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.09597731972978	-20.797850541481687	CLASP2
Golgi medial cisterna-derived vesicle fusion with Golgi cis cisterna membrane	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.115634187243185	-20.819259269917655	VTI1A
negative regulation of synaptic transmission	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.154572283172058	-20.86166760995385	NLGN2
miRNA metabolic process	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.37045748334782	-20.878474651626654	DDX17
positive regulation of acid-sensing ion channel activity	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.19896912166783	-20.910021187049658	ANK3
positive regulation of mitochondrial mRNA catabolic process	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.20726454004075	-20.919055910363916	GTPBP1
regulation of apolipoprotein binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.03715663773228	-20.926313784959945	LDLRAP1
negative regulation of ossification	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.215566695167063	-20.92809797082504	MEF2C
histone H2A-K119 monoubiquitination	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.264960935011764	-20.981894328073473	TRIM37
positive regulation of extrathymic T cell differentiation	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.24460362047974	-20.988972190469998	PRDM1;GATA3
action potential initiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.10751714026072	-21.00794449780176	AKAP6
mesonephric epithelium development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.312858178234933	-21.034060273247448	GATA3
dendrite arborization	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.545638725587516	-21.058024724497223	BTBD3
negative regulation of delayed rectifier potassium channel activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.18921855353123	-21.10273268671158	ANK3
cellular response to cortisol stimulus	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.59488991555087	-21.108504185847217	ZFP36L1
low-density lipoprotein particle disassembly involved in cholesterol transport	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.60380951788313	-21.117646233410404	LDLR
trans-Golgi-derived vesicle fusion with Golgi medial cisterna membrane	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.393428982580016	-21.121811715277317	VTI1A
positive regulation of synaptic transmission	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.61249086986864	-21.12654408892099	NLGN2
intermediate mesoderm formation	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.293671286616363	-21.15389536935925	EOMES;MSGN1
cardiac neural crest cell migration involved in outflow tract morphogenesis	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	21.900452329000608	-21.16886305111875	ERBB4
action potential	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.279348232983356	-21.207299165310957	AKAP6
pattern specification involved in metanephros development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.506919311912586	-21.245416538840008	ROBO2
stomach neuroendocrine cell differentiation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	20.741015373734783	-21.258273854846752	FGFR2
mitotic recombination involved in replication fork processing	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.558255890445725	-21.301328340041202	TOP2B
mRNA transport	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.587373956997364	-21.333041469254663	ZFP36L1
positive regulation of homotypic cell-cell adhesion	2/10	0.0424203970749310876886539745100890286266803741455078125	0.320909058430777605064321278405259363353252410888671875	0.02888251224218139900923318919012672267854213714599609375	0.1963095248506767642737713686074130237102508544921875	6.751847508934038	-21.336688653938378	CITED2;ANK3
regulation of receptor binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.429210372404444	-21.381165934724642	LDLRAP1
cardiac muscle cell myoblast differentiation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.6418607806567	-21.39238427198077	DDX17
positive regulation of cartilage development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.4817892856799	-21.44216683745965	SOX6
action potential propagation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.494336611975058	-21.45672397040961	AKAP6
pre-miRNA processing	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.702801478732646	-21.458756131836697	LIN28A
negative regulation of autophagic cell death	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.527086041369444	-21.494719140576933	MECOM
glial cell fate commitment	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	5.999391200400441	-21.539338420175785	NFIB;PHOX2B
metanephric capsule development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.79186386535582	-21.55575594362128	ROBO2
transmembrane receptor protein tyrosine phosphatase signaling pathway	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.101767527465093	-21.628022776948043	PTN
positive regulation of circadian sleep/wake cycle, sleep	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.148544018935386	-21.675965823502246	NKX2-1
cardiac glial cell differentiation	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.041756228536018	-21.691439633067446	NFIB;PHOX2B
regulation of heparan sulfate proteoglycan binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.716828152791514	-21.714853779399824	LDLRAP1
negative regulation of skeletal muscle fiber differentiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.72351446523172	-21.722611092539484	BDNF
membrane raft assembly	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	19.951417437380798	-21.729529261884835	ANK3
negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.74181075632928	-21.743838048444918	MECOM
regulation of collagen binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.746881153389527	-21.74972061197908	LDLRAP1
positive regulation of myelination	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.756771343340567	-21.761194993582848	PARD3
platelet-derived growth factor receptor-alpha signaling pathway	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.249325277748213	-21.779260457861966	PDGFRA
positive regulation of cartilage condensation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.850797519611163	-21.870282102385925	SOX6
positive regulation of skeletal muscle fiber development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.35096658208265	-21.88343658634801	MEF2C
positive regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.096534437173848	-21.888107317252214	SIX1;GATA3
midgut development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.104981161442662	-21.896778904474857	FGFR2
positive regulation of Fc receptor mediated stimulatory signaling pathway	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.167667019065103	-21.965051456126307	GATA3
DN3 thymocyte differentiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.94696940269643	-21.98185861320486	ZFP36L1
regulation of protein binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.94877639580448	-21.98395504700237	LDLRAP1
regulation of Ras GTPase binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.95643946764245	-21.99284557498629	LDLRAP1
negative regulation of telomere maintenance via telomere lengthening	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.224799895802505	-22.027276133685056	TNKS
negative regulation of toll-like receptor 2 signaling pathway	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	18.995780847889876	-22.038488582048103	TYRO3
regulation of C-C chemokine binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.059161057421036	-22.112020911951532	LDLRAP1
amyloid precursor protein catabolic process	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.32238640938899	-22.133559760359613	LDLRAP1
farnesyl diphosphate biosynthetic process	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.341537578019718	-22.154417720976536	AGPAT3
negative regulation of pinocytosis	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.68889327487358	-22.229790805211824	PACSIN3
negative regulation of vascular associated smooth muscle cell migration	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	17.937806940538554	-22.232780561957544	TRIB1
regulation of actin nucleation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.16355658323997	-22.23313831282074	FCHSD1
regulation of actin binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.166582796231765	-22.236649258803986	LDLRAP1
mitral valve formation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.171584052643126	-22.242451606872763	EFNA1
negative regulation of interleukin-1 beta secretion	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.427266795345655	-22.24778730448253	FOXP1
positive regulation of type B pancreatic cell development	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.621013623760036	-22.254138015431984	RHEB;NKX6-1
DN2 thymocyte differentiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.202406512723787	-22.27821114947844	ZFP36L1
plasma membrane ATP synthesis coupled proton transport	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.740282357914605	-22.282461476379595	ATP5G2
negative regulation of retinal cell programmed cell death	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.206194349237155	-22.282605714377826	MECOM
response to oxygen radical	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.47290478769107	-22.297492649640883	TXNRD1
dendrite guidance	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.76757766914942	-22.31043750314238	BTBD3
positive regulation of calcium ion transport into cytosol involved in cellular response to salt stress	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.259859628655164	-22.344866995299984	ZFP36L1
regulation of mRNA 3'-end processing	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	21.88684779338657	-22.432682095224678	ZFP36L1
regulation of protein kinase A signaling	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.342001737208193	-22.440166469217235	AKAP6
positive regulation of endoplasmic reticulum unfolded protein response	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.345418694841236	-22.444130748568746	GATA3
intramembranous bone morphogenesis	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.370035743643367	-22.472690909021942	FGFR2
negative regulation of potassium ion transport	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.708017132765374	-22.553558695983558	ANK3
somite development	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	22.013671448506862	-22.562668595077234	PTCH1
protein retention in Golgi apparatus	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	22.057970362623355	-22.608072276179236	GBF1
regulation of tyrosine phosphorylation of STAT protein	1/14	0.380376096966411669786367610868182964622974395751953125	0.76643914967559323425660977591178379952907562255859375	0.290171075878611628429126767514389939606189727783203125	0.5293904906524435904913161721196956932544708251953125	23.423091380742157	-22.640638020803724	EFNA1
positive regulation of mRNA catabolic process	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.517329964428665	-22.643578435519128	GTPBP1
negative regulation of calcium ion transport into cytosol	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.8046904243324	-22.658847712392618	PACSIN3
mesenchymal cell apoptotic process involved in metanephros development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.83892944352723	-22.696138184201324	ROBO2
negative regulation of complement activation, lectin pathway	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	20.903670834174843	-22.766649462257018	TYRO3
positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.69332327491685	-22.847762016850638	GTPBP1
S-adenosylmethionine cycle	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.799767156448104	-22.85495323999381	MSRA;AHCYL2
spinal cord motor neuron cell fate specification	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	18.486328222881717	-22.912638102197796	MYT1L
cellular magnesium ion homeostasis	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.759653895396777	-22.924717348868455	ANK3
negative regulation of chondrocyte development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.050012630722293	-22.926033544129652	GDF5
positive regulation of T-helper 2 cell cytokine production	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	22.41671140629456	-22.975759933312617	FZD5
positive regulation of heart rate by norepinephrine	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.113339972382928	-22.99500475021118	ATP2A2
negative regulation of endothelial cell-matrix adhesion via fibronectin	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.824916224064925	-23.000433272141525	SEMA3E
protein localization to chromosome, telomeric region	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.159006695920958	-23.0447413871458	TNKS
positive regulation of somatic stem cell division	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.432458759388815	-23.094160968041546	TAL1;FGFR2
smooth endoplasmic reticulum calcium ion homeostasis	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.245431046606036	-23.1388680557419	ATP2A2
mature B cell apoptotic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	18.683911743088576	-23.157530416067594	MEF2C
positive regulation of vascular endothelial growth factor signaling pathway	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	19.971757210947487	-23.170794966598926	GATA3
positive regulation by virus of host cell division	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.461508083253326	-23.198455420044148	TAL1;FGFR2
forebrain neuron fate commitment	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	6.908250121936695	-23.219579417116133	MYT1L;ID2
positive regulation of phospholipase activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	18.765359949302137	-23.258480331623815	FGFR2
retina vasculature development in camera-type eye	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.059305031237386	-23.272366028788586	PDGFRA
metanephric juxtaglomerular apparatus development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.083588231254655	-23.300538865199027	ROBO2
cellular response to gonadotropin-releasing hormone	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.10724106818704	-23.327980368174952	ZFP36L1
purine ribonucleoside monophosphate biosynthetic process	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	22.767032935000074	-23.334818101887198	PPAT
positive regulation of nerve growth factor receptor activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.20215799049196	-23.438100901003295	GATA3
regulation of cell adhesion mediated by integrin	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	18.9147415758981	-23.44362943792792	EFNA1
negative regulation of interleukin-8 production	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.20902894571724	-23.44607243265512	ARRB1
skeletal muscle fiber differentiation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	22.89889890772825	-23.469972669292858	MEF2C
regulation of calcineurin-NFAT signaling cascade	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.23762935043215	-23.479253995329422	RCAN1
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	18.97049884842403	-23.512737061223874	LDB1
negative regulation of calcium:sodium antiporter activity	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.59106117822892	-23.515301463666948	SLN
norepinephrine biosynthetic process	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.274088920139484	-23.521553588967382	GATA3
positive regulation of embryonic development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.605185837771177	-23.530684942249408	OTX2
positive regulation of cell budding	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.559086431618271	-23.548786478264528	TAL1;FGFR2
regulation of border follicle cell delamination	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.333672120577493	-23.59068071214541	EFNA5
negative regulation of protein processing involved in protein targeting to mitochondrion	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.337573016817938	-23.595206446462058	SIAH3
positive regulation of adrenergic receptor signaling pathway involved in positive regulation of heart rate	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.712846273701135	-23.647940300182235	RAPGEF2
sister chromatid segregation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.08371541128032	-23.653061851556767	TOP2B
regulation of synaptic transmission, dopaminergic	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	21.723486260785915	-23.659528545049067	NLGN2
regulation of calcium-transporting ATPase activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.54244637880602	-23.832896030538393	SLN
epithelial cell differentiation involved in mammary gland alveolus development	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.644313655139479	-23.854773860769733	ERBB4;ID2
regulation of inward rectifier potassium channel activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.57155349044293	-23.86666546347738	CACNA1D
fasciculation of motor neuron axon	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.608204780781346	-23.909187487189303	CNTN4
mesonephric collecting duct development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.6777854581798	-23.989913464007852	GATA3
neural tube patterning	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	23.42858665099594	-24.012870251741962	PTCH1
mini excitatory postsynaptic potential	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	7.145767312676983	-24.017907383819562	MEF2C;GRID2
negative regulation of complement activation, alternative pathway	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.796484931817655	-24.127625991616505	TYRO3
mesenchymal to epithelial transition involved in metanephros morphogenesis	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.470838653791343	-24.132876699030128	GATA3
regulation of transcription from RNA polymerase II promoter involved in metanephros development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.811530792871675	-24.145081869829742	ROBO2
pulmonary artery endothelial tube morphogenesis	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.493449383631795	-24.160901272856506	CTNNB1
digestive tract development	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.227193671826473	-24.20812740836226	FGFR2
evoked excitatory postsynaptic potential	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	7.206791663411854	-24.223018625198453	MEF2C;GRID2
mammary gland morphogenesis	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.26767495118577	-24.252216463546294	FGFR2
negative regulation of cAMP biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.57772272747806	-24.265352768358007	AKAP6
embryonic ectodermal digestive tract development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.921223367743625	-24.272344790907265	PKDCC
positive regulation of cell separation after cytokinesis	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.7616225638309215	-24.27594264266844	TAL1;FGFR2
metanephric nephron development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.949901458983884	-24.305616483785506	ROBO2
negative regulation of caveolin-mediated endocytosis	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.33911729515002	-24.330025897817375	PACSIN3
negative regulation of calcium ion import across plasma membrane	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.98195413944716	-24.3428033011146	SLN
positive regulation of cell-cell adhesion mediated by cadherin	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.36258553107775	-24.355585671749076	CITED2
regulation of metanephric glomerulus development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	20.998420153281323	-24.36190680945584	ROBO2
convergent extension involved in gastrulation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.00109803243658	-24.365013626156866	WNT8B
positive regulation of brain-derived neurotrophic factor receptor signaling pathway	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	6.32682140517432	-24.394149550623673	BDNF;GATA3
photoreceptor cell fate commitment	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.7986996181752275	-24.409058686358332	MYT1L;ID2
cell differentiation involved in metanephros development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.052152385401378	-24.424245767435412	ROBO2
negative regulation of defense response to bacterium, incompatible interaction	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.063126229418796	-24.436977380735	TYRO3
regulation of axon diameter	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.096093107872107	-24.475224830534348	SIPA1L1
peripheral nervous system myelin maintenance	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.749424127464113	-24.478165826315703	PARD3
positive regulation of transcription from RNA polymerase II promoter involved in neuron fate specification	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.117984900717357	-24.5006232087597	MYT1L
positive regulation of heart rate	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	23.922853700814045	-24.519463786972945	ATP2A2
T-tubule organization	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.51584595731806	-24.522504985984774	ANK3
negative regulation of mitotic metaphase/anaphase transition	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.81637054859173	-24.561141693726505	ZFP36L1
asparagine biosynthetic process from oxaloacetate	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.17085893311497	-24.561966502231687	STAT5B
methionine metabolic process	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.20717462470384	-24.604099171630185	MSRA
negative regulation of B cell differentiation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.87439587715327	-24.633060429457164	ZFP36L1
N-acetylglucosamine biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.876524617822376	-24.635698869280183	CHST5
metanephric pyramids development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.261061564134547	-24.666617617640636	ROBO2
negative regulation of histone acetylation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.329404713232666	-24.745907841249814	BRCA1
rhythmic synaptic transmission	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.330689291760674	-24.747398181102064	NLGN2
negative regulation of voltage-gated potassium channel activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	19.995015186838653	-24.782560457674627	CAB39
cell-cell signaling involved in metanephros development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.36680912116314	-24.78930361548489	ROBO2
atrial cardiac myofibril assembly	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.372690663501416	-24.79612725199159	PDGFRA
N-acetylglucosamine metabolic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.01630644409022	-24.808949628431755	CHST5
negative regulation of protein transport	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.39786779549614	-24.825337208688687	YRDC
microtubule anchoring at microtubule organizing center	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.046293908433967	-24.846117199505194	CLASP2
positive regulation of circadian sleep/wake cycle, wakefulness	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.852811327101865	-24.889501410471407	NKX2-1
positive regulation of platelet aggregation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.456893364906094	-24.893817380570365	ANK3
negative regulation of natural killer cell mediated immunity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.10267633322184	-24.915999659608325	TYRO3
negative regulation of MyD88-dependent toll-like receptor signaling pathway	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.917223612618525	-24.959654252862283	TYRO3
cardiac neuron fate commitment	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	6.960268402562852	-24.989131665234783	MYT1L;ID2
positive regulation of megakaryocyte differentiation	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	22.964422565759364	-25.01105967488922	MEF2C
immature T cell proliferation in thymus	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.24984801834969	-25.09840968281949	ZFP36L1
thyroid gland development	2/9	0.03469576566725522670520120982473599724471569061279296875	0.281420698303356864311552953950013034045696258544921875	0.02442796142331239706013690238251001574099063873291015625	0.1758692630799752187886753063139622099697589874267578125	7.471499418583304	-25.1127378210933	NKX2-1;SIX1
negative regulation of flagellated sperm motility	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.662934934983355	-25.132862294066477	GATA3
arginine catabolic process to succinate	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.705287199335412	-25.181998462872635	STAT5B
chemorepulsion involved in postnatal olfactory bulb interneuron migration	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.332956031974636	-25.20141682499626	ROBO1
mesonephric capsule development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.361882329565525	-25.237269146795686	GATA3
subpallium neuron fate commitment	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	7.031137399876079	-25.24356936826809	MYT1L;ID2
negative regulation of SNARE complex disassembly	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	6.557116393294645	-25.282091539372054	YRDC;SLN
cerebral cortex GABAergic interneuron fate commitment	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	7.044704410094946	-25.292278381348392	MYT1L;ID2
neuron fate determination	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	7.047196878351144	-25.301226975543788	MYT1L;ID2
glutamate catabolic process to oxaloacetate	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	21.833965966469897	-25.331288748065646	STAT5B
mesonephric juxtaglomerular apparatus development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.462357738398474	-25.361802080161556	GATA3
macrophage activation involved in immune response	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.52815141552942	-25.44334919407941	FOXP1
N-acetylglucosamine catabolic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.554068514122957	-25.475471803478808	CHST5
negative regulation of toll-like receptor 3 signaling pathway	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.59794917842982	-25.52985911981471	TYRO3
DN4 thymocyte differentiation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.599208727590867	-25.53142025157387	ZFP36L1
negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.029852909915803	-25.558552486317524	SLN
dolichyl monophosphate biosynthetic process	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.058095309703646	-25.591318699522343	AGPAT3
gastrulation with mouth forming second	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.67702936925255	-25.62787402961877	WNT8B
intergenic mRNA trans splicing	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.15931052218099	-25.708746370560114	DDX17
regulation of lipoprotein lipase activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.17865899919991	-25.731194049509245	LMF1
primitive hemopoiesis	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.207354122647555	-25.764485502781174	TAL1
mesenchymal cell development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.78801663587296	-25.765435747844563	FGFR2
pattern specification involved in mesonephros development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.8123626514719	-25.79561109894314	GATA3
positive regulation of mesenchymal cell proliferation involved in ureter development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.302642192148973	-25.875036632451934	FGFR2
XMP biosynthetic process	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	23.84030779487199	-25.965005617616892	PPAT
renal filtration cell differentiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.382543518403608	-25.967736399861014	PTCH1
substrate-bound cell migration, adhesion receptor recycling	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	20.959591075635597	-25.978091446611327	REP15
ectodermal digestive tract development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.404438718272996	-25.993138730841096	FGFR2
positive regulation of growth hormone receptor signaling pathway	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	19.581257507472408	-26.01663950307909	GATA3
hindgut development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.43903758295713	-26.03327957529487	FGFR2
detection of cAMP	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.03030609116954	-26.065738249144832	JUND
regulation of transcription from RNA polymerase II promoter involved in mesonephros development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.038842171933574	-26.076318182974816	GATA3
activation of phospholipase D activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.054515576096115	-26.095744379084508	FGFR2
regulation of non-motile cilium assembly	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.05946612352593	-26.101880270447005	CYLD
cardiac ventricle formation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.5394303762194	-26.149753093585442	MEF2C
cell-cell adhesion involved in establishment of planar polarity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.541003714293385	-26.151578445933783	VANGL2
urethra development	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.54494253792022	-26.15614818277281	PTCH1
cell-cell signaling involved in mesonephros development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.111636176952285	-26.166541761875617	GATA3
creatine biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.112433629443263	-26.1675301539516	STAT5B
regulation of interferon-beta biosynthetic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	19.736785657441477	-26.223281993163397	GATA3
peripheral nervous system myelin formation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.20795219233044	-26.28591938934162	PARD3
cell differentiation involved in mesonephros development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.24554057259783	-26.332507816395967	GATA3
metanephric mesenchymal cell differentiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.715282912284906	-26.35377335151732	SIX1
regulation of voltage-gated calcium channel activity	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.82651567204616	-26.482823161344978	CACNB1
positive regulation of heart rate by epinephrine-norepinephrine	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	22.856537757122652	-26.517654126413785	ATP2A2
regulation of motile cilium assembly	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.4177519622171	-26.545952974344583	CYLD
cellular response to growth hormone stimulus	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.446165632847432	-26.58116992735216	ZFP36L1
regulation of modification of synapse structure, modulating synaptic transmission	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.48699166686442	-26.631771222065808	NLGN2
myoblast development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.494345821122728	-26.64088623252309	DDX17
mesonephric nephron development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.514001050523586	-26.665247649925607	GATA3
cellular response to dexamethasone stimulus	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	24.487785575795087	-26.670187965244406	ZFP36L1
forelimb morphogenesis	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.021063236537934	-26.708532981491356	PTCH1
positive regulation of glutamate receptor signaling pathway	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.102164895870317	-26.708743150317638	GATA3
cell migration involved in gastrulation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.557964408676018	-26.719737460068497	WNT8B
negative regulation of error-prone translesion synthesis	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	18.69699092864757	-26.74024222397035	GDF2
mesonephric mesenchyme development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.60564381099865	-26.77883307263018	GATA3
mesonephric smooth muscle tissue development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.617727603525314	-26.793810171474657	GATA3
cellular hypotonic salinity response	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	7.465453226253093	-26.80287351315339	CAB39;ZFP36L1
negative regulation of core promoter binding	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.116353315849473	-26.819086442899767	MSX2
myoblast differentiation involved in skeletal muscle regeneration	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.16898849787633	-26.880152627406826	DDX17
modulation by symbiont of host synaptic transmission	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.802071623257298	-27.022292959376003	NLGN2
regulation of synaptic transmission, cholinergic	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.80517982407779	-27.026145378292853	NLGN2
embryonic heart tube left/right pattern formation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.359926250469897	-27.10167442291031	CITED2
clathrin coating of Golgi vesicle	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	24.8958034193198	-27.114569207733478	FCHO2
regulation of large conductance calcium-activated potassium channel activity	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.416850500421095	-27.126850206377842	CACNA1D
regulation of skeletal muscle fiber differentiation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.41717778812333	-27.127285057212095	DDX17
positive regulation of hepatocyte growth factor receptor signaling pathway	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.428556081898755	-27.142402828233816	GATA3
regulation of interleukin-6 biosynthetic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.44794632877512	-27.16816568144514	GATA3
positive regulation of cation channel activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.93883207652369	-27.19179891721715	ANK3
negative regulation of potassium ion import	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	7.586084099152776	-27.235968990430163	DLG1;CAB39
low-density lipoprotein particle mediated signaling	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	21.994657165336786	-27.260990594524614	LDLR
negative regulation of bicellular tight junction assembly	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.01726691956403	-27.289013959139943	PRKCH
somatic motor neuron fate commitment	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	7.625054901578263	-27.37588407079571	MYT1L;ID2
phospholipid scrambling	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.598734835722478	-27.378734909211335	ANK3
positive regulation of histone H4-K16 acetylation	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	7.1032737297845925	-27.387895210961393	ARRB1;BRCA1
positive regulation of antigen receptor-mediated signaling pathway	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.1166283002259	-27.41216612483731	GATA3
regulation of membrane repolarization during atrial cardiac muscle cell action potential	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.167663345944757	-27.475420845784967	CACNA1D
creatine metabolic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.1679574743674	-27.475785399417383	STAT5B
positive regulation of T-helper 1 cell differentiation	1/13	0.35881838209017669072409262298606336116790771484375	0.76035323823870781811962160645634867250919342041015625	0.273756986046809369650389953676494769752025604248046875	0.52663609428336044526730574943940155208110809326171875	26.875333724451124	-27.545575467740655	MYB
T-helper 17 cell lineage commitment	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.749327109531	-27.568595282204438	STAT3
positive regulation of miRNA mediated inhibition of translation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.830149944507966	-27.647217646168627	STAT3
radial growth involved in right ventricle morphogenesis	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	23.83068847872398	-27.647842441762226	GATA3
positive regulation of mesenchymal cell proliferation involved in lung development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.324715891094527	-27.67007757191578	FGFR2
error-free postreplication DNA repair	1/12	0.336511794437509781374728845548816025257110595703125	0.75121918332311110599874837134848348796367645263671875	0.256964605637090948153655745045398361980915069580078125	0.521558539066333093359162376145832240581512451171875	25.419769055738254	-27.68523175161094	BRCA1
L-glutamate transmembrane transport	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.337888469459486	-27.686404152149034	SLC1A6
ventricular septum development	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.352197167200874	-27.704138880706775	GATA3
negative regulation of cilium-dependent cell motility	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	20.857311758799135	-27.712069095916526	GATA3
positive regulation of corticotropin-releasing hormone receptor activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.36468786926579	-27.719620318264592	GATA3
positive regulation of advanced glycation end-product receptor activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.4007563751886	-27.76432495691065	GATA3
negative regulation of cardiac muscle cell myoblast differentiation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.405586289919803	-27.7703113316502	PRICKLE1
negative regulation of DNA biosynthetic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	19.433558671400085	-27.79367375906229	GDF2
positive regulation of potassium ion export	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.00158096378358	-27.903752387760466	AKAP6
polyamine biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.51754169062099	-27.909072991019514	SRM
mesendoderm migration	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.01234692906905	-27.918056588480354	WNT8B
regulation of synaptic transmission, glycinergic	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.541958849611035	-27.93933651986513	NLGN2
axon extension involved in regeneration	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.550852871399332	-27.95036009902327	USP9X
embryonic organ morphogenesis	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.038174243611625	-27.952372052210425	FGFR2
regulation of neuromuscular synaptic transmission	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.57225353600154	-27.9768848732924	NLGN2
regulation of high voltage-gated calcium channel activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.74384307793922	-28.1895592902528	CACNB1
negative regulation of amoeboid sperm motility	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.228733917768444	-28.205559179976362	GATA3
regulation of gliogenesis	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.800385328892634	-28.259639844809634	CTNNB1
cellular response to light stimulus	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.271969375303474	-28.263003974418716	TRPM1
trans-synaptic signaling, modulating synaptic transmission	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.962702252443663	-28.460821436002167	NLGN2
modulation of chemical synaptic transmission	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.964387104767383	-28.462909704212255	NLGN2
glutamate decarboxylation to succinate	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	22.970498063793563	-28.47048385257401	STAT5B
negative regulation of chemokine-mediated signaling pathway	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.46155935620926	-28.514902719161704	ROBO1
regulation of postsynaptic neurotransmitter receptor activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.00965324497301	-28.519014230557897	NLGN2
positive regulation of cytotoxic T cell differentiation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.54089967217494	-28.620318236921573	GATA3
positive regulation of extracellular matrix disassembly	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.607089196541626	-28.70826095427112	CLASP2
positive regulation of metanephric cap mesenchymal cell proliferation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.176126334757093	-28.72534712771246	FGFR2
regulation of homophilic cell adhesion	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.70965506206053	-28.844535100479977	EFNA5
regulation of cardiac muscle cell membrane repolarization	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.28301254887756	-28.857825849973	AKAP6
cellular response to angiotensin	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.799820267436363	-28.96433310850316	ZFP36L1
protein localization to telomeric heterochromatin	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.391071731918473	-28.991758393244137	TNKS
modification of synaptic structure, modulating synaptic transmission	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.424858945531618	-29.033635513928463	NLGN2
5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.43766030466949	-29.049501991338467	AGPAT3
phytyl diphosphate biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.484080321322043	-29.10703667477774	AGPAT3
regulation of microtubule polymerization	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	21.92394030852404	-29.129245211970115	CLASP2
endochondral ossification	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.589798739500036	-29.238067987607668	MEF2C
astrocyte development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.077735542879118	-29.333585263572047	STAT3
negative regulation of calcium ion export from cell	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.685479516565255	-29.3566582772423	PACSIN3
geranyl diphosphate biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.709680559680713	-29.386653944089428	AGPAT3
myoblast fusion	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.733815582922166	-29.416567783465872	MEF2C
regulation of interferon-gamma biosynthetic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.140327349338268	-29.416747872708502	GATA3
negative regulation of age-related resistance	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.179411932461473	-29.468677607499874	TYRO3
negative regulation of mesenchymal stem cell differentiation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.19270556450998	-29.48634019288595	PDGFRA
negative regulation of melanization defense response	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.84516344570724	-29.55457643789892	TYRO3
positive regulation of B cell receptor signaling pathway	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.30718449877058	-29.63844263892233	PRKCH
negative regulation of border follicle cell delamination	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	25.586481184441357	-29.684874654717774	CITED2
negative regulation of toll-like receptor 9 signaling pathway	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	23.960953825536368	-29.698091312067223	TYRO3
polyamine metabolic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.368586080864016	-29.720023856350988	SRM
phosphate ion transmembrane transport	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	25.683426383414034	-29.79734834967941	SLC37A4
negative regulation by organism of innate immune response in other organism involved in symbiotic interaction	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.434916756044235	-29.808154113741303	TYRO3
cellular response to salt stress	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.461415402899746	-29.84336154320778	ZFP36L1
B-1 B cell homeostasis	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.49066370941605	-29.882222308223504	MEF2C
negative regulation of bacterial-type flagellum-dependent cell motility	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.496092303404122	-29.889435010101426	GATA3
protein localization to endoplasmic reticulum exit site	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.200883217323668	-29.995468663471076	GBF1
positive regulation of gamma-delta T cell differentiation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.60701445242423	-30.036811733116366	GATA3
negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.266287983552008	-30.0765337468495	MSX2
regulation of microtubule-based process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.680953273874835	-30.13505055471548	CLASP2
positive regulation of platelet-derived growth factor receptor signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	21.095715905734743	-30.170873771088417	GATA3
negative regulation of antifungal innate immune response	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.361665099825906	-30.194747668081845	TYRO3
positive regulation of locomotor rhythm	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.463536325688544	-30.321010628637136	NKX2-1
positive regulation of glucose mediated signaling pathway	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	22.837093754739275	-30.342506618297577	GATA3
telomeric heterochromatin assembly	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	8.463186388285525	-30.384989016575506	TNRC18;BAHCC1
negative regulation of cardiac muscle cell differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	21.293019125746994	-30.453054786997942	SOX6
copal-8-ol diphosphate(3-) biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.66742279860507	-30.573715054932435	AGPAT3
neurohypophysis development	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	8.523855847091921	-30.60280778540536	SIX3;HESX1
hemocyte migration	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.73748558762148	-30.66055346382624	TAL1
ventricular septum intermedium development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	21.441477844755546	-30.665378904910757	GATA3
cellular response to corticosterone stimulus	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	26.526825980712825	-30.77584207647128	ZFP36L1
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.891713503280677	-30.8517092398219	ATP2A2
auditory receptor cell differentiation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	26.607362337749	-30.869278592674227	CTNNB1
negative regulation of prostaglandin biosynthetic process	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	26.610802097910746	-30.873269327019745	BRCA1
dimethylallyl diphosphate biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	24.941369250814343	-30.913254407646235	AGPAT3
positive regulation of large conductance calcium-activated potassium channel activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	25.00853521479769	-30.996502384582552	ANK3
gastrulation with mouth forming first	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	21.73664519700666	-31.087524186251688	WNT8B
pituitary gland development	2/8	0.027591320576958212884566279399223276413977146148681640625	0.24790144602192742961932481193798594176769256591796875	0.0202853741608700344212223853901377879083156585693359375	0.1578978711498744968988461323533556424081325531005859375	8.666364501739466	-31.11445005671658	SIX3;HESX1
negative regulation of innate immunity memory response	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.473627222595255	-31.188236866139633	TYRO3
regulation of acetylcholine secretion, neurotransmission	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.479126515312416	-31.195543501890157	MEF2C
imaginal disc-derived genitalia development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.48600570707893	-31.204683540633514	NEUROG1
cellular response to peptidoglycan	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	21.894968889114658	-31.313957086225685	FZD5
negative regulation of systemic acquired resistance	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.61620616865556	-31.377674395315907	TYRO3
bone trabecula formation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	25.318139264395818	-31.38023708072607	FGFR2
labyrinthine layer blood vessel development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.637037816882522	-31.405352366558	FGFR2
positive regulation of epidermal cell differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.012076407352605	-31.481443042435497	SFN
positive regulation of thyroid hormone generation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.047818829153783	-31.53256148284563	GATA3
negative regulation of protein sumoylation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.04782005347105	-31.532563233851466	CTNNB1
positive regulation of Wnt signaling pathway, planar cell polarity pathway	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	25.48099134020565	-31.582081959397208	MLLT3
positive regulation of CD40 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.083266842447546	-31.58325886326642	GATA3
negative regulation of toll-like receptor 10 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.093090404146135	-31.597308419172226	TYRO3
positive regulation of microtubule polymerization or depolymerization	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.801950322671185	-31.6244633818243	CLASP2
regulation of pyruvate kinase activity	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	8.207811299361145	-31.6466300370301	PRKAG1;OGT
regulation of endothelial cell chemotaxis	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.82227256112904	-31.651464525732028	PDGFRA
gastrulation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.136900659108022	-31.659965390769713	WNT8B
geranylgeranyl diphosphate biosynthetic process	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	25.58214121793012	-31.707450854422753	AGPAT3
sympathetic neuron projection extension	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	27.336607999001455	-31.71533342494008	SEMA3A
negative regulation of dendritic spine development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	23.916148295535873	-31.776192528477377	MEF2C
B cell homeostasis	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.22925668006306	-31.792052012654725	MEF2C
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	8.24788081427055	-31.801124952647847	PRKAG1;OGT
negative regulation of calcium ion transmembrane transporter activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.403738146149276	-32.04159359314457	SLN
positive regulation of bicellular tight junction assembly	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.128286877084804	-32.05805047344066	PRKCH
positive regulation of signal transduction by receptor internalization	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	20.75581500788448	-32.11715945312933	GATA3
negative regulation of mature B cell apoptotic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.47339170325405	-32.14121138703722	FOXP1
regulation of retinal cone cell fate commitment	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	8.347750203326195	-32.18618858193891	SIX3;FGFR2
cellular response to magnesium ion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.586800678562863	-32.30340772556586	ANK3
negative regulation of type B pancreatic cell development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.332801555772914	-32.32977891919989	RHEB
positive regulation of phospholipase A2 activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.638435909010784	-32.377255895826906	FGFR2
endosome to melanosome transport	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.40682463079608	-32.428129684315564	AP1G1
termination of Roundabout signal transduction	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.682744164129502	-32.44062510207606	ROBO1
L-glutamate transport	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.534365389701637	-32.59758672481099	SLC1A6
positive regulation of ephrin receptor signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	21.096827695370514	-32.64483609966761	GATA3
negative regulation of calcium ion import into sarcoplasmic reticulum	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.617402519943	-32.70791401518217	SLN
chromosome passenger complex localization to spindle midzone	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.87167929165515	-32.710838159029066	DLG1
regulation of oxidative stress-induced cell death	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.62214038643806	-32.714208981915974	JUND
regulation of RNA polymerase III activity	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.669139223720567	-32.776653991189576	BRCA1
genitalia development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.673275223015676	-32.782149287015436	NEUROG1
negative regulation of toll-like receptor 8 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	22.923546363495856	-32.78501790644198	TYRO3
regulation of transcription from RNA polymerase III promoter during mitotic cell cycle	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.70743900079704	-32.82754099335819	BRCA1
amyloid precursor protein metabolic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.729625097980065	-32.85701855332444	LDLRAP1
regulation of glycolytic process through fructose-6-phosphate	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	8.52975966259894	-32.88795739834588	PRKAG1;OGT
amyloid precursor protein biosynthetic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.800162514193488	-32.95073809755713	LDLRAP1
neurotransmitter uptake	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	26.589522842791308	-32.95603685392257	GABRA2
citrate metabolic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.04629674713628	-32.96057423013902	STAT5B
nor-spermidine metabolic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.061701777632656	-32.98260634474573	SRM
negative regulation of saliva secretion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.088189592818498	-33.0204889429005	NEUROG1
establishment or maintenance of epithelial cell apical/basal polarity	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.87435937672777	-33.04931976546468	DLG1
microtubule anchoring	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.1366057434443	-33.08973321863593	CLASP2
positive regulation of histone H3-K9 trimethylation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.91998979004691	-33.109946618119444	MYB
inactivation of X chromosome by genetic imprinting	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	24.952079742741663	-33.15258293657916	BRCA1
microtubule anchoring at cell cortex of cell tip	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.257375421853464	-33.262456758284436	CLASP2
negative regulation of calcineurin-NFAT signaling cascade	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	26.85225624470657	-33.281678337881104	RCAN1
suppression by virus of host toll-like receptor signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.274526176475668	-33.2869855894034	TYRO3
negative regulation of double-strand break repair	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.400629039600936	-33.46733659443808	DEK
negative regulation of lipid transport	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	25.193719335514746	-33.47363740269039	YRDC
negative regulation of histone H4 acetylation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	25.243593619835277	-33.53990287492302	BRCA1
regulation of chemokine biosynthetic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.472807115014287	-33.57056492819396	GATA3
negative regulation of DNA-directed DNA polymerase activity	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	21.7527530104168	-33.65980264878568	GDF2
positive regulation of feeding behavior	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	27.16195986269419	-33.665536442764704	STAT3
regulation of epithelial cell-cell adhesion involved in epithelium migration	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.57763184872101	-33.72048417354622	EFNA5
metanephric mesenchymal cell proliferation involved in metanephros development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	25.43322730022863	-33.791859680993994	SIX1
negative regulation of microtubule polymerization or depolymerization	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.630083908410295	-33.79550056450401	CLASP2
positive regulation of cardiac muscle cell differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.637571806886196	-33.80620967912883	MEF2C
metanephric glomerular visceral epithelial cell development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.665186629532425	-33.845704111647414	MAGI2
receptor recycling	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.666070947598747	-33.84696885416062	REP15
regulation of cell-cell adhesion mediated by cadherin	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.670602281524943	-33.85344952087574	EFNA5
cellular response to cortisone stimulus	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	27.31899743741697	-33.860174613995284	ZFP36L1
cellular response to vasopressin	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.75185271677069	-33.96965304943099	ZFP36L1
negative regulation of secretion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.762972480033035	-33.98555641934987	YRDC
regulation of homotypic cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.822272596550164	-34.070366830053345	EFNA5
positive regulation of vitamin D receptor signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.82365119922508	-34.072338493279716	GATA3
regulation of type III interferon production	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	25.658834087274766	-34.09161215837127	IFIH1
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.846444647257933	-34.10493744590498	KCNH5
cellular response to low-density lipoprotein particle stimulus	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.896658415800133	-34.176752656112924	LDLR
regulation of cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	23.924734349722726	-34.21690656518949	EFNA5
regulation of retinal rod cell fate commitment	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	8.883362846786989	-34.251335373517655	SIX3;FGFR2
positive regulation of natural killer cell differentiation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	25.806192100809163	-34.28739939596575	PRDM1
positive regulation of voltage-gated sodium channel activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	27.680265539866785	-34.30794364576302	ANK3
negative regulation of large conductance calcium-activated potassium channel activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.0032301234932	-34.329170405514965	CAB39
negative regulation of transporter activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.015628834833027	-34.346902913690066	YRDC
positive regulation of metalloendopeptidase activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.044183837616195	-34.38774198207503	STAT3
positive regulation by host of symbiont cAMP-mediated signal transduction	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.120566586717143	-34.496983796465734	RAPGEF2
positive regulation of systemic arterial blood pressure	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	25.975926475611935	-34.51291698792015	ID2
negative regulation of toll-like receptor 1 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.15261825126257	-34.54282375418391	TYRO3
positive regulation of ERBB signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	22.365054565029393	-34.60726660794225	GATA3
negative regulation of toll-like receptor 13 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.288475264962443	-34.73712504405583	TYRO3
negative regulation of toll-like receptor 21 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.291820163543132	-34.741908883263086	TYRO3
negative regulation of toll-like receptor 12 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.292751355025594	-34.74324066364919	TYRO3
positive regulation of cardiac muscle fiber development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.298805916822555	-34.751899835043595	MEF2C
medial-Golgi-derived vesicle fusion with Golgi trans cisterna membrane	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.307219385766267	-34.76393269093774	VTI1A
regulation of sodium ion export	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.314998958651632	-34.77505895527341	DLG1
negative regulation of toll-like receptor 7 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.35171714165424	-34.82757291921878	TYRO3
plasma membrane raft organization	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.353997378411222	-34.830834090144215	ANK3
regulation of calcium-independent cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.375019838637808	-34.860900194403875	EFNA5
positive regulation of T-helper 2 cell differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.376774107766106	-34.8634091318899	MYB
dynamin family protein polymerization involved in mitochondrial fission	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	26.278508013725293	-34.91494197504768	DNM3
pancreas development	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	9.06586329087005	-34.95499726641959	TCF7L2;NKX6-1
ventral spinal cord interneuron specification	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.452262649183634	-34.97137205973976	MYT1L
negative regulation of DNA amplification	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	22.605401823993358	-34.97917545552718	GDF2
negative regulation of gastrulation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.500278030156	-35.04004315887956	CLASP2
pancreas morphogenesis	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	9.092724082295495	-35.05856367380143	TCF7L2;NKX6-1
cis-Golgi-derived vesicle fusion with Golgi medial cisterna membrane	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.51667570431487	-35.06349494214198	VTI1A
endothelial tube lumen extension	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.536139036001696	-35.09133119695846	CTNNB1
negative regulation of butyryl-CoA biosynthetic process from acetyl-CoA	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	26.476350620443075	-35.1778055717989	BRCA1
positive regulation of peptidoglycan recognition protein signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	22.79239172090649	-35.268520120287484	GATA3
negative regulation of type III interferon production	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	22.820020018483145	-35.311271630567894	IFIH1
negative regulation of B cell apoptotic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.71652893144706	-35.34932295174798	FOXP1
regulation of smooth muscle cell chemotaxis	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	26.619277328287463	-35.36770515470007	PDGFRA
negative regulation of histone H3-K14 acetylation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	26.638857138011772	-35.39371987060592	BRCA1
negative regulation of toll-like receptor 15 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.747777576666934	-35.394014439567556	TYRO3
cellular response to insulin-like growth factor stimulus	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.797036307485158	-35.46446376474247	ZFP36L1
polyamine catabolic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.865452201781878	-35.56231146614242	SRM
negative regulation of toll-like receptor 5 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.917931833564616	-35.63736729042188	TYRO3
megakaryocyte development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	24.98472327471737	-35.73289171580822	TAL1
negative regulation of methyl-branched fatty acid biosynthetic process	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	26.917813371365582	-35.76435509449455	BRCA1
positive regulation of sodium:proton antiporter activity	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	28.856592019124257	-35.76592613878712	ANK3
regulation of glycine secretion, neurotransmission	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.021468618209926	-35.78544452440419	MEF2C
regulation of leukocyte cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.046904856729213	-35.82182316853298	EFNA5
positive regulation of skeletal muscle fiber differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.06018082734687	-35.840810323815305	MEF2C
negative regulation of histone H3-K9 acetylation	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	28.96995871057175	-35.90643700404185	BRCA1
regulation of peptidyl-tyrosine autophosphorylation	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	27.100438718530395	-36.007000278007325	EFNA1
positive regulation of primary miRNA processing	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.318694524242503	-36.21053392798156	LIN28A
actin filament fragmentation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	23.425661652120297	-36.2484301527261	MICAL3
cell-substrate adherens junction assembly	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.353785352921197	-36.260720466675885	CTNNB1
regulation of calcium-dependent cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.362201769598634	-36.2727575383882	EFNA5
negative regulation of toll-like receptor 6 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.36669332534945	-36.27918131477006	TYRO3
regulation of sodium ion import across plasma membrane	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.49797270762651	-36.46693572372808	DLG1
neural crest cell migration involved in heart formation	1/11	0.3134303597415313280549753471859730780124664306640625	0.73996546891932102330002862800029106438159942626953125	0.239785245567682825384991929240641184151172637939453125	0.51657998938210114570068753891973756253719329833984375	31.447538395531275	-36.484744765857975	ERBB4
positive regulation of homophilic cell adhesion	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	27.492121328600827	-36.527409412197954	CITED2
positive regulation of abscisic acid-activated signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	23.648515128135443	-36.59326944817867	GATA3
melanocyte migration	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	23.696633510342004	-36.6677269317016	ZEB2
negative regulation of histone H3-K27 acetylation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.655887478290875	-36.69278378850078	BRCA1
positive regulation of mesoderm formation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.675285391237832	-36.720526482115	OTX2
monocyte activation involved in immune response	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.696102172950788	-36.75029842710081	FOXP1
ribosomal large subunit export from nucleus	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.736627694444472	-36.80825760700999	ZNF593
spermidine metabolic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.7652431493743	-36.8491831334272	SRM
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.83821638493353	-36.95354869696453	ACVR2A
negative regulation of reverse transcription	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	23.888929958067877	-36.96528285381481	GDF2
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	21.949468076476645	-36.98695927155936	GATA3
desmosome maintenance	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	21.984025787159172	-37.045192329102235	NLGN2
regulation of heterotypic cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	25.998556460568107	-37.18286540771444	EFNA5
negative regulation of toll-like receptor 11 signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.038285221849176	-37.23968506944334	TYRO3
regulation of macrophage colony-stimulating factor production	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.056470803271882	-37.26569389910383	FOXP1
gamma-tubulin complex localization	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.13202739119615	-37.37375414636083	DLG1
positive regulation of circadian rhythm	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.139214916123887	-37.38403366985699	NKX2-1
substrate-dependent cerebral cortex tangential migration	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.185260757411342	-37.42381958339021	LHX6
positive regulation of epithelial cell proliferation involved in lung bud dilation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.171195647890663	-37.429772180251895	FGFR2
long term synaptic depression	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.225075551627114	-37.48542825035587	SLC24A2
regulation of potassium ion transport	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.25365935680698	-37.54771092020875	ANK3
regulation of interleukin-12 biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.295641232179534	-37.59462026297304	GATA3
monocyte activation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.291311040817423	-37.601559967599414	FOXP1
regulation of spontaneous neurotransmitter secretion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.299926479854744	-37.61388167902362	MEF2C
notochord development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.320163754558525	-37.64282481910414	FGFR2
regulation of substance P secretion, neurotransmission	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.32021702878134	-37.642901011344264	MEF2C
methionine biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.43324106461093	-37.807539666872344	MSRA
blood vessel lumenization	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.44305479392536	-37.82272524783371	CTNNB1
polyuridylation-dependent decapping of nuclear-transcribed mRNA	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.502178695080993	-37.91421246528025	EDC4
positive regulation of pre-miRNA processing	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.615995416705513	-38.06592018955809	LIN28A
microvillar actin bundle assembly	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	28.65464842806262	-38.07200114476242	RAPGEF2
positive regulation of neurotrophin TRK receptor signaling pathway	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.64063130491199	-38.10115418098259	GATA3
negative regulation of cardiac myofibril assembly	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.79765714161638	-38.37143028008228	SOX6
positive regulation of dermatome development	1/9	0.264834523510276031998955659219063818454742431640625	0.73858861214153648244717942361603491008281707763671875	0.20422983084473178561069062197930179536342620849609375	0.5051662884607235337597330726566724479198455810546875	29.011744598762718	-38.546457003253074	OTX2
aortic valve formation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	9.24573097866566	-38.552987885696965	EFNA1;GATA3
cellular response to thyrotropin-releasing hormone	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.960767939500354	-38.559010270570944	ZFP36L1
glycolytic fermentation to propionate	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.976133213621896	-38.58098552602332	STAT5B
positive regulation of activin receptor signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.934842004880192	-38.58370756846271	ACVR2A
microvillus assembly	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.986036686657943	-38.59514937029393	RAPGEF2
positive regulation of voltage-gated potassium channel activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	26.986583521029097	-38.59593144713169	ANK3
hindlimb morphogenesis	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.00572000062986	-38.62330024148963	PTCH1
polyamine acetylation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.96254087854715	-38.626568286863595	SRM
lung induction	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.995192029455417	-38.677092066327354	OTX2
cellular response to gastrin	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	24.99600487237595	-38.678349844240635	ZFP36L1
modulation by symbiont of host neurotransmitter secretion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.06296213698884	-38.70516735034678	MEF2C
putrescine metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.04857761783361	-38.759699926042344	SRM
regulation of cytokine biosynthetic process involved in immune response	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.050308328968583	-38.76237799604191	GATA3
regulation of epiboly involved in gastrulation with mouth forming second	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.07730823166669	-38.80415713985509	CLASP2
trigeminal nerve development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.16620445816914	-38.85282344573998	NEUROG1
regulation of interleukin-1 biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.14355716522489	-38.90666949901228	GATA3
regulation of epidermal cell division	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.21580498220268	-38.923761600021294	SFN
negative regulation of activation-induced cell death of T cells	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.222818226621413	-38.93379186934369	TSC22D4
cellular response to prolactin	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.17452781970641	-38.95459290977562	ZFP36L1
atrazine metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.2776958170396	-39.114233136842174	SRM
lateral line nerve glial cell differentiation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	9.413762709369053	-39.25364911985668	NFIB;PHOX2B
spleen trabecula formation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.497385905711162	-39.32647571209423	CITED2
endodermal digestive tract morphogenesis	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.451470528579847	-39.38312887123466	ID2
morphogenesis of embryonic epithelium	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.467282461777103	-39.407595960557124	FGFR2
positive regulation of hypoxia-inducible factor-1alpha signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.469516569566462	-39.41105297711268	GATA3
positive regulation of calcium:sodium antiporter activity	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.604678504850003	-39.479924472954245	ANK3
regulation of microtubule depolymerization	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.58263210637349	-39.58608584047544	CLASP2
positive regulation of protein localization to prospore membrane	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.58752001485318	-39.59364929852201	PRKCH
polyamine deacetylation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.600520957489657	-39.6137667136916	SRM
positive regulation of NK T cell differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.737902994719548	-39.67046075458757	PRDM1
cerebellar Purkinje cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.637899540793043	-39.67160563351386	PHOX2B
epithelial cell migration involved in nephron tubule morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	23.543681569699586	-39.673361936925104	VANGL2
trunk neural crest cell migration	1/10	0.28954720421940549623940341916750185191631317138671875	0.73858861214153648244717942361603491008281707763671875	0.22221001779023541455870827121543698012828826904296875	0.50931227109647247974777428680681623518466949462890625	32.02566267942863	-39.69378938368887	ERBB4
regulation of respiratory gaseous exchange by neurological system process	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	9.520635893256298	-39.6992905270335	NLGN2;PHOX2B
positive regulation of calcium-independent cell-cell adhesion	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	27.77404667478342	-39.72215307039721	CITED2
glial cell differentiation involved in amphid sensory organ development	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	9.548955692825144	-39.81737885257773	NFIB;PHOX2B
positive regulation of cytokine activity	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	23.697619656933032	-39.93276238084508	BDNF
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.834178025566782	-39.97532328518412	GATA3
trimethylenediamine metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.856930037488922	-40.01052932235998	SRM
macrophage activation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.886582887634397	-40.056413587371985	FOXP1
regulation of transcription involved in lymphatic endothelial cell fate commitment	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.892346225816222	-40.06533166894564	NR2F2
myoblast migration involved in skeletal muscle regeneration	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.904155306170995	-40.083604818740284	SIX1
positive regulation of sclerotome development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	25.99042126512953	-40.21709114814705	OTX2
regulation of double-strand break repair	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	28.244637617834265	-40.395187349207575	DEK
neurotransmitter loading into synaptic vesicle	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	28.33143753066044	-40.519327682956956	GABRA2
negative regulation of B cell deletion	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.227968051578344	-40.58466659700593	FOXP1
regulation of cell death	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.233211384410605	-40.592780032039705	JUND
aortic valve morphogenesis	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	9.744055521895321	-40.630909049811486	EFNA1;GATA3
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	24.16008552658731	-40.71206173451464	LDB1
positive regulation of neuronal signal transduction	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.318465100037166	-40.72470003507066	GATA3
positive regulation of pro-T cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.342642316859802	-40.76211140762002	GATA3
positive regulation of T-helper cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.357600574521978	-40.78525753540611	MYB
early stripe melanocyte differentiation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	9.781208190033695	-40.785828803367494	MEF2C;MITF
mesonephric glomerular visceral epithelial cell development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.40389241482811	-40.85688866219762	MAGI2
negative regulation of store-operated calcium channel activity	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.47951549386381	-40.97390639851891	SLN
spinal cord commissural neuron specification	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.496346442102272	-40.99995029263325	MYT1L
regulation of mesoderm formation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.497350053198772	-41.001503261649546	CLASP2
regulation of ectodermal cell fate specification	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.554203213400005	-41.08947677706696	CLASP2
spinal cord association neuron specification	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	28.733267957609733	-41.09402138584162	MYT1L
cerebellar granule cell differentiation	2/7	0.0211593747138862919854318533907644450664520263671875	0.2105670264248979683952001096258754841983318328857421875	0.016471434032991012774704842058781650848686695098876953125	0.136788299883131347911557895713485777378082275390625	10.670620196605634	-41.14241389223019	GRID2;PHOX2B
positive regulation of mRNA 3'-end processing	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	28.794269397370936	-41.18126501137744	ZFP36L1
cellular response to lipoteichoic acid	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	26.73229950707171	-41.36505964672025	FZD5
ear development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	24.643070919897625	-41.525938453936	GATA3
purine nucleotide biosynthetic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	29.059199353808282	-41.56016508329575	PPAT
regulation of calcium ion import across plasma membrane	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	29.09286259051995	-41.60830989478697	CTNNB1
negative regulation of monocyte differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	24.723802590046304	-41.661979062542564	FOXP1
spleen development	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	29.133052307381604	-41.66578881039936	CITED2
regulation of convergent extension involved in gastrulation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.02730170336459	-41.82154052081566	CLASP2
ureter smooth muscle cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.084273084773198	-41.90969696951547	MEF2C
regulation of interleukin-3 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	24.873718757402433	-41.914602185655596	GATA3
methionine catabolic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	29.408112426504854	-42.05917693577093	MSRA
endothelial tube morphogenesis	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.213175235178156	-42.10915774312685	CTNNB1
muscle cell fate determination	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.289857239189516	-42.2278140401252	MEF2C
cellular response to endothelin	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.293808582362736	-42.23392827455542	ZFP36L1
positive regulation of thyroid hormone mediated signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.37644705329125	-42.36180149691578	GATA3
cardiac muscle cell fate determination	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.43922860018134	-42.45894848687581	MEF2C
positive regulation of intracellular steroid hormone receptor signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	25.318130446210663	-42.66347851270295	GATA3
positive regulation of cell communication by electrical coupling involved in cardiac conduction	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.64160360510164	-42.772099779652514	ANK3
negative regulation of oligodendrocyte apoptotic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.642828965584368	-42.7739958795164	PRKCH
salivary gland morphogenesis	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	29.921097629543112	-42.79284304487397	FGFR2
negative regulation of microtubule nucleation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	30.00687782018294	-42.9155249825441	STMN2
L-cysteine catabolic process to taurine	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.751464769779048	-42.94209688852588	STAT5B
regulation of interleukin-2 biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.769713531264816	-42.970334680307985	GATA3
collateral sprouting of intact axon in response to injury	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	25.508084597294467	-42.9835694791501	BDNF
positive regulation of establishment of Sertoli cell barrier	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.782008662188545	-42.98935993565086	CITED2
mesenchymal cell differentiation involved in salivary gland development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	25.543126909614422	-43.04261913693878	FGFR2
positive regulation of cholesterol metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.81755893462605	-43.04436976147769	LDLRAP1
spermine metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.81895841678089	-43.04653529395626	SRM
regulation of interleukin-8 biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	27.971777503088934	-43.28300468629631	GATA3
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	25.689103997347694	-43.288604533020326	GATA3
regulation of striated muscle tissue development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.002614956116158	-43.33072198362371	NEUROG1
myotube cell development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.077906782016694	-43.447227145046966	MEF2C
thermospermine metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.165933249153856	-43.58343765184065	SRM
nephrocyte diaphragm assembly	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.22199705886532	-43.670189741092216	CTNNB1
protein targeting to vacuole involved in autophagy	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	25.918069503262068	-43.67443337462779	VTI1A
positive regulation of skeletal muscle tissue growth	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	30.544584724344965	-43.68454781181462	MEF2C
regulation of interleukin-18 biosynthetic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.267848269506356	-43.741139045791535	GATA3
oxaloacetate metabolic process	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	30.587571649118544	-43.74602726512857	STAT5B
negative regulation of macrophage colony-stimulating factor production	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.056629485079338	-43.90792023573472	FOXP1
lateral sprouting from an epithelium	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.063631259062745	-43.919718896561065	FGFR2
positive regulation of embryonic skeletal joint development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.176152269053198	-44.10932759228029	OTX2
negative regulation of SUMO transferase activity	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.548677456420148	-44.175688870588914	CTNNB1
cellular response to cholecystokinin	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.55457289171521	-44.184811356761834	ZFP36L1
positive regulation of convergent extension involved in gastrulation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.570878172567465	-44.21004184300682	OTX2
positive regulation of apolipoprotein A-I-mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.25087991946332	-44.23525085167538	GATA3
regulation of interleukin-14 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.279994518393213	-44.284311743769706	GATA3
positive regulation of myotome development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.327567315362312	-44.36447647021317	OTX2
post-embryonic limb morphogenesis	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.67226216183515	-44.36692152940158	PTCH1
regulation of necrotic cell death	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.777776372692493	-44.53019224333833	JUND
vesicle fusion with Golgi medial cisterna membrane	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.544015168735946	-44.72921186649946	VTI1A
tryptophan biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.60422905891647	-44.83067804763557	TPH1
negative regulation of centriole elongation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	10.755660480097522	-44.84911459663878	TRIM37;BRCA1
cellular hyperosmotic salinity response	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	28.990861727698807	-44.85991653126751	ZFP36L1
regulation of interleukin-13 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.67440979754695	-44.94893932450704	GATA3
regulation of programmed cell death	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.05598493858947	-44.960686968250144	JUND
mesenchymal cell fate commitment	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.714165545863377	-45.015931574099	FGFR2
regulation of cardiac muscle cell membrane potential	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.107482814923607	-45.04037381769897	ATP2A2
positive regulation of epiboly involved in gastrulation with mouth forming second	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.175942661343043	-45.14630730201431	OTX2
positive regulation of embryonic pattern specification	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.907835830046196	-45.34228458129821	OTX2
positive regulation of glucocorticoid mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	26.95824520422579	-45.42722921244777	GATA3
positive regulation of Fas signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.385163827060822	-45.47005221580232	GATA3
negative regulation of histone H3-K9 trimethylation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.45449251697641	-45.577330132272934	BRCA1
lens fiber cell development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.457288533282128	-45.58165663554396	SIX3
cardiac endothelial to mesenchymal transition	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.06089792337231	-45.60020889145221	FGFR2
positive regulation of auxin mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.183049706517636	-45.80604636379563	GATA3
regulation of interleukin-24 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.22688255150922	-45.87990891239187	GATA3
positive regulation of cardioblast differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	29.770877394079793	-46.06689816622526	SP7
positive adaptation of signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.37054722252565	-46.121997664480645	GATA3
regulation of hepatocyte growth factor biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.40582408394621	-46.1814425600036	GATA3
positive regulation of otic vesicle morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.409601280777817	-46.18780749900279	OTX2
regulation of interleukin-22 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.466579576289647	-46.28382139273889	GATA3
cornified envelope assembly	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.482547188231443	-46.31072835059763	ANK3
mesenchymal to epithelial transition involved in mesonephros morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.52497725549477	-46.38222708415646	GATA3
positive regulation of heart looping	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.030474142724504	-46.46859331366076	OTX2
positive regulation of embryonic camera-type eye development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.668835267362113	-46.62464163412578	OTX2
diaphragm development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.14586415003479	-46.64714565008669	PHOX2B
auditory receptor cell fate specification	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.173978868652057	-46.69064983917624	MYT1L
prostate induction	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.7683087763307	-46.79226403900598	OTX2
metanephric mesenchyme morphogenesis	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.323674941562466	-46.92228673906885	SIX1
late stripe melanocyte differentiation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	11.257471504316145	-46.94157374154046	MEF2C;MITF
positive regulation of sphingolipid mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	27.8988665772845	-47.0122664577269	GATA3
negative regulation of potassium ion export	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.42820938408641	-47.08404137783443	CAB39
chylomicron remnant clearance	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.43711251974245	-47.09781792322131	LDLR
metanephric cap development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.48605437102985	-47.173549627378996	SIX1
negative regulation of histone H3-K18 acetylation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.505512669873877	-47.203659034618504	BRCA1
regulation of vascular smooth muscle cell proliferation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	11.347135882976866	-47.31545761424473	TCF7L2;CTNNB1
positive regulation of sevenless signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.14197056814811	-47.421920002746624	GATA3
regulation of postsynaptic specialization assembly	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	33.203617827929214	-47.487469337676515	MEF2C
positive regulation of netrin-activated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.198985695530414	-47.51799596171768	GATA3
regulation of interleukin-7 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.209351061050505	-47.53546259694504	GATA3
carnitine metabolic process, CoA-linked	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.771490346014016	-47.61522790976605	CRAT
photoreceptor cell fate specification	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.274111567446436	-47.6445902625507	MYT1L
nose development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.286423880095725	-47.66533769045699	PHOX2B
positive regulation by symbiont of host cAMP-mediated signal transduction	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.28745722339333	-47.66707897303972	GATA3
positive regulation by symbiont of host salicylic acid-mediated defense response	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.325978824031512	-47.731991565404854	GATA3
negative regulation of chemotaxis	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.929829345169033	-47.86023871187518	PDGFRA
positive regulation of signal transduction involved in conjugation with cellular fusion	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.42961485516986	-47.90662821944242	GATA3
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	30.96124621753208	-47.908852591832165	CYLD
regulation of interleukin-4 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.463196189938145	-47.963215989908264	GATA3
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.47517272712355	-47.98339760394772	MEF2C
forebrain generation of neurons	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	31.158740345440133	-48.214451306923344	SIX1
protein localization to endoplasmic reticulum tubular network	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	31.167787150639807	-48.22845016387158	GBF1
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	31.189206953848284	-48.26159476623192	MSX1
regulation of myoblast differentiation	1/8	0.2392635504184364159119269288567011244595050811767578125	0.73858861214153648244717942361603491008281707763671875	0.1858353851785241872551779351852019317448139190673828125	0.4930103205458740145417095845914445817470550537109375	33.74577276034158	-48.26285369074982	ZFP36L1
spermidine biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.70817505401457	-48.37602887614392	SRM
regulation of Rac protein signal transduction	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	31.302370786383268	-48.43670236149969	OGT
regulation of interleukin-35 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	28.745891187820494	-48.43958417963008	GATA3
camera-type eye photoreceptor cell differentiation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	11.756665437777645	-49.02312010210006	DSCAM;STAT3
establishment of epithelial cell polarity	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.156876585912464	-49.13213400031227	PARD3
left/right axis specification	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	31.772194295752918	-49.163698461605705	CITED2
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	11.914067284201437	-49.67945668515285	OTX2;FGFR2
cellular hypotonic response	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	32.24171041103565	-49.89021890585813	CAB39
mesenchymal to epithelial transition involved in renal vesicle formation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.624314456474934	-49.919811652464915	GATA3
positive regulation of Roundabout signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.644852950074867	-49.954420984391916	GATA3
regulation of interleukin-11 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.670526380815332	-49.99768317798359	GATA3
regulation of interferon-alpha biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.779822400598192	-50.181857455837026	GATA3
positive regulation of cell communication by electrical coupling	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.79962256272348	-50.21522262840279	ANK3
regulation of presynapse assembly	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.808906423894133	-50.23086682505509	MEF2C
negative regulation of feeding behavior	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.839747558116535	-50.2828370947399	STAT3
pericentric heterochromatin assembly	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	12.087328238718946	-50.40192281530429	TNRC18;BAHCC1
melanocyte differentiation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	12.09323655784921	-50.42655941314382	MEF2C;MITF
ventricular cardiac muscle cell development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	29.959781112827805	-50.48510514897509	MEF2C
positive regulation of gibberellic acid mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.0037496142618	-50.55919629169	GATA3
regulation of interleukin-17 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.049849200031943	-50.636878515941405	GATA3
positive regulation of calcium-dependent cell-cell adhesion	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	32.73868644779413	-50.659230318365566	CITED2
positive regulation of Toll signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.101489290327105	-50.72389702180551	GATA3
regulation of interleukin-21 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.15348013577056	-50.81150658374163	GATA3
zonula adherens maintenance	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.157563082711818	-50.81838674100549	NLGN2
positive regulation of signal transduction in response to host	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.263463588089614	-50.9968392513624	GATA3
positive regulation of T-helper 17 cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	32.9947296957887	-51.05542684544075	MYB
mesenchymal cell differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.30836425800505	-51.07250118738935	FGFR2
regulation of telomere maintenance via telomerase	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	33.04129777348405	-51.12748541679528	TNKS
regulation of interleukin-16 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.415389921867167	-51.25284969772624	GATA3
positive regulation of brassinosteroid mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.540652066868557	-51.46392842816709	GATA3
glycine import	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.704972607281942	-51.740824301660446	SLC6A5
negative regulation of calcium ion transport into cytosol involved in cellular response to salt stress	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.710877732998203	-51.75077500495766	ZFP36L1
regulation of cell cycle phase transition	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	33.47810288354377	-51.80338946413819	SIX3
regulation of hematopoietic stem cell proliferation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.771077254922215	-51.852216974203245	ZFP36L1
myotube differentiation involved in skeletal muscle regeneration	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	33.5189309109345	-51.86656598914416	MEF2C
regulation of calcium ion import into sarcoplasmic reticulum	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.80356435178515	-51.90696084883081	CTNNB1
regulation of lymphotoxin A biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.81920604486189	-51.93331860213727	GATA3
embryonic liver development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	33.58839905384489	-51.97405969256743	FGFR2
regulation of smooth muscle cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	33.706343287239164	-52.156564390603236	FGFR2
regulation of astrocyte chemotaxis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	30.974792616193962	-52.195496899898764	PDGFRA
integrin biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.022432622891483	-52.27577488118189	ANK3
regulation of interleukin-26 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.037233478494862	-52.3007157426861	GATA3
positive regulation of motor neuron migration	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.04919806519879	-52.32087721901789	RAPGEF2
plasma membrane invagination	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.085151350130943	-52.38146195304565	FCHO2
embryonic lung development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	33.85555050931379	-52.387444851867166	FGFR2
regulation of interleukin-19 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.277144655964698	-52.704989090857964	GATA3
bronchus development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.327759568119856	-52.79028007321314	PHOX2B
receptor localization to synapse	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.33506676087437	-52.80259339396693	DLG1
negative regulation of relaxation of cardiac muscle	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	34.22089169409533	-52.95276695952551	NEUROG1
positive regulation of red or far-red light signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.467702693813102	-53.02609766443295	GATA3
hypochord development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.525254615152036	-53.12307817271436	FGFR2
regulation of TRAIL biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.568808536305436	-53.19647070788672	GATA3
regulation of connective tissue growth factor biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.685722838280164	-53.39348252203799	GATA3
Golgi vesicle uncoating	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	34.581910330873185	-53.51140043735046	CUX1
regulation of interleukin-5 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.83829916760209	-53.650588273246704	GATA3
positive regulation of cytokinin-activated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.881459809332267	-53.72331809486453	GATA3
regulation of interleukin-10 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.90311510482262	-53.75980934510916	GATA3
senescence-associated heterochromatin focus assembly	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	12.910178482084262	-53.833056117517685	TNRC18;BAHCC1
renal tubule morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.950975858298722	-53.84045930588994	MEF2C
regulation of interleukin-20 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.973176926824607	-53.877870236054214	GATA3
regulation of keratinocyte differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	31.97830388224435	-53.886509647753684	ZFP36L1
membrane invagination	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.110373721050735	-54.10905999530257	FCHO2
positive regulation of phospholipase D activity	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.115388100747126	-54.11750970610907	FGFR2
apical protein localization	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	12.980199363736974	-54.12503024139517	VANGL2;SHROOM3
oxygen transport	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.134633035060915	-54.14993926655071	IPCEF1
plasma membrane proton-transporting ATP synthase complex assembly	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.14485869249701	-54.167170480254654	ANK3
regulation of interleukin-27 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.187136410581516	-54.238412490832665	GATA3
regulation of ureter smooth muscle cell differentiation	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	13.01547115755387	-54.27210709695883	NEUROG1;FGFR2
regulation of atrial cardiac muscle cell membrane repolarization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.26429488251671	-54.3684319176807	CACNA1D
negative regulation of smooth muscle cell differentiation	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	35.13793508652319	-54.37178273167689	FGFR2
positive regulation of salicylic acid mediated signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.287417995009974	-54.4073965803796	GATA3
neural plate axis specification	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	13.077749225345455	-54.531795119317884	FZD5;PTCH1
anterograde dendritic transport of neurotransmitter receptor complex	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.368651851244444	-54.54428342071429	DLG1
regulation of interleukin-15 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.38906419343938	-54.578680175422456	GATA3
cyclic purine nucleotide metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	35.30475560697799	-54.629917681013524	PPAT
cellular response to oscillatory fluid shear stress	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	35.35599226522441	-54.70920032648519	MEF2C
peptidyl-tyrosine sulfation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.492753699555614	-54.75340693992749	CHST5
positive regulation of semaphorin-plexin signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.512658849097605	-54.7869490263616	GATA3
negative regulation of intracellular transport	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.63071386376754	-54.98588305083027	YRDC
SHREC complex localization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.78733335090987	-55.24980191081732	DLG1
regulation of interleukin-23 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	32.90638793741518	-55.45042030971527	GATA3
establishment of epithelial cell planar polarity	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.06977259834808	-55.72573913650721	PARD3
multi-organism membrane invagination	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.086230235391476	-55.753471833669124	FCHO2
P-TEFb-cap methyltransferase complex localization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.12078969097636	-55.811707831539856	DLG1
positive regulation of anti-Mullerian hormone signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.151348606618036	-55.863202535843556	GATA3
epithelial cell differentiation involved in mammary gland cord morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.205696444746096	-55.9547838565542	ERBB4
positive regulation of leukocyte cell-cell adhesion	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	36.18223258623682	-55.987709126379585	CITED2
type B pancreatic cell maturation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.39280648750852	-56.270082227650974	NKX6-1
L-methionine salvage from S-adenosylmethionine	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.64283459632122	-56.69140357562984	AHCYL2
postsynaptic neurotransmitter receptor diffusion trapping	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.64662167276749	-56.697785162727456	DLG1
proteasome localization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.74278180204035	-56.859824204975354	DLG1
eye photoreceptor cell differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.885135941318225	-57.099704585368336	STAT3
creatinine catabolic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.91280570743768	-57.146330795577526	STAT5B
regulation of interleukin-9 biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.94253876042193	-57.19643384208034	GATA3
photosystem II repair	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	33.94723708124861	-57.204350963372555	MSRA
positive regulation of membrane depolarization during cardiac muscle cell action potential	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.037170214630784	-57.35589692020305	ANK3
regulation of type B pancreatic cell development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.045459454263074	-57.36986508415142	RHEB
trigeminal nerve maturation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.10898229977042	-57.47690717243381	NEUROG1
prepulse inhibition	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.19135070526298	-57.61570583710312	GRID2
regulation of leukocyte chemotaxis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.195188808008666	-57.6221734084101	PDGFRA
regulation of synaptic plasticity by receptor localization to synapse	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.2420858399179	-57.701199405903076	DLG1
positive regulation of histone H3-K9 dimethylation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.36323301504191	-57.905344017360804	MYB
epithelial cell differentiation involved in mammary gland bud morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.371874141128714	-57.919905143740706	ERBB4
enteric nervous system development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.39081958633365	-57.951830036304614	PHOX2B
astral microtubule nucleation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.41429185754271	-57.99138306493362	DLG1
regulation of retinoic acid biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.43682059200005	-58.02934614362466	TCF7L2
citrate catabolic process to diacetyl	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.43886491542643	-58.03279102470541	STAT5B
vocal learning	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.6203660688683	-58.33863787924901	NRXN2
cerebral cortex tangential migration	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.62441610351255	-58.34546257613521	LHX6
Golgi to transport vesicle transport	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.80949332332404	-58.65733544555556	CUX1
centromere localization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.81813283910979	-58.67189385842371	DLG1
kidney smooth muscle cell differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	34.91048347322698	-58.82751353589807	MEF2C
vascular endothelial cell response to fluid shear stress	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	38.1890690385907	-59.093050271119886	MEF2C
positive regulation of RNA biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	35.16925432870734	-59.263567250683806	MITF
regulation of hypoxia-induced intrinsic apoptotic signaling pathway	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	35.44061640398398	-59.72083837867344	CYLD
negative regulation of chromatin silencing at rDNA	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	35.64984255587386	-60.07340451519816	ATAD2
forebrain neuron development	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	38.85623534248208	-60.12541091586907	RAPGEF2
nuclear pore localization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	35.725922908540106	-60.20160720765649	DLG1
neuromast hair cell differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	35.79883107766119	-60.32446446654084	CTNNB1
succinate metabolic process	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	39.08159521854475	-60.474128567818305	STAT5B
regulation of synaptic growth at neuromuscular junction	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	35.909115304209486	-60.51030396759047	MEF2C
negative regulation of synapse assembly	2/6	0.0154551187808425229130993017179207527078688144683837890625	0.170331297404752779467429490978247486054897308349609375	0.01300342429100460883706347203769837506115436553955078125	0.11275211834681753142461957395425997674465179443359375	14.537491054454383	-60.61864852049737	ROBO2;MEF2C
neurotransmitter receptor transport to postsynaptic membrane	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	36.0966756211547	-60.826361093879015	DLG1
regulation of cornification	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	36.35027669342959	-61.25370322803796	ZFP36L1
CLRC ubiquitin ligase complex localization to heterochromatin	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	36.456749984109706	-61.43312093657527	DLG1
positive regulation of epithelial cell-cell adhesion involved in epithelium migration	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	39.885439029643635	-61.71798142768755	CITED2
positive regulation of hematopoietic stem cell differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	36.76232716523392	-61.94804780009558	SP7
RITS complex localization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	36.911532488692	-62.19947308305076	DLG1
non-sensory hair organization	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.23257518240178	-62.7404608188493	CTNNB1
vestibular receptor cell differentiation	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.24882104812266	-62.76783666101803	CTNNB1
trigeminal nerve morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.29599801019932	-62.84733436769619	NEUROG1
cellular response to pulsatile fluid shear stress	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	40.71496545986863	-63.00157509143917	MEF2C
valine biosynthetic process	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.495244540818746	-63.18308388505776	STAT5B
embryonic brain development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.50733302073574	-63.20345413333837	FGFR2
SAGA complex localization to transcription regulatory region	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.63326864330244	-63.415667738081936	DLG1
mitochondrial RNA 3'-end processing	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.67551144341607	-63.48685090852941	LIN28A
embryonic organ development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	37.7072986332163	-63.540415372615826	FGFR2
neurotransmitter receptor localization to postsynaptic specialization membrane	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	38.116408842144565	-64.22980531967454	DLG1
mesonephric duct morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	38.21561985345292	-64.39698539081644	GATA3
peptidyl-diphthamide biosynthetic process from peptidyl-histidine	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	41.88193208127406	-64.8073173878472	DPH1
cellular response to fluid shear stress	1/7	0.2128045216901610359183649734404752962291240692138671875	0.73858861214153648244717942361603491008281707763671875	0.1670171683841734644460075287497602403163909912109375	0.4884190844811817644455231857136823236942291259765625	42.30253397552109	-65.458148882476	MEF2C
photoreceptor cell morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	39.47853856927828	-66.52512457591057	MEF2C
neural crest cell differentiation involved in parathyroid gland development	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	40.325483464872434	-67.95230797048988	MEF2C
neurotransmitter transport	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	41.42710502313012	-69.80864597221193	GABRA2
notochord morphogenesis	1/6	0.1854266435453734429561478691539377905428409576416015625	0.73858861214153648244717942361603491008281707763671875	0.1477654503728911550286539977605571039021015167236328125	0.482693649175157613040454407382640056312084197998046875	41.88826827142493	-70.58575028393328	FGFR2
